data_2k5t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k5t _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 92.7 mttt . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.823 0.344 . . . . 0.90000000000000002 110.338 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.58 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 47.3 tp -76.0 115.94 16.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.867 -0.606 . . . . 0.90000000000000002 109.805 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.0 m -82.67 101.23 10.7 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.016 0.436 . . . . 0.90000000000000002 110.662 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.495 HD11 ' HB3' ' A' ' 40' ' ' TYR . 8.4 tp -90.18 113.38 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 121.749 0.785 . . . . 0.90000000000000002 110.102 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.7 mt -106.57 153.34 7.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.657 -0.701 . . . . 0.90000000000000002 109.516 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 -100.86 126.55 47.47 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.993 -0.743 . . . . 0.90000000000000002 108.993 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.5 mt -80.9 91.51 6.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.339 0.59 . . . . 0.90000000000000002 110.875 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -93.13 -23.95 18.43 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.224 -0.898 . . . . 0.90000000000000002 109.662 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -140.06 139.53 35.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.08 -0.963 . . . . 0.90000000000000002 109.599 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -115.38 116.0 27.53 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.254 -0.43 . . . . 0.90000000000000002 110.519 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.4 p -84.89 171.12 12.45 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.728 -0.842 . . . . 0.90000000000000002 108.728 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 17' ' ' ILE . 30.7 m-20 -74.24 -21.35 59.82 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.555 -0.535 . . . . 0.90000000000000002 109.555 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -69.78 -49.26 54.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.461 -0.791 . . . . 0.90000000000000002 109.418 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.455 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 62.8 m-20 -61.31 -38.8 88.15 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 109.366 -0.605 . . . . 0.90000000000000002 109.366 175.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.616 ' HG2' HE21 ' A' ' 20' ' ' GLN . 46.6 ttm-85 -53.8 -47.05 71.2 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.5 -0.773 . . . . 0.90000000000000002 111.059 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 13' ' ' ASP . 77.8 mt -66.59 -48.31 80.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.90000000000000002 111.459 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.492 ' HB3' HD12 ' A' ' 48' ' ' LEU . 1.2 m-20 -65.43 -32.26 73.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.661 -0.245 . . . . 0.90000000000000002 111.342 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 78.1 mt -64.89 -42.48 94.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.90000000000000002 110.526 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.616 HE21 ' HG2' ' A' ' 16' ' ' ARG . 73.6 mt-30 -69.04 -20.65 64.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.366 0.603 . . . . 0.90000000000000002 110.346 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -76.99 -26.53 53.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.642 -0.708 . . . . 0.90000000000000002 109.557 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.6 mt -82.57 -37.43 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.542 -0.754 . . . . 0.90000000000000002 110.46 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -117.86 85.89 23.67 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.90000000000000002 110.369 177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 C--N 1.346 0.42 0 C-N-CA 122.642 2.228 . . . . 0.90000000000000002 113.102 -175.527 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 CA--C 1.52 -0.177 0 N-CA-C 108.953 -0.758 . . . . 0.90000000000000002 108.953 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -134.03 111.34 10.3 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.299 -0.864 . . . . 0.90000000000000002 110.309 -169.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -103.61 159.12 4.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.066 -0.516 . . . . 0.90000000000000002 111.16 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -130.73 -166.4 1.68 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.866 -1.161 . . . . 0.90000000000000002 107.866 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -79.14 -11.59 59.98 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.93 -0.708 . . . . 0.90000000000000002 110.767 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -96.24 -59.83 1.75 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.068 -0.515 . . . . 0.90000000000000002 110.117 174.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -74.31 97.47 3.02 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.527 -0.545 . . . . 0.90000000000000002 109.527 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 38' ' ' ARG . 22.7 mtp180 -115.81 115.43 26.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.235 0.54 . . . . 0.90000000000000002 110.488 -173.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.2 mt -98.59 118.85 45.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.734 -0.666 . . . . 0.90000000000000002 109.661 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.495 ' HB3' HD11 ' A' ' 5' ' ' ILE . 96.7 m-85 -106.28 142.74 35.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.944 -0.571 . . . . 0.90000000000000002 110.343 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.429 ' HB1' HD23 ' A' ' 48' ' ' LEU . . . -123.55 117.69 25.66 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.775 -0.648 . . . . 0.90000000000000002 110.38 -175.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.484 ' HB2' HD22 ' A' ' 3' ' ' LEU . . . -91.71 99.78 12.61 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.03 0.443 . . . . 0.90000000000000002 109.869 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.66 ' HG2' HD21 ' A' ' 48' ' ' LEU . 4.1 mtm180 -104.21 111.02 23.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.922 -0.581 . . . . 0.90000000000000002 110.413 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -97.46 107.82 20.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.407 -0.815 . . . . 0.90000000000000002 108.931 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.0 t30 60.53 65.32 1.07 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.421 -0.809 . . . . 0.90000000000000002 110.012 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 72.58 -29.85 0.2 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.967 -1.015 . . . . 0.90000000000000002 113.655 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -101.56 145.56 28.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.981 0.42 . . . . 0.90000000000000002 111.821 -170.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.66 HD21 ' HG2' ' A' ' 43' ' ' ARG . 54.7 mt -65.22 117.84 8.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.904 -0.589 . . . . 0.90000000000000002 110.962 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.9 tp -106.95 -27.14 10.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.075 -0.511 . . . . 0.90000000000000002 109.912 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.47 ' HB2' ' HB3' ' A' ' 42' ' ' ALA . . . -152.76 149.22 28.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.90000000000000002 110.547 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -138.35 135.51 35.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.399 -0.364 . . . . 0.90000000000000002 110.358 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.457 ' HB ' HD13 ' A' ' 66' ' ' LEU . 8.8 p -140.62 140.98 33.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.919 0.39 . . . . 0.90000000000000002 110.781 -177.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -114.51 123.5 49.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.858 -0.423 . . . . 0.90000000000000002 109.858 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.501 ' HB ' HD21 ' A' ' 63' ' ' LEU . 6.7 p -125.2 124.37 67.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.317 0.579 . . . . 0.90000000000000002 110.414 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.9 m -97.89 99.47 10.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.834 -0.621 . . . . 0.90000000000000002 110.059 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.486 HD22 ' HA2' ' A' ' 61' ' ' GLY . 96.9 mt -85.86 70.44 10.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.602 -0.726 . . . . 0.90000000000000002 109.938 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 m -67.31 99.06 0.67 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.873 -0.603 . . . . 0.90000000000000002 110.005 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.18 -116.43 5.24 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.532 -0.842 . . . . 0.90000000000000002 111.373 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.7 m -114.13 14.71 18.29 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.872 0.844 . . . . 0.90000000000000002 109.386 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -101.31 134.57 44.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.133 -0.94 . . . . 0.90000000000000002 109.853 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.486 ' HA2' HD22 ' A' ' 56' ' ' LEU . . . -106.09 106.01 2.51 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.395 -0.907 . . . . 0.90000000000000002 112.657 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.57 108.45 20.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.929 0.395 . . . . 0.90000000000000002 110.748 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.515 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 56.6 mt -93.94 119.93 33.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.491 -0.559 . . . . 0.90000000000000002 109.491 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -99.25 -75.32 0.57 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.211 -0.449 . . . . 0.90000000000000002 111.927 -174.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 p -121.92 141.92 50.8 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.256 0.551 . . . . 0.90000000000000002 112.191 -173.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.457 HD13 ' HB ' ' A' ' 52' ' ' VAL . 33.9 tp -140.85 119.99 12.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.164 -0.926 . . . . 0.90000000000000002 109.858 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -128.41 114.75 17.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.793 0.33 . . . . 0.90000000000000002 111.191 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.441 HG12 ' HB ' ' A' ' 72' ' ' THR . 11.2 t -95.33 151.73 3.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.59 -1.263 . . . . 0.90000000000000002 107.59 167.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -54.06 140.28 32.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.409 -0.219 . . . . 0.90000000000000002 110.409 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.4 mp0 -52.19 -38.25 57.25 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.251 0.62 . . . . 0.90000000000000002 112.426 -172.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.38 -22.97 27.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.186 0.517 . . . . 0.90000000000000002 111.201 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.441 ' HB ' HG12 ' A' ' 68' ' ' VAL . 6.9 m -90.86 64.02 5.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.285 0.564 . . . . 0.90000000000000002 109.953 -177.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 12.6 ttp180 -94.75 12.65 27.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.774 -0.648 . . . . 0.90000000000000002 111.198 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 74' ' ' ARG . 36.6 ttp180 173.85 90.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.867 -0.606 . . . . 0.90000000000000002 109.715 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -156.46 17.57 0.33 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.116 0.484 . . . . 0.90000000000000002 110.243 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.28 -34.46 1.76 Allowed Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.077 -0.583 . . . . 0.90000000000000002 113.379 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.469 HG11 HD21 ' A' ' 3' ' ' LEU . 59.5 t -39.74 -52.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.079 0.951 . . . . 0.90000000000000002 113.309 -176.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.92 -55.12 31.87 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.118 -0.563 . . . . 0.90000000000000002 113.266 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.462 ' HB3' HD12 ' A' ' 115' ' ' LEU . 24.9 mt-30 -67.83 -39.65 83.86 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.793 -0.239 . . . . 0.90000000000000002 110.614 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.58 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 47.2 t80 -53.72 -47.78 70.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.927 -0.579 . . . . 0.90000000000000002 110.159 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 85' ' ' VAL . 43.0 tp -62.19 -50.96 69.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.827 -0.624 . . . . 0.90000000000000002 111.249 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.43 HD23 HD23 ' A' ' 66' ' ' LEU . 4.4 mm? -59.65 -46.58 88.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.495 -0.32 . . . . 0.90000000000000002 111.154 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 48.0 mt-10 -61.37 -44.73 96.67 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.046 -0.261 . . . . 0.90000000000000002 110.359 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -56.55 -43.75 80.24 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.329 -0.396 . . . . 0.90000000000000002 110.906 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 81' ' ' LEU . 96.9 t -61.06 -46.77 96.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.352 . . . . 0.90000000000000002 110.609 178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -72.29 -18.44 61.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.395 -0.366 . . . . 0.90000000000000002 111.915 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 23.1 mtm180 -88.73 -22.1 23.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.537 0.208 . . . . 0.90000000000000002 111.329 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -103.08 -7.35 21.41 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.997 -0.281 . . . . 0.90000000000000002 111.638 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -118.37 85.61 25.94 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.90000000000000002 110.187 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.49 162.99 12.75 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.18 2.587 . . . . 0.90000000000000002 111.44 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.83 -45.87 3.25 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.628 -0.796 . . . . 0.90000000000000002 111.782 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.86 99.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.467 -0.568 . . . . 0.90000000000000002 109.467 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 16.5 m -92.55 -25.48 18.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.179 -0.464 . . . . 0.90000000000000002 111.154 -175.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.6 t -102.35 98.75 8.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.84 0.352 . . . . 0.90000000000000002 110.728 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -97.2 113.19 24.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.086 -0.506 . . . . 0.90000000000000002 109.948 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -112.7 123.03 49.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.946 -0.57 . . . . 0.90000000000000002 110.014 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.726 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 63.3 mtp -111.4 123.43 50.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.317 -0.401 . . . . 0.90000000000000002 110.375 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.16 153.72 27.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.937 -0.574 . . . . 0.90000000000000002 110.739 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -84.58 -26.55 27.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.249 -0.432 . . . . 0.90000000000000002 110.242 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 59.09 14.38 3.44 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.887 0.699 . . . . 0.90000000000000002 112.887 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.18 20.88 78.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.905 -0.664 . . . . 0.90000000000000002 112.392 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.8 t -67.92 134.31 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.583 0.23 . . . . 0.90000000000000002 110.49 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.442 ' C ' ' H ' ' A' ' 105' ' ' ARG . 5.5 mm-40 -93.28 -17.2 23.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.044 0.449 . . . . 0.90000000000000002 111.072 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -83.88 19.53 1.7 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.22 -0.659 . . . . 0.90000000000000002 109.22 171.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 103' ' ' GLU . 6.9 ttp180 -64.77 -26.96 68.58 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.199 -0.91 . . . . 0.90000000000000002 111.106 -176.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.0 -48.18 87.35 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.384 -0.912 . . . . 0.90000000000000002 111.207 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 80.2 t -65.8 -42.47 92.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.994 0.425 . . . . 0.90000000000000002 110.362 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.634 ' O ' ' HG2' ' A' ' 112' ' ' MET . 96.1 mmm -59.2 -48.41 81.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.90000000000000002 111.242 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.1 m -63.43 -35.54 80.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.365 0.126 . . . . 0.90000000000000002 111.14 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.86 99.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.391 0.615 . . . . 0.90000000000000002 109.937 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -62.12 -44.35 96.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.08 -0.964 . . . . 0.90000000000000002 110.453 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.634 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.1 mmt -62.44 -48.08 81.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.81 -0.632 . . . . 0.90000000000000002 111.616 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -64.93 -38.7 91.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.283 -0.417 . . . . 0.90000000000000002 111.244 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.83 -21.9 56.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.347 -0.388 . . . . 0.90000000000000002 111.424 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.537 HD22 ' HE2' ' A' ' 117' ' ' PHE . 40.9 tp -87.56 -45.69 10.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.466 -0.334 . . . . 0.90000000000000002 110.527 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 138.04 44.52 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.497 -0.859 . . . . 0.90000000000000002 113.231 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.554 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 87.3 m-85 -120.7 153.74 36.52 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.12 -0.326 . . . . 0.90000000000000002 110.12 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.0 m -120.05 146.79 45.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.107 -0.497 . . . . 0.90000000000000002 110.126 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.1 m -97.12 121.79 39.41 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.557 -0.534 . . . . 0.90000000000000002 109.557 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -136.08 103.8 5.47 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.509 0.559 . . . . 0.90000000000000002 112.509 -175.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 58.0 36.19 25.9 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.108 -0.951 . . . . 0.90000000000000002 113.28 165.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.83 49.16 0.55 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.225 -0.988 . . . . 0.90000000000000002 113.366 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.39 179.36 19.96 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.627 -0.797 . . . . 0.90000000000000002 111.87 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.726 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 6.9 m-90 -102.95 137.83 40.63 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.783 -0.451 . . . . 0.90000000000000002 109.783 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -125.56 137.37 53.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.758 0.314 . . . . 0.90000000000000002 110.445 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -137.21 91.7 2.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.133 0.492 . . . . 0.90000000000000002 109.999 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 93' ' ' SER . 52.4 t -91.21 112.36 24.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.087 -0.506 . . . . 0.90000000000000002 110.228 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 CA-C-N 115.77 -0.65 . . . . 0.90000000000000002 111.865 179.96 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 121.184 0.516 . . . . 0.90000000000000002 109.956 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.1 tp -76.13 114.63 15.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.574 -0.739 . . . . 0.90000000000000002 109.877 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.9 m -82.8 89.79 6.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.953 0.406 . . . . 0.90000000000000002 110.655 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.484 HD13 ' HB3' ' A' ' 40' ' ' TYR . 5.2 tp -95.75 111.04 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.726 -0.67 . . . . 0.90000000000000002 109.994 175.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.3 pt -130.51 171.01 18.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.654 -0.703 . . . . 0.90000000000000002 109.836 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -92.79 137.2 32.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.792 -0.447 . . . . 0.90000000000000002 109.792 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.434 ' O ' HG22 ' A' ' 33' ' ' VAL . 53.9 tp -78.99 70.55 5.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.245 0.545 . . . . 0.90000000000000002 109.689 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -69.49 -43.8 72.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.444 -0.798 . . . . 0.90000000000000002 111.443 -174.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -111.44 132.07 54.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.082 -0.508 . . . . 0.90000000000000002 109.967 -175.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.557 ' CE1' ' HB3' ' A' ' 31' ' ' LEU . 72.3 m-85 -99.46 114.88 28.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.052 -0.522 . . . . 0.90000000000000002 111.245 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.8 p -102.46 163.92 11.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.756 -0.831 . . . . 0.90000000000000002 108.756 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.577 ' O ' HG13 ' A' ' 17' ' ' ILE . 34.1 t70 -66.12 -29.84 70.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.567 -0.531 . . . . 0.90000000000000002 109.567 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -66.99 -50.19 63.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.541 -0.754 . . . . 0.90000000000000002 111.008 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.43 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 32.9 m-20 -61.74 -35.04 76.92 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.90000000000000002 110.622 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.405 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 35.6 ttm180 -61.47 -38.01 85.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.90000000000000002 110.526 176.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 13' ' ' ASP . 72.9 mt -60.48 -42.49 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.193 0.52 . . . . 0.90000000000000002 110.331 176.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.406 ' HB3' HD13 ' A' ' 48' ' ' LEU . 80.5 m-20 -68.73 -33.54 74.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.90000000000000002 110.666 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 96.4 mt -65.0 -34.44 78.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.293 -0.412 . . . . 0.90000000000000002 110.372 175.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 25.4 mt-30 -69.71 -24.71 63.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.183 -0.462 . . . . 0.90000000000000002 110.733 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.4 ' HZ2' HG21 ' A' ' 17' ' ' ILE . 62.3 mttp -66.52 -44.36 82.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.231 0.539 . . . . 0.90000000000000002 109.867 172.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.2 mt -75.45 -45.59 39.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.508 -0.769 . . . . 0.90000000000000002 111.33 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -123.89 74.48 56.4 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.554 -0.294 . . . . 0.90000000000000002 111.668 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 C--N 1.344 0.3 0 C-N-CA 121.922 1.748 . . . . 0.90000000000000002 111.341 175.072 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.557 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 51.4 mt . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 121.198 0.523 . . . . 0.90000000000000002 111.505 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -129.96 139.97 51.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.763 -0.653 . . . . 0.90000000000000002 110.353 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 13.7 m -125.72 154.19 34.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.90000000000000002 111.386 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.487 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 22.9 t70 74.4 -30.11 0.2 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.98 -1.009 . . . . 0.90000000000000002 111.53 175.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 33' ' ' VAL . 4.4 t70 -81.71 68.94 8.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.908 -0.775 . . . . 0.90000000000000002 108.908 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 35' ' ' ASP . 19.7 m120 83.22 -40.02 0.09 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 113.852 -1.522 . . . . 0.90000000000000002 110.207 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.529 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 90.2 m-70 -101.59 110.4 22.39 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.012 -0.54 . . . . 0.90000000000000002 109.641 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.487 ' HG2' ' HA ' ' A' ' 34' ' ' ASP . 69.8 mtt180 -109.2 117.19 33.47 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.097 0.475 . . . . 0.90000000000000002 110.651 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.577 HG12 ' HG2' ' A' ' 53' ' ' ARG . 53.8 mt -98.67 110.71 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.395 -0.82 . . . . 0.90000000000000002 110.115 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.484 ' HB3' HD13 ' A' ' 5' ' ' ILE . 73.3 m-85 -97.61 141.16 30.99 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.1 -0.704 . . . . 0.90000000000000002 109.1 175.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.464 ' HB1' HD23 ' A' ' 48' ' ' LEU . . . -124.62 113.74 18.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.969 0.414 . . . . 0.90000000000000002 111.089 -170.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . . . -92.13 101.5 14.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.681 -0.69 . . . . 0.90000000000000002 109.528 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.493 ' HB3' HD22 ' A' ' 48' ' ' LEU . 28.5 ptt180 -102.51 118.84 37.74 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.546 0.689 . . . . 0.90000000000000002 110.858 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -97.44 133.41 42.07 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.498 -0.927 . . . . 0.90000000000000002 108.498 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.5 t30 64.61 23.35 12.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.003 0.906 . . . . 0.90000000000000002 108.607 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 66.47 20.74 10.88 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 114.268 -1.333 . . . . 0.90000000000000002 112.419 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -126.88 142.73 51.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.244 -0.651 . . . . 0.90000000000000002 109.244 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.493 HD22 ' HB3' ' A' ' 43' ' ' ARG . 55.5 mt -54.49 130.39 39.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.182 0.515 . . . . 0.90000000000000002 112.14 -172.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 34.4 tp -125.6 -40.65 2.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.652 -0.703 . . . . 0.90000000000000002 110.205 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -133.12 143.99 49.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.016 -0.538 . . . . 0.90000000000000002 110.325 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -135.07 132.28 37.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.346 -0.388 . . . . 0.90000000000000002 110.387 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.59 132.46 62.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.081 0.467 . . . . 0.90000000000000002 110.927 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.577 ' HG2' HG12 ' A' ' 39' ' ' ILE . 27.8 mtm180 -111.11 121.65 45.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.201 -0.454 . . . . 0.90000000000000002 109.985 176.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.66 119.55 59.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.411 0.624 . . . . 0.90000000000000002 109.71 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 89.9 m -95.56 95.53 8.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.666 -0.697 . . . . 0.90000000000000002 110.571 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.565 ' HA ' ' HA3' ' A' ' 61' ' ' GLY . 89.2 mt -80.38 124.27 28.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.717 -0.674 . . . . 0.90000000000000002 110.119 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.7 t -98.59 50.15 0.98 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.955 -0.757 . . . . 0.90000000000000002 108.955 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.71 -104.83 2.45 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.353 -0.84 . . . . 0.90000000000000002 111.549 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.5 p -94.49 -29.53 14.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.381 0.61 . . . . 0.90000000000000002 110.648 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.798 ' HB3' ' HB3' ' A' ' 94' ' ' CYS . 36.0 mt-10 -119.19 151.33 38.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.564 -0.744 . . . . 0.90000000000000002 109.008 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 56' ' ' LEU . . . -151.7 -179.84 27.7 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 119.461 -1.352 . . . . 0.90000000000000002 113.894 -173.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.63 135.33 48.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.222 -0.489 . . . . 0.90000000000000002 110.205 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.466 HD21 ' HE3' ' A' ' 97' ' ' MET . 7.8 tt -93.77 112.84 24.77 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.742 -0.836 . . . . 0.90000000000000002 108.742 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -97.24 -56.89 2.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.721 0.637 . . . . 0.90000000000000002 112.721 -168.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.1 m -107.81 106.22 16.41 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.024 0.44 . . . . 0.90000000000000002 111.553 -173.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.3 tp -124.58 109.07 12.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.739 -0.664 . . . . 0.90000000000000002 109.785 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -138.94 136.84 35.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.233 0.54 . . . . 0.90000000000000002 111.246 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' A' ' 50' ' ' ALA . 14.5 t -110.8 152.0 12.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.479 -0.934 . . . . 0.90000000000000002 108.479 174.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -57.79 150.56 19.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.746 0.308 . . . . 0.90000000000000002 110.18 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -51.7 -38.43 55.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.786 0.662 . . . . 0.90000000000000002 112.786 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.51 -20.85 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.999 0.428 . . . . 0.90000000000000002 111.931 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.435 ' HB ' ' CG1' ' A' ' 68' ' ' VAL . 2.0 m -113.09 24.92 11.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.157 0.503 . . . . 0.90000000000000002 111.255 -175.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 16.5 mtp180 -78.25 38.84 0.3 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.29 0.478 . . . . 0.90000000000000002 112.29 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 8.3 ttm180 174.37 19.95 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.276 0.23 . . . . 0.90000000000000002 111.057 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -141.04 75.28 1.49 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.544 0.942 . . . . 0.90000000000000002 113.544 -167.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.74 -61.45 4.27 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 115.703 1.041 . . . . 0.90000000000000002 115.703 161.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -43.42 -51.97 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.643 0.979 . . . . 0.90000000000000002 113.643 -168.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.09 -41.18 77.14 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.957 -0.639 . . . . 0.90000000000000002 113.595 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -68.64 -53.07 24.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.919 0.39 . . . . 0.90000000000000002 110.623 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -58.21 -40.87 82.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.75 -0.659 . . . . 0.90000000000000002 110.421 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.525 ' O ' HG22 ' A' ' 85' ' ' VAL . 26.9 tp -56.3 -55.07 37.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.506 -0.77 . . . . 0.90000000000000002 111.384 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.449 ' HB2' HD13 ' A' ' 115' ' ' LEU . 55.6 mt -62.34 -41.74 98.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.453 -0.339 . . . . 0.90000000000000002 111.376 -176.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -62.94 -37.87 88.75 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.752 -0.379 . . . . 0.90000000000000002 110.782 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.84 -39.1 80.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.387 -0.369 . . . . 0.90000000000000002 110.43 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 81' ' ' LEU . 72.5 t -58.49 -45.94 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.815 0.34 . . . . 0.90000000000000002 111.039 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.41 HD11 ' O ' ' A' ' 82' ' ' LEU . 11.1 mp -68.22 -23.75 64.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.122 0.487 . . . . 0.90000000000000002 110.744 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.6 mtp85 -76.73 -33.06 58.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.572 . . . . 0.90000000000000002 110.852 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -71.01 -49.69 42.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.90000000000000002 110.869 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -118.27 86.21 26.76 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.763 0.316 . . . . 0.90000000000000002 111.377 -178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.75 170.61 11.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.966 2.444 . . . . 0.90000000000000002 111.481 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.06 -14.85 62.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.596 -0.812 . . . . 0.90000000000000002 112.216 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 60' ' ' GLU . 53.3 t -78.24 118.53 25.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.065 -0.346 . . . . 0.90000000000000002 110.065 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 128' ' ' GLY . 2.4 p -84.46 -40.23 17.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.434 -0.348 . . . . 0.90000000000000002 111.572 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.798 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 45.1 t -101.93 100.14 10.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.904 0.383 . . . . 0.90000000000000002 110.866 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -97.3 97.66 9.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.094 -0.706 . . . . 0.90000000000000002 109.094 170.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -96.8 128.27 43.58 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.597 -0.52 . . . . 0.90000000000000002 109.597 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.812 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 96.0 mmm -107.16 109.5 21.34 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.907 -0.775 . . . . 0.90000000000000002 108.907 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.12 149.66 42.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.983 -0.553 . . . . 0.90000000000000002 111.667 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -75.6 -43.51 47.77 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.213 -0.662 . . . . 0.90000000000000002 109.213 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 61.07 8.74 2.07 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.07 -0.968 . . . . 0.90000000000000002 112.773 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.87 17.78 66.93 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.605 -0.807 . . . . 0.90000000000000002 111.882 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 82.8 t -67.69 111.9 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 121.217 0.532 . . . . 0.90000000000000002 110.064 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -79.79 1.26 27.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.821 -0.627 . . . . 0.90000000000000002 110.744 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -101.1 21.31 14.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.683 -0.69 . . . . 0.90000000000000002 109.442 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -58.9 -27.25 65.05 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.975 -0.557 . . . . 0.90000000000000002 111.902 -175.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.36 -53.03 45.11 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.719 -0.753 . . . . 0.90000000000000002 111.568 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 43.7 t -62.97 -37.36 79.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.169 0.509 . . . . 0.90000000000000002 110.047 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.585 ' O ' ' HG2' ' A' ' 112' ' ' MET . 96.9 mmm -65.13 -36.18 83.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.717 -0.674 . . . . 0.90000000000000002 111.232 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 93.3 m -63.9 -45.04 91.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.712 0.291 . . . . 0.90000000000000002 110.693 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.28 94.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.182 0.515 . . . . 0.90000000000000002 110.209 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -61.92 -48.22 81.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.433 -0.803 . . . . 0.90000000000000002 111.227 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.585 ' HG2' ' O ' ' A' ' 108' ' ' MET . 26.3 mmt -57.59 -48.87 78.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 0.90000000000000002 111.114 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -72.14 -21.87 61.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.989 -0.55 . . . . 0.90000000000000002 111.541 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.56 -34.96 35.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.991 0.424 . . . . 0.90000000000000002 110.545 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.449 HD13 ' HB2' ' A' ' 82' ' ' LEU . 7.4 tt -75.42 -56.37 4.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.929 -0.578 . . . . 0.90000000000000002 110.002 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 149.19 33.35 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.462 -0.875 . . . . 0.90000000000000002 112.993 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.514 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 89.0 m-85 -107.9 167.62 9.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.911 -0.403 . . . . 0.90000000000000002 109.911 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 31.9 m -117.23 137.64 52.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.848 -0.427 . . . . 0.90000000000000002 109.848 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.435 HG22 ' CD1' ' A' ' 124' ' ' TRP . 15.8 m -97.65 132.65 43.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.939 0.399 . . . . 0.90000000000000002 110.59 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.541 ' NE2' ' HB3' ' A' ' 125' ' ' GLU . 48.4 mt-30 -126.65 -171.62 2.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.961 -0.563 . . . . 0.90000000000000002 109.6 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -85.48 109.02 18.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.88 0.372 . . . . 0.90000000000000002 110.474 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.8 7.09 32.01 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.901 -0.666 . . . . 0.90000000000000002 112.429 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.86 -175.38 27.21 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.751 -0.738 . . . . 0.90000000000000002 112.51 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.812 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 9.7 m-90 -107.55 160.76 15.43 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.095 -0.706 . . . . 0.90000000000000002 109.095 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.541 ' HB3' ' NE2' ' A' ' 120' ' ' GLN . 55.7 tt0 -157.76 150.85 23.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.058 0.456 . . . . 0.90000000000000002 110.791 176.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -133.49 117.3 17.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.71 -0.677 . . . . 0.90000000000000002 109.537 174.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 33.7 t -85.0 108.91 17.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.95 0.405 . . . . 0.90000000000000002 110.016 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 93' ' ' SER . . . . . . . . 0 N--CA 1.449 -0.457 0 CA-C-N 115.888 -0.596 . . . . 0.90000000000000002 112.285 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.8 tttm . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 121.112 0.482 . . . . 0.90000000000000002 109.965 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.537 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 36.5 tp -75.88 137.51 40.47 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.725 -0.843 . . . . 0.90000000000000002 108.725 175.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 m -111.16 109.35 19.37 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.607 -0.437 . . . . 0.90000000000000002 110.801 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.491 HG22 ' OE1' ' A' ' 84' ' ' GLU . 11.2 tp -89.81 113.17 25.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.541 0.686 . . . . 0.90000000000000002 109.822 176.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.99 149.9 16.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.185 0.517 . . . . 0.90000000000000002 110.489 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -74.77 112.57 11.12 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.942 -1.026 . . . . 0.90000000000000002 109.441 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.1 tp -67.77 101.93 1.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.689 -0.485 . . . . 0.90000000000000002 109.689 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -98.77 -49.79 4.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.652 -0.704 . . . . 0.90000000000000002 110.987 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -127.01 149.05 50.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.053 -0.521 . . . . 0.90000000000000002 110.997 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -107.81 136.52 47.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.872 -0.603 . . . . 0.90000000000000002 110.66 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.661 ' HB2' ' OD1' ' A' ' 15' ' ' ASP . 8.3 m -115.9 162.39 17.41 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.234 -1.025 . . . . 0.90000000000000002 108.234 170.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -63.02 -42.82 99.9 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.091 0.404 . . . . 0.90000000000000002 112.091 -171.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -64.92 -52.24 57.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.608 0.242 . . . . 0.90000000000000002 111.178 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.661 ' OD1' ' HB2' ' A' ' 12' ' ' SER . 0.5 OUTLIER -72.04 -19.05 61.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.564 -0.289 . . . . 0.90000000000000002 111.543 -179.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -64.25 -44.64 91.16 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.596 -0.52 . . . . 0.90000000000000002 109.596 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.5 mt -68.38 -33.79 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.731 -0.668 . . . . 0.90000000000000002 110.259 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -63.41 -39.41 94.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.743 -0.662 . . . . 0.90000000000000002 109.961 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.0 mt -64.56 -36.92 85.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.982 -0.553 . . . . 0.90000000000000002 110.807 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -73.28 -13.3 61.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.026 -0.534 . . . . 0.90000000000000002 111.009 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -89.14 -24.34 22.23 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.363 -0.606 . . . . 0.90000000000000002 109.363 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.3 mt -77.75 -49.36 22.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.644 -0.707 . . . . 0.90000000000000002 109.728 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -104.92 91.64 4.52 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.003 -0.74 . . . . 0.90000000000000002 109.003 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo . . . . . 0 C--N 1.344 0.297 0 C-N-CA 122.875 2.383 . . . . 0.90000000000000002 113.432 -170.067 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.5 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 121.113 0.482 . . . . 0.90000000000000002 110.062 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -88.25 117.56 27.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.598 -0.728 . . . . 0.90000000000000002 109.962 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.4 m -122.73 137.18 57.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.978 -0.556 . . . . 0.90000000000000002 111.171 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.869 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 11.7 t70 72.15 8.33 5.87 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.629 -0.714 . . . . 0.90000000000000002 111.748 170.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.5 ' C ' ' H ' ' A' ' 37' ' ' HIS . 7.8 m-20 -120.27 77.54 1.27 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.765 -0.457 . . . . 0.90000000000000002 109.765 175.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 35' ' ' ASP . 13.5 m120 75.85 -34.99 0.25 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.044 -0.98 . . . . 0.90000000000000002 110.148 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.5 ' H ' ' C ' ' A' ' 35' ' ' ASP . 86.1 m-70 -112.76 112.45 23.95 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.139 -1.06 . . . . 0.90000000000000002 108.139 173.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.869 ' HG2' ' HA ' ' A' ' 34' ' ' ASP . 79.4 mtt180 -113.84 126.18 54.9 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.016 0.436 . . . . 0.90000000000000002 110.551 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.562 HG12 ' HG2' ' A' ' 53' ' ' ARG . 71.8 mt -100.35 119.81 48.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.821 -0.627 . . . . 0.90000000000000002 109.935 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -102.49 133.0 48.18 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.344 -0.613 . . . . 0.90000000000000002 109.344 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.477 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.57 125.06 51.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.029 -0.532 . . . . 0.90000000000000002 110.802 -175.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 50' ' ' ALA . . . -92.06 98.78 11.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.197 0.522 . . . . 0.90000000000000002 110.159 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 43' ' ' ARG . 15.6 ttm180 -87.61 126.88 35.2 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.399 -0.819 . . . . 0.90000000000000002 110.495 -177.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -124.53 95.47 4.54 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.601 -0.888 . . . . 0.90000000000000002 108.601 175.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.2 m120 60.94 74.26 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.225 -0.898 . . . . 0.90000000000000002 110.981 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 71.42 -43.55 0.57 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.772 -1.103 . . . . 0.90000000000000002 113.181 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -88.76 153.76 20.82 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.758 0.313 . . . . 0.90000000000000002 111.111 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.477 HD22 ' HB1' ' A' ' 41' ' ' ALA . 79.5 mt -90.24 108.09 19.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.016 0.436 . . . . 0.90000000000000002 110.145 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.4 tp -83.38 -31.41 26.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.776 -0.647 . . . . 0.90000000000000002 110.639 -175.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.501 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . . . -144.45 157.13 44.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.084 -0.507 . . . . 0.90000000000000002 110.755 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.29 135.59 22.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.304 -0.407 . . . . 0.90000000000000002 110.115 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 65' ' ' SER . 7.1 p -135.14 138.69 48.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.001 0.429 . . . . 0.90000000000000002 111.141 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.562 ' HG2' HG12 ' A' ' 39' ' ' ILE . 88.4 mtt180 -103.16 131.24 50.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.071 -0.513 . . . . 0.90000000000000002 109.892 176.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.434 ' HB ' HD23 ' A' ' 63' ' ' LEU . 7.1 p -125.24 122.33 62.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.356 0.598 . . . . 0.90000000000000002 110.937 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 62' ' ' ALA . 34.8 m -93.35 110.02 21.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.736 -0.665 . . . . 0.90000000000000002 109.971 175.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.446 HD22 ' HA2' ' A' ' 61' ' ' GLY . 92.3 mt -94.98 98.63 10.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.163 -0.471 . . . . 0.90000000000000002 110.635 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 t -95.71 97.87 10.03 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.785 -0.82 . . . . 0.90000000000000002 108.785 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.76 -107.27 2.06 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.552 -0.832 . . . . 0.90000000000000002 111.404 -174.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.4 p -115.43 12.6 16.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.92 0.391 . . . . 0.90000000000000002 111.187 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.05 138.08 42.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.293 -0.412 . . . . 0.90000000000000002 110.019 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.446 ' HA2' HD22 ' A' ' 56' ' ' LEU . . . -116.03 113.54 2.87 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.701 -0.762 . . . . 0.90000000000000002 112.385 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.51 ' HB2' ' HB ' ' A' ' 55' ' ' THR . . . -96.35 110.96 23.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.963 0.411 . . . . 0.90000000000000002 110.753 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.717 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 53.7 mt -93.85 109.78 21.46 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.073 -0.512 . . . . 0.90000000000000002 109.743 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 65' ' ' SER . 4.9 p-10 -102.85 -75.06 0.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.788 0.328 . . . . 0.90000000000000002 111.818 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 13.6 m -82.18 85.76 6.75 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.892 0.377 . . . . 0.90000000000000002 111.384 -175.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.476 HD22 ' HE3' ' A' ' 97' ' ' MET . 47.0 tp -102.67 100.73 10.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.986 -0.552 . . . . 0.90000000000000002 109.613 173.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -135.12 126.55 28.56 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.258 -0.577 . . . . 0.90000000000000002 111.568 -175.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.489 HG13 ' HB3' ' A' ' 50' ' ' ALA . 12.1 t -111.75 155.48 13.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.07 -1.085 . . . . 0.90000000000000002 108.07 174.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -60.21 137.57 58.09 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.204 -0.295 . . . . 0.90000000000000002 110.204 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -48.2 -41.53 27.47 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.793 0.683 . . . . 0.90000000000000002 112.609 -173.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.5 m -73.09 2.44 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.795 0.665 . . . . 0.90000000000000002 112.795 -174.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 m -98.69 7.76 45.72 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.099 0.476 . . . . 0.90000000000000002 111.014 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 73' ' ' ARG . 30.4 mtm180 -70.34 106.7 3.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.836 0.351 . . . . 0.90000000000000002 110.369 177.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 60.7 ttt180 -157.67 -81.07 0.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.022 -0.536 . . . . 0.90000000000000002 111.471 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 27.4 ttt180 164.86 95.71 0.0 OUTLIER 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 109.272 -0.64 . . . . 0.90000000000000002 109.272 -169.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.02 -79.53 0.2 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.514 -0.85 . . . . 0.90000000000000002 112.506 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.468 HG11 HD21 ' A' ' 3' ' ' LEU . 69.3 t -47.47 -46.56 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 123.194 0.597 . . . . 0.90000000000000002 112.589 -174.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.97 -62.67 6.1 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.06 -0.591 . . . . 0.90000000000000002 113.548 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -68.21 -32.61 72.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.79 0.295 . . . . 0.90000000000000002 111.143 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.537 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 30.3 t80 -59.44 -49.25 78.51 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.97 -0.382 . . . . 0.90000000000000002 109.97 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 85' ' ' VAL . 55.9 tp -52.32 -56.04 17.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.464 -0.789 . . . . 0.90000000000000002 111.104 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 86' ' ' LEU . 4.2 mm? -58.23 -44.46 88.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.908 -0.587 . . . . 0.90000000000000002 111.029 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.708 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 5.4 mt-10 -63.27 -49.34 74.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.799 -0.36 . . . . 0.90000000000000002 111.584 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.491 ' OE1' HG22 ' A' ' 5' ' ' ILE . 35.2 tt0 -63.73 -34.95 79.03 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.778 -0.369 . . . . 0.90000000000000002 111.064 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 81' ' ' LEU . 75.5 t -61.46 -43.9 97.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.868 0.366 . . . . 0.90000000000000002 110.342 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 82' ' ' LEU . 11.0 mp -72.01 -24.16 61.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.01 -0.541 . . . . 0.90000000000000002 111.344 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.708 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 19.2 mmt180 -76.93 -39.02 52.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.055 0.455 . . . . 0.90000000000000002 109.98 176.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -67.73 -34.76 77.49 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.659 -0.701 . . . . 0.90000000000000002 110.793 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -119.59 79.79 22.48 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.997 -0.547 . . . . 0.90000000000000002 110.036 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -86.74 -9.48 6.57 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.544 2.163 . . . . 0.90000000000000002 112.908 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.87 -35.04 55.1 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.189 -0.764 . . . . 0.90000000000000002 111.189 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.4 t -73.47 104.85 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.294 -0.632 . . . . 0.90000000000000002 109.294 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 p -106.01 12.22 30.71 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.059 0.457 . . . . 0.90000000000000002 110.656 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 47.8 t -130.51 99.97 5.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.835 -0.62 . . . . 0.90000000000000002 109.342 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -107.79 120.3 41.87 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.886 -0.597 . . . . 0.90000000000000002 110.442 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.505 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 13.7 t-105 -115.98 120.42 39.08 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.654 -0.703 . . . . 0.90000000000000002 109.191 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.717 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 76.1 mtp -107.15 126.5 52.46 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.099 0.476 . . . . 0.90000000000000002 110.099 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.2 146.53 24.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.608 -0.724 . . . . 0.90000000000000002 110.971 -176.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.68 16.67 10.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.843 -0.617 . . . . 0.90000000000000002 110.282 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.38 106.88 4.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.674 -0.693 . . . . 0.90000000000000002 110.701 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.52 0.81 56.65 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.893 -0.67 . . . . 0.90000000000000002 112.162 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 80.7 t -86.82 107.27 16.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.792 0.329 . . . . 0.90000000000000002 110.381 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.69 -46.04 33.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.072 0.463 . . . . 0.90000000000000002 110.032 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -94.71 81.64 3.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.257 0.551 . . . . 0.90000000000000002 110.459 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.5 mtt85 -71.03 -28.85 64.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.837 -0.62 . . . . 0.90000000000000002 111.411 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.3 -54.62 28.56 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.887 -0.673 . . . . 0.90000000000000002 112.351 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.22 -42.4 93.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.942 0.401 . . . . 0.90000000000000002 110.765 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.581 ' O ' ' HG2' ' A' ' 112' ' ' MET . 97.8 mmm -64.5 -36.52 84.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.937 -0.574 . . . . 0.90000000000000002 111.675 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 85.8 m -64.68 -43.96 91.88 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.98 -0.288 . . . . 0.90000000000000002 110.858 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.58 -36.59 84.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.264 0.554 . . . . 0.90000000000000002 110.376 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -64.74 -44.41 90.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.558 -0.746 . . . . 0.90000000000000002 110.411 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.581 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.5 mmt -62.24 -42.73 99.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.932 -0.577 . . . . 0.90000000000000002 111.009 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -57.15 -40.32 76.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.90000000000000002 110.544 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.41 -29.83 69.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.887 -0.597 . . . . 0.90000000000000002 111.209 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.5 mt -85.0 -7.52 59.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.022 0.439 . . . . 0.90000000000000002 111.228 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.36 21.66 56.13 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.644 -0.788 . . . . 0.90000000000000002 112.144 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 37.5 m-85 -85.6 132.19 34.22 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.072 -0.344 . . . . 0.90000000000000002 110.072 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 65.2 p -95.7 162.19 13.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.172 -0.467 . . . . 0.90000000000000002 109.998 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.2 t -97.21 117.16 30.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.7 0.762 . . . . 0.90000000000000002 109.7 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.94 169.71 10.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.185 -0.916 . . . . 0.90000000000000002 109.24 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -70.8 94.48 1.04 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.045 0.45 . . . . 0.90000000000000002 110.748 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.83 -11.24 5.42 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.98 -0.629 . . . . 0.90000000000000002 112.41 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.25 -146.91 16.02 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.889 -0.672 . . . . 0.90000000000000002 112.312 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.498 ' CE3' ' HE3' ' A' ' 112' ' ' MET . 7.5 m-90 -103.1 133.56 48.0 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.054 -0.35 . . . . 0.90000000000000002 110.054 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -121.04 131.54 54.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.159 -0.473 . . . . 0.90000000000000002 111.183 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -137.03 115.55 11.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.003 -0.544 . . . . 0.90000000000000002 109.91 172.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 22.4 t -112.72 115.98 29.4 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.942 0.401 . . . . 0.90000000000000002 110.182 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.516 0 N-CA-C 111.533 -0.627 . . . . 0.90000000000000002 111.533 -178.876 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.0 tttp . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 121.13 0.49 . . . . 0.90000000000000002 110.388 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 42' ' ' ALA . 38.7 tp -79.52 115.01 18.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.664 -0.698 . . . . 0.90000000000000002 109.688 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -82.86 103.61 12.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.834 0.35 . . . . 0.90000000000000002 110.377 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.508 HD12 ' HB3' ' A' ' 40' ' ' TYR . 11.6 tt -105.7 126.25 61.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.545 0.688 . . . . 0.90000000000000002 111.159 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.5 mt -125.51 160.89 31.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.23 -0.895 . . . . 0.90000000000000002 109.476 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -85.74 141.33 29.79 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.108 -0.701 . . . . 0.90000000000000002 109.108 174.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.1 mt -77.53 103.55 7.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.044 0.449 . . . . 0.90000000000000002 110.626 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -79.39 -45.76 18.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.497 -0.774 . . . . 0.90000000000000002 110.503 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -137.85 166.65 23.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.472 -0.785 . . . . 0.90000000000000002 109.945 -176.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -127.89 111.47 13.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.808 0.337 . . . . 0.90000000000000002 111.089 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.0 m -99.55 -179.97 4.37 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.857 -0.423 . . . . 0.90000000000000002 109.857 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -62.59 -48.92 77.32 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.821 0.344 . . . . 0.90000000000000002 110.872 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -57.77 -39.31 77.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.724 -0.671 . . . . 0.90000000000000002 110.558 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -67.02 -46.2 75.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.868 -0.605 . . . . 0.90000000000000002 110.328 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.9 ttp85 -60.7 -46.6 89.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.424 -0.353 . . . . 0.90000000000000002 110.649 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 80.0 mt -61.57 -46.18 97.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.90000000000000002 110.881 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.96 -38.72 86.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.21 0.529 . . . . 0.90000000000000002 110.395 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.498 HD23 HD13 ' A' ' 22' ' ' ILE . 76.7 mt -68.58 -25.03 64.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 0.90000000000000002 111.264 177.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -79.94 -19.96 46.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.248 0.547 . . . . 0.90000000000000002 109.894 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -74.74 -29.1 61.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.414 -0.587 . . . . 0.90000000000000002 109.414 171.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.498 HD13 HD23 ' A' ' 19' ' ' LEU . 73.0 mt -79.78 -48.73 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.377 -0.829 . . . . 0.90000000000000002 110.302 174.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -115.79 100.55 53.66 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.90000000000000002 109.767 175.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 C--N 1.345 0.387 0 C-N-CA 123.065 2.51 . . . . 0.90000000000000002 112.951 -176.514 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.7 mt . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 121.355 0.598 . . . . 0.90000000000000002 109.443 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -80.57 118.09 21.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.311 -0.859 . . . . 0.90000000000000002 109.712 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.43 118.5 39.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.664 -0.698 . . . . 0.90000000000000002 110.785 -173.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.435 ' OD1' ' HB2' ' A' ' 37' ' ' HIS . 6.3 p-10 -135.24 -164.5 1.54 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 0.90000000000000002 109.856 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -68.57 -29.75 68.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.805 0.336 . . . . 0.90000000000000002 110.972 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -89.86 -63.31 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.076 -0.511 . . . . 0.90000000000000002 110.162 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.435 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 56.3 m80 -78.37 98.74 6.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.234 0.54 . . . . 0.90000000000000002 110.651 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.553 ' HD3' HD11 ' A' ' 56' ' ' LEU . 27.7 mtp-105 -115.68 116.9 28.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.529 -0.76 . . . . 0.90000000000000002 109.449 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.2 mt -98.48 127.14 51.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.781 0.324 . . . . 0.90000000000000002 110.586 -176.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.508 ' HB3' HD12 ' A' ' 5' ' ' ILE . 55.3 m-85 -99.08 140.23 33.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.963 -0.562 . . . . 0.90000000000000002 110.409 176.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.512 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -114.16 113.4 24.63 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.689 -0.687 . . . . 0.90000000000000002 109.543 174.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.562 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . . . -92.05 104.93 17.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.184 -0.462 . . . . 0.90000000000000002 109.809 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 7.7 ptp180 -112.6 136.41 52.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.361 0.6 . . . . 0.90000000000000002 111.756 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.413 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 44.5 t80 -99.88 95.71 7.08 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.549 -0.908 . . . . 0.90000000000000002 108.549 172.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.8 t30 69.59 -76.41 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.55 -0.75 . . . . 0.90000000000000002 110.388 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -151.31 71.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.527 0.679 . . . . 0.90000000000000002 110.028 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 15.9 ptp180 -167.41 122.24 1.03 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.321 -0.854 . . . . 0.90000000000000002 109.029 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 41' ' ' ALA . 59.0 mt -78.11 90.83 4.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.038 -0.356 . . . . 0.90000000000000002 110.038 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.559 ' HA ' ' HD3' ' A' ' 69' ' ' ARG . 62.7 mt -79.05 -39.95 32.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.90000000000000002 111.307 -175.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.562 ' HB1' ' HB3' ' A' ' 42' ' ' ALA . . . -132.9 141.81 48.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.066 -0.515 . . . . 0.90000000000000002 110.698 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.413 ' HB2' HG22 ' A' ' 22' ' ' ILE . . . -135.09 132.78 38.56 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.997 -0.547 . . . . 0.90000000000000002 109.84 177.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.458 HG22 HD23 ' A' ' 63' ' ' LEU . 7.5 p -138.9 135.35 42.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.027 0.442 . . . . 0.90000000000000002 111.224 -176.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.517 ' HG3' ' HB2' ' A' ' 65' ' ' SER . 33.1 mtt-85 -101.5 106.14 17.22 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.395 -0.595 . . . . 0.90000000000000002 109.395 176.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.93 119.45 50.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.273 0.559 . . . . 0.90000000000000002 110.017 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.0 m -92.93 97.42 10.72 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.92 -0.582 . . . . 0.90000000000000002 110.049 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.553 HD11 ' HD3' ' A' ' 38' ' ' ARG . 81.9 mt -87.29 85.67 7.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.861 -0.609 . . . . 0.90000000000000002 110.046 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -86.67 85.19 7.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.723 -0.672 . . . . 0.90000000000000002 109.465 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.14 -119.84 5.05 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.673 -0.694 . . . . 0.90000000000000002 112.189 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.0 p -96.84 8.62 43.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.021 0.439 . . . . 0.90000000000000002 111.124 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -126.52 137.16 53.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.169 -0.468 . . . . 0.90000000000000002 110.265 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -119.56 121.95 5.13 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.535 -0.841 . . . . 0.90000000000000002 112.357 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.06 119.59 35.74 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.078 -0.342 . . . . 0.90000000000000002 110.078 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.486 HD12 ' SD ' ' A' ' 97' ' ' MET . 5.9 mp -93.88 122.75 36.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.67 -0.492 . . . . 0.90000000000000002 109.67 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -95.35 -79.85 0.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.94 -0.573 . . . . 0.90000000000000002 111.106 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.517 ' HB2' ' HG3' ' A' ' 53' ' ' ARG . 13.5 m -86.9 122.51 30.87 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.087 -0.506 . . . . 0.90000000000000002 110.959 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.441 HD13 ' HB ' ' A' ' 52' ' ' VAL . 52.3 tp -140.6 116.43 10.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.229 -0.442 . . . . 0.90000000000000002 110.421 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -143.84 138.11 28.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.509 -0.314 . . . . 0.90000000000000002 110.985 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.493 HG11 ' HB2' ' A' ' 50' ' ' ALA . 7.3 t -114.57 142.86 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.454 -0.943 . . . . 0.90000000000000002 108.454 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.559 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 10.3 mtp180 -63.38 147.43 51.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.124 0.488 . . . . 0.90000000000000002 111.114 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -58.95 -17.99 29.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.717 1.006 . . . . 0.90000000000000002 113.717 -167.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.42 -16.56 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.489 0.661 . . . . 0.90000000000000002 110.6 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.466 HG22 HG22 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -106.02 15.86 25.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.746 -0.661 . . . . 0.90000000000000002 111.586 -173.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -86.06 144.73 27.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.988 0.423 . . . . 0.90000000000000002 111.572 -173.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.2 mtp-105 56.19 26.99 10.98 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.182 -0.917 . . . . 0.90000000000000002 111.911 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -112.32 2.36 16.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.3 0.571 . . . . 0.90000000000000002 110.903 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.96 -5.98 64.12 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.631 -0.795 . . . . 0.90000000000000002 113.114 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.466 HG22 HG22 ' A' ' 72' ' ' THR . 86.7 t -59.46 -41.81 85.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.008 0.433 . . . . 0.90000000000000002 110.926 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 81' ' ' LEU . . . -64.56 -25.74 70.4 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.059 -0.591 . . . . 0.90000000000000002 112.367 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.495 ' HA ' HD21 ' A' ' 115' ' ' LEU . 62.7 tt0 -68.6 -47.45 66.67 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 0.90000000000000002 109.688 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -61.95 -40.29 95.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.976 -0.556 . . . . 0.90000000000000002 109.946 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 85' ' ' VAL . 51.2 tp -45.23 -63.97 0.82 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.131 -0.94 . . . . 0.90000000000000002 111.806 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.95 -37.19 85.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.657 -0.247 . . . . 0.90000000000000002 111.575 -176.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 79' ' ' GLN . 41.5 mt-10 -60.27 -40.74 91.45 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 111.859 0.318 . . . . 0.90000000000000002 111.859 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -79.67 -25.51 41.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.294 -0.562 . . . . 0.90000000000000002 110.792 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 81' ' ' LEU . 73.3 t -62.75 -46.17 97.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.149 0.499 . . . . 0.90000000000000002 110.012 173.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.55 -22.05 62.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.564 -0.744 . . . . 0.90000000000000002 110.95 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -75.78 -45.65 35.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.90000000000000002 110.339 173.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -57.61 -48.85 78.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.947 -0.569 . . . . 0.90000000000000002 111.098 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -120.27 89.0 42.82 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.523 -0.308 . . . . 0.90000000000000002 110.196 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -83.13 -15.39 7.93 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.877 2.385 . . . . 0.90000000000000002 114.02 -173.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.48 57.87 5.05 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.796 -0.716 . . . . 0.90000000000000002 113.1 -174.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.4 t -129.68 128.46 65.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.758 0.313 . . . . 0.90000000000000002 110.383 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.7 m -75.56 -48.02 24.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.103 -0.499 . . . . 0.90000000000000002 111.123 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 127' ' ' CYS . 47.1 t -131.42 124.35 30.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.48 -0.327 . . . . 0.90000000000000002 110.835 -177.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -96.98 113.86 25.43 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.485 -0.561 . . . . 0.90000000000000002 109.485 174.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -108.53 129.0 55.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.924 0.392 . . . . 0.90000000000000002 110.079 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.814 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 95.9 mmm -110.9 108.42 18.2 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.273 -0.64 . . . . 0.90000000000000002 109.273 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.76 147.5 35.3 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.191 -0.203 . . . . 0.90000000000000002 110.948 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -63.25 -34.69 78.21 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.939 -0.393 . . . . 0.90000000000000002 109.939 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.89 9.21 2.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.341 -0.845 . . . . 0.90000000000000002 112.582 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.69 17.03 80.26 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.882 -0.675 . . . . 0.90000000000000002 111.892 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.25 118.35 14.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.779 -0.452 . . . . 0.90000000000000002 109.779 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -77.33 5.96 7.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.145 -0.479 . . . . 0.90000000000000002 112.049 -173.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -111.97 24.13 13.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.163 0.506 . . . . 0.90000000000000002 109.834 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -57.47 -28.69 63.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.317 -0.856 . . . . 0.90000000000000002 112.225 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.3 -46.1 74.04 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.477 -0.868 . . . . 0.90000000000000002 111.4 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.2 t -66.63 -37.04 78.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.113 0.482 . . . . 0.90000000000000002 110.047 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.608 ' O ' ' HG2' ' A' ' 112' ' ' MET . 68.6 mtp -66.59 -32.67 74.16 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 115.834 -0.621 . . . . 0.90000000000000002 110.749 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.0 m -62.49 -44.43 96.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.644 0.259 . . . . 0.90000000000000002 110.582 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.74 95.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.495 0.664 . . . . 0.90000000000000002 110.135 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -61.69 -39.47 91.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.325 -0.852 . . . . 0.90000000000000002 111.035 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.608 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.4 mmt -63.36 -36.96 85.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.90000000000000002 110.768 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -67.82 -27.8 67.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.90000000000000002 110.721 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.73 -40.34 66.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.917 0.389 . . . . 0.90000000000000002 110.435 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.495 HD21 ' HA ' ' A' ' 79' ' ' GLN . 97.1 mt -68.82 -48.65 63.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.022 -0.535 . . . . 0.90000000000000002 111.161 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 124.39 27.18 1.36 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.034 -0.603 . . . . 0.90000000000000002 111.776 -176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 26.2 m-85 -98.79 154.43 18.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.941 -0.392 . . . . 0.90000000000000002 109.941 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.0 m -108.76 157.88 18.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.269 -0.423 . . . . 0.90000000000000002 109.872 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.418 HG22 ' CD1' ' A' ' 124' ' ' TRP . 3.3 p -97.39 117.23 31.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.952 0.406 . . . . 0.90000000000000002 110.871 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 120' ' ' GLN . 14.4 mm-40 -102.62 -179.53 4.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.066 -0.515 . . . . 0.90000000000000002 109.913 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -91.05 50.72 1.82 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.327 0.584 . . . . 0.90000000000000002 109.977 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 165.16 43.71 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.389 -0.823 . . . . 0.90000000000000002 111.356 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 113.44 -176.82 17.63 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 121.171 -0.538 . . . . 0.90000000000000002 111.79 -176.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.814 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 9.4 m-90 -96.42 148.8 22.41 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.152 -0.685 . . . . 0.90000000000000002 109.152 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -138.65 137.82 37.23 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.016 0.436 . . . . 0.90000000000000002 111.413 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.446 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 57.5 tttm -136.97 95.52 3.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.693 -0.685 . . . . 0.90000000000000002 109.59 169.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 94' ' ' CYS . 42.5 t -76.83 110.44 11.44 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.994 -0.372 . . . . 0.90000000000000002 109.994 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.532 0 C-N-CA 120.956 -0.64 . . . . 0.90000000000000002 112.092 -178.888 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 81.1 mttt . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 121.023 0.439 . . . . 0.90000000000000002 110.67 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.465 HD13 ' HB1' ' A' ' 42' ' ' ALA . 49.7 tp -76.1 115.68 16.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.713 -0.676 . . . . 0.90000000000000002 109.622 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.7 m -87.82 92.05 8.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.051 0.453 . . . . 0.90000000000000002 110.601 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.526 HD13 ' HB3' ' A' ' 40' ' ' TYR . 6.4 tp -81.91 105.96 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.795 0.807 . . . . 0.90000000000000002 109.981 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.9 mt -99.11 148.75 5.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.856 -0.611 . . . . 0.90000000000000002 109.367 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -95.67 139.62 31.66 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.822 -0.807 . . . . 0.90000000000000002 108.822 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 11' ' ' PHE . 4.4 mm? -75.48 62.58 1.39 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.818 0.818 . . . . 0.90000000000000002 110.586 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -94.72 -29.11 14.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.362 -1.29 . . . . 0.90000000000000002 108.608 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -127.53 107.12 9.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.732 -1.122 . . . . 0.90000000000000002 108.77 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 8' ' ' LEU . 69.8 m-85 -87.83 112.38 22.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.987 0.423 . . . . 0.90000000000000002 111.736 -175.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.508 ' HB3' ' OD1' ' A' ' 15' ' ' ASP . 28.4 t -92.26 157.98 16.37 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.38 -0.6 . . . . 0.90000000000000002 109.38 172.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.04 -47.08 84.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.096 0.406 . . . . 0.90000000000000002 112.096 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -63.92 -41.49 97.65 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.684 -0.406 . . . . 0.90000000000000002 110.384 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.508 ' OD1' ' HB3' ' A' ' 12' ' ' SER . 1.6 m-20 -55.65 -44.77 77.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.90000000000000002 110.453 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.678 ' HG2' HD11 ' A' ' 31' ' ' LEU . 24.4 mtp180 -60.44 -39.28 86.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.894 -0.594 . . . . 0.90000000000000002 111.301 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 57.9 mt -77.76 -37.78 24.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.394 -0.366 . . . . 0.90000000000000002 111.491 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -68.41 -33.05 73.55 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.814 -0.439 . . . . 0.90000000000000002 109.814 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.454 HD21 HD13 ' A' ' 22' ' ' ILE . 73.7 mt -63.87 -37.28 86.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.141 -0.481 . . . . 0.90000000000000002 110.241 172.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -65.67 -22.82 66.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.34 0.591 . . . . 0.90000000000000002 110.398 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -80.0 -28.56 39.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.549 . . . . 0.90000000000000002 110.238 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.508 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 69.5 mt -76.78 -36.01 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.833 -0.621 . . . . 0.90000000000000002 110.231 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -109.72 81.1 1.83 Allowed Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.256 -0.646 . . . . 0.90000000000000002 109.256 171.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 21.1 Cg_exo . . . . . 0 C--N 1.344 0.334 0 C-N-CA 123.129 2.553 . . . . 0.90000000000000002 113.534 -169.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.678 HD11 ' HG2' ' A' ' 16' ' ' ARG . 51.2 mt . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 121.154 0.502 . . . . 0.90000000000000002 111.242 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -83.16 98.43 9.34 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.273 -0.639 . . . . 0.90000000000000002 109.273 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' A' ' 38' ' ' ARG . 8.2 p -93.13 135.76 26.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.865 -0.607 . . . . 0.90000000000000002 111.198 -175.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -131.7 -179.56 5.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.995 -0.743 . . . . 0.90000000000000002 108.995 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.82 -23.71 66.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.688 0.28 . . . . 0.90000000000000002 111.339 -175.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.62 ' O ' ' HA ' ' A' ' 55' ' ' THR . 32.0 m-80 -85.84 -62.34 1.55 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.26 -0.427 . . . . 0.90000000000000002 109.907 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -89.66 94.62 9.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.212 -0.449 . . . . 0.90000000000000002 110.553 -175.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.502 ' HA ' HG22 ' A' ' 33' ' ' VAL . 53.6 mtt180 -110.27 139.08 45.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.286 0.565 . . . . 0.90000000000000002 111.006 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.8 mt -106.96 134.77 47.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.526 -0.761 . . . . 0.90000000000000002 109.787 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.526 ' HB3' HD13 ' A' ' 5' ' ' ILE . 86.0 m-85 -118.84 140.34 50.12 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.329 -0.619 . . . . 0.90000000000000002 109.329 174.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.476 ' HB3' HD22 ' A' ' 48' ' ' LEU . . . -129.2 124.09 33.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.103 0.478 . . . . 0.90000000000000002 110.566 -173.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.648 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . . . -92.0 104.14 16.58 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.041 -0.527 . . . . 0.90000000000000002 109.966 -176.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -87.27 122.76 31.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.921 -1.036 . . . . 0.90000000000000002 110.701 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -140.31 124.99 18.09 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.301 -0.629 . . . . 0.90000000000000002 109.301 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.2 t30 62.07 36.56 15.26 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.49 0.662 . . . . 0.90000000000000002 110.005 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 37.3 tt0 67.01 18.41 10.56 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.098 -0.955 . . . . 0.90000000000000002 111.213 177.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -133.7 146.24 50.63 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.752 -0.462 . . . . 0.90000000000000002 109.752 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 41' ' ' ALA . 78.7 mt -79.88 101.45 8.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.197 0.522 . . . . 0.90000000000000002 110.414 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.8 tp -81.74 -21.74 37.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.091 -0.504 . . . . 0.90000000000000002 110.615 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.648 ' HB2' ' HB2' ' A' ' 42' ' ' ALA . . . -141.05 140.25 34.22 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.508 -0.477 . . . . 0.90000000000000002 111.605 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -128.52 122.39 31.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.031 -0.531 . . . . 0.90000000000000002 109.899 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 40' ' ' TYR . 7.9 p -132.59 135.97 56.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.297 -0.41 . . . . 0.90000000000000002 110.955 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -111.26 129.83 55.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.855 0.359 . . . . 0.90000000000000002 110.146 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.7 p -127.35 139.59 51.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.064 0.459 . . . . 0.90000000000000002 110.189 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 29.1 m -108.28 101.71 10.89 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 116.005 -0.543 . . . . 0.90000000000000002 110.083 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.89 91.07 5.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.656 -0.702 . . . . 0.90000000000000002 109.507 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -103.54 99.16 8.97 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.668 -0.696 . . . . 0.90000000000000002 110.118 -175.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.48 -105.55 0.92 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.076 -0.583 . . . . 0.90000000000000002 112.358 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.8 p -107.36 2.42 24.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.854 0.359 . . . . 0.90000000000000002 111.131 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -102.66 122.24 44.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.057 -0.52 . . . . 0.90000000000000002 111.334 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.94 85.76 0.91 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.274 -1.13 . . . . 0.90000000000000002 110.274 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -92.92 128.61 38.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.691 0.281 . . . . 0.90000000000000002 110.447 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.461 HD23 ' HE3' ' A' ' 97' ' ' MET . 1.5 tp -93.52 121.65 35.14 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.28 -0.637 . . . . 0.90000000000000002 109.28 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -113.47 95.82 5.56 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.173 -0.467 . . . . 0.90000000000000002 110.185 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.0 p 69.93 127.87 0.03 OUTLIER 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.655 1.182 . . . . 0.90000000000000002 112.344 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.478 HD22 ' HE1' ' A' ' 108' ' ' MET . 47.0 tp -123.8 122.63 38.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.769 -1.105 . . . . 0.90000000000000002 109.004 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 70.5 mtp85 -129.82 96.31 4.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.137 0.494 . . . . 0.90000000000000002 111.076 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.448 HG12 ' HB3' ' A' ' 50' ' ' ALA . 2.3 t -86.17 142.84 12.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.585 -0.895 . . . . 0.90000000000000002 108.585 175.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' A' ' 48' ' ' LEU . 5.0 ttt180 -61.43 139.79 58.15 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.653 -0.499 . . . . 0.90000000000000002 109.653 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.6 -17.56 23.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.90000000000000002 112.151 -172.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.01 -21.05 27.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.973 0.416 . . . . 0.90000000000000002 111.138 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.4 m -62.72 -43.1 99.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.369 . . . . 0.90000000000000002 111.481 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 48.79 47.81 20.79 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.884 -0.598 . . . . 0.90000000000000002 112.09 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.9 mtm180 55.24 66.9 1.11 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.351 -0.386 . . . . 0.90000000000000002 111.64 175.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -144.52 75.31 1.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.884 0.373 . . . . 0.90000000000000002 111.654 -175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.08 -43.34 2.84 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 114.998 0.759 . . . . 0.90000000000000002 114.998 167.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.6 t -49.72 -48.28 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.326 0.491 . . . . 0.90000000000000002 112.326 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.19 -44.24 94.98 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.974 -0.631 . . . . 0.90000000000000002 112.808 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.461 ' HA ' HD12 ' A' ' 115' ' ' LEU . 73.5 mt-30 -55.07 -56.94 14.21 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.44 0.638 . . . . 0.90000000000000002 110.104 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -60.59 -45.62 93.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.954 -1.021 . . . . 0.90000000000000002 111.13 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.498 ' O ' HG22 ' A' ' 85' ' ' VAL . 27.0 tp -54.09 -57.51 10.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.875 -0.602 . . . . 0.90000000000000002 111.569 -174.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.435 HD11 ' HA ' ' A' ' 82' ' ' LEU . 4.1 mm? -62.56 -45.75 91.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.589 -0.278 . . . . 0.90000000000000002 111.695 -176.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -60.39 -37.99 82.54 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.975 0.416 . . . . 0.90000000000000002 110.797 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HG2' HG23 ' A' ' 5' ' ' ILE . 10.4 tp10 -69.21 -39.05 78.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.947 -0.57 . . . . 0.90000000000000002 110.533 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 81' ' ' LEU . 91.4 t -62.16 -42.4 95.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.803 0.335 . . . . 0.90000000000000002 110.55 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.74 -17.78 63.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.90000000000000002 111.158 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -85.62 -37.59 19.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.171 0.51 . . . . 0.90000000000000002 109.699 174.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.454 ' C ' HD21 ' A' ' 88' ' ' ASN . 0.2 OUTLIER -65.94 -44.04 86.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.56 -0.745 . . . . 0.90000000000000002 110.077 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -120.28 77.84 26.08 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.181 -0.463 . . . . 0.90000000000000002 110.585 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -89.0 -0.71 6.31 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.569 2.179 . . . . 0.90000000000000002 112.909 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.46 -50.3 38.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.938 -0.649 . . . . 0.90000000000000002 112.13 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 m -62.04 119.69 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.21 0.529 . . . . 0.90000000000000002 111.025 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 m -92.04 -18.52 23.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.776 -0.647 . . . . 0.90000000000000002 111.275 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.2 t -109.35 98.63 8.0 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.255 -0.276 . . . . 0.90000000000000002 110.255 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -95.31 132.13 40.65 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.188 0.518 . . . . 0.90000000000000002 110.933 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.444 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 75.0 t-105 -127.6 127.15 43.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.241 -0.89 . . . . 0.90000000000000002 109.762 -177.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.981 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 74.7 mmm -106.99 110.98 23.26 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.39 -0.596 . . . . 0.90000000000000002 109.39 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -92.0 154.31 18.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.021 -0.536 . . . . 0.90000000000000002 111.295 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.67 -1.29 41.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.719 -0.673 . . . . 0.90000000000000002 110.876 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.53 127.81 33.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.90000000000000002 110.861 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.93 2.61 86.17 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.964 -0.636 . . . . 0.90000000000000002 112.163 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.735 HG13 ' HG3' ' A' ' 108' ' ' MET . 60.6 t -117.31 112.51 39.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.822 0.344 . . . . 0.90000000000000002 110.723 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -80.56 -34.84 35.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.065 -0.516 . . . . 0.90000000000000002 110.557 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 108' ' ' MET . 7.6 m-20 -87.71 61.53 6.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.015 -0.539 . . . . 0.90000000000000002 110.858 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -63.35 -40.31 96.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.90000000000000002 111.301 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.94 -45.15 97.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.97 -0.633 . . . . 0.90000000000000002 112.111 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.9 -43.91 98.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.789 0.328 . . . . 0.90000000000000002 110.591 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.735 ' HG3' HG13 ' A' ' 102' ' ' VAL . 97.8 mmm -65.61 -29.41 70.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.90000000000000002 110.937 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 71.8 m -61.86 -47.61 84.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.90000000000000002 110.13 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.58 -37.9 83.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.185 -0.462 . . . . 0.90000000000000002 110.356 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.432 ' HB3' ' HA ' ' A' ' 108' ' ' MET . 66.4 t80 -58.5 -52.95 63.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.487 -0.778 . . . . 0.90000000000000002 111.268 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.512 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 65.1 mtt -76.85 -27.3 55.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.134 -0.485 . . . . 0.90000000000000002 111.907 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -69.36 -33.79 73.61 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.468 -0.493 . . . . 0.90000000000000002 109.704 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.11 73.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.929 -0.578 . . . . 0.90000000000000002 110.613 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.716 HD23 ' HE2' ' A' ' 117' ' ' PHE . 32.5 tp -80.59 -51.96 8.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.119 -0.492 . . . . 0.90000000000000002 111.018 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 141.91 69.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.658 -0.782 . . . . 0.90000000000000002 112.285 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.716 ' HE2' HD23 ' A' ' 115' ' ' LEU . 91.1 m-85 -143.75 148.54 35.79 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.121 -0.325 . . . . 0.90000000000000002 110.121 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 124' ' ' TRP . 18.9 m -115.69 149.93 37.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.343 -0.389 . . . . 0.90000000000000002 109.967 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.2 p -97.0 115.07 26.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.144 0.497 . . . . 0.90000000000000002 110.322 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.415 ' HG3' ' HG3' ' A' ' 121' ' ' GLN . 55.5 tp60 -134.6 115.7 14.15 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.615 -0.72 . . . . 0.90000000000000002 110.468 -176.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.415 ' HG3' ' HG3' ' A' ' 120' ' ' GLN . 92.5 mt-30 62.56 35.19 14.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.583 -0.735 . . . . 0.90000000000000002 112.323 172.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.29 4.37 56.34 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.77 -0.728 . . . . 0.90000000000000002 113.877 172.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -155.08 175.94 32.91 Favored Glycine 0 C--O 1.225 -0.406 0 C-N-CA 120.327 -0.94 . . . . 0.90000000000000002 112.036 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.981 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 28.8 m-90 -95.14 127.03 40.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 117.005 0.402 . . . . 0.90000000000000002 110.042 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -110.82 140.3 45.38 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.89 0.376 . . . . 0.90000000000000002 110.623 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -137.03 93.4 2.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.657 -0.497 . . . . 0.90000000000000002 109.657 172.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 51.0 t -86.93 132.01 33.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.886 -0.597 . . . . 0.90000000000000002 110.704 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 C-N-CA 121.132 -0.556 . . . . 0.90000000000000002 111.94 178.613 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.2 mttm . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 121.017 0.436 . . . . 0.90000000000000002 110.573 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 42' ' ' ALA . 49.4 tp -93.37 113.7 25.94 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.471 -0.786 . . . . 0.90000000000000002 110.464 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.6 m -83.01 100.09 10.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.249 0.547 . . . . 0.90000000000000002 110.581 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.452 HD11 HD11 ' A' ' 81' ' ' LEU . 85.5 mt -95.03 129.83 44.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.084 -0.507 . . . . 0.90000000000000002 110.393 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.5 mt -124.75 149.84 29.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.481 -0.781 . . . . 0.90000000000000002 109.066 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 7' ' ' ARG . 15.2 ptt-85 -92.57 138.56 31.4 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.382 -0.599 . . . . 0.90000000000000002 109.382 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 41' ' ' ALA . 4.3 mm? -74.92 50.89 0.48 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.035 0.445 . . . . 0.90000000000000002 111.612 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -87.79 -24.39 23.77 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.001 -0.741 . . . . 0.90000000000000002 109.001 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -123.53 107.31 11.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.17 -0.923 . . . . 0.90000000000000002 108.695 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -83.67 115.24 22.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.202 0.525 . . . . 0.90000000000000002 111.539 -173.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.8 t -98.37 153.32 18.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.405 -0.816 . . . . 0.90000000000000002 108.893 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 17' ' ' ILE . 43.1 t0 -66.92 -49.86 64.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.706 -0.225 . . . . 0.90000000000000002 111.439 -172.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -64.95 -37.79 88.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.723 0.297 . . . . 0.90000000000000002 111.049 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.65 -39.37 88.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.297 0.57 . . . . 0.90000000000000002 110.168 176.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -68.26 -29.32 68.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.623 -0.717 . . . . 0.90000000000000002 110.6 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 13' ' ' ASP . 43.2 mm -63.84 -44.28 98.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.307 -0.406 . . . . 0.90000000000000002 110.428 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.519 ' O ' HG13 ' A' ' 22' ' ' ILE . 7.7 m-20 -64.86 -38.4 90.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.236 -0.438 . . . . 0.90000000000000002 110.807 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.9 mt -60.2 -41.84 93.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.962 0.411 . . . . 0.90000000000000002 110.284 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -73.6 -13.54 61.03 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.368 0.604 . . . . 0.90000000000000002 110.483 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -92.01 -23.37 19.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.404 0.621 . . . . 0.90000000000000002 109.68 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 18' ' ' ASP . 96.1 mt -77.66 -35.36 21.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.475 -0.784 . . . . 0.90000000000000002 109.399 174.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -112.23 80.81 3.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.834 -0.802 . . . . 0.90000000000000002 108.834 169.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.344 0.309 0 C-N-CA 122.971 2.447 . . . . 0.90000000000000002 113.65 -168.842 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.458 0.647 . . . . 0.90000000000000002 111.698 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -161.2 135.21 6.89 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.684 -1.143 . . . . 0.90000000000000002 108.498 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.0 m -123.64 141.28 44.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.36 0.6 . . . . 0.90000000000000002 111.949 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -116.7 172.52 7.18 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.607 -0.886 . . . . 0.90000000000000002 108.607 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.14 -28.09 67.85 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.373 0.606 . . . . 0.90000000000000002 109.477 171.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -98.86 -0.61 42.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.357 -0.838 . . . . 0.90000000000000002 111.141 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -144.55 91.32 2.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.992 -0.373 . . . . 0.90000000000000002 109.992 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.453 ' HB2' HG13 ' A' ' 54' ' ' VAL . 57.3 mtt180 -109.07 153.8 23.15 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.246 -0.434 . . . . 0.90000000000000002 110.769 -174.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 8' ' ' LEU . 66.1 mt -122.78 118.48 55.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.559 -0.534 . . . . 0.90000000000000002 109.559 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -104.58 127.28 52.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.112 0.482 . . . . 0.90000000000000002 110.52 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.478 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -108.23 129.67 55.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.592 -0.731 . . . . 0.90000000000000002 110.094 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.501 ' HB2' HD11 ' A' ' 3' ' ' LEU . . . -91.92 103.93 16.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.836 -0.62 . . . . 0.90000000000000002 110.131 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -101.44 118.68 37.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.144 -0.48 . . . . 0.90000000000000002 109.92 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -122.99 109.84 14.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.255 -0.43 . . . . 0.90000000000000002 110.531 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 69.02 -69.93 0.15 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.168 0.917 . . . . 0.90000000000000002 112.366 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.633 ' HG2' ' HG3' ' A' ' 47' ' ' ARG . 35.7 tt0 -94.2 -66.74 0.9 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.861 0.363 . . . . 0.90000000000000002 111.381 -174.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.633 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 11.8 mtm180 -147.61 -150.79 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.31 -0.626 . . . . 0.90000000000000002 109.31 -174.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.478 HD23 ' HB3' ' A' ' 41' ' ' ALA . 37.8 mt -78.15 122.94 26.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.119 0.485 . . . . 0.90000000000000002 110.414 -176.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.439 ' O ' ' HD3' ' A' ' 69' ' ' ARG . 32.3 tp -99.55 -25.32 14.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.054 -0.521 . . . . 0.90000000000000002 110.076 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.5 ' HB2' HG12 ' A' ' 68' ' ' VAL . . . -152.5 163.65 39.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.917 -0.583 . . . . 0.90000000000000002 110.636 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.29 143.43 29.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.409 -0.36 . . . . 0.90000000000000002 110.675 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.479 ' HB ' HD13 ' A' ' 66' ' ' LEU . 11.7 p -147.02 140.52 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.044 -0.526 . . . . 0.90000000000000002 110.361 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 -101.77 140.01 36.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.683 -0.488 . . . . 0.90000000000000002 109.683 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.453 HG13 ' HB2' ' A' ' 38' ' ' ARG . 6.2 p -130.51 122.28 52.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.594 0.711 . . . . 0.90000000000000002 111.653 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 62' ' ' ALA . 39.2 m -91.33 140.5 29.71 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.408 -0.815 . . . . 0.90000000000000002 108.859 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.2 mt -127.1 141.47 51.76 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.886 0.374 . . . . 0.90000000000000002 110.862 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.7 m -144.23 84.49 1.76 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.926 -0.579 . . . . 0.90000000000000002 109.475 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.15 -110.18 3.29 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.912 -0.661 . . . . 0.90000000000000002 112.146 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 p -98.02 3.05 49.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.959 0.409 . . . . 0.90000000000000002 111.281 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' A' ' 94' ' ' CYS . 42.7 mt-10 -112.24 151.43 29.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.404 -0.362 . . . . 0.90000000000000002 110.397 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.08 158.25 27.37 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.923 -0.656 . . . . 0.90000000000000002 111.567 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -134.39 123.33 23.91 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.76 0.314 . . . . 0.90000000000000002 110.486 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.86 118.24 31.19 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.72 -0.474 . . . . 0.90000000000000002 109.72 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -129.68 133.42 47.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.738 -0.665 . . . . 0.90000000000000002 110.468 -174.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 m 64.98 100.83 0.04 OUTLIER 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.444 0.64 . . . . 0.90000000000000002 111.641 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.479 HD13 ' HB ' ' A' ' 52' ' ' VAL . 56.7 tp -132.31 121.34 23.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.548 -0.751 . . . . 0.90000000000000002 110.149 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 67' ' ' ARG . 31.1 ttt180 -144.0 131.41 20.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.994 0.426 . . . . 0.90000000000000002 110.811 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.5 HG12 ' HB2' ' A' ' 50' ' ' ALA . 9.0 t -109.97 164.26 6.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.668 -0.864 . . . . 0.90000000000000002 108.668 173.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -54.66 135.29 46.95 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.93 -0.396 . . . . 0.90000000000000002 109.93 173.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -62.52 -26.52 68.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.91 -0.586 . . . . 0.90000000000000002 111.101 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 p -77.82 -14.62 14.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.983 -0.553 . . . . 0.90000000000000002 111.002 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 m -91.43 64.21 5.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.671 0.748 . . . . 0.90000000000000002 111.385 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 73' ' ' ARG . 52.2 mtt-85 -106.88 91.66 3.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.58 -0.736 . . . . 0.90000000000000002 109.018 174.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -131.67 -9.44 3.58 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.196 0.443 . . . . 0.90000000000000002 112.196 -171.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 69.16 88.37 0.11 Allowed 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.94 0.4 . . . . 0.90000000000000002 109.976 -174.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 147.52 -43.05 0.86 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.459 -1.353 . . . . 0.90000000000000002 114.006 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.44 -54.48 18.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 117.209 0.504 . . . . 0.90000000000000002 111.757 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.07 -38.53 96.74 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.784 -0.722 . . . . 0.90000000000000002 112.321 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.534 ' HG3' ' HG ' ' A' ' 115' ' ' LEU . 7.8 tt0 -62.33 -52.42 63.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.791 0.329 . . . . 0.90000000000000002 110.665 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -62.38 -33.75 75.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.90000000000000002 110.699 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.46 ' O ' HG22 ' A' ' 85' ' ' VAL . 48.0 tp -54.14 -57.62 10.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.90000000000000002 110.574 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.07 -41.45 95.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.062 -0.517 . . . . 0.90000000000000002 110.572 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -54.36 -46.55 73.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.94 0.4 . . . . 0.90000000000000002 111.228 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -66.06 -36.8 84.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.122 -0.49 . . . . 0.90000000000000002 110.392 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 81' ' ' LEU . 81.2 t -66.2 -46.37 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.90000000000000002 110.88 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.423 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 10.9 mp -65.79 -22.85 66.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 0.90000000000000002 111.359 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.4 mtm-85 -89.25 -15.74 32.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.90000000000000002 110.735 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.426 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 46.4 t-20 -81.87 -42.59 19.38 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.179 -0.675 . . . . 0.90000000000000002 109.179 175.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -118.14 76.96 12.32 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.781 -0.645 . . . . 0.90000000000000002 110.405 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 6.0 Cg_exo -79.0 -13.9 13.87 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.992 2.461 . . . . 0.90000000000000002 112.282 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.67 -20.91 72.53 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.161 -0.542 . . . . 0.90000000000000002 112.043 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -76.05 106.56 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.66 -0.496 . . . . 0.90000000000000002 109.66 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.7 m -90.82 -11.78 38.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.888 -0.597 . . . . 0.90000000000000002 111.085 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.415 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 40.2 t -131.28 95.54 3.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.88 0.371 . . . . 0.90000000000000002 110.501 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.975 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 95.5 m95 -91.38 107.24 19.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.044 -0.525 . . . . 0.90000000000000002 110.424 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.608 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 76.9 t-105 -97.47 130.98 44.51 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.668 -0.493 . . . . 0.90000000000000002 109.668 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.461 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 58.9 mtp -114.48 131.82 56.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.719 0.295 . . . . 0.90000000000000002 110.481 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.84 165.42 11.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.939 -0.573 . . . . 0.90000000000000002 111.586 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -108.71 73.61 0.88 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.835 0.826 . . . . 0.90000000000000002 109.115 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.77 113.59 27.28 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.352 -0.84 . . . . 0.90000000000000002 111.521 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.51 1.02 81.37 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.074 -0.584 . . . . 0.90000000000000002 112.91 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.97 118.23 46.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.946 0.403 . . . . 0.90000000000000002 110.336 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -93.22 -20.59 20.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.341 0.591 . . . . 0.90000000000000002 109.48 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -86.74 41.19 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.34 -0.845 . . . . 0.90000000000000002 110.641 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -52.95 -43.85 66.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.127 -0.488 . . . . 0.90000000000000002 111.053 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.7 -46.52 92.11 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.062 -0.59 . . . . 0.90000000000000002 112.501 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.8 t -64.56 -45.26 96.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.09 0.472 . . . . 0.90000000000000002 110.308 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.479 ' O ' ' HG2' ' A' ' 112' ' ' MET . 37.6 ttm -67.05 -29.2 68.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.90000000000000002 111.032 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 96.9 m -61.61 -45.39 94.3 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.175 -0.305 . . . . 0.90000000000000002 110.175 175.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.04 -39.35 92.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.146 0.498 . . . . 0.90000000000000002 110.437 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -60.52 -49.08 78.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.656 -0.702 . . . . 0.90000000000000002 111.042 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.507 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 22.2 mmt -66.85 -35.29 79.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.427 -0.351 . . . . 0.90000000000000002 111.132 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -71.4 -25.54 62.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.524 -0.307 . . . . 0.90000000000000002 111.024 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.42 -38.9 54.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.92 0.39 . . . . 0.90000000000000002 110.227 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.569 HD23 ' CE2' ' A' ' 117' ' ' PHE . 7.3 tt -70.72 -49.55 45.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.912 -0.586 . . . . 0.90000000000000002 110.078 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 134.64 47.83 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.511 -0.852 . . . . 0.90000000000000002 112.983 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.57 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 83.1 m-85 -110.43 149.2 30.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.589 0.233 . . . . 0.90000000000000002 110.422 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.0 m -94.67 143.09 26.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.28 -0.418 . . . . 0.90000000000000002 109.912 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.8 p -97.43 122.5 40.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.0 0.429 . . . . 0.90000000000000002 111.093 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -120.13 -171.48 2.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.258 -0.428 . . . . 0.90000000000000002 110.356 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -84.42 94.07 8.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.134 0.492 . . . . 0.90000000000000002 110.255 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 136.52 -48.55 0.91 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.777 -0.647 . . . . 0.90000000000000002 112.022 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -167.74 -153.16 7.91 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.957 -0.639 . . . . 0.90000000000000002 112.279 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 15.5 m-90 -108.49 141.77 39.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.597 0.237 . . . . 0.90000000000000002 110.481 -176.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -120.18 132.52 55.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.395 -0.366 . . . . 0.90000000000000002 111.018 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.975 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 57.8 tptt -119.08 85.86 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.476 -0.564 . . . . 0.90000000000000002 109.476 172.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 39.2 t -98.86 137.0 38.07 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.777 -0.647 . . . . 0.90000000000000002 109.904 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 C-N-CA 120.836 -0.697 . . . . 0.90000000000000002 112.07 -179.943 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.9 tttm . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 120.957 0.408 . . . . 0.90000000000000002 110.354 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.4 tp -75.96 106.28 7.46 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.193 -1.04 . . . . 0.90000000000000002 108.193 172.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.6 m -96.64 111.46 23.59 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.851 -0.613 . . . . 0.90000000000000002 109.655 -177.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.537 HD12 ' HB3' ' A' ' 42' ' ' ALA . 15.7 tt -122.01 129.35 75.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 121.416 0.627 . . . . 0.90000000000000002 110.871 -175.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.4 168.17 24.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.51 -0.768 . . . . 0.90000000000000002 109.755 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -75.03 124.37 26.86 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.953 -0.758 . . . . 0.90000000000000002 108.953 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.0 tp -89.92 78.44 6.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.343 0.592 . . . . 0.90000000000000002 110.143 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.531 ' HA ' HG21 ' A' ' 33' ' ' VAL . 29.3 tt0 -86.64 -40.68 14.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.267 -0.879 . . . . 0.90000000000000002 110.513 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -102.99 122.21 44.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.646 -0.706 . . . . 0.90000000000000002 109.965 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -105.7 110.41 22.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.827 -0.624 . . . . 0.90000000000000002 110.709 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.551 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 0.7 OUTLIER -80.29 168.95 18.41 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.721 -0.844 . . . . 0.90000000000000002 108.721 172.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.478 ' O ' HG13 ' A' ' 17' ' ' ILE . 17.1 t70 -61.08 -45.99 92.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.751 0.31 . . . . 0.90000000000000002 110.388 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.515 ' HA ' HD11 ' A' ' 17' ' ' ILE . 97.6 mt-30 -66.73 -34.87 78.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.989 -0.551 . . . . 0.90000000000000002 111.13 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.26 -35.61 79.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.784 0.326 . . . . 0.90000000000000002 110.234 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 12' ' ' SER . 42.5 mtt180 -65.93 -47.08 75.9 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.472 -0.566 . . . . 0.90000000000000002 109.472 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.515 HD11 ' HA ' ' A' ' 14' ' ' GLN . 69.1 mt -54.37 -48.43 68.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.67 -0.695 . . . . 0.90000000000000002 110.99 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.552 ' O ' HG13 ' A' ' 22' ' ' ILE . 99.7 m-20 -54.69 -57.84 9.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.90000000000000002 111.104 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.03 -41.18 99.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.429 -0.351 . . . . 0.90000000000000002 111.38 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -73.43 -10.54 59.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.215 -0.448 . . . . 0.90000000000000002 110.837 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -99.54 -25.06 14.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.075 0.465 . . . . 0.90000000000000002 110.111 175.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 18' ' ' ASP . 76.4 mt -65.03 -44.35 95.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.289 -0.634 . . . . 0.90000000000000002 109.289 172.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -87.85 117.48 68.52 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.899 -0.591 . . . . 0.90000000000000002 109.467 172.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo . . . . . 0 C--N 1.345 0.366 0 C-N-CA 122.985 2.456 . . . . 0.90000000000000002 112.92 -176.119 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 CA--C 1.529 0.148 0 CA-C-O 120.832 0.349 . . . . 0.90000000000000002 111.406 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -74.32 107.68 6.63 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.719 -0.474 . . . . 0.90000000000000002 109.719 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' A' ' 9' ' ' GLU . 16.9 m -104.35 136.42 37.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.858 -0.61 . . . . 0.90000000000000002 111.453 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -140.23 -161.73 1.24 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.682 -0.69 . . . . 0.90000000000000002 109.617 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -81.63 -19.83 40.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.997 0.427 . . . . 0.90000000000000002 110.222 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.18 -68.19 0.81 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.827 -0.434 . . . . 0.90000000000000002 109.827 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -72.53 97.32 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.077 -0.342 . . . . 0.90000000000000002 110.077 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.6 HH11 HD13 ' A' ' 56' ' ' LEU . 71.5 mtt180 -113.54 127.62 56.14 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.011 0.434 . . . . 0.90000000000000002 111.163 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.717 HG12 ' HG2' ' A' ' 53' ' ' ARG . 64.5 mt -101.88 119.34 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 0.90000000000000002 109.804 176.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.404 ' HB2' HG12 ' A' ' 52' ' ' VAL . 80.6 m-85 -98.78 133.6 42.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.282 -0.417 . . . . 0.90000000000000002 109.96 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.472 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.09 113.38 26.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.919 -0.582 . . . . 0.90000000000000002 110.283 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.734 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -98.42 110.83 23.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.038 -0.528 . . . . 0.90000000000000002 110.387 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.53 ' HB3' HD21 ' A' ' 48' ' ' LEU . 23.8 ptt180 -107.94 134.12 51.31 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.225 0.536 . . . . 0.90000000000000002 110.257 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -97.15 94.2 6.99 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.856 -0.611 . . . . 0.90000000000000002 109.793 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.691 HD21 ' HG3' ' A' ' 46' ' ' GLU . 9.3 t30 72.25 -46.98 0.66 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.031 -0.986 . . . . 0.90000000000000002 112.142 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.691 ' HG3' HD21 ' A' ' 45' ' ' ASN . 46.0 mt-10 -128.21 -67.83 0.79 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.362 . . . . 0.90000000000000002 111.848 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -104.55 162.21 13.45 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.275 -0.421 . . . . 0.90000000000000002 111.966 -170.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.53 HD21 ' HB3' ' A' ' 43' ' ' ARG . 92.3 mt -59.87 127.42 31.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.43 -0.804 . . . . 0.90000000000000002 110.34 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.69 HD23 HG12 ' A' ' 77' ' ' VAL . 31.3 tp -115.95 -29.49 6.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.272 -0.422 . . . . 0.90000000000000002 110.489 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.734 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -136.61 139.74 42.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.822 0.344 . . . . 0.90000000000000002 111.41 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.63 116.66 22.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.845 -0.616 . . . . 0.90000000000000002 109.843 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.404 HG12 ' HB2' ' A' ' 40' ' ' TYR . 7.4 p -124.51 131.34 72.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.396 0.617 . . . . 0.90000000000000002 111.315 -177.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.717 ' HG2' HG12 ' A' ' 39' ' ' ILE . 41.3 mtp-105 -107.75 119.05 38.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.589 -0.732 . . . . 0.90000000000000002 109.645 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.48 128.62 68.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.405 0.621 . . . . 0.90000000000000002 110.821 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.0 m -94.11 100.88 12.9 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.634 -0.712 . . . . 0.90000000000000002 109.94 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.6 HD13 HH11 ' A' ' 38' ' ' ARG . 93.3 mt -87.04 86.54 7.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.644 -0.707 . . . . 0.90000000000000002 109.639 177.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -95.92 105.87 17.95 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.749 -0.659 . . . . 0.90000000000000002 109.383 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.15 -113.54 4.75 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.675 -0.774 . . . . 0.90000000000000002 111.553 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 p -113.16 8.67 18.31 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.894 0.378 . . . . 0.90000000000000002 110.939 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -107.75 137.96 44.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.44 . . . . 0.90000000000000002 110.312 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.47 114.22 3.0 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.856 -0.687 . . . . 0.90000000000000002 111.923 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -111.37 128.93 56.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.562 0.22 . . . . 0.90000000000000002 110.47 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.495 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 6.9 mp -93.49 108.49 20.17 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.378 0.609 . . . . 0.90000000000000002 109.611 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.54 -28.43 33.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.91 -1.041 . . . . 0.90000000000000002 111.809 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.418 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 15.6 m -152.4 127.77 9.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.663 0.268 . . . . 0.90000000000000002 110.965 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.4 tp -131.28 109.68 10.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.164 -0.471 . . . . 0.90000000000000002 109.736 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -143.27 109.38 5.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.17 0.51 . . . . 0.90000000000000002 110.853 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.495 HG11 ' HB2' ' A' ' 50' ' ' ALA . 12.4 t -97.7 157.8 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.856 -0.794 . . . . 0.90000000000000002 108.856 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -58.22 146.45 33.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 0.90000000000000002 110.707 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -52.02 -35.5 47.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.379 -0.828 . . . . 0.90000000000000002 112.484 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -75.98 7.9 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.469 0.652 . . . . 0.90000000000000002 111.487 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.481 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 1.8 m -103.91 8.93 36.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.618 0.723 . . . . 0.90000000000000002 110.238 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.9 ttp85 -65.74 107.19 1.7 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.201 -0.908 . . . . 0.90000000000000002 110.614 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 61.58 91.38 0.06 Allowed 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.606 0.567 . . . . 0.90000000000000002 110.093 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -164.42 -42.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.267 -0.424 . . . . 0.90000000000000002 111.044 -170.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.6 -24.34 6.85 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.256 -0.973 . . . . 0.90000000000000002 113.435 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.69 HG12 HD23 ' A' ' 49' ' ' LEU . 84.5 t -55.38 -42.54 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 112.011 0.375 . . . . 0.90000000000000002 112.011 -177.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.25 -31.82 70.49 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.005 -0.617 . . . . 0.90000000000000002 113.006 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.522 ' HA ' HD21 ' A' ' 115' ' ' LEU . 53.0 tt0 -65.16 -43.85 90.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.849 -0.426 . . . . 0.90000000000000002 109.849 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -69.0 -36.87 78.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.573 -0.74 . . . . 0.90000000000000002 110.42 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.494 ' O ' HG22 ' A' ' 85' ' ' VAL . 63.2 tp -49.29 -58.72 4.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.07 -0.514 . . . . 0.90000000000000002 111.268 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.17 -33.21 75.47 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.003 -0.279 . . . . 0.90000000000000002 110.95 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -58.26 -54.04 51.53 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.646 0.26 . . . . 0.90000000000000002 110.817 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.38 -36.78 85.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.069 -0.514 . . . . 0.90000000000000002 111.162 -175.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 81' ' ' LEU . 93.3 t -61.37 -49.15 85.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.912 0.387 . . . . 0.90000000000000002 110.763 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.473 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 10.4 mp -78.18 -4.59 48.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.088 0.47 . . . . 0.90000000000000002 110.938 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -87.76 -38.54 15.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.831 -0.622 . . . . 0.90000000000000002 109.943 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -71.1 -37.96 72.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.866 -0.606 . . . . 0.90000000000000002 110.097 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.435 ' O ' ' HZ2' ' A' ' 95' ' ' TRP . 20.1 m120 -120.12 74.48 21.15 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.817 -0.628 . . . . 0.90000000000000002 109.883 176.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -88.09 -3.42 7.03 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.741 2.294 . . . . 0.90000000000000002 113.733 -173.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -94.25 19.33 53.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.734 -0.746 . . . . 0.90000000000000002 112.851 -175.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.7 t -107.17 125.14 63.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.58 -0.526 . . . . 0.90000000000000002 109.58 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.0 m -91.76 -42.92 9.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.902 0.382 . . . . 0.90000000000000002 110.779 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 40.6 t -104.43 96.46 6.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.051 0.453 . . . . 0.90000000000000002 110.558 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.473 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 86.5 m95 -90.87 131.0 36.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.945 -0.571 . . . . 0.90000000000000002 109.94 175.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.63 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 67.9 t-105 -120.66 133.44 55.36 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.624 -0.51 . . . . 0.90000000000000002 109.624 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.495 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 75.2 mtp -119.15 124.84 47.82 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.732 -0.47 . . . . 0.90000000000000002 109.732 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -84.46 173.39 10.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.452 . . . . 0.90000000000000002 110.832 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -57.57 -35.28 70.17 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.055 -0.52 . . . . 0.90000000000000002 111.077 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.488 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . 63.99 11.74 6.34 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.025 -0.534 . . . . 0.90000000000000002 111.919 175.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.59 12.21 84.72 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.859 -0.686 . . . . 0.90000000000000002 111.803 -176.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.488 HG21 ' HB1' ' A' ' 100' ' ' ALA . 45.2 t -80.85 101.49 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.962 0.41 . . . . 0.90000000000000002 110.281 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -89.08 -1.37 58.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.463 0.649 . . . . 0.90000000000000002 109.724 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -85.75 44.45 1.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.201 -0.909 . . . . 0.90000000000000002 109.084 172.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -56.33 -41.69 76.47 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 115.232 -0.895 . . . . 0.90000000000000002 112.2 -173.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -51.95 -54.21 26.72 Favored Glycine 0 C--O 1.236 0.275 0 C-N-CA 120.983 -0.627 . . . . 0.90000000000000002 112.706 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.2 t -66.73 -43.38 90.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.931 0.396 . . . . 0.90000000000000002 111.009 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.552 ' O ' ' HG2' ' A' ' 112' ' ' MET . 34.8 ttm -69.75 -35.66 75.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.296 -0.411 . . . . 0.90000000000000002 111.868 -176.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 33.7 m -66.58 -36.93 83.82 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.731 -0.388 . . . . 0.90000000000000002 110.402 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.94 -37.46 86.08 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.285 0.564 . . . . 0.90000000000000002 109.922 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.402 ' HB3' ' O ' ' A' ' 108' ' ' MET . 59.9 t80 -61.15 -46.63 89.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.15 -0.932 . . . . 0.90000000000000002 110.524 174.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.552 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.5 mmt -58.77 -43.85 90.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.511 . . . . 0.90000000000000002 110.734 178.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -62.33 -33.93 75.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.005 -0.543 . . . . 0.90000000000000002 110.985 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.54 -36.2 68.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.352 -0.385 . . . . 0.90000000000000002 111.247 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 79' ' ' GLN . 11.1 mp -90.66 7.98 36.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.408 -0.36 . . . . 0.90000000000000002 111.34 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.24 68.09 1.68 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.043 -0.599 . . . . 0.90000000000000002 112.82 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 57.9 m-85 -117.85 151.6 37.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.135 0.493 . . . . 0.90000000000000002 111.026 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.682 ' HB ' ' HB2' ' A' ' 125' ' ' GLU . 24.3 m -91.4 136.0 33.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.431 -0.804 . . . . 0.90000000000000002 109.37 176.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 41.7 p -101.29 108.65 20.35 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.82 -0.352 . . . . 0.90000000000000002 111.423 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -95.96 160.57 14.39 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.254 -0.647 . . . . 0.90000000000000002 109.254 172.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -78.86 88.01 4.7 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.253 0.549 . . . . 0.90000000000000002 109.767 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.98 3.84 6.81 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.518 -0.764 . . . . 0.90000000000000002 112.884 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.438 ' HA3' ' CZ2' ' A' ' 96' ' ' TRP . . . 173.15 173.59 39.63 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.485 -0.864 . . . . 0.90000000000000002 112.358 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -116.0 150.65 36.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.231 -0.285 . . . . 0.90000000000000002 110.231 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.682 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 53.1 mt-10 -126.51 156.38 40.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.774 0.321 . . . . 0.90000000000000002 111.03 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.422 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 56.2 tttp -137.35 121.2 17.55 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.591 -0.522 . . . . 0.90000000000000002 109.591 167.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.7 t -86.31 105.27 16.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.243 -0.435 . . . . 0.90000000000000002 110.148 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 CA-C-N 115.884 -0.598 . . . . 0.90000000000000002 112.43 -179.76 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 110.373 -0.232 . . . . 0.90000000000000002 110.373 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 42' ' ' ALA . 59.7 tp -83.82 111.69 19.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.15 -0.685 . . . . 0.90000000000000002 109.15 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.401 ' HB ' ' HB3' ' A' ' 43' ' ' ARG . 7.2 m -82.78 89.56 6.8 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.215 0.531 . . . . 0.90000000000000002 109.794 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 tt -102.65 118.78 50.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.415 0.626 . . . . 0.90000000000000002 109.982 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.8 mt -114.87 150.96 16.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.591 -0.731 . . . . 0.90000000000000002 110.416 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.512 ' HB3' ' CE2' ' A' ' 40' ' ' TYR . 17.1 ptt180 -91.61 119.07 31.19 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.572 -0.74 . . . . 0.90000000000000002 109.567 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.79 72.91 1.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.913 -0.585 . . . . 0.90000000000000002 111.127 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -96.15 -9.06 31.54 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.939 -1.134 . . . . 0.90000000000000002 107.939 171.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -143.08 143.68 31.95 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.181 -1.372 . . . . 0.90000000000000002 108.1 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -124.63 145.96 49.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.142 0.496 . . . . 0.90000000000000002 111.571 -173.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -119.31 177.52 4.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.479 -0.934 . . . . 0.90000000000000002 108.479 172.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -75.06 -34.53 61.83 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.505 -0.478 . . . . 0.90000000000000002 110.487 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -64.7 -53.79 41.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.556 -0.293 . . . . 0.90000000000000002 110.583 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -62.69 -31.86 72.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.90000000000000002 110.738 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -63.24 -40.25 96.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.05 -0.523 . . . . 0.90000000000000002 109.833 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.1 mt -77.94 -26.0 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.067 -0.515 . . . . 0.90000000000000002 110.948 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.469 ' HB3' HD11 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -72.67 -35.53 67.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.968 0.413 . . . . 0.90000000000000002 110.362 174.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.04 -30.65 71.71 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.539 -0.541 . . . . 0.90000000000000002 109.539 170.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -72.08 -21.92 61.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.328 -0.851 . . . . 0.90000000000000002 110.536 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -72.59 -33.55 66.81 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.529 -0.545 . . . . 0.90000000000000002 109.529 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.4 mm -75.4 -51.73 20.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.57 -0.741 . . . . 0.90000000000000002 110.188 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -119.27 110.29 37.87 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.207 -0.451 . . . . 0.90000000000000002 110.112 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo . . . . . 0 CA--C 1.527 0.156 0 C-N-CA 122.684 2.256 . . . . 0.90000000000000002 111.762 178.539 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 CA--C 1.52 -0.186 0 CA-C-O 121.154 0.502 . . . . 0.90000000000000002 109.844 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.35 95.43 1.03 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.552 -0.749 . . . . 0.90000000000000002 109.931 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -102.55 165.17 3.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.284 0.564 . . . . 0.90000000000000002 111.94 -174.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.75 -164.51 0.91 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.778 -1.101 . . . . 0.90000000000000002 108.049 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.54 -24.41 61.12 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.8 -0.36 . . . . 0.90000000000000002 111.546 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.516 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 33.9 m-80 -87.15 -62.78 1.43 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.002 -0.37 . . . . 0.90000000000000002 110.002 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.605 ' HB2' HG21 ' A' ' 55' ' ' THR . 77.9 t60 -87.0 97.98 11.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 0.90000000000000002 110.12 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -111.73 148.68 32.95 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.689 -0.687 . . . . 0.90000000000000002 110.516 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.582 HG12 ' HG2' ' A' ' 53' ' ' ARG . 68.9 mt -115.46 118.06 57.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.506 -0.553 . . . . 0.90000000000000002 109.506 175.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.512 ' CE2' ' HB3' ' A' ' 7' ' ' ARG . 79.1 m-85 -103.01 122.43 44.6 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.689 -0.486 . . . . 0.90000000000000002 109.689 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.91 128.71 56.54 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.906 0.384 . . . . 0.90000000000000002 110.884 -177.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.683 ' HB1' ' HB3' ' A' ' 50' ' ' ALA . . . -92.22 103.96 16.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.768 -0.651 . . . . 0.90000000000000002 110.21 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.401 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 14.7 ttt85 -85.74 104.64 15.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.902 -1.044 . . . . 0.90000000000000002 109.569 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -123.95 115.39 21.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.224 -0.444 . . . . 0.90000000000000002 109.913 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 61.97 60.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.635 -0.711 . . . . 0.90000000000000002 111.645 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 67.92 10.38 7.76 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.184 0.809 . . . . 0.90000000000000002 113.184 170.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -149.5 155.89 41.09 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.345 -0.242 . . . . 0.90000000000000002 110.345 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 18' ' ' ASP . 69.1 mt -75.82 110.99 10.71 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.545 -0.539 . . . . 0.90000000000000002 109.545 173.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.6 tp -94.61 -26.96 16.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.168 -0.469 . . . . 0.90000000000000002 110.332 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.683 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . . . -137.49 145.03 42.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.087 -0.506 . . . . 0.90000000000000002 111.217 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.39 121.66 21.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.221 -0.445 . . . . 0.90000000000000002 110.255 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.474 HG13 ' HB2' ' A' ' 40' ' ' TYR . 7.6 p -126.2 121.09 58.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.35 0.595 . . . . 0.90000000000000002 110.551 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.763 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 9.8 mtp180 -103.08 138.96 39.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.977 -0.556 . . . . 0.90000000000000002 110.108 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -137.76 135.9 45.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.954 0.407 . . . . 0.90000000000000002 110.31 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.605 HG21 ' HB2' ' A' ' 37' ' ' HIS . 6.7 m -117.91 100.64 7.71 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.127 0.489 . . . . 0.90000000000000002 110.124 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.6 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 49.0 mt -78.52 160.84 27.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.681 -0.691 . . . . 0.90000000000000002 110.371 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.6 m -154.43 83.4 1.12 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.154 0.502 . . . . 0.90000000000000002 109.652 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.9 -120.54 8.78 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.577 -0.738 . . . . 0.90000000000000002 112.289 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 p -82.26 -6.84 59.51 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.015 0.436 . . . . 0.90000000000000002 111.504 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.533 ' HG2' ' HB3' ' A' ' 94' ' ' CYS . 44.8 mt-10 -112.41 159.98 18.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.953 -0.567 . . . . 0.90000000000000002 110.33 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' A' ' 56' ' ' LEU . . . -153.74 116.07 0.71 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.934 -0.65 . . . . 0.90000000000000002 111.563 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.86 140.87 32.38 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.234 -0.284 . . . . 0.90000000000000002 110.234 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.476 HD21 ' HE2' ' A' ' 97' ' ' MET . 0.6 OUTLIER -93.38 130.74 39.06 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.263 -0.643 . . . . 0.90000000000000002 109.263 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.763 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 3.4 t70 -120.49 99.26 6.46 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.501 -0.772 . . . . 0.90000000000000002 110.95 -171.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.8 t 70.72 111.41 0.06 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.954 0.883 . . . . 0.90000000000000002 111.905 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.1 tp -117.25 126.01 52.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.208 -0.906 . . . . 0.90000000000000002 109.481 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 68.0 ttt-85 -143.84 110.98 5.77 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.261 -0.576 . . . . 0.90000000000000002 111.959 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.499 HG13 ' HB1' ' A' ' 50' ' ' ALA . 17.1 t -98.32 146.31 8.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.634 -1.247 . . . . 0.90000000000000002 107.634 166.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 69' ' ' ARG . 16.0 ttt180 -57.42 136.53 56.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.792 -0.447 . . . . 0.90000000000000002 109.792 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -54.89 -27.87 46.22 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.325 0.65 . . . . 0.90000000000000002 112.554 -168.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.8 t -69.38 -14.31 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.373 -0.376 . . . . 0.90000000000000002 111.351 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.11 18.47 9.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.334 0.587 . . . . 0.90000000000000002 110.669 -177.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -62.32 119.45 9.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.807 -0.633 . . . . 0.90000000000000002 110.496 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.4 mtt-85 63.89 67.88 0.6 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.493 -0.776 . . . . 0.90000000000000002 111.326 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -165.56 59.16 0.11 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.198 0.444 . . . . 0.90000000000000002 112.198 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.83 -59.45 1.33 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 115.724 1.05 . . . . 0.90000000000000002 115.724 167.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.1 t -42.77 -50.51 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 113.761 1.023 . . . . 0.90000000000000002 113.761 -167.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.78 -49.0 73.68 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.517 -0.849 . . . . 0.90000000000000002 112.987 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.514 ' HA ' HD21 ' A' ' 115' ' ' LEU . 46.3 tt0 -68.28 -39.1 82.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.991 0.424 . . . . 0.90000000000000002 110.402 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -61.01 -45.82 93.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.721 -0.672 . . . . 0.90000000000000002 110.158 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.492 HD12 ' HB2' ' A' ' 42' ' ' ALA . 1.2 mp -51.85 -57.56 8.99 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.825 -0.625 . . . . 0.90000000000000002 111.817 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.443 HD13 ' HE2' ' A' ' 97' ' ' MET . 4.0 mm? -56.19 -48.27 76.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.90000000000000002 111.434 -176.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -69.04 -33.9 74.35 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.65 -0.42 . . . . 0.90000000000000002 111.437 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -65.02 -42.67 94.18 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.012 0.434 . . . . 0.90000000000000002 110.206 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 81' ' ' LEU . 88.2 t -62.56 -48.66 87.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.90000000000000002 110.713 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.2 -20.53 65.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.90000000000000002 111.15 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -80.34 -52.89 7.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.144 -0.48 . . . . 0.90000000000000002 111.175 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -73.51 -19.12 61.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.90000000000000002 111.621 -172.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -113.57 83.5 7.12 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.17 -0.307 . . . . 0.90000000000000002 110.17 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -86.0 -0.67 8.56 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.641 2.227 . . . . 0.90000000000000002 113.153 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -82.96 -14.89 74.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.682 -0.771 . . . . 0.90000000000000002 112.371 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.443 HG22 HD23 ' A' ' 56' ' ' LEU . 38.5 t -92.06 120.94 42.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.811 0.339 . . . . 0.90000000000000002 110.309 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 128' ' ' GLY . 7.4 t -96.89 -26.14 15.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.37 -0.377 . . . . 0.90000000000000002 110.431 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.533 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 22.9 t -118.44 104.88 11.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.317 -0.402 . . . . 0.90000000000000002 110.536 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.427 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 91.9 m95 -96.47 112.35 24.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.268 -0.424 . . . . 0.90000000000000002 110.424 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -100.85 134.17 44.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.901 -0.59 . . . . 0.90000000000000002 109.714 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.697 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 92.1 mmm -106.95 106.59 17.19 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.65 -0.5 . . . . 0.90000000000000002 109.65 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.17 141.31 29.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.004 0.43 . . . . 0.90000000000000002 110.788 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 102' ' ' VAL . 19.1 p-10 -90.23 -46.46 8.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.893 -0.594 . . . . 0.90000000000000002 110.535 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 66.24 -66.06 0.18 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.476 0.71 . . . . 0.90000000000000002 111.786 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -145.0 37.5 1.33 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.165 -0.54 . . . . 0.90000000000000002 111.863 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 99' ' ' ASP . 75.0 t -82.84 105.95 13.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.988 0.423 . . . . 0.90000000000000002 110.342 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -85.52 -34.22 21.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.732 -0.667 . . . . 0.90000000000000002 109.914 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.57 56.87 2.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.866 -0.606 . . . . 0.90000000000000002 110.151 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -61.04 -42.66 98.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.561 -0.745 . . . . 0.90000000000000002 111.112 -175.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.28 -52.77 47.12 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.909 -0.662 . . . . 0.90000000000000002 112.549 -177.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.79 -45.15 87.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.90000000000000002 111.129 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.554 ' O ' ' HG2' ' A' ' 112' ' ' MET . 69.3 mtp -75.5 -23.31 56.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.414 -0.357 . . . . 0.90000000000000002 111.957 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 80.9 m -71.41 -39.28 71.22 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.726 -0.39 . . . . 0.90000000000000002 110.136 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.4 -39.84 92.21 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.247 0.546 . . . . 0.90000000000000002 109.664 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -60.56 -52.88 63.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.136 -0.938 . . . . 0.90000000000000002 110.765 174.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.554 ' HG2' ' O ' ' A' ' 108' ' ' MET . 25.5 mmt -58.03 -45.87 86.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.90000000000000002 111.416 -177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -65.02 -30.54 71.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.945 0.402 . . . . 0.90000000000000002 110.815 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.64 -23.22 61.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.872 0.368 . . . . 0.90000000000000002 110.814 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.514 HD21 ' HA ' ' A' ' 79' ' ' GLN . 11.2 mp -98.0 4.73 49.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.191 -0.459 . . . . 0.90000000000000002 111.016 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.99 23.27 52.9 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.98 -0.629 . . . . 0.90000000000000002 113.462 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.528 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 88.8 m-85 -91.73 141.55 28.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.026 0.413 . . . . 0.90000000000000002 110.413 176.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.7 m -96.27 132.63 41.54 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.181 -0.463 . . . . 0.90000000000000002 110.383 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.432 ' HB ' ' CD1' ' A' ' 124' ' ' TRP . 3.0 t -97.29 126.88 42.79 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.439 -0.578 . . . . 0.90000000000000002 109.439 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -121.01 -72.75 0.67 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.459 0.647 . . . . 0.90000000000000002 110.745 -174.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -116.87 -142.91 0.37 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.209 -0.905 . . . . 0.90000000000000002 108.752 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.94 62.73 0.72 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.722 -0.751 . . . . 0.90000000000000002 111.533 170.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.04 164.88 14.57 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.743 -0.543 . . . . 0.90000000000000002 111.743 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.697 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 14.4 m-90 -112.98 157.15 21.86 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.646 -0.501 . . . . 0.90000000000000002 109.646 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -141.09 139.37 34.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.792 0.329 . . . . 0.90000000000000002 110.543 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 95' ' ' TRP . 86.3 tttt -137.01 122.82 19.99 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.135 -0.691 . . . . 0.90000000000000002 109.135 173.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 31.2 t -74.2 142.01 45.43 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.895 0.379 . . . . 0.90000000000000002 110.719 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 93' ' ' SER . . . . . . . . 0 N--CA 1.448 -0.5 0 CA-C-N 116.105 -0.498 . . . . 0.90000000000000002 111.992 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.513 -0.551 . . . . 0.90000000000000002 109.513 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.512 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 54.4 tp -75.71 108.33 8.48 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.698 -0.853 . . . . 0.90000000000000002 108.698 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.0 m -82.85 92.86 7.36 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.205 0.526 . . . . 0.90000000000000002 110.579 -173.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' A' ' 40' ' ' TYR . 7.9 tp -89.92 113.49 26.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.441 -0.799 . . . . 0.90000000000000002 109.694 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.5 mt -121.1 157.48 24.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.981 -0.554 . . . . 0.90000000000000002 110.096 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 47.7 ttt-85 -90.25 125.23 35.42 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.108 -0.701 . . . . 0.90000000000000002 109.108 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.08 128.12 35.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.218 0.533 . . . . 0.90000000000000002 111.717 -177.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -102.5 -51.49 3.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.381 -0.827 . . . . 0.90000000000000002 110.718 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -124.39 164.18 20.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.715 -0.675 . . . . 0.90000000000000002 110.241 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -136.46 114.02 10.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.162 -0.472 . . . . 0.90000000000000002 110.637 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.7 p -93.16 175.18 6.87 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.568 -0.901 . . . . 0.90000000000000002 108.568 170.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.88 -38.16 81.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.782 0.325 . . . . 0.90000000000000002 110.667 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -64.68 -44.97 88.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.07 -0.514 . . . . 0.90000000000000002 110.517 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -61.79 -49.77 75.03 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.179 0.514 . . . . 0.90000000000000002 110.14 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -58.88 -47.1 86.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.279 -0.873 . . . . 0.90000000000000002 111.069 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.8 mt -67.37 -36.38 76.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.483 -0.326 . . . . 0.90000000000000002 111.54 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -68.79 -41.33 78.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.558 -0.457 . . . . 0.90000000000000002 110.04 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.76 -43.47 93.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.90000000000000002 110.727 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -77.33 -1.4 29.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.427 0.632 . . . . 0.90000000000000002 110.284 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -93.34 -33.5 13.87 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.265 -0.642 . . . . 0.90000000000000002 109.265 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.5 mt -68.94 -44.65 81.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.852 -0.613 . . . . 0.90000000000000002 109.435 174.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -100.48 97.03 5.88 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.611 -0.885 . . . . 0.90000000000000002 108.611 170.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 N--CA 1.476 0.454 0 C-N-CA 123.176 2.584 . . . . 0.90000000000000002 114.189 -169.349 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.8 mt . . . . . 0 N--CA 1.461 0.09 0 CA-C-O 121.093 0.473 . . . . 0.90000000000000002 110.376 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -73.34 141.1 47.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.729 -0.668 . . . . 0.90000000000000002 110.062 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.1 149.56 24.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.95 0.405 . . . . 0.90000000000000002 110.76 -177.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -147.95 -162.38 1.54 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.753 -0.832 . . . . 0.90000000000000002 108.753 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -84.57 -24.2 29.33 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.164 -0.614 . . . . 0.90000000000000002 110.955 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -86.01 -49.99 7.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.396 0.617 . . . . 0.90000000000000002 109.416 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -94.01 101.48 13.52 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.666 -0.865 . . . . 0.90000000000000002 108.666 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -109.1 137.75 46.52 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.02 0.438 . . . . 0.90000000000000002 111.41 -173.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.521 HG12 ' HG2' ' A' ' 53' ' ' ARG . 57.8 mt -108.18 112.37 39.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.646 -0.872 . . . . 0.90000000000000002 108.646 170.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.505 ' HB3' HD12 ' A' ' 5' ' ' ILE . 11.7 m-85 -94.27 137.02 33.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.235 -0.439 . . . . 0.90000000000000002 109.982 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.498 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -118.66 116.31 26.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.894 -0.594 . . . . 0.90000000000000002 110.47 -176.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.623 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . . . -92.31 91.51 7.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.924 -0.58 . . . . 0.90000000000000002 109.68 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.502 ' HB3' HD23 ' A' ' 48' ' ' LEU . 13.5 ptm180 -92.21 133.02 36.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.033 -0.53 . . . . 0.90000000000000002 110.573 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -108.94 99.43 8.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.817 -0.628 . . . . 0.90000000000000002 109.716 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 67.22 -69.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.044 -0.98 . . . . 0.90000000000000002 112.309 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -101.17 -59.82 1.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.244 0.461 . . . . 0.90000000000000002 112.244 -170.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -132.81 -177.51 4.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.942 0.401 . . . . 0.90000000000000002 111.944 -171.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 43' ' ' ARG . 21.8 mt -78.32 113.32 16.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.602 -0.726 . . . . 0.90000000000000002 111.219 -171.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.436 HD12 ' HD2' ' A' ' 69' ' ' ARG . 46.5 tp -89.72 -30.43 18.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.943 0.401 . . . . 0.90000000000000002 110.736 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . . . -142.49 146.48 34.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.232 -0.44 . . . . 0.90000000000000002 110.777 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -133.62 133.81 42.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.268 -0.423 . . . . 0.90000000000000002 110.483 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.466 ' HB ' HD13 ' A' ' 66' ' ' LEU . 10.2 p -148.34 140.58 18.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.304 -0.407 . . . . 0.90000000000000002 110.962 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.661 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 23.8 mtp85 -100.07 150.91 21.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.471 -0.332 . . . . 0.90000000000000002 110.235 175.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.9 p -151.22 138.93 13.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.011 0.434 . . . . 0.90000000000000002 110.779 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.1 m -111.99 115.82 29.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.085 -0.507 . . . . 0.90000000000000002 109.769 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.3 mt -99.45 86.87 3.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.3 0.571 . . . . 0.90000000000000002 110.744 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -95.08 77.98 3.53 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.579 -0.737 . . . . 0.90000000000000002 110.207 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.81 -85.98 0.28 Allowed Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.774 -0.648 . . . . 0.90000000000000002 112.879 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.6 p -114.9 -2.22 12.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.962 0.411 . . . . 0.90000000000000002 111.135 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -104.31 125.69 50.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.90000000000000002 110.487 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.37 96.24 0.72 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.314 -0.714 . . . . 0.90000000000000002 111.314 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -98.48 113.57 25.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.796 0.331 . . . . 0.90000000000000002 111.153 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.545 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 5.9 mp -93.87 116.55 29.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.238 -0.437 . . . . 0.90000000000000002 110.224 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.661 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 22.2 m-20 -109.38 131.59 54.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.755 -0.657 . . . . 0.90000000000000002 109.692 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.8 m 61.11 98.89 0.03 OUTLIER 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.573 0.701 . . . . 0.90000000000000002 112.06 175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.466 HD13 ' HB ' ' A' ' 52' ' ' VAL . 22.2 tp -123.89 118.28 26.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.611 -0.722 . . . . 0.90000000000000002 110.099 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -143.98 139.26 28.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.196 0.522 . . . . 0.90000000000000002 111.223 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.1 m -101.71 169.26 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.386 -0.824 . . . . 0.90000000000000002 109.868 173.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.436 ' HD2' HD12 ' A' ' 49' ' ' LEU . 95.2 mtt180 -65.75 157.18 30.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.852 -0.425 . . . . 0.90000000000000002 109.852 172.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 6.6 tp10 -56.5 -39.08 72.66 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.051 0.389 . . . . 0.90000000000000002 112.051 -172.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.79 36.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.148 0.499 . . . . 0.90000000000000002 110.65 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 m -127.21 4.91 6.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.3 0.571 . . . . 0.90000000000000002 110.944 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 8.4 mtm180 -81.1 130.14 34.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.353 -0.385 . . . . 0.90000000000000002 110.74 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.9 mtp-105 62.55 36.56 13.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.756 -0.656 . . . . 0.90000000000000002 111.261 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -125.43 17.91 8.22 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.761 -0.376 . . . . 0.90000000000000002 112.012 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.08 -37.98 2.18 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.08 -0.581 . . . . 0.90000000000000002 114.438 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.5 t -48.33 -44.83 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 112.664 0.616 . . . . 0.90000000000000002 112.664 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.78 97.57 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.854 -0.689 . . . . 0.90000000000000002 112.878 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.431 ' HG3' HD22 ' A' ' 115' ' ' LEU . 53.2 tt0 -65.35 -39.21 92.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.033 0.444 . . . . 0.90000000000000002 110.027 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.512 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 30.0 t80 -59.05 -49.35 78.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.513 -0.767 . . . . 0.90000000000000002 110.238 175.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.433 HD13 HD13 ' A' ' 5' ' ' ILE . 51.6 tp -50.82 -54.12 26.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.851 -0.613 . . . . 0.90000000000000002 112.064 -176.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.412 ' O ' HD13 ' A' ' 86' ' ' LEU . 3.9 mm? -63.73 -50.42 69.19 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.104 -0.238 . . . . 0.90000000000000002 111.396 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -66.21 -25.86 67.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.568 -0.287 . . . . 0.90000000000000002 111.584 -176.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -65.97 -46.8 76.76 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.157 -0.312 . . . . 0.90000000000000002 110.157 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 81' ' ' LEU . 57.9 t -62.67 -44.41 99.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.90000000000000002 110.952 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.451 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 11.2 mp -65.99 -27.9 68.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.90000000000000002 111.244 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.8 ttp85 -87.6 -19.31 27.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.114 -0.494 . . . . 0.90000000000000002 110.583 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.467 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 9.7 t30 -81.62 -46.24 14.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.108 -0.496 . . . . 0.90000000000000002 110.663 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -102.82 97.83 10.11 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 0.90000000000000002 109.981 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 83.0 Cg_endo -89.41 148.48 5.28 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.809 2.339 . . . . 0.90000000000000002 113.498 -173.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.83 7.26 78.43 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.689 -0.687 . . . . 0.90000000000000002 113.481 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.72 116.73 20.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.717 -0.475 . . . . 0.90000000000000002 109.717 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.1 m -77.49 -32.41 54.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.92 -0.582 . . . . 0.90000000000000002 112.18 -172.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.0 t -127.49 103.88 7.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.768 0.318 . . . . 0.90000000000000002 111.458 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.451 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 98.0 m95 -94.41 98.32 10.8 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.491 -0.559 . . . . 0.90000000000000002 109.491 171.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.491 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 63.6 t-105 -101.96 120.48 40.47 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.81 -0.632 . . . . 0.90000000000000002 110.081 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.545 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 73.6 mtp -111.75 126.74 55.38 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.927 0.394 . . . . 0.90000000000000002 110.571 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.63 99.17 5.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.905 -0.589 . . . . 0.90000000000000002 111.133 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.405 ' HB3' ' HB ' ' A' ' 102' ' ' VAL . 7.7 m-20 -76.37 -31.86 58.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.823 -0.626 . . . . 0.90000000000000002 110.602 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 67.93 -71.54 0.11 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.352 -0.84 . . . . 0.90000000000000002 112.004 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -101.53 40.68 2.34 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.976 -0.63 . . . . 0.90000000000000002 112.978 -174.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.487 HG11 ' HG2' ' A' ' 105' ' ' ARG . 13.2 p -81.7 125.43 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 110.011 -0.366 . . . . 0.90000000000000002 110.011 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -90.38 -30.7 17.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.189 0.519 . . . . 0.90000000000000002 109.724 177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.15 45.63 0.75 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.208 -0.905 . . . . 0.90000000000000002 110.387 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.487 ' HG2' HG11 ' A' ' 102' ' ' VAL . 22.0 mtm180 -55.21 -47.08 75.82 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.948 0.351 . . . . 0.90000000000000002 111.948 -172.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.76 -48.28 85.06 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.786 -0.721 . . . . 0.90000000000000002 112.406 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.16 -41.77 92.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.994 0.426 . . . . 0.90000000000000002 110.653 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.497 ' O ' ' HG2' ' A' ' 112' ' ' MET . 10.3 tpt -64.75 -39.03 92.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.58 . . . . 0.90000000000000002 110.378 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 85.5 m -65.02 -38.84 92.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.702 0.287 . . . . 0.90000000000000002 110.698 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.6 -41.48 99.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.204 0.525 . . . . 0.90000000000000002 110.137 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -63.15 -42.4 99.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.529 -0.759 . . . . 0.90000000000000002 110.337 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.512 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 24.7 mmt -61.71 -39.33 91.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.514 . . . . 0.90000000000000002 111.024 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -70.74 -21.15 62.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.482 -0.326 . . . . 0.90000000000000002 111.252 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.98 -26.72 39.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.115 0.483 . . . . 0.90000000000000002 110.375 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.431 HD22 ' HG3' ' A' ' 79' ' ' GLN . 92.1 mt -84.51 -37.76 20.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.767 -0.651 . . . . 0.90000000000000002 110.572 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.08 25.98 3.39 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.949 -0.569 . . . . 0.90000000000000002 112.311 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 39.7 m-85 -95.9 142.49 28.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.798 0.332 . . . . 0.90000000000000002 110.99 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.6 m -104.74 148.45 26.59 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.233 -0.654 . . . . 0.90000000000000002 109.233 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.9 m -97.19 112.23 24.12 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.035 -0.357 . . . . 0.90000000000000002 110.035 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -135.46 133.89 39.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.082 -0.508 . . . . 0.90000000000000002 110.484 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 58.13 30.02 18.75 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.528 0.566 . . . . 0.90000000000000002 112.528 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.82 -4.03 78.33 Favored Glycine 0 CA--C 1.517 0.172 0 C-N-CA 120.752 -0.737 . . . . 0.90000000000000002 113.237 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -129.17 -179.46 15.97 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.726 -0.749 . . . . 0.90000000000000002 111.259 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.432 ' CD1' ' HG3' ' A' ' 112' ' ' MET . 26.6 m-90 -112.22 137.49 50.24 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.694 -0.484 . . . . 0.90000000000000002 109.694 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 24.7 tt0 -132.52 137.24 47.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.024 0.44 . . . . 0.90000000000000002 110.982 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -119.4 102.54 8.75 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.331 -0.989 . . . . 0.90000000000000002 108.331 169.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.5 t -78.11 141.61 38.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.02 -0.536 . . . . 0.90000000000000002 110.754 -174.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 CA-C-N 115.829 -0.623 . . . . 0.90000000000000002 111.723 178.498 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 tttm . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.065 -0.717 . . . . 0.90000000000000002 109.065 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.5 tp -75.73 115.81 15.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.013 0.435 . . . . 0.90000000000000002 110.311 -175.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.3 m -88.37 89.56 8.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.83 -0.623 . . . . 0.90000000000000002 110.312 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.479 HD12 ' HB3' ' A' ' 40' ' ' TYR . 9.4 tt -96.23 132.57 40.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.003 0.43 . . . . 0.90000000000000002 110.357 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.82 141.08 44.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.226 0.536 . . . . 0.90000000000000002 110.625 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -79.33 126.9 31.4 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.811 -0.631 . . . . 0.90000000000000002 109.745 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.9 mt -84.62 95.46 8.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.789 0.328 . . . . 0.90000000000000002 110.824 -176.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -110.49 -8.27 14.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.049 -0.523 . . . . 0.90000000000000002 110.0 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -135.1 141.37 46.01 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.93 -0.767 . . . . 0.90000000000000002 108.93 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -130.03 115.68 17.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.143 0.497 . . . . 0.90000000000000002 112.276 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.3 m -100.08 164.18 12.1 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.625 -0.88 . . . . 0.90000000000000002 108.625 168.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -59.9 -37.98 80.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.623 0.249 . . . . 0.90000000000000002 110.855 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -55.14 -49.99 70.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.842 -0.617 . . . . 0.90000000000000002 111.121 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -67.1 -37.91 84.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.726 -0.67 . . . . 0.90000000000000002 110.639 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -68.13 -40.61 82.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.90000000000000002 111.059 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.8 mt -61.68 -36.6 74.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.795 0.331 . . . . 0.90000000000000002 110.383 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -44.18 92.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 0.90000000000000002 110.153 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.83 -40.0 96.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.889 -0.596 . . . . 0.90000000000000002 110.93 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -72.52 -15.84 61.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.078 0.466 . . . . 0.90000000000000002 110.568 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -84.76 -27.84 26.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.956 -0.565 . . . . 0.90000000000000002 109.684 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.2 mt -82.66 -37.28 14.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.739 -0.664 . . . . 0.90000000000000002 109.9 175.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.605 ' HD1' ' HD2' ' A' ' 67' ' ' ARG . 2.8 m0 -111.26 87.15 7.12 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.90000000000000002 109.782 175.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--N 1.343 0.265 0 C-N-CA 122.499 2.133 . . . . 0.90000000000000002 112.398 -176.565 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 CA--C 1.519 -0.236 0 CA-C-O 121.528 0.68 . . . . 0.90000000000000002 109.727 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -133.8 -179.58 5.63 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.044 -0.98 . . . . 0.90000000000000002 110.078 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.7 m -130.98 162.29 39.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.263 0.554 . . . . 0.90000000000000002 111.084 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -125.64 163.52 22.6 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.003 -1.11 . . . . 0.90000000000000002 108.003 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -60.68 -28.21 68.44 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.897 0.379 . . . . 0.90000000000000002 110.533 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -93.29 -46.06 7.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.926 -0.579 . . . . 0.90000000000000002 110.253 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -93.52 94.13 8.48 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.209 -0.45 . . . . 0.90000000000000002 110.015 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.3 mtp85 -110.95 149.49 30.58 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.642 0.258 . . . . 0.90000000000000002 110.971 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.4 mt -120.09 134.46 63.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.366 -0.379 . . . . 0.90000000000000002 110.284 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.479 ' HB3' HD12 ' A' ' 5' ' ' ILE . 81.8 m-85 -113.84 139.52 49.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.729 -0.471 . . . . 0.90000000000000002 109.729 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.466 ' HB3' HD23 ' A' ' 48' ' ' LEU . . . -119.57 121.34 39.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.939 0.4 . . . . 0.90000000000000002 110.793 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -92.18 100.51 13.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.133 -0.485 . . . . 0.90000000000000002 109.798 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -93.33 119.75 32.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.723 -0.672 . . . . 0.90000000000000002 110.591 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -99.01 92.23 5.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.147 -0.479 . . . . 0.90000000000000002 110.014 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.8 t30 69.36 -68.17 0.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.225 -0.898 . . . . 0.90000000000000002 112.051 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -105.84 -53.29 2.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.783 0.325 . . . . 0.90000000000000002 111.758 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.436 ' HG2' ' H ' ' A' ' 48' ' ' LEU . 35.7 ttt180 -127.47 174.18 9.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.552 -0.295 . . . . 0.90000000000000002 110.727 -168.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.466 HD23 ' HB3' ' A' ' 41' ' ' ALA . 63.5 mt -73.17 123.74 24.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.876 0.37 . . . . 0.90000000000000002 110.355 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.69 HD12 ' HD3' ' A' ' 69' ' ' ARG . 39.9 tp -95.04 -34.11 12.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.024 -0.535 . . . . 0.90000000000000002 110.16 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.503 ' HB2' HG11 ' A' ' 68' ' ' VAL . . . -143.22 140.52 30.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.821 -0.627 . . . . 0.90000000000000002 110.665 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.82 130.49 51.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.216 -0.447 . . . . 0.90000000000000002 110.182 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 65' ' ' SER . 11.9 p -142.46 142.27 27.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.424 -0.353 . . . . 0.90000000000000002 110.706 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.1 mtm180 -112.4 159.03 19.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.891 0.376 . . . . 0.90000000000000002 110.735 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.59 128.99 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.356 0.598 . . . . 0.90000000000000002 110.857 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.5 m -104.83 97.98 7.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.872 -0.604 . . . . 0.90000000000000002 110.011 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.497 HD23 ' HA3' ' A' ' 61' ' ' GLY . 97.4 mt -80.34 126.14 30.78 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.048 -0.524 . . . . 0.90000000000000002 109.779 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.5 m -105.79 77.99 1.3 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.533 -0.543 . . . . 0.90000000000000002 109.533 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.87 -85.93 1.37 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.395 -0.907 . . . . 0.90000000000000002 111.271 -174.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.2 p -111.32 -63.33 1.42 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.197 0.523 . . . . 0.90000000000000002 110.452 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.521 ' HA ' HG12 ' A' ' 92' ' ' VAL . 30.1 mt-10 -76.04 147.51 38.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.47 -0.786 . . . . 0.90000000000000002 109.811 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.497 ' HA3' HD23 ' A' ' 56' ' ' LEU . . . -142.21 165.46 26.65 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.867 -1.159 . . . . 0.90000000000000002 113.504 -173.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -116.38 134.03 55.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.794 0.33 . . . . 0.90000000000000002 110.887 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 76.7 mt -93.83 132.93 37.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.032 -0.531 . . . . 0.90000000000000002 110.452 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -142.77 163.48 32.7 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.815 -0.439 . . . . 0.90000000000000002 109.815 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 36.0 m 54.59 86.61 0.05 OUTLIER 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.64 0.588 . . . . 0.90000000000000002 111.732 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.516 HD21 ' HE2' ' A' ' 108' ' ' MET . 55.9 tp -122.51 107.02 11.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.825 -0.625 . . . . 0.90000000000000002 109.832 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.605 ' HD2' ' HD1' ' A' ' 23' ' ' TRP . 34.8 mtt180 -130.18 105.82 8.19 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.151 -0.477 . . . . 0.90000000000000002 111.215 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 50' ' ' ALA . 8.9 t -95.91 146.95 6.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.293 -1.003 . . . . 0.90000000000000002 108.293 171.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.69 ' HD3' HD12 ' A' ' 49' ' ' LEU . 31.1 mtp85 -52.51 126.32 19.12 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.522 -0.547 . . . . 0.90000000000000002 109.522 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -58.03 -23.1 52.91 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.786 0.661 . . . . 0.90000000000000002 112.786 -169.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.4 t -66.29 -21.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.052 0.453 . . . . 0.90000000000000002 110.765 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.717 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 1.3 m -86.47 32.22 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.406 0.622 . . . . 0.90000000000000002 110.907 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -81.44 127.95 33.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.023 -0.535 . . . . 0.90000000000000002 110.84 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 61.35 35.79 17.8 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.804 -0.635 . . . . 0.90000000000000002 110.898 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.717 ' HD2' ' HA ' ' A' ' 72' ' ' THR . 95.3 mtt180 -112.91 2.69 15.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.90000000000000002 111.807 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.52 -12.18 52.8 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 121.003 -0.618 . . . . 0.90000000000000002 114.105 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.435 HG11 HD23 ' A' ' 49' ' ' LEU . 92.8 t -61.24 -43.88 97.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.275 0.538 . . . . 0.90000000000000002 111.773 -177.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.57 -33.93 79.21 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.63 -0.795 . . . . 0.90000000000000002 112.441 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -63.01 -47.44 83.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.953 0.406 . . . . 0.90000000000000002 110.278 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -61.76 -43.31 99.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.762 -0.653 . . . . 0.90000000000000002 110.594 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 44.2 tp -53.44 -55.86 21.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.866 -0.606 . . . . 0.90000000000000002 111.443 -177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.475 ' HB2' HD11 ' A' ' 115' ' ' LEU . 4.3 mm? -65.68 -40.39 92.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.424 -0.353 . . . . 0.90000000000000002 111.053 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 7.3 mm-40 -53.46 -50.74 64.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.79 0.329 . . . . 0.90000000000000002 111.145 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -60.49 -45.36 94.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.236 -0.438 . . . . 0.90000000000000002 110.8 -177.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.3 t -63.56 -49.46 82.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.42 -0.355 . . . . 0.90000000000000002 111.174 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.59 -20.3 66.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.90000000000000002 111.997 -176.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 42.8 mtm180 -92.91 -30.19 15.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.657 0.265 . . . . 0.90000000000000002 111.257 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.453 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 17.3 m-80 -82.09 -20.14 38.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.606 0.241 . . . . 0.90000000000000002 111.415 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -113.69 86.83 11.16 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.87 0.367 . . . . 0.90000000000000002 110.443 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 5.0 Cg_exo -81.05 -13.45 11.41 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.227 2.618 . . . . 0.90000000000000002 112.528 -176.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.05 -8.38 87.89 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.989 -0.624 . . . . 0.90000000000000002 112.497 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 60' ' ' GLU . 21.7 t -94.47 101.98 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.98 -0.378 . . . . 0.90000000000000002 109.98 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 p -77.92 -36.16 49.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.208 -0.451 . . . . 0.90000000000000002 111.445 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 51.6 t -116.36 116.04 26.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.311 -0.404 . . . . 0.90000000000000002 110.389 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -97.86 102.13 13.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.733 -0.667 . . . . 0.90000000000000002 109.899 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.504 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 35.8 t-105 -97.08 133.29 41.94 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.036 -0.728 . . . . 0.90000000000000002 109.036 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.544 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 47.1 mtp -114.36 130.03 56.67 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.992 0.425 . . . . 0.90000000000000002 109.982 176.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.5 160.75 14.65 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.473 -0.785 . . . . 0.90000000000000002 110.646 -176.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -87.22 -2.48 58.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.072 -0.513 . . . . 0.90000000000000002 109.985 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.47 114.23 5.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.90000000000000002 110.292 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.57 -14.25 59.28 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.586 -0.816 . . . . 0.90000000000000002 111.72 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.523 HG13 ' HG3' ' A' ' 108' ' ' MET . 55.1 t -89.76 97.63 7.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.352 0.596 . . . . 0.90000000000000002 110.125 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -76.78 -50.46 13.47 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.306 -0.861 . . . . 0.90000000000000002 109.77 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -91.09 92.92 8.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.708 -0.678 . . . . 0.90000000000000002 109.658 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -73.56 -23.76 60.01 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.322 -0.399 . . . . 0.90000000000000002 110.899 -176.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.25 -56.16 8.15 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.894 -0.669 . . . . 0.90000000000000002 112.567 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.3 t -66.15 -41.1 88.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.654 0.264 . . . . 0.90000000000000002 110.68 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.523 ' HG3' HG13 ' A' ' 102' ' ' VAL . 94.8 mmm -63.72 -37.72 88.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 0.90000000000000002 111.326 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 m -62.58 -45.88 90.88 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.995 -0.282 . . . . 0.90000000000000002 110.425 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.58 -40.58 95.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.969 0.414 . . . . 0.90000000000000002 110.617 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -58.72 -49.18 78.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.64 -0.709 . . . . 0.90000000000000002 110.825 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.537 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 64.9 mtt -69.76 -40.22 76.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.923 -0.58 . . . . 0.90000000000000002 111.511 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -61.4 -44.01 97.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.77 0.319 . . . . 0.90000000000000002 110.686 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.27 72.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.188 0.518 . . . . 0.90000000000000002 110.437 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.475 HD11 ' HB2' ' A' ' 82' ' ' LEU . 2.7 tt -68.19 -33.41 74.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.604 -0.725 . . . . 0.90000000000000002 109.92 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 132.75 1.59 4.13 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.619 -0.8 . . . . 0.90000000000000002 113.065 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.537 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 98.3 m-85 -83.19 174.1 11.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.039 0.447 . . . . 0.90000000000000002 110.863 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.1 m -149.73 151.35 33.5 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.192 -0.67 . . . . 0.90000000000000002 109.192 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.7 t -97.3 110.21 22.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.698 0.761 . . . . 0.90000000000000002 109.794 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -141.25 129.11 21.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.243 -0.89 . . . . 0.90000000000000002 110.286 -174.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.458 HE21 ' HB2' ' A' ' 121' ' ' GLN . 0.9 OUTLIER 63.42 32.68 14.31 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.208 0.528 . . . . 0.90000000000000002 111.361 176.271 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 111.14 -74.41 0.21 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.788 -0.72 . . . . 0.90000000000000002 112.562 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -91.09 -156.52 32.79 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.714 -0.755 . . . . 0.90000000000000002 112.295 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.544 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 26.6 m-90 -104.37 119.85 39.89 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.058 -0.349 . . . . 0.90000000000000002 110.058 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -119.36 117.83 29.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.27 -0.423 . . . . 0.90000000000000002 109.903 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -126.34 136.56 52.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.921 0.391 . . . . 0.90000000000000002 111.181 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 52.6 t -80.55 135.16 36.04 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.045 -0.525 . . . . 0.90000000000000002 109.775 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 C-N-CA 120.877 -0.677 . . . . 0.90000000000000002 112.137 179.464 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.7 mttp . . . . . 0 CA--C 1.519 -0.219 0 CA-C-O 120.887 0.375 . . . . 0.90000000000000002 110.18 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.445 HD23 ' HB1' ' A' ' 42' ' ' ALA . 43.8 tp -111.4 112.18 23.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.186 -0.461 . . . . 0.90000000000000002 110.111 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.1 m -82.76 94.04 7.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.084 0.469 . . . . 0.90000000000000002 110.532 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' A' ' 42' ' ' ALA . 12.7 tt -108.7 128.84 64.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.045 0.45 . . . . 0.90000000000000002 110.788 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.4 mt -124.19 155.31 31.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.927 -0.579 . . . . 0.90000000000000002 110.455 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.45 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 12.8 ptt180 -80.22 119.56 23.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.062 -0.517 . . . . 0.90000000000000002 109.801 174.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 41' ' ' ALA . 83.7 mt -76.78 88.11 3.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.209 0.528 . . . . 0.90000000000000002 110.679 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -102.18 8.59 40.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.823 0.82 . . . . 0.90000000000000002 109.258 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -157.54 142.97 17.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.947 -1.024 . . . . 0.90000000000000002 108.496 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -126.43 121.22 31.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.86 0.362 . . . . 0.90000000000000002 111.067 -177.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.2 170.46 8.24 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.107 -0.701 . . . . 0.90000000000000002 109.107 175.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 17' ' ' ILE . 4.0 m-20 -60.33 -46.47 89.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.726 0.298 . . . . 0.90000000000000002 110.732 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -59.11 -41.2 87.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.90000000000000002 111.022 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -62.35 -45.42 93.28 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.059 -0.519 . . . . 0.90000000000000002 110.564 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -59.27 -45.11 92.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.497 -0.32 . . . . 0.90000000000000002 110.886 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 13' ' ' ASP . 60.6 mt -67.01 -32.1 56.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.009 0.433 . . . . 0.90000000000000002 111.173 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -77.09 -38.69 51.85 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.54 -0.464 . . . . 0.90000000000000002 110.078 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.49 HD21 HD11 ' A' ' 22' ' ' ILE . 97.3 mt -61.65 -34.16 75.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.90000000000000002 110.294 174.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -64.35 -36.11 83.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.602 . . . . 0.90000000000000002 110.297 176.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -70.8 -21.99 62.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.08 -0.509 . . . . 0.90000000000000002 111.082 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.599 HD12 ' HB2' ' A' ' 48' ' ' LEU . 63.5 mt -79.09 -48.44 21.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.767 0.318 . . . . 0.90000000000000002 110.619 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.408 ' CD1' ' HD2' ' A' ' 67' ' ' ARG . 4.4 m0 -106.83 97.86 19.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.90000000000000002 111.027 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 12.9 Cg_exo . . . . . 0 C--N 1.341 0.163 0 C-N-CA 122.674 2.249 . . . . 0.90000000000000002 111.832 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 N--CA 1.461 0.115 0 N-CA-C 109.397 -0.594 . . . . 0.90000000000000002 109.397 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -62.68 115.94 4.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.287 -0.87 . . . . 0.90000000000000002 112.081 -172.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.512 HG13 ' HA ' ' A' ' 38' ' ' ARG . 73.3 t -112.31 118.32 57.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.457 -0.792 . . . . 0.90000000000000002 109.16 170.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 14.2 p-10 -100.0 -52.2 3.48 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.806 -0.442 . . . . 0.90000000000000002 109.806 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 16.9 t70 166.9 -40.4 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.608 -1.256 . . . . 0.90000000000000002 107.608 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -71.69 -56.14 6.37 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 114.755 -1.112 . . . . 0.90000000000000002 109.67 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -91.14 101.92 14.66 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.482 -0.933 . . . . 0.90000000000000002 108.482 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.512 ' HA ' HG13 ' A' ' 33' ' ' VAL . 12.0 ptp180 -123.56 142.34 51.12 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.099 0.476 . . . . 0.90000000000000002 111.112 -175.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.559 HG12 ' HG2' ' A' ' 53' ' ' ARG . 52.3 mt -107.19 134.42 48.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.757 -0.656 . . . . 0.90000000000000002 110.204 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.47 ' HB3' HD11 ' A' ' 5' ' ' ILE . 76.6 m-85 -111.05 121.6 45.77 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.45 -0.574 . . . . 0.90000000000000002 109.45 174.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.482 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -108.86 119.98 41.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.332 -0.395 . . . . 0.90000000000000002 110.832 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.686 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . . . -96.44 105.8 17.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.803 -0.635 . . . . 0.90000000000000002 110.827 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.512 ' HB3' HD21 ' A' ' 48' ' ' LEU . 4.9 ptm180 -107.54 134.31 50.74 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.063 -0.517 . . . . 0.90000000000000002 110.464 178.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -97.2 82.39 3.16 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.924 -0.399 . . . . 0.90000000000000002 109.924 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.2 t30 50.35 23.94 1.38 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.092 -0.958 . . . . 0.90000000000000002 112.522 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.65 ' HG2' ' HG3' ' A' ' 47' ' ' ARG . 38.3 tt0 -166.86 -89.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.999 -0.438 . . . . 0.90000000000000002 110.732 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.65 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 85.7 mtt180 -108.24 163.86 12.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.668 0.271 . . . . 0.90000000000000002 110.759 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.599 ' HB2' HD12 ' A' ' 22' ' ' ILE . 19.6 mt -77.25 104.0 7.5 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.324 -0.621 . . . . 0.90000000000000002 109.324 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 67.1 mt -86.21 -30.61 22.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.773 0.321 . . . . 0.90000000000000002 110.867 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.686 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . . . -129.31 137.03 50.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.325 -0.398 . . . . 0.90000000000000002 110.626 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -131.78 125.15 31.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.461 -0.336 . . . . 0.90000000000000002 110.832 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.8 p -134.25 134.25 55.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.018 -0.537 . . . . 0.90000000000000002 110.613 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.559 ' HG2' HG12 ' A' ' 39' ' ' ILE . 63.6 mtm180 -108.88 141.9 40.26 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.787 -0.365 . . . . 0.90000000000000002 110.311 176.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.446 HG12 ' HG3' ' A' ' 38' ' ' ARG . 6.0 p -133.83 132.7 56.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.295 0.569 . . . . 0.90000000000000002 110.993 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.7 m -106.57 111.56 24.17 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.495 -0.775 . . . . 0.90000000000000002 109.63 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.4 mt -83.48 85.58 7.22 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.171 -0.468 . . . . 0.90000000000000002 110.238 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.6 t -82.98 83.7 7.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.90000000000000002 109.372 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.29 -116.38 7.52 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.564 -0.744 . . . . 0.90000000000000002 112.187 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.1 p -91.91 2.07 56.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.916 0.389 . . . . 0.90000000000000002 111.288 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.588 ' HG2' ' HB3' ' A' ' 94' ' ' CYS . 35.0 mt-10 -110.88 136.36 50.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.053 -0.522 . . . . 0.90000000000000002 110.64 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -115.01 104.17 1.32 Allowed Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.527 -0.629 . . . . 0.90000000000000002 111.527 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.0 124.02 36.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.723 0.297 . . . . 0.90000000000000002 110.746 -178.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.523 HD11 ' HG2' ' A' ' 97' ' ' MET . 94.6 mt -93.52 114.94 27.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.153 0.502 . . . . 0.90000000000000002 109.698 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 10.0 t70 -117.18 127.36 54.03 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.13 -0.941 . . . . 0.90000000000000002 109.309 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.617 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 25.0 m 66.71 92.26 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.423 0.63 . . . . 0.90000000000000002 111.146 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.0 tp -114.76 102.26 9.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.443 -0.799 . . . . 0.90000000000000002 109.292 174.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.408 ' HD2' ' CD1' ' A' ' 23' ' ' TRP . 87.7 mtt180 -136.39 115.05 11.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.043 -0.526 . . . . 0.90000000000000002 111.421 -175.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.404 HG12 ' HB1' ' A' ' 50' ' ' ALA . 11.8 t -98.53 150.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.964 -1.124 . . . . 0.90000000000000002 107.964 170.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -55.78 137.36 50.04 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.626 -0.509 . . . . 0.90000000000000002 109.626 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -62.04 -17.94 58.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.289 0.566 . . . . 0.90000000000000002 110.908 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.4 t -71.52 -24.73 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.793 -0.64 . . . . 0.90000000000000002 110.761 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.9 m -86.04 18.87 2.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.06 0.457 . . . . 0.90000000000000002 111.923 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -66.24 118.23 9.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.302 -0.629 . . . . 0.90000000000000002 109.302 172.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -163.58 -97.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.359 -0.537 . . . . 0.90000000000000002 112.19 -175.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 169.6 95.77 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.943 -0.762 . . . . 0.90000000000000002 108.943 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 133.96 -59.03 0.68 Allowed Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.504 -0.855 . . . . 0.90000000000000002 112.879 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.7 t -49.9 -54.32 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.23 0.456 . . . . 0.90000000000000002 112.23 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 81' ' ' LEU . . . -61.22 -43.99 98.69 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.941 -0.647 . . . . 0.90000000000000002 113.026 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -66.27 -46.15 78.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.784 0.325 . . . . 0.90000000000000002 110.134 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -60.14 -39.18 85.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.038 -0.528 . . . . 0.90000000000000002 110.46 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.457 ' O ' HG23 ' A' ' 85' ' ' VAL . 48.2 tp -50.53 -55.51 15.79 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.536 0.523 . . . . 0.90000000000000002 110.819 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.76 -43.69 88.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 0.90000000000000002 111.29 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.57 -39.42 93.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.712 -0.222 . . . . 0.90000000000000002 111.343 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -66.64 -44.56 81.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.608 -0.269 . . . . 0.90000000000000002 111.024 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 81' ' ' LEU . 97.0 t -58.78 -44.18 89.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.79 0.329 . . . . 0.90000000000000002 110.915 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.03 -18.91 57.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.298 -0.41 . . . . 0.90000000000000002 111.679 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.8 -42.3 11.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.973 0.416 . . . . 0.90000000000000002 110.151 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -72.75 -31.66 65.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.874 -0.603 . . . . 0.90000000000000002 110.117 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -122.99 76.56 50.16 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.97 -0.559 . . . . 0.90000000000000002 109.618 174.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -94.66 16.11 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.133 2.555 . . . . 0.90000000000000002 112.613 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.85 2.21 87.1 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.895 -0.669 . . . . 0.90000000000000002 112.731 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.5 128.61 52.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.731 0.301 . . . . 0.90000000000000002 110.278 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.7 m -91.61 -34.72 14.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.024 -0.535 . . . . 0.90000000000000002 111.335 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.588 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 48.9 t -117.72 102.92 9.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.894 0.378 . . . . 0.90000000000000002 110.65 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 94.8 m95 -92.2 142.52 27.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.8 0.333 . . . . 0.90000000000000002 110.594 178.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -134.9 142.45 46.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.003 -0.544 . . . . 0.90000000000000002 109.743 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.561 ' CE ' ' HE2' ' A' ' 112' ' ' MET . 80.2 mtp -130.03 125.84 36.25 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.633 -0.506 . . . . 0.90000000000000002 109.633 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -102.75 172.35 6.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.167 -0.469 . . . . 0.90000000000000002 111.596 -174.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.11 -8.64 59.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.707 -0.679 . . . . 0.90000000000000002 110.231 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.71 121.22 13.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.782 -0.645 . . . . 0.90000000000000002 111.231 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.617 ' HA3' ' HA ' ' A' ' 65' ' ' SER . . . 82.23 14.2 77.24 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.749 -0.738 . . . . 0.90000000000000002 112.187 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.16 93.25 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.915 0.388 . . . . 0.90000000000000002 110.387 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.75 -17.62 37.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.347 -0.388 . . . . 0.90000000000000002 110.515 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -112.47 72.92 0.79 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.727 0.775 . . . . 0.90000000000000002 110.02 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.502 ' HG3' ' HH2' ' A' ' 124' ' ' TRP . 41.5 ttp180 -76.22 -32.09 58.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.22 -0.9 . . . . 0.90000000000000002 111.321 -170.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.77 -53.41 45.49 Favored Glycine 0 C--O 1.238 0.352 0 C-N-CA 120.72 -0.752 . . . . 0.90000000000000002 112.115 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.82 -42.16 81.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.972 0.415 . . . . 0.90000000000000002 110.3 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.547 ' O ' ' HG2' ' A' ' 112' ' ' MET . 47.3 ttm -69.47 -25.12 63.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.384 -0.371 . . . . 0.90000000000000002 111.424 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 94.3 m -62.9 -48.57 78.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.709 0.29 . . . . 0.90000000000000002 110.243 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.86 -34.43 77.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.443 0.639 . . . . 0.90000000000000002 110.249 176.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.448 ' CE2' HD12 ' A' ' 115' ' ' LEU . 55.8 t80 -63.25 -42.4 99.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.185 -0.916 . . . . 0.90000000000000002 110.819 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.561 ' HE2' ' CE ' ' A' ' 97' ' ' MET . 25.1 mmt -62.81 -39.97 95.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.393 -0.367 . . . . 0.90000000000000002 111.37 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -69.33 -27.15 65.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.90000000000000002 110.624 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.46 -40.46 57.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.351 -0.386 . . . . 0.90000000000000002 110.438 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.448 HD12 ' CE2' ' A' ' 111' ' ' PHE . 92.9 mt -66.26 -60.78 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.90000000000000002 111.108 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.34 48.45 0.13 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.738 -0.664 . . . . 0.90000000000000002 111.825 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.416 ' CD2' ' HB2' ' A' ' 126' ' ' LYS . 41.3 m-85 -109.96 141.46 42.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.774 0.321 . . . . 0.90000000000000002 110.416 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.9 p -92.49 144.08 25.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.187 -0.46 . . . . 0.90000000000000002 110.257 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.4 p -97.48 148.28 23.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.372 -0.376 . . . . 0.90000000000000002 111.146 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -124.55 -161.93 1.04 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.143 -0.481 . . . . 0.90000000000000002 109.934 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -79.32 29.64 0.23 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.907 0.384 . . . . 0.90000000000000002 111.77 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.08 67.38 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.97 -0.633 . . . . 0.90000000000000002 112.087 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.62 169.01 11.78 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.655 -0.784 . . . . 0.90000000000000002 112.428 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.502 ' HH2' ' HG3' ' A' ' 105' ' ' ARG . 11.7 m-90 -113.93 133.44 55.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.698 0.285 . . . . 0.90000000000000002 110.472 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -123.1 145.3 48.69 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.256 -0.429 . . . . 0.90000000000000002 110.081 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 64.6 tttp -137.28 96.85 3.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.924 0.392 . . . . 0.90000000000000002 110.251 174.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 17.4 t -87.9 133.35 33.94 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.546 -0.539 . . . . 0.90000000000000002 109.546 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 C-N-CA 120.833 -0.698 . . . . 0.90000000000000002 112.005 -179.733 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 tttp . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.346 -0.613 . . . . 0.90000000000000002 109.346 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.414 HD13 ' HB3' ' A' ' 42' ' ' ALA . 49.1 tp -76.04 107.1 8.02 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.637 -0.505 . . . . 0.90000000000000002 109.637 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.502 ' HB ' ' HG2' ' A' ' 43' ' ' ARG . 9.0 m -86.65 98.87 11.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.175 -0.466 . . . . 0.90000000000000002 110.444 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.404 HD11 ' HG2' ' A' ' 84' ' ' GLU . 4.6 mp -89.75 127.8 42.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.721 -0.474 . . . . 0.90000000000000002 109.721 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 mm -101.54 146.94 9.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.389 -0.597 . . . . 0.90000000000000002 109.389 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 13.9 ptt180 -99.21 106.16 18.28 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.942 -0.762 . . . . 0.90000000000000002 108.942 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.9 mt -73.09 86.06 1.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.451 0.643 . . . . 0.90000000000000002 110.882 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -95.69 -22.33 17.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.782 -1.099 . . . . 0.90000000000000002 108.784 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -136.75 143.5 43.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.029 -0.987 . . . . 0.90000000000000002 109.127 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -120.93 144.63 48.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.256 0.551 . . . . 0.90000000000000002 111.782 -173.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.3 p -109.56 163.71 13.2 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.602 -1.259 . . . . 0.90000000000000002 107.602 166.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' O ' HG13 ' A' ' 17' ' ' ILE . 29.5 t70 -68.19 -31.11 70.41 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.327 0.584 . . . . 0.90000000000000002 109.491 177.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -65.97 -50.77 63.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.064 -0.971 . . . . 0.90000000000000002 111.114 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -66.42 -28.6 68.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.057 0.456 . . . . 0.90000000000000002 110.477 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -65.1 -32.62 74.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.516 . . . . 0.90000000000000002 110.282 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 13' ' ' ASP . 75.8 mt -65.92 -42.97 92.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.433 -0.348 . . . . 0.90000000000000002 110.566 175.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.19 -38.2 82.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.029 0.442 . . . . 0.90000000000000002 110.358 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.423 ' O ' ' HE3' ' A' ' 23' ' ' TRP . 96.4 mt -61.3 -40.0 92.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.065 -0.516 . . . . 0.90000000000000002 110.279 175.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -77.25 -6.2 52.19 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.578 0.704 . . . . 0.90000000000000002 110.458 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -89.77 -18.62 25.97 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.975 -0.75 . . . . 0.90000000000000002 108.975 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.55 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 91.5 mt -90.41 -38.77 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.04 -0.982 . . . . 0.90000000000000002 109.774 172.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.423 ' HE3' ' O ' ' A' ' 19' ' ' LEU . 18.2 m-90 -99.21 89.02 0.85 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.565 -0.743 . . . . 0.90000000000000002 109.369 171.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 13.0 Cg_exo . . . . . 0 C--N 1.344 0.303 0 C-N-CA 122.61 2.207 . . . . 0.90000000000000002 113.064 -169.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 121.428 0.632 . . . . 0.90000000000000002 110.049 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -67.8 135.18 52.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.33 -0.85 . . . . 0.90000000000000002 111.377 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.15 165.78 30.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.90000000000000002 110.943 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -156.29 -171.5 3.74 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 107.809 -1.182 . . . . 0.90000000000000002 107.809 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.37 -14.94 62.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 118.275 0.488 . . . . 0.90000000000000002 111.307 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 34.2 m-80 -97.29 -56.8 2.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.085 0.469 . . . . 0.90000000000000002 110.358 176.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -89.36 93.93 9.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.354 -0.385 . . . . 0.90000000000000002 110.167 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -112.63 156.1 23.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.251 -0.431 . . . . 0.90000000000000002 110.721 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.462 HG22 ' HG2' ' A' ' 53' ' ' ARG . 63.5 mt -113.3 122.05 66.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.049 -0.523 . . . . 0.90000000000000002 109.897 177.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -94.13 117.91 30.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.226 -0.443 . . . . 0.90000000000000002 110.122 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.482 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -108.14 113.3 26.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.045 -0.525 . . . . 0.90000000000000002 109.947 178.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.767 ' HB1' ' HB1' ' A' ' 50' ' ' ALA . . . -95.44 112.42 24.14 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.317 -0.402 . . . . 0.90000000000000002 110.903 -175.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.502 ' HG2' ' HB ' ' A' ' 4' ' ' THR . 4.7 ptm180 -102.74 125.95 49.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.408 0.623 . . . . 0.90000000000000002 109.941 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.512 ' HB3' HD13 ' A' ' 49' ' ' LEU . 57.1 t80 -109.51 95.58 5.71 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.654 -0.869 . . . . 0.90000000000000002 108.654 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.9 t30 60.06 81.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.202 -0.908 . . . . 0.90000000000000002 109.992 -173.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 72.83 -59.25 0.57 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.112 -0.949 . . . . 0.90000000000000002 112.165 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 59.9 mtt85 -72.44 132.28 43.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.424 0.528 . . . . 0.90000000000000002 112.424 -167.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.495 HD23 ' HB3' ' A' ' 43' ' ' ARG . 96.2 mt -76.16 100.19 4.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.039 -0.726 . . . . 0.90000000000000002 109.039 171.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.512 HD13 ' HB3' ' A' ' 44' ' ' PHE . 88.2 mt -107.0 -8.72 16.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.301 -0.409 . . . . 0.90000000000000002 111.77 -173.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.767 ' HB1' ' HB1' ' A' ' 42' ' ' ALA . . . -144.07 139.02 28.68 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.768 0.318 . . . . 0.90000000000000002 110.855 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.86 131.47 31.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.149 -0.478 . . . . 0.90000000000000002 110.2 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 65' ' ' SER . 10.0 p -141.45 130.2 23.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.179 -0.464 . . . . 0.90000000000000002 110.317 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.462 ' HG2' HG22 ' A' ' 39' ' ' ILE . 63.6 mtm180 -99.68 141.68 32.16 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.959 -0.386 . . . . 0.90000000000000002 109.959 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.0 p -130.94 127.88 61.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.573 0.702 . . . . 0.90000000000000002 111.121 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.4 m -100.04 93.62 5.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.372 -0.831 . . . . 0.90000000000000002 109.476 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.509 ' O ' ' HB3' ' A' ' 36' ' ' ASN . 94.2 mt -81.24 141.29 34.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.057 0.456 . . . . 0.90000000000000002 110.625 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 t -144.44 74.3 1.41 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.795 -0.817 . . . . 0.90000000000000002 108.795 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.21 -111.41 3.9 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.578 -0.737 . . . . 0.90000000000000002 111.854 -178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.0 p -95.85 12.81 28.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.051 0.453 . . . . 0.90000000000000002 111.204 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -118.95 139.06 52.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.358 -0.608 . . . . 0.90000000000000002 109.358 174.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.74 114.59 0.96 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.724 -0.751 . . . . 0.90000000000000002 111.861 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -103.24 119.33 38.68 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.607 0.242 . . . . 0.90000000000000002 110.768 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.47 HD22 ' HE1' ' A' ' 97' ' ' MET . 6.0 mp -93.42 126.27 38.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.108 0.48 . . . . 0.90000000000000002 110.688 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -125.17 138.9 54.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.284 -0.871 . . . . 0.90000000000000002 109.299 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 50.3 m 61.01 87.27 0.09 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.312 0.577 . . . . 0.90000000000000002 111.283 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.7 tp -108.58 106.35 16.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.336 -0.847 . . . . 0.90000000000000002 108.907 173.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.418 HH12 ' CD ' ' A' ' 103' ' ' GLU . 72.9 mtp85 -131.45 119.79 22.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.049 0.388 . . . . 0.90000000000000002 112.049 -173.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.424 HG12 ' HB ' ' A' ' 72' ' ' THR . 1.9 t -109.07 141.61 23.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.88 -1.156 . . . . 0.90000000000000002 107.88 169.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.6 ttt-85 -82.92 166.65 18.71 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.554 -0.458 . . . . 0.90000000000000002 110.983 -174.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -48.7 -39.58 25.13 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.464 -0.789 . . . . 0.90000000000000002 112.704 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.6 t -62.25 -28.28 44.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.968 -0.56 . . . . 0.90000000000000002 112.207 -173.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.469 ' HG1' ' HB3' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -97.18 19.03 13.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.376 0.51 . . . . 0.90000000000000002 112.376 -168.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -80.29 84.86 5.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.551 -0.537 . . . . 0.90000000000000002 109.551 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -134.73 -86.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 0.90000000000000002 112.071 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER 168.54 99.1 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.612 0.765 . . . . 0.90000000000000002 109.061 -168.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.85 -74.12 0.45 Allowed Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.533 -0.841 . . . . 0.90000000000000002 112.627 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.4 t -38.15 -54.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.895 1.072 . . . . 0.90000000000000002 113.895 -170.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.43 -59.34 10.9 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.59 -0.814 . . . . 0.90000000000000002 112.96 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 99.4 mt-30 -64.16 -34.34 77.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.804 0.335 . . . . 0.90000000000000002 110.723 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -63.34 -38.3 90.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.81 -0.632 . . . . 0.90000000000000002 110.529 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.467 ' O ' HG21 ' A' ' 85' ' ' VAL . 61.7 tp -55.58 -49.95 71.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 0.90000000000000002 109.994 176.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.46 -43.89 96.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.405 . . . . 0.90000000000000002 110.902 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 79' ' ' GLN . 40.1 mt-10 -59.33 -42.63 91.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.717 -0.22 . . . . 0.90000000000000002 111.266 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.404 ' HG2' HD11 ' A' ' 5' ' ' ILE . 9.1 tp10 -60.27 -44.12 95.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.90000000000000002 110.49 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 81' ' ' LEU . 99.3 t -60.61 -44.94 97.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.395 -0.366 . . . . 0.90000000000000002 111.16 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -73.9 -16.47 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.398 -0.364 . . . . 0.90000000000000002 111.658 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 87' ' ' ARG . 63.6 mtt180 -92.89 -30.56 15.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.034 0.445 . . . . 0.90000000000000002 110.632 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -73.92 -50.51 19.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.838 -0.619 . . . . 0.90000000000000002 110.737 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -82.54 146.9 54.58 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.958 -0.565 . . . . 0.90000000000000002 110.111 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -66.38 -165.79 0.1 OUTLIER 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.161 2.574 . . . . 0.90000000000000002 113.003 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.43 84.73 0.1 Allowed Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.703 -0.68 . . . . 0.90000000000000002 113.522 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.0 t -82.56 122.83 37.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.839 -0.8 . . . . 0.90000000000000002 108.839 171.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 7.1 m -68.74 -57.82 5.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.253 -0.431 . . . . 0.90000000000000002 111.544 -174.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.7 t -103.76 106.95 17.61 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.461 -0.336 . . . . 0.90000000000000002 111.657 -172.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -97.83 110.62 23.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.935 0.398 . . . . 0.90000000000000002 110.141 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.43 ' CE3' ' HG2' ' A' ' 125' ' ' GLU . 18.9 t-105 -104.12 131.74 51.09 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.295 -0.631 . . . . 0.90000000000000002 109.295 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.47 ' HE1' HD22 ' A' ' 63' ' ' LEU . 54.7 mtp -128.69 137.27 51.53 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.972 -0.381 . . . . 0.90000000000000002 109.972 175.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.66 169.33 11.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.339 -0.391 . . . . 0.90000000000000002 110.781 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.0 5.96 48.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.393 . . . . 0.90000000000000002 110.773 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.82 124.64 21.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.489 . . . . 0.90000000000000002 110.429 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.51 0.12 58.09 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.596 -0.602 . . . . 0.90000000000000002 111.596 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.529 HG21 ' SD ' ' A' ' 108' ' ' MET . 62.1 t -114.83 124.46 71.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.558 -0.321 . . . . 0.90000000000000002 110.201 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.418 ' CD ' HH12 ' A' ' 67' ' ' ARG . 17.6 mp0 -71.88 -26.49 62.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.541 -0.299 . . . . 0.90000000000000002 111.442 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -118.82 103.25 9.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.021 0.438 . . . . 0.90000000000000002 110.95 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -73.1 -28.25 62.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.007 -0.542 . . . . 0.90000000000000002 110.404 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.94 -51.68 51.34 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.132 -0.556 . . . . 0.90000000000000002 112.123 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.6 t -59.79 -40.86 83.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.921 0.391 . . . . 0.90000000000000002 110.306 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -61.55 -43.27 99.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.016 -0.538 . . . . 0.90000000000000002 110.643 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 57.3 m -61.15 -48.83 79.8 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.347 -0.388 . . . . 0.90000000000000002 110.781 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.14 96.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.90000000000000002 111.069 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -62.4 -47.65 83.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.918 -0.583 . . . . 0.90000000000000002 111.075 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.517 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 23.9 mmt -63.13 -46.22 88.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.90000000000000002 111.407 -177.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -68.55 -30.2 68.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.366 -0.379 . . . . 0.90000000000000002 110.743 -177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.46 -27.13 58.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.407 -0.361 . . . . 0.90000000000000002 110.884 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.578 HD11 ' HE2' ' A' ' 117' ' ' PHE . 4.7 tt -82.22 -51.52 7.86 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.622 -0.51 . . . . 0.90000000000000002 109.622 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 141.84 45.72 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.752 -0.737 . . . . 0.90000000000000002 112.415 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.578 ' HE2' HD11 ' A' ' 115' ' ' LEU . 94.7 m-85 -123.38 134.52 53.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.828 0.347 . . . . 0.90000000000000002 110.547 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.5 m -93.13 144.82 24.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.034 -0.53 . . . . 0.90000000000000002 109.835 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.8 t -97.23 116.44 29.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.544 0.687 . . . . 0.90000000000000002 110.206 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -141.1 140.17 34.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.445 -0.798 . . . . 0.90000000000000002 110.312 -174.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 54.74 30.99 14.54 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.746 -0.661 . . . . 0.90000000000000002 111.892 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.7 -57.15 0.52 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.994 -0.622 . . . . 0.90000000000000002 112.486 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -90.55 -147.93 19.5 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.802 -0.713 . . . . 0.90000000000000002 112.195 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 31.0 m-90 -121.52 124.24 43.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.696 0.284 . . . . 0.90000000000000002 110.307 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.43 ' HG2' ' CE3' ' A' ' 96' ' ' TRP . 42.3 mt-10 -119.33 121.17 38.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.11 -0.495 . . . . 0.90000000000000002 110.743 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -126.37 96.79 4.81 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.006 -0.543 . . . . 0.90000000000000002 109.536 172.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 93' ' ' SER . 34.2 t -104.21 123.88 48.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.842 -0.617 . . . . 0.90000000000000002 110.005 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 C-N-CA 121.095 -0.574 . . . . 0.90000000000000002 112.074 -179.795 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 tttp . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.766 0.317 . . . . 0.90000000000000002 110.55 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.521 HD13 ' HB1' ' A' ' 42' ' ' ALA . 47.6 tp -89.41 116.32 27.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.354 -0.385 . . . . 0.90000000000000002 110.347 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 m -89.32 93.22 9.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.308 -0.406 . . . . 0.90000000000000002 110.567 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.514 HD12 ' HB3' ' A' ' 40' ' ' TYR . 6.5 tp -88.05 124.39 41.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.175 0.512 . . . . 0.90000000000000002 110.052 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 mt -123.55 155.02 29.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.973 -0.558 . . . . 0.90000000000000002 110.219 -176.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -89.53 127.68 35.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.101 -0.5 . . . . 0.90000000000000002 110.131 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.422 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 42.0 tp -80.91 99.63 8.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.032 -0.531 . . . . 0.90000000000000002 109.601 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.487 ' HA ' HG12 ' A' ' 33' ' ' VAL . 36.0 mt-10 -102.04 -17.36 16.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.764 -0.653 . . . . 0.90000000000000002 111.655 -175.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -151.56 156.31 40.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.703 0.287 . . . . 0.90000000000000002 111.29 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.438 ' CE2' HG22 ' A' ' 33' ' ' VAL . 87.7 m-85 -119.1 109.64 16.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.966 -0.561 . . . . 0.90000000000000002 111.117 -177.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.0 p -90.74 158.86 16.64 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.684 -1.228 . . . . 0.90000000000000002 107.684 168.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.424 ' O ' HG13 ' A' ' 17' ' ' ILE . 5.4 m-20 -58.58 -38.34 77.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.934 0.397 . . . . 0.90000000000000002 110.184 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -61.54 -55.78 27.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.621 -0.718 . . . . 0.90000000000000002 110.676 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.493 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 70.1 m-20 -61.88 -37.67 85.42 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.099 -0.5 . . . . 0.90000000000000002 110.538 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -64.19 -36.4 83.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.014 -0.539 . . . . 0.90000000000000002 110.67 -176.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 13' ' ' ASP . 80.2 mt -66.5 -45.12 89.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.299 -0.409 . . . . 0.90000000000000002 110.743 177.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.537 ' O ' HG13 ' A' ' 22' ' ' ILE . 24.0 t0 -65.57 -35.06 79.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.333 . . . . 0.90000000000000002 110.593 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 95.0 mt -63.65 -41.43 98.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.438 -0.346 . . . . 0.90000000000000002 110.978 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -69.42 -21.45 63.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.514 0.673 . . . . 0.90000000000000002 109.695 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -85.78 -12.34 51.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.446 -0.797 . . . . 0.90000000000000002 110.134 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 18' ' ' ASP . 71.0 mt -85.1 -32.69 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.2 -0.667 . . . . 0.90000000000000002 109.2 171.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -116.04 72.09 4.42 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.751 -0.659 . . . . 0.90000000000000002 110.783 175.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.483 ' HD3' ' C ' ' A' ' 22' ' ' ILE . 18.0 Cg_exo . . . . . 0 C--N 1.347 0.465 0 C-N-CA 122.338 2.025 . . . . 0.90000000000000002 111.732 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 121.192 0.52 . . . . 0.90000000000000002 110.96 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -137.94 147.74 44.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.581 -0.736 . . . . 0.90000000000000002 110.178 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.487 HG12 ' HA ' ' A' ' 9' ' ' GLU . 59.7 t -93.74 126.23 46.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.976 -0.556 . . . . 0.90000000000000002 111.039 -176.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.624 ' HB3' ' HB2' ' A' ' 37' ' ' HIS . 30.9 t70 -138.71 158.02 45.01 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.623 -0.717 . . . . 0.90000000000000002 109.299 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -63.2 -35.87 81.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.723 0.296 . . . . 0.90000000000000002 110.805 178.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 55' ' ' THR . 15.8 m120 -86.29 -48.04 8.86 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.778 -0.453 . . . . 0.90000000000000002 109.778 176.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.624 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 40.4 m170 -87.28 84.47 7.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.90000000000000002 109.914 175.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -109.36 147.79 32.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.079 -0.509 . . . . 0.90000000000000002 110.144 -173.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' A' ' 8' ' ' LEU . 56.5 mt -126.56 139.07 52.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.854 0.359 . . . . 0.90000000000000002 110.379 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.514 ' HB3' HD12 ' A' ' 5' ' ' ILE . 76.9 m-85 -118.03 152.43 35.54 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.512 -0.551 . . . . 0.90000000000000002 109.512 176.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.465 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -136.67 126.51 25.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.999 0.428 . . . . 0.90000000000000002 111.154 -174.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.734 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . . . -92.04 104.02 16.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.765 -0.652 . . . . 0.90000000000000002 110.011 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -95.14 110.22 22.2 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.939 -0.573 . . . . 0.90000000000000002 110.34 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -119.39 135.24 54.82 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.086 -0.709 . . . . 0.90000000000000002 109.086 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.3 t30 61.51 30.65 18.87 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.618 0.723 . . . . 0.90000000000000002 109.072 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 65.84 17.11 10.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.676 -1.147 . . . . 0.90000000000000002 111.955 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -126.43 138.96 53.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.572 0.225 . . . . 0.90000000000000002 110.404 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.465 HD21 ' HB3' ' A' ' 41' ' ' ALA . 78.4 mt -63.65 106.58 0.99 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.322 -0.622 . . . . 0.90000000000000002 109.322 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.403 ' HA ' HD11 ' A' ' 49' ' ' LEU . 12.8 tp -105.03 -21.41 13.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.147 -0.479 . . . . 0.90000000000000002 110.823 -172.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.734 ' HB2' ' HB2' ' A' ' 42' ' ' ALA . . . -140.94 135.26 31.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.259 -0.428 . . . . 0.90000000000000002 110.482 178.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.65 132.93 53.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.429 -0.351 . . . . 0.90000000000000002 110.608 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.472 ' HB ' HD11 ' A' ' 66' ' ' LEU . 8.0 p -142.2 131.9 23.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.039 -0.528 . . . . 0.90000000000000002 110.596 -178.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 1.025 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 10.6 mtm180 -103.22 155.68 18.26 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.603 -0.439 . . . . 0.90000000000000002 109.88 176.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.79 126.5 14.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.251 0.548 . . . . 0.90000000000000002 110.414 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 77.6 m -102.49 107.61 18.63 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.807 -0.633 . . . . 0.90000000000000002 110.042 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.4 mt -83.54 95.29 8.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.863 -0.608 . . . . 0.90000000000000002 110.043 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.3 t -86.79 93.05 9.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.65 -0.704 . . . . 0.90000000000000002 109.368 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.83 -102.99 1.38 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.767 -0.652 . . . . 0.90000000000000002 111.789 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.2 m -120.83 12.96 11.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.926 0.87 . . . . 0.90000000000000002 109.521 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -112.87 157.88 20.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.478 -0.783 . . . . 0.90000000000000002 109.956 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 95' ' ' TRP . . . -125.15 120.76 4.04 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.208 -0.996 . . . . 0.90000000000000002 112.864 -174.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.78 132.07 53.78 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.532 -0.544 . . . . 0.90000000000000002 109.532 174.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.815 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 73.0 mt -95.43 119.14 33.41 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.206 0.527 . . . . 0.90000000000000002 110.281 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 1.025 ' HB2' ' HB2' ' A' ' 53' ' ' ARG . 1.3 m-20 -79.6 -157.66 0.14 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.94 -1.027 . . . . 0.90000000000000002 110.117 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 p -47.27 118.45 2.17 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.138 0.494 . . . . 0.90000000000000002 111.932 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.472 HD11 ' HB ' ' A' ' 52' ' ' VAL . 21.3 tp -117.64 116.97 28.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.242 -0.89 . . . . 0.90000000000000002 109.349 175.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -143.82 123.19 13.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.192 0.52 . . . . 0.90000000000000002 111.735 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.503 HG13 ' HB3' ' A' ' 50' ' ' ALA . 22.4 t -94.38 137.8 22.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.338 -0.986 . . . . 0.90000000000000002 108.338 169.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -56.87 136.55 55.74 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.331 -0.618 . . . . 0.90000000000000002 109.331 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -56.67 -15.82 5.19 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.527 0.936 . . . . 0.90000000000000002 113.527 -166.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.07 -15.59 19.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.696 0.284 . . . . 0.90000000000000002 111.487 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 m -108.99 68.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.406 0.622 . . . . 0.90000000000000002 110.34 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.8 ttt85 -92.85 103.31 15.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.772 -0.649 . . . . 0.90000000000000002 110.842 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 74' ' ' ARG . 20.9 mtp180 60.78 79.73 0.24 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.468 -0.787 . . . . 0.90000000000000002 111.805 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -142.21 16.76 2.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.575 -0.45 . . . . 0.90000000000000002 111.052 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.22 -19.98 11.7 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.934 -0.65 . . . . 0.90000000000000002 113.489 175.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.9 t -51.29 -46.59 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 112.339 0.496 . . . . 0.90000000000000002 112.339 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.0 -28.95 71.27 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.046 -0.597 . . . . 0.90000000000000002 113.101 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -69.65 -55.0 11.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.23 -0.285 . . . . 0.90000000000000002 110.23 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -56.11 -44.65 79.31 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.272 -0.422 . . . . 0.90000000000000002 110.165 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 85' ' ' VAL . 30.3 tp -52.89 -57.99 8.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.676 -0.693 . . . . 0.90000000000000002 111.496 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.3 mt -66.21 -39.69 89.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.283 -0.417 . . . . 0.90000000000000002 111.238 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -59.0 -43.01 91.42 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.824 -0.35 . . . . 0.90000000000000002 110.252 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -64.45 -36.42 84.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.90000000000000002 110.59 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 81' ' ' LEU . 93.2 t -63.34 -48.87 85.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.803 0.335 . . . . 0.90000000000000002 110.686 177.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.532 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 11.1 mp -66.22 -27.84 68.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.90000000000000002 110.896 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 87' ' ' ARG . 5.5 mtp180 -77.39 -33.66 55.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.942 -0.572 . . . . 0.90000000000000002 111.398 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -69.95 -44.09 70.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.90000000000000002 110.795 -176.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.604 HD21 ' HH2' ' A' ' 95' ' ' TRP . 90.9 m-20 -76.02 112.79 22.38 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.206 -0.452 . . . . 0.90000000000000002 110.359 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -87.42 22.54 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.143 2.562 . . . . 0.90000000000000002 113.766 -171.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -172.7 75.9 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.018 -1.087 . . . . 0.90000000000000002 113.093 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.4 t -141.69 129.09 20.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.105 -0.702 . . . . 0.90000000000000002 109.105 174.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.9 p -99.66 -33.13 10.73 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.146 0.425 . . . . 0.90000000000000002 112.146 -177.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.6 t -130.34 137.45 49.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.131 0.491 . . . . 0.90000000000000002 110.814 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.604 ' HH2' HD21 ' A' ' 89' ' ' ASN . 90.7 m95 -116.12 122.4 45.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.642 -0.708 . . . . 0.90000000000000002 110.345 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -114.18 121.3 43.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.763 -0.653 . . . . 0.90000000000000002 109.292 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.815 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 77.2 mtp -107.29 130.08 54.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.793 0.33 . . . . 0.90000000000000002 110.59 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -101.26 144.95 29.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.115 -0.493 . . . . 0.90000000000000002 110.711 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.415 ' HB2' HG13 ' A' ' 102' ' ' VAL . 2.7 p-10 -69.49 -34.26 74.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.908 0.385 . . . . 0.90000000000000002 110.148 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 61.65 20.68 11.52 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.637 -0.711 . . . . 0.90000000000000002 112.47 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.35 13.01 20.34 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.287 -0.959 . . . . 0.90000000000000002 113.243 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.517 HG12 ' HB3' ' A' ' 105' ' ' ARG . 12.2 p -85.53 119.67 34.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.115 0.483 . . . . 0.90000000000000002 109.725 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -93.27 -5.1 50.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.326 0.584 . . . . 0.90000000000000002 109.762 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -86.46 16.3 4.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.095 -0.957 . . . . 0.90000000000000002 109.14 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.517 ' HB3' HG12 ' A' ' 102' ' ' VAL . 5.1 ptt180 -56.62 -32.12 64.98 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.437 -0.801 . . . . 0.90000000000000002 112.167 -175.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.22 -48.35 70.78 Favored Glycine 0 C--O 1.235 0.193 0 C-N-CA 120.612 -0.804 . . . . 0.90000000000000002 111.726 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.1 t -61.24 -43.27 96.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-O 122.025 0.917 . . . . 0.90000000000000002 109.394 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.606 ' O ' ' HG2' ' A' ' 112' ' ' MET . 17.3 ttt -61.64 -37.97 85.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.526 -1.215 . . . . 0.90000000000000002 110.13 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 98.9 m -61.28 -36.24 79.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.471 -0.332 . . . . 0.90000000000000002 111.105 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.28 -45.17 88.42 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.13 0.49 . . . . 0.90000000000000002 109.748 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -63.5 -45.08 92.32 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.483 -0.781 . . . . 0.90000000000000002 111.019 173.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.606 ' HG2' ' O ' ' A' ' 108' ' ' MET . 59.5 mmm -60.57 -43.89 96.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.407 -0.361 . . . . 0.90000000000000002 111.102 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -62.83 -35.1 78.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.434 -0.348 . . . . 0.90000000000000002 110.807 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.51 -32.95 74.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.90000000000000002 111.167 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 33.5 tp -84.8 -42.84 14.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.368 -0.378 . . . . 0.90000000000000002 110.499 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 136.28 32.87 0.25 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.655 -0.783 . . . . 0.90000000000000002 113.149 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.54 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 78.5 m-85 -118.58 116.24 26.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.76 0.314 . . . . 0.90000000000000002 110.391 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.3 p -102.01 136.14 42.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.467 -0.333 . . . . 0.90000000000000002 110.895 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.698 ' HB ' ' CD1' ' A' ' 124' ' ' TRP . 11.6 t -97.37 134.9 40.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.139 0.495 . . . . 0.90000000000000002 110.737 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.619 ' HB2' ' OE2' ' A' ' 125' ' ' GLU . 19.0 mt-30 -140.31 -72.6 0.36 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.854 -0.612 . . . . 0.90000000000000002 110.289 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -86.14 61.54 6.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.645 -0.707 . . . . 0.90000000000000002 111.265 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.87 -36.96 2.49 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.009 -0.615 . . . . 0.90000000000000002 113.139 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -118.96 -172.81 15.45 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.881 -0.676 . . . . 0.90000000000000002 112.165 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.698 ' CD1' ' HB ' ' A' ' 119' ' ' THR . 15.8 m-90 -98.54 126.42 44.1 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.073 -0.343 . . . . 0.90000000000000002 110.073 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.619 ' OE2' ' HB2' ' A' ' 120' ' ' GLN . 35.4 mt-10 -111.69 122.17 47.09 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.901 -0.59 . . . . 0.90000000000000002 111.015 -175.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -137.12 148.64 46.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.301 -0.409 . . . . 0.90000000000000002 110.396 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 38.2 t -110.82 151.07 28.25 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.313 -0.625 . . . . 0.90000000000000002 109.313 173.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.329 0 C-N-CA 120.895 -0.669 . . . . 0.90000000000000002 112.535 179.34 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.5 tttm . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.964 0.411 . . . . 0.90000000000000002 110.663 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.491 HD23 ' HB3' ' A' ' 42' ' ' ALA . 23.3 tp -76.03 118.47 18.82 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.933 -0.766 . . . . 0.90000000000000002 108.933 176.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.555 ' O ' ' HB3' ' A' ' 43' ' ' ARG . 18.1 m -90.25 92.22 8.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.098 0.475 . . . . 0.90000000000000002 110.458 -176.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.524 HG21 ' HA ' ' A' ' 42' ' ' ALA . 9.2 pt -106.79 150.98 8.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 120.47 -0.492 . . . . 0.90000000000000002 111.091 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.1 mp -131.14 153.09 38.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.197 -0.668 . . . . 0.90000000000000002 109.197 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -82.98 140.07 32.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.868 0.366 . . . . 0.90000000000000002 110.036 176.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.9 tp -84.74 82.91 8.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.908 -0.587 . . . . 0.90000000000000002 110.279 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -75.76 -48.8 20.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.506 -0.77 . . . . 0.90000000000000002 110.783 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -120.19 157.24 29.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.757 -0.656 . . . . 0.90000000000000002 110.411 -176.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -117.97 103.7 10.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.306 -0.406 . . . . 0.90000000000000002 110.995 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -88.88 156.74 18.74 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.769 -0.456 . . . . 0.90000000000000002 109.769 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.432 ' O ' HG13 ' A' ' 17' ' ' ILE . 19.0 t70 -56.78 -52.86 63.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.288 -0.414 . . . . 0.90000000000000002 111.396 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.17 -35.99 80.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.343 -0.39 . . . . 0.90000000000000002 110.68 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.478 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 22.0 m-20 -63.48 -44.01 95.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.447 . . . . 0.90000000000000002 110.531 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -62.53 -34.89 77.81 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 120.648 0.261 . . . . 0.90000000000000002 110.958 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 13' ' ' ASP . 74.2 mt -63.13 -46.54 95.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.262 -0.426 . . . . 0.90000000000000002 110.613 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -71.69 -31.28 66.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.013 0.435 . . . . 0.90000000000000002 109.997 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 84.3 mt -63.67 -34.48 77.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 0.90000000000000002 110.587 174.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -77.22 -18.74 57.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.165 0.507 . . . . 0.90000000000000002 110.579 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -68.14 -36.81 80.26 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.888 -0.782 . . . . 0.90000000000000002 108.888 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.504 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 67.3 mt -73.76 -55.47 12.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.526 -0.761 . . . . 0.90000000000000002 110.23 176.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -101.18 97.34 7.07 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.748 -0.464 . . . . 0.90000000000000002 109.748 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 35.3 Cg_exo . . . . . 0 C--N 1.345 0.377 0 C-N-CA 122.554 2.169 . . . . 0.90000000000000002 111.853 -178.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.511 0.196 . . . . 0.90000000000000002 110.557 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -56.01 128.63 36.21 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.279 0.561 . . . . 0.90000000000000002 111.934 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.1 m -103.38 167.52 2.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.264 -0.88 . . . . 0.90000000000000002 111.399 -176.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -155.94 -158.25 0.79 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.933 -1.136 . . . . 0.90000000000000002 107.933 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -72.64 -29.35 63.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.005 0.431 . . . . 0.90000000000000002 110.77 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -85.68 -53.39 5.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.276 -0.42 . . . . 0.90000000000000002 110.663 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -92.82 112.39 24.34 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.777 -0.453 . . . . 0.90000000000000002 109.777 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -126.7 119.87 28.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.201 0.524 . . . . 0.90000000000000002 110.806 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 65.2 mt -98.56 133.92 39.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.677 -0.692 . . . . 0.90000000000000002 110.073 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -112.7 132.88 54.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.116 -0.493 . . . . 0.90000000000000002 110.082 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.52 123.27 48.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.861 -0.608 . . . . 0.90000000000000002 109.878 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.535 ' HB1' ' HB1' ' A' ' 50' ' ' ALA . . . -91.9 114.69 27.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.094 -0.503 . . . . 0.90000000000000002 110.453 -176.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.555 ' HB3' ' O ' ' A' ' 4' ' ' THR . 51.9 ttt180 -108.03 127.3 53.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.273 0.559 . . . . 0.90000000000000002 110.864 -177.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -99.41 82.49 2.68 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.425 -0.583 . . . . 0.90000000000000002 109.425 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 69.13 -68.35 0.19 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.185 -0.916 . . . . 0.90000000000000002 111.728 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -101.58 -57.74 2.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.026 0.38 . . . . 0.90000000000000002 112.026 -174.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 47' ' ' ARG . 10.0 ptp180 -114.51 171.66 7.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.983 0.42 . . . . 0.90000000000000002 111.076 -171.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.5 mt -75.34 133.55 41.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.861 -0.608 . . . . 0.90000000000000002 109.431 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.8 tp -111.01 -23.98 10.63 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.734 0.302 . . . . 0.90000000000000002 110.496 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.535 ' HB1' ' HB1' ' A' ' 42' ' ' ALA . . . -151.3 159.08 44.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.142 -0.481 . . . . 0.90000000000000002 111.158 -177.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -144.46 133.41 22.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.112 -0.495 . . . . 0.90000000000000002 109.963 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.08 137.76 37.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.383 -0.371 . . . . 0.90000000000000002 110.937 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 19.1 mtm180 -110.17 129.99 55.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.513 -0.312 . . . . 0.90000000000000002 110.207 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -133.73 139.47 48.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.316 0.579 . . . . 0.90000000000000002 110.809 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -111.02 114.7 28.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.735 -0.666 . . . . 0.90000000000000002 110.092 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.408 HD22 HG22 ' A' ' 92' ' ' VAL . 70.5 mt -86.84 93.06 9.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.965 0.412 . . . . 0.90000000000000002 109.99 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 t -111.58 94.41 4.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.047 -0.524 . . . . 0.90000000000000002 110.517 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.42 -107.72 2.04 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.813 -0.63 . . . . 0.90000000000000002 112.498 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.3 p -93.45 -15.13 25.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.739 0.304 . . . . 0.90000000000000002 111.036 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -99.66 122.19 42.33 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.247 0.546 . . . . 0.90000000000000002 111.988 -172.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.23 97.37 2.17 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.463 -1.455 . . . . 0.90000000000000002 109.463 167.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.47 107.54 19.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.21 0.528 . . . . 0.90000000000000002 110.437 -172.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.462 HD22 ' HE3' ' A' ' 97' ' ' MET . 7.9 tt -93.73 119.28 32.51 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.228 -0.896 . . . . 0.90000000000000002 110.041 -175.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 12.1 t70 -126.57 126.42 43.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.466 -0.788 . . . . 0.90000000000000002 110.348 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.0 t 71.39 108.86 0.06 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.799 0.809 . . . . 0.90000000000000002 111.111 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 45.4 tp -129.33 110.43 11.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.741 -1.118 . . . . 0.90000000000000002 109.321 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 67' ' ' ARG . 43.5 mtt180 -125.36 128.53 48.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.095 0.474 . . . . 0.90000000000000002 111.611 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 50' ' ' ALA . 1.7 t -121.76 153.97 25.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.095 -1.076 . . . . 0.90000000000000002 108.095 172.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.5 mtt-85 -65.22 158.58 25.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.947 0.403 . . . . 0.90000000000000002 111.433 -176.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 70' ' ' GLU . 1.5 mp0 -49.88 -38.6 36.25 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.565 -0.743 . . . . 0.90000000000000002 112.947 -170.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.8 m -78.3 19.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 113.049 0.759 . . . . 0.90000000000000002 113.049 -172.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.9 p -115.76 9.68 15.2 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.763 0.316 . . . . 0.90000000000000002 111.253 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.2 ttp-105 -57.55 106.12 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.815 -0.63 . . . . 0.90000000000000002 111.167 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 55.92 40.47 30.49 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.841 -0.618 . . . . 0.90000000000000002 111.119 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -111.29 7.39 21.05 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.992 0.425 . . . . 0.90000000000000002 111.631 -174.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.98 -23.89 12.73 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.664 -0.779 . . . . 0.90000000000000002 113.928 173.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.7 t -53.92 -42.07 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.771 0.319 . . . . 0.90000000000000002 111.713 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.85 -38.43 88.57 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.175 -0.536 . . . . 0.90000000000000002 112.89 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -59.55 -49.72 76.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.863 0.363 . . . . 0.90000000000000002 111.037 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -67.06 -33.88 76.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.90000000000000002 110.961 -174.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.478 ' O ' HG21 ' A' ' 85' ' ' VAL . 56.3 tp -57.72 -49.39 76.71 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.8 0.333 . . . . 0.90000000000000002 110.301 176.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.77 -42.46 97.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.132 -0.486 . . . . 0.90000000000000002 110.702 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.01 -46.89 84.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 0.90000000000000002 111.108 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -59.12 -43.17 91.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.622 0.248 . . . . 0.90000000000000002 110.974 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 81' ' ' LEU . 94.8 t -60.58 -52.27 63.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.402 -0.363 . . . . 0.90000000000000002 110.918 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.417 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 11.2 mp -64.85 -32.14 73.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.287 -0.415 . . . . 0.90000000000000002 111.571 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -76.74 -40.2 49.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.32 -0.4 . . . . 0.90000000000000002 111.929 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -71.19 -39.6 71.7 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.323 0.49 . . . . 0.90000000000000002 112.323 -174.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.509 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 47.6 m-80 -75.01 131.75 78.3 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.913 0.387 . . . . 0.90000000000000002 110.674 -177.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 16.9 Cg_exo -67.05 -69.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 123.383 2.722 . . . . 0.90000000000000002 114.456 -170.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.13 61.55 0.48 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.186 -1.007 . . . . 0.90000000000000002 113.637 -170.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.408 HG22 HD22 ' A' ' 56' ' ' LEU . 25.5 t -114.52 105.11 18.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.703 -0.48 . . . . 0.90000000000000002 109.703 175.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.9 t -83.25 -37.81 23.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.228 -0.442 . . . . 0.90000000000000002 111.485 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.0 t -108.93 109.01 19.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.902 0.382 . . . . 0.90000000000000002 110.822 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.417 ' CZ2' ' HA ' ' A' ' 86' ' ' LEU . 95.9 m95 -97.65 115.54 28.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.07 -0.514 . . . . 0.90000000000000002 109.698 175.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 -114.88 126.19 54.52 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.795 -0.639 . . . . 0.90000000000000002 109.964 -175.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.462 ' HE3' HD22 ' A' ' 63' ' ' LEU . 87.1 mtp -107.03 122.52 46.62 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.203 -0.665 . . . . 0.90000000000000002 109.203 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.0 173.71 8.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.563 -0.744 . . . . 0.90000000000000002 111.772 -172.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.31 -46.05 86.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.496 -0.775 . . . . 0.90000000000000002 111.051 -178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 62.18 17.01 8.84 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.775 -0.648 . . . . 0.90000000000000002 111.681 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.53 36.87 58.62 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.079 -0.581 . . . . 0.90000000000000002 112.47 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.1 t -106.53 109.99 30.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.645 0.222 . . . . 0.90000000000000002 110.724 177.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -90.95 -6.95 53.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.777 0.322 . . . . 0.90000000000000002 110.6 173.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.73 52.65 1.03 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.262 0.553 . . . . 0.90000000000000002 109.621 173.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 105' ' ' ARG . 48.2 mtt-85 -72.94 -21.87 60.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.867 -0.606 . . . . 0.90000000000000002 110.884 -172.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.69 -56.64 23.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.474 -0.869 . . . . 0.90000000000000002 111.535 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.1 t -61.51 -39.12 81.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.021 0.439 . . . . 0.90000000000000002 110.837 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 27.0 ttm -71.25 -37.8 71.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.842 -0.617 . . . . 0.90000000000000002 112.119 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 99.1 m -63.84 -47.35 81.12 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.173 -0.211 . . . . 0.90000000000000002 110.634 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.18 -39.08 74.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.348 0.594 . . . . 0.90000000000000002 110.602 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -62.77 -54.38 39.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.125 -0.943 . . . . 0.90000000000000002 111.374 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.447 ' HE2' ' CE ' ' A' ' 97' ' ' MET . 66.4 mtt -76.03 -33.26 59.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.905 0.335 . . . . 0.90000000000000002 111.905 -174.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -63.41 -41.03 98.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.943 0.401 . . . . 0.90000000000000002 110.119 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.24 -25.28 59.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.996 -0.547 . . . . 0.90000000000000002 110.762 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.6 tp -84.02 -0.12 50.4 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.268 0.556 . . . . 0.90000000000000002 110.637 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.41 53.38 4.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.88 -0.676 . . . . 0.90000000000000002 112.95 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -110.0 133.25 53.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.707 0.289 . . . . 0.90000000000000002 110.633 174.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.8 m -84.74 143.65 29.01 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.277 -0.638 . . . . 0.90000000000000002 109.277 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.4 p -97.32 108.27 20.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.011 0.434 . . . . 0.90000000000000002 111.038 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -96.8 163.42 12.99 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.815 -0.809 . . . . 0.90000000000000002 108.815 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -73.65 95.99 2.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.827 0.346 . . . . 0.90000000000000002 110.32 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.94 -30.53 2.94 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.788 -0.72 . . . . 0.90000000000000002 112.506 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.55 -173.93 42.58 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.629 -0.796 . . . . 0.90000000000000002 112.375 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -102.34 136.72 41.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.629 0.252 . . . . 0.90000000000000002 110.619 -177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -125.75 131.6 52.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.256 -0.429 . . . . 0.90000000000000002 110.857 -176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -132.02 133.77 44.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.607 -0.516 . . . . 0.90000000000000002 109.607 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 78.2 m -86.87 129.92 34.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.766 0.317 . . . . 0.90000000000000002 110.471 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 C-N-CA 121.088 -0.577 . . . . 0.90000000000000002 111.953 179.836 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 120.975 0.417 . . . . 0.90000000000000002 110.286 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.464 HD21 HG11 ' A' ' 77' ' ' VAL . 59.2 tp -75.86 137.05 40.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.142 -0.481 . . . . 0.90000000000000002 109.963 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 42' ' ' ALA . 19.1 m -82.89 89.63 6.86 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.209 0.528 . . . . 0.90000000000000002 110.577 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.47 HD11 ' HB3' ' A' ' 40' ' ' TYR . 5.5 tp -98.35 105.76 17.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.465 -0.789 . . . . 0.90000000000000002 109.003 174.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mt -94.74 149.22 4.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.359 0.6 . . . . 0.90000000000000002 111.535 -170.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -91.59 101.36 14.0 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.726 -1.124 . . . . 0.90000000000000002 108.124 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.477 HD13 ' HB2' ' A' ' 41' ' ' ALA . 94.3 mt -73.11 92.95 1.75 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.192 -0.458 . . . . 0.90000000000000002 111.691 -173.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -102.35 -2.69 28.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.736 0.779 . . . . 0.90000000000000002 109.082 173.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -131.92 120.86 23.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.952 -1.022 . . . . 0.90000000000000002 109.521 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -124.31 99.59 6.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.491 0.186 . . . . 0.90000000000000002 111.066 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.568 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 1.4 m -79.03 158.95 27.79 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.535 -0.913 . . . . 0.90000000000000002 108.535 173.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.554 ' O ' HG12 ' A' ' 17' ' ' ILE . 5.7 p-10 -58.14 -36.45 72.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.658 0.266 . . . . 0.90000000000000002 110.732 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -70.0 -36.56 75.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.90000000000000002 111.125 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -63.74 -38.34 90.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.272 0.558 . . . . 0.90000000000000002 109.765 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 12' ' ' SER . 77.5 mtt180 -68.28 -28.46 67.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.472 -0.785 . . . . 0.90000000000000002 110.468 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 13' ' ' ASP . 46.6 mm -66.8 -41.49 87.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.49 . . . . 0.90000000000000002 110.751 176.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.419 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 28.5 t0 -69.05 -32.48 71.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.04 0.447 . . . . 0.90000000000000002 109.859 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.6 mt -63.23 -38.57 91.68 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.13 -0.486 . . . . 0.90000000000000002 110.236 172.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -68.11 -22.77 64.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.791 -0.64 . . . . 0.90000000000000002 110.559 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HE2' HG21 ' A' ' 17' ' ' ILE . 66.3 mttm -76.84 -32.87 57.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.922 -0.581 . . . . 0.90000000000000002 110.311 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.6 mt -76.98 -39.0 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.847 -0.615 . . . . 0.90000000000000002 110.531 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.499 ' CD1' ' HD2' ' A' ' 67' ' ' ARG . 5.0 m-90 -114.56 90.27 20.97 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.211 -0.45 . . . . 0.90000000000000002 110.668 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 C--N 1.344 0.296 0 C-N-CA 122.786 2.324 . . . . 0.90000000000000002 112.701 178.607 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.251 0.548 . . . . 0.90000000000000002 111.204 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -73.51 111.18 8.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.757 -0.656 . . . . 0.90000000000000002 109.575 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.01 151.43 28.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.032 0.444 . . . . 0.90000000000000002 111.519 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 73.99 -6.66 1.78 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.042 -0.981 . . . . 0.90000000000000002 111.942 171.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -65.87 -29.7 70.19 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.856 -0.794 . . . . 0.90000000000000002 108.856 174.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 171.93 -29.03 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.841 -1.527 . . . . 0.90000000000000002 107.354 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -86.94 116.54 25.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.692 -1.14 . . . . 0.90000000000000002 108.468 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.492 ' HB2' HG12 ' A' ' 54' ' ' VAL . 51.5 mtt180 -109.09 125.78 52.49 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.046 0.45 . . . . 0.90000000000000002 110.4 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.467 HG22 HD12 ' A' ' 8' ' ' LEU . 54.8 mt -108.67 110.0 30.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.804 -0.634 . . . . 0.90000000000000002 109.803 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.47 ' HB3' HD11 ' A' ' 5' ' ' ILE . 65.4 m-85 -104.27 138.49 40.65 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.047 -0.723 . . . . 0.90000000000000002 109.047 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.477 ' HB2' HD13 ' A' ' 8' ' ' LEU . . . -128.68 120.55 26.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.973 0.416 . . . . 0.90000000000000002 111.296 -175.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.627 ' HB1' ' HB2' ' A' ' 50' ' ' ALA . . . -94.45 105.47 17.44 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.746 -0.661 . . . . 0.90000000000000002 109.535 177.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.486 ' HB3' HD23 ' A' ' 48' ' ' LEU . 11.9 ptt180 -99.46 134.71 41.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.383 0.611 . . . . 0.90000000000000002 110.74 -177.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -118.33 119.51 34.85 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.401 -0.963 . . . . 0.90000000000000002 108.401 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.1 t30 60.13 41.87 16.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.696 0.76 . . . . 0.90000000000000002 109.04 -173.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 76.49 -27.05 0.18 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.541 -1.209 . . . . 0.90000000000000002 112.933 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -82.21 137.03 35.01 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.126 -0.324 . . . . 0.90000000000000002 110.126 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.486 HD23 ' HB3' ' A' ' 43' ' ' ARG . 76.4 mt -69.43 97.69 1.02 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 0.90000000000000002 111.009 -175.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.4 tp -78.18 -39.0 42.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.089 -0.505 . . . . 0.90000000000000002 110.883 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.627 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . . . -131.23 126.48 35.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.082 -0.508 . . . . 0.90000000000000002 110.899 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -117.35 125.86 51.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.313 -0.403 . . . . 0.90000000000000002 110.334 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.47 127.95 60.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.146 0.498 . . . . 0.90000000000000002 111.017 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.614 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 5.1 mtp180 -107.04 127.36 53.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.657 -0.497 . . . . 0.90000000000000002 109.657 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.492 HG12 ' HB2' ' A' ' 38' ' ' ARG . 5.2 p -122.57 115.71 46.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.649 0.738 . . . . 0.90000000000000002 110.827 176.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.4 m -91.93 108.63 20.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.47 -0.786 . . . . 0.90000000000000002 109.968 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.14 154.27 19.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.106 0.479 . . . . 0.90000000000000002 110.612 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 5.5 t -136.55 30.4 2.89 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.402 -0.962 . . . . 0.90000000000000002 108.402 176.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.32 -108.07 3.43 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.142 -0.936 . . . . 0.90000000000000002 111.372 -176.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 p -84.67 -1.86 56.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.366 0.603 . . . . 0.90000000000000002 110.68 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 44.8 tt0 -109.93 127.57 54.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.458 -0.792 . . . . 0.90000000000000002 109.414 177.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -127.35 112.89 1.6 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.53 -0.843 . . . . 0.90000000000000002 112.11 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.36 118.5 33.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.888 0.375 . . . . 0.90000000000000002 110.53 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 5.6 mp -93.89 125.61 38.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.319 -0.4 . . . . 0.90000000000000002 109.97 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 4.4 p30 -122.84 135.75 54.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.057 -0.52 . . . . 0.90000000000000002 110.104 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.1 t 66.73 94.1 0.07 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.884 0.849 . . . . 0.90000000000000002 111.273 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.459 HD23 HD21 ' A' ' 82' ' ' LEU . 37.0 tp -122.99 108.01 12.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.999 -1.001 . . . . 0.90000000000000002 109.231 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.499 ' HD2' ' CD1' ' A' ' 23' ' ' TRP . 98.2 mtt180 -130.49 117.89 20.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.269 0.557 . . . . 0.90000000000000002 111.651 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.484 HG11 ' HB3' ' A' ' 50' ' ' ALA . 5.1 t -107.03 141.91 21.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.446 -0.946 . . . . 0.90000000000000002 108.446 171.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -62.65 151.23 38.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.872 0.367 . . . . 0.90000000000000002 110.993 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -54.58 -26.28 31.44 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.358 -0.837 . . . . 0.90000000000000002 113.022 -171.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.19 3.51 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.287 0.565 . . . . 0.90000000000000002 111.177 -176.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.76 13.16 16.11 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.13 -0.356 . . . . 0.90000000000000002 111.142 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -66.42 118.36 9.95 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.435 -0.348 . . . . 0.90000000000000002 110.741 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 50.47 73.88 0.25 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.263 -0.881 . . . . 0.90000000000000002 110.634 -172.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -138.24 11.77 2.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.873 -0.603 . . . . 0.90000000000000002 110.265 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.95 -32.65 1.96 Allowed Glycine 0 CA--C 1.521 0.43 0 CA-C-N 116.063 -0.517 . . . . 0.90000000000000002 113.539 177.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.464 HG11 HD21 ' A' ' 3' ' ' LEU . 85.4 t -49.74 -42.17 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.281 0.632 . . . . 0.90000000000000002 112.576 -176.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -52.66 -44.57 60.19 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.144 -0.551 . . . . 0.90000000000000002 113.395 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -64.99 -43.58 92.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.90000000000000002 110.785 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -63.5 -49.1 74.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.90000000000000002 110.54 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.419 ' O ' HG23 ' A' ' 85' ' ' VAL . 30.6 tp -49.47 -60.79 2.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.678 -0.692 . . . . 0.90000000000000002 111.798 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.459 HD21 HD23 ' A' ' 66' ' ' LEU . 4.1 mm? -64.78 -43.11 94.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.188 -0.46 . . . . 0.90000000000000002 111.581 -175.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.601 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 40.3 tt0 -63.91 -39.41 94.1 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 121.003 -0.279 . . . . 0.90000000000000002 110.707 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -60.69 -40.46 92.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.962 0.41 . . . . 0.90000000000000002 110.487 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 81' ' ' LEU . 90.1 t -64.16 -38.32 82.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.105 -0.498 . . . . 0.90000000000000002 110.816 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 82' ' ' LEU . 10.6 mp -70.1 -24.94 63.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.42 . . . . 0.90000000000000002 111.159 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.601 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 63.6 mtt180 -76.88 -36.9 56.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.126 0.489 . . . . 0.90000000000000002 109.956 174.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -66.58 -47.45 72.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.286 -0.87 . . . . 0.90000000000000002 111.553 -176.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -75.42 147.6 82.45 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.168 -0.469 . . . . 0.90000000000000002 110.387 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.88 -165.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.987 2.458 . . . . 0.90000000000000002 112.612 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.68 96.29 0.15 Allowed Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.206 -0.521 . . . . 0.90000000000000002 112.83 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.8 t -102.26 -50.4 9.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.072 0.463 . . . . 0.90000000000000002 110.047 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.6 m 70.79 -50.12 0.67 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.05 -0.977 . . . . 0.90000000000000002 112.037 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 47.8 t -89.4 86.36 6.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.058 0.456 . . . . 0.90000000000000002 110.399 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.435 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 96.1 m95 -95.76 121.09 37.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.969 -0.559 . . . . 0.90000000000000002 110.372 178.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -117.11 134.31 54.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.703 -0.681 . . . . 0.90000000000000002 110.555 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.695 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 92.8 mmm -107.15 111.17 23.47 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.176 -0.675 . . . . 0.90000000000000002 109.176 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.95 150.63 22.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.157 -0.474 . . . . 0.90000000000000002 111.18 -174.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.605 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -70.13 -63.81 1.01 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.9 -0.591 . . . . 0.90000000000000002 109.703 179.268 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.61 16.78 6.85 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.67 -0.695 . . . . 0.90000000000000002 111.388 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.15 12.16 12.57 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.743 -0.741 . . . . 0.90000000000000002 113.389 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 99' ' ' ASP . 69.2 t -69.29 104.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 117.262 0.531 . . . . 0.90000000000000002 110.723 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.55 -10.59 45.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.373 0.606 . . . . 0.90000000000000002 109.967 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.13 47.35 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.556 -0.747 . . . . 0.90000000000000002 110.039 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -61.42 -40.1 93.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.546 . . . . 0.90000000000000002 111.93 -173.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.94 -53.17 39.2 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.907 -0.663 . . . . 0.90000000000000002 112.456 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.29 -43.94 98.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.797 0.332 . . . . 0.90000000000000002 110.674 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 91.2 mmm -64.7 -39.07 93.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.90000000000000002 111.462 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 98.9 m -60.86 -43.72 98.01 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.184 -0.206 . . . . 0.90000000000000002 110.818 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.65 -44.76 93.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.083 0.468 . . . . 0.90000000000000002 110.776 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -64.82 -45.11 87.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.749 -0.659 . . . . 0.90000000000000002 110.831 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.556 ' HA ' ' HE3' ' A' ' 112' ' ' MET . 16.9 mmt -62.13 -45.46 93.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.072 -0.513 . . . . 0.90000000000000002 111.105 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -63.54 -34.98 78.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.595 0.236 . . . . 0.90000000000000002 111.16 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.91 -29.45 69.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.005 0.431 . . . . 0.90000000000000002 110.852 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.2 tp -96.71 13.3 28.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.213 0.53 . . . . 0.90000000000000002 110.73 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.86 57.67 4.03 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.961 -0.563 . . . . 0.90000000000000002 113.124 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.527 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 55.6 m-85 -126.0 153.81 43.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.906 0.384 . . . . 0.90000000000000002 110.325 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.9 p -128.22 145.47 51.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.96 -0.563 . . . . 0.90000000000000002 109.809 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.9 t -97.16 124.57 41.25 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.54 -0.541 . . . . 0.90000000000000002 109.54 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -141.79 106.63 4.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.139 -0.482 . . . . 0.90000000000000002 111.851 -172.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 57.75 35.98 26.07 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.805 -0.634 . . . . 0.90000000000000002 112.575 168.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 158.29 -85.1 0.13 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.438 -0.887 . . . . 0.90000000000000002 112.281 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -121.35 -137.21 5.21 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.864 -0.684 . . . . 0.90000000000000002 111.685 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.695 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 19.2 m-90 -112.29 141.47 45.97 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.14 -0.319 . . . . 0.90000000000000002 110.14 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -128.07 142.73 51.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.383 -0.371 . . . . 0.90000000000000002 110.717 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.452 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 54.4 tttp -132.5 89.69 2.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.841 -0.8 . . . . 0.90000000000000002 108.841 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 38.1 t -86.79 97.75 10.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.991 -0.549 . . . . 0.90000000000000002 110.554 -176.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 C-N-CA 121.04 -0.6 . . . . 0.90000000000000002 112.284 179.528 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 92.8 mttt . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 120.95 0.405 . . . . 0.90000000000000002 110.918 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.4 ' HB3' ' CE2' ' A' ' 80' ' ' TYR . 59.2 tp -87.17 114.98 24.25 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.018 -0.734 . . . . 0.90000000000000002 109.018 174.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 m -82.87 93.44 7.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.342 0.592 . . . . 0.90000000000000002 110.787 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.497 HG23 ' HA ' ' A' ' 42' ' ' ALA . 13.3 pt -113.12 148.55 15.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.223 -0.444 . . . . 0.90000000000000002 110.137 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.454 ' N ' HD11 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -133.94 144.4 35.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.078 -0.51 . . . . 0.90000000000000002 110.359 -177.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -91.94 142.18 27.83 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.261 -0.644 . . . . 0.90000000000000002 109.261 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.52 98.09 1.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.187 0.518 . . . . 0.90000000000000002 111.373 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -89.14 -42.12 11.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.343 -0.844 . . . . 0.90000000000000002 109.077 173.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -136.72 140.31 42.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.766 -1.106 . . . . 0.90000000000000002 109.196 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.489 ' HE2' HG23 ' A' ' 33' ' ' VAL . 34.9 m-85 -97.42 92.95 6.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.975 0.417 . . . . 0.90000000000000002 111.686 -176.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 m -71.94 139.3 48.64 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.022 -0.732 . . . . 0.90000000000000002 109.022 171.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.449 ' O ' HG13 ' A' ' 17' ' ' ILE . 27.1 m-20 -59.32 -41.59 89.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.576 0.227 . . . . 0.90000000000000002 111.106 -177.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -61.59 -39.84 92.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.215 -0.448 . . . . 0.90000000000000002 110.956 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -72.2 -30.98 65.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.752 0.311 . . . . 0.90000000000000002 110.603 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -68.98 -31.23 69.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 0.90000000000000002 110.619 176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 13' ' ' ASP . 79.9 mt -70.27 -36.99 69.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.073 0.463 . . . . 0.90000000000000002 109.829 174.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -64.86 -41.68 95.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.722 -0.672 . . . . 0.90000000000000002 110.016 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.4 mt -59.91 -35.54 75.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.82 -0.627 . . . . 0.90000000000000002 110.708 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -69.35 -25.36 64.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.199 0.523 . . . . 0.90000000000000002 110.097 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -72.81 -27.48 61.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.90000000000000002 109.974 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.772 HD11 ' HB3' ' A' ' 48' ' ' LEU . 60.4 mt -71.23 -43.48 74.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.975 -0.557 . . . . 0.90000000000000002 110.309 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -113.99 87.6 13.09 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.90000000000000002 111.62 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo . . . . . 0 N--CA 1.461 -0.416 0 C-N-CA 122.116 1.878 . . . . 0.90000000000000002 110.768 173.172 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 121.471 0.653 . . . . 0.90000000000000002 110.634 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -131.43 148.53 52.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.299 -0.864 . . . . 0.90000000000000002 110.853 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.489 HG23 ' HE2' ' A' ' 11' ' ' PHE . 15.6 m -132.72 -179.2 3.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.803 -0.635 . . . . 0.90000000000000002 110.434 176.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -146.51 -169.24 3.22 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.577 -1.268 . . . . 0.90000000000000002 107.577 176.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -82.4 -25.75 33.44 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.279 0.561 . . . . 0.90000000000000002 109.696 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 9.2 p30 -96.96 -27.58 14.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.706 -0.679 . . . . 0.90000000000000002 110.722 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -108.42 95.78 5.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.847 -0.427 . . . . 0.90000000000000002 109.847 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.2 mtt85 -117.0 166.73 11.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.183 0.516 . . . . 0.90000000000000002 111.594 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -129.73 135.58 61.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.659 -0.7 . . . . 0.90000000000000002 109.724 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -99.78 129.16 45.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.793 0.33 . . . . 0.90000000000000002 110.603 177.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.44 ' HB2' HD22 ' A' ' 48' ' ' LEU . . . -112.91 116.21 29.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.015 -0.539 . . . . 0.90000000000000002 110.111 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.497 ' HA ' HG23 ' A' ' 5' ' ' ILE . . . -91.9 113.22 25.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.214 -0.448 . . . . 0.90000000000000002 110.188 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -113.38 126.13 55.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.394 0.616 . . . . 0.90000000000000002 111.369 -172.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -97.16 85.58 3.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.748 -0.834 . . . . 0.90000000000000002 108.748 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 64.66 -77.86 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.994 -1.003 . . . . 0.90000000000000002 111.067 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -107.73 -39.28 5.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.858 -0.61 . . . . 0.90000000000000002 111.209 -174.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.624 ' HA ' ' CZ ' ' A' ' 47' ' ' ARG . 2.1 mmp_? -99.05 129.87 45.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.466 . . . . 0.90000000000000002 111.533 -170.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.772 ' HB3' HD11 ' A' ' 22' ' ' ILE . 54.3 mt -67.56 115.41 7.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.152 -0.684 . . . . 0.90000000000000002 109.152 169.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 15.8 tp -97.54 -27.16 14.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.729 -0.669 . . . . 0.90000000000000002 110.769 -170.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.512 ' HB3' HG11 ' A' ' 68' ' ' VAL . . . -152.35 158.0 42.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.072 -0.513 . . . . 0.90000000000000002 110.699 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.57 144.16 26.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.156 -0.474 . . . . 0.90000000000000002 110.108 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 65' ' ' SER . 11.0 p -148.45 143.64 18.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.733 0.302 . . . . 0.90000000000000002 111.088 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -96.54 146.91 24.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.731 0.3 . . . . 0.90000000000000002 110.997 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.03 121.58 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.45 0.643 . . . . 0.90000000000000002 110.783 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.51 ' HB ' ' HB1' ' A' ' 62' ' ' ALA . 21.2 m -110.12 109.25 19.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.817 -0.629 . . . . 0.90000000000000002 110.453 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.522 HD23 HG23 ' A' ' 92' ' ' VAL . 65.0 mt -89.69 113.17 24.62 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.271 0.558 . . . . 0.90000000000000002 110.936 -178.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -114.62 86.17 2.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.698 -0.683 . . . . 0.90000000000000002 109.475 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.88 -107.77 2.22 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.655 -0.783 . . . . 0.90000000000000002 111.681 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.7 p -104.77 1.03 28.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.214 0.53 . . . . 0.90000000000000002 110.575 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -98.97 138.15 36.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.554 -0.748 . . . . 0.90000000000000002 109.918 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -119.98 107.94 1.39 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.741 -0.742 . . . . 0.90000000000000002 111.611 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -92.62 104.59 16.86 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.782 -0.451 . . . . 0.90000000000000002 109.782 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.483 HD21 ' HE3' ' A' ' 97' ' ' MET . 8.9 tt -104.56 127.64 52.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.861 -0.608 . . . . 0.90000000000000002 109.734 -176.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -147.43 176.76 9.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.911 -0.586 . . . . 0.90000000000000002 110.301 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 16.2 m 50.82 80.36 0.08 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.858 0.724 . . . . 0.90000000000000002 111.965 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.4 tp -120.58 120.45 35.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.862 -0.608 . . . . 0.90000000000000002 110.084 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.8 ttt-85 -140.32 124.04 17.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.814 0.34 . . . . 0.90000000000000002 110.51 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 50' ' ' ALA . 10.5 t -111.1 146.66 15.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.873 -1.158 . . . . 0.90000000000000002 107.873 172.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 49' ' ' LEU . 66.7 mtp85 -60.94 139.6 57.97 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.698 -0.401 . . . . 0.90000000000000002 110.117 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.454 ' H ' ' CD ' ' A' ' 70' ' ' GLU . 1.8 mp0 -52.32 -30.97 30.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.395 -0.821 . . . . 0.90000000000000002 112.839 -171.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.6 t -72.15 -17.15 18.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.995 0.426 . . . . 0.90000000000000002 111.308 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.541 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . 2.3 m -95.35 5.06 52.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.766 0.793 . . . . 0.90000000000000002 110.806 -176.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 74' ' ' ARG . 57.7 ttt180 -71.89 134.66 46.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.438 -0.801 . . . . 0.90000000000000002 110.139 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.503 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 29.1 tpt180 69.25 43.39 1.08 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.754 0.787 . . . . 0.90000000000000002 110.191 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.541 ' HD3' ' HA ' ' A' ' 72' ' ' THR . 16.3 mtp180 -134.95 1.9 3.05 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.472 0.545 . . . . 0.90000000000000002 112.472 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.14 -13.6 9.49 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.915 -0.66 . . . . 0.90000000000000002 113.998 176.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -57.5 -43.98 83.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 117.009 0.405 . . . . 0.90000000000000002 111.48 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.28 -39.53 92.7 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.981 -0.628 . . . . 0.90000000000000002 112.406 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.526 ' HA ' HD23 ' A' ' 115' ' ' LEU . 41.1 tt0 -62.43 -47.42 84.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.382 . . . . 0.90000000000000002 110.51 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.421 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 81.9 t80 -57.72 -41.75 82.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.674 -0.694 . . . . 0.90000000000000002 110.686 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.474 HD11 ' HB1' ' A' ' 42' ' ' ALA . 68.3 tp -56.71 -49.99 73.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.90000000000000002 110.748 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.1 -40.68 98.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.90000000000000002 110.963 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 33.5 mt-10 -65.9 -36.77 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.465 -0.334 . . . . 0.90000000000000002 111.109 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 80' ' ' TYR . 7.3 mm-40 -61.79 -39.69 92.58 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.73 0.3 . . . . 0.90000000000000002 111.117 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 81' ' ' LEU . 58.9 t -60.78 -54.51 34.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.005 0.431 . . . . 0.90000000000000002 110.545 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.7 mp -74.9 -4.57 38.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.039 -0.528 . . . . 0.90000000000000002 111.07 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 68.7 ttt180 -80.26 -48.87 12.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.17 -0.468 . . . . 0.90000000000000002 110.226 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -87.67 -8.29 56.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.90000000000000002 110.271 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 15.9 t30 -45.76 120.65 5.22 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.094 -0.957 . . . . 0.90000000000000002 111.583 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 7.7 Cg_exo -73.02 -61.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.146 2.564 . . . . 0.90000000000000002 112.888 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -154.54 35.06 0.69 Allowed Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.211 -0.995 . . . . 0.90000000000000002 113.153 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.522 HG23 HD23 ' A' ' 56' ' ' LEU . 62.3 t -99.84 107.12 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.556 -0.535 . . . . 0.90000000000000002 109.556 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 51.1 m -111.33 -13.83 13.87 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.142 0.423 . . . . 0.90000000000000002 112.142 -174.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 81.8 m -103.82 94.6 5.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.858 0.361 . . . . 0.90000000000000002 110.056 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -97.26 115.97 28.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.142 0.496 . . . . 0.90000000000000002 111.434 -175.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.519 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 74.1 t-105 -104.14 114.29 28.42 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.265 -0.88 . . . . 0.90000000000000002 108.959 175.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.674 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 80.6 mtp -107.35 122.67 47.05 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.548 -0.538 . . . . 0.90000000000000002 109.548 -176.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -124.61 168.74 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.263 -0.426 . . . . 0.90000000000000002 111.423 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.85 -68.03 0.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.441 -0.799 . . . . 0.90000000000000002 111.077 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.99 19.91 10.32 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.539 -0.755 . . . . 0.90000000000000002 111.845 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.73 -20.05 3.29 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.806 -0.711 . . . . 0.90000000000000002 111.661 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 95.7 t -67.79 101.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.121 0.486 . . . . 0.90000000000000002 110.854 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -93.35 -16.56 24.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.952 -0.567 . . . . 0.90000000000000002 110.263 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.05 54.19 1.87 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.795 -0.639 . . . . 0.90000000000000002 110.469 176.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -60.17 -46.95 87.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.757 -0.656 . . . . 0.90000000000000002 111.36 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.16 -49.7 62.23 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 121.031 -0.604 . . . . 0.90000000000000002 112.66 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.45 -46.72 96.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.959 0.409 . . . . 0.90000000000000002 111.269 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 78.0 mtp -78.62 -22.01 47.6 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.17 0.433 . . . . 0.90000000000000002 112.17 -175.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 96.5 m -67.33 -40.44 85.91 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.91 -0.404 . . . . 0.90000000000000002 109.91 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.28 -39.29 92.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.187 0.518 . . . . 0.90000000000000002 110.021 175.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -58.52 -51.89 67.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.357 -0.838 . . . . 0.90000000000000002 110.789 175.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.525 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 67.1 mtt -70.98 -27.15 63.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.038 -0.528 . . . . 0.90000000000000002 111.481 -176.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -66.59 -34.16 77.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.922 0.391 . . . . 0.90000000000000002 109.983 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.65 -32.9 66.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.926 -0.579 . . . . 0.90000000000000002 110.75 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 79' ' ' GLN . 11.0 mp -83.34 -4.8 58.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.049 -0.523 . . . . 0.90000000000000002 111.004 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.19 41.41 17.64 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.934 -0.65 . . . . 0.90000000000000002 113.167 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.525 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 59.7 m-85 -92.98 144.24 25.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.857 0.361 . . . . 0.90000000000000002 110.186 174.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.24 144.67 25.08 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.979 -0.555 . . . . 0.90000000000000002 111.26 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.7 p -97.46 140.64 31.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.932 -0.577 . . . . 0.90000000000000002 111.33 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.439 ' HG3' ' HB3' ' A' ' 125' ' ' GLU . 19.3 mm-40 -120.35 -166.77 1.35 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.90000000000000002 109.762 177.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -85.02 96.12 9.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.286 0.565 . . . . 0.90000000000000002 111.122 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.84 44.93 4.69 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.848 -0.691 . . . . 0.90000000000000002 112.542 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.35 -171.93 24.94 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.671 -0.776 . . . . 0.90000000000000002 112.174 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.674 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 15.8 m-90 -116.86 149.56 39.87 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.183 -0.302 . . . . 0.90000000000000002 110.183 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.439 ' HB3' ' HG3' ' A' ' 120' ' ' GLN . 31.2 tt0 -155.8 132.34 10.33 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.172 -0.307 . . . . 0.90000000000000002 110.172 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -137.07 132.58 34.35 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.915 -0.402 . . . . 0.90000000000000002 109.915 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 93' ' ' SER . 49.0 t -119.67 113.2 20.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.316 -0.402 . . . . 0.90000000000000002 110.134 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 C-N-CA 121.009 -0.615 . . . . 0.90000000000000002 112.186 -179.68 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 C--O 1.234 0.249 0 CA-C-O 120.869 0.366 . . . . 0.90000000000000002 110.709 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.7 tp -86.09 98.07 10.66 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.42 -0.956 . . . . 0.90000000000000002 108.42 173.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 13.5 m -88.07 89.81 8.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.733 -0.667 . . . . 0.90000000000000002 110.276 -174.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.501 HD11 ' HB3' ' A' ' 40' ' ' TYR . 13.8 tt -96.12 129.41 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.474 0.654 . . . . 0.90000000000000002 110.767 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mt -129.01 154.59 40.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.296 -0.866 . . . . 0.90000000000000002 109.323 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.8 ptt-85 -76.74 113.82 14.82 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.886 -0.783 . . . . 0.90000000000000002 108.886 173.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.604 HD23 HD13 ' A' ' 19' ' ' LEU . 31.1 tp -77.96 100.84 6.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.9 -0.591 . . . . 0.90000000000000002 109.997 -174.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.808 ' HA ' HG12 ' A' ' 33' ' ' VAL . 42.2 mt-10 -113.97 -18.95 11.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.509 -0.769 . . . . 0.90000000000000002 110.902 -175.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.81 113.99 24.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.286 -0.415 . . . . 0.90000000000000002 110.382 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -107.83 101.4 10.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.901 -0.59 . . . . 0.90000000000000002 110.632 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.8 p -84.68 171.28 12.51 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.403 -0.591 . . . . 0.90000000000000002 109.403 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.469 ' O ' HG13 ' A' ' 17' ' ' ILE . 6.6 p-10 -60.38 -31.98 70.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.564 0.221 . . . . 0.90000000000000002 110.561 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -67.27 -51.02 58.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.503 -0.317 . . . . 0.90000000000000002 110.556 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -60.87 -36.81 80.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.277 -0.419 . . . . 0.90000000000000002 109.99 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -55.47 -47.39 76.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.598 -0.728 . . . . 0.90000000000000002 110.159 176.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 13' ' ' ASP . 74.7 mt -65.79 -43.84 93.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.90000000000000002 110.898 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.492 ' O ' HG13 ' A' ' 22' ' ' ILE . 12.9 m-20 -58.76 -52.83 64.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.69 0.281 . . . . 0.90000000000000002 110.955 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.604 HD13 HD23 ' A' ' 8' ' ' LEU . 95.0 mt -64.74 -38.15 90.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.90000000000000002 111.34 -178.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -74.2 -11.48 60.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.098 0.475 . . . . 0.90000000000000002 110.56 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -98.27 -28.16 13.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.379 -0.373 . . . . 0.90000000000000002 110.089 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 18' ' ' ASP . 74.4 mt -65.23 -48.53 83.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.923 -0.769 . . . . 0.90000000000000002 108.923 172.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -107.49 92.3 8.25 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 107.886 -1.153 . . . . 0.90000000000000002 107.886 168.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo . . . . . 0 N--CA 1.477 0.538 0 C-N-CA 123.648 2.899 . . . . 0.90000000000000002 114.509 -167.307 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.5 mt . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.231 0.539 . . . . 0.90000000000000002 109.895 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -136.46 127.38 27.58 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.483 -0.78 . . . . 0.90000000000000002 109.605 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.808 HG12 ' HA ' ' A' ' 9' ' ' GLU . 15.0 p -106.49 131.32 56.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.513 0.673 . . . . 0.90000000000000002 110.42 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.513 ' HB2' ' H ' ' A' ' 37' ' ' HIS . 14.6 m-20 -130.62 179.28 6.04 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.481 -0.933 . . . . 0.90000000000000002 108.481 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -85.68 -9.47 57.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.805 -0.813 . . . . 0.90000000000000002 108.805 172.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -94.63 -34.47 12.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.415 -0.811 . . . . 0.90000000000000002 109.685 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.513 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 36.0 m80 -120.33 101.0 7.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.762 -0.653 . . . . 0.90000000000000002 109.768 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -109.11 129.0 55.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.82 0.343 . . . . 0.90000000000000002 110.275 -178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.402 HG12 ' HG2' ' A' ' 53' ' ' ARG . 63.7 mt -103.33 116.73 47.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.651 -0.5 . . . . 0.90000000000000002 109.651 176.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.501 ' HB3' HD11 ' A' ' 5' ' ' ILE . 78.8 m-85 -97.55 125.67 42.4 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.884 -0.413 . . . . 0.90000000000000002 109.884 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.47 ' HB3' HD23 ' A' ' 48' ' ' LEU . . . -109.37 113.4 26.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.952 -0.567 . . . . 0.90000000000000002 110.56 -177.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . . . -92.68 102.32 14.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.246 -0.434 . . . . 0.90000000000000002 109.959 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 4' ' ' THR . 19.9 ptt85 -103.37 129.53 50.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.344 0.592 . . . . 0.90000000000000002 110.408 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -105.46 124.61 49.84 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.776 -0.647 . . . . 0.90000000000000002 109.544 -177.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 70.91 -56.91 0.61 Allowed 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.957 0.786 . . . . 0.90000000000000002 110.983 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -154.75 -45.96 0.09 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.505 -0.316 . . . . 0.90000000000000002 111.325 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -104.92 162.83 12.99 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.868 -0.333 . . . . 0.90000000000000002 111.12 -170.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' A' ' 41' ' ' ALA . 84.0 mt -60.78 132.75 54.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.965 -0.561 . . . . 0.90000000000000002 111.865 -176.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 37.1 tp -111.76 -30.38 7.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.551 -0.75 . . . . 0.90000000000000002 109.821 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.509 ' HB1' HG12 ' A' ' 68' ' ' VAL . . . -150.11 147.56 27.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.857 -0.61 . . . . 0.90000000000000002 110.578 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -135.41 127.36 29.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.68 0.276 . . . . 0.90000000000000002 110.434 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.411 ' HB ' HD12 ' A' ' 66' ' ' LEU . 7.1 p -131.37 134.01 61.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.03 0.443 . . . . 0.90000000000000002 110.99 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.526 ' HD3' ' HB2' ' A' ' 65' ' ' SER . 21.4 mtp-105 -110.17 126.69 54.36 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.499 -0.556 . . . . 0.90000000000000002 109.499 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.5 p -120.66 134.62 63.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.422 0.63 . . . . 0.90000000000000002 111.629 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.9 m -100.71 107.69 19.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.401 -0.818 . . . . 0.90000000000000002 109.856 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.9 mt -96.33 130.29 43.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.373 -0.376 . . . . 0.90000000000000002 110.584 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 m -135.78 97.47 3.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.152 -0.476 . . . . 0.90000000000000002 110.191 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.64 -112.56 4.53 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.928 -0.578 . . . . 0.90000000000000002 112.378 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -106.9 11.98 29.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.586 0.708 . . . . 0.90000000000000002 110.278 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -125.61 154.59 42.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.724 -0.671 . . . . 0.90000000000000002 110.344 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.39 132.28 5.24 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.817 -0.706 . . . . 0.90000000000000002 112.079 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.77 126.43 51.02 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.507 -0.553 . . . . 0.90000000000000002 109.507 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 mp -93.46 117.06 29.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.014 0.435 . . . . 0.90000000000000002 110.701 -175.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 20.2 m-20 -109.35 118.53 36.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.605 -0.725 . . . . 0.90000000000000002 110.283 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.526 ' HB2' ' HD3' ' A' ' 53' ' ' ARG . 34.5 m 73.05 107.16 0.07 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.86 0.838 . . . . 0.90000000000000002 111.797 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.411 HD12 ' HB ' ' A' ' 52' ' ' VAL . 29.9 tp -131.97 130.79 41.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.832 -1.076 . . . . 0.90000000000000002 109.504 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.2 ttt-85 -144.02 130.48 19.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.819 0.342 . . . . 0.90000000000000002 110.841 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.509 HG12 ' HB1' ' A' ' 50' ' ' ALA . 13.6 t -107.11 156.42 7.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.356 -0.979 . . . . 0.90000000000000002 108.356 172.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.424 ' HB3' ' HG1' ' A' ' 72' ' ' THR . 76.3 ttt180 -53.87 127.0 24.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.536 -0.913 . . . . 0.90000000000000002 108.536 173.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -57.37 -31.65 65.98 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.361 0.504 . . . . 0.90000000000000002 112.361 -168.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -82.87 16.7 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.365 0.602 . . . . 0.90000000000000002 110.979 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.424 ' HG1' ' HB3' ' A' ' 69' ' ' ARG . 1.8 m -111.73 16.14 20.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.575 0.702 . . . . 0.90000000000000002 110.414 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -75.45 137.01 40.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.847 -0.615 . . . . 0.90000000000000002 111.077 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 71.66 27.76 2.88 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.409 -0.814 . . . . 0.90000000000000002 111.698 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -124.98 22.67 7.96 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.284 -0.566 . . . . 0.90000000000000002 112.443 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.79 -27.21 1.64 Allowed Glycine 0 CA--C 1.521 0.454 0 N-CA-C 114.681 0.632 . . . . 0.90000000000000002 114.681 172.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.2 t -50.88 -46.46 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.381 0.512 . . . . 0.90000000000000002 112.381 -175.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.88 -45.51 94.93 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.571 -0.824 . . . . 0.90000000000000002 112.604 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.498 ' HG2' ' HG ' ' A' ' 115' ' ' LEU . 51.2 mt-30 -65.57 -41.68 92.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.871 0.367 . . . . 0.90000000000000002 110.733 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -68.21 -41.92 80.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.90000000000000002 110.585 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.3 tp -48.23 -51.57 24.89 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.331 0.394 . . . . 0.90000000000000002 111.026 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 86' ' ' LEU . 4.4 mm? -60.07 -52.44 65.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.002 -0.544 . . . . 0.90000000000000002 111.433 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -72.09 -16.52 62.02 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.951 -0.3 . . . . 0.90000000000000002 111.726 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -69.77 -42.9 73.2 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.432 -0.581 . . . . 0.90000000000000002 109.432 172.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.55 -41.3 88.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.01 -0.541 . . . . 0.90000000000000002 110.352 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 82' ' ' LEU . 10.9 mp -67.43 -20.38 65.5 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.093 -0.503 . . . . 0.90000000000000002 111.1 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 54.0 ttp85 -83.65 -41.05 18.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.90000000000000002 109.876 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -64.35 -38.94 92.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.523 -0.762 . . . . 0.90000000000000002 110.729 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -119.11 78.77 17.73 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.32 -0.4 . . . . 0.90000000000000002 110.662 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.29 2.21 8.55 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.595 2.197 . . . . 0.90000000000000002 112.319 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.54 10.76 72.47 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.897 -0.592 . . . . 0.90000000000000002 111.97 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.8 t -107.68 127.26 63.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.608 -0.516 . . . . 0.90000000000000002 109.608 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 m -85.53 -53.36 5.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.805 0.336 . . . . 0.90000000000000002 111.576 -175.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.5 t -103.83 116.38 32.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.904 0.383 . . . . 0.90000000000000002 111.09 -174.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -106.9 112.33 25.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.881 -0.599 . . . . 0.90000000000000002 110.064 176.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -105.51 136.46 45.03 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.297 -0.411 . . . . 0.90000000000000002 110.121 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.641 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 97.4 mmm -107.27 119.74 40.22 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.506 -0.553 . . . . 0.90000000000000002 109.506 177.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.65 144.98 25.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.009 0.433 . . . . 0.90000000000000002 111.766 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.407 ' CG ' HH21 ' A' ' 105' ' ' ARG . 10.6 t70 -80.26 -69.61 0.58 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.495 -0.775 . . . . 0.90000000000000002 109.908 177.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 64.73 23.17 12.71 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.571 -0.741 . . . . 0.90000000000000002 112.945 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.4 40.29 0.96 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.332 -0.937 . . . . 0.90000000000000002 112.905 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.735 HG13 ' HG3' ' A' ' 108' ' ' MET . 77.0 t -88.31 112.48 23.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.84 0.353 . . . . 0.90000000000000002 110.368 176.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -82.57 -32.27 28.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.301 -0.409 . . . . 0.90000000000000002 110.677 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -87.49 55.23 3.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.222 0.534 . . . . 0.90000000000000002 109.859 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.407 HH21 ' CG ' ' A' ' 99' ' ' ASP . 34.7 ttm180 -66.23 -31.11 71.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.561 -0.745 . . . . 0.90000000000000002 111.043 -176.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.74 -56.39 25.53 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.913 -0.661 . . . . 0.90000000000000002 112.062 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.5 t -61.48 -42.42 93.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.90000000000000002 111.001 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.735 ' HG3' HG13 ' A' ' 102' ' ' VAL . 93.0 mmm -64.46 -38.23 90.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.90000000000000002 111.538 -177.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 61.5 m -67.52 -41.26 84.67 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 121.087 -0.245 . . . . 0.90000000000000002 110.411 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.14 88.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.302 0.573 . . . . 0.90000000000000002 110.245 176.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -61.98 -48.71 79.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.415 -0.811 . . . . 0.90000000000000002 110.716 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.53 ' HG2' ' O ' ' A' ' 108' ' ' MET . 26.4 mmt -62.44 -43.2 99.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.93 -0.577 . . . . 0.90000000000000002 111.122 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -62.09 -39.33 92.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.501 -0.318 . . . . 0.90000000000000002 111.204 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.51 -22.11 61.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.112 0.482 . . . . 0.90000000000000002 110.888 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.498 ' HG ' ' HG2' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -91.05 -2.69 57.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.299 0.571 . . . . 0.90000000000000002 110.31 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.85 32.61 20.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.841 -0.695 . . . . 0.90000000000000002 113.03 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 75.7 m-85 -98.63 139.85 33.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.041 0.448 . . . . 0.90000000000000002 110.419 176.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.1 m -90.41 144.21 26.02 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.852 -0.613 . . . . 0.90000000000000002 109.853 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 30.2 p -97.31 115.97 28.64 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.801 0.334 . . . . 0.90000000000000002 110.438 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -137.02 161.46 36.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.352 -0.385 . . . . 0.90000000000000002 110.072 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -45.45 106.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.836 0.71 . . . . 0.90000000000000002 112.188 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 120.93 -21.18 8.42 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.486 -0.864 . . . . 0.90000000000000002 113.382 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 159.07 -131.69 2.83 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.244 -0.979 . . . . 0.90000000000000002 112.741 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.641 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 12.8 m-90 -125.98 140.0 52.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.637 0.256 . . . . 0.90000000000000002 110.504 -177.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -128.46 134.35 48.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 0.90000000000000002 109.93 -175.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.51 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 84.8 tttt -137.19 92.17 2.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.07 0.462 . . . . 0.90000000000000002 110.54 173.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 39.9 t -80.22 131.32 35.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.908 -0.587 . . . . 0.90000000000000002 110.496 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 C-N-CA 120.867 -0.682 . . . . 0.90000000000000002 111.993 179.132 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 109.962 -0.385 . . . . 0.90000000000000002 109.962 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.504 HD23 HG12 ' A' ' 77' ' ' VAL . 52.5 tp -95.72 127.73 41.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.232 -0.44 . . . . 0.90000000000000002 110.476 -177.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.9 m -89.69 95.32 10.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.898 0.38 . . . . 0.90000000000000002 110.624 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.529 HG22 ' HA ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -103.49 129.1 55.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.118 0.485 . . . . 0.90000000000000002 110.052 177.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.18 151.9 36.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.769 -0.651 . . . . 0.90000000000000002 109.888 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -75.29 130.18 38.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.876 -0.416 . . . . 0.90000000000000002 109.876 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.458 HD23 HD12 ' A' ' 19' ' ' LEU . 38.6 tp -76.01 59.36 1.29 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.605 0.717 . . . . 0.90000000000000002 110.165 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -91.39 -13.91 31.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.474 -0.785 . . . . 0.90000000000000002 109.511 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -112.92 107.21 15.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.015 -0.993 . . . . 0.90000000000000002 109.834 177.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -88.43 82.94 6.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.296 0.569 . . . . 0.90000000000000002 110.892 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.8 m -85.66 150.56 24.53 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.327 -0.851 . . . . 0.90000000000000002 109.303 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.62 -35.72 70.84 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.245 -0.28 . . . . 0.90000000000000002 110.245 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -52.14 -55.77 18.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.678 -0.692 . . . . 0.90000000000000002 110.526 175.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.436 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 18.8 m-20 -68.51 -41.3 80.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.649 -0.705 . . . . 0.90000000000000002 111.299 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -61.11 -39.14 88.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.728 0.27 . . . . 0.90000000000000002 111.728 -176.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.7 mt -70.13 -41.64 79.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.939 0.4 . . . . 0.90000000000000002 110.375 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.48 -34.54 78.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.90000000000000002 110.104 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.458 HD12 HD23 ' A' ' 8' ' ' LEU . 73.0 mt -62.39 -39.26 92.63 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.092 -0.504 . . . . 0.90000000000000002 110.83 174.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -75.13 -10.43 59.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.026 0.441 . . . . 0.90000000000000002 111.001 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -86.46 -22.94 26.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.501 -0.318 . . . . 0.90000000000000002 110.24 170.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.36 -45.82 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.228 0.537 . . . . 0.90000000000000002 109.611 173.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -107.6 108.09 61.16 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.573 -0.739 . . . . 0.90000000000000002 109.39 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo . . . . . 0 C--N 1.352 0.733 0 C-N-CA 124.46 3.44 . . . . 0.90000000000000002 114.193 -172.715 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.1 mt . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.807 0.337 . . . . 0.90000000000000002 110.378 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -135.68 106.0 6.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.803 -0.635 . . . . 0.90000000000000002 110.405 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.4 t -98.18 135.89 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.773 -0.649 . . . . 0.90000000000000002 110.132 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -146.23 -173.86 4.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.526 -0.546 . . . . 0.90000000000000002 109.526 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.81 -20.98 66.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.12 0.486 . . . . 0.90000000000000002 111.084 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -93.11 -55.7 3.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.221 -0.445 . . . . 0.90000000000000002 110.483 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -84.32 98.13 9.84 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.56 -0.533 . . . . 0.90000000000000002 109.56 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -108.91 121.35 44.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.964 0.411 . . . . 0.90000000000000002 110.41 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.845 HG12 ' HG2' ' A' ' 53' ' ' ARG . 56.4 mt -98.88 115.39 39.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.087 -0.506 . . . . 0.90000000000000002 110.215 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -94.05 122.34 36.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.598 -0.728 . . . . 0.90000000000000002 109.364 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.477 ' HB2' HD21 ' A' ' 48' ' ' LEU . . . -108.11 123.36 48.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.905 -0.589 . . . . 0.90000000000000002 110.09 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.761 ' HB1' ' HB1' ' A' ' 50' ' ' ALA . . . -91.89 100.4 13.08 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.416 -0.587 . . . . 0.90000000000000002 109.416 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -95.06 115.61 27.64 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.844 -1.071 . . . . 0.90000000000000002 109.792 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.484 ' HB3' HD13 ' A' ' 49' ' ' LEU . 73.2 t80 -97.28 88.66 4.5 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.25 -0.648 . . . . 0.90000000000000002 109.25 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.62 -65.09 0.36 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.417 -1.265 . . . . 0.90000000000000002 111.859 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 47' ' ' ARG . 4.9 pt-20 -109.16 -51.24 2.9 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.671 0.619 . . . . 0.90000000000000002 112.671 -174.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.459 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 28.0 ptt-85 -127.0 173.8 9.36 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.634 -0.426 . . . . 0.90000000000000002 111.685 -171.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.477 HD21 ' HB2' ' A' ' 41' ' ' ALA . 41.9 mt -87.06 111.25 20.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.53 . . . . 0.90000000000000002 110.348 -175.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.484 HD13 ' HB3' ' A' ' 44' ' ' PHE . 9.9 mp -88.13 -31.41 19.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.687 0.28 . . . . 0.90000000000000002 110.68 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.761 ' HB1' ' HB1' ' A' ' 42' ' ' ALA . . . -127.07 131.99 50.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.268 -0.424 . . . . 0.90000000000000002 110.992 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.12 115.94 21.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.286 -0.415 . . . . 0.90000000000000002 110.155 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.2 p -126.8 136.55 60.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.098 0.475 . . . . 0.90000000000000002 111.151 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.845 ' HG2' HG12 ' A' ' 39' ' ' ILE . 99.0 mtt180 -111.77 115.72 29.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.134 -0.485 . . . . 0.90000000000000002 110.64 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.6 p -107.18 107.46 22.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.849 0.833 . . . . 0.90000000000000002 110.032 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.9 m -87.5 106.82 18.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.296 -0.865 . . . . 0.90000000000000002 110.185 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.8 mt -80.63 104.51 11.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.07 -0.514 . . . . 0.90000000000000002 110.39 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -103.13 106.34 16.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.611 -0.722 . . . . 0.90000000000000002 109.238 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.86 -96.79 0.61 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.008 -0.837 . . . . 0.90000000000000002 111.008 -174.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.1 p -128.27 2.68 5.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.909 0.385 . . . . 0.90000000000000002 110.776 175.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.533 ' HA ' HG12 ' A' ' 92' ' ' VAL . 23.8 mm-40 -104.84 141.59 36.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.31 -0.405 . . . . 0.90000000000000002 110.721 -175.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.12 112.35 4.38 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.786 -0.721 . . . . 0.90000000000000002 112.352 -177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.581 ' HA ' ' HB3' ' A' ' 96' ' ' TRP . . . -105.28 111.72 24.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.696 0.284 . . . . 0.90000000000000002 110.438 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 53' ' ' ARG . 5.2 mp -93.45 110.76 22.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.19 0.519 . . . . 0.90000000000000002 109.803 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.605 ' HA ' ' HB2' ' A' ' 98' ' ' ALA . 1.8 p30 -96.06 -36.14 11.12 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.496 -0.774 . . . . 0.90000000000000002 111.801 -173.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.0 m -120.58 125.29 47.42 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.791 0.329 . . . . 0.90000000000000002 111.158 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.4 tp -145.61 102.72 3.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.922 -0.581 . . . . 0.90000000000000002 110.052 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -131.43 113.0 13.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.417 -0.356 . . . . 0.90000000000000002 110.775 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 50' ' ' ALA . 2.9 t -110.22 136.04 47.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.308 -0.997 . . . . 0.90000000000000002 108.308 172.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -87.56 -176.28 5.51 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.044 0.757 . . . . 0.90000000000000002 113.044 -174.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -55.33 -27.07 44.67 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.399 -1.273 . . . . 0.90000000000000002 114.387 -165.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.6 t -65.43 -30.57 50.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.168 0.509 . . . . 0.90000000000000002 111.691 -175.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.578 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 6.5 m -98.77 32.66 2.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.463 0.649 . . . . 0.90000000000000002 111.16 -173.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -65.27 97.57 0.28 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.868 -0.606 . . . . 0.90000000000000002 111.886 -178.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 53.02 80.04 0.11 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.731 -0.668 . . . . 0.90000000000000002 112.091 170.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 75' ' ' ARG . 9.3 mmt180 -136.61 -54.27 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.90000000000000002 111.239 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.78 -21.67 0.46 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.68 -0.772 . . . . 0.90000000000000002 111.775 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.578 ' HB ' ' CG2' ' A' ' 72' ' ' THR . 72.6 t -55.85 -44.23 76.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 122.332 0.253 . . . . 0.90000000000000002 111.499 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -54.11 -49.44 59.37 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.789 -0.719 . . . . 0.90000000000000002 112.905 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -60.65 -52.32 65.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.454 0.169 . . . . 0.90000000000000002 110.592 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -58.96 -42.45 89.9 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.255 -0.43 . . . . 0.90000000000000002 111.128 -176.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 85' ' ' VAL . 63.6 tp -52.56 -53.31 48.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.776 0.322 . . . . 0.90000000000000002 110.679 178.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.42 ' O ' HD13 ' A' ' 86' ' ' LEU . 46.8 mt -70.31 -45.47 66.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.296 -0.411 . . . . 0.90000000000000002 111.423 -177.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -62.67 -32.22 73.24 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.07 -0.252 . . . . 0.90000000000000002 111.071 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -67.69 -41.42 83.64 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.065 -0.346 . . . . 0.90000000000000002 110.065 176.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 81' ' ' LEU . 85.1 t -63.09 -46.27 96.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 121.205 0.526 . . . . 0.90000000000000002 110.645 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.468 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 10.9 mp -70.47 -19.85 62.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.789 -0.641 . . . . 0.90000000000000002 111.108 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -86.91 -30.22 21.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.318 -0.401 . . . . 0.90000000000000002 110.191 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -63.62 -52.87 58.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.90000000000000002 110.51 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -118.5 101.17 51.13 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 0.90000000000000002 110.784 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.91 -6.13 12.28 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.224 2.616 . . . . 0.90000000000000002 112.035 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.36 48.77 4.1 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.241 -0.504 . . . . 0.90000000000000002 112.691 -177.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 60' ' ' GLU . 97.4 t -135.94 134.51 50.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.13 -0.693 . . . . 0.90000000000000002 109.13 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 61.8 p -96.57 -32.83 12.06 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.566 -0.454 . . . . 0.90000000000000002 110.933 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 77.8 m -130.37 113.98 15.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.891 0.376 . . . . 0.90000000000000002 111.322 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.468 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 95.6 m95 -90.94 113.49 25.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.161 -0.681 . . . . 0.90000000000000002 109.161 173.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.581 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . 2.9 t-105 -96.94 128.09 43.57 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.622 -0.717 . . . . 0.90000000000000002 109.959 -172.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 1.008 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 13.4 mmt -108.45 115.38 29.99 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.354 -0.61 . . . . 0.90000000000000002 109.354 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.605 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . . . -99.48 173.84 6.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.513 -0.767 . . . . 0.90000000000000002 112.566 -169.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -129.29 93.04 3.48 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.067 -0.97 . . . . 0.90000000000000002 109.42 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -92.36 26.85 2.43 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.817 -1.083 . . . . 0.90000000000000002 110.975 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.5 46.48 0.85 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.773 -0.727 . . . . 0.90000000000000002 111.423 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 56.8 t -78.01 98.92 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.93 0.395 . . . . 0.90000000000000002 110.895 -178.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -70.83 -33.66 70.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.69 -0.686 . . . . 0.90000000000000002 110.114 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -79.41 47.39 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.766 . . . . 0.90000000000000002 110.089 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.97 -57.4 13.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.123 -0.944 . . . . 0.90000000000000002 111.879 -172.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.29 99.34 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 121.178 -0.534 . . . . 0.90000000000000002 112.527 -175.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.9 t -58.39 -47.52 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.90000000000000002 110.78 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 89.5 mmm -71.01 -32.62 69.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.90000000000000002 111.131 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 80.1 m -59.25 -44.18 92.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.982 0.42 . . . . 0.90000000000000002 110.041 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.32 -41.32 96.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.902 -0.59 . . . . 0.90000000000000002 110.893 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -66.32 -52.4 47.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.052 -0.522 . . . . 0.90000000000000002 111.278 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -56.75 -50.05 73.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.36 -0.382 . . . . 0.90000000000000002 111.609 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -65.52 -31.8 73.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.619 0.247 . . . . 0.90000000000000002 111.116 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.65 -31.04 63.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.931 0.396 . . . . 0.90000000000000002 111.21 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.703 HD21 ' HE1' ' A' ' 117' ' ' PHE . 21.0 tp -88.36 -9.84 51.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.122 0.487 . . . . 0.90000000000000002 110.542 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.95 36.54 4.96 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.74 -0.743 . . . . 0.90000000000000002 113.13 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.703 ' HE1' HD21 ' A' ' 115' ' ' LEU . 62.5 m-85 -99.68 102.2 13.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.957 0.378 . . . . 0.90000000000000002 110.239 174.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.18 143.7 56.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.159 -0.473 . . . . 0.90000000000000002 110.828 177.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 m -99.28 136.25 39.5 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.209 -0.45 . . . . 0.90000000000000002 111.034 -174.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -79.18 11.85 2.62 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.989 -0.551 . . . . 0.90000000000000002 110.787 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 63.66 29.19 15.09 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.67 0.748 . . . . 0.90000000000000002 109.549 -172.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -168.85 -64.89 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.019 -1.233 . . . . 0.90000000000000002 110.019 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -109.73 -168.68 20.08 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.251 -1.14 . . . . 0.90000000000000002 110.251 169.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 1.008 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 12.9 m-90 -113.96 144.55 42.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.876 0.838 . . . . 0.90000000000000002 110.339 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -149.14 114.81 5.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.011 -0.366 . . . . 0.90000000000000002 110.011 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 61.7 tttp -96.71 111.67 23.74 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.092 -0.336 . . . . 0.90000000000000002 110.092 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 56.0 m -88.78 95.31 10.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.113 -0.494 . . . . 0.90000000000000002 110.736 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.945 -0.645 . . . . 0.90000000000000002 112.568 179.53 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 2' ' ' LYS . 51.4 mtpt . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.85 -0.426 . . . . 0.90000000000000002 109.85 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.458 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 43.1 tp -81.88 99.61 9.14 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.547 -0.538 . . . . 0.90000000000000002 109.547 176.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.572 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 16.7 m -83.11 96.71 8.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.931 0.396 . . . . 0.90000000000000002 110.174 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 tt -104.47 123.93 58.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.437 0.637 . . . . 0.90000000000000002 110.937 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.2 177.95 6.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.174 -0.921 . . . . 0.90000000000000002 109.314 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -94.8 147.01 23.79 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 110.024 -0.361 . . . . 0.90000000000000002 110.024 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.7 mt -75.96 98.86 4.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.205 0.526 . . . . 0.90000000000000002 110.765 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -106.87 -23.94 12.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.389 -0.823 . . . . 0.90000000000000002 109.154 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -124.97 124.96 43.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.724 -1.125 . . . . 0.90000000000000002 109.791 -172.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.96 91.92 3.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.523 -0.308 . . . . 0.90000000000000002 110.783 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -83.33 173.74 11.31 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.637 -0.505 . . . . 0.90000000000000002 109.637 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.553 ' O ' HG13 ' A' ' 17' ' ' ILE . 30.2 t70 -62.6 -52.63 62.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.577 -0.283 . . . . 0.90000000000000002 111.468 -178.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.515 ' HA ' HD13 ' A' ' 17' ' ' ILE . 52.4 tt0 -72.18 -25.73 61.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.906 0.384 . . . . 0.90000000000000002 110.316 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -62.48 -42.34 99.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.126 -0.694 . . . . 0.90000000000000002 109.126 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 16' ' ' ARG . 22.2 ttt85 -65.05 -39.09 92.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.819 -0.628 . . . . 0.90000000000000002 110.217 174.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.589 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 76.4 mt -59.82 -41.97 87.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.366 -0.379 . . . . 0.90000000000000002 111.356 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.95 -40.11 83.31 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.251 0.548 . . . . 0.90000000000000002 110.38 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.69 -31.91 73.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.90000000000000002 110.333 173.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -78.94 -10.1 59.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.625 -0.716 . . . . 0.90000000000000002 110.221 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 64.3 mttm -82.33 -31.62 29.79 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.857 -0.794 . . . . 0.90000000000000002 108.857 170.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.1 mt -72.16 -46.25 59.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.336 -0.847 . . . . 0.90000000000000002 109.783 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -117.97 97.38 50.71 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.007 -0.542 . . . . 0.90000000000000002 109.798 175.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 N--CA 1.476 0.479 0 C-N-CA 123.174 2.583 . . . . 0.90000000000000002 113.154 -175.241 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.3 mt . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 120.992 0.425 . . . . 0.90000000000000002 110.866 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -73.49 98.64 2.82 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.955 -0.757 . . . . 0.90000000000000002 108.955 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.4 m -92.97 151.39 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.382 0.611 . . . . 0.90000000000000002 110.67 -175.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -151.59 171.97 16.78 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.026 -0.988 . . . . 0.90000000000000002 108.593 -173.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.96 -29.08 68.83 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.866 -0.42 . . . . 0.90000000000000002 109.866 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -90.13 -33.28 16.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.077 -0.51 . . . . 0.90000000000000002 110.772 176.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -104.56 99.4 9.08 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.51 -0.313 . . . . 0.90000000000000002 110.168 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -114.64 139.47 49.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.305 0.574 . . . . 0.90000000000000002 111.668 -173.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.3 mt -119.48 116.57 51.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.658 -0.701 . . . . 0.90000000000000002 109.201 171.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -99.61 129.73 45.78 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.797 -0.445 . . . . 0.90000000000000002 109.797 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.475 ' HB3' HD23 ' A' ' 48' ' ' LEU . . . -118.19 120.71 38.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.74 -0.663 . . . . 0.90000000000000002 110.519 -176.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.811 ' HB1' ' HB3' ' A' ' 50' ' ' ALA . . . -92.09 107.09 18.96 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.663 -0.698 . . . . 0.90000000000000002 110.071 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 4' ' ' THR . 26.3 ptt180 -96.53 132.62 41.94 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.403 0.62 . . . . 0.90000000000000002 110.507 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.458 ' HB3' HD12 ' A' ' 49' ' ' LEU . 77.5 t80 -101.1 104.23 15.34 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.617 -0.883 . . . . 0.90000000000000002 108.617 176.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 31.3 t30 72.1 -62.19 0.47 Allowed 'General case' 0 C--N 1.331 -0.217 0 O-C-N 124.005 0.816 . . . . 0.90000000000000002 110.801 -176.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -136.45 -57.72 0.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.359 0.503 . . . . 0.90000000000000002 112.359 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -94.61 167.29 11.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.975 0.417 . . . . 0.90000000000000002 111.727 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.475 HD23 ' HB3' ' A' ' 41' ' ' ALA . 35.9 mt -91.21 106.6 18.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.615 -0.721 . . . . 0.90000000000000002 110.934 -171.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 44' ' ' PHE . 10.9 mp -92.93 -15.18 26.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.344 -0.389 . . . . 0.90000000000000002 111.122 -178.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.811 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . . . -137.21 125.97 23.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.754 0.311 . . . . 0.90000000000000002 111.017 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -123.67 130.22 52.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.322 -0.399 . . . . 0.90000000000000002 110.636 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.6 p -135.15 134.05 53.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.057 0.456 . . . . 0.90000000000000002 111.002 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.625 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 39.5 mtp180 -99.45 134.73 41.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.244 -0.434 . . . . 0.90000000000000002 110.188 177.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.2 p -139.91 126.76 23.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.611 0.719 . . . . 0.90000000000000002 111.596 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -108.93 115.22 29.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.543 -0.753 . . . . 0.90000000000000002 109.756 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -85.69 106.73 17.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.247 0.546 . . . . 0.90000000000000002 110.807 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -93.63 45.96 1.17 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.451 -0.795 . . . . 0.90000000000000002 109.28 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.54 -105.87 3.05 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.77 -0.65 . . . . 0.90000000000000002 111.761 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.5 p -83.04 -17.45 43.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.112 0.482 . . . . 0.90000000000000002 110.991 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -106.01 118.47 36.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.616 -0.72 . . . . 0.90000000000000002 110.694 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.73 114.07 4.89 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.144 -0.782 . . . . 0.90000000000000002 111.144 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.37 105.1 17.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.902 0.382 . . . . 0.90000000000000002 111.275 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.408 HD11 ' HE3' ' A' ' 95' ' ' TRP . 5.0 mp -95.16 111.97 23.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.048 -0.524 . . . . 0.90000000000000002 109.908 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.625 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 10.3 t0 -118.23 138.31 52.42 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.748 -0.464 . . . . 0.90000000000000002 109.748 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.447 ' HB2' ' HD3' ' A' ' 53' ' ' ARG . 20.2 m 68.39 91.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.628 0.727 . . . . 0.90000000000000002 111.501 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.7 tp -108.14 110.65 22.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.978 -1.01 . . . . 0.90000000000000002 108.409 171.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -127.3 104.62 8.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.06 0.457 . . . . 0.90000000000000002 111.302 -176.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.475 HG13 ' HB1' ' A' ' 50' ' ' ALA . 8.3 t -100.91 144.69 12.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.391 -0.966 . . . . 0.90000000000000002 108.391 172.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -61.83 155.6 22.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.257 0.551 . . . . 0.90000000000000002 112.363 -174.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -48.72 -41.04 30.69 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.322 -1.308 . . . . 0.90000000000000002 113.481 -165.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.83 -13.92 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.975 0.417 . . . . 0.90000000000000002 112.095 -171.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 m -88.02 60.6 5.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.438 0.637 . . . . 0.90000000000000002 111.607 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.8 ptt-85 -115.99 130.47 56.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.855 -0.611 . . . . 0.90000000000000002 110.675 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 52.81 53.57 11.91 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.956 -0.565 . . . . 0.90000000000000002 111.479 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.6 ttt180 -135.98 14.13 3.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.901 0.381 . . . . 0.90000000000000002 111.257 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.09 -35.64 2.56 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.108 -0.568 . . . . 0.90000000000000002 113.972 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.447 HG13 HD23 ' A' ' 3' ' ' LEU . 49.6 t -50.26 -41.79 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 122.974 0.51 . . . . 0.90000000000000002 112.355 -175.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.35 -45.28 93.03 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.953 -0.641 . . . . 0.90000000000000002 113.145 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -65.69 -49.87 66.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.927 0.394 . . . . 0.90000000000000002 110.245 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.458 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 48.0 t80 -54.4 -42.5 70.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.414 -0.812 . . . . 0.90000000000000002 110.366 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.41 ' O ' HG21 ' A' ' 85' ' ' VAL . 59.3 tp -52.76 -67.65 0.23 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.059 -0.973 . . . . 0.90000000000000002 111.847 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.1 -41.27 97.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.427 -0.351 . . . . 0.90000000000000002 111.693 -174.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 23.8 mt-10 -61.79 -37.53 84.69 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.698 -0.401 . . . . 0.90000000000000002 111.804 -177.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -70.77 -31.97 68.93 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.292 -0.563 . . . . 0.90000000000000002 110.535 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 81' ' ' LEU . 67.1 t -61.58 -45.41 98.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 110.013 -0.365 . . . . 0.90000000000000002 110.013 174.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.544 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 11.2 mp -67.32 -18.72 65.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.964 -0.562 . . . . 0.90000000000000002 111.19 178.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 79.3 mtp180 -81.27 -41.17 22.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.057 0.456 . . . . 0.90000000000000002 110.833 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -80.42 -29.95 37.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.142 -0.481 . . . . 0.90000000000000002 111.902 -174.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.523 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 0.9 OUTLIER -86.0 117.38 68.6 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.894 0.378 . . . . 0.90000000000000002 110.181 176.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.523 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 1.4 Cg_endo -83.45 -73.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.426 2.751 . . . . 0.90000000000000002 113.877 -172.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.43 53.45 4.67 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.092 -0.575 . . . . 0.90000000000000002 113.64 -171.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.6 t -124.2 115.2 44.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.685 -0.487 . . . . 0.90000000000000002 109.685 176.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 p -105.57 -24.36 12.6 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.404 -0.362 . . . . 0.90000000000000002 111.766 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 46.1 t -116.67 106.07 13.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.841 0.353 . . . . 0.90000000000000002 110.116 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.544 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 97.7 m95 -93.34 111.98 23.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.108 0.48 . . . . 0.90000000000000002 110.248 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -111.45 123.85 51.07 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.025 -0.731 . . . . 0.90000000000000002 109.025 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 68.6 mtp -119.03 117.11 27.88 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.707 -0.479 . . . . 0.90000000000000002 109.707 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.22 146.75 24.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.038 0.447 . . . . 0.90000000000000002 111.82 -171.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.482 ' HB3' ' CZ3' ' A' ' 124' ' ' TRP . 5.8 p-10 -98.8 14.95 26.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.669 -0.696 . . . . 0.90000000000000002 110.651 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.93 -55.87 29.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.90000000000000002 110.855 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -97.97 44.67 1.78 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.605 -0.807 . . . . 0.90000000000000002 112.312 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.409 HG11 ' SD ' ' A' ' 108' ' ' MET . 57.3 t -135.48 101.85 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.796 0.331 . . . . 0.90000000000000002 110.763 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -67.67 -41.83 83.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.065 0.46 . . . . 0.90000000000000002 110.766 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -84.93 59.51 5.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.362 0.601 . . . . 0.90000000000000002 110.489 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -63.16 -39.8 95.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.276 -0.875 . . . . 0.90000000000000002 111.291 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.69 -54.28 38.36 Favored Glycine 0 C--O 1.236 0.243 0 C-N-CA 120.957 -0.639 . . . . 0.90000000000000002 112.64 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.1 t -59.07 -43.44 89.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.114 0.483 . . . . 0.90000000000000002 110.562 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.538 ' SD ' ' HE3' ' A' ' 112' ' ' MET . 37.1 ttm -68.06 -27.01 66.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.961 -0.563 . . . . 0.90000000000000002 111.154 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 91.9 m -62.25 -52.62 63.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.785 0.326 . . . . 0.90000000000000002 110.161 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.61 84.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.506 . . . . 0.90000000000000002 110.537 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -60.26 -57.83 11.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.552 -0.749 . . . . 0.90000000000000002 111.347 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.538 ' HE3' ' SD ' ' A' ' 108' ' ' MET . 61.8 mtt -67.34 -33.06 74.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.439 -0.346 . . . . 0.90000000000000002 111.445 -175.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -63.71 -37.62 88.05 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.652 -0.419 . . . . 0.90000000000000002 110.09 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.71 -30.37 71.04 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.185 -0.461 . . . . 0.90000000000000002 110.368 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.0 mp -84.13 2.2 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 0.90000000000000002 111.085 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.16 23.34 32.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.988 -0.625 . . . . 0.90000000000000002 113.789 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.512 ' HB3' ' HB3' ' A' ' 124' ' ' TRP . 91.4 m-85 -92.84 134.0 35.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.234 0.517 . . . . 0.90000000000000002 110.426 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.4 m -90.67 145.1 25.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.22 -0.446 . . . . 0.90000000000000002 110.484 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.426 HG23 ' CD1' ' A' ' 124' ' ' TRP . 70.9 p -97.43 118.23 33.44 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.998 -0.371 . . . . 0.90000000000000002 109.998 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -124.12 -93.79 0.5 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.713 -0.395 . . . . 0.90000000000000002 111.311 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -154.83 123.47 6.11 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.034 -0.728 . . . . 0.90000000000000002 109.034 -177.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.36 11.66 66.35 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.495 -0.859 . . . . 0.90000000000000002 111.373 -174.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.9 -152.34 18.05 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.136 -0.554 . . . . 0.90000000000000002 112.906 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.512 ' HB3' ' HB3' ' A' ' 117' ' ' PHE . 22.7 m-90 -102.13 150.65 23.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.183 -0.508 . . . . 0.90000000000000002 110.015 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -134.01 134.79 42.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.236 -0.438 . . . . 0.90000000000000002 110.371 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -137.07 93.09 2.79 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.403 -0.591 . . . . 0.90000000000000002 109.403 171.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.2 p -102.78 142.27 34.19 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.787 -0.642 . . . . 0.90000000000000002 110.586 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.501 0 C-N-CA 120.944 -0.646 . . . . 0.90000000000000002 112.187 179.445 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.8 mttt . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.882 -0.414 . . . . 0.90000000000000002 109.882 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.482 HD23 ' HB2' ' A' ' 42' ' ' ALA . 51.9 tp -76.63 122.32 24.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.948 -0.569 . . . . 0.90000000000000002 109.951 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.2 p -90.58 121.86 32.88 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.244 0.545 . . . . 0.90000000000000002 110.835 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.504 HG22 ' HA ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -117.1 125.94 74.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.803 -0.635 . . . . 0.90000000000000002 110.376 -178.35 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.1 mm -103.34 151.33 6.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.429 -0.582 . . . . 0.90000000000000002 109.429 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.2 ptt85 -95.36 106.37 18.42 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.505 -0.554 . . . . 0.90000000000000002 109.505 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.2 mt -75.91 83.72 2.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.94 -0.573 . . . . 0.90000000000000002 110.145 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.77 ' HA ' HG11 ' A' ' 33' ' ' VAL . 30.6 mt-10 -81.81 -26.13 34.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.273 -0.876 . . . . 0.90000000000000002 109.993 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -147.49 122.94 10.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.998 -1.001 . . . . 0.90000000000000002 108.71 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -93.34 133.76 36.26 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.978 -0.289 . . . . 0.90000000000000002 110.935 -173.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 m -77.47 174.3 11.01 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.363 -0.976 . . . . 0.90000000000000002 108.363 168.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.484 ' O ' HG13 ' A' ' 17' ' ' ILE . 8.6 p-10 -65.08 -45.52 84.93 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.515 -0.474 . . . . 0.90000000000000002 110.492 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -63.69 -40.11 95.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.90000000000000002 110.317 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.406 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 24.1 m-20 -57.07 -50.87 71.44 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.779 -0.646 . . . . 0.90000000000000002 110.092 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -66.08 -30.47 70.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.843 -0.617 . . . . 0.90000000000000002 110.83 -177.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 13' ' ' ASP . 84.3 mt -72.62 -39.47 61.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.55 -0.296 . . . . 0.90000000000000002 110.996 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -69.72 -34.96 74.6 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.492 -0.558 . . . . 0.90000000000000002 109.492 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 79.6 mt -64.57 -32.27 73.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.90000000000000002 110.385 173.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -71.31 -23.31 61.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.979 0.419 . . . . 0.90000000000000002 110.45 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -70.67 -38.25 73.75 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.3 -0.63 . . . . 0.90000000000000002 109.3 173.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.89 -43.95 52.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.265 -0.88 . . . . 0.90000000000000002 110.514 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -121.52 89.2 47.09 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.143 -0.481 . . . . 0.90000000000000002 109.998 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo . . . . . 0 C--N 1.344 0.309 0 C-N-CA 122.622 2.215 . . . . 0.90000000000000002 112.212 -177.322 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 C--O 1.228 -0.066 0 CA-C-O 120.99 0.424 . . . . 0.90000000000000002 110.485 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -72.43 128.23 34.98 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.617 -0.512 . . . . 0.90000000000000002 109.617 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.77 HG11 ' HA ' ' A' ' 9' ' ' GLU . 39.8 t -113.22 122.86 68.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.94 -0.573 . . . . 0.90000000000000002 110.454 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -148.33 -171.0 3.74 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.718 -0.845 . . . . 0.90000000000000002 108.718 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -69.95 -31.41 69.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.267 0.556 . . . . 0.90000000000000002 109.836 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -84.28 -8.14 59.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.439 -0.8 . . . . 0.90000000000000002 111.52 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -152.48 97.72 2.3 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.96 -0.296 . . . . 0.90000000000000002 110.355 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -111.98 135.73 52.23 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.255 -0.429 . . . . 0.90000000000000002 110.209 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.519 HG22 ' HG2' ' A' ' 53' ' ' ARG . 59.0 mt -101.56 118.79 48.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.187 -0.461 . . . . 0.90000000000000002 110.286 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -100.72 125.31 47.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.306 0.574 . . . . 0.90000000000000002 110.457 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.469 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -108.14 119.36 39.25 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.525 -0.761 . . . . 0.90000000000000002 110.1 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.11 114.76 27.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.895 -0.593 . . . . 0.90000000000000002 110.029 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.431 ' HB3' HD23 ' A' ' 48' ' ' LEU . 34.2 ptt180 -109.72 132.4 54.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.575 0.702 . . . . 0.90000000000000002 111.219 -175.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' A' ' 45' ' ' ASN . 75.6 t80 -98.1 102.84 14.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.366 -0.833 . . . . 0.90000000000000002 109.078 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 10.4 t30 74.31 -43.12 0.52 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.719 0.637 . . . . 0.90000000000000002 111.435 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -159.83 -56.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.023 0.44 . . . . 0.90000000000000002 111.332 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -85.73 153.22 22.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.923 -0.58 . . . . 0.90000000000000002 111.007 -171.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.469 HD21 ' HB3' ' A' ' 41' ' ' ALA . 52.0 mt -71.06 122.75 20.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.027 -0.533 . . . . 0.90000000000000002 110.855 -175.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.4 tp -105.29 -15.08 15.15 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.035 0.445 . . . . 0.90000000000000002 110.206 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -154.48 150.07 27.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.207 -0.451 . . . . 0.90000000000000002 110.458 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -135.24 125.52 26.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.869 0.366 . . . . 0.90000000000000002 110.666 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.35 138.29 48.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.925 -0.579 . . . . 0.90000000000000002 110.445 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.519 ' HG2' HG22 ' A' ' 39' ' ' ILE . 21.2 mtm180 -118.18 133.37 55.96 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.686 -0.486 . . . . 0.90000000000000002 109.686 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.1 p -120.78 126.15 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.631 0.729 . . . . 0.90000000000000002 111.176 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.7 m -90.69 94.58 9.75 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.158 -0.928 . . . . 0.90000000000000002 109.535 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.11 92.15 5.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.844 -0.616 . . . . 0.90000000000000002 110.456 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.6 m -93.29 84.42 4.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.634 -0.712 . . . . 0.90000000000000002 109.823 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.45 -101.39 0.83 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.678 -0.772 . . . . 0.90000000000000002 111.699 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.4 p -112.85 6.98 18.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.154 0.502 . . . . 0.90000000000000002 110.488 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -101.14 111.75 24.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.813 -0.631 . . . . 0.90000000000000002 110.41 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.98 94.06 1.7 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.887 -0.673 . . . . 0.90000000000000002 111.711 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.92 123.39 45.05 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.806 -0.232 . . . . 0.90000000000000002 110.517 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.41 HD11 ' SD ' ' A' ' 97' ' ' MET . 6.8 mp -93.45 118.84 31.82 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.818 -0.438 . . . . 0.90000000000000002 109.818 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -101.15 -12.8 18.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.556 -0.747 . . . . 0.90000000000000002 112.673 -170.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.4 m -155.31 133.4 11.54 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.076 -0.249 . . . . 0.90000000000000002 111.28 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.9 tp -148.44 115.93 6.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.488 . . . . 0.90000000000000002 110.865 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -138.71 132.6 31.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.373 -0.376 . . . . 0.90000000000000002 110.425 173.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.461 HG12 ' HB1' ' A' ' 50' ' ' ALA . 3.5 t -103.85 152.01 6.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.563 -0.903 . . . . 0.90000000000000002 108.563 172.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -71.93 154.68 41.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.612 0.244 . . . . 0.90000000000000002 110.787 -175.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -43.03 -47.25 5.81 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.969 1.1 . . . . 0.90000000000000002 113.969 -170.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.3 m -81.05 26.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 113.251 0.834 . . . . 0.90000000000000002 113.251 -171.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.83 29.52 6.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.044 0.449 . . . . 0.90000000000000002 111.417 -177.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -67.11 108.96 2.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.44 . . . . 0.90000000000000002 110.825 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 56.23 42.27 28.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.141 0.496 . . . . 0.90000000000000002 110.666 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.4 ttt180 -108.59 19.36 19.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.812 -0.631 . . . . 0.90000000000000002 111.103 -172.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.51 -40.51 2.42 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.145 -0.55 . . . . 0.90000000000000002 113.862 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.4 t -46.81 -46.72 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 123.21 0.604 . . . . 0.90000000000000002 112.581 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.68 -41.73 90.26 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.908 -0.663 . . . . 0.90000000000000002 113.11 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.514 ' HG3' ' HG ' ' A' ' 115' ' ' LEU . 52.7 tt0 -69.36 -38.53 78.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.996 0.426 . . . . 0.90000000000000002 110.356 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.437 ' HE2' ' H ' ' A' ' 3' ' ' LEU . 74.8 t80 -68.56 -38.39 80.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.931 -0.577 . . . . 0.90000000000000002 110.184 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.418 HD11 ' HB1' ' A' ' 42' ' ' ALA . 50.2 tp -53.61 -56.78 14.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.314 -0.403 . . . . 0.90000000000000002 111.211 177.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.442 ' O ' HD13 ' A' ' 86' ' ' LEU . 4.4 mm? -60.15 -45.72 92.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.90000000000000002 111.145 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -67.84 -37.51 81.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.353 -0.385 . . . . 0.90000000000000002 111.369 -176.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -58.78 -46.99 86.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.797 0.332 . . . . 0.90000000000000002 110.539 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 73.3 t -63.82 -46.36 94.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.90000000000000002 110.91 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 82' ' ' LEU . 11.0 mp -69.09 -29.06 67.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.218 -0.446 . . . . 0.90000000000000002 111.312 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.0 ttt-85 -75.27 -30.75 60.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.107 0.48 . . . . 0.90000000000000002 109.721 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -75.94 -33.62 59.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.624 -0.716 . . . . 0.90000000000000002 110.052 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -115.8 70.78 3.65 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.828 -0.624 . . . . 0.90000000000000002 110.344 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.33 -6.7 13.84 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.289 1.992 . . . . 0.90000000000000002 112.051 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.07 -14.97 81.73 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.947 -0.645 . . . . 0.90000000000000002 112.153 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.8 t -87.78 113.36 24.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.962 0.411 . . . . 0.90000000000000002 110.203 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 2.5 p -89.5 -22.91 22.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.968 -0.56 . . . . 0.90000000000000002 111.426 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.4 m -108.05 99.3 8.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.824 0.345 . . . . 0.90000000000000002 111.363 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -109.05 126.13 52.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.321 -0.399 . . . . 0.90000000000000002 110.272 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.425 ' HE3' ' HG2' ' A' ' 125' ' ' GLU . 51.9 t-105 -115.58 127.82 55.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.963 -0.562 . . . . 0.90000000000000002 110.198 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.854 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 87.5 mmm -108.0 120.76 43.23 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.245 -0.434 . . . . 0.90000000000000002 109.96 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.79 142.7 47.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.602 -0.272 . . . . 0.90000000000000002 110.45 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.819 ' HB2' ' HB ' ' A' ' 102' ' ' VAL . 4.6 p-10 -86.61 -35.55 19.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.461 -0.336 . . . . 0.90000000000000002 110.107 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.54 22.87 12.58 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.897 -0.592 . . . . 0.90000000000000002 111.955 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 125.39 37.21 0.53 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.572 -0.823 . . . . 0.90000000000000002 112.646 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.819 ' HB ' ' HB2' ' A' ' 99' ' ' ASP . 76.8 t -102.22 125.68 56.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.752 -0.462 . . . . 0.90000000000000002 109.752 176.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -84.18 -35.81 23.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.016 -0.538 . . . . 0.90000000000000002 110.632 -177.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -83.18 67.67 9.29 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.486 0.66 . . . . 0.90000000000000002 110.886 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -72.55 -17.73 61.7 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.694 -0.684 . . . . 0.90000000000000002 109.614 176.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.08 -57.86 12.47 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.939 -0.648 . . . . 0.90000000000000002 112.048 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.16 -43.56 97.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.623 0.249 . . . . 0.90000000000000002 111.15 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.606 ' SD ' HG12 ' A' ' 102' ' ' VAL . 50.6 mtp -71.11 -31.04 67.27 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.333 -0.547 . . . . 0.90000000000000002 112.008 -175.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.687 HG21 HG22 ' A' ' 119' ' ' THR . 36.6 m -68.92 -43.95 74.11 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.801 -0.359 . . . . 0.90000000000000002 110.243 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.12 -38.78 87.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.198 0.523 . . . . 0.90000000000000002 110.287 176.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -61.4 -51.53 68.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.474 -0.785 . . . . 0.90000000000000002 111.33 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.478 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 66.1 mtt -75.93 -34.5 59.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.376 -0.374 . . . . 0.90000000000000002 111.922 -174.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -74.1 -22.61 59.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.888 0.375 . . . . 0.90000000000000002 110.572 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.05 -19.22 25.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.041 0.448 . . . . 0.90000000000000002 110.63 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.514 ' HG ' ' HG3' ' A' ' 79' ' ' GLN . 6.1 tt -80.32 -55.17 5.08 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.213 -0.662 . . . . 0.90000000000000002 109.213 175.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 146.93 46.74 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.639 -0.791 . . . . 0.90000000000000002 112.401 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.536 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 97.2 m-85 -121.33 143.01 49.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.802 0.335 . . . . 0.90000000000000002 110.274 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.9 m -81.09 121.72 26.44 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.255 -0.646 . . . . 0.90000000000000002 109.255 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.687 HG22 HG21 ' A' ' 109' ' ' THR . 67.2 p -97.38 130.43 44.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.141 0.496 . . . . 0.90000000000000002 111.054 -173.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -129.36 176.09 8.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.808 -0.633 . . . . 0.90000000000000002 110.53 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -81.71 87.95 6.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.988 -0.551 . . . . 0.90000000000000002 110.081 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 129.92 -50.77 0.88 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.721 -0.752 . . . . 0.90000000000000002 112.292 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -135.32 178.92 18.22 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.331 -0.938 . . . . 0.90000000000000002 112.506 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.854 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 8.2 m-90 -127.3 140.98 51.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.848 -0.797 . . . . 0.90000000000000002 108.848 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.425 ' HG2' ' HE3' ' A' ' 96' ' ' TRP . 42.3 mt-10 -129.03 150.79 50.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.933 0.397 . . . . 0.90000000000000002 111.452 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.536 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 78.8 tttt -136.15 121.8 19.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.155 -0.475 . . . . 0.90000000000000002 109.766 171.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 93' ' ' SER . 53.9 t -129.93 108.98 10.53 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.056 -0.52 . . . . 0.90000000000000002 110.23 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 121.037 -0.601 . . . . 0.90000000000000002 112.13 178.315 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.773 0.321 . . . . 0.90000000000000002 110.85 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -116.5 130.14 56.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.438 -0.346 . . . . 0.90000000000000002 110.338 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.58 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 47.3 tp -76.0 115.94 16.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.867 -0.606 . . . . 0.90000000000000002 109.805 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.0 m -82.67 101.23 10.7 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.016 0.436 . . . . 0.90000000000000002 110.662 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.495 HD11 ' HB3' ' A' ' 40' ' ' TYR . 8.4 tp -90.18 113.38 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 121.749 0.785 . . . . 0.90000000000000002 110.102 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.7 mt -106.57 153.34 7.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.657 -0.701 . . . . 0.90000000000000002 109.516 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 -100.86 126.55 47.47 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.993 -0.743 . . . . 0.90000000000000002 108.993 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.5 mt -80.9 91.51 6.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.339 0.59 . . . . 0.90000000000000002 110.875 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -93.13 -23.95 18.43 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.224 -0.898 . . . . 0.90000000000000002 109.662 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -140.06 139.53 35.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.08 -0.963 . . . . 0.90000000000000002 109.599 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -115.38 116.0 27.53 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.254 -0.43 . . . . 0.90000000000000002 110.519 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.4 p -84.89 171.12 12.45 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.728 -0.842 . . . . 0.90000000000000002 108.728 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 17' ' ' ILE . 30.7 m-20 -74.24 -21.35 59.82 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.555 -0.535 . . . . 0.90000000000000002 109.555 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -69.78 -49.26 54.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.461 -0.791 . . . . 0.90000000000000002 109.418 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.455 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 62.8 m-20 -61.31 -38.8 88.15 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 109.366 -0.605 . . . . 0.90000000000000002 109.366 175.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.616 ' HG2' HE21 ' A' ' 20' ' ' GLN . 46.6 ttm-85 -53.8 -47.05 71.2 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.5 -0.773 . . . . 0.90000000000000002 111.059 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 13' ' ' ASP . 77.8 mt -66.59 -48.31 80.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.90000000000000002 111.459 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.492 ' HB3' HD12 ' A' ' 48' ' ' LEU . 1.2 m-20 -65.43 -32.26 73.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.661 -0.245 . . . . 0.90000000000000002 111.342 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 78.1 mt -64.89 -42.48 94.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.90000000000000002 110.526 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.616 HE21 ' HG2' ' A' ' 16' ' ' ARG . 73.6 mt-30 -69.04 -20.65 64.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.366 0.603 . . . . 0.90000000000000002 110.346 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -76.99 -26.53 53.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.642 -0.708 . . . . 0.90000000000000002 109.557 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.6 mt -82.57 -37.43 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.542 -0.754 . . . . 0.90000000000000002 110.46 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -117.86 85.89 23.67 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.90000000000000002 110.369 177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.38 -9.66 21.78 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.642 2.228 . . . . 0.90000000000000002 113.102 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -101.15 -5.21 25.95 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.46 0.648 . . . . 0.90000000000000002 110.04 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -99.73 116.34 31.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.119 -0.491 . . . . 0.90000000000000002 110.441 -175.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.5 t -72.47 130.13 86.3 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.312 -0.625 . . . . 0.90000000000000002 109.312 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.12 104.63 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.26 2.64 . . . . 0.90000000000000002 113.369 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.1 m -81.49 -161.74 0.45 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.555 -0.748 . . . . 0.90000000000000002 109.834 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.5 m -70.4 -26.18 63.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.621 -0.263 . . . . 0.90000000000000002 110.97 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.8 mt 58.13 78.7 0.23 Allowed 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 108.953 -0.758 . . . . 0.90000000000000002 108.953 -172.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -134.03 111.34 10.3 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.299 -0.864 . . . . 0.90000000000000002 110.309 -169.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -103.61 159.12 4.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.066 -0.516 . . . . 0.90000000000000002 111.16 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -130.73 -166.4 1.68 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.866 -1.161 . . . . 0.90000000000000002 107.866 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -79.14 -11.59 59.98 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.93 -0.708 . . . . 0.90000000000000002 110.767 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -96.24 -59.83 1.75 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.068 -0.515 . . . . 0.90000000000000002 110.117 174.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -74.31 97.47 3.02 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.527 -0.545 . . . . 0.90000000000000002 109.527 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 38' ' ' ARG . 22.7 mtp180 -115.81 115.43 26.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.235 0.54 . . . . 0.90000000000000002 110.488 -173.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.2 mt -98.59 118.85 45.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.734 -0.666 . . . . 0.90000000000000002 109.661 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.495 ' HB3' HD11 ' A' ' 5' ' ' ILE . 96.7 m-85 -106.28 142.74 35.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.944 -0.571 . . . . 0.90000000000000002 110.343 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.429 ' HB1' HD23 ' A' ' 48' ' ' LEU . . . -123.55 117.69 25.66 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.775 -0.648 . . . . 0.90000000000000002 110.38 -175.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.484 ' HB2' HD22 ' A' ' 3' ' ' LEU . . . -91.71 99.78 12.61 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.03 0.443 . . . . 0.90000000000000002 109.869 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.66 ' HG2' HD21 ' A' ' 48' ' ' LEU . 4.1 mtm180 -104.21 111.02 23.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.922 -0.581 . . . . 0.90000000000000002 110.413 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -97.46 107.82 20.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.407 -0.815 . . . . 0.90000000000000002 108.931 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.0 t30 60.53 65.32 1.07 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.421 -0.809 . . . . 0.90000000000000002 110.012 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 72.58 -29.85 0.2 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.967 -1.015 . . . . 0.90000000000000002 113.655 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -101.56 145.56 28.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.981 0.42 . . . . 0.90000000000000002 111.821 -170.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.66 HD21 ' HG2' ' A' ' 43' ' ' ARG . 54.7 mt -65.22 117.84 8.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.904 -0.589 . . . . 0.90000000000000002 110.962 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.9 tp -106.95 -27.14 10.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.075 -0.511 . . . . 0.90000000000000002 109.912 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.47 ' HB2' ' HB3' ' A' ' 42' ' ' ALA . . . -152.76 149.22 28.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.90000000000000002 110.547 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -138.35 135.51 35.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.399 -0.364 . . . . 0.90000000000000002 110.358 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.457 ' HB ' HD13 ' A' ' 66' ' ' LEU . 8.8 p -140.62 140.98 33.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.919 0.39 . . . . 0.90000000000000002 110.781 -177.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -114.51 123.5 49.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.858 -0.423 . . . . 0.90000000000000002 109.858 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.501 ' HB ' HD21 ' A' ' 63' ' ' LEU . 6.7 p -125.2 124.37 67.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.317 0.579 . . . . 0.90000000000000002 110.414 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.9 m -97.89 99.47 10.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.834 -0.621 . . . . 0.90000000000000002 110.059 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.486 HD22 ' HA2' ' A' ' 61' ' ' GLY . 96.9 mt -85.86 70.44 10.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.602 -0.726 . . . . 0.90000000000000002 109.938 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 m -67.31 99.06 0.67 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.873 -0.603 . . . . 0.90000000000000002 110.005 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.18 -116.43 5.24 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.532 -0.842 . . . . 0.90000000000000002 111.373 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.7 m -114.13 14.71 18.29 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.872 0.844 . . . . 0.90000000000000002 109.386 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -101.31 134.57 44.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.133 -0.94 . . . . 0.90000000000000002 109.853 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.486 ' HA2' HD22 ' A' ' 56' ' ' LEU . . . -106.09 106.01 2.51 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.395 -0.907 . . . . 0.90000000000000002 112.657 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.57 108.45 20.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.929 0.395 . . . . 0.90000000000000002 110.748 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.515 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 56.6 mt -93.94 119.93 33.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.491 -0.559 . . . . 0.90000000000000002 109.491 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -99.25 -75.32 0.57 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.211 -0.449 . . . . 0.90000000000000002 111.927 -174.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 p -121.92 141.92 50.8 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.256 0.551 . . . . 0.90000000000000002 112.191 -173.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.457 HD13 ' HB ' ' A' ' 52' ' ' VAL . 33.9 tp -140.85 119.99 12.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.164 -0.926 . . . . 0.90000000000000002 109.858 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.77 ' HA ' ' C6P' ' A' ' 999' ' ' COA . 13.0 mtp180 -128.41 114.75 17.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.793 0.33 . . . . 0.90000000000000002 111.191 176.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.479 ' HB ' ' H10' ' A' ' 999' ' ' COA . 11.2 t -95.33 151.73 3.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.59 -1.263 . . . . 0.90000000000000002 107.59 167.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -54.06 140.28 32.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.409 -0.219 . . . . 0.90000000000000002 110.409 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.4 mp0 -52.19 -38.25 57.25 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.251 0.62 . . . . 0.90000000000000002 112.426 -172.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.38 -22.97 27.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.186 0.517 . . . . 0.90000000000000002 111.201 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.441 ' HB ' HG12 ' A' ' 68' ' ' VAL . 6.9 m -90.86 64.02 5.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.285 0.564 . . . . 0.90000000000000002 109.953 -177.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.698 ' HA ' H121 ' A' ' 999' ' ' COA . 12.6 ttp180 -94.75 12.65 27.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.774 -0.648 . . . . 0.90000000000000002 111.198 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 74' ' ' ARG . 36.6 ttp180 173.85 90.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.867 -0.606 . . . . 0.90000000000000002 109.715 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -156.46 17.57 0.33 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.116 0.484 . . . . 0.90000000000000002 110.243 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.28 -34.46 1.76 Allowed Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.077 -0.583 . . . . 0.90000000000000002 113.379 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.469 HG11 HD21 ' A' ' 3' ' ' LEU . 59.5 t -39.74 -52.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.079 0.951 . . . . 0.90000000000000002 113.309 -176.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.92 -55.12 31.87 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.118 -0.563 . . . . 0.90000000000000002 113.266 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.462 ' HB3' HD12 ' A' ' 115' ' ' LEU . 24.9 mt-30 -67.83 -39.65 83.86 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.793 -0.239 . . . . 0.90000000000000002 110.614 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.58 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 47.2 t80 -53.72 -47.78 70.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.927 -0.579 . . . . 0.90000000000000002 110.159 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 85' ' ' VAL . 43.0 tp -62.19 -50.96 69.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.827 -0.624 . . . . 0.90000000000000002 111.249 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.43 HD23 HD23 ' A' ' 66' ' ' LEU . 4.4 mm? -59.65 -46.58 88.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.495 -0.32 . . . . 0.90000000000000002 111.154 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 48.0 mt-10 -61.37 -44.73 96.67 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.046 -0.261 . . . . 0.90000000000000002 110.359 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -56.55 -43.75 80.24 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.329 -0.396 . . . . 0.90000000000000002 110.906 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 81' ' ' LEU . 96.9 t -61.06 -46.77 96.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.352 . . . . 0.90000000000000002 110.609 178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -72.29 -18.44 61.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.395 -0.366 . . . . 0.90000000000000002 111.915 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 23.1 mtm180 -88.73 -22.1 23.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.537 0.208 . . . . 0.90000000000000002 111.329 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -103.08 -7.35 21.41 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.997 -0.281 . . . . 0.90000000000000002 111.638 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -118.37 85.61 25.94 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.90000000000000002 110.187 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.49 162.99 12.75 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.18 2.587 . . . . 0.90000000000000002 111.44 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.83 -45.87 3.25 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.628 -0.796 . . . . 0.90000000000000002 111.782 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.86 99.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.467 -0.568 . . . . 0.90000000000000002 109.467 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 16.5 m -92.55 -25.48 18.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.179 -0.464 . . . . 0.90000000000000002 111.154 -175.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.6 t -102.35 98.75 8.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.84 0.352 . . . . 0.90000000000000002 110.728 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -97.2 113.19 24.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.086 -0.506 . . . . 0.90000000000000002 109.948 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -112.7 123.03 49.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.946 -0.57 . . . . 0.90000000000000002 110.014 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.726 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 63.3 mtp -111.4 123.43 50.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.317 -0.401 . . . . 0.90000000000000002 110.375 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.16 153.72 27.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.937 -0.574 . . . . 0.90000000000000002 110.739 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -84.58 -26.55 27.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.249 -0.432 . . . . 0.90000000000000002 110.242 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 59.09 14.38 3.44 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.887 0.699 . . . . 0.90000000000000002 112.887 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.18 20.88 78.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.905 -0.664 . . . . 0.90000000000000002 112.392 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.8 t -67.92 134.31 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.583 0.23 . . . . 0.90000000000000002 110.49 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.442 ' C ' ' H ' ' A' ' 105' ' ' ARG . 5.5 mm-40 -93.28 -17.2 23.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.044 0.449 . . . . 0.90000000000000002 111.072 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -83.88 19.53 1.7 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.22 -0.659 . . . . 0.90000000000000002 109.22 171.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 103' ' ' GLU . 6.9 ttp180 -64.77 -26.96 68.58 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.199 -0.91 . . . . 0.90000000000000002 111.106 -176.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.0 -48.18 87.35 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.384 -0.912 . . . . 0.90000000000000002 111.207 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 80.2 t -65.8 -42.47 92.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.994 0.425 . . . . 0.90000000000000002 110.362 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.634 ' O ' ' HG2' ' A' ' 112' ' ' MET . 96.1 mmm -59.2 -48.41 81.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.90000000000000002 111.242 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.1 m -63.43 -35.54 80.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.365 0.126 . . . . 0.90000000000000002 111.14 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.86 99.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.391 0.615 . . . . 0.90000000000000002 109.937 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -62.12 -44.35 96.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.08 -0.964 . . . . 0.90000000000000002 110.453 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.634 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.1 mmt -62.44 -48.08 81.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.81 -0.632 . . . . 0.90000000000000002 111.616 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -64.93 -38.7 91.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.283 -0.417 . . . . 0.90000000000000002 111.244 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.83 -21.9 56.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.347 -0.388 . . . . 0.90000000000000002 111.424 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.537 HD22 ' HE2' ' A' ' 117' ' ' PHE . 40.9 tp -87.56 -45.69 10.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.466 -0.334 . . . . 0.90000000000000002 110.527 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 138.04 44.52 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.497 -0.859 . . . . 0.90000000000000002 113.231 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.554 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 87.3 m-85 -120.7 153.74 36.52 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.12 -0.326 . . . . 0.90000000000000002 110.12 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.0 m -120.05 146.79 45.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.107 -0.497 . . . . 0.90000000000000002 110.126 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.1 m -97.12 121.79 39.41 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.557 -0.534 . . . . 0.90000000000000002 109.557 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -136.08 103.8 5.47 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.509 0.559 . . . . 0.90000000000000002 112.509 -175.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 58.0 36.19 25.9 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.108 -0.951 . . . . 0.90000000000000002 113.28 165.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.83 49.16 0.55 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.225 -0.988 . . . . 0.90000000000000002 113.366 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.39 179.36 19.96 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.627 -0.797 . . . . 0.90000000000000002 111.87 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.726 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 6.9 m-90 -102.95 137.83 40.63 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.783 -0.451 . . . . 0.90000000000000002 109.783 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -125.56 137.37 53.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.758 0.314 . . . . 0.90000000000000002 110.445 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -137.21 91.7 2.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.133 0.492 . . . . 0.90000000000000002 109.999 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 93' ' ' SER . 52.4 t -91.21 112.36 24.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.087 -0.506 . . . . 0.90000000000000002 110.228 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 CA-C-N 115.77 -0.65 . . . . 0.90000000000000002 111.865 179.96 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 999' ' ' COA . . . . . 0.77 ' C6P' ' HA ' ' A' ' 67' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.884 0.373 . . . . 0.90000000000000002 110.303 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -82.72 90.89 6.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.184 0.516 . . . . 0.90000000000000002 109.956 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.1 tp -76.13 114.63 15.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.574 -0.739 . . . . 0.90000000000000002 109.877 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.9 m -82.8 89.79 6.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.953 0.406 . . . . 0.90000000000000002 110.655 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.484 HD13 ' HB3' ' A' ' 40' ' ' TYR . 5.2 tp -95.75 111.04 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.726 -0.67 . . . . 0.90000000000000002 109.994 175.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.3 pt -130.51 171.01 18.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.654 -0.703 . . . . 0.90000000000000002 109.836 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -92.79 137.2 32.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.792 -0.447 . . . . 0.90000000000000002 109.792 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.434 ' O ' HG22 ' A' ' 33' ' ' VAL . 53.9 tp -78.99 70.55 5.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.245 0.545 . . . . 0.90000000000000002 109.689 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -69.49 -43.8 72.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.444 -0.798 . . . . 0.90000000000000002 111.443 -174.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -111.44 132.07 54.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.082 -0.508 . . . . 0.90000000000000002 109.967 -175.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.557 ' CE1' ' HB3' ' A' ' 31' ' ' LEU . 72.3 m-85 -99.46 114.88 28.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.052 -0.522 . . . . 0.90000000000000002 111.245 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.8 p -102.46 163.92 11.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.756 -0.831 . . . . 0.90000000000000002 108.756 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.577 ' O ' HG13 ' A' ' 17' ' ' ILE . 34.1 t70 -66.12 -29.84 70.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.567 -0.531 . . . . 0.90000000000000002 109.567 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -66.99 -50.19 63.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.541 -0.754 . . . . 0.90000000000000002 111.008 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.43 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 32.9 m-20 -61.74 -35.04 76.92 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.90000000000000002 110.622 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.405 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 35.6 ttm180 -61.47 -38.01 85.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.90000000000000002 110.526 176.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 13' ' ' ASP . 72.9 mt -60.48 -42.49 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.193 0.52 . . . . 0.90000000000000002 110.331 176.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.406 ' HB3' HD13 ' A' ' 48' ' ' LEU . 80.5 m-20 -68.73 -33.54 74.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.90000000000000002 110.666 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 96.4 mt -65.0 -34.44 78.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.293 -0.412 . . . . 0.90000000000000002 110.372 175.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 25.4 mt-30 -69.71 -24.71 63.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.183 -0.462 . . . . 0.90000000000000002 110.733 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.4 ' HZ2' HG21 ' A' ' 17' ' ' ILE . 62.3 mttp -66.52 -44.36 82.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.231 0.539 . . . . 0.90000000000000002 109.867 172.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.2 mt -75.45 -45.59 39.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.508 -0.769 . . . . 0.90000000000000002 111.33 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 6.0 m-90 -123.89 74.48 56.4 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.554 -0.294 . . . . 0.90000000000000002 111.668 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.79 -21.86 9.4 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 121.922 1.748 . . . . 0.90000000000000002 111.341 175.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -89.84 -3.48 58.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.057 -0.974 . . . . 0.90000000000000002 110.378 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.514 ' HB3' ' HB3' ' A' ' 23' ' ' TRP . 31.9 t80 -92.11 142.75 27.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.636 -0.711 . . . . 0.90000000000000002 110.134 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.8 m -66.59 125.04 89.88 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.246 -0.434 . . . . 0.90000000000000002 110.258 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.51 97.62 0.26 Allowed 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.626 2.218 . . . . 0.90000000000000002 112.277 -177.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.3 p -88.26 178.4 6.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.709 -0.678 . . . . 0.90000000000000002 110.572 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 26.0 m -68.84 -27.0 65.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.548 -0.296 . . . . 0.90000000000000002 110.838 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.557 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 51.4 mt 74.12 105.63 0.07 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.927 0.767 . . . . 0.90000000000000002 111.505 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -129.96 139.97 51.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.763 -0.653 . . . . 0.90000000000000002 110.353 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 13.7 m -125.72 154.19 34.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.90000000000000002 111.386 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.487 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 22.9 t70 74.4 -30.11 0.2 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.98 -1.009 . . . . 0.90000000000000002 111.53 175.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 33' ' ' VAL . 4.4 t70 -81.71 68.94 8.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.908 -0.775 . . . . 0.90000000000000002 108.908 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 35' ' ' ASP . 19.7 m120 83.22 -40.02 0.09 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 113.852 -1.522 . . . . 0.90000000000000002 110.207 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.529 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 90.2 m-70 -101.59 110.4 22.39 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.012 -0.54 . . . . 0.90000000000000002 109.641 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.487 ' HG2' ' HA ' ' A' ' 34' ' ' ASP . 69.8 mtt180 -109.2 117.19 33.47 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.097 0.475 . . . . 0.90000000000000002 110.651 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.577 HG12 ' HG2' ' A' ' 53' ' ' ARG . 53.8 mt -98.67 110.71 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.395 -0.82 . . . . 0.90000000000000002 110.115 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.484 ' HB3' HD13 ' A' ' 5' ' ' ILE . 73.3 m-85 -97.61 141.16 30.99 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.1 -0.704 . . . . 0.90000000000000002 109.1 175.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.464 ' HB1' HD23 ' A' ' 48' ' ' LEU . . . -124.62 113.74 18.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.969 0.414 . . . . 0.90000000000000002 111.089 -170.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . . . -92.13 101.5 14.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.681 -0.69 . . . . 0.90000000000000002 109.528 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.493 ' HB3' HD22 ' A' ' 48' ' ' LEU . 28.5 ptt180 -102.51 118.84 37.74 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.546 0.689 . . . . 0.90000000000000002 110.858 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -97.44 133.41 42.07 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.498 -0.927 . . . . 0.90000000000000002 108.498 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.5 t30 64.61 23.35 12.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.003 0.906 . . . . 0.90000000000000002 108.607 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 66.47 20.74 10.88 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 114.268 -1.333 . . . . 0.90000000000000002 112.419 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -126.88 142.73 51.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.244 -0.651 . . . . 0.90000000000000002 109.244 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.493 HD22 ' HB3' ' A' ' 43' ' ' ARG . 55.5 mt -54.49 130.39 39.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.182 0.515 . . . . 0.90000000000000002 112.14 -172.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 34.4 tp -125.6 -40.65 2.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.652 -0.703 . . . . 0.90000000000000002 110.205 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -133.12 143.99 49.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.016 -0.538 . . . . 0.90000000000000002 110.325 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -135.07 132.28 37.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.346 -0.388 . . . . 0.90000000000000002 110.387 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.59 132.46 62.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.081 0.467 . . . . 0.90000000000000002 110.927 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.577 ' HG2' HG12 ' A' ' 39' ' ' ILE . 27.8 mtm180 -111.11 121.65 45.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.201 -0.454 . . . . 0.90000000000000002 109.985 176.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.66 119.55 59.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.411 0.624 . . . . 0.90000000000000002 109.71 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 89.9 m -95.56 95.53 8.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.666 -0.697 . . . . 0.90000000000000002 110.571 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.565 ' HA ' ' HA3' ' A' ' 61' ' ' GLY . 89.2 mt -80.38 124.27 28.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.717 -0.674 . . . . 0.90000000000000002 110.119 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.7 t -98.59 50.15 0.98 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.955 -0.757 . . . . 0.90000000000000002 108.955 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.71 -104.83 2.45 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.353 -0.84 . . . . 0.90000000000000002 111.549 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.5 p -94.49 -29.53 14.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.381 0.61 . . . . 0.90000000000000002 110.648 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.798 ' HB3' ' HB3' ' A' ' 94' ' ' CYS . 36.0 mt-10 -119.19 151.33 38.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.564 -0.744 . . . . 0.90000000000000002 109.008 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 56' ' ' LEU . . . -151.7 -179.84 27.7 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 119.461 -1.352 . . . . 0.90000000000000002 113.894 -173.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.63 135.33 48.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.222 -0.489 . . . . 0.90000000000000002 110.205 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.466 HD21 ' HE3' ' A' ' 97' ' ' MET . 7.8 tt -93.77 112.84 24.77 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.742 -0.836 . . . . 0.90000000000000002 108.742 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -97.24 -56.89 2.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.721 0.637 . . . . 0.90000000000000002 112.721 -168.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.404 ' HA ' ' S1P' ' A' ' 999' ' ' COA . 32.1 m -107.81 106.22 16.41 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.024 0.44 . . . . 0.90000000000000002 111.553 -173.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.3 tp -124.58 109.07 12.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.739 -0.664 . . . . 0.90000000000000002 109.785 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.444 ' HG3' ' O9P' ' A' ' 999' ' ' COA . 65.1 ttt180 -138.94 136.84 35.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.233 0.54 . . . . 0.90000000000000002 111.246 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' A' ' 50' ' ' ALA . 14.5 t -110.8 152.0 12.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.479 -0.934 . . . . 0.90000000000000002 108.479 174.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -57.79 150.56 19.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.746 0.308 . . . . 0.90000000000000002 110.18 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -51.7 -38.43 55.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.786 0.662 . . . . 0.90000000000000002 112.786 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.51 -20.85 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.999 0.428 . . . . 0.90000000000000002 111.931 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.435 ' HB ' ' CG1' ' A' ' 68' ' ' VAL . 2.0 m -113.09 24.92 11.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.157 0.503 . . . . 0.90000000000000002 111.255 -175.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.455 ' HG2' ' H10' ' A' ' 999' ' ' COA . 16.5 mtp180 -78.25 38.84 0.3 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.29 0.478 . . . . 0.90000000000000002 112.29 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 8.3 ttm180 174.37 19.95 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.276 0.23 . . . . 0.90000000000000002 111.057 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -141.04 75.28 1.49 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.544 0.942 . . . . 0.90000000000000002 113.544 -167.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.74 -61.45 4.27 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 115.703 1.041 . . . . 0.90000000000000002 115.703 161.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -43.42 -51.97 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.643 0.979 . . . . 0.90000000000000002 113.643 -168.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.09 -41.18 77.14 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.957 -0.639 . . . . 0.90000000000000002 113.595 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -68.64 -53.07 24.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.919 0.39 . . . . 0.90000000000000002 110.623 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -58.21 -40.87 82.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.75 -0.659 . . . . 0.90000000000000002 110.421 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.525 ' O ' HG22 ' A' ' 85' ' ' VAL . 26.9 tp -56.3 -55.07 37.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.506 -0.77 . . . . 0.90000000000000002 111.384 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.449 ' HB2' HD13 ' A' ' 115' ' ' LEU . 55.6 mt -62.34 -41.74 98.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.453 -0.339 . . . . 0.90000000000000002 111.376 -176.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -62.94 -37.87 88.75 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.752 -0.379 . . . . 0.90000000000000002 110.782 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.84 -39.1 80.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.387 -0.369 . . . . 0.90000000000000002 110.43 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 81' ' ' LEU . 72.5 t -58.49 -45.94 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.815 0.34 . . . . 0.90000000000000002 111.039 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.41 HD11 ' O ' ' A' ' 82' ' ' LEU . 11.1 mp -68.22 -23.75 64.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.122 0.487 . . . . 0.90000000000000002 110.744 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.6 mtp85 -76.73 -33.06 58.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.572 . . . . 0.90000000000000002 110.852 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -71.01 -49.69 42.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.90000000000000002 110.869 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -118.27 86.21 26.76 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.763 0.316 . . . . 0.90000000000000002 111.377 -178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.75 170.61 11.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.966 2.444 . . . . 0.90000000000000002 111.481 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.06 -14.85 62.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.596 -0.812 . . . . 0.90000000000000002 112.216 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 60' ' ' GLU . 53.3 t -78.24 118.53 25.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.065 -0.346 . . . . 0.90000000000000002 110.065 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 128' ' ' GLY . 2.4 p -84.46 -40.23 17.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.434 -0.348 . . . . 0.90000000000000002 111.572 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.798 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 45.1 t -101.93 100.14 10.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.904 0.383 . . . . 0.90000000000000002 110.866 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -97.3 97.66 9.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.094 -0.706 . . . . 0.90000000000000002 109.094 170.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -96.8 128.27 43.58 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.597 -0.52 . . . . 0.90000000000000002 109.597 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.812 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 96.0 mmm -107.16 109.5 21.34 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.907 -0.775 . . . . 0.90000000000000002 108.907 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.12 149.66 42.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.983 -0.553 . . . . 0.90000000000000002 111.667 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -75.6 -43.51 47.77 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.213 -0.662 . . . . 0.90000000000000002 109.213 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 61.07 8.74 2.07 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.07 -0.968 . . . . 0.90000000000000002 112.773 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.87 17.78 66.93 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.605 -0.807 . . . . 0.90000000000000002 111.882 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 82.8 t -67.69 111.9 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 121.217 0.532 . . . . 0.90000000000000002 110.064 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -79.79 1.26 27.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.821 -0.627 . . . . 0.90000000000000002 110.744 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -101.1 21.31 14.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.683 -0.69 . . . . 0.90000000000000002 109.442 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -58.9 -27.25 65.05 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.975 -0.557 . . . . 0.90000000000000002 111.902 -175.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.36 -53.03 45.11 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.719 -0.753 . . . . 0.90000000000000002 111.568 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 43.7 t -62.97 -37.36 79.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.169 0.509 . . . . 0.90000000000000002 110.047 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.585 ' O ' ' HG2' ' A' ' 112' ' ' MET . 96.9 mmm -65.13 -36.18 83.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.717 -0.674 . . . . 0.90000000000000002 111.232 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 93.3 m -63.9 -45.04 91.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.712 0.291 . . . . 0.90000000000000002 110.693 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.28 94.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.182 0.515 . . . . 0.90000000000000002 110.209 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -61.92 -48.22 81.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.433 -0.803 . . . . 0.90000000000000002 111.227 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.585 ' HG2' ' O ' ' A' ' 108' ' ' MET . 26.3 mmt -57.59 -48.87 78.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 0.90000000000000002 111.114 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -72.14 -21.87 61.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.989 -0.55 . . . . 0.90000000000000002 111.541 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.56 -34.96 35.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.991 0.424 . . . . 0.90000000000000002 110.545 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.449 HD13 ' HB2' ' A' ' 82' ' ' LEU . 7.4 tt -75.42 -56.37 4.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.929 -0.578 . . . . 0.90000000000000002 110.002 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 149.19 33.35 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.462 -0.875 . . . . 0.90000000000000002 112.993 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.514 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 89.0 m-85 -107.9 167.62 9.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.911 -0.403 . . . . 0.90000000000000002 109.911 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 31.9 m -117.23 137.64 52.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.848 -0.427 . . . . 0.90000000000000002 109.848 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.435 HG22 ' CD1' ' A' ' 124' ' ' TRP . 15.8 m -97.65 132.65 43.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.939 0.399 . . . . 0.90000000000000002 110.59 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.541 ' NE2' ' HB3' ' A' ' 125' ' ' GLU . 48.4 mt-30 -126.65 -171.62 2.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.961 -0.563 . . . . 0.90000000000000002 109.6 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -85.48 109.02 18.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.88 0.372 . . . . 0.90000000000000002 110.474 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.8 7.09 32.01 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.901 -0.666 . . . . 0.90000000000000002 112.429 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.86 -175.38 27.21 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.751 -0.738 . . . . 0.90000000000000002 112.51 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.812 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 9.7 m-90 -107.55 160.76 15.43 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.095 -0.706 . . . . 0.90000000000000002 109.095 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.541 ' HB3' ' NE2' ' A' ' 120' ' ' GLN . 55.7 tt0 -157.76 150.85 23.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.058 0.456 . . . . 0.90000000000000002 110.791 176.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -133.49 117.3 17.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.71 -0.677 . . . . 0.90000000000000002 109.537 174.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 33.7 t -85.0 108.91 17.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.95 0.405 . . . . 0.90000000000000002 110.016 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 93' ' ' SER . . . . . . . . 0 N--CA 1.449 -0.457 0 CA-C-N 115.888 -0.596 . . . . 0.90000000000000002 112.285 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 999' ' ' COA . . . . . 0.499 ' O9A' ' P1A' ' A' ' 999' ' ' COA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtm . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 110.346 -0.242 . . . . 0.90000000000000002 110.346 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -90.79 92.06 8.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.112 0.482 . . . . 0.90000000000000002 109.965 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.537 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 36.5 tp -75.88 137.51 40.47 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.725 -0.843 . . . . 0.90000000000000002 108.725 175.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 m -111.16 109.35 19.37 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.607 -0.437 . . . . 0.90000000000000002 110.801 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.491 HG22 ' OE1' ' A' ' 84' ' ' GLU . 11.2 tp -89.81 113.17 25.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.541 0.686 . . . . 0.90000000000000002 109.822 176.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.99 149.9 16.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.185 0.517 . . . . 0.90000000000000002 110.489 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -74.77 112.57 11.12 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.942 -1.026 . . . . 0.90000000000000002 109.441 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.1 tp -67.77 101.93 1.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.689 -0.485 . . . . 0.90000000000000002 109.689 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -98.77 -49.79 4.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.652 -0.704 . . . . 0.90000000000000002 110.987 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -127.01 149.05 50.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.053 -0.521 . . . . 0.90000000000000002 110.997 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -107.81 136.52 47.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.872 -0.603 . . . . 0.90000000000000002 110.66 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.661 ' HB2' ' OD1' ' A' ' 15' ' ' ASP . 8.3 m -115.9 162.39 17.41 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.234 -1.025 . . . . 0.90000000000000002 108.234 170.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -63.02 -42.82 99.9 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.091 0.404 . . . . 0.90000000000000002 112.091 -171.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -64.92 -52.24 57.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.608 0.242 . . . . 0.90000000000000002 111.178 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.661 ' OD1' ' HB2' ' A' ' 12' ' ' SER . 0.5 OUTLIER -72.04 -19.05 61.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.564 -0.289 . . . . 0.90000000000000002 111.543 -179.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -64.25 -44.64 91.16 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.596 -0.52 . . . . 0.90000000000000002 109.596 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.5 mt -68.38 -33.79 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.731 -0.668 . . . . 0.90000000000000002 110.259 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -63.41 -39.41 94.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.743 -0.662 . . . . 0.90000000000000002 109.961 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.0 mt -64.56 -36.92 85.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.982 -0.553 . . . . 0.90000000000000002 110.807 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -73.28 -13.3 61.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.026 -0.534 . . . . 0.90000000000000002 111.009 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -89.14 -24.34 22.23 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.363 -0.606 . . . . 0.90000000000000002 109.363 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.3 mt -77.75 -49.36 22.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.644 -0.707 . . . . 0.90000000000000002 109.728 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -104.92 91.64 4.52 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.003 -0.74 . . . . 0.90000000000000002 109.003 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.09 -36.37 70.61 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.875 2.383 . . . . 0.90000000000000002 113.432 -170.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -105.49 26.92 8.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.869 0.366 . . . . 0.90000000000000002 111.243 -175.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -79.19 126.89 31.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.995 0.426 . . . . 0.90000000000000002 110.364 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.0 t -89.64 120.0 69.52 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.865 -0.607 . . . . 0.90000000000000002 109.922 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.74 114.67 2.06 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.757 2.305 . . . . 0.90000000000000002 111.426 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.2 p -164.68 -78.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.943 -0.571 . . . . 0.90000000000000002 111.397 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.7 m -74.04 -75.21 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.90000000000000002 112.222 -174.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.5 mt 51.64 49.45 20.84 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.113 0.482 . . . . 0.90000000000000002 110.062 -173.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -88.25 117.56 27.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.598 -0.728 . . . . 0.90000000000000002 109.962 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.4 m -122.73 137.18 57.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.978 -0.556 . . . . 0.90000000000000002 111.171 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.869 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 11.7 t70 72.15 8.33 5.87 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.629 -0.714 . . . . 0.90000000000000002 111.748 170.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.5 ' C ' ' H ' ' A' ' 37' ' ' HIS . 7.8 m-20 -120.27 77.54 1.27 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.765 -0.457 . . . . 0.90000000000000002 109.765 175.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 35' ' ' ASP . 13.5 m120 75.85 -34.99 0.25 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.044 -0.98 . . . . 0.90000000000000002 110.148 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.5 ' H ' ' C ' ' A' ' 35' ' ' ASP . 86.1 m-70 -112.76 112.45 23.95 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.139 -1.06 . . . . 0.90000000000000002 108.139 173.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.869 ' HG2' ' HA ' ' A' ' 34' ' ' ASP . 79.4 mtt180 -113.84 126.18 54.9 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.016 0.436 . . . . 0.90000000000000002 110.551 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.562 HG12 ' HG2' ' A' ' 53' ' ' ARG . 71.8 mt -100.35 119.81 48.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.821 -0.627 . . . . 0.90000000000000002 109.935 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -102.49 133.0 48.18 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.344 -0.613 . . . . 0.90000000000000002 109.344 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.477 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.57 125.06 51.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.029 -0.532 . . . . 0.90000000000000002 110.802 -175.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 50' ' ' ALA . . . -92.06 98.78 11.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.197 0.522 . . . . 0.90000000000000002 110.159 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 43' ' ' ARG . 15.6 ttm180 -87.61 126.88 35.2 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.399 -0.819 . . . . 0.90000000000000002 110.495 -177.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -124.53 95.47 4.54 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.601 -0.888 . . . . 0.90000000000000002 108.601 175.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.2 m120 60.94 74.26 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.225 -0.898 . . . . 0.90000000000000002 110.981 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 71.42 -43.55 0.57 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.772 -1.103 . . . . 0.90000000000000002 113.181 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -88.76 153.76 20.82 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.758 0.313 . . . . 0.90000000000000002 111.111 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.477 HD22 ' HB1' ' A' ' 41' ' ' ALA . 79.5 mt -90.24 108.09 19.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.016 0.436 . . . . 0.90000000000000002 110.145 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.4 tp -83.38 -31.41 26.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.776 -0.647 . . . . 0.90000000000000002 110.639 -175.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.501 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . . . -144.45 157.13 44.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.084 -0.507 . . . . 0.90000000000000002 110.755 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.29 135.59 22.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.304 -0.407 . . . . 0.90000000000000002 110.115 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 65' ' ' SER . 7.1 p -135.14 138.69 48.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.001 0.429 . . . . 0.90000000000000002 111.141 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.562 ' HG2' HG12 ' A' ' 39' ' ' ILE . 88.4 mtt180 -103.16 131.24 50.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.071 -0.513 . . . . 0.90000000000000002 109.892 176.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.434 ' HB ' HD23 ' A' ' 63' ' ' LEU . 7.1 p -125.24 122.33 62.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.356 0.598 . . . . 0.90000000000000002 110.937 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 62' ' ' ALA . 34.8 m -93.35 110.02 21.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.736 -0.665 . . . . 0.90000000000000002 109.971 175.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.446 HD22 ' HA2' ' A' ' 61' ' ' GLY . 92.3 mt -94.98 98.63 10.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.163 -0.471 . . . . 0.90000000000000002 110.635 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 t -95.71 97.87 10.03 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.785 -0.82 . . . . 0.90000000000000002 108.785 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.76 -107.27 2.06 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.552 -0.832 . . . . 0.90000000000000002 111.404 -174.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.4 p -115.43 12.6 16.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.92 0.391 . . . . 0.90000000000000002 111.187 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.05 138.08 42.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.293 -0.412 . . . . 0.90000000000000002 110.019 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.446 ' HA2' HD22 ' A' ' 56' ' ' LEU . . . -116.03 113.54 2.87 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.701 -0.762 . . . . 0.90000000000000002 112.385 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.51 ' HB2' ' HB ' ' A' ' 55' ' ' THR . . . -96.35 110.96 23.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.963 0.411 . . . . 0.90000000000000002 110.753 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.717 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 53.7 mt -93.85 109.78 21.46 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.073 -0.512 . . . . 0.90000000000000002 109.743 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 65' ' ' SER . 4.9 p-10 -102.85 -75.06 0.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.788 0.328 . . . . 0.90000000000000002 111.818 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 13.6 m -82.18 85.76 6.75 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.892 0.377 . . . . 0.90000000000000002 111.384 -175.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.476 HD22 ' HE3' ' A' ' 97' ' ' MET . 47.0 tp -102.67 100.73 10.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.986 -0.552 . . . . 0.90000000000000002 109.613 173.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -135.12 126.55 28.56 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.258 -0.577 . . . . 0.90000000000000002 111.568 -175.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.489 HG13 ' HB3' ' A' ' 50' ' ' ALA . 12.1 t -111.75 155.48 13.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.07 -1.085 . . . . 0.90000000000000002 108.07 174.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -60.21 137.57 58.09 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.204 -0.295 . . . . 0.90000000000000002 110.204 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -48.2 -41.53 27.47 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.793 0.683 . . . . 0.90000000000000002 112.609 -173.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.5 m -73.09 2.44 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.795 0.665 . . . . 0.90000000000000002 112.795 -174.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 m -98.69 7.76 45.72 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.099 0.476 . . . . 0.90000000000000002 111.014 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.882 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 30.4 mtm180 -70.34 106.7 3.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.836 0.351 . . . . 0.90000000000000002 110.369 177.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 60.7 ttt180 -157.67 -81.07 0.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.022 -0.536 . . . . 0.90000000000000002 111.471 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 27.4 ttt180 164.86 95.71 0.0 OUTLIER 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 109.272 -0.64 . . . . 0.90000000000000002 109.272 -169.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.02 -79.53 0.2 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.514 -0.85 . . . . 0.90000000000000002 112.506 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.468 HG11 HD21 ' A' ' 3' ' ' LEU . 69.3 t -47.47 -46.56 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 123.194 0.597 . . . . 0.90000000000000002 112.589 -174.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.97 -62.67 6.1 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.06 -0.591 . . . . 0.90000000000000002 113.548 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -68.21 -32.61 72.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.79 0.295 . . . . 0.90000000000000002 111.143 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.537 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 30.3 t80 -59.44 -49.25 78.51 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.97 -0.382 . . . . 0.90000000000000002 109.97 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 85' ' ' VAL . 55.9 tp -52.32 -56.04 17.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.464 -0.789 . . . . 0.90000000000000002 111.104 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 86' ' ' LEU . 4.2 mm? -58.23 -44.46 88.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.908 -0.587 . . . . 0.90000000000000002 111.029 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.708 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 5.4 mt-10 -63.27 -49.34 74.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.799 -0.36 . . . . 0.90000000000000002 111.584 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.491 ' OE1' HG22 ' A' ' 5' ' ' ILE . 35.2 tt0 -63.73 -34.95 79.03 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.778 -0.369 . . . . 0.90000000000000002 111.064 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 81' ' ' LEU . 75.5 t -61.46 -43.9 97.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.868 0.366 . . . . 0.90000000000000002 110.342 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 82' ' ' LEU . 11.0 mp -72.01 -24.16 61.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.01 -0.541 . . . . 0.90000000000000002 111.344 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.708 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 19.2 mmt180 -76.93 -39.02 52.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.055 0.455 . . . . 0.90000000000000002 109.98 176.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -67.73 -34.76 77.49 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.659 -0.701 . . . . 0.90000000000000002 110.793 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -119.59 79.79 22.48 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.997 -0.547 . . . . 0.90000000000000002 110.036 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -86.74 -9.48 6.57 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.544 2.163 . . . . 0.90000000000000002 112.908 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.87 -35.04 55.1 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.189 -0.764 . . . . 0.90000000000000002 111.189 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.4 t -73.47 104.85 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.294 -0.632 . . . . 0.90000000000000002 109.294 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 p -106.01 12.22 30.71 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.059 0.457 . . . . 0.90000000000000002 110.656 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 47.8 t -130.51 99.97 5.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.835 -0.62 . . . . 0.90000000000000002 109.342 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -107.79 120.3 41.87 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.886 -0.597 . . . . 0.90000000000000002 110.442 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.505 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 13.7 t-105 -115.98 120.42 39.08 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.654 -0.703 . . . . 0.90000000000000002 109.191 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.717 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 76.1 mtp -107.15 126.5 52.46 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.099 0.476 . . . . 0.90000000000000002 110.099 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.2 146.53 24.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.608 -0.724 . . . . 0.90000000000000002 110.971 -176.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.68 16.67 10.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.843 -0.617 . . . . 0.90000000000000002 110.282 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.38 106.88 4.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.674 -0.693 . . . . 0.90000000000000002 110.701 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.52 0.81 56.65 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.893 -0.67 . . . . 0.90000000000000002 112.162 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.472 HG23 ' S1P' ' A' ' 999' ' ' COA . 80.7 t -86.82 107.27 16.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.792 0.329 . . . . 0.90000000000000002 110.381 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.69 -46.04 33.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.072 0.463 . . . . 0.90000000000000002 110.032 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -94.71 81.64 3.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.257 0.551 . . . . 0.90000000000000002 110.459 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.5 mtt85 -71.03 -28.85 64.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.837 -0.62 . . . . 0.90000000000000002 111.411 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.3 -54.62 28.56 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.887 -0.673 . . . . 0.90000000000000002 112.351 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.7 HG12 ' N7A' ' A' ' 999' ' ' COA . 55.3 t -61.22 -42.4 93.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.942 0.401 . . . . 0.90000000000000002 110.765 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.581 ' O ' ' HG2' ' A' ' 112' ' ' MET . 97.8 mmm -64.5 -36.52 84.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.937 -0.574 . . . . 0.90000000000000002 111.675 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 85.8 m -64.68 -43.96 91.88 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.98 -0.288 . . . . 0.90000000000000002 110.858 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.58 -36.59 84.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.264 0.554 . . . . 0.90000000000000002 110.376 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -64.74 -44.41 90.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.558 -0.746 . . . . 0.90000000000000002 110.411 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.581 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.5 mmt -62.24 -42.73 99.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.932 -0.577 . . . . 0.90000000000000002 111.009 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -57.15 -40.32 76.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.90000000000000002 110.544 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.41 -29.83 69.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.887 -0.597 . . . . 0.90000000000000002 111.209 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.5 mt -85.0 -7.52 59.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.022 0.439 . . . . 0.90000000000000002 111.228 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.36 21.66 56.13 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.644 -0.788 . . . . 0.90000000000000002 112.144 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 37.5 m-85 -85.6 132.19 34.22 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.072 -0.344 . . . . 0.90000000000000002 110.072 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 65.2 p -95.7 162.19 13.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.172 -0.467 . . . . 0.90000000000000002 109.998 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.2 t -97.21 117.16 30.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.7 0.762 . . . . 0.90000000000000002 109.7 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.94 169.71 10.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.185 -0.916 . . . . 0.90000000000000002 109.24 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -70.8 94.48 1.04 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.045 0.45 . . . . 0.90000000000000002 110.748 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.83 -11.24 5.42 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.98 -0.629 . . . . 0.90000000000000002 112.41 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.25 -146.91 16.02 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.889 -0.672 . . . . 0.90000000000000002 112.312 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.498 ' CE3' ' HE3' ' A' ' 112' ' ' MET . 7.5 m-90 -103.1 133.56 48.0 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.054 -0.35 . . . . 0.90000000000000002 110.054 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -121.04 131.54 54.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.159 -0.473 . . . . 0.90000000000000002 111.183 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -137.03 115.55 11.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.003 -0.544 . . . . 0.90000000000000002 109.91 172.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 22.4 t -112.72 115.98 29.4 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.942 0.401 . . . . 0.90000000000000002 110.182 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.516 0 N-CA-C 111.533 -0.627 . . . . 0.90000000000000002 111.533 -178.876 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 999' ' ' COA . . . . . 0.882 ' O4A' ' HA ' ' A' ' 73' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.743 0.306 . . . . 0.90000000000000002 110.232 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -93.19 113.79 26.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.13 0.49 . . . . 0.90000000000000002 110.388 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 42' ' ' ALA . 38.7 tp -79.52 115.01 18.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.664 -0.698 . . . . 0.90000000000000002 109.688 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -82.86 103.61 12.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.834 0.35 . . . . 0.90000000000000002 110.377 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.508 HD12 ' HB3' ' A' ' 40' ' ' TYR . 11.6 tt -105.7 126.25 61.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.545 0.688 . . . . 0.90000000000000002 111.159 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.5 mt -125.51 160.89 31.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.23 -0.895 . . . . 0.90000000000000002 109.476 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -85.74 141.33 29.79 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.108 -0.701 . . . . 0.90000000000000002 109.108 174.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.1 mt -77.53 103.55 7.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.044 0.449 . . . . 0.90000000000000002 110.626 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -79.39 -45.76 18.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.497 -0.774 . . . . 0.90000000000000002 110.503 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -137.85 166.65 23.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.472 -0.785 . . . . 0.90000000000000002 109.945 -176.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -127.89 111.47 13.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.808 0.337 . . . . 0.90000000000000002 111.089 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.0 m -99.55 -179.97 4.37 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.857 -0.423 . . . . 0.90000000000000002 109.857 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -62.59 -48.92 77.32 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.821 0.344 . . . . 0.90000000000000002 110.872 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -57.77 -39.31 77.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.724 -0.671 . . . . 0.90000000000000002 110.558 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -67.02 -46.2 75.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.868 -0.605 . . . . 0.90000000000000002 110.328 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.9 ttp85 -60.7 -46.6 89.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.424 -0.353 . . . . 0.90000000000000002 110.649 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 80.0 mt -61.57 -46.18 97.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.90000000000000002 110.881 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.96 -38.72 86.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.21 0.529 . . . . 0.90000000000000002 110.395 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.498 HD23 HD13 ' A' ' 22' ' ' ILE . 76.7 mt -68.58 -25.03 64.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 0.90000000000000002 111.264 177.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -79.94 -19.96 46.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.248 0.547 . . . . 0.90000000000000002 109.894 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -74.74 -29.1 61.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.414 -0.587 . . . . 0.90000000000000002 109.414 171.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.498 HD13 HD23 ' A' ' 19' ' ' LEU . 73.0 mt -79.78 -48.73 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.377 -0.829 . . . . 0.90000000000000002 110.302 174.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -115.79 100.55 53.66 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.90000000000000002 109.767 175.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -58.11 -29.08 86.04 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.065 2.51 . . . . 0.90000000000000002 112.951 -176.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -136.22 85.99 2.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.024 -0.732 . . . . 0.90000000000000002 109.024 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -91.87 154.5 18.83 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.002 -0.999 . . . . 0.90000000000000002 111.064 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.0 m -100.06 120.8 55.89 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.876 -0.602 . . . . 0.90000000000000002 109.442 171.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.71 -28.09 80.33 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.574 2.183 . . . . 0.90000000000000002 112.053 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.3 m -61.56 -41.01 96.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.898 -0.592 . . . . 0.90000000000000002 111.489 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 p -86.94 4.07 43.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.924 0.392 . . . . 0.90000000000000002 111.03 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.7 mt -94.02 -1.07 55.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.355 0.598 . . . . 0.90000000000000002 109.443 172.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -80.57 118.09 21.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.311 -0.859 . . . . 0.90000000000000002 109.712 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.43 118.5 39.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.664 -0.698 . . . . 0.90000000000000002 110.785 -173.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.435 ' OD1' ' HB2' ' A' ' 37' ' ' HIS . 6.3 p-10 -135.24 -164.5 1.54 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 0.90000000000000002 109.856 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -68.57 -29.75 68.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.805 0.336 . . . . 0.90000000000000002 110.972 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -89.86 -63.31 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.076 -0.511 . . . . 0.90000000000000002 110.162 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.435 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 56.3 m80 -78.37 98.74 6.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.234 0.54 . . . . 0.90000000000000002 110.651 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.553 ' HD3' HD11 ' A' ' 56' ' ' LEU . 27.7 mtp-105 -115.68 116.9 28.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.529 -0.76 . . . . 0.90000000000000002 109.449 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.2 mt -98.48 127.14 51.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.781 0.324 . . . . 0.90000000000000002 110.586 -176.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.508 ' HB3' HD12 ' A' ' 5' ' ' ILE . 55.3 m-85 -99.08 140.23 33.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.963 -0.562 . . . . 0.90000000000000002 110.409 176.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.512 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -114.16 113.4 24.63 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.689 -0.687 . . . . 0.90000000000000002 109.543 174.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.562 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . . . -92.05 104.93 17.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.184 -0.462 . . . . 0.90000000000000002 109.809 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 7.7 ptp180 -112.6 136.41 52.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.361 0.6 . . . . 0.90000000000000002 111.756 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.413 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 44.5 t80 -99.88 95.71 7.08 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.549 -0.908 . . . . 0.90000000000000002 108.549 172.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.8 t30 69.59 -76.41 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.55 -0.75 . . . . 0.90000000000000002 110.388 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -151.31 71.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.527 0.679 . . . . 0.90000000000000002 110.028 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 15.9 ptp180 -167.41 122.24 1.03 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.321 -0.854 . . . . 0.90000000000000002 109.029 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 41' ' ' ALA . 59.0 mt -78.11 90.83 4.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.038 -0.356 . . . . 0.90000000000000002 110.038 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.559 ' HA ' ' HD3' ' A' ' 69' ' ' ARG . 62.7 mt -79.05 -39.95 32.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.90000000000000002 111.307 -175.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.562 ' HB1' ' HB3' ' A' ' 42' ' ' ALA . . . -132.9 141.81 48.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.066 -0.515 . . . . 0.90000000000000002 110.698 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.413 ' HB2' HG22 ' A' ' 22' ' ' ILE . . . -135.09 132.78 38.56 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.997 -0.547 . . . . 0.90000000000000002 109.84 177.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.458 HG22 HD23 ' A' ' 63' ' ' LEU . 7.5 p -138.9 135.35 42.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.027 0.442 . . . . 0.90000000000000002 111.224 -176.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.517 ' HG3' ' HB2' ' A' ' 65' ' ' SER . 33.1 mtt-85 -101.5 106.14 17.22 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.395 -0.595 . . . . 0.90000000000000002 109.395 176.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.93 119.45 50.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.273 0.559 . . . . 0.90000000000000002 110.017 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.0 m -92.93 97.42 10.72 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.92 -0.582 . . . . 0.90000000000000002 110.049 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.553 HD11 ' HD3' ' A' ' 38' ' ' ARG . 81.9 mt -87.29 85.67 7.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.861 -0.609 . . . . 0.90000000000000002 110.046 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -86.67 85.19 7.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.723 -0.672 . . . . 0.90000000000000002 109.465 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.14 -119.84 5.05 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.673 -0.694 . . . . 0.90000000000000002 112.189 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.0 p -96.84 8.62 43.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.021 0.439 . . . . 0.90000000000000002 111.124 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -126.52 137.16 53.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.169 -0.468 . . . . 0.90000000000000002 110.265 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -119.56 121.95 5.13 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.535 -0.841 . . . . 0.90000000000000002 112.357 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.06 119.59 35.74 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.078 -0.342 . . . . 0.90000000000000002 110.078 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.486 HD12 ' SD ' ' A' ' 97' ' ' MET . 5.9 mp -93.88 122.75 36.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.67 -0.492 . . . . 0.90000000000000002 109.67 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -95.35 -79.85 0.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.94 -0.573 . . . . 0.90000000000000002 111.106 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.517 ' HB2' ' HG3' ' A' ' 53' ' ' ARG . 13.5 m -86.9 122.51 30.87 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.087 -0.506 . . . . 0.90000000000000002 110.959 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.441 HD13 ' HB ' ' A' ' 52' ' ' VAL . 52.3 tp -140.6 116.43 10.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.229 -0.442 . . . . 0.90000000000000002 110.421 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.639 ' HA ' ' O5P' ' A' ' 999' ' ' COA . 50.9 ttt180 -143.84 138.11 28.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.509 -0.314 . . . . 0.90000000000000002 110.985 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.542 HG21 ' OAP' ' A' ' 999' ' ' COA . 7.3 t -114.57 142.86 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.454 -0.943 . . . . 0.90000000000000002 108.454 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.559 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 10.3 mtp180 -63.38 147.43 51.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.124 0.488 . . . . 0.90000000000000002 111.114 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -58.95 -17.99 29.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.717 1.006 . . . . 0.90000000000000002 113.717 -167.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.42 -16.56 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.489 0.661 . . . . 0.90000000000000002 110.6 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.466 HG22 HG22 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -106.02 15.86 25.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.746 -0.661 . . . . 0.90000000000000002 111.586 -173.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.632 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 19.5 ptt-85 -86.06 144.73 27.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.988 0.423 . . . . 0.90000000000000002 111.572 -173.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HA ' H52A ' A' ' 999' ' ' COA . 31.2 mtp-105 56.19 26.99 10.98 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.182 -0.917 . . . . 0.90000000000000002 111.911 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -112.32 2.36 16.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.3 0.571 . . . . 0.90000000000000002 110.903 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.96 -5.98 64.12 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.631 -0.795 . . . . 0.90000000000000002 113.114 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.466 HG22 HG22 ' A' ' 72' ' ' THR . 86.7 t -59.46 -41.81 85.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.008 0.433 . . . . 0.90000000000000002 110.926 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 81' ' ' LEU . . . -64.56 -25.74 70.4 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.059 -0.591 . . . . 0.90000000000000002 112.367 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.495 ' HA ' HD21 ' A' ' 115' ' ' LEU . 62.7 tt0 -68.6 -47.45 66.67 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 0.90000000000000002 109.688 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -61.95 -40.29 95.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.976 -0.556 . . . . 0.90000000000000002 109.946 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 85' ' ' VAL . 51.2 tp -45.23 -63.97 0.82 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.131 -0.94 . . . . 0.90000000000000002 111.806 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.95 -37.19 85.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.657 -0.247 . . . . 0.90000000000000002 111.575 -176.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 79' ' ' GLN . 41.5 mt-10 -60.27 -40.74 91.45 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 111.859 0.318 . . . . 0.90000000000000002 111.859 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -79.67 -25.51 41.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.294 -0.562 . . . . 0.90000000000000002 110.792 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 81' ' ' LEU . 73.3 t -62.75 -46.17 97.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.149 0.499 . . . . 0.90000000000000002 110.012 173.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.55 -22.05 62.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.564 -0.744 . . . . 0.90000000000000002 110.95 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -75.78 -45.65 35.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.90000000000000002 110.339 173.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -57.61 -48.85 78.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.947 -0.569 . . . . 0.90000000000000002 111.098 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -120.27 89.0 42.82 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.523 -0.308 . . . . 0.90000000000000002 110.196 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -83.13 -15.39 7.93 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.877 2.385 . . . . 0.90000000000000002 114.02 -173.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.48 57.87 5.05 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.796 -0.716 . . . . 0.90000000000000002 113.1 -174.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.4 t -129.68 128.46 65.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.758 0.313 . . . . 0.90000000000000002 110.383 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.7 m -75.56 -48.02 24.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.103 -0.499 . . . . 0.90000000000000002 111.123 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 127' ' ' CYS . 47.1 t -131.42 124.35 30.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.48 -0.327 . . . . 0.90000000000000002 110.835 -177.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -96.98 113.86 25.43 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.485 -0.561 . . . . 0.90000000000000002 109.485 174.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -108.53 129.0 55.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.924 0.392 . . . . 0.90000000000000002 110.079 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.814 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 95.9 mmm -110.9 108.42 18.2 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.273 -0.64 . . . . 0.90000000000000002 109.273 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.76 147.5 35.3 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.191 -0.203 . . . . 0.90000000000000002 110.948 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -63.25 -34.69 78.21 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.939 -0.393 . . . . 0.90000000000000002 109.939 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.89 9.21 2.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.341 -0.845 . . . . 0.90000000000000002 112.582 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.69 17.03 80.26 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.882 -0.675 . . . . 0.90000000000000002 111.892 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.25 118.35 14.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.779 -0.452 . . . . 0.90000000000000002 109.779 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -77.33 5.96 7.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.145 -0.479 . . . . 0.90000000000000002 112.049 -173.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -111.97 24.13 13.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.163 0.506 . . . . 0.90000000000000002 109.834 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -57.47 -28.69 63.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.317 -0.856 . . . . 0.90000000000000002 112.225 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.3 -46.1 74.04 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.477 -0.868 . . . . 0.90000000000000002 111.4 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.2 t -66.63 -37.04 78.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.113 0.482 . . . . 0.90000000000000002 110.047 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.638 ' HG2' ' CDP' ' A' ' 999' ' ' COA . 68.6 mtp -66.59 -32.67 74.16 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 115.834 -0.621 . . . . 0.90000000000000002 110.749 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.0 m -62.49 -44.43 96.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.644 0.259 . . . . 0.90000000000000002 110.582 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.483 ' HB3' ' N7A' ' A' ' 999' ' ' COA . . . -63.27 -39.74 95.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.495 0.664 . . . . 0.90000000000000002 110.135 175.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -61.69 -39.47 91.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.325 -0.852 . . . . 0.90000000000000002 111.035 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.608 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.4 mmt -63.36 -36.96 85.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.90000000000000002 110.768 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -67.82 -27.8 67.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.90000000000000002 110.721 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.73 -40.34 66.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.917 0.389 . . . . 0.90000000000000002 110.435 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.495 HD21 ' HA ' ' A' ' 79' ' ' GLN . 97.1 mt -68.82 -48.65 63.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.022 -0.535 . . . . 0.90000000000000002 111.161 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 124.39 27.18 1.36 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.034 -0.603 . . . . 0.90000000000000002 111.776 -176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 26.2 m-85 -98.79 154.43 18.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.941 -0.392 . . . . 0.90000000000000002 109.941 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.0 m -108.76 157.88 18.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.269 -0.423 . . . . 0.90000000000000002 109.872 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.418 HG22 ' CD1' ' A' ' 124' ' ' TRP . 3.3 p -97.39 117.23 31.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.952 0.406 . . . . 0.90000000000000002 110.871 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 120' ' ' GLN . 14.4 mm-40 -102.62 -179.53 4.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.066 -0.515 . . . . 0.90000000000000002 109.913 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -91.05 50.72 1.82 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.327 0.584 . . . . 0.90000000000000002 109.977 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 165.16 43.71 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.389 -0.823 . . . . 0.90000000000000002 111.356 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 113.44 -176.82 17.63 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 121.171 -0.538 . . . . 0.90000000000000002 111.79 -176.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.814 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 9.4 m-90 -96.42 148.8 22.41 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.152 -0.685 . . . . 0.90000000000000002 109.152 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -138.65 137.82 37.23 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.016 0.436 . . . . 0.90000000000000002 111.413 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.446 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 57.5 tttm -136.97 95.52 3.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.693 -0.685 . . . . 0.90000000000000002 109.59 169.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 94' ' ' CYS . 42.5 t -76.83 110.44 11.44 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.994 -0.372 . . . . 0.90000000000000002 109.994 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.532 0 C-N-CA 120.956 -0.64 . . . . 0.90000000000000002 112.092 -178.888 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 999' ' ' COA . . . . . 0.676 ' C9P' ' O5P' ' A' ' 999' ' ' COA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 120.959 0.409 . . . . 0.90000000000000002 110.809 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -108.83 127.51 54.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.023 0.439 . . . . 0.90000000000000002 110.67 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.465 HD13 ' HB1' ' A' ' 42' ' ' ALA . 49.7 tp -76.1 115.68 16.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.713 -0.676 . . . . 0.90000000000000002 109.622 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.7 m -87.82 92.05 8.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.051 0.453 . . . . 0.90000000000000002 110.601 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.526 HD13 ' HB3' ' A' ' 40' ' ' TYR . 6.4 tp -81.91 105.96 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.795 0.807 . . . . 0.90000000000000002 109.981 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.9 mt -99.11 148.75 5.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.856 -0.611 . . . . 0.90000000000000002 109.367 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -95.67 139.62 31.66 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.822 -0.807 . . . . 0.90000000000000002 108.822 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 11' ' ' PHE . 4.4 mm? -75.48 62.58 1.39 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.818 0.818 . . . . 0.90000000000000002 110.586 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -94.72 -29.11 14.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.362 -1.29 . . . . 0.90000000000000002 108.608 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -127.53 107.12 9.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.732 -1.122 . . . . 0.90000000000000002 108.77 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 8' ' ' LEU . 69.8 m-85 -87.83 112.38 22.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.987 0.423 . . . . 0.90000000000000002 111.736 -175.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.508 ' HB3' ' OD1' ' A' ' 15' ' ' ASP . 28.4 t -92.26 157.98 16.37 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.38 -0.6 . . . . 0.90000000000000002 109.38 172.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.04 -47.08 84.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.096 0.406 . . . . 0.90000000000000002 112.096 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -63.92 -41.49 97.65 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.684 -0.406 . . . . 0.90000000000000002 110.384 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.508 ' OD1' ' HB3' ' A' ' 12' ' ' SER . 1.6 m-20 -55.65 -44.77 77.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.90000000000000002 110.453 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.678 ' HG2' HD11 ' A' ' 31' ' ' LEU . 24.4 mtp180 -60.44 -39.28 86.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.894 -0.594 . . . . 0.90000000000000002 111.301 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 57.9 mt -77.76 -37.78 24.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.394 -0.366 . . . . 0.90000000000000002 111.491 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -68.41 -33.05 73.55 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.814 -0.439 . . . . 0.90000000000000002 109.814 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.454 HD21 HD13 ' A' ' 22' ' ' ILE . 73.7 mt -63.87 -37.28 86.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.141 -0.481 . . . . 0.90000000000000002 110.241 172.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.455 ' HB2' ' HG3' ' A' ' 28' ' ' PRO . 52.3 tt0 -65.67 -22.82 66.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.34 0.591 . . . . 0.90000000000000002 110.398 176.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -80.0 -28.56 39.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.549 . . . . 0.90000000000000002 110.238 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.508 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 69.5 mt -76.78 -36.01 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.833 -0.621 . . . . 0.90000000000000002 110.231 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.442 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 5.7 m-90 -109.72 81.1 1.83 Allowed Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.256 -0.646 . . . . 0.90000000000000002 109.256 171.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 21.1 Cg_exo -65.8 -24.83 53.8 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.129 2.553 . . . . 0.90000000000000002 113.534 -169.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -104.54 3.62 32.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.254 0.55 . . . . 0.90000000000000002 110.605 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' HB3' ' HB3' ' A' ' 23' ' ' TRP . 52.4 t80 -118.49 114.07 22.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.411 -0.359 . . . . 0.90000000000000002 110.844 -175.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.2 m -64.04 116.12 24.79 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.806 -0.813 . . . . 0.90000000000000002 108.806 170.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.643 ' HB2' HD13 ' A' ' 31' ' ' LEU . 30.0 Cg_endo -63.3 84.26 0.12 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.931 2.421 . . . . 0.90000000000000002 113.678 -170.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.1 m -112.15 -1.57 15.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.655 -0.702 . . . . 0.90000000000000002 109.535 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 p -80.4 4.74 17.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.518 -0.764 . . . . 0.90000000000000002 110.267 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.678 HD11 ' HG2' ' A' ' 16' ' ' ARG . 51.2 mt -77.4 7.48 5.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.221 -0.9 . . . . 0.90000000000000002 111.242 -176.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -83.16 98.43 9.34 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.273 -0.639 . . . . 0.90000000000000002 109.273 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' A' ' 38' ' ' ARG . 8.2 p -93.13 135.76 26.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.865 -0.607 . . . . 0.90000000000000002 111.198 -175.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -131.7 -179.56 5.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.995 -0.743 . . . . 0.90000000000000002 108.995 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.82 -23.71 66.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.688 0.28 . . . . 0.90000000000000002 111.339 -175.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.62 ' O ' ' HA ' ' A' ' 55' ' ' THR . 32.0 m-80 -85.84 -62.34 1.55 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.26 -0.427 . . . . 0.90000000000000002 109.907 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -89.66 94.62 9.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.212 -0.449 . . . . 0.90000000000000002 110.553 -175.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.502 ' HA ' HG22 ' A' ' 33' ' ' VAL . 53.6 mtt180 -110.27 139.08 45.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.286 0.565 . . . . 0.90000000000000002 111.006 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.8 mt -106.96 134.77 47.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.526 -0.761 . . . . 0.90000000000000002 109.787 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.526 ' HB3' HD13 ' A' ' 5' ' ' ILE . 86.0 m-85 -118.84 140.34 50.12 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.329 -0.619 . . . . 0.90000000000000002 109.329 174.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.476 ' HB3' HD22 ' A' ' 48' ' ' LEU . . . -129.2 124.09 33.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.103 0.478 . . . . 0.90000000000000002 110.566 -173.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.648 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . . . -92.0 104.14 16.58 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.041 -0.527 . . . . 0.90000000000000002 109.966 -176.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -87.27 122.76 31.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.921 -1.036 . . . . 0.90000000000000002 110.701 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -140.31 124.99 18.09 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.301 -0.629 . . . . 0.90000000000000002 109.301 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.2 t30 62.07 36.56 15.26 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.49 0.662 . . . . 0.90000000000000002 110.005 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 37.3 tt0 67.01 18.41 10.56 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.098 -0.955 . . . . 0.90000000000000002 111.213 177.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -133.7 146.24 50.63 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.752 -0.462 . . . . 0.90000000000000002 109.752 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 41' ' ' ALA . 78.7 mt -79.88 101.45 8.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.197 0.522 . . . . 0.90000000000000002 110.414 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.8 tp -81.74 -21.74 37.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.091 -0.504 . . . . 0.90000000000000002 110.615 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.648 ' HB2' ' HB2' ' A' ' 42' ' ' ALA . . . -141.05 140.25 34.22 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.508 -0.477 . . . . 0.90000000000000002 111.605 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -128.52 122.39 31.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.031 -0.531 . . . . 0.90000000000000002 109.899 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 40' ' ' TYR . 7.9 p -132.59 135.97 56.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.297 -0.41 . . . . 0.90000000000000002 110.955 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -111.26 129.83 55.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.855 0.359 . . . . 0.90000000000000002 110.146 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.7 p -127.35 139.59 51.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.064 0.459 . . . . 0.90000000000000002 110.189 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 29.1 m -108.28 101.71 10.89 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 116.005 -0.543 . . . . 0.90000000000000002 110.083 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.89 91.07 5.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.656 -0.702 . . . . 0.90000000000000002 109.507 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -103.54 99.16 8.97 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.668 -0.696 . . . . 0.90000000000000002 110.118 -175.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.48 -105.55 0.92 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.076 -0.583 . . . . 0.90000000000000002 112.358 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.8 p -107.36 2.42 24.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.854 0.359 . . . . 0.90000000000000002 111.131 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -102.66 122.24 44.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.057 -0.52 . . . . 0.90000000000000002 111.334 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.94 85.76 0.91 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.274 -1.13 . . . . 0.90000000000000002 110.274 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -92.92 128.61 38.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.691 0.281 . . . . 0.90000000000000002 110.447 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.461 HD23 ' HE3' ' A' ' 97' ' ' MET . 1.5 tp -93.52 121.65 35.14 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.28 -0.637 . . . . 0.90000000000000002 109.28 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -113.47 95.82 5.56 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.173 -0.467 . . . . 0.90000000000000002 110.185 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.0 p 69.93 127.87 0.03 OUTLIER 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.655 1.182 . . . . 0.90000000000000002 112.344 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.478 HD22 ' HE1' ' A' ' 108' ' ' MET . 47.0 tp -123.8 122.63 38.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.769 -1.105 . . . . 0.90000000000000002 109.004 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 70.5 mtp85 -129.82 96.31 4.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.137 0.494 . . . . 0.90000000000000002 111.076 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.474 HG22 ' O9P' ' A' ' 999' ' ' COA . 2.3 t -86.17 142.84 12.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.585 -0.895 . . . . 0.90000000000000002 108.585 175.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' A' ' 48' ' ' LEU . 5.0 ttt180 -61.43 139.79 58.15 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.653 -0.499 . . . . 0.90000000000000002 109.653 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.6 -17.56 23.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.90000000000000002 112.151 -172.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.01 -21.05 27.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.973 0.416 . . . . 0.90000000000000002 111.138 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.4 m -62.72 -43.1 99.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.369 . . . . 0.90000000000000002 111.481 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 48.79 47.81 20.79 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.884 -0.598 . . . . 0.90000000000000002 112.09 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.685 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 32.9 mtm180 55.24 66.9 1.11 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.351 -0.386 . . . . 0.90000000000000002 111.64 175.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -144.52 75.31 1.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.884 0.373 . . . . 0.90000000000000002 111.654 -175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.08 -43.34 2.84 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 114.998 0.759 . . . . 0.90000000000000002 114.998 167.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.6 t -49.72 -48.28 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.326 0.491 . . . . 0.90000000000000002 112.326 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.19 -44.24 94.98 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.974 -0.631 . . . . 0.90000000000000002 112.808 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.461 ' HA ' HD12 ' A' ' 115' ' ' LEU . 73.5 mt-30 -55.07 -56.94 14.21 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.44 0.638 . . . . 0.90000000000000002 110.104 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -60.59 -45.62 93.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.954 -1.021 . . . . 0.90000000000000002 111.13 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.498 ' O ' HG22 ' A' ' 85' ' ' VAL . 27.0 tp -54.09 -57.51 10.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.875 -0.602 . . . . 0.90000000000000002 111.569 -174.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.435 HD11 ' HA ' ' A' ' 82' ' ' LEU . 4.1 mm? -62.56 -45.75 91.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.589 -0.278 . . . . 0.90000000000000002 111.695 -176.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -60.39 -37.99 82.54 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.975 0.416 . . . . 0.90000000000000002 110.797 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HG2' HG23 ' A' ' 5' ' ' ILE . 10.4 tp10 -69.21 -39.05 78.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.947 -0.57 . . . . 0.90000000000000002 110.533 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 81' ' ' LEU . 91.4 t -62.16 -42.4 95.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.803 0.335 . . . . 0.90000000000000002 110.55 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.74 -17.78 63.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.90000000000000002 111.158 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -85.62 -37.59 19.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.171 0.51 . . . . 0.90000000000000002 109.699 174.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.454 ' C ' HD21 ' A' ' 88' ' ' ASN . 0.2 OUTLIER -65.94 -44.04 86.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.56 -0.745 . . . . 0.90000000000000002 110.077 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -120.28 77.84 26.08 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.181 -0.463 . . . . 0.90000000000000002 110.585 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -89.0 -0.71 6.31 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.569 2.179 . . . . 0.90000000000000002 112.909 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.46 -50.3 38.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.938 -0.649 . . . . 0.90000000000000002 112.13 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 m -62.04 119.69 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.21 0.529 . . . . 0.90000000000000002 111.025 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 m -92.04 -18.52 23.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.776 -0.647 . . . . 0.90000000000000002 111.275 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.2 t -109.35 98.63 8.0 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.255 -0.276 . . . . 0.90000000000000002 110.255 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -95.31 132.13 40.65 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.188 0.518 . . . . 0.90000000000000002 110.933 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.444 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 75.0 t-105 -127.6 127.15 43.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.241 -0.89 . . . . 0.90000000000000002 109.762 -177.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.981 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 74.7 mmm -106.99 110.98 23.26 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.39 -0.596 . . . . 0.90000000000000002 109.39 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -92.0 154.31 18.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.021 -0.536 . . . . 0.90000000000000002 111.295 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.67 -1.29 41.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.719 -0.673 . . . . 0.90000000000000002 110.876 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.53 127.81 33.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.90000000000000002 110.861 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.93 2.61 86.17 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.964 -0.636 . . . . 0.90000000000000002 112.163 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.735 HG13 ' HG3' ' A' ' 108' ' ' MET . 60.6 t -117.31 112.51 39.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.822 0.344 . . . . 0.90000000000000002 110.723 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -80.56 -34.84 35.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.065 -0.516 . . . . 0.90000000000000002 110.557 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 108' ' ' MET . 7.6 m-20 -87.71 61.53 6.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.015 -0.539 . . . . 0.90000000000000002 110.858 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -63.35 -40.31 96.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.90000000000000002 111.301 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.94 -45.15 97.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.97 -0.633 . . . . 0.90000000000000002 112.111 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.9 -43.91 98.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.789 0.328 . . . . 0.90000000000000002 110.591 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.735 ' HG3' HG13 ' A' ' 102' ' ' VAL . 97.8 mmm -65.61 -29.41 70.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.90000000000000002 110.937 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 71.8 m -61.86 -47.61 84.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.90000000000000002 110.13 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.58 -37.9 83.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.185 -0.462 . . . . 0.90000000000000002 110.356 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.432 ' HB3' ' HA ' ' A' ' 108' ' ' MET . 66.4 t80 -58.5 -52.95 63.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.487 -0.778 . . . . 0.90000000000000002 111.268 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.512 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 65.1 mtt -76.85 -27.3 55.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.134 -0.485 . . . . 0.90000000000000002 111.907 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -69.36 -33.79 73.61 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.468 -0.493 . . . . 0.90000000000000002 109.704 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.11 73.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.929 -0.578 . . . . 0.90000000000000002 110.613 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.716 HD23 ' HE2' ' A' ' 117' ' ' PHE . 32.5 tp -80.59 -51.96 8.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.119 -0.492 . . . . 0.90000000000000002 111.018 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 141.91 69.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.658 -0.782 . . . . 0.90000000000000002 112.285 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.716 ' HE2' HD23 ' A' ' 115' ' ' LEU . 91.1 m-85 -143.75 148.54 35.79 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.121 -0.325 . . . . 0.90000000000000002 110.121 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 124' ' ' TRP . 18.9 m -115.69 149.93 37.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.343 -0.389 . . . . 0.90000000000000002 109.967 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.2 p -97.0 115.07 26.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.144 0.497 . . . . 0.90000000000000002 110.322 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.415 ' HG3' ' HG3' ' A' ' 121' ' ' GLN . 55.5 tp60 -134.6 115.7 14.15 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.615 -0.72 . . . . 0.90000000000000002 110.468 -176.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.415 ' HG3' ' HG3' ' A' ' 120' ' ' GLN . 92.5 mt-30 62.56 35.19 14.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.583 -0.735 . . . . 0.90000000000000002 112.323 172.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.29 4.37 56.34 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.77 -0.728 . . . . 0.90000000000000002 113.877 172.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -155.08 175.94 32.91 Favored Glycine 0 C--O 1.225 -0.406 0 C-N-CA 120.327 -0.94 . . . . 0.90000000000000002 112.036 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.981 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 28.8 m-90 -95.14 127.03 40.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 117.005 0.402 . . . . 0.90000000000000002 110.042 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -110.82 140.3 45.38 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.89 0.376 . . . . 0.90000000000000002 110.623 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -137.03 93.4 2.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.657 -0.497 . . . . 0.90000000000000002 109.657 172.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 51.0 t -86.93 132.01 33.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.886 -0.597 . . . . 0.90000000000000002 110.704 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 C-N-CA 121.132 -0.556 . . . . 0.90000000000000002 111.94 178.613 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 999' ' ' COA . . . . . 0.685 ' O4A' ' HA ' ' A' ' 74' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.8 mtm . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.677 0.275 . . . . 0.90000000000000002 110.516 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -107.3 128.79 54.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.017 0.436 . . . . 0.90000000000000002 110.573 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 42' ' ' ALA . 49.4 tp -93.37 113.7 25.94 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.471 -0.786 . . . . 0.90000000000000002 110.464 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.6 m -83.01 100.09 10.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.249 0.547 . . . . 0.90000000000000002 110.581 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.452 HD11 HD11 ' A' ' 81' ' ' LEU . 85.5 mt -95.03 129.83 44.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.084 -0.507 . . . . 0.90000000000000002 110.393 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.5 mt -124.75 149.84 29.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.481 -0.781 . . . . 0.90000000000000002 109.066 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 7' ' ' ARG . 15.2 ptt-85 -92.57 138.56 31.4 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.382 -0.599 . . . . 0.90000000000000002 109.382 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 41' ' ' ALA . 4.3 mm? -74.92 50.89 0.48 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.035 0.445 . . . . 0.90000000000000002 111.612 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -87.79 -24.39 23.77 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.001 -0.741 . . . . 0.90000000000000002 109.001 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -123.53 107.31 11.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.17 -0.923 . . . . 0.90000000000000002 108.695 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -83.67 115.24 22.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.202 0.525 . . . . 0.90000000000000002 111.539 -173.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.8 t -98.37 153.32 18.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.405 -0.816 . . . . 0.90000000000000002 108.893 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 17' ' ' ILE . 43.1 t0 -66.92 -49.86 64.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.706 -0.225 . . . . 0.90000000000000002 111.439 -172.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -64.95 -37.79 88.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.723 0.297 . . . . 0.90000000000000002 111.049 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.65 -39.37 88.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.297 0.57 . . . . 0.90000000000000002 110.168 176.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -68.26 -29.32 68.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.623 -0.717 . . . . 0.90000000000000002 110.6 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 13' ' ' ASP . 43.2 mm -63.84 -44.28 98.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.307 -0.406 . . . . 0.90000000000000002 110.428 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.519 ' O ' HG13 ' A' ' 22' ' ' ILE . 7.7 m-20 -64.86 -38.4 90.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.236 -0.438 . . . . 0.90000000000000002 110.807 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.9 mt -60.2 -41.84 93.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.962 0.411 . . . . 0.90000000000000002 110.284 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -73.6 -13.54 61.03 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.368 0.604 . . . . 0.90000000000000002 110.483 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -92.01 -23.37 19.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.404 0.621 . . . . 0.90000000000000002 109.68 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 18' ' ' ASP . 96.1 mt -77.66 -35.36 21.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.475 -0.784 . . . . 0.90000000000000002 109.399 174.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 5.3 m-90 -112.23 80.81 3.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.834 -0.802 . . . . 0.90000000000000002 108.834 169.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.97 -8.72 22.54 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.971 2.447 . . . . 0.90000000000000002 113.65 -168.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -115.42 4.26 14.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.866 0.365 . . . . 0.90000000000000002 110.697 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.537 ' CE2' ' HA ' ' A' ' 28' ' ' PRO . 58.6 t80 -133.66 122.46 23.48 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.108 0.48 . . . . 0.90000000000000002 111.843 -174.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.7 m -81.64 115.62 58.01 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.754 -0.657 . . . . 0.90000000000000002 109.248 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.537 ' HA ' ' CE2' ' A' ' 26' ' ' TYR . 49.5 Cg_exo -54.77 109.04 0.34 Allowed 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 123.069 2.513 . . . . 0.90000000000000002 112.718 -174.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.4 t -118.77 -24.17 6.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.691 -0.686 . . . . 0.90000000000000002 109.93 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.1 m -73.34 5.19 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.83 -0.623 . . . . 0.90000000000000002 111.526 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.415 HD13 ' HB2' ' A' ' 28' ' ' PRO . 87.3 mt -59.1 90.3 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.458 0.647 . . . . 0.90000000000000002 111.698 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -161.2 135.21 6.89 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.684 -1.143 . . . . 0.90000000000000002 108.498 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.0 m -123.64 141.28 44.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.36 0.6 . . . . 0.90000000000000002 111.949 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -116.7 172.52 7.18 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.607 -0.886 . . . . 0.90000000000000002 108.607 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.14 -28.09 67.85 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.373 0.606 . . . . 0.90000000000000002 109.477 171.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -98.86 -0.61 42.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.357 -0.838 . . . . 0.90000000000000002 111.141 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -144.55 91.32 2.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.992 -0.373 . . . . 0.90000000000000002 109.992 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.453 ' HB2' HG13 ' A' ' 54' ' ' VAL . 57.3 mtt180 -109.07 153.8 23.15 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.246 -0.434 . . . . 0.90000000000000002 110.769 -174.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 8' ' ' LEU . 66.1 mt -122.78 118.48 55.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.559 -0.534 . . . . 0.90000000000000002 109.559 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -104.58 127.28 52.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.112 0.482 . . . . 0.90000000000000002 110.52 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.478 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -108.23 129.67 55.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.592 -0.731 . . . . 0.90000000000000002 110.094 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.501 ' HB2' HD11 ' A' ' 3' ' ' LEU . . . -91.92 103.93 16.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.836 -0.62 . . . . 0.90000000000000002 110.131 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -101.44 118.68 37.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.144 -0.48 . . . . 0.90000000000000002 109.92 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -122.99 109.84 14.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.255 -0.43 . . . . 0.90000000000000002 110.531 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 69.02 -69.93 0.15 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.168 0.917 . . . . 0.90000000000000002 112.366 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.633 ' HG2' ' HG3' ' A' ' 47' ' ' ARG . 35.7 tt0 -94.2 -66.74 0.9 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.861 0.363 . . . . 0.90000000000000002 111.381 -174.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.633 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 11.8 mtm180 -147.61 -150.79 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.31 -0.626 . . . . 0.90000000000000002 109.31 -174.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.478 HD23 ' HB3' ' A' ' 41' ' ' ALA . 37.8 mt -78.15 122.94 26.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.119 0.485 . . . . 0.90000000000000002 110.414 -176.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.439 ' O ' ' HD3' ' A' ' 69' ' ' ARG . 32.3 tp -99.55 -25.32 14.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.054 -0.521 . . . . 0.90000000000000002 110.076 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.5 ' HB2' HG12 ' A' ' 68' ' ' VAL . . . -152.5 163.65 39.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.917 -0.583 . . . . 0.90000000000000002 110.636 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.29 143.43 29.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.409 -0.36 . . . . 0.90000000000000002 110.675 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.479 ' HB ' HD13 ' A' ' 66' ' ' LEU . 11.7 p -147.02 140.52 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.044 -0.526 . . . . 0.90000000000000002 110.361 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 -101.77 140.01 36.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.683 -0.488 . . . . 0.90000000000000002 109.683 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.453 HG13 ' HB2' ' A' ' 38' ' ' ARG . 6.2 p -130.51 122.28 52.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.594 0.711 . . . . 0.90000000000000002 111.653 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 62' ' ' ALA . 39.2 m -91.33 140.5 29.71 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.408 -0.815 . . . . 0.90000000000000002 108.859 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.2 mt -127.1 141.47 51.76 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.886 0.374 . . . . 0.90000000000000002 110.862 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.7 m -144.23 84.49 1.76 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.926 -0.579 . . . . 0.90000000000000002 109.475 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.15 -110.18 3.29 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.912 -0.661 . . . . 0.90000000000000002 112.146 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 p -98.02 3.05 49.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.959 0.409 . . . . 0.90000000000000002 111.281 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' A' ' 94' ' ' CYS . 42.7 mt-10 -112.24 151.43 29.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.404 -0.362 . . . . 0.90000000000000002 110.397 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.08 158.25 27.37 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.923 -0.656 . . . . 0.90000000000000002 111.567 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -134.39 123.33 23.91 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.76 0.314 . . . . 0.90000000000000002 110.486 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.86 118.24 31.19 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.72 -0.474 . . . . 0.90000000000000002 109.72 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -129.68 133.42 47.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.738 -0.665 . . . . 0.90000000000000002 110.468 -174.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 m 64.98 100.83 0.04 OUTLIER 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.444 0.64 . . . . 0.90000000000000002 111.641 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.479 HD13 ' HB ' ' A' ' 52' ' ' VAL . 56.7 tp -132.31 121.34 23.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.548 -0.751 . . . . 0.90000000000000002 110.149 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 67' ' ' ARG . 31.1 ttt180 -144.0 131.41 20.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.994 0.426 . . . . 0.90000000000000002 110.811 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.539 ' HB ' ' H10' ' A' ' 999' ' ' COA . 9.0 t -109.97 164.26 6.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.668 -0.864 . . . . 0.90000000000000002 108.668 173.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -54.66 135.29 46.95 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.93 -0.396 . . . . 0.90000000000000002 109.93 173.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -62.52 -26.52 68.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.91 -0.586 . . . . 0.90000000000000002 111.101 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 p -77.82 -14.62 14.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.983 -0.553 . . . . 0.90000000000000002 111.002 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 m -91.43 64.21 5.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.671 0.748 . . . . 0.90000000000000002 111.385 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.574 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 52.2 mtt-85 -106.88 91.66 3.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.58 -0.736 . . . . 0.90000000000000002 109.018 174.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -131.67 -9.44 3.58 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.196 0.443 . . . . 0.90000000000000002 112.196 -171.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.58 ' HA ' ' O8A' ' A' ' 999' ' ' COA . 74.2 mtt180 69.16 88.37 0.11 Allowed 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.94 0.4 . . . . 0.90000000000000002 109.976 -174.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 147.52 -43.05 0.86 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.459 -1.353 . . . . 0.90000000000000002 114.006 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.44 -54.48 18.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 117.209 0.504 . . . . 0.90000000000000002 111.757 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.07 -38.53 96.74 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.784 -0.722 . . . . 0.90000000000000002 112.321 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.534 ' HG3' ' HG ' ' A' ' 115' ' ' LEU . 7.8 tt0 -62.33 -52.42 63.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.791 0.329 . . . . 0.90000000000000002 110.665 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -62.38 -33.75 75.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.90000000000000002 110.699 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.46 ' O ' HG22 ' A' ' 85' ' ' VAL . 48.0 tp -54.14 -57.62 10.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.90000000000000002 110.574 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.07 -41.45 95.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.062 -0.517 . . . . 0.90000000000000002 110.572 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -54.36 -46.55 73.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.94 0.4 . . . . 0.90000000000000002 111.228 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -66.06 -36.8 84.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.122 -0.49 . . . . 0.90000000000000002 110.392 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 81' ' ' LEU . 81.2 t -66.2 -46.37 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.90000000000000002 110.88 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.423 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 10.9 mp -65.79 -22.85 66.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 0.90000000000000002 111.359 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.4 mtm-85 -89.25 -15.74 32.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.90000000000000002 110.735 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.426 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 46.4 t-20 -81.87 -42.59 19.38 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.179 -0.675 . . . . 0.90000000000000002 109.179 175.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -118.14 76.96 12.32 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.781 -0.645 . . . . 0.90000000000000002 110.405 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 6.0 Cg_exo -79.0 -13.9 13.87 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.992 2.461 . . . . 0.90000000000000002 112.282 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.67 -20.91 72.53 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.161 -0.542 . . . . 0.90000000000000002 112.043 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -76.05 106.56 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.66 -0.496 . . . . 0.90000000000000002 109.66 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.7 m -90.82 -11.78 38.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.888 -0.597 . . . . 0.90000000000000002 111.085 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.415 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 40.2 t -131.28 95.54 3.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.88 0.371 . . . . 0.90000000000000002 110.501 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.975 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 95.5 m95 -91.38 107.24 19.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.044 -0.525 . . . . 0.90000000000000002 110.424 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.608 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 76.9 t-105 -97.47 130.98 44.51 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.668 -0.493 . . . . 0.90000000000000002 109.668 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.461 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 58.9 mtp -114.48 131.82 56.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.719 0.295 . . . . 0.90000000000000002 110.481 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.84 165.42 11.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.939 -0.573 . . . . 0.90000000000000002 111.586 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -108.71 73.61 0.88 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.835 0.826 . . . . 0.90000000000000002 109.115 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.77 113.59 27.28 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.352 -0.84 . . . . 0.90000000000000002 111.521 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.51 1.02 81.37 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.074 -0.584 . . . . 0.90000000000000002 112.91 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.97 118.23 46.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.946 0.403 . . . . 0.90000000000000002 110.336 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -93.22 -20.59 20.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.341 0.591 . . . . 0.90000000000000002 109.48 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -86.74 41.19 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.34 -0.845 . . . . 0.90000000000000002 110.641 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -52.95 -43.85 66.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.127 -0.488 . . . . 0.90000000000000002 111.053 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.7 -46.52 92.11 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.062 -0.59 . . . . 0.90000000000000002 112.501 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.8 t -64.56 -45.26 96.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.09 0.472 . . . . 0.90000000000000002 110.308 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.479 ' O ' ' HG2' ' A' ' 112' ' ' MET . 37.6 ttm -67.05 -29.2 68.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.90000000000000002 111.032 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 96.9 m -61.61 -45.39 94.3 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.175 -0.305 . . . . 0.90000000000000002 110.175 175.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.04 -39.35 92.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.146 0.498 . . . . 0.90000000000000002 110.437 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.412 ' HA ' ' O4B' ' A' ' 999' ' ' COA . 12.4 t80 -60.52 -49.08 78.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.656 -0.702 . . . . 0.90000000000000002 111.042 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.507 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 22.2 mmt -66.85 -35.29 79.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.427 -0.351 . . . . 0.90000000000000002 111.132 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -71.4 -25.54 62.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.524 -0.307 . . . . 0.90000000000000002 111.024 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.42 -38.9 54.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.92 0.39 . . . . 0.90000000000000002 110.227 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.569 HD23 ' CE2' ' A' ' 117' ' ' PHE . 7.3 tt -70.72 -49.55 45.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.912 -0.586 . . . . 0.90000000000000002 110.078 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 134.64 47.83 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.511 -0.852 . . . . 0.90000000000000002 112.983 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.57 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 83.1 m-85 -110.43 149.2 30.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.589 0.233 . . . . 0.90000000000000002 110.422 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.0 m -94.67 143.09 26.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.28 -0.418 . . . . 0.90000000000000002 109.912 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.8 p -97.43 122.5 40.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.0 0.429 . . . . 0.90000000000000002 111.093 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -120.13 -171.48 2.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.258 -0.428 . . . . 0.90000000000000002 110.356 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -84.42 94.07 8.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.134 0.492 . . . . 0.90000000000000002 110.255 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 136.52 -48.55 0.91 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.777 -0.647 . . . . 0.90000000000000002 112.022 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -167.74 -153.16 7.91 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.957 -0.639 . . . . 0.90000000000000002 112.279 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 15.5 m-90 -108.49 141.77 39.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.597 0.237 . . . . 0.90000000000000002 110.481 -176.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -120.18 132.52 55.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.395 -0.366 . . . . 0.90000000000000002 111.018 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.975 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 57.8 tptt -119.08 85.86 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.476 -0.564 . . . . 0.90000000000000002 109.476 172.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 39.2 t -98.86 137.0 38.07 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.777 -0.647 . . . . 0.90000000000000002 109.904 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 C-N-CA 120.836 -0.697 . . . . 0.90000000000000002 112.07 -179.943 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 999' ' ' COA . . . . . 0.58 ' O8A' ' HA ' ' A' ' 75' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtm . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.822 0.344 . . . . 0.90000000000000002 110.371 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -92.76 141.94 27.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.957 0.408 . . . . 0.90000000000000002 110.354 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.4 tp -75.96 106.28 7.46 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.193 -1.04 . . . . 0.90000000000000002 108.193 172.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.6 m -96.64 111.46 23.59 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.851 -0.613 . . . . 0.90000000000000002 109.655 -177.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.537 HD12 ' HB3' ' A' ' 42' ' ' ALA . 15.7 tt -122.01 129.35 75.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 121.416 0.627 . . . . 0.90000000000000002 110.871 -175.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.4 168.17 24.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.51 -0.768 . . . . 0.90000000000000002 109.755 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -75.03 124.37 26.86 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.953 -0.758 . . . . 0.90000000000000002 108.953 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.0 tp -89.92 78.44 6.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.343 0.592 . . . . 0.90000000000000002 110.143 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.531 ' HA ' HG21 ' A' ' 33' ' ' VAL . 29.3 tt0 -86.64 -40.68 14.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.267 -0.879 . . . . 0.90000000000000002 110.513 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -102.99 122.21 44.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.646 -0.706 . . . . 0.90000000000000002 109.965 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -105.7 110.41 22.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.827 -0.624 . . . . 0.90000000000000002 110.709 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.551 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 0.7 OUTLIER -80.29 168.95 18.41 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.721 -0.844 . . . . 0.90000000000000002 108.721 172.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.478 ' O ' HG13 ' A' ' 17' ' ' ILE . 17.1 t70 -61.08 -45.99 92.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.751 0.31 . . . . 0.90000000000000002 110.388 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.515 ' HA ' HD11 ' A' ' 17' ' ' ILE . 97.6 mt-30 -66.73 -34.87 78.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.989 -0.551 . . . . 0.90000000000000002 111.13 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.26 -35.61 79.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.784 0.326 . . . . 0.90000000000000002 110.234 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' A' ' 12' ' ' SER . 42.5 mtt180 -65.93 -47.08 75.9 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.472 -0.566 . . . . 0.90000000000000002 109.472 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.515 HD11 ' HA ' ' A' ' 14' ' ' GLN . 69.1 mt -54.37 -48.43 68.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.67 -0.695 . . . . 0.90000000000000002 110.99 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.552 ' O ' HG13 ' A' ' 22' ' ' ILE . 99.7 m-20 -54.69 -57.84 9.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.90000000000000002 111.104 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.03 -41.18 99.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.429 -0.351 . . . . 0.90000000000000002 111.38 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -73.43 -10.54 59.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.215 -0.448 . . . . 0.90000000000000002 110.837 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -99.54 -25.06 14.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.075 0.465 . . . . 0.90000000000000002 110.111 175.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 18' ' ' ASP . 76.4 mt -65.03 -44.35 95.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.289 -0.634 . . . . 0.90000000000000002 109.289 172.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -87.85 117.48 68.52 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.899 -0.591 . . . . 0.90000000000000002 109.467 172.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.31 -45.61 36.21 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.985 2.456 . . . . 0.90000000000000002 112.92 -176.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -147.31 92.49 2.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.111 0.482 . . . . 0.90000000000000002 109.849 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -154.28 135.85 14.3 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.601 -0.727 . . . . 0.90000000000000002 110.207 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.1 p -96.38 147.93 33.71 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.175 -0.466 . . . . 0.90000000000000002 109.849 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.632 ' HB3' HD11 ' A' ' 31' ' ' LEU . 52.4 Cg_exo -55.58 100.2 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.874 2.382 . . . . 0.90000000000000002 112.404 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.2 m -131.38 -53.29 1.02 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.07 -0.514 . . . . 0.90000000000000002 110.813 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 p -79.27 4.7 14.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.90000000000000002 111.6 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.632 HD11 ' HB3' ' A' ' 28' ' ' PRO . 86.6 mt -80.59 11.53 3.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.832 0.349 . . . . 0.90000000000000002 111.406 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -74.32 107.68 6.63 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.719 -0.474 . . . . 0.90000000000000002 109.719 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' A' ' 9' ' ' GLU . 16.9 m -104.35 136.42 37.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.858 -0.61 . . . . 0.90000000000000002 111.453 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -140.23 -161.73 1.24 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.682 -0.69 . . . . 0.90000000000000002 109.617 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -81.63 -19.83 40.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.997 0.427 . . . . 0.90000000000000002 110.222 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.18 -68.19 0.81 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.827 -0.434 . . . . 0.90000000000000002 109.827 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -72.53 97.32 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.077 -0.342 . . . . 0.90000000000000002 110.077 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.6 HH11 HD13 ' A' ' 56' ' ' LEU . 71.5 mtt180 -113.54 127.62 56.14 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.011 0.434 . . . . 0.90000000000000002 111.163 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.717 HG12 ' HG2' ' A' ' 53' ' ' ARG . 64.5 mt -101.88 119.34 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 0.90000000000000002 109.804 176.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.404 ' HB2' HG12 ' A' ' 52' ' ' VAL . 80.6 m-85 -98.78 133.6 42.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.282 -0.417 . . . . 0.90000000000000002 109.96 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.472 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.09 113.38 26.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.919 -0.582 . . . . 0.90000000000000002 110.283 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.734 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -98.42 110.83 23.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.038 -0.528 . . . . 0.90000000000000002 110.387 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.53 ' HB3' HD21 ' A' ' 48' ' ' LEU . 23.8 ptt180 -107.94 134.12 51.31 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.225 0.536 . . . . 0.90000000000000002 110.257 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -97.15 94.2 6.99 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.856 -0.611 . . . . 0.90000000000000002 109.793 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.691 HD21 ' HG3' ' A' ' 46' ' ' GLU . 9.3 t30 72.25 -46.98 0.66 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.031 -0.986 . . . . 0.90000000000000002 112.142 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.691 ' HG3' HD21 ' A' ' 45' ' ' ASN . 46.0 mt-10 -128.21 -67.83 0.79 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.362 . . . . 0.90000000000000002 111.848 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -104.55 162.21 13.45 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.275 -0.421 . . . . 0.90000000000000002 111.966 -170.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.53 HD21 ' HB3' ' A' ' 43' ' ' ARG . 92.3 mt -59.87 127.42 31.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.43 -0.804 . . . . 0.90000000000000002 110.34 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.69 HD23 HG12 ' A' ' 77' ' ' VAL . 31.3 tp -115.95 -29.49 6.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.272 -0.422 . . . . 0.90000000000000002 110.489 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.734 ' HB1' ' HB2' ' A' ' 42' ' ' ALA . . . -136.61 139.74 42.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.822 0.344 . . . . 0.90000000000000002 111.41 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.63 116.66 22.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.845 -0.616 . . . . 0.90000000000000002 109.843 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.404 HG12 ' HB2' ' A' ' 40' ' ' TYR . 7.4 p -124.51 131.34 72.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.396 0.617 . . . . 0.90000000000000002 111.315 -177.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.717 ' HG2' HG12 ' A' ' 39' ' ' ILE . 41.3 mtp-105 -107.75 119.05 38.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.589 -0.732 . . . . 0.90000000000000002 109.645 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.48 128.62 68.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.405 0.621 . . . . 0.90000000000000002 110.821 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.0 m -94.11 100.88 12.9 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.634 -0.712 . . . . 0.90000000000000002 109.94 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.6 HD13 HH11 ' A' ' 38' ' ' ARG . 93.3 mt -87.04 86.54 7.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.644 -0.707 . . . . 0.90000000000000002 109.639 177.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -95.92 105.87 17.95 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.749 -0.659 . . . . 0.90000000000000002 109.383 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.15 -113.54 4.75 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.675 -0.774 . . . . 0.90000000000000002 111.553 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 p -113.16 8.67 18.31 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.894 0.378 . . . . 0.90000000000000002 110.939 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -107.75 137.96 44.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.44 . . . . 0.90000000000000002 110.312 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.47 114.22 3.0 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.856 -0.687 . . . . 0.90000000000000002 111.923 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -111.37 128.93 56.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.562 0.22 . . . . 0.90000000000000002 110.47 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.495 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 6.9 mp -93.49 108.49 20.17 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.378 0.609 . . . . 0.90000000000000002 109.611 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.54 -28.43 33.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.91 -1.041 . . . . 0.90000000000000002 111.809 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.418 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 15.6 m -152.4 127.77 9.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.663 0.268 . . . . 0.90000000000000002 110.965 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.4 tp -131.28 109.68 10.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.164 -0.471 . . . . 0.90000000000000002 109.736 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -143.27 109.38 5.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.17 0.51 . . . . 0.90000000000000002 110.853 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.54 ' HB ' ' H10' ' A' ' 999' ' ' COA . 12.4 t -97.7 157.8 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.856 -0.794 . . . . 0.90000000000000002 108.856 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -58.22 146.45 33.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 0.90000000000000002 110.707 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -52.02 -35.5 47.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.379 -0.828 . . . . 0.90000000000000002 112.484 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -75.98 7.9 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.469 0.652 . . . . 0.90000000000000002 111.487 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.481 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 1.8 m -103.91 8.93 36.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.618 0.723 . . . . 0.90000000000000002 110.238 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.9 ttp85 -65.74 107.19 1.7 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.201 -0.908 . . . . 0.90000000000000002 110.614 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 61.58 91.38 0.06 Allowed 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.606 0.567 . . . . 0.90000000000000002 110.093 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -164.42 -42.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.267 -0.424 . . . . 0.90000000000000002 111.044 -170.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.6 -24.34 6.85 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.256 -0.973 . . . . 0.90000000000000002 113.435 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.69 HG12 HD23 ' A' ' 49' ' ' LEU . 84.5 t -55.38 -42.54 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 112.011 0.375 . . . . 0.90000000000000002 112.011 -177.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.25 -31.82 70.49 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.005 -0.617 . . . . 0.90000000000000002 113.006 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.522 ' HA ' HD21 ' A' ' 115' ' ' LEU . 53.0 tt0 -65.16 -43.85 90.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.849 -0.426 . . . . 0.90000000000000002 109.849 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -69.0 -36.87 78.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.573 -0.74 . . . . 0.90000000000000002 110.42 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.494 ' O ' HG22 ' A' ' 85' ' ' VAL . 63.2 tp -49.29 -58.72 4.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.07 -0.514 . . . . 0.90000000000000002 111.268 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.17 -33.21 75.47 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.003 -0.279 . . . . 0.90000000000000002 110.95 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -58.26 -54.04 51.53 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.646 0.26 . . . . 0.90000000000000002 110.817 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.38 -36.78 85.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.069 -0.514 . . . . 0.90000000000000002 111.162 -175.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 81' ' ' LEU . 93.3 t -61.37 -49.15 85.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.912 0.387 . . . . 0.90000000000000002 110.763 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.473 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 10.4 mp -78.18 -4.59 48.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.088 0.47 . . . . 0.90000000000000002 110.938 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -87.76 -38.54 15.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.831 -0.622 . . . . 0.90000000000000002 109.943 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -71.1 -37.96 72.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.866 -0.606 . . . . 0.90000000000000002 110.097 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.435 ' O ' ' HZ2' ' A' ' 95' ' ' TRP . 20.1 m120 -120.12 74.48 21.15 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.817 -0.628 . . . . 0.90000000000000002 109.883 176.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -88.09 -3.42 7.03 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.741 2.294 . . . . 0.90000000000000002 113.733 -173.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -94.25 19.33 53.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.734 -0.746 . . . . 0.90000000000000002 112.851 -175.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.7 t -107.17 125.14 63.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.58 -0.526 . . . . 0.90000000000000002 109.58 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.0 m -91.76 -42.92 9.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.902 0.382 . . . . 0.90000000000000002 110.779 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 40.6 t -104.43 96.46 6.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.051 0.453 . . . . 0.90000000000000002 110.558 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.473 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 86.5 m95 -90.87 131.0 36.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.945 -0.571 . . . . 0.90000000000000002 109.94 175.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.63 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 67.9 t-105 -120.66 133.44 55.36 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.624 -0.51 . . . . 0.90000000000000002 109.624 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.495 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 75.2 mtp -119.15 124.84 47.82 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.732 -0.47 . . . . 0.90000000000000002 109.732 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -84.46 173.39 10.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.452 . . . . 0.90000000000000002 110.832 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -57.57 -35.28 70.17 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.055 -0.52 . . . . 0.90000000000000002 111.077 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.488 ' HB1' HG21 ' A' ' 102' ' ' VAL . . . 63.99 11.74 6.34 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.025 -0.534 . . . . 0.90000000000000002 111.919 175.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.59 12.21 84.72 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.859 -0.686 . . . . 0.90000000000000002 111.803 -176.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.708 HG22 ' C3P' ' A' ' 999' ' ' COA . 45.2 t -80.85 101.49 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.962 0.41 . . . . 0.90000000000000002 110.281 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -89.08 -1.37 58.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.463 0.649 . . . . 0.90000000000000002 109.724 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -85.75 44.45 1.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.201 -0.909 . . . . 0.90000000000000002 109.084 172.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -56.33 -41.69 76.47 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 115.232 -0.895 . . . . 0.90000000000000002 112.2 -173.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -51.95 -54.21 26.72 Favored Glycine 0 C--O 1.236 0.275 0 C-N-CA 120.983 -0.627 . . . . 0.90000000000000002 112.706 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.2 t -66.73 -43.38 90.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.931 0.396 . . . . 0.90000000000000002 111.009 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.552 ' O ' ' HG2' ' A' ' 112' ' ' MET . 34.8 ttm -69.75 -35.66 75.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.296 -0.411 . . . . 0.90000000000000002 111.868 -176.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 33.7 m -66.58 -36.93 83.82 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.731 -0.388 . . . . 0.90000000000000002 110.402 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.94 -37.46 86.08 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.285 0.564 . . . . 0.90000000000000002 109.922 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.402 ' HB3' ' O ' ' A' ' 108' ' ' MET . 59.9 t80 -61.15 -46.63 89.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.15 -0.932 . . . . 0.90000000000000002 110.524 174.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.552 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.5 mmt -58.77 -43.85 90.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.511 . . . . 0.90000000000000002 110.734 178.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -62.33 -33.93 75.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.005 -0.543 . . . . 0.90000000000000002 110.985 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.54 -36.2 68.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.352 -0.385 . . . . 0.90000000000000002 111.247 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 79' ' ' GLN . 11.1 mp -90.66 7.98 36.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.408 -0.36 . . . . 0.90000000000000002 111.34 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.24 68.09 1.68 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.043 -0.599 . . . . 0.90000000000000002 112.82 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 57.9 m-85 -117.85 151.6 37.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.135 0.493 . . . . 0.90000000000000002 111.026 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.682 ' HB ' ' HB2' ' A' ' 125' ' ' GLU . 24.3 m -91.4 136.0 33.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.431 -0.804 . . . . 0.90000000000000002 109.37 176.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 41.7 p -101.29 108.65 20.35 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.82 -0.352 . . . . 0.90000000000000002 111.423 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -95.96 160.57 14.39 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.254 -0.647 . . . . 0.90000000000000002 109.254 172.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -78.86 88.01 4.7 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.253 0.549 . . . . 0.90000000000000002 109.767 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.98 3.84 6.81 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.518 -0.764 . . . . 0.90000000000000002 112.884 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.438 ' HA3' ' CZ2' ' A' ' 96' ' ' TRP . . . 173.15 173.59 39.63 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.485 -0.864 . . . . 0.90000000000000002 112.358 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -116.0 150.65 36.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.231 -0.285 . . . . 0.90000000000000002 110.231 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.682 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 53.1 mt-10 -126.51 156.38 40.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.774 0.321 . . . . 0.90000000000000002 111.03 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.422 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 56.2 tttp -137.35 121.2 17.55 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.591 -0.522 . . . . 0.90000000000000002 109.591 167.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.7 t -86.31 105.27 16.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.243 -0.435 . . . . 0.90000000000000002 110.148 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 CA-C-N 115.884 -0.598 . . . . 0.90000000000000002 112.43 -179.76 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 999' ' ' COA . . . . . 0.708 ' C3P' HG22 ' A' ' 102' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.3 mtp . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.867 0.365 . . . . 0.90000000000000002 110.379 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -108.99 118.1 35.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.045 -0.525 . . . . 0.90000000000000002 110.373 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 42' ' ' ALA . 59.7 tp -83.82 111.69 19.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.15 -0.685 . . . . 0.90000000000000002 109.15 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.401 ' HB ' ' HB3' ' A' ' 43' ' ' ARG . 7.2 m -82.78 89.56 6.8 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.215 0.531 . . . . 0.90000000000000002 109.794 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 tt -102.65 118.78 50.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.415 0.626 . . . . 0.90000000000000002 109.982 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.8 mt -114.87 150.96 16.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.591 -0.731 . . . . 0.90000000000000002 110.416 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.512 ' HB3' ' CE2' ' A' ' 40' ' ' TYR . 17.1 ptt180 -91.61 119.07 31.19 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.572 -0.74 . . . . 0.90000000000000002 109.567 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.79 72.91 1.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.913 -0.585 . . . . 0.90000000000000002 111.127 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -96.15 -9.06 31.54 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.939 -1.134 . . . . 0.90000000000000002 107.939 171.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -143.08 143.68 31.95 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.181 -1.372 . . . . 0.90000000000000002 108.1 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -124.63 145.96 49.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.142 0.496 . . . . 0.90000000000000002 111.571 -173.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -119.31 177.52 4.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.479 -0.934 . . . . 0.90000000000000002 108.479 172.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -75.06 -34.53 61.83 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.505 -0.478 . . . . 0.90000000000000002 110.487 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -64.7 -53.79 41.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.556 -0.293 . . . . 0.90000000000000002 110.583 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -62.69 -31.86 72.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.90000000000000002 110.738 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -63.24 -40.25 96.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.05 -0.523 . . . . 0.90000000000000002 109.833 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.1 mt -77.94 -26.0 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.067 -0.515 . . . . 0.90000000000000002 110.948 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.469 ' HB3' HD11 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -72.67 -35.53 67.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.968 0.413 . . . . 0.90000000000000002 110.362 174.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.04 -30.65 71.71 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.539 -0.541 . . . . 0.90000000000000002 109.539 170.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -72.08 -21.92 61.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.328 -0.851 . . . . 0.90000000000000002 110.536 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -72.59 -33.55 66.81 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.529 -0.545 . . . . 0.90000000000000002 109.529 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.4 mm -75.4 -51.73 20.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.57 -0.741 . . . . 0.90000000000000002 110.188 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -119.27 110.29 37.87 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.207 -0.451 . . . . 0.90000000000000002 110.112 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.79 -16.21 26.44 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 122.684 2.256 . . . . 0.90000000000000002 111.762 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -137.25 86.05 2.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.448 -0.796 . . . . 0.90000000000000002 108.991 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.418 ' CE2' HD11 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -133.25 135.68 45.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.918 -0.583 . . . . 0.90000000000000002 110.822 -176.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.2 m -96.18 143.17 25.66 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.901 -0.591 . . . . 0.90000000000000002 110.297 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.08 -15.04 31.46 Favored 'Trans proline' 0 N--CA 1.475 0.394 0 C-N-CA 123.472 2.782 . . . . 0.90000000000000002 114.024 -174.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.0 m -62.29 -28.38 69.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.902 0.382 . . . . 0.90000000000000002 111.192 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.1 p -85.65 -16.44 39.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.973 0.416 . . . . 0.90000000000000002 110.614 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.418 HD11 ' CE2' ' A' ' 26' ' ' TYR . 84.3 mt -86.27 -2.99 58.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.734 -0.667 . . . . 0.90000000000000002 109.844 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.35 95.43 1.03 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.552 -0.749 . . . . 0.90000000000000002 109.931 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -102.55 165.17 3.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.284 0.564 . . . . 0.90000000000000002 111.94 -174.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.75 -164.51 0.91 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.778 -1.101 . . . . 0.90000000000000002 108.049 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.54 -24.41 61.12 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.8 -0.36 . . . . 0.90000000000000002 111.546 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.516 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 33.9 m-80 -87.15 -62.78 1.43 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.002 -0.37 . . . . 0.90000000000000002 110.002 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.605 ' HB2' HG21 ' A' ' 55' ' ' THR . 77.9 t60 -87.0 97.98 11.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 0.90000000000000002 110.12 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -111.73 148.68 32.95 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.689 -0.687 . . . . 0.90000000000000002 110.516 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.582 HG12 ' HG2' ' A' ' 53' ' ' ARG . 68.9 mt -115.46 118.06 57.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.506 -0.553 . . . . 0.90000000000000002 109.506 175.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.512 ' CE2' ' HB3' ' A' ' 7' ' ' ARG . 79.1 m-85 -103.01 122.43 44.6 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.689 -0.486 . . . . 0.90000000000000002 109.689 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.91 128.71 56.54 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.906 0.384 . . . . 0.90000000000000002 110.884 -177.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.683 ' HB1' ' HB3' ' A' ' 50' ' ' ALA . . . -92.22 103.96 16.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.768 -0.651 . . . . 0.90000000000000002 110.21 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.401 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 14.7 ttt85 -85.74 104.64 15.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.902 -1.044 . . . . 0.90000000000000002 109.569 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -123.95 115.39 21.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.224 -0.444 . . . . 0.90000000000000002 109.913 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 61.97 60.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.635 -0.711 . . . . 0.90000000000000002 111.645 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 67.92 10.38 7.76 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.184 0.809 . . . . 0.90000000000000002 113.184 170.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -149.5 155.89 41.09 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.345 -0.242 . . . . 0.90000000000000002 110.345 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 18' ' ' ASP . 69.1 mt -75.82 110.99 10.71 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.545 -0.539 . . . . 0.90000000000000002 109.545 173.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.6 tp -94.61 -26.96 16.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.168 -0.469 . . . . 0.90000000000000002 110.332 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.683 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . . . -137.49 145.03 42.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.087 -0.506 . . . . 0.90000000000000002 111.217 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.39 121.66 21.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.221 -0.445 . . . . 0.90000000000000002 110.255 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.474 HG13 ' HB2' ' A' ' 40' ' ' TYR . 7.6 p -126.2 121.09 58.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.35 0.595 . . . . 0.90000000000000002 110.551 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.763 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 9.8 mtp180 -103.08 138.96 39.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.977 -0.556 . . . . 0.90000000000000002 110.108 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -137.76 135.9 45.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.954 0.407 . . . . 0.90000000000000002 110.31 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.605 HG21 ' HB2' ' A' ' 37' ' ' HIS . 6.7 m -117.91 100.64 7.71 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.127 0.489 . . . . 0.90000000000000002 110.124 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.6 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 49.0 mt -78.52 160.84 27.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.681 -0.691 . . . . 0.90000000000000002 110.371 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.6 m -154.43 83.4 1.12 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.154 0.502 . . . . 0.90000000000000002 109.652 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.9 -120.54 8.78 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.577 -0.738 . . . . 0.90000000000000002 112.289 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 p -82.26 -6.84 59.51 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.015 0.436 . . . . 0.90000000000000002 111.504 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.533 ' HG2' ' HB3' ' A' ' 94' ' ' CYS . 44.8 mt-10 -112.41 159.98 18.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.953 -0.567 . . . . 0.90000000000000002 110.33 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' A' ' 56' ' ' LEU . . . -153.74 116.07 0.71 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.934 -0.65 . . . . 0.90000000000000002 111.563 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.86 140.87 32.38 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.234 -0.284 . . . . 0.90000000000000002 110.234 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.476 HD21 ' HE2' ' A' ' 97' ' ' MET . 0.6 OUTLIER -93.38 130.74 39.06 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.263 -0.643 . . . . 0.90000000000000002 109.263 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.763 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 3.4 t70 -120.49 99.26 6.46 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.501 -0.772 . . . . 0.90000000000000002 110.95 -171.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.8 t 70.72 111.41 0.06 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.954 0.883 . . . . 0.90000000000000002 111.905 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.438 ' O ' ' C5P' ' A' ' 999' ' ' COA . 35.1 tp -117.25 126.01 52.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.208 -0.906 . . . . 0.90000000000000002 109.481 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 68.0 ttt-85 -143.84 110.98 5.77 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.261 -0.576 . . . . 0.90000000000000002 111.959 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.499 HG13 ' HB1' ' A' ' 50' ' ' ALA . 17.1 t -98.32 146.31 8.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.634 -1.247 . . . . 0.90000000000000002 107.634 166.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 69' ' ' ARG . 16.0 ttt180 -57.42 136.53 56.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.792 -0.447 . . . . 0.90000000000000002 109.792 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -54.89 -27.87 46.22 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.325 0.65 . . . . 0.90000000000000002 112.554 -168.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.8 t -69.38 -14.31 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.373 -0.376 . . . . 0.90000000000000002 111.351 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.11 18.47 9.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.334 0.587 . . . . 0.90000000000000002 110.669 -177.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -62.32 119.45 9.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.807 -0.633 . . . . 0.90000000000000002 110.496 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.533 ' HA ' ' O8A' ' A' ' 999' ' ' COA . 66.4 mtt-85 63.89 67.88 0.6 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.493 -0.776 . . . . 0.90000000000000002 111.326 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -165.56 59.16 0.11 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.198 0.444 . . . . 0.90000000000000002 112.198 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.83 -59.45 1.33 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 115.724 1.05 . . . . 0.90000000000000002 115.724 167.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.1 t -42.77 -50.51 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 113.761 1.023 . . . . 0.90000000000000002 113.761 -167.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.78 -49.0 73.68 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.517 -0.849 . . . . 0.90000000000000002 112.987 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.514 ' HA ' HD21 ' A' ' 115' ' ' LEU . 46.3 tt0 -68.28 -39.1 82.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.991 0.424 . . . . 0.90000000000000002 110.402 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -61.01 -45.82 93.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.721 -0.672 . . . . 0.90000000000000002 110.158 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.492 HD12 ' HB2' ' A' ' 42' ' ' ALA . 1.2 mp -51.85 -57.56 8.99 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.825 -0.625 . . . . 0.90000000000000002 111.817 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.443 HD13 ' HE2' ' A' ' 97' ' ' MET . 4.0 mm? -56.19 -48.27 76.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.90000000000000002 111.434 -176.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -69.04 -33.9 74.35 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.65 -0.42 . . . . 0.90000000000000002 111.437 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -65.02 -42.67 94.18 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.012 0.434 . . . . 0.90000000000000002 110.206 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 81' ' ' LEU . 88.2 t -62.56 -48.66 87.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.90000000000000002 110.713 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.2 -20.53 65.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.90000000000000002 111.15 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -80.34 -52.89 7.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.144 -0.48 . . . . 0.90000000000000002 111.175 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -73.51 -19.12 61.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.90000000000000002 111.621 -172.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -113.57 83.5 7.12 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.17 -0.307 . . . . 0.90000000000000002 110.17 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -86.0 -0.67 8.56 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.641 2.227 . . . . 0.90000000000000002 113.153 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -82.96 -14.89 74.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.682 -0.771 . . . . 0.90000000000000002 112.371 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.443 HG22 HD23 ' A' ' 56' ' ' LEU . 38.5 t -92.06 120.94 42.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.811 0.339 . . . . 0.90000000000000002 110.309 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 128' ' ' GLY . 7.4 t -96.89 -26.14 15.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.37 -0.377 . . . . 0.90000000000000002 110.431 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.533 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 22.9 t -118.44 104.88 11.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.317 -0.402 . . . . 0.90000000000000002 110.536 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.427 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 91.9 m95 -96.47 112.35 24.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.268 -0.424 . . . . 0.90000000000000002 110.424 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -100.85 134.17 44.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.901 -0.59 . . . . 0.90000000000000002 109.714 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.697 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 92.1 mmm -106.95 106.59 17.19 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.65 -0.5 . . . . 0.90000000000000002 109.65 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.17 141.31 29.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.004 0.43 . . . . 0.90000000000000002 110.788 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 102' ' ' VAL . 19.1 p-10 -90.23 -46.46 8.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.893 -0.594 . . . . 0.90000000000000002 110.535 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 66.24 -66.06 0.18 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.476 0.71 . . . . 0.90000000000000002 111.786 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -145.0 37.5 1.33 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.165 -0.54 . . . . 0.90000000000000002 111.863 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 99' ' ' ASP . 75.0 t -82.84 105.95 13.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.988 0.423 . . . . 0.90000000000000002 110.342 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -85.52 -34.22 21.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.732 -0.667 . . . . 0.90000000000000002 109.914 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.57 56.87 2.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.866 -0.606 . . . . 0.90000000000000002 110.151 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -61.04 -42.66 98.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.561 -0.745 . . . . 0.90000000000000002 111.112 -175.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.28 -52.77 47.12 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.909 -0.662 . . . . 0.90000000000000002 112.549 -177.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.79 -45.15 87.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.90000000000000002 111.129 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.554 ' O ' ' HG2' ' A' ' 112' ' ' MET . 69.3 mtp -75.5 -23.31 56.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.414 -0.357 . . . . 0.90000000000000002 111.957 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 80.9 m -71.41 -39.28 71.22 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.726 -0.39 . . . . 0.90000000000000002 110.136 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.4 -39.84 92.21 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.247 0.546 . . . . 0.90000000000000002 109.664 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -60.56 -52.88 63.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.136 -0.938 . . . . 0.90000000000000002 110.765 174.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.554 ' HG2' ' O ' ' A' ' 108' ' ' MET . 25.5 mmt -58.03 -45.87 86.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.90000000000000002 111.416 -177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -65.02 -30.54 71.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.945 0.402 . . . . 0.90000000000000002 110.815 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.64 -23.22 61.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.872 0.368 . . . . 0.90000000000000002 110.814 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.514 HD21 ' HA ' ' A' ' 79' ' ' GLN . 11.2 mp -98.0 4.73 49.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.191 -0.459 . . . . 0.90000000000000002 111.016 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.99 23.27 52.9 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.98 -0.629 . . . . 0.90000000000000002 113.462 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.528 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 88.8 m-85 -91.73 141.55 28.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.026 0.413 . . . . 0.90000000000000002 110.413 176.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.7 m -96.27 132.63 41.54 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.181 -0.463 . . . . 0.90000000000000002 110.383 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.432 ' HB ' ' CD1' ' A' ' 124' ' ' TRP . 3.0 t -97.29 126.88 42.79 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.439 -0.578 . . . . 0.90000000000000002 109.439 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -121.01 -72.75 0.67 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.459 0.647 . . . . 0.90000000000000002 110.745 -174.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -116.87 -142.91 0.37 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.209 -0.905 . . . . 0.90000000000000002 108.752 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.94 62.73 0.72 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.722 -0.751 . . . . 0.90000000000000002 111.533 170.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.04 164.88 14.57 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.743 -0.543 . . . . 0.90000000000000002 111.743 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.697 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 14.4 m-90 -112.98 157.15 21.86 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.646 -0.501 . . . . 0.90000000000000002 109.646 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -141.09 139.37 34.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.792 0.329 . . . . 0.90000000000000002 110.543 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 95' ' ' TRP . 86.3 tttt -137.01 122.82 19.99 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.135 -0.691 . . . . 0.90000000000000002 109.135 173.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 31.2 t -74.2 142.01 45.43 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.895 0.379 . . . . 0.90000000000000002 110.719 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 93' ' ' SER . . . . . . . . 0 N--CA 1.448 -0.5 0 CA-C-N 116.105 -0.498 . . . . 0.90000000000000002 111.992 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 999' ' ' COA . . . . . 0.54 ' P1A' ' O8A' ' A' ' 999' ' ' COA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 121.021 0.439 . . . . 0.90000000000000002 110.702 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -121.84 129.75 52.85 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.73 -0.668 . . . . 0.90000000000000002 109.513 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.512 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 54.4 tp -75.71 108.33 8.48 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.698 -0.853 . . . . 0.90000000000000002 108.698 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.0 m -82.85 92.86 7.36 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.205 0.526 . . . . 0.90000000000000002 110.579 -173.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' A' ' 40' ' ' TYR . 7.9 tp -89.92 113.49 26.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.441 -0.799 . . . . 0.90000000000000002 109.694 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.5 mt -121.1 157.48 24.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.981 -0.554 . . . . 0.90000000000000002 110.096 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 47.7 ttt-85 -90.25 125.23 35.42 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.108 -0.701 . . . . 0.90000000000000002 109.108 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.08 128.12 35.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.218 0.533 . . . . 0.90000000000000002 111.717 -177.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -102.5 -51.49 3.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.381 -0.827 . . . . 0.90000000000000002 110.718 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -124.39 164.18 20.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.715 -0.675 . . . . 0.90000000000000002 110.241 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -136.46 114.02 10.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.162 -0.472 . . . . 0.90000000000000002 110.637 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.7 p -93.16 175.18 6.87 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.568 -0.901 . . . . 0.90000000000000002 108.568 170.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.88 -38.16 81.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.782 0.325 . . . . 0.90000000000000002 110.667 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -64.68 -44.97 88.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.07 -0.514 . . . . 0.90000000000000002 110.517 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -61.79 -49.77 75.03 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.179 0.514 . . . . 0.90000000000000002 110.14 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -58.88 -47.1 86.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.279 -0.873 . . . . 0.90000000000000002 111.069 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.8 mt -67.37 -36.38 76.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.483 -0.326 . . . . 0.90000000000000002 111.54 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -68.79 -41.33 78.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.558 -0.457 . . . . 0.90000000000000002 110.04 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.76 -43.47 93.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.90000000000000002 110.727 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -77.33 -1.4 29.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.427 0.632 . . . . 0.90000000000000002 110.284 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -93.34 -33.5 13.87 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.265 -0.642 . . . . 0.90000000000000002 109.265 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.5 mt -68.94 -44.65 81.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.852 -0.613 . . . . 0.90000000000000002 109.435 174.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.4 ' C ' ' H ' ' A' ' 25' ' ' GLU . 6.5 m0 -100.48 97.03 5.88 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.611 -0.885 . . . . 0.90000000000000002 108.611 170.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.48 20.51 0.25 Allowed 'Trans proline' 0 N--CA 1.476 0.454 0 C-N-CA 123.176 2.584 . . . . 0.90000000000000002 114.189 -169.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 23' ' ' TRP . 12.5 tp10 -157.5 -81.09 0.06 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.33 -0.619 . . . . 0.90000000000000002 109.33 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.5 t80 60.8 -173.59 0.13 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 123.773 0.67 . . . . 0.90000000000000002 110.812 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.3 m -116.09 140.68 26.65 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-O 120.564 0.221 . . . . 0.90000000000000002 110.599 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.36 137.52 56.13 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.6 2.2 . . . . 0.90000000000000002 112.014 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.8 t 71.43 -1.42 2.77 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.95 -0.568 . . . . 0.90000000000000002 112.036 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 m -83.73 4.97 26.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.93 0.395 . . . . 0.90000000000000002 111.193 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.8 mt -85.11 21.81 1.57 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.093 0.473 . . . . 0.90000000000000002 110.376 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -73.34 141.1 47.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.729 -0.668 . . . . 0.90000000000000002 110.062 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.1 149.56 24.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.95 0.405 . . . . 0.90000000000000002 110.76 -177.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -147.95 -162.38 1.54 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.753 -0.832 . . . . 0.90000000000000002 108.753 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -84.57 -24.2 29.33 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.164 -0.614 . . . . 0.90000000000000002 110.955 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -86.01 -49.99 7.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.396 0.617 . . . . 0.90000000000000002 109.416 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -94.01 101.48 13.52 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.666 -0.865 . . . . 0.90000000000000002 108.666 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -109.1 137.75 46.52 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.02 0.438 . . . . 0.90000000000000002 111.41 -173.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.521 HG12 ' HG2' ' A' ' 53' ' ' ARG . 57.8 mt -108.18 112.37 39.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.646 -0.872 . . . . 0.90000000000000002 108.646 170.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.505 ' HB3' HD12 ' A' ' 5' ' ' ILE . 11.7 m-85 -94.27 137.02 33.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.235 -0.439 . . . . 0.90000000000000002 109.982 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.498 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -118.66 116.31 26.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.894 -0.594 . . . . 0.90000000000000002 110.47 -176.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.623 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . . . -92.31 91.51 7.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.924 -0.58 . . . . 0.90000000000000002 109.68 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.502 ' HB3' HD23 ' A' ' 48' ' ' LEU . 13.5 ptm180 -92.21 133.02 36.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.033 -0.53 . . . . 0.90000000000000002 110.573 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -108.94 99.43 8.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.817 -0.628 . . . . 0.90000000000000002 109.716 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 67.22 -69.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.044 -0.98 . . . . 0.90000000000000002 112.309 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -101.17 -59.82 1.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.244 0.461 . . . . 0.90000000000000002 112.244 -170.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -132.81 -177.51 4.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.942 0.401 . . . . 0.90000000000000002 111.944 -171.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 43' ' ' ARG . 21.8 mt -78.32 113.32 16.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.602 -0.726 . . . . 0.90000000000000002 111.219 -171.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.436 HD12 ' HD2' ' A' ' 69' ' ' ARG . 46.5 tp -89.72 -30.43 18.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.943 0.401 . . . . 0.90000000000000002 110.736 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . . . -142.49 146.48 34.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.232 -0.44 . . . . 0.90000000000000002 110.777 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -133.62 133.81 42.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.268 -0.423 . . . . 0.90000000000000002 110.483 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.466 ' HB ' HD13 ' A' ' 66' ' ' LEU . 10.2 p -148.34 140.58 18.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.304 -0.407 . . . . 0.90000000000000002 110.962 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.661 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 23.8 mtp85 -100.07 150.91 21.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.471 -0.332 . . . . 0.90000000000000002 110.235 175.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.9 p -151.22 138.93 13.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.011 0.434 . . . . 0.90000000000000002 110.779 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.1 m -111.99 115.82 29.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.085 -0.507 . . . . 0.90000000000000002 109.769 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.3 mt -99.45 86.87 3.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.3 0.571 . . . . 0.90000000000000002 110.744 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -95.08 77.98 3.53 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.579 -0.737 . . . . 0.90000000000000002 110.207 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.81 -85.98 0.28 Allowed Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.774 -0.648 . . . . 0.90000000000000002 112.879 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.6 p -114.9 -2.22 12.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.962 0.411 . . . . 0.90000000000000002 111.135 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -104.31 125.69 50.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.90000000000000002 110.487 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.37 96.24 0.72 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.314 -0.714 . . . . 0.90000000000000002 111.314 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -98.48 113.57 25.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.796 0.331 . . . . 0.90000000000000002 111.153 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.545 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 5.9 mp -93.87 116.55 29.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.238 -0.437 . . . . 0.90000000000000002 110.224 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.661 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 22.2 m-20 -109.38 131.59 54.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.755 -0.657 . . . . 0.90000000000000002 109.692 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.8 m 61.11 98.89 0.03 OUTLIER 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.573 0.701 . . . . 0.90000000000000002 112.06 175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.466 HD13 ' HB ' ' A' ' 52' ' ' VAL . 22.2 tp -123.89 118.28 26.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.611 -0.722 . . . . 0.90000000000000002 110.099 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.42 ' HA ' ' O9P' ' A' ' 999' ' ' COA . 26.7 ttt180 -143.98 139.26 28.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.196 0.522 . . . . 0.90000000000000002 111.223 174.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.1 m -101.71 169.26 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.386 -0.824 . . . . 0.90000000000000002 109.868 173.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.436 ' HD2' HD12 ' A' ' 49' ' ' LEU . 95.2 mtt180 -65.75 157.18 30.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.852 -0.425 . . . . 0.90000000000000002 109.852 172.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 6.6 tp10 -56.5 -39.08 72.66 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.051 0.389 . . . . 0.90000000000000002 112.051 -172.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.79 36.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.148 0.499 . . . . 0.90000000000000002 110.65 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 m -127.21 4.91 6.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.3 0.571 . . . . 0.90000000000000002 110.944 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 8.4 mtm180 -81.1 130.14 34.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.353 -0.385 . . . . 0.90000000000000002 110.74 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.9 mtp-105 62.55 36.56 13.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.756 -0.656 . . . . 0.90000000000000002 111.261 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -125.43 17.91 8.22 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.761 -0.376 . . . . 0.90000000000000002 112.012 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.08 -37.98 2.18 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.08 -0.581 . . . . 0.90000000000000002 114.438 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.5 t -48.33 -44.83 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 112.664 0.616 . . . . 0.90000000000000002 112.664 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.78 97.57 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.854 -0.689 . . . . 0.90000000000000002 112.878 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.431 ' HG3' HD22 ' A' ' 115' ' ' LEU . 53.2 tt0 -65.35 -39.21 92.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.033 0.444 . . . . 0.90000000000000002 110.027 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.512 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 30.0 t80 -59.05 -49.35 78.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.513 -0.767 . . . . 0.90000000000000002 110.238 175.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.433 HD13 HD13 ' A' ' 5' ' ' ILE . 51.6 tp -50.82 -54.12 26.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.851 -0.613 . . . . 0.90000000000000002 112.064 -176.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.412 ' O ' HD13 ' A' ' 86' ' ' LEU . 3.9 mm? -63.73 -50.42 69.19 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.104 -0.238 . . . . 0.90000000000000002 111.396 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -66.21 -25.86 67.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.568 -0.287 . . . . 0.90000000000000002 111.584 -176.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -65.97 -46.8 76.76 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.157 -0.312 . . . . 0.90000000000000002 110.157 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 81' ' ' LEU . 57.9 t -62.67 -44.41 99.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.90000000000000002 110.952 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.451 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 11.2 mp -65.99 -27.9 68.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.90000000000000002 111.244 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.8 ttp85 -87.6 -19.31 27.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.114 -0.494 . . . . 0.90000000000000002 110.583 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.467 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 9.7 t30 -81.62 -46.24 14.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.108 -0.496 . . . . 0.90000000000000002 110.663 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -102.82 97.83 10.11 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 0.90000000000000002 109.981 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 83.0 Cg_endo -89.41 148.48 5.28 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.809 2.339 . . . . 0.90000000000000002 113.498 -173.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.83 7.26 78.43 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.689 -0.687 . . . . 0.90000000000000002 113.481 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.72 116.73 20.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.717 -0.475 . . . . 0.90000000000000002 109.717 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.1 m -77.49 -32.41 54.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.92 -0.582 . . . . 0.90000000000000002 112.18 -172.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.0 t -127.49 103.88 7.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.768 0.318 . . . . 0.90000000000000002 111.458 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.451 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 98.0 m95 -94.41 98.32 10.8 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.491 -0.559 . . . . 0.90000000000000002 109.491 171.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.491 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 63.6 t-105 -101.96 120.48 40.47 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.81 -0.632 . . . . 0.90000000000000002 110.081 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.545 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 73.6 mtp -111.75 126.74 55.38 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.927 0.394 . . . . 0.90000000000000002 110.571 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.63 99.17 5.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.905 -0.589 . . . . 0.90000000000000002 111.133 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.447 ' HB3' ' H31' ' A' ' 999' ' ' COA . 7.7 m-20 -76.37 -31.86 58.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.823 -0.626 . . . . 0.90000000000000002 110.602 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 67.93 -71.54 0.11 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.352 -0.84 . . . . 0.90000000000000002 112.004 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -101.53 40.68 2.34 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.976 -0.63 . . . . 0.90000000000000002 112.978 -174.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.487 HG11 ' HG2' ' A' ' 105' ' ' ARG . 13.2 p -81.7 125.43 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 110.011 -0.366 . . . . 0.90000000000000002 110.011 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -90.38 -30.7 17.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.189 0.519 . . . . 0.90000000000000002 109.724 177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.15 45.63 0.75 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.208 -0.905 . . . . 0.90000000000000002 110.387 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.487 ' HG2' HG11 ' A' ' 102' ' ' VAL . 22.0 mtm180 -55.21 -47.08 75.82 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.948 0.351 . . . . 0.90000000000000002 111.948 -172.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.76 -48.28 85.06 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.786 -0.721 . . . . 0.90000000000000002 112.406 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.16 -41.77 92.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.994 0.426 . . . . 0.90000000000000002 110.653 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.497 ' O ' ' HG2' ' A' ' 112' ' ' MET . 10.3 tpt -64.75 -39.03 92.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.58 . . . . 0.90000000000000002 110.378 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 85.5 m -65.02 -38.84 92.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.702 0.287 . . . . 0.90000000000000002 110.698 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.558 ' HB1' ' N7A' ' A' ' 999' ' ' COA . . . -62.6 -41.48 99.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.204 0.525 . . . . 0.90000000000000002 110.137 176.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -63.15 -42.4 99.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.529 -0.759 . . . . 0.90000000000000002 110.337 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.512 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 24.7 mmt -61.71 -39.33 91.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.514 . . . . 0.90000000000000002 111.024 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -70.74 -21.15 62.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.482 -0.326 . . . . 0.90000000000000002 111.252 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.98 -26.72 39.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.115 0.483 . . . . 0.90000000000000002 110.375 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.431 HD22 ' HG3' ' A' ' 79' ' ' GLN . 92.1 mt -84.51 -37.76 20.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.767 -0.651 . . . . 0.90000000000000002 110.572 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.08 25.98 3.39 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.949 -0.569 . . . . 0.90000000000000002 112.311 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 39.7 m-85 -95.9 142.49 28.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.798 0.332 . . . . 0.90000000000000002 110.99 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.6 m -104.74 148.45 26.59 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.233 -0.654 . . . . 0.90000000000000002 109.233 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.9 m -97.19 112.23 24.12 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.035 -0.357 . . . . 0.90000000000000002 110.035 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -135.46 133.89 39.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.082 -0.508 . . . . 0.90000000000000002 110.484 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 58.13 30.02 18.75 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.528 0.566 . . . . 0.90000000000000002 112.528 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.82 -4.03 78.33 Favored Glycine 0 CA--C 1.517 0.172 0 C-N-CA 120.752 -0.737 . . . . 0.90000000000000002 113.237 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -129.17 -179.46 15.97 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.726 -0.749 . . . . 0.90000000000000002 111.259 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.432 ' CD1' ' HG3' ' A' ' 112' ' ' MET . 26.6 m-90 -112.22 137.49 50.24 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.694 -0.484 . . . . 0.90000000000000002 109.694 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 24.7 tt0 -132.52 137.24 47.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.024 0.44 . . . . 0.90000000000000002 110.982 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -119.4 102.54 8.75 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.331 -0.989 . . . . 0.90000000000000002 108.331 169.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.5 t -78.11 141.61 38.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.02 -0.536 . . . . 0.90000000000000002 110.754 -174.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 CA-C-N 115.829 -0.623 . . . . 0.90000000000000002 111.723 178.498 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 999' ' ' COA . . . . . 0.558 ' N7A' ' HB1' ' A' ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.3 mtp . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.953 -0.388 . . . . 0.90000000000000002 109.953 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 tttm -90.49 152.03 21.11 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.065 -0.717 . . . . 0.90000000000000002 109.065 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.5 tp -75.73 115.81 15.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.013 0.435 . . . . 0.90000000000000002 110.311 -175.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.3 m -88.37 89.56 8.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.83 -0.623 . . . . 0.90000000000000002 110.312 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.479 HD12 ' HB3' ' A' ' 40' ' ' TYR . 9.4 tt -96.23 132.57 40.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.003 0.43 . . . . 0.90000000000000002 110.357 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.82 141.08 44.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.226 0.536 . . . . 0.90000000000000002 110.625 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -79.33 126.9 31.4 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.811 -0.631 . . . . 0.90000000000000002 109.745 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.9 mt -84.62 95.46 8.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.789 0.328 . . . . 0.90000000000000002 110.824 -176.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -110.49 -8.27 14.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.049 -0.523 . . . . 0.90000000000000002 110.0 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -135.1 141.37 46.01 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.93 -0.767 . . . . 0.90000000000000002 108.93 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -130.03 115.68 17.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.143 0.497 . . . . 0.90000000000000002 112.276 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.3 m -100.08 164.18 12.1 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.625 -0.88 . . . . 0.90000000000000002 108.625 168.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -59.9 -37.98 80.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.623 0.249 . . . . 0.90000000000000002 110.855 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -55.14 -49.99 70.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.842 -0.617 . . . . 0.90000000000000002 111.121 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -67.1 -37.91 84.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.726 -0.67 . . . . 0.90000000000000002 110.639 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -68.13 -40.61 82.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.90000000000000002 111.059 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.8 mt -61.68 -36.6 74.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.795 0.331 . . . . 0.90000000000000002 110.383 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -44.18 92.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 0.90000000000000002 110.153 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.83 -40.0 96.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.889 -0.596 . . . . 0.90000000000000002 110.93 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -72.52 -15.84 61.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.078 0.466 . . . . 0.90000000000000002 110.568 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -84.76 -27.84 26.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.956 -0.565 . . . . 0.90000000000000002 109.684 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.2 mt -82.66 -37.28 14.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.739 -0.664 . . . . 0.90000000000000002 109.9 175.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.605 ' HD1' ' HD2' ' A' ' 67' ' ' ARG . 2.8 m0 -111.26 87.15 7.12 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.90000000000000002 109.782 175.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.76 -9.57 25.08 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.499 2.133 . . . . 0.90000000000000002 112.398 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -102.88 2.78 35.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.804 -0.634 . . . . 0.90000000000000002 110.903 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -74.05 127.22 32.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.28 -0.418 . . . . 0.90000000000000002 110.379 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.9 m -67.81 124.21 88.86 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.901 -0.591 . . . . 0.90000000000000002 110.54 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.32 115.77 2.61 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.821 2.347 . . . . 0.90000000000000002 111.873 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.3 p -152.37 -166.3 2.44 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.518 -0.765 . . . . 0.90000000000000002 109.876 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.3 m -55.27 -43.23 74.49 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.393 0.433 . . . . 0.90000000000000002 112.122 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.1 mt 57.11 76.83 0.29 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.528 0.68 . . . . 0.90000000000000002 109.727 -169.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -133.8 -179.58 5.63 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.044 -0.98 . . . . 0.90000000000000002 110.078 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.7 m -130.98 162.29 39.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.263 0.554 . . . . 0.90000000000000002 111.084 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -125.64 163.52 22.6 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.003 -1.11 . . . . 0.90000000000000002 108.003 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -60.68 -28.21 68.44 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.897 0.379 . . . . 0.90000000000000002 110.533 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -93.29 -46.06 7.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.926 -0.579 . . . . 0.90000000000000002 110.253 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -93.52 94.13 8.48 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.209 -0.45 . . . . 0.90000000000000002 110.015 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.3 mtp85 -110.95 149.49 30.58 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.642 0.258 . . . . 0.90000000000000002 110.971 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.4 mt -120.09 134.46 63.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.366 -0.379 . . . . 0.90000000000000002 110.284 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.479 ' HB3' HD12 ' A' ' 5' ' ' ILE . 81.8 m-85 -113.84 139.52 49.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.729 -0.471 . . . . 0.90000000000000002 109.729 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.466 ' HB3' HD23 ' A' ' 48' ' ' LEU . . . -119.57 121.34 39.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.939 0.4 . . . . 0.90000000000000002 110.793 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . . . -92.18 100.51 13.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.133 -0.485 . . . . 0.90000000000000002 109.798 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -93.33 119.75 32.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.723 -0.672 . . . . 0.90000000000000002 110.591 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -99.01 92.23 5.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.147 -0.479 . . . . 0.90000000000000002 110.014 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.8 t30 69.36 -68.17 0.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.225 -0.898 . . . . 0.90000000000000002 112.051 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -105.84 -53.29 2.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.783 0.325 . . . . 0.90000000000000002 111.758 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.436 ' HG2' ' H ' ' A' ' 48' ' ' LEU . 35.7 ttt180 -127.47 174.18 9.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.552 -0.295 . . . . 0.90000000000000002 110.727 -168.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.466 HD23 ' HB3' ' A' ' 41' ' ' ALA . 63.5 mt -73.17 123.74 24.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.876 0.37 . . . . 0.90000000000000002 110.355 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.69 HD12 ' HD3' ' A' ' 69' ' ' ARG . 39.9 tp -95.04 -34.11 12.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.024 -0.535 . . . . 0.90000000000000002 110.16 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.503 ' HB2' HG11 ' A' ' 68' ' ' VAL . . . -143.22 140.52 30.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.821 -0.627 . . . . 0.90000000000000002 110.665 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.82 130.49 51.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.216 -0.447 . . . . 0.90000000000000002 110.182 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 65' ' ' SER . 11.9 p -142.46 142.27 27.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.424 -0.353 . . . . 0.90000000000000002 110.706 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.1 mtm180 -112.4 159.03 19.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.891 0.376 . . . . 0.90000000000000002 110.735 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.59 128.99 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.356 0.598 . . . . 0.90000000000000002 110.857 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.5 m -104.83 97.98 7.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.872 -0.604 . . . . 0.90000000000000002 110.011 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.497 HD23 ' HA3' ' A' ' 61' ' ' GLY . 97.4 mt -80.34 126.14 30.78 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.048 -0.524 . . . . 0.90000000000000002 109.779 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.5 m -105.79 77.99 1.3 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.533 -0.543 . . . . 0.90000000000000002 109.533 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.87 -85.93 1.37 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.395 -0.907 . . . . 0.90000000000000002 111.271 -174.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.2 p -111.32 -63.33 1.42 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.197 0.523 . . . . 0.90000000000000002 110.452 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.521 ' HA ' HG12 ' A' ' 92' ' ' VAL . 30.1 mt-10 -76.04 147.51 38.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.47 -0.786 . . . . 0.90000000000000002 109.811 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.497 ' HA3' HD23 ' A' ' 56' ' ' LEU . . . -142.21 165.46 26.65 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.867 -1.159 . . . . 0.90000000000000002 113.504 -173.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -116.38 134.03 55.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.794 0.33 . . . . 0.90000000000000002 110.887 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 76.7 mt -93.83 132.93 37.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.032 -0.531 . . . . 0.90000000000000002 110.452 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -142.77 163.48 32.7 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.815 -0.439 . . . . 0.90000000000000002 109.815 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 36.0 m 54.59 86.61 0.05 OUTLIER 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.64 0.588 . . . . 0.90000000000000002 111.732 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.516 HD21 ' HE2' ' A' ' 108' ' ' MET . 55.9 tp -122.51 107.02 11.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.825 -0.625 . . . . 0.90000000000000002 109.832 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.605 ' HD2' ' HD1' ' A' ' 23' ' ' TRP . 34.8 mtt180 -130.18 105.82 8.19 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.151 -0.477 . . . . 0.90000000000000002 111.215 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.569 ' HB ' ' H10' ' A' ' 999' ' ' COA . 8.9 t -95.91 146.95 6.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.293 -1.003 . . . . 0.90000000000000002 108.293 171.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.69 ' HD3' HD12 ' A' ' 49' ' ' LEU . 31.1 mtp85 -52.51 126.32 19.12 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.522 -0.547 . . . . 0.90000000000000002 109.522 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -58.03 -23.1 52.91 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.786 0.661 . . . . 0.90000000000000002 112.786 -169.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.4 t -66.29 -21.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.052 0.453 . . . . 0.90000000000000002 110.765 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.717 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 1.3 m -86.47 32.22 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.406 0.622 . . . . 0.90000000000000002 110.907 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -81.44 127.95 33.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.023 -0.535 . . . . 0.90000000000000002 110.84 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.621 ' HA ' ' O8A' ' A' ' 999' ' ' COA . 32.3 ttm180 61.35 35.79 17.8 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.804 -0.635 . . . . 0.90000000000000002 110.898 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.717 ' HD2' ' HA ' ' A' ' 72' ' ' THR . 95.3 mtt180 -112.91 2.69 15.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.90000000000000002 111.807 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.52 -12.18 52.8 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 121.003 -0.618 . . . . 0.90000000000000002 114.105 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.435 HG11 HD23 ' A' ' 49' ' ' LEU . 92.8 t -61.24 -43.88 97.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.275 0.538 . . . . 0.90000000000000002 111.773 -177.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.57 -33.93 79.21 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.63 -0.795 . . . . 0.90000000000000002 112.441 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -63.01 -47.44 83.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.953 0.406 . . . . 0.90000000000000002 110.278 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -61.76 -43.31 99.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.762 -0.653 . . . . 0.90000000000000002 110.594 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 44.2 tp -53.44 -55.86 21.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.866 -0.606 . . . . 0.90000000000000002 111.443 -177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.475 ' HB2' HD11 ' A' ' 115' ' ' LEU . 4.3 mm? -65.68 -40.39 92.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.424 -0.353 . . . . 0.90000000000000002 111.053 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 7.3 mm-40 -53.46 -50.74 64.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.79 0.329 . . . . 0.90000000000000002 111.145 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -60.49 -45.36 94.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.236 -0.438 . . . . 0.90000000000000002 110.8 -177.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.3 t -63.56 -49.46 82.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.42 -0.355 . . . . 0.90000000000000002 111.174 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.59 -20.3 66.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.90000000000000002 111.997 -176.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 42.8 mtm180 -92.91 -30.19 15.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.657 0.265 . . . . 0.90000000000000002 111.257 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.453 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 17.3 m-80 -82.09 -20.14 38.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.606 0.241 . . . . 0.90000000000000002 111.415 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -113.69 86.83 11.16 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.87 0.367 . . . . 0.90000000000000002 110.443 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 5.0 Cg_exo -81.05 -13.45 11.41 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.227 2.618 . . . . 0.90000000000000002 112.528 -176.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.05 -8.38 87.89 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.989 -0.624 . . . . 0.90000000000000002 112.497 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 60' ' ' GLU . 21.7 t -94.47 101.98 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.98 -0.378 . . . . 0.90000000000000002 109.98 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 p -77.92 -36.16 49.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.208 -0.451 . . . . 0.90000000000000002 111.445 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 51.6 t -116.36 116.04 26.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.311 -0.404 . . . . 0.90000000000000002 110.389 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -97.86 102.13 13.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.733 -0.667 . . . . 0.90000000000000002 109.899 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.504 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 35.8 t-105 -97.08 133.29 41.94 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.036 -0.728 . . . . 0.90000000000000002 109.036 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.544 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 47.1 mtp -114.36 130.03 56.67 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.992 0.425 . . . . 0.90000000000000002 109.982 176.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.5 160.75 14.65 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.473 -0.785 . . . . 0.90000000000000002 110.646 -176.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -87.22 -2.48 58.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.072 -0.513 . . . . 0.90000000000000002 109.985 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.47 114.23 5.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.90000000000000002 110.292 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.57 -14.25 59.28 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.586 -0.816 . . . . 0.90000000000000002 111.72 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.523 HG13 ' HG3' ' A' ' 108' ' ' MET . 55.1 t -89.76 97.63 7.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.352 0.596 . . . . 0.90000000000000002 110.125 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.413 ' H ' ' H22' ' A' ' 999' ' ' COA . 30.4 mt-10 -76.78 -50.46 13.47 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.306 -0.861 . . . . 0.90000000000000002 109.77 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -91.09 92.92 8.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.708 -0.678 . . . . 0.90000000000000002 109.658 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -73.56 -23.76 60.01 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.322 -0.399 . . . . 0.90000000000000002 110.899 -176.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.25 -56.16 8.15 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.894 -0.669 . . . . 0.90000000000000002 112.567 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.446 HG13 ' C6A' ' A' ' 999' ' ' COA . 72.3 t -66.15 -41.1 88.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.654 0.264 . . . . 0.90000000000000002 110.68 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.523 ' HG3' HG13 ' A' ' 102' ' ' VAL . 94.8 mmm -63.72 -37.72 88.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 0.90000000000000002 111.326 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 m -62.58 -45.88 90.88 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.995 -0.282 . . . . 0.90000000000000002 110.425 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.58 -40.58 95.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.969 0.414 . . . . 0.90000000000000002 110.617 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.598 ' HD1' H52A ' A' ' 999' ' ' COA . 40.7 t80 -58.72 -49.18 78.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.64 -0.709 . . . . 0.90000000000000002 110.825 176.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.537 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 64.9 mtt -69.76 -40.22 76.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.923 -0.58 . . . . 0.90000000000000002 111.511 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -61.4 -44.01 97.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.77 0.319 . . . . 0.90000000000000002 110.686 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.27 72.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.188 0.518 . . . . 0.90000000000000002 110.437 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.475 HD11 ' HB2' ' A' ' 82' ' ' LEU . 2.7 tt -68.19 -33.41 74.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.604 -0.725 . . . . 0.90000000000000002 109.92 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 132.75 1.59 4.13 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.619 -0.8 . . . . 0.90000000000000002 113.065 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.537 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 98.3 m-85 -83.19 174.1 11.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.039 0.447 . . . . 0.90000000000000002 110.863 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.1 m -149.73 151.35 33.5 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.192 -0.67 . . . . 0.90000000000000002 109.192 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.7 t -97.3 110.21 22.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.698 0.761 . . . . 0.90000000000000002 109.794 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -141.25 129.11 21.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.243 -0.89 . . . . 0.90000000000000002 110.286 -174.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.458 HE21 ' HB2' ' A' ' 121' ' ' GLN . 0.9 OUTLIER 63.42 32.68 14.31 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.208 0.528 . . . . 0.90000000000000002 111.361 176.271 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 111.14 -74.41 0.21 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.788 -0.72 . . . . 0.90000000000000002 112.562 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -91.09 -156.52 32.79 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.714 -0.755 . . . . 0.90000000000000002 112.295 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.544 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 26.6 m-90 -104.37 119.85 39.89 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.058 -0.349 . . . . 0.90000000000000002 110.058 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -119.36 117.83 29.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.27 -0.423 . . . . 0.90000000000000002 109.903 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -126.34 136.56 52.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.921 0.391 . . . . 0.90000000000000002 111.181 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 52.6 t -80.55 135.16 36.04 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.045 -0.525 . . . . 0.90000000000000002 109.775 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 C-N-CA 120.877 -0.677 . . . . 0.90000000000000002 112.137 179.464 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 999' ' ' COA . . . . . 0.621 ' O8A' ' HA ' ' A' ' 74' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.4 mtm . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.549 0.214 . . . . 0.90000000000000002 110.802 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -103.68 153.33 20.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.887 0.375 . . . . 0.90000000000000002 110.18 174.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.445 HD23 ' HB1' ' A' ' 42' ' ' ALA . 43.8 tp -111.4 112.18 23.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.186 -0.461 . . . . 0.90000000000000002 110.111 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.1 m -82.76 94.04 7.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.084 0.469 . . . . 0.90000000000000002 110.532 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' A' ' 42' ' ' ALA . 12.7 tt -108.7 128.84 64.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.045 0.45 . . . . 0.90000000000000002 110.788 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.4 mt -124.19 155.31 31.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.927 -0.579 . . . . 0.90000000000000002 110.455 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.45 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 12.8 ptt180 -80.22 119.56 23.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.062 -0.517 . . . . 0.90000000000000002 109.801 174.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 41' ' ' ALA . 83.7 mt -76.78 88.11 3.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.209 0.528 . . . . 0.90000000000000002 110.679 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -102.18 8.59 40.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.823 0.82 . . . . 0.90000000000000002 109.258 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -157.54 142.97 17.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.947 -1.024 . . . . 0.90000000000000002 108.496 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -126.43 121.22 31.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.86 0.362 . . . . 0.90000000000000002 111.067 -177.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.2 170.46 8.24 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.107 -0.701 . . . . 0.90000000000000002 109.107 175.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 17' ' ' ILE . 4.0 m-20 -60.33 -46.47 89.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.726 0.298 . . . . 0.90000000000000002 110.732 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -59.11 -41.2 87.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.90000000000000002 111.022 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -62.35 -45.42 93.28 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.059 -0.519 . . . . 0.90000000000000002 110.564 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -59.27 -45.11 92.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.497 -0.32 . . . . 0.90000000000000002 110.886 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 13' ' ' ASP . 60.6 mt -67.01 -32.1 56.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.009 0.433 . . . . 0.90000000000000002 111.173 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -77.09 -38.69 51.85 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.54 -0.464 . . . . 0.90000000000000002 110.078 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.49 HD21 HD11 ' A' ' 22' ' ' ILE . 97.3 mt -61.65 -34.16 75.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.90000000000000002 110.294 174.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -64.35 -36.11 83.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.602 . . . . 0.90000000000000002 110.297 176.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -70.8 -21.99 62.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.08 -0.509 . . . . 0.90000000000000002 111.082 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.599 HD12 ' HB2' ' A' ' 48' ' ' LEU . 63.5 mt -79.09 -48.44 21.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.767 0.318 . . . . 0.90000000000000002 110.619 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.408 ' CD1' ' HD2' ' A' ' 67' ' ' ARG . 4.4 m0 -106.83 97.86 19.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.90000000000000002 111.027 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 12.9 Cg_exo -70.64 -21.54 29.26 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.674 2.249 . . . . 0.90000000000000002 111.832 178.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -84.7 -22.34 29.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.673 -0.694 . . . . 0.90000000000000002 110.942 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.403 ' OH ' ' HB3' ' A' ' 29' ' ' SER . 87.4 t80 -95.68 126.16 40.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.179 -0.464 . . . . 0.90000000000000002 111.193 -172.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -82.15 129.14 65.16 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.547 -0.909 . . . . 0.90000000000000002 108.547 172.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.8 96.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.148 2.565 . . . . 0.90000000000000002 112.624 -176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.403 ' HB3' ' OH ' ' A' ' 26' ' ' TYR . 11.4 t -107.1 -157.9 0.63 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.845 -0.616 . . . . 0.90000000000000002 110.144 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.1 m -57.11 -42.18 80.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.086 -0.507 . . . . 0.90000000000000002 112.124 -176.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.3 mt 56.46 44.02 25.01 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 109.397 -0.594 . . . . 0.90000000000000002 109.397 -173.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -62.68 115.94 4.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.287 -0.87 . . . . 0.90000000000000002 112.081 -172.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.512 HG13 ' HA ' ' A' ' 38' ' ' ARG . 73.3 t -112.31 118.32 57.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.457 -0.792 . . . . 0.90000000000000002 109.16 170.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 14.2 p-10 -100.0 -52.2 3.48 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.806 -0.442 . . . . 0.90000000000000002 109.806 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 16.9 t70 166.9 -40.4 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.608 -1.256 . . . . 0.90000000000000002 107.608 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -71.69 -56.14 6.37 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 114.755 -1.112 . . . . 0.90000000000000002 109.67 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -91.14 101.92 14.66 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.482 -0.933 . . . . 0.90000000000000002 108.482 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.512 ' HA ' HG13 ' A' ' 33' ' ' VAL . 12.0 ptp180 -123.56 142.34 51.12 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.099 0.476 . . . . 0.90000000000000002 111.112 -175.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.559 HG12 ' HG2' ' A' ' 53' ' ' ARG . 52.3 mt -107.19 134.42 48.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.757 -0.656 . . . . 0.90000000000000002 110.204 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.47 ' HB3' HD11 ' A' ' 5' ' ' ILE . 76.6 m-85 -111.05 121.6 45.77 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.45 -0.574 . . . . 0.90000000000000002 109.45 174.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.482 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -108.86 119.98 41.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.332 -0.395 . . . . 0.90000000000000002 110.832 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.686 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . . . -96.44 105.8 17.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.803 -0.635 . . . . 0.90000000000000002 110.827 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.512 ' HB3' HD21 ' A' ' 48' ' ' LEU . 4.9 ptm180 -107.54 134.31 50.74 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.063 -0.517 . . . . 0.90000000000000002 110.464 178.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -97.2 82.39 3.16 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.924 -0.399 . . . . 0.90000000000000002 109.924 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.2 t30 50.35 23.94 1.38 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.092 -0.958 . . . . 0.90000000000000002 112.522 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.65 ' HG2' ' HG3' ' A' ' 47' ' ' ARG . 38.3 tt0 -166.86 -89.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.999 -0.438 . . . . 0.90000000000000002 110.732 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.65 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 85.7 mtt180 -108.24 163.86 12.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.668 0.271 . . . . 0.90000000000000002 110.759 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.599 ' HB2' HD12 ' A' ' 22' ' ' ILE . 19.6 mt -77.25 104.0 7.5 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.324 -0.621 . . . . 0.90000000000000002 109.324 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 67.1 mt -86.21 -30.61 22.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.773 0.321 . . . . 0.90000000000000002 110.867 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.686 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . . . -129.31 137.03 50.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.325 -0.398 . . . . 0.90000000000000002 110.626 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -131.78 125.15 31.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.461 -0.336 . . . . 0.90000000000000002 110.832 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.8 p -134.25 134.25 55.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.018 -0.537 . . . . 0.90000000000000002 110.613 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.559 ' HG2' HG12 ' A' ' 39' ' ' ILE . 63.6 mtm180 -108.88 141.9 40.26 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.787 -0.365 . . . . 0.90000000000000002 110.311 176.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.446 HG12 ' HG3' ' A' ' 38' ' ' ARG . 6.0 p -133.83 132.7 56.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.295 0.569 . . . . 0.90000000000000002 110.993 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.7 m -106.57 111.56 24.17 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.495 -0.775 . . . . 0.90000000000000002 109.63 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.4 mt -83.48 85.58 7.22 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.171 -0.468 . . . . 0.90000000000000002 110.238 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.6 t -82.98 83.7 7.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.90000000000000002 109.372 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.29 -116.38 7.52 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.564 -0.744 . . . . 0.90000000000000002 112.187 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.1 p -91.91 2.07 56.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.916 0.389 . . . . 0.90000000000000002 111.288 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.588 ' HG2' ' HB3' ' A' ' 94' ' ' CYS . 35.0 mt-10 -110.88 136.36 50.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.053 -0.522 . . . . 0.90000000000000002 110.64 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -115.01 104.17 1.32 Allowed Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.527 -0.629 . . . . 0.90000000000000002 111.527 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.0 124.02 36.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.723 0.297 . . . . 0.90000000000000002 110.746 -178.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.523 HD11 ' HG2' ' A' ' 97' ' ' MET . 94.6 mt -93.52 114.94 27.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.153 0.502 . . . . 0.90000000000000002 109.698 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 10.0 t70 -117.18 127.36 54.03 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.13 -0.941 . . . . 0.90000000000000002 109.309 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.617 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 25.0 m 66.71 92.26 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.423 0.63 . . . . 0.90000000000000002 111.146 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.0 tp -114.76 102.26 9.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.443 -0.799 . . . . 0.90000000000000002 109.292 174.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.517 ' HG2' ' H32' ' A' ' 999' ' ' COA . 87.7 mtt180 -136.39 115.05 11.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.043 -0.526 . . . . 0.90000000000000002 111.421 -175.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.404 HG12 ' HB1' ' A' ' 50' ' ' ALA . 11.8 t -98.53 150.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.964 -1.124 . . . . 0.90000000000000002 107.964 170.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -55.78 137.36 50.04 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.626 -0.509 . . . . 0.90000000000000002 109.626 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -62.04 -17.94 58.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.289 0.566 . . . . 0.90000000000000002 110.908 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.4 t -71.52 -24.73 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.793 -0.64 . . . . 0.90000000000000002 110.761 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.9 m -86.04 18.87 2.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.06 0.457 . . . . 0.90000000000000002 111.923 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.562 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 99.9 mtt180 -66.24 118.23 9.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.302 -0.629 . . . . 0.90000000000000002 109.302 172.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -163.58 -97.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.359 -0.537 . . . . 0.90000000000000002 112.19 -175.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.442 ' HA ' ' O5B' ' A' ' 999' ' ' COA . 34.0 ttm180 169.6 95.77 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.943 -0.762 . . . . 0.90000000000000002 108.943 -172.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 133.96 -59.03 0.68 Allowed Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.504 -0.855 . . . . 0.90000000000000002 112.879 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.7 t -49.9 -54.32 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.23 0.456 . . . . 0.90000000000000002 112.23 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 81' ' ' LEU . . . -61.22 -43.99 98.69 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.941 -0.647 . . . . 0.90000000000000002 113.026 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -66.27 -46.15 78.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.784 0.325 . . . . 0.90000000000000002 110.134 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -60.14 -39.18 85.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.038 -0.528 . . . . 0.90000000000000002 110.46 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.457 ' O ' HG23 ' A' ' 85' ' ' VAL . 48.2 tp -50.53 -55.51 15.79 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.536 0.523 . . . . 0.90000000000000002 110.819 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.76 -43.69 88.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 0.90000000000000002 111.29 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.57 -39.42 93.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.712 -0.222 . . . . 0.90000000000000002 111.343 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -66.64 -44.56 81.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.608 -0.269 . . . . 0.90000000000000002 111.024 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 81' ' ' LEU . 97.0 t -58.78 -44.18 89.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.79 0.329 . . . . 0.90000000000000002 110.915 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.03 -18.91 57.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.298 -0.41 . . . . 0.90000000000000002 111.679 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.8 -42.3 11.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.973 0.416 . . . . 0.90000000000000002 110.151 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -72.75 -31.66 65.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.874 -0.603 . . . . 0.90000000000000002 110.117 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -122.99 76.56 50.16 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.97 -0.559 . . . . 0.90000000000000002 109.618 174.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -94.66 16.11 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.133 2.555 . . . . 0.90000000000000002 112.613 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.85 2.21 87.1 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.895 -0.669 . . . . 0.90000000000000002 112.731 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.5 128.61 52.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.731 0.301 . . . . 0.90000000000000002 110.278 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.7 m -91.61 -34.72 14.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.024 -0.535 . . . . 0.90000000000000002 111.335 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.588 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 48.9 t -117.72 102.92 9.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.894 0.378 . . . . 0.90000000000000002 110.65 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 94.8 m95 -92.2 142.52 27.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.8 0.333 . . . . 0.90000000000000002 110.594 178.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -134.9 142.45 46.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.003 -0.544 . . . . 0.90000000000000002 109.743 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.561 ' CE ' ' HE2' ' A' ' 112' ' ' MET . 80.2 mtp -130.03 125.84 36.25 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.633 -0.506 . . . . 0.90000000000000002 109.633 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -102.75 172.35 6.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.167 -0.469 . . . . 0.90000000000000002 111.596 -174.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.11 -8.64 59.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.707 -0.679 . . . . 0.90000000000000002 110.231 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.71 121.22 13.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.782 -0.645 . . . . 0.90000000000000002 111.231 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.617 ' HA3' ' HA ' ' A' ' 65' ' ' SER . . . 82.23 14.2 77.24 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.749 -0.738 . . . . 0.90000000000000002 112.187 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.16 93.25 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.915 0.388 . . . . 0.90000000000000002 110.387 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.75 -17.62 37.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.347 -0.388 . . . . 0.90000000000000002 110.515 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -112.47 72.92 0.79 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.727 0.775 . . . . 0.90000000000000002 110.02 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.502 ' HG3' ' HH2' ' A' ' 124' ' ' TRP . 41.5 ttp180 -76.22 -32.09 58.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.22 -0.9 . . . . 0.90000000000000002 111.321 -170.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.77 -53.41 45.49 Favored Glycine 0 C--O 1.238 0.352 0 C-N-CA 120.72 -0.752 . . . . 0.90000000000000002 112.115 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.82 -42.16 81.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.972 0.415 . . . . 0.90000000000000002 110.3 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.547 ' O ' ' HG2' ' A' ' 112' ' ' MET . 47.3 ttm -69.47 -25.12 63.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.384 -0.371 . . . . 0.90000000000000002 111.424 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 94.3 m -62.9 -48.57 78.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.709 0.29 . . . . 0.90000000000000002 110.243 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.86 -34.43 77.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.443 0.639 . . . . 0.90000000000000002 110.249 176.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.448 ' CE2' HD12 ' A' ' 115' ' ' LEU . 55.8 t80 -63.25 -42.4 99.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.185 -0.916 . . . . 0.90000000000000002 110.819 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.561 ' HE2' ' CE ' ' A' ' 97' ' ' MET . 25.1 mmt -62.81 -39.97 95.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.393 -0.367 . . . . 0.90000000000000002 111.37 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -69.33 -27.15 65.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.90000000000000002 110.624 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.46 -40.46 57.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.351 -0.386 . . . . 0.90000000000000002 110.438 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.448 HD12 ' CE2' ' A' ' 111' ' ' PHE . 92.9 mt -66.26 -60.78 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.90000000000000002 111.108 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.34 48.45 0.13 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.738 -0.664 . . . . 0.90000000000000002 111.825 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.416 ' CD2' ' HB2' ' A' ' 126' ' ' LYS . 41.3 m-85 -109.96 141.46 42.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.774 0.321 . . . . 0.90000000000000002 110.416 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.9 p -92.49 144.08 25.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.187 -0.46 . . . . 0.90000000000000002 110.257 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.4 p -97.48 148.28 23.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.372 -0.376 . . . . 0.90000000000000002 111.146 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -124.55 -161.93 1.04 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.143 -0.481 . . . . 0.90000000000000002 109.934 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -79.32 29.64 0.23 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.907 0.384 . . . . 0.90000000000000002 111.77 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.08 67.38 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.97 -0.633 . . . . 0.90000000000000002 112.087 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.62 169.01 11.78 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.655 -0.784 . . . . 0.90000000000000002 112.428 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.502 ' HH2' ' HG3' ' A' ' 105' ' ' ARG . 11.7 m-90 -113.93 133.44 55.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.698 0.285 . . . . 0.90000000000000002 110.472 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -123.1 145.3 48.69 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.256 -0.429 . . . . 0.90000000000000002 110.081 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 64.6 tttp -137.28 96.85 3.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.924 0.392 . . . . 0.90000000000000002 110.251 174.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 17.4 t -87.9 133.35 33.94 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.546 -0.539 . . . . 0.90000000000000002 109.546 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 C-N-CA 120.833 -0.698 . . . . 0.90000000000000002 112.005 -179.733 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 999' ' ' COA . . . . . 0.664 ' S1P' ' C7P' ' A' ' 999' ' ' COA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 mtt . . . . . 0 N--CA 1.482 1.144 0 CA-C-O 121.043 0.449 . . . . 0.90000000000000002 110.751 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -93.99 136.96 33.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.346 -0.613 . . . . 0.90000000000000002 109.346 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.414 HD13 ' HB3' ' A' ' 42' ' ' ALA . 49.1 tp -76.04 107.1 8.02 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.637 -0.505 . . . . 0.90000000000000002 109.637 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.502 ' HB ' ' HG2' ' A' ' 43' ' ' ARG . 9.0 m -86.65 98.87 11.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.175 -0.466 . . . . 0.90000000000000002 110.444 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.404 HD11 ' HG2' ' A' ' 84' ' ' GLU . 4.6 mp -89.75 127.8 42.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.721 -0.474 . . . . 0.90000000000000002 109.721 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 mm -101.54 146.94 9.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.389 -0.597 . . . . 0.90000000000000002 109.389 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 13.9 ptt180 -99.21 106.16 18.28 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.942 -0.762 . . . . 0.90000000000000002 108.942 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.9 mt -73.09 86.06 1.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.451 0.643 . . . . 0.90000000000000002 110.882 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -95.69 -22.33 17.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.782 -1.099 . . . . 0.90000000000000002 108.784 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -136.75 143.5 43.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.029 -0.987 . . . . 0.90000000000000002 109.127 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -120.93 144.63 48.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.256 0.551 . . . . 0.90000000000000002 111.782 -173.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.3 p -109.56 163.71 13.2 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.602 -1.259 . . . . 0.90000000000000002 107.602 166.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' O ' HG13 ' A' ' 17' ' ' ILE . 29.5 t70 -68.19 -31.11 70.41 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.327 0.584 . . . . 0.90000000000000002 109.491 177.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -65.97 -50.77 63.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.064 -0.971 . . . . 0.90000000000000002 111.114 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -66.42 -28.6 68.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.057 0.456 . . . . 0.90000000000000002 110.477 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -65.1 -32.62 74.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.516 . . . . 0.90000000000000002 110.282 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 13' ' ' ASP . 75.8 mt -65.92 -42.97 92.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.433 -0.348 . . . . 0.90000000000000002 110.566 175.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.19 -38.2 82.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.029 0.442 . . . . 0.90000000000000002 110.358 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.423 ' O ' ' HE3' ' A' ' 23' ' ' TRP . 96.4 mt -61.3 -40.0 92.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.065 -0.516 . . . . 0.90000000000000002 110.279 175.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -77.25 -6.2 52.19 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.578 0.704 . . . . 0.90000000000000002 110.458 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -89.77 -18.62 25.97 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.975 -0.75 . . . . 0.90000000000000002 108.975 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.55 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 91.5 mt -90.41 -38.77 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.04 -0.982 . . . . 0.90000000000000002 109.774 172.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.869 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 18.2 m-90 -99.21 89.02 0.85 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.565 -0.743 . . . . 0.90000000000000002 109.369 171.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 13.0 Cg_exo -69.47 -59.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.61 2.207 . . . . 0.90000000000000002 113.064 -169.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -94.01 9.45 37.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.205 0.526 . . . . 0.90000000000000002 110.681 -176.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.869 ' HB3' ' HB3' ' A' ' 23' ' ' TRP . 91.3 t80 -97.32 130.47 44.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.823 -0.626 . . . . 0.90000000000000002 110.274 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 p -94.0 110.93 50.88 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.046 -0.524 . . . . 0.90000000000000002 110.516 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.44 137.71 43.9 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.915 2.41 . . . . 0.90000000000000002 112.365 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.6 p -97.43 -95.81 0.21 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.974 -0.557 . . . . 0.90000000000000002 110.836 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.422 ' CB ' ' HG3' ' A' ' 32' ' ' GLN . 51.0 m -98.32 -46.68 5.71 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.764 0.283 . . . . 0.90000000000000002 111.764 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 30' ' ' SER . 97.4 mt 67.47 42.27 2.19 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.428 0.632 . . . . 0.90000000000000002 110.049 -174.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.422 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 89.7 mt-30 -67.8 135.18 52.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.33 -0.85 . . . . 0.90000000000000002 111.377 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.15 165.78 30.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.90000000000000002 110.943 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -156.29 -171.5 3.74 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 107.809 -1.182 . . . . 0.90000000000000002 107.809 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.37 -14.94 62.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 118.275 0.488 . . . . 0.90000000000000002 111.307 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 34.2 m-80 -97.29 -56.8 2.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.085 0.469 . . . . 0.90000000000000002 110.358 176.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -89.36 93.93 9.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.354 -0.385 . . . . 0.90000000000000002 110.167 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -112.63 156.1 23.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.251 -0.431 . . . . 0.90000000000000002 110.721 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.462 HG22 ' HG2' ' A' ' 53' ' ' ARG . 63.5 mt -113.3 122.05 66.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.049 -0.523 . . . . 0.90000000000000002 109.897 177.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -94.13 117.91 30.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.226 -0.443 . . . . 0.90000000000000002 110.122 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.482 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -108.14 113.3 26.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.045 -0.525 . . . . 0.90000000000000002 109.947 178.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.767 ' HB1' ' HB1' ' A' ' 50' ' ' ALA . . . -95.44 112.42 24.14 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.317 -0.402 . . . . 0.90000000000000002 110.903 -175.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.502 ' HG2' ' HB ' ' A' ' 4' ' ' THR . 4.7 ptm180 -102.74 125.95 49.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.408 0.623 . . . . 0.90000000000000002 109.941 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.512 ' HB3' HD13 ' A' ' 49' ' ' LEU . 57.1 t80 -109.51 95.58 5.71 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.654 -0.869 . . . . 0.90000000000000002 108.654 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.9 t30 60.06 81.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.202 -0.908 . . . . 0.90000000000000002 109.992 -173.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 72.83 -59.25 0.57 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.112 -0.949 . . . . 0.90000000000000002 112.165 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 59.9 mtt85 -72.44 132.28 43.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.424 0.528 . . . . 0.90000000000000002 112.424 -167.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.495 HD23 ' HB3' ' A' ' 43' ' ' ARG . 96.2 mt -76.16 100.19 4.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.039 -0.726 . . . . 0.90000000000000002 109.039 171.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.512 HD13 ' HB3' ' A' ' 44' ' ' PHE . 88.2 mt -107.0 -8.72 16.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.301 -0.409 . . . . 0.90000000000000002 111.77 -173.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.767 ' HB1' ' HB1' ' A' ' 42' ' ' ALA . . . -144.07 139.02 28.68 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.768 0.318 . . . . 0.90000000000000002 110.855 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.86 131.47 31.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.149 -0.478 . . . . 0.90000000000000002 110.2 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 65' ' ' SER . 10.0 p -141.45 130.2 23.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.179 -0.464 . . . . 0.90000000000000002 110.317 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.462 ' HG2' HG22 ' A' ' 39' ' ' ILE . 63.6 mtm180 -99.68 141.68 32.16 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.959 -0.386 . . . . 0.90000000000000002 109.959 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.0 p -130.94 127.88 61.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.573 0.702 . . . . 0.90000000000000002 111.121 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.4 m -100.04 93.62 5.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.372 -0.831 . . . . 0.90000000000000002 109.476 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.509 ' O ' ' HB3' ' A' ' 36' ' ' ASN . 94.2 mt -81.24 141.29 34.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.057 0.456 . . . . 0.90000000000000002 110.625 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 t -144.44 74.3 1.41 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.795 -0.817 . . . . 0.90000000000000002 108.795 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.21 -111.41 3.9 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.578 -0.737 . . . . 0.90000000000000002 111.854 -178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.0 p -95.85 12.81 28.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.051 0.453 . . . . 0.90000000000000002 111.204 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -118.95 139.06 52.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.358 -0.608 . . . . 0.90000000000000002 109.358 174.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.74 114.59 0.96 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.724 -0.751 . . . . 0.90000000000000002 111.861 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -103.24 119.33 38.68 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.607 0.242 . . . . 0.90000000000000002 110.768 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.47 HD22 ' HE1' ' A' ' 97' ' ' MET . 6.0 mp -93.42 126.27 38.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.108 0.48 . . . . 0.90000000000000002 110.688 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -125.17 138.9 54.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.284 -0.871 . . . . 0.90000000000000002 109.299 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 50.3 m 61.01 87.27 0.09 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.312 0.577 . . . . 0.90000000000000002 111.283 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.7 tp -108.58 106.35 16.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.336 -0.847 . . . . 0.90000000000000002 108.907 173.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.496 ' HG2' ' H32' ' A' ' 999' ' ' COA . 72.9 mtp85 -131.45 119.79 22.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.049 0.388 . . . . 0.90000000000000002 112.049 -173.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.424 HG12 ' HB ' ' A' ' 72' ' ' THR . 1.9 t -109.07 141.61 23.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.88 -1.156 . . . . 0.90000000000000002 107.88 169.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.6 ttt-85 -82.92 166.65 18.71 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.554 -0.458 . . . . 0.90000000000000002 110.983 -174.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -48.7 -39.58 25.13 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.464 -0.789 . . . . 0.90000000000000002 112.704 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.6 t -62.25 -28.28 44.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.968 -0.56 . . . . 0.90000000000000002 112.207 -173.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.469 ' HG1' ' HB3' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -97.18 19.03 13.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.376 0.51 . . . . 0.90000000000000002 112.376 -168.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.44 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 41.6 ttt-85 -80.29 84.86 5.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.551 -0.537 . . . . 0.90000000000000002 109.551 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -134.73 -86.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 0.90000000000000002 112.071 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.487 ' HA ' ' O7A' ' A' ' 999' ' ' COA . 0.3 OUTLIER 168.54 99.1 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.612 0.765 . . . . 0.90000000000000002 109.061 -168.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.85 -74.12 0.45 Allowed Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.533 -0.841 . . . . 0.90000000000000002 112.627 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.4 t -38.15 -54.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.895 1.072 . . . . 0.90000000000000002 113.895 -170.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.43 -59.34 10.9 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.59 -0.814 . . . . 0.90000000000000002 112.96 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 99.4 mt-30 -64.16 -34.34 77.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.804 0.335 . . . . 0.90000000000000002 110.723 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -63.34 -38.3 90.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.81 -0.632 . . . . 0.90000000000000002 110.529 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.467 ' O ' HG21 ' A' ' 85' ' ' VAL . 61.7 tp -55.58 -49.95 71.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 0.90000000000000002 109.994 176.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.46 -43.89 96.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.405 . . . . 0.90000000000000002 110.902 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 79' ' ' GLN . 40.1 mt-10 -59.33 -42.63 91.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.717 -0.22 . . . . 0.90000000000000002 111.266 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.404 ' HG2' HD11 ' A' ' 5' ' ' ILE . 9.1 tp10 -60.27 -44.12 95.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.90000000000000002 110.49 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 81' ' ' LEU . 99.3 t -60.61 -44.94 97.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.395 -0.366 . . . . 0.90000000000000002 111.16 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -73.9 -16.47 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.398 -0.364 . . . . 0.90000000000000002 111.658 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 87' ' ' ARG . 63.6 mtt180 -92.89 -30.56 15.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.034 0.445 . . . . 0.90000000000000002 110.632 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -73.92 -50.51 19.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.838 -0.619 . . . . 0.90000000000000002 110.737 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -82.54 146.9 54.58 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.958 -0.565 . . . . 0.90000000000000002 110.111 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -66.38 -165.79 0.1 OUTLIER 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.161 2.574 . . . . 0.90000000000000002 113.003 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.43 84.73 0.1 Allowed Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.703 -0.68 . . . . 0.90000000000000002 113.522 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.0 t -82.56 122.83 37.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.839 -0.8 . . . . 0.90000000000000002 108.839 171.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 7.1 m -68.74 -57.82 5.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.253 -0.431 . . . . 0.90000000000000002 111.544 -174.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.7 t -103.76 106.95 17.61 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.461 -0.336 . . . . 0.90000000000000002 111.657 -172.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -97.83 110.62 23.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.935 0.398 . . . . 0.90000000000000002 110.141 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.43 ' CE3' ' HG2' ' A' ' 125' ' ' GLU . 18.9 t-105 -104.12 131.74 51.09 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.295 -0.631 . . . . 0.90000000000000002 109.295 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.47 ' HE1' HD22 ' A' ' 63' ' ' LEU . 54.7 mtp -128.69 137.27 51.53 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.972 -0.381 . . . . 0.90000000000000002 109.972 175.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.66 169.33 11.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.339 -0.391 . . . . 0.90000000000000002 110.781 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.0 5.96 48.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.393 . . . . 0.90000000000000002 110.773 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.82 124.64 21.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.489 . . . . 0.90000000000000002 110.429 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.51 0.12 58.09 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.596 -0.602 . . . . 0.90000000000000002 111.596 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.689 HG13 ' C5P' ' A' ' 999' ' ' COA . 62.1 t -114.83 124.46 71.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.558 -0.321 . . . . 0.90000000000000002 110.201 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.418 ' CD ' HH12 ' A' ' 67' ' ' ARG . 17.6 mp0 -71.88 -26.49 62.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.541 -0.299 . . . . 0.90000000000000002 111.442 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -118.82 103.25 9.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.021 0.438 . . . . 0.90000000000000002 110.95 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -73.1 -28.25 62.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.007 -0.542 . . . . 0.90000000000000002 110.404 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.94 -51.68 51.34 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.132 -0.556 . . . . 0.90000000000000002 112.123 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.6 t -59.79 -40.86 83.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.921 0.391 . . . . 0.90000000000000002 110.306 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -61.55 -43.27 99.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.016 -0.538 . . . . 0.90000000000000002 110.643 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 57.3 m -61.15 -48.83 79.8 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.347 -0.388 . . . . 0.90000000000000002 110.781 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.14 96.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.90000000000000002 111.069 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -62.4 -47.65 83.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.918 -0.583 . . . . 0.90000000000000002 111.075 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.517 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 23.9 mmt -63.13 -46.22 88.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.90000000000000002 111.407 -177.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -68.55 -30.2 68.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.366 -0.379 . . . . 0.90000000000000002 110.743 -177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.46 -27.13 58.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.407 -0.361 . . . . 0.90000000000000002 110.884 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.578 HD11 ' HE2' ' A' ' 117' ' ' PHE . 4.7 tt -82.22 -51.52 7.86 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.622 -0.51 . . . . 0.90000000000000002 109.622 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 141.84 45.72 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.752 -0.737 . . . . 0.90000000000000002 112.415 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.578 ' HE2' HD11 ' A' ' 115' ' ' LEU . 94.7 m-85 -123.38 134.52 53.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.828 0.347 . . . . 0.90000000000000002 110.547 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.5 m -93.13 144.82 24.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.034 -0.53 . . . . 0.90000000000000002 109.835 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.8 t -97.23 116.44 29.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.544 0.687 . . . . 0.90000000000000002 110.206 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -141.1 140.17 34.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.445 -0.798 . . . . 0.90000000000000002 110.312 -174.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 54.74 30.99 14.54 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.746 -0.661 . . . . 0.90000000000000002 111.892 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.7 -57.15 0.52 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.994 -0.622 . . . . 0.90000000000000002 112.486 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -90.55 -147.93 19.5 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.802 -0.713 . . . . 0.90000000000000002 112.195 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 31.0 m-90 -121.52 124.24 43.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.696 0.284 . . . . 0.90000000000000002 110.307 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.43 ' HG2' ' CE3' ' A' ' 96' ' ' TRP . 42.3 mt-10 -119.33 121.17 38.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.11 -0.495 . . . . 0.90000000000000002 110.743 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -126.37 96.79 4.81 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.006 -0.543 . . . . 0.90000000000000002 109.536 172.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 93' ' ' SER . 34.2 t -104.21 123.88 48.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.842 -0.617 . . . . 0.90000000000000002 110.005 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 C-N-CA 121.095 -0.574 . . . . 0.90000000000000002 112.074 -179.795 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 999' ' ' COA . . . . . 0.689 ' C5P' HG13 ' A' ' 102' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 120.894 0.378 . . . . 0.90000000000000002 110.051 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -90.4 121.04 32.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.18 -0.463 . . . . 0.90000000000000002 110.55 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.521 HD13 ' HB1' ' A' ' 42' ' ' ALA . 47.6 tp -89.41 116.32 27.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.354 -0.385 . . . . 0.90000000000000002 110.347 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 m -89.32 93.22 9.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.308 -0.406 . . . . 0.90000000000000002 110.567 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.514 HD12 ' HB3' ' A' ' 40' ' ' TYR . 6.5 tp -88.05 124.39 41.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.175 0.512 . . . . 0.90000000000000002 110.052 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 mt -123.55 155.02 29.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.973 -0.558 . . . . 0.90000000000000002 110.219 -176.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -89.53 127.68 35.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.101 -0.5 . . . . 0.90000000000000002 110.131 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.422 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 42.0 tp -80.91 99.63 8.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.032 -0.531 . . . . 0.90000000000000002 109.601 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.487 ' HA ' HG12 ' A' ' 33' ' ' VAL . 36.0 mt-10 -102.04 -17.36 16.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.764 -0.653 . . . . 0.90000000000000002 111.655 -175.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -151.56 156.31 40.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.703 0.287 . . . . 0.90000000000000002 111.29 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.438 ' CE2' HG22 ' A' ' 33' ' ' VAL . 87.7 m-85 -119.1 109.64 16.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.966 -0.561 . . . . 0.90000000000000002 111.117 -177.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.0 p -90.74 158.86 16.64 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.684 -1.228 . . . . 0.90000000000000002 107.684 168.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.424 ' O ' HG13 ' A' ' 17' ' ' ILE . 5.4 m-20 -58.58 -38.34 77.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.934 0.397 . . . . 0.90000000000000002 110.184 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -61.54 -55.78 27.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.621 -0.718 . . . . 0.90000000000000002 110.676 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.493 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 70.1 m-20 -61.88 -37.67 85.42 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.099 -0.5 . . . . 0.90000000000000002 110.538 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -64.19 -36.4 83.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.014 -0.539 . . . . 0.90000000000000002 110.67 -176.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 13' ' ' ASP . 80.2 mt -66.5 -45.12 89.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.299 -0.409 . . . . 0.90000000000000002 110.743 177.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.537 ' O ' HG13 ' A' ' 22' ' ' ILE . 24.0 t0 -65.57 -35.06 79.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.333 . . . . 0.90000000000000002 110.593 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 95.0 mt -63.65 -41.43 98.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.438 -0.346 . . . . 0.90000000000000002 110.978 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -69.42 -21.45 63.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.514 0.673 . . . . 0.90000000000000002 109.695 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -85.78 -12.34 51.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.446 -0.797 . . . . 0.90000000000000002 110.134 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 18' ' ' ASP . 71.0 mt -85.1 -32.69 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.2 -0.667 . . . . 0.90000000000000002 109.2 171.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 5.6 m-90 -116.04 72.09 4.42 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.751 -0.659 . . . . 0.90000000000000002 110.783 175.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.483 ' HD3' ' C ' ' A' ' 22' ' ' ILE . 18.0 Cg_exo -67.87 -45.21 3.32 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.338 2.025 . . . . 0.90000000000000002 111.732 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -103.17 71.27 1.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.948 0.88 . . . . 0.90000000000000002 109.321 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.588 ' HB3' ' HB3' ' A' ' 23' ' ' TRP . 55.8 t80 -155.29 137.57 14.84 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.367 -1.288 . . . . 0.90000000000000002 108.655 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.2 m -69.74 109.02 3.87 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.179 -0.304 . . . . 0.90000000000000002 110.179 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -56.93 124.33 15.99 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.211 2.607 . . . . 0.90000000000000002 113.104 -173.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.4 m -85.82 -177.12 6.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.706 -0.679 . . . . 0.90000000000000002 109.502 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.6 t -70.03 -33.29 71.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.718 0.294 . . . . 0.90000000000000002 110.287 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.0 mt 64.92 84.95 0.15 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.552 -0.749 . . . . 0.90000000000000002 110.96 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -137.94 147.74 44.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.581 -0.736 . . . . 0.90000000000000002 110.178 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.487 HG12 ' HA ' ' A' ' 9' ' ' GLU . 59.7 t -93.74 126.23 46.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.976 -0.556 . . . . 0.90000000000000002 111.039 -176.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.624 ' HB3' ' HB2' ' A' ' 37' ' ' HIS . 30.9 t70 -138.71 158.02 45.01 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.623 -0.717 . . . . 0.90000000000000002 109.299 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -63.2 -35.87 81.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.723 0.296 . . . . 0.90000000000000002 110.805 178.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 55' ' ' THR . 15.8 m120 -86.29 -48.04 8.86 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.778 -0.453 . . . . 0.90000000000000002 109.778 176.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.624 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 40.4 m170 -87.28 84.47 7.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.90000000000000002 109.914 175.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -109.36 147.79 32.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.079 -0.509 . . . . 0.90000000000000002 110.144 -173.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' A' ' 8' ' ' LEU . 56.5 mt -126.56 139.07 52.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.854 0.359 . . . . 0.90000000000000002 110.379 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.514 ' HB3' HD12 ' A' ' 5' ' ' ILE . 76.9 m-85 -118.03 152.43 35.54 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.512 -0.551 . . . . 0.90000000000000002 109.512 176.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.465 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -136.67 126.51 25.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.999 0.428 . . . . 0.90000000000000002 111.154 -174.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.734 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . . . -92.04 104.02 16.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.765 -0.652 . . . . 0.90000000000000002 110.011 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -95.14 110.22 22.2 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.939 -0.573 . . . . 0.90000000000000002 110.34 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -119.39 135.24 54.82 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.086 -0.709 . . . . 0.90000000000000002 109.086 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.3 t30 61.51 30.65 18.87 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.618 0.723 . . . . 0.90000000000000002 109.072 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 65.84 17.11 10.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.676 -1.147 . . . . 0.90000000000000002 111.955 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -126.43 138.96 53.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.572 0.225 . . . . 0.90000000000000002 110.404 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.465 HD21 ' HB3' ' A' ' 41' ' ' ALA . 78.4 mt -63.65 106.58 0.99 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.322 -0.622 . . . . 0.90000000000000002 109.322 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.403 ' HA ' HD11 ' A' ' 49' ' ' LEU . 12.8 tp -105.03 -21.41 13.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.147 -0.479 . . . . 0.90000000000000002 110.823 -172.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.734 ' HB2' ' HB2' ' A' ' 42' ' ' ALA . . . -140.94 135.26 31.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.259 -0.428 . . . . 0.90000000000000002 110.482 178.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.65 132.93 53.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.429 -0.351 . . . . 0.90000000000000002 110.608 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.472 ' HB ' HD11 ' A' ' 66' ' ' LEU . 8.0 p -142.2 131.9 23.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.039 -0.528 . . . . 0.90000000000000002 110.596 -178.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 1.025 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 10.6 mtm180 -103.22 155.68 18.26 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.603 -0.439 . . . . 0.90000000000000002 109.88 176.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.79 126.5 14.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.251 0.548 . . . . 0.90000000000000002 110.414 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 77.6 m -102.49 107.61 18.63 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.807 -0.633 . . . . 0.90000000000000002 110.042 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.4 mt -83.54 95.29 8.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.863 -0.608 . . . . 0.90000000000000002 110.043 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.3 t -86.79 93.05 9.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.65 -0.704 . . . . 0.90000000000000002 109.368 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.83 -102.99 1.38 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.767 -0.652 . . . . 0.90000000000000002 111.789 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.2 m -120.83 12.96 11.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.926 0.87 . . . . 0.90000000000000002 109.521 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -112.87 157.88 20.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.478 -0.783 . . . . 0.90000000000000002 109.956 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 95' ' ' TRP . . . -125.15 120.76 4.04 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.208 -0.996 . . . . 0.90000000000000002 112.864 -174.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.78 132.07 53.78 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.532 -0.544 . . . . 0.90000000000000002 109.532 174.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.815 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 73.0 mt -95.43 119.14 33.41 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.206 0.527 . . . . 0.90000000000000002 110.281 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 1.025 ' HB2' ' HB2' ' A' ' 53' ' ' ARG . 1.3 m-20 -79.6 -157.66 0.14 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.94 -1.027 . . . . 0.90000000000000002 110.117 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 p -47.27 118.45 2.17 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.138 0.494 . . . . 0.90000000000000002 111.932 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.472 HD11 ' HB ' ' A' ' 52' ' ' VAL . 21.3 tp -117.64 116.97 28.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.242 -0.89 . . . . 0.90000000000000002 109.349 175.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.562 ' HA ' ' H71' ' A' ' 999' ' ' COA . 53.6 ttt180 -143.82 123.19 13.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.192 0.52 . . . . 0.90000000000000002 111.735 177.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.503 HG13 ' HB3' ' A' ' 50' ' ' ALA . 22.4 t -94.38 137.8 22.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.338 -0.986 . . . . 0.90000000000000002 108.338 169.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -56.87 136.55 55.74 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.331 -0.618 . . . . 0.90000000000000002 109.331 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -56.67 -15.82 5.19 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.527 0.936 . . . . 0.90000000000000002 113.527 -166.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.07 -15.59 19.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.696 0.284 . . . . 0.90000000000000002 111.487 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 m -108.99 68.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.406 0.622 . . . . 0.90000000000000002 110.34 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.8 ttt85 -92.85 103.31 15.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.772 -0.649 . . . . 0.90000000000000002 110.842 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.553 ' HG2' ' C2A' ' A' ' 999' ' ' COA . 20.9 mtp180 60.78 79.73 0.24 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.468 -0.787 . . . . 0.90000000000000002 111.805 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -142.21 16.76 2.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.575 -0.45 . . . . 0.90000000000000002 111.052 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.22 -19.98 11.7 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.934 -0.65 . . . . 0.90000000000000002 113.489 175.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.9 t -51.29 -46.59 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 112.339 0.496 . . . . 0.90000000000000002 112.339 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.0 -28.95 71.27 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.046 -0.597 . . . . 0.90000000000000002 113.101 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.448 ' HG3' ' O1A' ' A' ' 999' ' ' COA . 20.5 mt-30 -69.65 -55.0 11.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.23 -0.285 . . . . 0.90000000000000002 110.23 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -56.11 -44.65 79.31 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.272 -0.422 . . . . 0.90000000000000002 110.165 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 85' ' ' VAL . 30.3 tp -52.89 -57.99 8.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.676 -0.693 . . . . 0.90000000000000002 111.496 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.3 mt -66.21 -39.69 89.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.283 -0.417 . . . . 0.90000000000000002 111.238 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -59.0 -43.01 91.42 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.824 -0.35 . . . . 0.90000000000000002 110.252 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -64.45 -36.42 84.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.90000000000000002 110.59 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 81' ' ' LEU . 93.2 t -63.34 -48.87 85.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.803 0.335 . . . . 0.90000000000000002 110.686 177.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.532 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 11.1 mp -66.22 -27.84 68.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.90000000000000002 110.896 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 87' ' ' ARG . 5.5 mtp180 -77.39 -33.66 55.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.942 -0.572 . . . . 0.90000000000000002 111.398 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -69.95 -44.09 70.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.90000000000000002 110.795 -176.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.604 HD21 ' HH2' ' A' ' 95' ' ' TRP . 90.9 m-20 -76.02 112.79 22.38 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.206 -0.452 . . . . 0.90000000000000002 110.359 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -87.42 22.54 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.143 2.562 . . . . 0.90000000000000002 113.766 -171.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -172.7 75.9 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.018 -1.087 . . . . 0.90000000000000002 113.093 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.4 t -141.69 129.09 20.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.105 -0.702 . . . . 0.90000000000000002 109.105 174.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.9 p -99.66 -33.13 10.73 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.146 0.425 . . . . 0.90000000000000002 112.146 -177.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.6 t -130.34 137.45 49.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.131 0.491 . . . . 0.90000000000000002 110.814 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.604 ' HH2' HD21 ' A' ' 89' ' ' ASN . 90.7 m95 -116.12 122.4 45.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.642 -0.708 . . . . 0.90000000000000002 110.345 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -114.18 121.3 43.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.763 -0.653 . . . . 0.90000000000000002 109.292 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.815 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 77.2 mtp -107.29 130.08 54.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.793 0.33 . . . . 0.90000000000000002 110.59 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -101.26 144.95 29.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.115 -0.493 . . . . 0.90000000000000002 110.711 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.415 ' HB2' HG13 ' A' ' 102' ' ' VAL . 2.7 p-10 -69.49 -34.26 74.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.908 0.385 . . . . 0.90000000000000002 110.148 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 61.65 20.68 11.52 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.637 -0.711 . . . . 0.90000000000000002 112.47 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.35 13.01 20.34 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.287 -0.959 . . . . 0.90000000000000002 113.243 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.517 HG12 ' HB3' ' A' ' 105' ' ' ARG . 12.2 p -85.53 119.67 34.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.115 0.483 . . . . 0.90000000000000002 109.725 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -93.27 -5.1 50.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.326 0.584 . . . . 0.90000000000000002 109.762 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -86.46 16.3 4.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.095 -0.957 . . . . 0.90000000000000002 109.14 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.517 ' HB3' HG12 ' A' ' 102' ' ' VAL . 5.1 ptt180 -56.62 -32.12 64.98 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.437 -0.801 . . . . 0.90000000000000002 112.167 -175.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.22 -48.35 70.78 Favored Glycine 0 C--O 1.235 0.193 0 C-N-CA 120.612 -0.804 . . . . 0.90000000000000002 111.726 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.1 t -61.24 -43.27 96.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-O 122.025 0.917 . . . . 0.90000000000000002 109.394 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.606 ' O ' ' HG2' ' A' ' 112' ' ' MET . 17.3 ttt -61.64 -37.97 85.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.526 -1.215 . . . . 0.90000000000000002 110.13 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 98.9 m -61.28 -36.24 79.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.471 -0.332 . . . . 0.90000000000000002 111.105 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.28 -45.17 88.42 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.13 0.49 . . . . 0.90000000000000002 109.748 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.616 ' HB2' ' C4A' ' A' ' 999' ' ' COA . 7.3 t80 -63.5 -45.08 92.32 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.483 -0.781 . . . . 0.90000000000000002 111.019 173.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.606 ' HG2' ' O ' ' A' ' 108' ' ' MET . 59.5 mmm -60.57 -43.89 96.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.407 -0.361 . . . . 0.90000000000000002 111.102 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -62.83 -35.1 78.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.434 -0.348 . . . . 0.90000000000000002 110.807 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.51 -32.95 74.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.90000000000000002 111.167 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 33.5 tp -84.8 -42.84 14.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.368 -0.378 . . . . 0.90000000000000002 110.499 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 136.28 32.87 0.25 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.655 -0.783 . . . . 0.90000000000000002 113.149 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.54 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 78.5 m-85 -118.58 116.24 26.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.76 0.314 . . . . 0.90000000000000002 110.391 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.3 p -102.01 136.14 42.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.467 -0.333 . . . . 0.90000000000000002 110.895 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.698 ' HB ' ' CD1' ' A' ' 124' ' ' TRP . 11.6 t -97.37 134.9 40.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.139 0.495 . . . . 0.90000000000000002 110.737 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.619 ' HB2' ' OE2' ' A' ' 125' ' ' GLU . 19.0 mt-30 -140.31 -72.6 0.36 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.854 -0.612 . . . . 0.90000000000000002 110.289 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -86.14 61.54 6.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.645 -0.707 . . . . 0.90000000000000002 111.265 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.87 -36.96 2.49 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.009 -0.615 . . . . 0.90000000000000002 113.139 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -118.96 -172.81 15.45 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.881 -0.676 . . . . 0.90000000000000002 112.165 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.698 ' CD1' ' HB ' ' A' ' 119' ' ' THR . 15.8 m-90 -98.54 126.42 44.1 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.073 -0.343 . . . . 0.90000000000000002 110.073 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.619 ' OE2' ' HB2' ' A' ' 120' ' ' GLN . 35.4 mt-10 -111.69 122.17 47.09 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.901 -0.59 . . . . 0.90000000000000002 111.015 -175.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -137.12 148.64 46.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.301 -0.409 . . . . 0.90000000000000002 110.396 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 38.2 t -110.82 151.07 28.25 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.313 -0.625 . . . . 0.90000000000000002 109.313 173.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.329 0 C-N-CA 120.895 -0.669 . . . . 0.90000000000000002 112.535 179.34 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 999' ' ' COA . . . . . 0.616 ' C4A' ' HB2' ' A' ' 111' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.1 mtp . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 109.814 -0.439 . . . . 0.90000000000000002 109.814 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -74.75 137.62 42.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.964 0.411 . . . . 0.90000000000000002 110.663 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.491 HD23 ' HB3' ' A' ' 42' ' ' ALA . 23.3 tp -76.03 118.47 18.82 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.933 -0.766 . . . . 0.90000000000000002 108.933 176.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.555 ' O ' ' HB3' ' A' ' 43' ' ' ARG . 18.1 m -90.25 92.22 8.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.098 0.475 . . . . 0.90000000000000002 110.458 -176.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.524 HG21 ' HA ' ' A' ' 42' ' ' ALA . 9.2 pt -106.79 150.98 8.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 120.47 -0.492 . . . . 0.90000000000000002 111.091 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.1 mp -131.14 153.09 38.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.197 -0.668 . . . . 0.90000000000000002 109.197 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -82.98 140.07 32.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.868 0.366 . . . . 0.90000000000000002 110.036 176.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.9 tp -84.74 82.91 8.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.908 -0.587 . . . . 0.90000000000000002 110.279 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -75.76 -48.8 20.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.506 -0.77 . . . . 0.90000000000000002 110.783 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -120.19 157.24 29.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.757 -0.656 . . . . 0.90000000000000002 110.411 -176.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -117.97 103.7 10.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.306 -0.406 . . . . 0.90000000000000002 110.995 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -88.88 156.74 18.74 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.769 -0.456 . . . . 0.90000000000000002 109.769 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.432 ' O ' HG13 ' A' ' 17' ' ' ILE . 19.0 t70 -56.78 -52.86 63.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.288 -0.414 . . . . 0.90000000000000002 111.396 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.17 -35.99 80.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.343 -0.39 . . . . 0.90000000000000002 110.68 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.478 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 22.0 m-20 -63.48 -44.01 95.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.447 . . . . 0.90000000000000002 110.531 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -62.53 -34.89 77.81 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 120.648 0.261 . . . . 0.90000000000000002 110.958 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 13' ' ' ASP . 74.2 mt -63.13 -46.54 95.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.262 -0.426 . . . . 0.90000000000000002 110.613 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -71.69 -31.28 66.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.013 0.435 . . . . 0.90000000000000002 109.997 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 84.3 mt -63.67 -34.48 77.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 0.90000000000000002 110.587 174.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.4 ' HB2' ' HE2' ' A' ' 26' ' ' TYR . 45.1 tt0 -77.22 -18.74 57.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.165 0.507 . . . . 0.90000000000000002 110.579 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -68.14 -36.81 80.26 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.888 -0.782 . . . . 0.90000000000000002 108.888 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.504 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 67.3 mt -73.76 -55.47 12.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.526 -0.761 . . . . 0.90000000000000002 110.23 176.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -101.18 97.34 7.07 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.748 -0.464 . . . . 0.90000000000000002 109.748 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 35.3 Cg_exo -57.69 -32.17 93.92 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.554 2.169 . . . . 0.90000000000000002 111.853 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -144.56 91.51 2.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.388 -0.824 . . . . 0.90000000000000002 110.029 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.4 ' HE2' ' HB2' ' A' ' 20' ' ' GLN . 44.6 p90 -103.42 167.27 9.92 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.578 -0.737 . . . . 0.90000000000000002 110.013 176.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.0 t -80.37 128.89 71.29 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.7 -0.481 . . . . 0.90000000000000002 109.7 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.95 128.41 27.82 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.997 2.465 . . . . 0.90000000000000002 112.786 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.0 m 69.57 1.52 3.39 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.326 -0.852 . . . . 0.90000000000000002 112.792 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.1 m -78.72 -8.82 59.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.216 0.531 . . . . 0.90000000000000002 110.27 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.03 -21.49 62.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.6 -0.727 . . . . 0.90000000000000002 110.557 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -56.01 128.63 36.21 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.279 0.561 . . . . 0.90000000000000002 111.934 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.1 m -103.38 167.52 2.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.264 -0.88 . . . . 0.90000000000000002 111.399 -176.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -155.94 -158.25 0.79 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.933 -1.136 . . . . 0.90000000000000002 107.933 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -72.64 -29.35 63.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.005 0.431 . . . . 0.90000000000000002 110.77 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -85.68 -53.39 5.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.276 -0.42 . . . . 0.90000000000000002 110.663 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -92.82 112.39 24.34 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.777 -0.453 . . . . 0.90000000000000002 109.777 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -126.7 119.87 28.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.201 0.524 . . . . 0.90000000000000002 110.806 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 65.2 mt -98.56 133.92 39.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.677 -0.692 . . . . 0.90000000000000002 110.073 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -112.7 132.88 54.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.116 -0.493 . . . . 0.90000000000000002 110.082 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.52 123.27 48.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.861 -0.608 . . . . 0.90000000000000002 109.878 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.535 ' HB1' ' HB1' ' A' ' 50' ' ' ALA . . . -91.9 114.69 27.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.094 -0.503 . . . . 0.90000000000000002 110.453 -176.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.555 ' HB3' ' O ' ' A' ' 4' ' ' THR . 51.9 ttt180 -108.03 127.3 53.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.273 0.559 . . . . 0.90000000000000002 110.864 -177.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -99.41 82.49 2.68 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.425 -0.583 . . . . 0.90000000000000002 109.425 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 69.13 -68.35 0.19 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.185 -0.916 . . . . 0.90000000000000002 111.728 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -101.58 -57.74 2.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.026 0.38 . . . . 0.90000000000000002 112.026 -174.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 47' ' ' ARG . 10.0 ptp180 -114.51 171.66 7.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.983 0.42 . . . . 0.90000000000000002 111.076 -171.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.5 mt -75.34 133.55 41.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.861 -0.608 . . . . 0.90000000000000002 109.431 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.8 tp -111.01 -23.98 10.63 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.734 0.302 . . . . 0.90000000000000002 110.496 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.535 ' HB1' ' HB1' ' A' ' 42' ' ' ALA . . . -151.3 159.08 44.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.142 -0.481 . . . . 0.90000000000000002 111.158 -177.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -144.46 133.41 22.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.112 -0.495 . . . . 0.90000000000000002 109.963 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.08 137.76 37.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.383 -0.371 . . . . 0.90000000000000002 110.937 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 19.1 mtm180 -110.17 129.99 55.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.513 -0.312 . . . . 0.90000000000000002 110.207 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -133.73 139.47 48.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.316 0.579 . . . . 0.90000000000000002 110.809 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -111.02 114.7 28.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.735 -0.666 . . . . 0.90000000000000002 110.092 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.408 HD22 HG22 ' A' ' 92' ' ' VAL . 70.5 mt -86.84 93.06 9.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.965 0.412 . . . . 0.90000000000000002 109.99 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 t -111.58 94.41 4.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.047 -0.524 . . . . 0.90000000000000002 110.517 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.42 -107.72 2.04 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.813 -0.63 . . . . 0.90000000000000002 112.498 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.3 p -93.45 -15.13 25.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.739 0.304 . . . . 0.90000000000000002 111.036 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -99.66 122.19 42.33 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.247 0.546 . . . . 0.90000000000000002 111.988 -172.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.23 97.37 2.17 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.463 -1.455 . . . . 0.90000000000000002 109.463 167.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.47 107.54 19.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.21 0.528 . . . . 0.90000000000000002 110.437 -172.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.462 HD22 ' HE3' ' A' ' 97' ' ' MET . 7.9 tt -93.73 119.28 32.51 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.228 -0.896 . . . . 0.90000000000000002 110.041 -175.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 12.1 t70 -126.57 126.42 43.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.466 -0.788 . . . . 0.90000000000000002 110.348 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.0 t 71.39 108.86 0.06 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.799 0.809 . . . . 0.90000000000000002 111.111 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 45.4 tp -129.33 110.43 11.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.741 -1.118 . . . . 0.90000000000000002 109.321 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.461 ' HA ' ' O9P' ' A' ' 999' ' ' COA . 43.5 mtt180 -125.36 128.53 48.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.095 0.474 . . . . 0.90000000000000002 111.611 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 50' ' ' ALA . 1.7 t -121.76 153.97 25.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.095 -1.076 . . . . 0.90000000000000002 108.095 172.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.5 mtt-85 -65.22 158.58 25.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.947 0.403 . . . . 0.90000000000000002 111.433 -176.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 70' ' ' GLU . 1.5 mp0 -49.88 -38.6 36.25 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.565 -0.743 . . . . 0.90000000000000002 112.947 -170.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.8 m -78.3 19.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 113.049 0.759 . . . . 0.90000000000000002 113.049 -172.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.9 p -115.76 9.68 15.2 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.763 0.316 . . . . 0.90000000000000002 111.253 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.2 ttp-105 -57.55 106.12 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.815 -0.63 . . . . 0.90000000000000002 111.167 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.472 ' HA ' ' C5B' ' A' ' 999' ' ' COA . 94.4 mtt180 55.92 40.47 30.49 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.841 -0.618 . . . . 0.90000000000000002 111.119 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -111.29 7.39 21.05 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.992 0.425 . . . . 0.90000000000000002 111.631 -174.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.462 ' HA2' ' O9A' ' A' ' 999' ' ' COA . . . 87.98 -23.89 12.73 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.664 -0.779 . . . . 0.90000000000000002 113.928 173.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.7 t -53.92 -42.07 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.771 0.319 . . . . 0.90000000000000002 111.713 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.85 -38.43 88.57 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.175 -0.536 . . . . 0.90000000000000002 112.89 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -59.55 -49.72 76.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.863 0.363 . . . . 0.90000000000000002 111.037 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -67.06 -33.88 76.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.90000000000000002 110.961 -174.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.478 ' O ' HG21 ' A' ' 85' ' ' VAL . 56.3 tp -57.72 -49.39 76.71 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.8 0.333 . . . . 0.90000000000000002 110.301 176.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.77 -42.46 97.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.132 -0.486 . . . . 0.90000000000000002 110.702 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.01 -46.89 84.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 0.90000000000000002 111.108 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -59.12 -43.17 91.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.622 0.248 . . . . 0.90000000000000002 110.974 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 81' ' ' LEU . 94.8 t -60.58 -52.27 63.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.402 -0.363 . . . . 0.90000000000000002 110.918 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.417 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 11.2 mp -64.85 -32.14 73.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.287 -0.415 . . . . 0.90000000000000002 111.571 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -76.74 -40.2 49.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.32 -0.4 . . . . 0.90000000000000002 111.929 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -71.19 -39.6 71.7 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.323 0.49 . . . . 0.90000000000000002 112.323 -174.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.509 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 47.6 m-80 -75.01 131.75 78.3 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.913 0.387 . . . . 0.90000000000000002 110.674 -177.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 16.9 Cg_exo -67.05 -69.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 123.383 2.722 . . . . 0.90000000000000002 114.456 -170.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.13 61.55 0.48 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.186 -1.007 . . . . 0.90000000000000002 113.637 -170.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.408 HG22 HD22 ' A' ' 56' ' ' LEU . 25.5 t -114.52 105.11 18.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.703 -0.48 . . . . 0.90000000000000002 109.703 175.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.9 t -83.25 -37.81 23.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.228 -0.442 . . . . 0.90000000000000002 111.485 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.0 t -108.93 109.01 19.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.902 0.382 . . . . 0.90000000000000002 110.822 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.417 ' CZ2' ' HA ' ' A' ' 86' ' ' LEU . 95.9 m95 -97.65 115.54 28.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.07 -0.514 . . . . 0.90000000000000002 109.698 175.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 -114.88 126.19 54.52 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.795 -0.639 . . . . 0.90000000000000002 109.964 -175.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.462 ' HE3' HD22 ' A' ' 63' ' ' LEU . 87.1 mtp -107.03 122.52 46.62 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.203 -0.665 . . . . 0.90000000000000002 109.203 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.0 173.71 8.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.563 -0.744 . . . . 0.90000000000000002 111.772 -172.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.31 -46.05 86.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.496 -0.775 . . . . 0.90000000000000002 111.051 -178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 62.18 17.01 8.84 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.775 -0.648 . . . . 0.90000000000000002 111.681 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.53 36.87 58.62 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.079 -0.581 . . . . 0.90000000000000002 112.47 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.1 t -106.53 109.99 30.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.645 0.222 . . . . 0.90000000000000002 110.724 177.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -90.95 -6.95 53.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.777 0.322 . . . . 0.90000000000000002 110.6 173.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.73 52.65 1.03 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.262 0.553 . . . . 0.90000000000000002 109.621 173.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 105' ' ' ARG . 48.2 mtt-85 -72.94 -21.87 60.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.867 -0.606 . . . . 0.90000000000000002 110.884 -172.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.69 -56.64 23.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.474 -0.869 . . . . 0.90000000000000002 111.535 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.1 t -61.51 -39.12 81.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.021 0.439 . . . . 0.90000000000000002 110.837 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 27.0 ttm -71.25 -37.8 71.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.842 -0.617 . . . . 0.90000000000000002 112.119 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 99.1 m -63.84 -47.35 81.12 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.173 -0.211 . . . . 0.90000000000000002 110.634 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.452 ' HB3' ' C4A' ' A' ' 999' ' ' COA . . . -57.18 -39.08 74.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.348 0.594 . . . . 0.90000000000000002 110.602 177.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -62.77 -54.38 39.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.125 -0.943 . . . . 0.90000000000000002 111.374 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.447 ' HE2' ' CE ' ' A' ' 97' ' ' MET . 66.4 mtt -76.03 -33.26 59.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.905 0.335 . . . . 0.90000000000000002 111.905 -174.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -63.41 -41.03 98.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.943 0.401 . . . . 0.90000000000000002 110.119 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.24 -25.28 59.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.996 -0.547 . . . . 0.90000000000000002 110.762 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.6 tp -84.02 -0.12 50.4 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.268 0.556 . . . . 0.90000000000000002 110.637 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.41 53.38 4.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.88 -0.676 . . . . 0.90000000000000002 112.95 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -110.0 133.25 53.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.707 0.289 . . . . 0.90000000000000002 110.633 174.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.8 m -84.74 143.65 29.01 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.277 -0.638 . . . . 0.90000000000000002 109.277 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.4 p -97.32 108.27 20.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.011 0.434 . . . . 0.90000000000000002 111.038 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -96.8 163.42 12.99 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.815 -0.809 . . . . 0.90000000000000002 108.815 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -73.65 95.99 2.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.827 0.346 . . . . 0.90000000000000002 110.32 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.94 -30.53 2.94 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.788 -0.72 . . . . 0.90000000000000002 112.506 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.55 -173.93 42.58 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.629 -0.796 . . . . 0.90000000000000002 112.375 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -102.34 136.72 41.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.629 0.252 . . . . 0.90000000000000002 110.619 -177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -125.75 131.6 52.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.256 -0.429 . . . . 0.90000000000000002 110.857 -176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -132.02 133.77 44.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.607 -0.516 . . . . 0.90000000000000002 109.607 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 78.2 m -86.87 129.92 34.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.766 0.317 . . . . 0.90000000000000002 110.471 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 C-N-CA 121.088 -0.577 . . . . 0.90000000000000002 111.953 179.836 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 999' ' ' COA . . . . . 0.577 ' O9A' ' P1A' ' A' ' 999' ' ' COA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 109.676 -0.49 . . . . 0.90000000000000002 109.676 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.16 117.01 10.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.975 0.417 . . . . 0.90000000000000002 110.286 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.464 HD21 HG11 ' A' ' 77' ' ' VAL . 59.2 tp -75.86 137.05 40.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.142 -0.481 . . . . 0.90000000000000002 109.963 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 42' ' ' ALA . 19.1 m -82.89 89.63 6.86 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.209 0.528 . . . . 0.90000000000000002 110.577 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.47 HD11 ' HB3' ' A' ' 40' ' ' TYR . 5.5 tp -98.35 105.76 17.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.465 -0.789 . . . . 0.90000000000000002 109.003 174.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mt -94.74 149.22 4.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.359 0.6 . . . . 0.90000000000000002 111.535 -170.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -91.59 101.36 14.0 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.726 -1.124 . . . . 0.90000000000000002 108.124 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.477 HD13 ' HB2' ' A' ' 41' ' ' ALA . 94.3 mt -73.11 92.95 1.75 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.192 -0.458 . . . . 0.90000000000000002 111.691 -173.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -102.35 -2.69 28.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.736 0.779 . . . . 0.90000000000000002 109.082 173.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -131.92 120.86 23.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.952 -1.022 . . . . 0.90000000000000002 109.521 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -124.31 99.59 6.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.491 0.186 . . . . 0.90000000000000002 111.066 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.568 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 1.4 m -79.03 158.95 27.79 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.535 -0.913 . . . . 0.90000000000000002 108.535 173.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.554 ' O ' HG12 ' A' ' 17' ' ' ILE . 5.7 p-10 -58.14 -36.45 72.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.658 0.266 . . . . 0.90000000000000002 110.732 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -70.0 -36.56 75.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.90000000000000002 111.125 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -63.74 -38.34 90.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.272 0.558 . . . . 0.90000000000000002 109.765 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 12' ' ' SER . 77.5 mtt180 -68.28 -28.46 67.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.472 -0.785 . . . . 0.90000000000000002 110.468 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 13' ' ' ASP . 46.6 mm -66.8 -41.49 87.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.49 . . . . 0.90000000000000002 110.751 176.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.419 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 28.5 t0 -69.05 -32.48 71.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.04 0.447 . . . . 0.90000000000000002 109.859 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.6 mt -63.23 -38.57 91.68 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.13 -0.486 . . . . 0.90000000000000002 110.236 172.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -68.11 -22.77 64.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.791 -0.64 . . . . 0.90000000000000002 110.559 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HE2' HG21 ' A' ' 17' ' ' ILE . 66.3 mttm -76.84 -32.87 57.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.922 -0.581 . . . . 0.90000000000000002 110.311 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.6 mt -76.98 -39.0 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.847 -0.615 . . . . 0.90000000000000002 110.531 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.499 ' CD1' ' HD2' ' A' ' 67' ' ' ARG . 5.0 m-90 -114.56 90.27 20.97 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.211 -0.45 . . . . 0.90000000000000002 110.668 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.67 -28.53 87.57 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.786 2.324 . . . . 0.90000000000000002 112.701 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.38 2.11 48.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.791 0.329 . . . . 0.90000000000000002 111.108 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.406 ' HB3' ' HB2' ' A' ' 23' ' ' TRP . 43.7 t80 -115.41 149.85 37.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.131 -0.322 . . . . 0.90000000000000002 110.131 -175.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.4 m -116.37 154.78 48.95 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.317 -0.401 . . . . 0.90000000000000002 110.078 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.7 99.35 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.553 2.169 . . . . 0.90000000000000002 112.535 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 m -87.76 -173.17 4.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.99 -0.55 . . . . 0.90000000000000002 110.479 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 p -70.81 -30.39 66.82 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.579 -0.526 . . . . 0.90000000000000002 109.579 170.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.1 mt 67.76 77.11 0.26 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.216 -0.902 . . . . 0.90000000000000002 111.204 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -73.51 111.18 8.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.757 -0.656 . . . . 0.90000000000000002 109.575 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.01 151.43 28.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.032 0.444 . . . . 0.90000000000000002 111.519 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 73.99 -6.66 1.78 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.042 -0.981 . . . . 0.90000000000000002 111.942 171.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -65.87 -29.7 70.19 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.856 -0.794 . . . . 0.90000000000000002 108.856 174.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 171.93 -29.03 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.841 -1.527 . . . . 0.90000000000000002 107.354 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -86.94 116.54 25.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.692 -1.14 . . . . 0.90000000000000002 108.468 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.492 ' HB2' HG12 ' A' ' 54' ' ' VAL . 51.5 mtt180 -109.09 125.78 52.49 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.046 0.45 . . . . 0.90000000000000002 110.4 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.467 HG22 HD12 ' A' ' 8' ' ' LEU . 54.8 mt -108.67 110.0 30.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.804 -0.634 . . . . 0.90000000000000002 109.803 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.47 ' HB3' HD11 ' A' ' 5' ' ' ILE . 65.4 m-85 -104.27 138.49 40.65 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.047 -0.723 . . . . 0.90000000000000002 109.047 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.477 ' HB2' HD13 ' A' ' 8' ' ' LEU . . . -128.68 120.55 26.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.973 0.416 . . . . 0.90000000000000002 111.296 -175.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.627 ' HB1' ' HB2' ' A' ' 50' ' ' ALA . . . -94.45 105.47 17.44 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.746 -0.661 . . . . 0.90000000000000002 109.535 177.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.486 ' HB3' HD23 ' A' ' 48' ' ' LEU . 11.9 ptt180 -99.46 134.71 41.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.383 0.611 . . . . 0.90000000000000002 110.74 -177.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -118.33 119.51 34.85 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.401 -0.963 . . . . 0.90000000000000002 108.401 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.1 t30 60.13 41.87 16.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.696 0.76 . . . . 0.90000000000000002 109.04 -173.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 76.49 -27.05 0.18 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.541 -1.209 . . . . 0.90000000000000002 112.933 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -82.21 137.03 35.01 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.126 -0.324 . . . . 0.90000000000000002 110.126 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.486 HD23 ' HB3' ' A' ' 43' ' ' ARG . 76.4 mt -69.43 97.69 1.02 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 0.90000000000000002 111.009 -175.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.4 tp -78.18 -39.0 42.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.089 -0.505 . . . . 0.90000000000000002 110.883 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.627 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . . . -131.23 126.48 35.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.082 -0.508 . . . . 0.90000000000000002 110.899 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -117.35 125.86 51.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.313 -0.403 . . . . 0.90000000000000002 110.334 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.47 127.95 60.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.146 0.498 . . . . 0.90000000000000002 111.017 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.614 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 5.1 mtp180 -107.04 127.36 53.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.657 -0.497 . . . . 0.90000000000000002 109.657 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.492 HG12 ' HB2' ' A' ' 38' ' ' ARG . 5.2 p -122.57 115.71 46.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.649 0.738 . . . . 0.90000000000000002 110.827 176.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.4 m -91.93 108.63 20.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.47 -0.786 . . . . 0.90000000000000002 109.968 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.14 154.27 19.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.106 0.479 . . . . 0.90000000000000002 110.612 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 5.5 t -136.55 30.4 2.89 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.402 -0.962 . . . . 0.90000000000000002 108.402 176.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.32 -108.07 3.43 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.142 -0.936 . . . . 0.90000000000000002 111.372 -176.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 p -84.67 -1.86 56.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.366 0.603 . . . . 0.90000000000000002 110.68 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 44.8 tt0 -109.93 127.57 54.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.458 -0.792 . . . . 0.90000000000000002 109.414 177.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -127.35 112.89 1.6 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.53 -0.843 . . . . 0.90000000000000002 112.11 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.36 118.5 33.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.888 0.375 . . . . 0.90000000000000002 110.53 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 5.6 mp -93.89 125.61 38.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.319 -0.4 . . . . 0.90000000000000002 109.97 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 4.4 p30 -122.84 135.75 54.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.057 -0.52 . . . . 0.90000000000000002 110.104 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.1 t 66.73 94.1 0.07 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.884 0.849 . . . . 0.90000000000000002 111.273 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.459 HD23 HD21 ' A' ' 82' ' ' LEU . 37.0 tp -122.99 108.01 12.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.999 -1.001 . . . . 0.90000000000000002 109.231 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.499 ' HD2' ' CD1' ' A' ' 23' ' ' TRP . 98.2 mtt180 -130.49 117.89 20.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.269 0.557 . . . . 0.90000000000000002 111.651 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.484 HG11 ' HB3' ' A' ' 50' ' ' ALA . 5.1 t -107.03 141.91 21.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.446 -0.946 . . . . 0.90000000000000002 108.446 171.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -62.65 151.23 38.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.872 0.367 . . . . 0.90000000000000002 110.993 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -54.58 -26.28 31.44 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.358 -0.837 . . . . 0.90000000000000002 113.022 -171.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.19 3.51 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.287 0.565 . . . . 0.90000000000000002 111.177 -176.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.76 13.16 16.11 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.13 -0.356 . . . . 0.90000000000000002 111.142 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -66.42 118.36 9.95 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.435 -0.348 . . . . 0.90000000000000002 110.741 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.429 ' HA ' ' O8A' ' A' ' 999' ' ' COA . 51.5 ttt180 50.47 73.88 0.25 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.263 -0.881 . . . . 0.90000000000000002 110.634 -172.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -138.24 11.77 2.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.873 -0.603 . . . . 0.90000000000000002 110.265 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.95 -32.65 1.96 Allowed Glycine 0 CA--C 1.521 0.43 0 CA-C-N 116.063 -0.517 . . . . 0.90000000000000002 113.539 177.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.464 HG11 HD21 ' A' ' 3' ' ' LEU . 85.4 t -49.74 -42.17 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.281 0.632 . . . . 0.90000000000000002 112.576 -176.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -52.66 -44.57 60.19 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.144 -0.551 . . . . 0.90000000000000002 113.395 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -64.99 -43.58 92.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.90000000000000002 110.785 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -63.5 -49.1 74.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.90000000000000002 110.54 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.419 ' O ' HG23 ' A' ' 85' ' ' VAL . 30.6 tp -49.47 -60.79 2.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.678 -0.692 . . . . 0.90000000000000002 111.798 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.459 HD21 HD23 ' A' ' 66' ' ' LEU . 4.1 mm? -64.78 -43.11 94.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.188 -0.46 . . . . 0.90000000000000002 111.581 -175.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.601 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 40.3 tt0 -63.91 -39.41 94.1 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 121.003 -0.279 . . . . 0.90000000000000002 110.707 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -60.69 -40.46 92.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.962 0.41 . . . . 0.90000000000000002 110.487 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 81' ' ' LEU . 90.1 t -64.16 -38.32 82.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.105 -0.498 . . . . 0.90000000000000002 110.816 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 82' ' ' LEU . 10.6 mp -70.1 -24.94 63.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.42 . . . . 0.90000000000000002 111.159 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.601 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 63.6 mtt180 -76.88 -36.9 56.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.126 0.489 . . . . 0.90000000000000002 109.956 174.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -66.58 -47.45 72.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.286 -0.87 . . . . 0.90000000000000002 111.553 -176.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -75.42 147.6 82.45 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.168 -0.469 . . . . 0.90000000000000002 110.387 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.88 -165.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.987 2.458 . . . . 0.90000000000000002 112.612 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.68 96.29 0.15 Allowed Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.206 -0.521 . . . . 0.90000000000000002 112.83 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.8 t -102.26 -50.4 9.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.072 0.463 . . . . 0.90000000000000002 110.047 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.6 m 70.79 -50.12 0.67 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.05 -0.977 . . . . 0.90000000000000002 112.037 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 47.8 t -89.4 86.36 6.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.058 0.456 . . . . 0.90000000000000002 110.399 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.435 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 96.1 m95 -95.76 121.09 37.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.969 -0.559 . . . . 0.90000000000000002 110.372 178.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -117.11 134.31 54.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.703 -0.681 . . . . 0.90000000000000002 110.555 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.695 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 92.8 mmm -107.15 111.17 23.47 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.176 -0.675 . . . . 0.90000000000000002 109.176 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.95 150.63 22.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.157 -0.474 . . . . 0.90000000000000002 111.18 -174.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.605 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -70.13 -63.81 1.01 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.9 -0.591 . . . . 0.90000000000000002 109.703 179.268 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.61 16.78 6.85 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.67 -0.695 . . . . 0.90000000000000002 111.388 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.15 12.16 12.57 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.743 -0.741 . . . . 0.90000000000000002 113.389 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 99' ' ' ASP . 69.2 t -69.29 104.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 117.262 0.531 . . . . 0.90000000000000002 110.723 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.55 -10.59 45.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.373 0.606 . . . . 0.90000000000000002 109.967 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.13 47.35 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.556 -0.747 . . . . 0.90000000000000002 110.039 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -61.42 -40.1 93.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.546 . . . . 0.90000000000000002 111.93 -173.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.94 -53.17 39.2 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.907 -0.663 . . . . 0.90000000000000002 112.456 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.29 -43.94 98.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.797 0.332 . . . . 0.90000000000000002 110.674 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 91.2 mmm -64.7 -39.07 93.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.90000000000000002 111.462 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 98.9 m -60.86 -43.72 98.01 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.184 -0.206 . . . . 0.90000000000000002 110.818 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.65 -44.76 93.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.083 0.468 . . . . 0.90000000000000002 110.776 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.546 ' HD1' H52A ' A' ' 999' ' ' COA . 17.0 t80 -64.82 -45.11 87.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.749 -0.659 . . . . 0.90000000000000002 110.831 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.556 ' HA ' ' HE3' ' A' ' 112' ' ' MET . 16.9 mmt -62.13 -45.46 93.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.072 -0.513 . . . . 0.90000000000000002 111.105 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -63.54 -34.98 78.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.595 0.236 . . . . 0.90000000000000002 111.16 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.91 -29.45 69.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.005 0.431 . . . . 0.90000000000000002 110.852 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.2 tp -96.71 13.3 28.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.213 0.53 . . . . 0.90000000000000002 110.73 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.86 57.67 4.03 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.961 -0.563 . . . . 0.90000000000000002 113.124 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.527 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 55.6 m-85 -126.0 153.81 43.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.906 0.384 . . . . 0.90000000000000002 110.325 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.9 p -128.22 145.47 51.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.96 -0.563 . . . . 0.90000000000000002 109.809 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.9 t -97.16 124.57 41.25 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.54 -0.541 . . . . 0.90000000000000002 109.54 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -141.79 106.63 4.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.139 -0.482 . . . . 0.90000000000000002 111.851 -172.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 57.75 35.98 26.07 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.805 -0.634 . . . . 0.90000000000000002 112.575 168.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 158.29 -85.1 0.13 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.438 -0.887 . . . . 0.90000000000000002 112.281 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -121.35 -137.21 5.21 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.864 -0.684 . . . . 0.90000000000000002 111.685 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.695 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 19.2 m-90 -112.29 141.47 45.97 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.14 -0.319 . . . . 0.90000000000000002 110.14 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -128.07 142.73 51.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.383 -0.371 . . . . 0.90000000000000002 110.717 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.452 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 54.4 tttp -132.5 89.69 2.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.841 -0.8 . . . . 0.90000000000000002 108.841 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 38.1 t -86.79 97.75 10.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.991 -0.549 . . . . 0.90000000000000002 110.554 -176.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 C-N-CA 121.04 -0.6 . . . . 0.90000000000000002 112.284 179.528 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 999' ' ' COA . . . . . 0.596 ' C5P' ' C9P' ' A' ' 999' ' ' COA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 120.882 0.373 . . . . 0.90000000000000002 110.089 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -121.76 108.08 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.95 0.405 . . . . 0.90000000000000002 110.918 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.4 ' HB3' ' CE2' ' A' ' 80' ' ' TYR . 59.2 tp -87.17 114.98 24.25 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.018 -0.734 . . . . 0.90000000000000002 109.018 174.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 m -82.87 93.44 7.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.342 0.592 . . . . 0.90000000000000002 110.787 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.497 HG23 ' HA ' ' A' ' 42' ' ' ALA . 13.3 pt -113.12 148.55 15.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.223 -0.444 . . . . 0.90000000000000002 110.137 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.454 ' N ' HD11 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -133.94 144.4 35.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.078 -0.51 . . . . 0.90000000000000002 110.359 -177.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -91.94 142.18 27.83 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.261 -0.644 . . . . 0.90000000000000002 109.261 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.52 98.09 1.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.187 0.518 . . . . 0.90000000000000002 111.373 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -89.14 -42.12 11.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.343 -0.844 . . . . 0.90000000000000002 109.077 173.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -136.72 140.31 42.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.766 -1.106 . . . . 0.90000000000000002 109.196 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.489 ' HE2' HG23 ' A' ' 33' ' ' VAL . 34.9 m-85 -97.42 92.95 6.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.975 0.417 . . . . 0.90000000000000002 111.686 -176.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 m -71.94 139.3 48.64 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.022 -0.732 . . . . 0.90000000000000002 109.022 171.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.449 ' O ' HG13 ' A' ' 17' ' ' ILE . 27.1 m-20 -59.32 -41.59 89.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.576 0.227 . . . . 0.90000000000000002 111.106 -177.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -61.59 -39.84 92.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.215 -0.448 . . . . 0.90000000000000002 110.956 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -72.2 -30.98 65.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.752 0.311 . . . . 0.90000000000000002 110.603 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -68.98 -31.23 69.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 0.90000000000000002 110.619 176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 13' ' ' ASP . 79.9 mt -70.27 -36.99 69.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.073 0.463 . . . . 0.90000000000000002 109.829 174.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -64.86 -41.68 95.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.722 -0.672 . . . . 0.90000000000000002 110.016 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.4 mt -59.91 -35.54 75.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.82 -0.627 . . . . 0.90000000000000002 110.708 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -69.35 -25.36 64.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.199 0.523 . . . . 0.90000000000000002 110.097 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -72.81 -27.48 61.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.90000000000000002 109.974 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.772 HD11 ' HB3' ' A' ' 48' ' ' LEU . 60.4 mt -71.23 -43.48 74.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.975 -0.557 . . . . 0.90000000000000002 110.309 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.58 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 4.0 m-90 -113.99 87.6 13.09 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.90000000000000002 111.62 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.27 -9.48 12.64 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.116 1.878 . . . . 0.90000000000000002 110.768 173.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -101.65 8.38 41.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.745 -1.116 . . . . 0.90000000000000002 109.95 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.58 ' HB3' ' HB3' ' A' ' 23' ' ' TRP . 91.9 t80 -129.61 132.72 46.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.504 -0.771 . . . . 0.90000000000000002 109.827 -175.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.5 t -70.82 121.95 85.38 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.698 -0.482 . . . . 0.90000000000000002 109.698 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.43 107.27 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.924 2.416 . . . . 0.90000000000000002 112.735 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 m -83.52 178.55 7.95 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.747 -0.661 . . . . 0.90000000000000002 110.013 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.9 m -60.83 -28.51 68.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 0.90000000000000002 110.446 175.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.8 mt 65.12 98.13 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.28 -0.873 . . . . 0.90000000000000002 110.634 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -131.43 148.53 52.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.299 -0.864 . . . . 0.90000000000000002 110.853 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.489 HG23 ' HE2' ' A' ' 11' ' ' PHE . 15.6 m -132.72 -179.2 3.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.803 -0.635 . . . . 0.90000000000000002 110.434 176.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -146.51 -169.24 3.22 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.577 -1.268 . . . . 0.90000000000000002 107.577 176.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -82.4 -25.75 33.44 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.279 0.561 . . . . 0.90000000000000002 109.696 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 9.2 p30 -96.96 -27.58 14.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.706 -0.679 . . . . 0.90000000000000002 110.722 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -108.42 95.78 5.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.847 -0.427 . . . . 0.90000000000000002 109.847 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.2 mtt85 -117.0 166.73 11.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.183 0.516 . . . . 0.90000000000000002 111.594 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -129.73 135.58 61.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.659 -0.7 . . . . 0.90000000000000002 109.724 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -99.78 129.16 45.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.793 0.33 . . . . 0.90000000000000002 110.603 177.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.44 ' HB2' HD22 ' A' ' 48' ' ' LEU . . . -112.91 116.21 29.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.015 -0.539 . . . . 0.90000000000000002 110.111 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.497 ' HA ' HG23 ' A' ' 5' ' ' ILE . . . -91.9 113.22 25.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.214 -0.448 . . . . 0.90000000000000002 110.188 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -113.38 126.13 55.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.394 0.616 . . . . 0.90000000000000002 111.369 -172.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -97.16 85.58 3.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.748 -0.834 . . . . 0.90000000000000002 108.748 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 64.66 -77.86 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.994 -1.003 . . . . 0.90000000000000002 111.067 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -107.73 -39.28 5.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.858 -0.61 . . . . 0.90000000000000002 111.209 -174.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.624 ' HA ' ' CZ ' ' A' ' 47' ' ' ARG . 2.1 mmp_? -99.05 129.87 45.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.466 . . . . 0.90000000000000002 111.533 -170.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.772 ' HB3' HD11 ' A' ' 22' ' ' ILE . 54.3 mt -67.56 115.41 7.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.152 -0.684 . . . . 0.90000000000000002 109.152 169.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 15.8 tp -97.54 -27.16 14.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.729 -0.669 . . . . 0.90000000000000002 110.769 -170.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.512 ' HB3' HG11 ' A' ' 68' ' ' VAL . . . -152.35 158.0 42.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.072 -0.513 . . . . 0.90000000000000002 110.699 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.57 144.16 26.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.156 -0.474 . . . . 0.90000000000000002 110.108 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 65' ' ' SER . 11.0 p -148.45 143.64 18.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.733 0.302 . . . . 0.90000000000000002 111.088 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -96.54 146.91 24.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.731 0.3 . . . . 0.90000000000000002 110.997 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.03 121.58 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.45 0.643 . . . . 0.90000000000000002 110.783 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.51 ' HB ' ' HB1' ' A' ' 62' ' ' ALA . 21.2 m -110.12 109.25 19.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.817 -0.629 . . . . 0.90000000000000002 110.453 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.522 HD23 HG23 ' A' ' 92' ' ' VAL . 65.0 mt -89.69 113.17 24.62 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.271 0.558 . . . . 0.90000000000000002 110.936 -178.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -114.62 86.17 2.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.698 -0.683 . . . . 0.90000000000000002 109.475 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.88 -107.77 2.22 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.655 -0.783 . . . . 0.90000000000000002 111.681 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.7 p -104.77 1.03 28.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.214 0.53 . . . . 0.90000000000000002 110.575 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -98.97 138.15 36.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.554 -0.748 . . . . 0.90000000000000002 109.918 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -119.98 107.94 1.39 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.741 -0.742 . . . . 0.90000000000000002 111.611 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -92.62 104.59 16.86 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.782 -0.451 . . . . 0.90000000000000002 109.782 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.483 HD21 ' HE3' ' A' ' 97' ' ' MET . 8.9 tt -104.56 127.64 52.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.861 -0.608 . . . . 0.90000000000000002 109.734 -176.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -147.43 176.76 9.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.911 -0.586 . . . . 0.90000000000000002 110.301 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 16.2 m 50.82 80.36 0.08 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.858 0.724 . . . . 0.90000000000000002 111.965 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.4 tp -120.58 120.45 35.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.862 -0.608 . . . . 0.90000000000000002 110.084 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.637 ' HG3' ' O5P' ' A' ' 999' ' ' COA . 39.8 ttt-85 -140.32 124.04 17.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.814 0.34 . . . . 0.90000000000000002 110.51 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.512 HG11 ' HB3' ' A' ' 50' ' ' ALA . 10.5 t -111.1 146.66 15.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.873 -1.158 . . . . 0.90000000000000002 107.873 172.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 49' ' ' LEU . 66.7 mtp85 -60.94 139.6 57.97 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.698 -0.401 . . . . 0.90000000000000002 110.117 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.454 ' H ' ' CD ' ' A' ' 70' ' ' GLU . 1.8 mp0 -52.32 -30.97 30.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.395 -0.821 . . . . 0.90000000000000002 112.839 -171.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.6 t -72.15 -17.15 18.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.995 0.426 . . . . 0.90000000000000002 111.308 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.541 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . 2.3 m -95.35 5.06 52.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.766 0.793 . . . . 0.90000000000000002 110.806 -176.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.644 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 57.7 ttt180 -71.89 134.66 46.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.438 -0.801 . . . . 0.90000000000000002 110.139 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.622 ' HD3' ' O2B' ' A' ' 999' ' ' COA . 29.1 tpt180 69.25 43.39 1.08 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.754 0.787 . . . . 0.90000000000000002 110.191 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.541 ' HD3' ' HA ' ' A' ' 72' ' ' THR . 16.3 mtp180 -134.95 1.9 3.05 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.472 0.545 . . . . 0.90000000000000002 112.472 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.14 -13.6 9.49 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.915 -0.66 . . . . 0.90000000000000002 113.998 176.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -57.5 -43.98 83.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 117.009 0.405 . . . . 0.90000000000000002 111.48 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.28 -39.53 92.7 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.981 -0.628 . . . . 0.90000000000000002 112.406 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.526 ' HA ' HD23 ' A' ' 115' ' ' LEU . 41.1 tt0 -62.43 -47.42 84.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.382 . . . . 0.90000000000000002 110.51 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.421 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 81.9 t80 -57.72 -41.75 82.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.674 -0.694 . . . . 0.90000000000000002 110.686 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.474 HD11 ' HB1' ' A' ' 42' ' ' ALA . 68.3 tp -56.71 -49.99 73.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.90000000000000002 110.748 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.1 -40.68 98.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.90000000000000002 110.963 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 33.5 mt-10 -65.9 -36.77 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.465 -0.334 . . . . 0.90000000000000002 111.109 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 80' ' ' TYR . 7.3 mm-40 -61.79 -39.69 92.58 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.73 0.3 . . . . 0.90000000000000002 111.117 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 81' ' ' LEU . 58.9 t -60.78 -54.51 34.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.005 0.431 . . . . 0.90000000000000002 110.545 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.7 mp -74.9 -4.57 38.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.039 -0.528 . . . . 0.90000000000000002 111.07 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 68.7 ttt180 -80.26 -48.87 12.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.17 -0.468 . . . . 0.90000000000000002 110.226 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -87.67 -8.29 56.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.90000000000000002 110.271 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 15.9 t30 -45.76 120.65 5.22 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.094 -0.957 . . . . 0.90000000000000002 111.583 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 7.7 Cg_exo -73.02 -61.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.146 2.564 . . . . 0.90000000000000002 112.888 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -154.54 35.06 0.69 Allowed Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.211 -0.995 . . . . 0.90000000000000002 113.153 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.522 HG23 HD23 ' A' ' 56' ' ' LEU . 62.3 t -99.84 107.12 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.556 -0.535 . . . . 0.90000000000000002 109.556 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 51.1 m -111.33 -13.83 13.87 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.142 0.423 . . . . 0.90000000000000002 112.142 -174.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 81.8 m -103.82 94.6 5.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.858 0.361 . . . . 0.90000000000000002 110.056 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -97.26 115.97 28.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.142 0.496 . . . . 0.90000000000000002 111.434 -175.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.519 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 74.1 t-105 -104.14 114.29 28.42 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.265 -0.88 . . . . 0.90000000000000002 108.959 175.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.674 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 80.6 mtp -107.35 122.67 47.05 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.548 -0.538 . . . . 0.90000000000000002 109.548 -176.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -124.61 168.74 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.263 -0.426 . . . . 0.90000000000000002 111.423 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.85 -68.03 0.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.441 -0.799 . . . . 0.90000000000000002 111.077 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.99 19.91 10.32 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.539 -0.755 . . . . 0.90000000000000002 111.845 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.73 -20.05 3.29 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.806 -0.711 . . . . 0.90000000000000002 111.661 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 95.7 t -67.79 101.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.121 0.486 . . . . 0.90000000000000002 110.854 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -93.35 -16.56 24.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.952 -0.567 . . . . 0.90000000000000002 110.263 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.05 54.19 1.87 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.795 -0.639 . . . . 0.90000000000000002 110.469 176.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -60.17 -46.95 87.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.757 -0.656 . . . . 0.90000000000000002 111.36 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.16 -49.7 62.23 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 121.031 -0.604 . . . . 0.90000000000000002 112.66 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.45 -46.72 96.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.959 0.409 . . . . 0.90000000000000002 111.269 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 78.0 mtp -78.62 -22.01 47.6 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.17 0.433 . . . . 0.90000000000000002 112.17 -175.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 96.5 m -67.33 -40.44 85.91 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.91 -0.404 . . . . 0.90000000000000002 109.91 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.451 ' HB3' ' N7A' ' A' ' 999' ' ' COA . . . -65.28 -39.29 92.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.187 0.518 . . . . 0.90000000000000002 110.021 175.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.453 ' HD1' ' C5B' ' A' ' 999' ' ' COA . 53.7 t80 -58.52 -51.89 67.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.357 -0.838 . . . . 0.90000000000000002 110.789 175.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.525 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 67.1 mtt -70.98 -27.15 63.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.038 -0.528 . . . . 0.90000000000000002 111.481 -176.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -66.59 -34.16 77.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.922 0.391 . . . . 0.90000000000000002 109.983 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.65 -32.9 66.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.926 -0.579 . . . . 0.90000000000000002 110.75 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 79' ' ' GLN . 11.0 mp -83.34 -4.8 58.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.049 -0.523 . . . . 0.90000000000000002 111.004 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.19 41.41 17.64 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.934 -0.65 . . . . 0.90000000000000002 113.167 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.525 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 59.7 m-85 -92.98 144.24 25.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.857 0.361 . . . . 0.90000000000000002 110.186 174.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.24 144.67 25.08 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.979 -0.555 . . . . 0.90000000000000002 111.26 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.7 p -97.46 140.64 31.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.932 -0.577 . . . . 0.90000000000000002 111.33 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.439 ' HG3' ' HB3' ' A' ' 125' ' ' GLU . 19.3 mm-40 -120.35 -166.77 1.35 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.90000000000000002 109.762 177.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -85.02 96.12 9.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.286 0.565 . . . . 0.90000000000000002 111.122 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.84 44.93 4.69 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.848 -0.691 . . . . 0.90000000000000002 112.542 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.35 -171.93 24.94 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.671 -0.776 . . . . 0.90000000000000002 112.174 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.674 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 15.8 m-90 -116.86 149.56 39.87 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.183 -0.302 . . . . 0.90000000000000002 110.183 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.439 ' HB3' ' HG3' ' A' ' 120' ' ' GLN . 31.2 tt0 -155.8 132.34 10.33 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.172 -0.307 . . . . 0.90000000000000002 110.172 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -137.07 132.58 34.35 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.915 -0.402 . . . . 0.90000000000000002 109.915 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 93' ' ' SER . 49.0 t -119.67 113.2 20.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.316 -0.402 . . . . 0.90000000000000002 110.134 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 C-N-CA 121.009 -0.615 . . . . 0.90000000000000002 112.186 -179.68 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 999' ' ' COA . . . . . 0.644 ' O4A' ' HA ' ' A' ' 73' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 121.198 0.523 . . . . 0.90000000000000002 109.944 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -121.75 155.04 36.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.995 -0.548 . . . . 0.90000000000000002 110.709 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.7 tp -86.09 98.07 10.66 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.42 -0.956 . . . . 0.90000000000000002 108.42 173.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 13.5 m -88.07 89.81 8.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.733 -0.667 . . . . 0.90000000000000002 110.276 -174.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.501 HD11 ' HB3' ' A' ' 40' ' ' TYR . 13.8 tt -96.12 129.41 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.474 0.654 . . . . 0.90000000000000002 110.767 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mt -129.01 154.59 40.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.296 -0.866 . . . . 0.90000000000000002 109.323 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.8 ptt-85 -76.74 113.82 14.82 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.886 -0.783 . . . . 0.90000000000000002 108.886 173.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.604 HD23 HD13 ' A' ' 19' ' ' LEU . 31.1 tp -77.96 100.84 6.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.9 -0.591 . . . . 0.90000000000000002 109.997 -174.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.808 ' HA ' HG12 ' A' ' 33' ' ' VAL . 42.2 mt-10 -113.97 -18.95 11.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.509 -0.769 . . . . 0.90000000000000002 110.902 -175.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.81 113.99 24.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.286 -0.415 . . . . 0.90000000000000002 110.382 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -107.83 101.4 10.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.901 -0.59 . . . . 0.90000000000000002 110.632 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.8 p -84.68 171.28 12.51 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.403 -0.591 . . . . 0.90000000000000002 109.403 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.469 ' O ' HG13 ' A' ' 17' ' ' ILE . 6.6 p-10 -60.38 -31.98 70.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.564 0.221 . . . . 0.90000000000000002 110.561 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -67.27 -51.02 58.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.503 -0.317 . . . . 0.90000000000000002 110.556 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -60.87 -36.81 80.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.277 -0.419 . . . . 0.90000000000000002 109.99 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -55.47 -47.39 76.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.598 -0.728 . . . . 0.90000000000000002 110.159 176.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 13' ' ' ASP . 74.7 mt -65.79 -43.84 93.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.90000000000000002 110.898 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.492 ' O ' HG13 ' A' ' 22' ' ' ILE . 12.9 m-20 -58.76 -52.83 64.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.69 0.281 . . . . 0.90000000000000002 110.955 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.604 HD13 HD23 ' A' ' 8' ' ' LEU . 95.0 mt -64.74 -38.15 90.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.90000000000000002 111.34 -178.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -74.2 -11.48 60.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.098 0.475 . . . . 0.90000000000000002 110.56 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -98.27 -28.16 13.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.379 -0.373 . . . . 0.90000000000000002 110.089 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 18' ' ' ASP . 74.4 mt -65.23 -48.53 83.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.923 -0.769 . . . . 0.90000000000000002 108.923 172.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 4.8 m-90 -107.49 92.3 8.25 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 107.886 -1.153 . . . . 0.90000000000000002 107.886 168.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.63 -3.53 4.52 Favored 'Trans proline' 0 N--CA 1.477 0.538 0 C-N-CA 123.648 2.899 . . . . 0.90000000000000002 114.509 -167.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -134.72 21.26 3.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.986 0.422 . . . . 0.90000000000000002 110.766 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.612 ' HB2' ' HB2' ' A' ' 23' ' ' TRP . 52.4 t80 -81.9 123.82 29.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.977 -0.556 . . . . 0.90000000000000002 109.634 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.9 m -64.13 125.42 88.07 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.35 -0.386 . . . . 0.90000000000000002 110.7 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.6 -31.41 94.36 Favored 'Trans proline' 0 CA--C 1.528 0.203 0 C-N-CA 122.897 2.398 . . . . 0.90000000000000002 112.48 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 p -71.12 -12.86 61.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.144 -0.48 . . . . 0.90000000000000002 111.112 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 57.3 m -88.12 4.31 45.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.314 -0.403 . . . . 0.90000000000000002 110.772 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.5 mt -82.86 86.5 6.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.231 0.539 . . . . 0.90000000000000002 109.895 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -136.46 127.38 27.58 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.483 -0.78 . . . . 0.90000000000000002 109.605 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.808 HG12 ' HA ' ' A' ' 9' ' ' GLU . 15.0 p -106.49 131.32 56.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.513 0.673 . . . . 0.90000000000000002 110.42 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.513 ' HB2' ' H ' ' A' ' 37' ' ' HIS . 14.6 m-20 -130.62 179.28 6.04 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.481 -0.933 . . . . 0.90000000000000002 108.481 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -85.68 -9.47 57.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.805 -0.813 . . . . 0.90000000000000002 108.805 172.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -94.63 -34.47 12.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.415 -0.811 . . . . 0.90000000000000002 109.685 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.513 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 36.0 m80 -120.33 101.0 7.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.762 -0.653 . . . . 0.90000000000000002 109.768 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -109.11 129.0 55.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.82 0.343 . . . . 0.90000000000000002 110.275 -178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.402 HG12 ' HG2' ' A' ' 53' ' ' ARG . 63.7 mt -103.33 116.73 47.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.651 -0.5 . . . . 0.90000000000000002 109.651 176.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.501 ' HB3' HD11 ' A' ' 5' ' ' ILE . 78.8 m-85 -97.55 125.67 42.4 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.884 -0.413 . . . . 0.90000000000000002 109.884 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.47 ' HB3' HD23 ' A' ' 48' ' ' LEU . . . -109.37 113.4 26.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.952 -0.567 . . . . 0.90000000000000002 110.56 -177.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . . . -92.68 102.32 14.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.246 -0.434 . . . . 0.90000000000000002 109.959 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 4' ' ' THR . 19.9 ptt85 -103.37 129.53 50.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.344 0.592 . . . . 0.90000000000000002 110.408 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -105.46 124.61 49.84 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.776 -0.647 . . . . 0.90000000000000002 109.544 -177.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 70.91 -56.91 0.61 Allowed 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.957 0.786 . . . . 0.90000000000000002 110.983 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -154.75 -45.96 0.09 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.505 -0.316 . . . . 0.90000000000000002 111.325 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -104.92 162.83 12.99 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.868 -0.333 . . . . 0.90000000000000002 111.12 -170.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' A' ' 41' ' ' ALA . 84.0 mt -60.78 132.75 54.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.965 -0.561 . . . . 0.90000000000000002 111.865 -176.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 37.1 tp -111.76 -30.38 7.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.551 -0.75 . . . . 0.90000000000000002 109.821 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.509 ' HB1' HG12 ' A' ' 68' ' ' VAL . . . -150.11 147.56 27.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.857 -0.61 . . . . 0.90000000000000002 110.578 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -135.41 127.36 29.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.68 0.276 . . . . 0.90000000000000002 110.434 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.411 ' HB ' HD12 ' A' ' 66' ' ' LEU . 7.1 p -131.37 134.01 61.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.03 0.443 . . . . 0.90000000000000002 110.99 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.526 ' HD3' ' HB2' ' A' ' 65' ' ' SER . 21.4 mtp-105 -110.17 126.69 54.36 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.499 -0.556 . . . . 0.90000000000000002 109.499 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.5 p -120.66 134.62 63.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.422 0.63 . . . . 0.90000000000000002 111.629 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.9 m -100.71 107.69 19.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.401 -0.818 . . . . 0.90000000000000002 109.856 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.9 mt -96.33 130.29 43.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.373 -0.376 . . . . 0.90000000000000002 110.584 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 m -135.78 97.47 3.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.152 -0.476 . . . . 0.90000000000000002 110.191 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.64 -112.56 4.53 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.928 -0.578 . . . . 0.90000000000000002 112.378 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -106.9 11.98 29.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.586 0.708 . . . . 0.90000000000000002 110.278 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -125.61 154.59 42.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.724 -0.671 . . . . 0.90000000000000002 110.344 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.39 132.28 5.24 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.817 -0.706 . . . . 0.90000000000000002 112.079 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.77 126.43 51.02 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.507 -0.553 . . . . 0.90000000000000002 109.507 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 mp -93.46 117.06 29.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.014 0.435 . . . . 0.90000000000000002 110.701 -175.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 20.2 m-20 -109.35 118.53 36.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.605 -0.725 . . . . 0.90000000000000002 110.283 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.526 ' HB2' ' HD3' ' A' ' 53' ' ' ARG . 34.5 m 73.05 107.16 0.07 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.86 0.838 . . . . 0.90000000000000002 111.797 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.411 HD12 ' HB ' ' A' ' 52' ' ' VAL . 29.9 tp -131.97 130.79 41.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.832 -1.076 . . . . 0.90000000000000002 109.504 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.2 ttt-85 -144.02 130.48 19.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.819 0.342 . . . . 0.90000000000000002 110.841 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.509 HG12 ' HB1' ' A' ' 50' ' ' ALA . 13.6 t -107.11 156.42 7.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.356 -0.979 . . . . 0.90000000000000002 108.356 172.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.424 ' HB3' ' HG1' ' A' ' 72' ' ' THR . 76.3 ttt180 -53.87 127.0 24.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.536 -0.913 . . . . 0.90000000000000002 108.536 173.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -57.37 -31.65 65.98 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.361 0.504 . . . . 0.90000000000000002 112.361 -168.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -82.87 16.7 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.365 0.602 . . . . 0.90000000000000002 110.979 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.424 ' HG1' ' HB3' ' A' ' 69' ' ' ARG . 1.8 m -111.73 16.14 20.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.575 0.702 . . . . 0.90000000000000002 110.414 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.746 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 99.9 mtt180 -75.45 137.01 40.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.847 -0.615 . . . . 0.90000000000000002 111.077 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 71.66 27.76 2.88 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.409 -0.814 . . . . 0.90000000000000002 111.698 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -124.98 22.67 7.96 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.284 -0.566 . . . . 0.90000000000000002 112.443 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.79 -27.21 1.64 Allowed Glycine 0 CA--C 1.521 0.454 0 N-CA-C 114.681 0.632 . . . . 0.90000000000000002 114.681 172.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.2 t -50.88 -46.46 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.381 0.512 . . . . 0.90000000000000002 112.381 -175.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.88 -45.51 94.93 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.571 -0.824 . . . . 0.90000000000000002 112.604 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.498 ' HG2' ' HG ' ' A' ' 115' ' ' LEU . 51.2 mt-30 -65.57 -41.68 92.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.871 0.367 . . . . 0.90000000000000002 110.733 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -68.21 -41.92 80.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.90000000000000002 110.585 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.3 tp -48.23 -51.57 24.89 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.331 0.394 . . . . 0.90000000000000002 111.026 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 86' ' ' LEU . 4.4 mm? -60.07 -52.44 65.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.002 -0.544 . . . . 0.90000000000000002 111.433 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -72.09 -16.52 62.02 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.951 -0.3 . . . . 0.90000000000000002 111.726 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -69.77 -42.9 73.2 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.432 -0.581 . . . . 0.90000000000000002 109.432 172.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.55 -41.3 88.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.01 -0.541 . . . . 0.90000000000000002 110.352 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 82' ' ' LEU . 10.9 mp -67.43 -20.38 65.5 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.093 -0.503 . . . . 0.90000000000000002 111.1 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 54.0 ttp85 -83.65 -41.05 18.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.90000000000000002 109.876 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -64.35 -38.94 92.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.523 -0.762 . . . . 0.90000000000000002 110.729 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -119.11 78.77 17.73 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.32 -0.4 . . . . 0.90000000000000002 110.662 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.29 2.21 8.55 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.595 2.197 . . . . 0.90000000000000002 112.319 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.54 10.76 72.47 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.897 -0.592 . . . . 0.90000000000000002 111.97 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.8 t -107.68 127.26 63.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.608 -0.516 . . . . 0.90000000000000002 109.608 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 m -85.53 -53.36 5.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.805 0.336 . . . . 0.90000000000000002 111.576 -175.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.5 t -103.83 116.38 32.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.904 0.383 . . . . 0.90000000000000002 111.09 -174.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -106.9 112.33 25.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.881 -0.599 . . . . 0.90000000000000002 110.064 176.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -105.51 136.46 45.03 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.297 -0.411 . . . . 0.90000000000000002 110.121 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.641 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 97.4 mmm -107.27 119.74 40.22 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.506 -0.553 . . . . 0.90000000000000002 109.506 177.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.65 144.98 25.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.009 0.433 . . . . 0.90000000000000002 111.766 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.407 ' CG ' HH21 ' A' ' 105' ' ' ARG . 10.6 t70 -80.26 -69.61 0.58 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.495 -0.775 . . . . 0.90000000000000002 109.908 177.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 64.73 23.17 12.71 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.571 -0.741 . . . . 0.90000000000000002 112.945 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.4 40.29 0.96 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.332 -0.937 . . . . 0.90000000000000002 112.905 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.735 HG13 ' HG3' ' A' ' 108' ' ' MET . 77.0 t -88.31 112.48 23.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.84 0.353 . . . . 0.90000000000000002 110.368 176.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -82.57 -32.27 28.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.301 -0.409 . . . . 0.90000000000000002 110.677 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -87.49 55.23 3.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.222 0.534 . . . . 0.90000000000000002 109.859 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.407 HH21 ' CG ' ' A' ' 99' ' ' ASP . 34.7 ttm180 -66.23 -31.11 71.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.561 -0.745 . . . . 0.90000000000000002 111.043 -176.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.74 -56.39 25.53 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.913 -0.661 . . . . 0.90000000000000002 112.062 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.5 t -61.48 -42.42 93.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.90000000000000002 111.001 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.735 ' HG3' HG13 ' A' ' 102' ' ' VAL . 93.0 mmm -64.46 -38.23 90.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.90000000000000002 111.538 -177.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 61.5 m -67.52 -41.26 84.67 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 121.087 -0.245 . . . . 0.90000000000000002 110.411 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.14 88.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.302 0.573 . . . . 0.90000000000000002 110.245 176.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -61.98 -48.71 79.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.415 -0.811 . . . . 0.90000000000000002 110.716 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.53 ' HG2' ' O ' ' A' ' 108' ' ' MET . 26.4 mmt -62.44 -43.2 99.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.93 -0.577 . . . . 0.90000000000000002 111.122 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -62.09 -39.33 92.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.501 -0.318 . . . . 0.90000000000000002 111.204 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.51 -22.11 61.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.112 0.482 . . . . 0.90000000000000002 110.888 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.498 ' HG ' ' HG2' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -91.05 -2.69 57.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.299 0.571 . . . . 0.90000000000000002 110.31 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.85 32.61 20.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.841 -0.695 . . . . 0.90000000000000002 113.03 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 75.7 m-85 -98.63 139.85 33.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.041 0.448 . . . . 0.90000000000000002 110.419 176.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.1 m -90.41 144.21 26.02 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.852 -0.613 . . . . 0.90000000000000002 109.853 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 30.2 p -97.31 115.97 28.64 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.801 0.334 . . . . 0.90000000000000002 110.438 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -137.02 161.46 36.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.352 -0.385 . . . . 0.90000000000000002 110.072 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -45.45 106.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.836 0.71 . . . . 0.90000000000000002 112.188 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 120.93 -21.18 8.42 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.486 -0.864 . . . . 0.90000000000000002 113.382 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 159.07 -131.69 2.83 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.244 -0.979 . . . . 0.90000000000000002 112.741 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.641 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 12.8 m-90 -125.98 140.0 52.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.637 0.256 . . . . 0.90000000000000002 110.504 -177.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -128.46 134.35 48.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 0.90000000000000002 109.93 -175.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.51 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 84.8 tttt -137.19 92.17 2.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.07 0.462 . . . . 0.90000000000000002 110.54 173.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 39.9 t -80.22 131.32 35.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.908 -0.587 . . . . 0.90000000000000002 110.496 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 C-N-CA 120.867 -0.682 . . . . 0.90000000000000002 111.993 179.132 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 999' ' ' COA . . . . . 0.746 ' O4A' ' HA ' ' A' ' 73' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.2 mmm . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 120.792 0.329 . . . . 0.90000000000000002 110.597 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.47 135.05 33.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.193 -0.458 . . . . 0.90000000000000002 109.962 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.504 HD23 HG12 ' A' ' 77' ' ' VAL . 52.5 tp -95.72 127.73 41.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.232 -0.44 . . . . 0.90000000000000002 110.476 -177.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.9 m -89.69 95.32 10.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.898 0.38 . . . . 0.90000000000000002 110.624 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.529 HG22 ' HA ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -103.49 129.1 55.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.118 0.485 . . . . 0.90000000000000002 110.052 177.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.18 151.9 36.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.769 -0.651 . . . . 0.90000000000000002 109.888 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -75.29 130.18 38.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.876 -0.416 . . . . 0.90000000000000002 109.876 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.458 HD23 HD12 ' A' ' 19' ' ' LEU . 38.6 tp -76.01 59.36 1.29 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.605 0.717 . . . . 0.90000000000000002 110.165 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -91.39 -13.91 31.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.474 -0.785 . . . . 0.90000000000000002 109.511 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -112.92 107.21 15.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.015 -0.993 . . . . 0.90000000000000002 109.834 177.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -88.43 82.94 6.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.296 0.569 . . . . 0.90000000000000002 110.892 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.8 m -85.66 150.56 24.53 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.327 -0.851 . . . . 0.90000000000000002 109.303 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.62 -35.72 70.84 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.245 -0.28 . . . . 0.90000000000000002 110.245 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -52.14 -55.77 18.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.678 -0.692 . . . . 0.90000000000000002 110.526 175.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.436 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 18.8 m-20 -68.51 -41.3 80.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.649 -0.705 . . . . 0.90000000000000002 111.299 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -61.11 -39.14 88.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.728 0.27 . . . . 0.90000000000000002 111.728 -176.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.7 mt -70.13 -41.64 79.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.939 0.4 . . . . 0.90000000000000002 110.375 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.48 -34.54 78.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.90000000000000002 110.104 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.458 HD12 HD23 ' A' ' 8' ' ' LEU . 73.0 mt -62.39 -39.26 92.63 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.092 -0.504 . . . . 0.90000000000000002 110.83 174.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -75.13 -10.43 59.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.026 0.441 . . . . 0.90000000000000002 111.001 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -86.46 -22.94 26.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.501 -0.318 . . . . 0.90000000000000002 110.24 170.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.36 -45.82 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.228 0.537 . . . . 0.90000000000000002 109.611 173.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -107.6 108.09 61.16 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.573 -0.739 . . . . 0.90000000000000002 109.39 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -36.13 -56.11 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 124.46 3.44 . . . . 0.90000000000000002 114.193 -172.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -145.99 87.48 1.76 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.469 0.652 . . . . 0.90000000000000002 109.797 174.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.673 ' HE2' ' HG ' ' A' ' 31' ' ' LEU . 74.7 t80 -100.04 137.6 38.26 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.034 -0.985 . . . . 0.90000000000000002 111.195 -176.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 p -74.32 122.21 87.0 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.959 -0.564 . . . . 0.90000000000000002 110.917 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.35 -4.33 15.03 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.812 2.341 . . . . 0.90000000000000002 113.106 -176.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 m -65.03 -30.83 71.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.90000000000000002 111.441 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.512 ' HB2' ' HH ' ' A' ' 26' ' ' TYR . 14.5 m -93.88 4.82 53.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.97 0.414 . . . . 0.90000000000000002 111.547 -176.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.673 ' HG ' ' HE2' ' A' ' 26' ' ' TYR . 43.1 mt -81.89 86.51 6.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.90000000000000002 110.378 176.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -135.68 106.0 6.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.803 -0.635 . . . . 0.90000000000000002 110.405 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.4 t -98.18 135.89 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.773 -0.649 . . . . 0.90000000000000002 110.132 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -146.23 -173.86 4.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.526 -0.546 . . . . 0.90000000000000002 109.526 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.81 -20.98 66.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.12 0.486 . . . . 0.90000000000000002 111.084 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -93.11 -55.7 3.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.221 -0.445 . . . . 0.90000000000000002 110.483 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -84.32 98.13 9.84 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.56 -0.533 . . . . 0.90000000000000002 109.56 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -108.91 121.35 44.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.964 0.411 . . . . 0.90000000000000002 110.41 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.845 HG12 ' HG2' ' A' ' 53' ' ' ARG . 56.4 mt -98.88 115.39 39.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.087 -0.506 . . . . 0.90000000000000002 110.215 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -94.05 122.34 36.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.598 -0.728 . . . . 0.90000000000000002 109.364 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.477 ' HB2' HD21 ' A' ' 48' ' ' LEU . . . -108.11 123.36 48.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.905 -0.589 . . . . 0.90000000000000002 110.09 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.761 ' HB1' ' HB1' ' A' ' 50' ' ' ALA . . . -91.89 100.4 13.08 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.416 -0.587 . . . . 0.90000000000000002 109.416 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -95.06 115.61 27.64 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.844 -1.071 . . . . 0.90000000000000002 109.792 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.484 ' HB3' HD13 ' A' ' 49' ' ' LEU . 73.2 t80 -97.28 88.66 4.5 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.25 -0.648 . . . . 0.90000000000000002 109.25 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.62 -65.09 0.36 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.417 -1.265 . . . . 0.90000000000000002 111.859 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 47' ' ' ARG . 4.9 pt-20 -109.16 -51.24 2.9 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.671 0.619 . . . . 0.90000000000000002 112.671 -174.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.459 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 28.0 ptt-85 -127.0 173.8 9.36 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.634 -0.426 . . . . 0.90000000000000002 111.685 -171.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.477 HD21 ' HB2' ' A' ' 41' ' ' ALA . 41.9 mt -87.06 111.25 20.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.53 . . . . 0.90000000000000002 110.348 -175.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.484 HD13 ' HB3' ' A' ' 44' ' ' PHE . 9.9 mp -88.13 -31.41 19.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.687 0.28 . . . . 0.90000000000000002 110.68 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.761 ' HB1' ' HB1' ' A' ' 42' ' ' ALA . . . -127.07 131.99 50.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.268 -0.424 . . . . 0.90000000000000002 110.992 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.12 115.94 21.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.286 -0.415 . . . . 0.90000000000000002 110.155 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.2 p -126.8 136.55 60.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.098 0.475 . . . . 0.90000000000000002 111.151 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.845 ' HG2' HG12 ' A' ' 39' ' ' ILE . 99.0 mtt180 -111.77 115.72 29.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.134 -0.485 . . . . 0.90000000000000002 110.64 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.6 p -107.18 107.46 22.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.849 0.833 . . . . 0.90000000000000002 110.032 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.9 m -87.5 106.82 18.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.296 -0.865 . . . . 0.90000000000000002 110.185 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.8 mt -80.63 104.51 11.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.07 -0.514 . . . . 0.90000000000000002 110.39 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -103.13 106.34 16.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.611 -0.722 . . . . 0.90000000000000002 109.238 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.86 -96.79 0.61 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.008 -0.837 . . . . 0.90000000000000002 111.008 -174.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.1 p -128.27 2.68 5.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.909 0.385 . . . . 0.90000000000000002 110.776 175.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.533 ' HA ' HG12 ' A' ' 92' ' ' VAL . 23.8 mm-40 -104.84 141.59 36.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.31 -0.405 . . . . 0.90000000000000002 110.721 -175.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.12 112.35 4.38 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.786 -0.721 . . . . 0.90000000000000002 112.352 -177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.581 ' HA ' ' HB3' ' A' ' 96' ' ' TRP . . . -105.28 111.72 24.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.696 0.284 . . . . 0.90000000000000002 110.438 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 53' ' ' ARG . 5.2 mp -93.45 110.76 22.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.19 0.519 . . . . 0.90000000000000002 109.803 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.605 ' HA ' ' HB2' ' A' ' 98' ' ' ALA . 1.8 p30 -96.06 -36.14 11.12 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.496 -0.774 . . . . 0.90000000000000002 111.801 -173.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.0 m -120.58 125.29 47.42 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.791 0.329 . . . . 0.90000000000000002 111.158 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.411 ' HB3' ' H22' ' A' ' 999' ' ' COA . 56.4 tp -145.61 102.72 3.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.922 -0.581 . . . . 0.90000000000000002 110.052 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.498 ' HD2' ' H71' ' A' ' 999' ' ' COA . 26.2 mmm180 -131.43 113.0 13.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.417 -0.356 . . . . 0.90000000000000002 110.775 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 50' ' ' ALA . 2.9 t -110.22 136.04 47.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.308 -0.997 . . . . 0.90000000000000002 108.308 172.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -87.56 -176.28 5.51 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.044 0.757 . . . . 0.90000000000000002 113.044 -174.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -55.33 -27.07 44.67 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.399 -1.273 . . . . 0.90000000000000002 114.387 -165.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.6 t -65.43 -30.57 50.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.168 0.509 . . . . 0.90000000000000002 111.691 -175.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.578 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 6.5 m -98.77 32.66 2.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.463 0.649 . . . . 0.90000000000000002 111.16 -173.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -65.27 97.57 0.28 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.868 -0.606 . . . . 0.90000000000000002 111.886 -178.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.437 ' HG2' ' C2A' ' A' ' 999' ' ' COA . 67.6 mtp180 53.02 80.04 0.11 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.731 -0.668 . . . . 0.90000000000000002 112.091 170.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 75' ' ' ARG . 9.3 mmt180 -136.61 -54.27 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.90000000000000002 111.239 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.78 -21.67 0.46 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.68 -0.772 . . . . 0.90000000000000002 111.775 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.578 ' HB ' ' CG2' ' A' ' 72' ' ' THR . 72.6 t -55.85 -44.23 76.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 122.332 0.253 . . . . 0.90000000000000002 111.499 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.404 ' HA3' ' O1A' ' A' ' 999' ' ' COA . . . -54.11 -49.44 59.37 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.789 -0.719 . . . . 0.90000000000000002 112.905 178.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -60.65 -52.32 65.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.454 0.169 . . . . 0.90000000000000002 110.592 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -58.96 -42.45 89.9 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.255 -0.43 . . . . 0.90000000000000002 111.128 -176.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 85' ' ' VAL . 63.6 tp -52.56 -53.31 48.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.776 0.322 . . . . 0.90000000000000002 110.679 178.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.42 ' O ' HD13 ' A' ' 86' ' ' LEU . 46.8 mt -70.31 -45.47 66.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.296 -0.411 . . . . 0.90000000000000002 111.423 -177.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -62.67 -32.22 73.24 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.07 -0.252 . . . . 0.90000000000000002 111.071 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -67.69 -41.42 83.64 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.065 -0.346 . . . . 0.90000000000000002 110.065 176.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 81' ' ' LEU . 85.1 t -63.09 -46.27 96.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 121.205 0.526 . . . . 0.90000000000000002 110.645 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.468 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 10.9 mp -70.47 -19.85 62.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.789 -0.641 . . . . 0.90000000000000002 111.108 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -86.91 -30.22 21.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.318 -0.401 . . . . 0.90000000000000002 110.191 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -63.62 -52.87 58.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.90000000000000002 110.51 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -118.5 101.17 51.13 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 0.90000000000000002 110.784 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.91 -6.13 12.28 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.224 2.616 . . . . 0.90000000000000002 112.035 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.36 48.77 4.1 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.241 -0.504 . . . . 0.90000000000000002 112.691 -177.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 60' ' ' GLU . 97.4 t -135.94 134.51 50.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.13 -0.693 . . . . 0.90000000000000002 109.13 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 61.8 p -96.57 -32.83 12.06 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.566 -0.454 . . . . 0.90000000000000002 110.933 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 77.8 m -130.37 113.98 15.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.891 0.376 . . . . 0.90000000000000002 111.322 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.468 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 95.6 m95 -90.94 113.49 25.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.161 -0.681 . . . . 0.90000000000000002 109.161 173.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.581 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . 2.9 t-105 -96.94 128.09 43.57 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.622 -0.717 . . . . 0.90000000000000002 109.959 -172.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 1.008 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 13.4 mmt -108.45 115.38 29.99 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.354 -0.61 . . . . 0.90000000000000002 109.354 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.605 ' HB2' ' HA ' ' A' ' 64' ' ' ASP . . . -99.48 173.84 6.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.513 -0.767 . . . . 0.90000000000000002 112.566 -169.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -129.29 93.04 3.48 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.067 -0.97 . . . . 0.90000000000000002 109.42 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -92.36 26.85 2.43 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.817 -1.083 . . . . 0.90000000000000002 110.975 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.5 46.48 0.85 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.773 -0.727 . . . . 0.90000000000000002 111.423 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 56.8 t -78.01 98.92 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.93 0.395 . . . . 0.90000000000000002 110.895 -178.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -70.83 -33.66 70.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.69 -0.686 . . . . 0.90000000000000002 110.114 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -79.41 47.39 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.766 . . . . 0.90000000000000002 110.089 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.97 -57.4 13.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.123 -0.944 . . . . 0.90000000000000002 111.879 -172.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.29 99.34 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 121.178 -0.534 . . . . 0.90000000000000002 112.527 -175.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.9 t -58.39 -47.52 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.90000000000000002 110.78 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.486 ' HG3' ' H31' ' A' ' 999' ' ' COA . 89.5 mmm -71.01 -32.62 69.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.90000000000000002 111.131 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 80.1 m -59.25 -44.18 92.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.982 0.42 . . . . 0.90000000000000002 110.041 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.32 -41.32 96.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.902 -0.59 . . . . 0.90000000000000002 110.893 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -66.32 -52.4 47.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.052 -0.522 . . . . 0.90000000000000002 111.278 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -56.75 -50.05 73.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.36 -0.382 . . . . 0.90000000000000002 111.609 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -65.52 -31.8 73.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.619 0.247 . . . . 0.90000000000000002 111.116 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.65 -31.04 63.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.931 0.396 . . . . 0.90000000000000002 111.21 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.703 HD21 ' HE1' ' A' ' 117' ' ' PHE . 21.0 tp -88.36 -9.84 51.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.122 0.487 . . . . 0.90000000000000002 110.542 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.95 36.54 4.96 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.74 -0.743 . . . . 0.90000000000000002 113.13 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.703 ' HE1' HD21 ' A' ' 115' ' ' LEU . 62.5 m-85 -99.68 102.2 13.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.957 0.378 . . . . 0.90000000000000002 110.239 174.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.18 143.7 56.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.159 -0.473 . . . . 0.90000000000000002 110.828 177.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 m -99.28 136.25 39.5 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.209 -0.45 . . . . 0.90000000000000002 111.034 -174.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -79.18 11.85 2.62 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.989 -0.551 . . . . 0.90000000000000002 110.787 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 63.66 29.19 15.09 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.67 0.748 . . . . 0.90000000000000002 109.549 -172.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -168.85 -64.89 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.019 -1.233 . . . . 0.90000000000000002 110.019 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -109.73 -168.68 20.08 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.251 -1.14 . . . . 0.90000000000000002 110.251 169.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 1.008 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 12.9 m-90 -113.96 144.55 42.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.876 0.838 . . . . 0.90000000000000002 110.339 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -149.14 114.81 5.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.011 -0.366 . . . . 0.90000000000000002 110.011 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 61.7 tttp -96.71 111.67 23.74 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.092 -0.336 . . . . 0.90000000000000002 110.092 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 56.0 m -88.78 95.31 10.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.113 -0.494 . . . . 0.90000000000000002 110.736 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.945 -0.645 . . . . 0.90000000000000002 112.568 179.53 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 999' ' ' COA . . . . . 0.498 ' H71' ' HD2' ' A' ' 67' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.753 0.311 . . . . 0.90000000000000002 110.436 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 2' ' ' LYS . 51.4 mtpt -109.93 164.67 12.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.228 -0.442 . . . . 0.90000000000000002 109.85 176.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.458 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 43.1 tp -81.88 99.61 9.14 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.547 -0.538 . . . . 0.90000000000000002 109.547 176.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.572 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 16.7 m -83.11 96.71 8.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.931 0.396 . . . . 0.90000000000000002 110.174 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 tt -104.47 123.93 58.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.437 0.637 . . . . 0.90000000000000002 110.937 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.2 177.95 6.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.174 -0.921 . . . . 0.90000000000000002 109.314 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -94.8 147.01 23.79 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 110.024 -0.361 . . . . 0.90000000000000002 110.024 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.7 mt -75.96 98.86 4.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.205 0.526 . . . . 0.90000000000000002 110.765 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -106.87 -23.94 12.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.389 -0.823 . . . . 0.90000000000000002 109.154 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -124.97 124.96 43.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.724 -1.125 . . . . 0.90000000000000002 109.791 -172.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.96 91.92 3.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.523 -0.308 . . . . 0.90000000000000002 110.783 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -83.33 173.74 11.31 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.637 -0.505 . . . . 0.90000000000000002 109.637 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.553 ' O ' HG13 ' A' ' 17' ' ' ILE . 30.2 t70 -62.6 -52.63 62.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.577 -0.283 . . . . 0.90000000000000002 111.468 -178.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.515 ' HA ' HD13 ' A' ' 17' ' ' ILE . 52.4 tt0 -72.18 -25.73 61.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.906 0.384 . . . . 0.90000000000000002 110.316 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -62.48 -42.34 99.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.126 -0.694 . . . . 0.90000000000000002 109.126 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 16' ' ' ARG . 22.2 ttt85 -65.05 -39.09 92.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.819 -0.628 . . . . 0.90000000000000002 110.217 174.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.589 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 76.4 mt -59.82 -41.97 87.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.366 -0.379 . . . . 0.90000000000000002 111.356 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.95 -40.11 83.31 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.251 0.548 . . . . 0.90000000000000002 110.38 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.69 -31.91 73.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.90000000000000002 110.333 173.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -78.94 -10.1 59.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.625 -0.716 . . . . 0.90000000000000002 110.221 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 64.3 mttm -82.33 -31.62 29.79 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.857 -0.794 . . . . 0.90000000000000002 108.857 170.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.1 mt -72.16 -46.25 59.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.336 -0.847 . . . . 0.90000000000000002 109.783 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 6.5 m-90 -117.97 97.38 50.71 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.007 -0.542 . . . . 0.90000000000000002 109.798 175.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -58.49 -25.05 72.36 Favored 'Trans proline' 0 N--CA 1.476 0.479 0 C-N-CA 123.174 2.583 . . . . 0.90000000000000002 113.154 -175.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -143.07 86.16 1.9 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.42 -0.585 . . . . 0.90000000000000002 109.42 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.633 ' HE2' ' HG ' ' A' ' 31' ' ' LEU . 91.9 t80 -125.52 123.2 38.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.778 -0.646 . . . . 0.90000000000000002 111.446 -176.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.1 m -88.64 138.61 29.75 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.737 -0.665 . . . . 0.90000000000000002 109.257 171.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HB3' HD11 ' A' ' 31' ' ' LEU . 12.5 Cg_endo -55.8 97.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.951 2.434 . . . . 0.90000000000000002 112.756 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.7 m -108.58 -60.49 1.73 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.521 . . . . 0.90000000000000002 110.19 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.435 ' O ' HD11 ' A' ' 39' ' ' ILE . 29.4 p -97.24 -0.43 46.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.051 -0.522 . . . . 0.90000000000000002 110.765 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.633 ' HG ' ' HE2' ' A' ' 26' ' ' TYR . 64.3 mt -62.4 -21.11 65.11 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.992 0.425 . . . . 0.90000000000000002 110.866 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -73.49 98.64 2.82 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.955 -0.757 . . . . 0.90000000000000002 108.955 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.4 m -92.97 151.39 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.382 0.611 . . . . 0.90000000000000002 110.67 -175.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -151.59 171.97 16.78 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.026 -0.988 . . . . 0.90000000000000002 108.593 -173.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.96 -29.08 68.83 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.866 -0.42 . . . . 0.90000000000000002 109.866 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -90.13 -33.28 16.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.077 -0.51 . . . . 0.90000000000000002 110.772 176.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -104.56 99.4 9.08 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.51 -0.313 . . . . 0.90000000000000002 110.168 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -114.64 139.47 49.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.305 0.574 . . . . 0.90000000000000002 111.668 -173.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.435 HD11 ' O ' ' A' ' 30' ' ' SER . 55.3 mt -119.48 116.57 51.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.658 -0.701 . . . . 0.90000000000000002 109.201 171.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -99.61 129.73 45.78 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.797 -0.445 . . . . 0.90000000000000002 109.797 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.475 ' HB3' HD23 ' A' ' 48' ' ' LEU . . . -118.19 120.71 38.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.74 -0.663 . . . . 0.90000000000000002 110.519 -176.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.811 ' HB1' ' HB3' ' A' ' 50' ' ' ALA . . . -92.09 107.09 18.96 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.663 -0.698 . . . . 0.90000000000000002 110.071 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 4' ' ' THR . 26.3 ptt180 -96.53 132.62 41.94 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.403 0.62 . . . . 0.90000000000000002 110.507 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.458 ' HB3' HD12 ' A' ' 49' ' ' LEU . 77.5 t80 -101.1 104.23 15.34 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.617 -0.883 . . . . 0.90000000000000002 108.617 176.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 31.3 t30 72.1 -62.19 0.47 Allowed 'General case' 0 C--N 1.331 -0.217 0 O-C-N 124.005 0.816 . . . . 0.90000000000000002 110.801 -176.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -136.45 -57.72 0.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.359 0.503 . . . . 0.90000000000000002 112.359 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -94.61 167.29 11.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.975 0.417 . . . . 0.90000000000000002 111.727 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.475 HD23 ' HB3' ' A' ' 41' ' ' ALA . 35.9 mt -91.21 106.6 18.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.615 -0.721 . . . . 0.90000000000000002 110.934 -171.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 44' ' ' PHE . 10.9 mp -92.93 -15.18 26.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.344 -0.389 . . . . 0.90000000000000002 111.122 -178.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.811 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . . . -137.21 125.97 23.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.754 0.311 . . . . 0.90000000000000002 111.017 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -123.67 130.22 52.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.322 -0.399 . . . . 0.90000000000000002 110.636 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.6 p -135.15 134.05 53.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.057 0.456 . . . . 0.90000000000000002 111.002 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.625 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 39.5 mtp180 -99.45 134.73 41.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.244 -0.434 . . . . 0.90000000000000002 110.188 177.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.2 p -139.91 126.76 23.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.611 0.719 . . . . 0.90000000000000002 111.596 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -108.93 115.22 29.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.543 -0.753 . . . . 0.90000000000000002 109.756 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -85.69 106.73 17.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.247 0.546 . . . . 0.90000000000000002 110.807 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -93.63 45.96 1.17 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.451 -0.795 . . . . 0.90000000000000002 109.28 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.54 -105.87 3.05 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.77 -0.65 . . . . 0.90000000000000002 111.761 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.5 p -83.04 -17.45 43.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.112 0.482 . . . . 0.90000000000000002 110.991 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -106.01 118.47 36.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.616 -0.72 . . . . 0.90000000000000002 110.694 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.73 114.07 4.89 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.144 -0.782 . . . . 0.90000000000000002 111.144 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.37 105.1 17.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.902 0.382 . . . . 0.90000000000000002 111.275 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.408 HD11 ' HE3' ' A' ' 95' ' ' TRP . 5.0 mp -95.16 111.97 23.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.048 -0.524 . . . . 0.90000000000000002 109.908 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.625 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 10.3 t0 -118.23 138.31 52.42 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.748 -0.464 . . . . 0.90000000000000002 109.748 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.447 ' HB2' ' HD3' ' A' ' 53' ' ' ARG . 20.2 m 68.39 91.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.628 0.727 . . . . 0.90000000000000002 111.501 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.7 tp -108.14 110.65 22.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.978 -1.01 . . . . 0.90000000000000002 108.409 171.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.567 ' HA ' ' O5P' ' A' ' 999' ' ' COA . 83.1 mtt-85 -127.3 104.62 8.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.06 0.457 . . . . 0.90000000000000002 111.302 -176.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.475 HG13 ' HB1' ' A' ' 50' ' ' ALA . 8.3 t -100.91 144.69 12.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.391 -0.966 . . . . 0.90000000000000002 108.391 172.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -61.83 155.6 22.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.257 0.551 . . . . 0.90000000000000002 112.363 -174.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -48.72 -41.04 30.69 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.322 -1.308 . . . . 0.90000000000000002 113.481 -165.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.83 -13.92 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.975 0.417 . . . . 0.90000000000000002 112.095 -171.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 m -88.02 60.6 5.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.438 0.637 . . . . 0.90000000000000002 111.607 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.519 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 29.8 ptt-85 -115.99 130.47 56.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.855 -0.611 . . . . 0.90000000000000002 110.675 176.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 52.81 53.57 11.91 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.956 -0.565 . . . . 0.90000000000000002 111.479 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.6 ttt180 -135.98 14.13 3.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.901 0.381 . . . . 0.90000000000000002 111.257 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.09 -35.64 2.56 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.108 -0.568 . . . . 0.90000000000000002 113.972 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.447 HG13 HD23 ' A' ' 3' ' ' LEU . 49.6 t -50.26 -41.79 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 122.974 0.51 . . . . 0.90000000000000002 112.355 -175.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.35 -45.28 93.03 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.953 -0.641 . . . . 0.90000000000000002 113.145 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -65.69 -49.87 66.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.927 0.394 . . . . 0.90000000000000002 110.245 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.458 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 48.0 t80 -54.4 -42.5 70.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.414 -0.812 . . . . 0.90000000000000002 110.366 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.41 ' O ' HG21 ' A' ' 85' ' ' VAL . 59.3 tp -52.76 -67.65 0.23 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.059 -0.973 . . . . 0.90000000000000002 111.847 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.1 -41.27 97.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.427 -0.351 . . . . 0.90000000000000002 111.693 -174.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 23.8 mt-10 -61.79 -37.53 84.69 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.698 -0.401 . . . . 0.90000000000000002 111.804 -177.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -70.77 -31.97 68.93 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.292 -0.563 . . . . 0.90000000000000002 110.535 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 81' ' ' LEU . 67.1 t -61.58 -45.41 98.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 110.013 -0.365 . . . . 0.90000000000000002 110.013 174.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.544 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 11.2 mp -67.32 -18.72 65.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.964 -0.562 . . . . 0.90000000000000002 111.19 178.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 79.3 mtp180 -81.27 -41.17 22.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.057 0.456 . . . . 0.90000000000000002 110.833 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -80.42 -29.95 37.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.142 -0.481 . . . . 0.90000000000000002 111.902 -174.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.523 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 0.9 OUTLIER -86.0 117.38 68.6 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.894 0.378 . . . . 0.90000000000000002 110.181 176.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.523 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 1.4 Cg_endo -83.45 -73.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.426 2.751 . . . . 0.90000000000000002 113.877 -172.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.43 53.45 4.67 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.092 -0.575 . . . . 0.90000000000000002 113.64 -171.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.6 t -124.2 115.2 44.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.685 -0.487 . . . . 0.90000000000000002 109.685 176.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 p -105.57 -24.36 12.6 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.404 -0.362 . . . . 0.90000000000000002 111.766 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 46.1 t -116.67 106.07 13.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.841 0.353 . . . . 0.90000000000000002 110.116 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.544 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 97.7 m95 -93.34 111.98 23.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.108 0.48 . . . . 0.90000000000000002 110.248 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -111.45 123.85 51.07 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.025 -0.731 . . . . 0.90000000000000002 109.025 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 68.6 mtp -119.03 117.11 27.88 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.707 -0.479 . . . . 0.90000000000000002 109.707 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.22 146.75 24.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.038 0.447 . . . . 0.90000000000000002 111.82 -171.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.482 ' HB3' ' CZ3' ' A' ' 124' ' ' TRP . 5.8 p-10 -98.8 14.95 26.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.669 -0.696 . . . . 0.90000000000000002 110.651 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.93 -55.87 29.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.90000000000000002 110.855 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -97.97 44.67 1.78 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.605 -0.807 . . . . 0.90000000000000002 112.312 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.409 HG11 ' SD ' ' A' ' 108' ' ' MET . 57.3 t -135.48 101.85 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.796 0.331 . . . . 0.90000000000000002 110.763 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.711 ' HB2' ' S1P' ' A' ' 999' ' ' COA . 2.3 mp0 -67.67 -41.83 83.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.065 0.46 . . . . 0.90000000000000002 110.766 178.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -84.93 59.51 5.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.362 0.601 . . . . 0.90000000000000002 110.489 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -63.16 -39.8 95.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.276 -0.875 . . . . 0.90000000000000002 111.291 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.69 -54.28 38.36 Favored Glycine 0 C--O 1.236 0.243 0 C-N-CA 120.957 -0.639 . . . . 0.90000000000000002 112.64 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.1 t -59.07 -43.44 89.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.114 0.483 . . . . 0.90000000000000002 110.562 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.538 ' SD ' ' HE3' ' A' ' 112' ' ' MET . 37.1 ttm -68.06 -27.01 66.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.961 -0.563 . . . . 0.90000000000000002 111.154 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 91.9 m -62.25 -52.62 63.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.785 0.326 . . . . 0.90000000000000002 110.161 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.61 84.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.506 . . . . 0.90000000000000002 110.537 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -60.26 -57.83 11.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.552 -0.749 . . . . 0.90000000000000002 111.347 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.538 ' HE3' ' SD ' ' A' ' 108' ' ' MET . 61.8 mtt -67.34 -33.06 74.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.439 -0.346 . . . . 0.90000000000000002 111.445 -175.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -63.71 -37.62 88.05 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.652 -0.419 . . . . 0.90000000000000002 110.09 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.71 -30.37 71.04 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.185 -0.461 . . . . 0.90000000000000002 110.368 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.0 mp -84.13 2.2 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 0.90000000000000002 111.085 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.16 23.34 32.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.988 -0.625 . . . . 0.90000000000000002 113.789 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.512 ' HB3' ' HB3' ' A' ' 124' ' ' TRP . 91.4 m-85 -92.84 134.0 35.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.234 0.517 . . . . 0.90000000000000002 110.426 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.4 m -90.67 145.1 25.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.22 -0.446 . . . . 0.90000000000000002 110.484 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.426 HG23 ' CD1' ' A' ' 124' ' ' TRP . 70.9 p -97.43 118.23 33.44 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.998 -0.371 . . . . 0.90000000000000002 109.998 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -124.12 -93.79 0.5 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.713 -0.395 . . . . 0.90000000000000002 111.311 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -154.83 123.47 6.11 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.034 -0.728 . . . . 0.90000000000000002 109.034 -177.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.36 11.66 66.35 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.495 -0.859 . . . . 0.90000000000000002 111.373 -174.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.9 -152.34 18.05 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.136 -0.554 . . . . 0.90000000000000002 112.906 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.512 ' HB3' ' HB3' ' A' ' 117' ' ' PHE . 22.7 m-90 -102.13 150.65 23.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.183 -0.508 . . . . 0.90000000000000002 110.015 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -134.01 134.79 42.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.236 -0.438 . . . . 0.90000000000000002 110.371 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -137.07 93.09 2.79 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.403 -0.591 . . . . 0.90000000000000002 109.403 171.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.2 p -102.78 142.27 34.19 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.787 -0.642 . . . . 0.90000000000000002 110.586 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.501 0 C-N-CA 120.944 -0.646 . . . . 0.90000000000000002 112.187 179.445 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 999' ' ' COA . . . . . 0.711 ' S1P' ' HB2' ' A' ' 103' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtm . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.44 0.162 . . . . 0.90000000000000002 110.667 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -109.97 135.13 51.31 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.882 -0.414 . . . . 0.90000000000000002 109.882 172.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.482 HD23 ' HB2' ' A' ' 42' ' ' ALA . 51.9 tp -76.63 122.32 24.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.948 -0.569 . . . . 0.90000000000000002 109.951 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.2 p -90.58 121.86 32.88 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.244 0.545 . . . . 0.90000000000000002 110.835 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.504 HG22 ' HA ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -117.1 125.94 74.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.803 -0.635 . . . . 0.90000000000000002 110.376 -178.35 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.1 mm -103.34 151.33 6.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.429 -0.582 . . . . 0.90000000000000002 109.429 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.2 ptt85 -95.36 106.37 18.42 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.505 -0.554 . . . . 0.90000000000000002 109.505 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.2 mt -75.91 83.72 2.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.94 -0.573 . . . . 0.90000000000000002 110.145 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.77 ' HA ' HG11 ' A' ' 33' ' ' VAL . 30.6 mt-10 -81.81 -26.13 34.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.273 -0.876 . . . . 0.90000000000000002 109.993 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -147.49 122.94 10.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.998 -1.001 . . . . 0.90000000000000002 108.71 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -93.34 133.76 36.26 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.978 -0.289 . . . . 0.90000000000000002 110.935 -173.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 m -77.47 174.3 11.01 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.363 -0.976 . . . . 0.90000000000000002 108.363 168.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.484 ' O ' HG13 ' A' ' 17' ' ' ILE . 8.6 p-10 -65.08 -45.52 84.93 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.515 -0.474 . . . . 0.90000000000000002 110.492 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -63.69 -40.11 95.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.90000000000000002 110.317 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.406 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 24.1 m-20 -57.07 -50.87 71.44 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.779 -0.646 . . . . 0.90000000000000002 110.092 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -66.08 -30.47 70.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.843 -0.617 . . . . 0.90000000000000002 110.83 -177.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 13' ' ' ASP . 84.3 mt -72.62 -39.47 61.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.55 -0.296 . . . . 0.90000000000000002 110.996 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -69.72 -34.96 74.6 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.492 -0.558 . . . . 0.90000000000000002 109.492 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 79.6 mt -64.57 -32.27 73.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.90000000000000002 110.385 173.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -71.31 -23.31 61.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.979 0.419 . . . . 0.90000000000000002 110.45 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -70.67 -38.25 73.75 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.3 -0.63 . . . . 0.90000000000000002 109.3 173.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.89 -43.95 52.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.265 -0.88 . . . . 0.90000000000000002 110.514 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.685 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 5.3 m-90 -121.52 89.2 47.09 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.143 -0.481 . . . . 0.90000000000000002 109.998 177.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -62.26 -40.03 43.64 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.622 2.215 . . . . 0.90000000000000002 112.212 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -133.92 83.71 2.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.821 -0.627 . . . . 0.90000000000000002 109.922 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.685 ' HB2' ' HB3' ' A' ' 23' ' ' TRP . 15.6 t80 -127.89 151.9 48.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.522 -0.763 . . . . 0.90000000000000002 109.732 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.453 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 66.3 m -63.26 117.75 36.71 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 121.078 0.466 . . . . 0.90000000000000002 111.673 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 27' ' ' SER . 32.8 Cg_exo -62.04 -36.32 71.41 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.498 2.798 . . . . 0.90000000000000002 112.866 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.7 m -69.08 -22.91 63.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.907 0.384 . . . . 0.90000000000000002 111.092 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.3 t -77.76 -8.15 57.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.18 0.514 . . . . 0.90000000000000002 110.442 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.3 mt -83.78 16.37 2.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 0.90000000000000002 110.485 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -72.43 128.23 34.98 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.617 -0.512 . . . . 0.90000000000000002 109.617 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.77 HG11 ' HA ' ' A' ' 9' ' ' GLU . 39.8 t -113.22 122.86 68.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.94 -0.573 . . . . 0.90000000000000002 110.454 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -148.33 -171.0 3.74 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.718 -0.845 . . . . 0.90000000000000002 108.718 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -69.95 -31.41 69.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.267 0.556 . . . . 0.90000000000000002 109.836 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -84.28 -8.14 59.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.439 -0.8 . . . . 0.90000000000000002 111.52 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -152.48 97.72 2.3 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.96 -0.296 . . . . 0.90000000000000002 110.355 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -111.98 135.73 52.23 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.255 -0.429 . . . . 0.90000000000000002 110.209 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.519 HG22 ' HG2' ' A' ' 53' ' ' ARG . 59.0 mt -101.56 118.79 48.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.187 -0.461 . . . . 0.90000000000000002 110.286 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -100.72 125.31 47.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.306 0.574 . . . . 0.90000000000000002 110.457 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.469 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -108.14 119.36 39.25 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.525 -0.761 . . . . 0.90000000000000002 110.1 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.11 114.76 27.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.895 -0.593 . . . . 0.90000000000000002 110.029 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.431 ' HB3' HD23 ' A' ' 48' ' ' LEU . 34.2 ptt180 -109.72 132.4 54.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.575 0.702 . . . . 0.90000000000000002 111.219 -175.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' A' ' 45' ' ' ASN . 75.6 t80 -98.1 102.84 14.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.366 -0.833 . . . . 0.90000000000000002 109.078 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 10.4 t30 74.31 -43.12 0.52 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.719 0.637 . . . . 0.90000000000000002 111.435 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -159.83 -56.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.023 0.44 . . . . 0.90000000000000002 111.332 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -85.73 153.22 22.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.923 -0.58 . . . . 0.90000000000000002 111.007 -171.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.469 HD21 ' HB3' ' A' ' 41' ' ' ALA . 52.0 mt -71.06 122.75 20.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.027 -0.533 . . . . 0.90000000000000002 110.855 -175.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.4 tp -105.29 -15.08 15.15 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.035 0.445 . . . . 0.90000000000000002 110.206 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -154.48 150.07 27.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.207 -0.451 . . . . 0.90000000000000002 110.458 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -135.24 125.52 26.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.869 0.366 . . . . 0.90000000000000002 110.666 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.35 138.29 48.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.925 -0.579 . . . . 0.90000000000000002 110.445 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.519 ' HG2' HG22 ' A' ' 39' ' ' ILE . 21.2 mtm180 -118.18 133.37 55.96 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.686 -0.486 . . . . 0.90000000000000002 109.686 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.1 p -120.78 126.15 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.631 0.729 . . . . 0.90000000000000002 111.176 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.7 m -90.69 94.58 9.75 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.158 -0.928 . . . . 0.90000000000000002 109.535 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.11 92.15 5.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.844 -0.616 . . . . 0.90000000000000002 110.456 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.6 m -93.29 84.42 4.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.634 -0.712 . . . . 0.90000000000000002 109.823 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.45 -101.39 0.83 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.678 -0.772 . . . . 0.90000000000000002 111.699 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.4 p -112.85 6.98 18.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.154 0.502 . . . . 0.90000000000000002 110.488 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -101.14 111.75 24.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.813 -0.631 . . . . 0.90000000000000002 110.41 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.98 94.06 1.7 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.887 -0.673 . . . . 0.90000000000000002 111.711 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.92 123.39 45.05 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.806 -0.232 . . . . 0.90000000000000002 110.517 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.41 HD11 ' SD ' ' A' ' 97' ' ' MET . 6.8 mp -93.45 118.84 31.82 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.818 -0.438 . . . . 0.90000000000000002 109.818 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -101.15 -12.8 18.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.556 -0.747 . . . . 0.90000000000000002 112.673 -170.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.4 m -155.31 133.4 11.54 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.076 -0.249 . . . . 0.90000000000000002 111.28 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.9 tp -148.44 115.93 6.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.488 . . . . 0.90000000000000002 110.865 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.424 ' HG2' ' C5P' ' A' ' 999' ' ' COA . 24.6 mtp180 -138.71 132.6 31.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.373 -0.376 . . . . 0.90000000000000002 110.425 173.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.461 HG12 ' HB1' ' A' ' 50' ' ' ALA . 3.5 t -103.85 152.01 6.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.563 -0.903 . . . . 0.90000000000000002 108.563 172.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -71.93 154.68 41.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.612 0.244 . . . . 0.90000000000000002 110.787 -175.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -43.03 -47.25 5.81 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.969 1.1 . . . . 0.90000000000000002 113.969 -170.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.3 m -81.05 26.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 113.251 0.834 . . . . 0.90000000000000002 113.251 -171.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.83 29.52 6.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.044 0.449 . . . . 0.90000000000000002 111.417 -177.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -67.11 108.96 2.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.44 . . . . 0.90000000000000002 110.825 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.464 ' HA ' ' O2A' ' A' ' 999' ' ' COA . 20.2 mtp180 56.23 42.27 28.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.141 0.496 . . . . 0.90000000000000002 110.666 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.4 ttt180 -108.59 19.36 19.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.812 -0.631 . . . . 0.90000000000000002 111.103 -172.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.51 -40.51 2.42 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.145 -0.55 . . . . 0.90000000000000002 113.862 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.4 t -46.81 -46.72 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 123.21 0.604 . . . . 0.90000000000000002 112.581 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.68 -41.73 90.26 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.908 -0.663 . . . . 0.90000000000000002 113.11 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.514 ' HG3' ' HG ' ' A' ' 115' ' ' LEU . 52.7 tt0 -69.36 -38.53 78.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.996 0.426 . . . . 0.90000000000000002 110.356 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.437 ' HE2' ' H ' ' A' ' 3' ' ' LEU . 74.8 t80 -68.56 -38.39 80.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.931 -0.577 . . . . 0.90000000000000002 110.184 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.418 HD11 ' HB1' ' A' ' 42' ' ' ALA . 50.2 tp -53.61 -56.78 14.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.314 -0.403 . . . . 0.90000000000000002 111.211 177.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.442 ' O ' HD13 ' A' ' 86' ' ' LEU . 4.4 mm? -60.15 -45.72 92.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.90000000000000002 111.145 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -67.84 -37.51 81.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.353 -0.385 . . . . 0.90000000000000002 111.369 -176.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -58.78 -46.99 86.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.797 0.332 . . . . 0.90000000000000002 110.539 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 73.3 t -63.82 -46.36 94.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.90000000000000002 110.91 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 82' ' ' LEU . 11.0 mp -69.09 -29.06 67.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.218 -0.446 . . . . 0.90000000000000002 111.312 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.0 ttt-85 -75.27 -30.75 60.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.107 0.48 . . . . 0.90000000000000002 109.721 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -75.94 -33.62 59.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.624 -0.716 . . . . 0.90000000000000002 110.052 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -115.8 70.78 3.65 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.828 -0.624 . . . . 0.90000000000000002 110.344 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.33 -6.7 13.84 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.289 1.992 . . . . 0.90000000000000002 112.051 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.07 -14.97 81.73 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.947 -0.645 . . . . 0.90000000000000002 112.153 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.8 t -87.78 113.36 24.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.962 0.411 . . . . 0.90000000000000002 110.203 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 2.5 p -89.5 -22.91 22.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.968 -0.56 . . . . 0.90000000000000002 111.426 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.4 m -108.05 99.3 8.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.824 0.345 . . . . 0.90000000000000002 111.363 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -109.05 126.13 52.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.321 -0.399 . . . . 0.90000000000000002 110.272 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.425 ' HE3' ' HG2' ' A' ' 125' ' ' GLU . 51.9 t-105 -115.58 127.82 55.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.963 -0.562 . . . . 0.90000000000000002 110.198 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.854 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 87.5 mmm -108.0 120.76 43.23 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.245 -0.434 . . . . 0.90000000000000002 109.96 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.79 142.7 47.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.602 -0.272 . . . . 0.90000000000000002 110.45 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.819 ' HB2' ' HB ' ' A' ' 102' ' ' VAL . 4.6 p-10 -86.61 -35.55 19.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.461 -0.336 . . . . 0.90000000000000002 110.107 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.54 22.87 12.58 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.897 -0.592 . . . . 0.90000000000000002 111.955 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 125.39 37.21 0.53 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.572 -0.823 . . . . 0.90000000000000002 112.646 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.819 ' HB ' ' HB2' ' A' ' 99' ' ' ASP . 76.8 t -102.22 125.68 56.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.752 -0.462 . . . . 0.90000000000000002 109.752 176.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -84.18 -35.81 23.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.016 -0.538 . . . . 0.90000000000000002 110.632 -177.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -83.18 67.67 9.29 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.486 0.66 . . . . 0.90000000000000002 110.886 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -72.55 -17.73 61.7 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.694 -0.684 . . . . 0.90000000000000002 109.614 176.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.08 -57.86 12.47 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.939 -0.648 . . . . 0.90000000000000002 112.048 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.16 -43.56 97.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.623 0.249 . . . . 0.90000000000000002 111.15 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.606 ' SD ' HG12 ' A' ' 102' ' ' VAL . 50.6 mtp -71.11 -31.04 67.27 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.333 -0.547 . . . . 0.90000000000000002 112.008 -175.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.687 HG21 HG22 ' A' ' 119' ' ' THR . 36.6 m -68.92 -43.95 74.11 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.801 -0.359 . . . . 0.90000000000000002 110.243 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.12 -38.78 87.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.198 0.523 . . . . 0.90000000000000002 110.287 176.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.648 ' HA ' ' O4B' ' A' ' 999' ' ' COA . 31.4 t80 -61.4 -51.53 68.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.474 -0.785 . . . . 0.90000000000000002 111.33 176.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.478 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 66.1 mtt -75.93 -34.5 59.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.376 -0.374 . . . . 0.90000000000000002 111.922 -174.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -74.1 -22.61 59.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.888 0.375 . . . . 0.90000000000000002 110.572 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.05 -19.22 25.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.041 0.448 . . . . 0.90000000000000002 110.63 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.514 ' HG ' ' HG3' ' A' ' 79' ' ' GLN . 6.1 tt -80.32 -55.17 5.08 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.213 -0.662 . . . . 0.90000000000000002 109.213 175.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 146.93 46.74 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.639 -0.791 . . . . 0.90000000000000002 112.401 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.536 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 97.2 m-85 -121.33 143.01 49.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.802 0.335 . . . . 0.90000000000000002 110.274 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.9 m -81.09 121.72 26.44 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.255 -0.646 . . . . 0.90000000000000002 109.255 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.687 HG22 HG21 ' A' ' 109' ' ' THR . 67.2 p -97.38 130.43 44.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.141 0.496 . . . . 0.90000000000000002 111.054 -173.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -129.36 176.09 8.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.808 -0.633 . . . . 0.90000000000000002 110.53 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -81.71 87.95 6.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.988 -0.551 . . . . 0.90000000000000002 110.081 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 129.92 -50.77 0.88 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.721 -0.752 . . . . 0.90000000000000002 112.292 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -135.32 178.92 18.22 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.331 -0.938 . . . . 0.90000000000000002 112.506 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.854 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 8.2 m-90 -127.3 140.98 51.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.848 -0.797 . . . . 0.90000000000000002 108.848 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.425 ' HG2' ' HE3' ' A' ' 96' ' ' TRP . 42.3 mt-10 -129.03 150.79 50.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.933 0.397 . . . . 0.90000000000000002 111.452 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.536 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 78.8 tttt -136.15 121.8 19.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.155 -0.475 . . . . 0.90000000000000002 109.766 171.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 93' ' ' SER . 53.9 t -129.93 108.98 10.53 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.056 -0.52 . . . . 0.90000000000000002 110.23 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 121.037 -0.601 . . . . 0.90000000000000002 112.13 178.315 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 999' ' ' COA . . . . . 0.648 ' O4B' ' HA ' ' A' ' 111' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 92.7 mttt . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.823 0.344 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.592 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 47.3 tp -76.0 115.94 16.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.805 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.0 m -82.67 101.23 10.7 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.016 0.436 . . . . 0.0 110.662 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.642 HD11 ' HB3' ' A' ' 40' ' ' TYR . 8.4 tp -90.18 113.38 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 121.749 0.785 . . . . 0.0 110.102 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.7 mt -106.57 153.34 7.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.516 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 -100.86 126.55 47.47 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.5 mt -80.9 91.51 6.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.339 0.59 . . . . 0.0 110.875 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -93.13 -23.95 18.43 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.662 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -140.06 139.53 35.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.599 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -115.38 116.0 27.53 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.519 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.4 p -84.89 171.12 12.45 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 17' ' ' ILE . 30.7 m-20 -74.24 -21.35 59.82 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -69.78 -49.26 54.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.418 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 62.8 m-20 -61.31 -38.8 88.15 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.477 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 46.6 ttm-85 -53.8 -47.05 71.2 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.059 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 13' ' ' ASP . 77.8 mt -66.59 -48.31 80.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.459 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.528 ' HB3' HD12 ' A' ' 48' ' ' LEU . 1.2 m-20 -65.43 -32.26 73.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.342 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 78.1 mt -64.89 -42.48 94.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.526 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 25.8 mt-30 -69.04 -20.65 64.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.366 0.603 . . . . 0.0 110.346 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -76.99 -26.53 53.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.557 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 18' ' ' ASP . 70.6 mt -82.57 -37.43 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.46 175.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -117.86 85.89 23.67 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.369 177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 C--N 1.346 0.42 0 C-N-CA 122.642 2.228 . . . . 0.0 113.102 -175.527 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 CA--C 1.52 -0.177 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -134.03 111.34 10.3 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.309 -169.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -103.61 159.12 4.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.16 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -130.73 -166.4 1.68 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -79.14 -11.59 59.98 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.767 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -96.24 -59.83 1.75 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.117 174.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -74.31 97.47 3.02 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 38' ' ' ARG . 22.7 mtp180 -115.81 115.43 26.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.235 0.54 . . . . 0.0 110.488 -173.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.2 mt -98.59 118.85 45.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.661 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.642 ' HB3' HD11 ' A' ' 5' ' ' ILE . 96.7 m-85 -106.28 142.74 35.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.343 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.443 ' HB1' HD21 ' A' ' 48' ' ' LEU . . . -123.55 117.69 25.66 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.38 -175.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.497 ' HB1' HD21 ' A' ' 3' ' ' LEU . . . -91.71 99.78 12.61 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.03 0.443 . . . . 0.0 109.869 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.681 ' HG2' HD23 ' A' ' 48' ' ' LEU . 4.1 mtm180 -104.21 111.02 23.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.413 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -97.46 107.82 20.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.931 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.0 t30 60.53 65.32 1.07 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.012 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 72.58 -29.85 0.2 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.655 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -101.56 145.56 28.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.981 0.42 . . . . 0.0 111.821 -170.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.681 HD23 ' HG2' ' A' ' 43' ' ' ARG . 54.7 mt -65.22 117.84 8.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.962 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.9 tp -106.95 -27.14 10.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.912 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -152.76 149.22 28.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.547 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -138.35 135.51 35.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.358 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.482 ' HB ' HD13 ' A' ' 66' ' ' LEU . 8.8 p -140.62 140.98 33.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.919 0.39 . . . . 0.0 110.781 -177.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -114.51 123.5 49.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.506 ' HB ' HD23 ' A' ' 63' ' ' LEU . 6.7 p -125.2 124.37 67.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.317 0.579 . . . . 0.0 110.414 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.9 m -97.89 99.47 10.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.059 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.53 HD23 ' HA2' ' A' ' 61' ' ' GLY . 96.9 mt -85.86 70.44 10.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.938 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 m -67.31 99.06 0.67 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.005 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.18 -116.43 5.24 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.373 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.7 m -114.13 14.71 18.29 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.872 0.844 . . . . 0.0 109.386 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -101.31 134.57 44.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.853 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.53 ' HA2' HD23 ' A' ' 56' ' ' LEU . . . -106.09 106.01 2.51 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.657 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.57 108.45 20.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.929 0.395 . . . . 0.0 110.748 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.534 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 56.6 mt -93.94 119.93 33.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -99.25 -75.32 0.57 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.927 -174.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 p -121.92 141.92 50.8 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.256 0.551 . . . . 0.0 112.191 -173.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.482 HD13 ' HB ' ' A' ' 52' ' ' VAL . 33.9 tp -140.85 119.99 12.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.858 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 67' ' ' ARG . 13.0 mtp180 -128.41 114.75 17.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.793 0.33 . . . . 0.0 111.191 176.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.459 HG12 ' HB ' ' A' ' 72' ' ' THR . 11.2 t -95.33 151.73 3.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 167.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -54.06 140.28 32.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 34.4 mp0 -52.19 -38.25 57.25 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.251 0.62 . . . . 0.0 112.426 -172.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.38 -22.97 27.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.186 0.517 . . . . 0.0 111.201 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.459 ' HB ' HG12 ' A' ' 68' ' ' VAL . 6.9 m -90.86 64.02 5.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.285 0.564 . . . . 0.0 109.953 -177.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 12.6 ttp180 -94.75 12.65 27.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.198 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 74' ' ' ARG . 36.6 ttp180 173.85 90.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.715 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -156.46 17.57 0.33 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.116 0.484 . . . . 0.0 110.243 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.28 -34.46 1.76 Allowed Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.077 -0.583 . . . . 0.0 113.379 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.562 HG13 HD22 ' A' ' 3' ' ' LEU . 59.5 t -39.74 -52.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.079 0.951 . . . . 0.0 113.309 -176.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.92 -55.12 31.87 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.266 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.453 ' HB3' HD13 ' A' ' 115' ' ' LEU . 97.3 mt-30 -67.83 -39.65 83.86 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.793 -0.239 . . . . 0.0 110.614 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.592 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 47.2 t80 -53.72 -47.78 70.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.159 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.574 HD11 HD13 ' A' ' 5' ' ' ILE . 43.0 tp -62.19 -50.96 69.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.249 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.442 HD21 HD22 ' A' ' 66' ' ' LEU . 4.4 mm? -59.65 -46.58 88.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.154 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 48.0 mt-10 -61.37 -44.73 96.67 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.046 -0.261 . . . . 0.0 110.359 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -56.55 -43.75 80.24 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.906 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 81' ' ' LEU . 96.9 t -61.06 -46.77 96.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.352 . . . . 0.0 110.609 178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -72.29 -18.44 61.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.915 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.511 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 23.1 mtm180 -88.73 -22.1 23.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.537 0.208 . . . . 0.0 111.329 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -103.08 -7.35 21.41 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.638 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -118.37 85.61 25.94 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.0 110.187 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.49 162.99 12.75 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.18 2.587 . . . . 0.0 111.44 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.83 -45.87 3.25 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.782 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.86 99.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 16.5 m -92.55 -25.48 18.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 -175.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.6 t -102.35 98.75 8.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.84 0.352 . . . . 0.0 110.728 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -97.2 113.19 24.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.948 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -112.7 123.03 49.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.014 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.752 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 63.3 mtp -111.4 123.43 50.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.375 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.16 153.72 27.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.739 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -84.58 -26.55 27.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.242 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 59.09 14.38 3.44 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.18 20.88 78.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.392 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.8 t -67.92 134.31 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.583 0.23 . . . . 0.0 110.49 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -93.28 -17.2 23.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.044 0.449 . . . . 0.0 111.072 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -83.88 19.53 1.7 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 171.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.458 ' HA ' ' HB2' ' A' ' 108' ' ' MET . 6.9 ttp180 -64.77 -26.96 68.58 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.106 -176.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.0 -48.18 87.35 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.207 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 80.2 t -65.8 -42.47 92.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.994 0.425 . . . . 0.0 110.362 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.642 ' O ' ' HG2' ' A' ' 112' ' ' MET . 96.1 mmm -59.2 -48.41 81.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.242 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.1 m -63.43 -35.54 80.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.365 0.126 . . . . 0.0 111.14 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.86 99.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.391 0.615 . . . . 0.0 109.937 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -62.12 -44.35 96.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.453 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.642 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.1 mmt -62.44 -48.08 81.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.616 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -64.93 -38.7 91.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.244 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.83 -21.9 56.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.424 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.525 HD23 ' HE2' ' A' ' 117' ' ' PHE . 40.9 tp -87.56 -45.69 10.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.527 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 138.04 44.52 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.231 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.585 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 87.3 m-85 -120.7 153.74 36.52 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.0 m -120.05 146.79 45.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.126 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.1 m -97.12 121.79 39.41 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -136.08 103.8 5.47 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 58.0 36.19 25.9 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.28 165.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.83 49.16 0.55 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.366 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.39 179.36 19.96 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.87 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.752 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 6.9 m-90 -102.95 137.83 40.63 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -125.56 137.37 53.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.758 0.314 . . . . 0.0 110.445 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.411 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 61.0 tttp -137.21 91.7 2.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.133 0.492 . . . . 0.0 109.999 172.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 93' ' ' SER . 52.4 t -91.21 112.36 24.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.228 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 CA-C-N 115.77 -0.65 . . . . 0.9 111.865 179.96 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 121.184 0.516 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.1 tp -76.13 114.63 15.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.877 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.9 m -82.8 89.79 6.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.953 0.406 . . . . 0.0 110.655 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.614 HD11 ' HB3' ' A' ' 40' ' ' TYR . 5.2 tp -95.75 111.04 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.994 175.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.3 pt -130.51 171.01 18.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.836 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -92.79 137.2 32.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.447 ' O ' HG21 ' A' ' 33' ' ' VAL . 53.9 tp -78.99 70.55 5.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.245 0.545 . . . . 0.0 109.689 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -69.49 -43.8 72.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.443 -174.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -111.44 132.07 54.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.967 -175.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' A' ' 31' ' ' LEU . 72.3 m-85 -99.46 114.88 28.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.245 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.8 p -102.46 163.92 11.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.58 ' O ' HG13 ' A' ' 17' ' ' ILE . 34.1 t70 -66.12 -29.84 70.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -66.99 -50.19 63.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.008 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.439 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 32.9 m-20 -61.74 -35.04 76.92 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.622 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.407 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 35.6 ttm180 -61.47 -38.01 85.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.526 176.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 13' ' ' ASP . 72.9 mt -60.48 -42.49 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.193 0.52 . . . . 0.0 110.331 176.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.436 ' HB3' HD12 ' A' ' 48' ' ' LEU . 80.5 m-20 -68.73 -33.54 74.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.666 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 96.4 mt -65.0 -34.44 78.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.372 175.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 98.2 mt-30 -69.71 -24.71 63.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.733 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -66.52 -44.36 82.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.231 0.539 . . . . 0.0 109.867 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.2 mt -75.45 -45.59 39.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.33 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -123.89 74.48 56.4 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.668 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 C--N 1.344 0.3 0 C-N-CA 121.922 1.748 . . . . 0.0 111.341 175.072 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.571 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 51.4 mt . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 121.198 0.523 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -129.96 139.97 51.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.353 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 13.7 m -125.72 154.19 34.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.386 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.516 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 22.9 t70 74.4 -30.11 0.2 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.53 175.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 36' ' ' ASN . 4.4 t70 -81.71 68.94 8.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 35' ' ' ASP . 19.7 m120 83.22 -40.02 0.09 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.207 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.519 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 90.2 m-70 -101.59 110.4 22.39 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.641 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.516 ' HG2' ' HA ' ' A' ' 34' ' ' ASP . 69.8 mtt180 -109.2 117.19 33.47 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.097 0.475 . . . . 0.0 110.651 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.557 HG12 ' HG2' ' A' ' 53' ' ' ARG . 53.8 mt -98.67 110.71 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.115 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.614 ' HB3' HD11 ' A' ' 5' ' ' ILE . 73.3 m-85 -97.61 141.16 30.99 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.476 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -124.62 113.74 18.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.969 0.414 . . . . 0.0 111.089 -170.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.485 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.13 101.5 14.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.528 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.516 ' HB3' HD23 ' A' ' 48' ' ' LEU . 28.5 ptt180 -102.51 118.84 37.74 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.546 0.689 . . . . 0.0 110.858 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -97.44 133.41 42.07 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.5 t30 64.61 23.35 12.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.003 0.906 . . . . 0.0 108.607 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 66.47 20.74 10.88 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.419 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -126.88 142.73 51.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' A' ' 43' ' ' ARG . 55.5 mt -54.49 130.39 39.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.182 0.515 . . . . 0.0 112.14 -172.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 34.4 tp -125.6 -40.65 2.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.205 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.529 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -133.12 143.99 49.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.325 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -135.07 132.28 37.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.387 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.59 132.46 62.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.081 0.467 . . . . 0.0 110.927 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.557 ' HG2' HG12 ' A' ' 39' ' ' ILE . 27.8 mtm180 -111.11 121.65 45.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.985 176.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.66 119.55 59.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.411 0.624 . . . . 0.0 109.71 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 89.9 m -95.56 95.53 8.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.571 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.584 ' HA ' ' HA3' ' A' ' 61' ' ' GLY . 89.2 mt -80.38 124.27 28.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.119 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.7 t -98.59 50.15 0.98 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.71 -104.83 2.45 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.549 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.5 p -94.49 -29.53 14.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.381 0.61 . . . . 0.0 110.648 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.81 ' HB3' ' HB3' ' A' ' 94' ' ' CYS . 36.0 mt-10 -119.19 151.33 38.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.008 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 56' ' ' LEU . . . -151.7 -179.84 27.7 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 119.461 -1.352 . . . . 0.0 113.894 -173.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.63 135.33 48.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.222 -0.489 . . . . 0.0 110.205 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.8 tt -93.77 112.84 24.77 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -97.24 -56.89 2.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -168.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.1 m -107.81 106.22 16.41 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.024 0.44 . . . . 0.0 111.553 -173.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.3 tp -124.58 109.07 12.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.785 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -138.94 136.84 35.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.233 0.54 . . . . 0.0 111.246 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.529 HG13 ' HB2' ' A' ' 50' ' ' ALA . 14.5 t -110.8 152.0 12.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -57.79 150.56 19.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.746 0.308 . . . . 0.0 110.18 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -51.7 -38.43 55.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.51 -20.85 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 111.931 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.442 ' HB ' ' CG1' ' A' ' 68' ' ' VAL . 2.0 m -113.09 24.92 11.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.157 0.503 . . . . 0.0 111.255 -175.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 16.5 mtp180 -78.25 38.84 0.3 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 8.3 ttm180 174.37 19.95 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.276 0.23 . . . . 0.0 111.057 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -141.04 75.28 1.49 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -167.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.74 -61.45 4.27 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 115.703 1.041 . . . . 0.0 115.703 161.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -43.42 -51.97 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -168.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.09 -41.18 77.14 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.957 -0.639 . . . . 0.0 113.595 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -68.64 -53.07 24.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.919 0.39 . . . . 0.0 110.623 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -58.21 -40.87 82.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.421 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.563 HD11 HD13 ' A' ' 5' ' ' ILE . 26.9 tp -56.3 -55.07 37.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.384 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.47 ' HB2' HD11 ' A' ' 115' ' ' LEU . 55.6 mt -62.34 -41.74 98.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.376 -176.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -62.94 -37.87 88.75 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.782 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.84 -39.1 80.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.43 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 81' ' ' LEU . 72.5 t -58.49 -45.94 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.815 0.34 . . . . 0.0 111.039 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 82' ' ' LEU . 11.1 mp -68.22 -23.75 64.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.122 0.487 . . . . 0.0 110.744 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.6 mtp85 -76.73 -33.06 58.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.852 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.41 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 89.6 m-20 -71.01 -49.69 42.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -118.27 86.21 26.76 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.763 0.316 . . . . 0.0 111.377 -178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 1.8 Cg_endo -83.75 170.61 11.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.966 2.444 . . . . 0.0 111.481 175.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.06 -14.85 62.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.216 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.559 HG13 ' HA ' ' A' ' 60' ' ' GLU . 53.3 t -78.24 118.53 25.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 128' ' ' GLY . 2.4 p -84.46 -40.23 17.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.572 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.81 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 45.1 t -101.93 100.14 10.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.904 0.383 . . . . 0.0 110.866 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -97.3 97.66 9.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -96.8 128.27 43.58 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.844 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 96.0 mmm -107.16 109.5 21.34 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.12 149.66 42.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.667 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -75.6 -43.51 47.77 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 61.07 8.74 2.07 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.773 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.87 17.78 66.93 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.882 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 104' ' ' ASP . 82.8 t -67.69 111.9 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 121.217 0.532 . . . . 0.0 110.064 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -79.79 1.26 27.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.744 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.421 ' H ' HG12 ' A' ' 102' ' ' VAL . 13.4 m-20 -101.1 21.31 14.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.442 174.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -58.9 -27.25 65.05 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.902 -175.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.36 -53.03 45.11 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.568 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 43.7 t -62.97 -37.36 79.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.169 0.509 . . . . 0.0 110.047 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.598 ' O ' ' HG2' ' A' ' 112' ' ' MET . 96.9 mmm -65.13 -36.18 83.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.232 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 93.3 m -63.9 -45.04 91.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.712 0.291 . . . . 0.0 110.693 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.28 94.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.182 0.515 . . . . 0.0 110.209 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -61.92 -48.22 81.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.227 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.598 ' HG2' ' O ' ' A' ' 108' ' ' MET . 26.3 mmt -57.59 -48.87 78.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 0.0 111.114 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -72.14 -21.87 61.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.541 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.56 -34.96 35.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.991 0.424 . . . . 0.0 110.545 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.47 HD11 ' HB2' ' A' ' 82' ' ' LEU . 7.4 tt -75.42 -56.37 4.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.002 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 149.19 33.35 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.993 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 89.0 m-85 -107.9 167.62 9.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 31.9 m -117.23 137.64 52.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.442 HG23 ' CD1' ' A' ' 124' ' ' TRP . 15.8 m -97.65 132.65 43.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.939 0.399 . . . . 0.0 110.59 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.556 ' NE2' ' HB3' ' A' ' 125' ' ' GLU . 48.4 mt-30 -126.65 -171.62 2.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.6 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -85.48 109.02 18.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.88 0.372 . . . . 0.0 110.474 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.8 7.09 32.01 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.429 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.86 -175.38 27.21 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.51 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.844 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 9.7 m-90 -107.55 160.76 15.43 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.556 ' HB3' ' NE2' ' A' ' 120' ' ' GLN . 55.7 tt0 -157.76 150.85 23.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.058 0.456 . . . . 0.0 110.791 176.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -133.49 117.3 17.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.537 174.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 33.7 t -85.0 108.91 17.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.95 0.405 . . . . 0.0 110.016 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 93' ' ' SER . . . . . . . . 0 N--CA 1.449 -0.457 0 CA-C-N 115.888 -0.596 . . . . 0.9 112.285 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.8 tttm . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 121.112 0.482 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.546 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 36.5 tp -75.88 137.51 40.47 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 m -111.16 109.35 19.37 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.801 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.555 HD13 HD11 ' A' ' 81' ' ' LEU . 11.2 tp -89.81 113.17 25.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.541 0.686 . . . . 0.0 109.822 176.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.99 149.9 16.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.185 0.517 . . . . 0.0 110.489 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -74.77 112.57 11.12 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.441 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.1 tp -67.77 101.93 1.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -98.77 -49.79 4.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.987 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -127.01 149.05 50.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.997 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -107.81 136.52 47.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.66 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.66 ' HB2' ' OD1' ' A' ' 15' ' ' ASP . 8.3 m -115.9 162.39 17.41 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 170.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -63.02 -42.82 99.9 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -171.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -64.92 -52.24 57.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.608 0.242 . . . . 0.0 111.178 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.66 ' OD1' ' HB2' ' A' ' 12' ' ' SER . 0.5 OUTLIER -72.04 -19.05 61.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.543 -179.017 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -64.25 -44.64 91.16 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.5 mt -68.38 -33.79 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.259 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -63.41 -39.41 94.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.961 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.0 mt -64.56 -36.92 85.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.807 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -73.28 -13.3 61.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.009 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -89.14 -24.34 22.23 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.3 mt -77.75 -49.36 22.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.728 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -104.92 91.64 4.52 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo . . . . . 0 C--N 1.344 0.297 0 C-N-CA 122.875 2.383 . . . . 0.0 113.432 -170.067 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.5 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 121.113 0.482 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -88.25 117.56 27.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.962 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.4 m -122.73 137.18 57.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.171 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.883 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 11.7 t70 72.15 8.33 5.87 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.748 170.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 37' ' ' HIS . 7.8 m-20 -120.27 77.54 1.27 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 75.85 -34.99 0.25 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.148 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.451 ' H ' ' C ' ' A' ' 35' ' ' ASP . 86.1 m-70 -112.76 112.45 23.95 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 173.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.883 ' HG2' ' HA ' ' A' ' 34' ' ' ASP . 79.4 mtt180 -113.84 126.18 54.9 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.016 0.436 . . . . 0.0 110.551 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.575 HG12 ' HG2' ' A' ' 53' ' ' ARG . 71.8 mt -100.35 119.81 48.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.935 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -102.49 133.0 48.18 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.525 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.57 125.06 51.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.802 -175.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.06 98.78 11.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.197 0.522 . . . . 0.0 110.159 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.417 ' HD3' HH11 ' A' ' 43' ' ' ARG . 15.6 ttm180 -87.61 126.88 35.2 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.495 -177.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -124.53 95.47 4.54 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.2 m120 60.94 74.26 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.981 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 71.42 -43.55 0.57 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.772 -1.103 . . . . 0.0 113.181 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -88.76 153.76 20.82 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.758 0.313 . . . . 0.0 111.111 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.525 HD22 ' HB1' ' A' ' 41' ' ' ALA . 79.5 mt -90.24 108.09 19.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.016 0.436 . . . . 0.0 110.145 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.4 tp -83.38 -31.41 26.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.639 -175.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.538 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -144.45 157.13 44.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.755 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.29 135.59 22.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.115 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 65' ' ' SER . 7.1 p -135.14 138.69 48.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.001 0.429 . . . . 0.0 111.141 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.575 ' HG2' HG12 ' A' ' 39' ' ' ILE . 88.4 mtt180 -103.16 131.24 50.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.892 176.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.43 ' HB ' HD23 ' A' ' 63' ' ' LEU . 7.1 p -125.24 122.33 62.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.356 0.598 . . . . 0.0 110.937 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 34.8 m -93.35 110.02 21.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.971 175.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.476 HD23 ' HA2' ' A' ' 61' ' ' GLY . 92.3 mt -94.98 98.63 10.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.635 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 t -95.71 97.87 10.03 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.76 -107.27 2.06 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.404 -174.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.4 p -115.43 12.6 16.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.92 0.391 . . . . 0.0 111.187 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.05 138.08 42.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.019 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.476 ' HA2' HD23 ' A' ' 56' ' ' LEU . . . -116.03 113.54 2.87 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.385 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.54 ' HB3' ' HB ' ' A' ' 55' ' ' THR . . . -96.35 110.96 23.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.963 0.411 . . . . 0.0 110.753 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.719 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 53.7 mt -93.85 109.78 21.46 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.743 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.85 -75.06 0.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.788 0.328 . . . . 0.0 111.818 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 13.6 m -82.18 85.76 6.75 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.892 0.377 . . . . 0.0 111.384 -175.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.521 HD21 HD21 ' A' ' 82' ' ' LEU . 47.0 tp -102.67 100.73 10.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.613 173.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -135.12 126.55 28.56 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.568 -175.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 50' ' ' ALA . 12.1 t -111.75 155.48 13.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 174.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -60.21 137.57 58.09 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -48.2 -41.53 27.47 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.793 0.683 . . . . 0.0 112.609 -173.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.5 m -73.09 2.44 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 m -98.69 7.76 45.72 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.099 0.476 . . . . 0.0 111.014 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 73' ' ' ARG . 30.4 mtm180 -70.34 106.7 3.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.836 0.351 . . . . 0.0 110.369 177.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 60.7 ttt180 -157.67 -81.07 0.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.471 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 27.4 ttt180 164.86 95.71 0.0 OUTLIER 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -169.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.02 -79.53 0.2 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.506 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.514 HG13 HD22 ' A' ' 3' ' ' LEU . 69.3 t -47.47 -46.56 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 123.194 0.597 . . . . 0.0 112.589 -174.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.97 -62.67 6.1 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.06 -0.591 . . . . 0.0 113.548 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -68.21 -32.61 72.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.79 0.295 . . . . 0.0 111.143 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.546 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 30.3 t80 -59.44 -49.25 78.51 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.555 HD11 HD13 ' A' ' 5' ' ' ILE . 55.9 tp -52.32 -56.04 17.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.104 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.521 HD21 HD21 ' A' ' 66' ' ' LEU . 4.2 mm? -58.23 -44.46 88.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.029 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.718 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 5.4 mt-10 -63.27 -49.34 74.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.584 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.5 ' OE1' HG22 ' A' ' 5' ' ' ILE . 35.2 tt0 -63.73 -34.95 79.03 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.064 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 81' ' ' LEU . 75.5 t -61.46 -43.9 97.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.868 0.366 . . . . 0.0 110.342 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 82' ' ' LEU . 11.0 mp -72.01 -24.16 61.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.344 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.718 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 19.2 mmt180 -76.93 -39.02 52.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.055 0.455 . . . . 0.0 109.98 176.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -67.73 -34.76 77.49 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.793 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -119.59 79.79 22.48 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.036 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -86.74 -9.48 6.57 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.544 2.163 . . . . 0.0 112.908 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.87 -35.04 55.1 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.4 t -73.47 104.85 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 p -106.01 12.22 30.71 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.059 0.457 . . . . 0.0 110.656 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 47.8 t -130.51 99.97 5.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.342 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -107.79 120.3 41.87 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.442 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.521 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 13.7 t-105 -115.98 120.42 39.08 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.191 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.719 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 76.1 mtp -107.15 126.5 52.46 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.099 0.476 . . . . 0.0 110.099 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.2 146.53 24.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.971 -176.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.68 16.67 10.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.282 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.38 106.88 4.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.701 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.52 0.81 56.65 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.162 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 80.7 t -86.82 107.27 16.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.792 0.329 . . . . 0.0 110.381 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.69 -46.04 33.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.072 0.463 . . . . 0.0 110.032 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -94.71 81.64 3.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.257 0.551 . . . . 0.0 110.459 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.5 mtt85 -71.03 -28.85 64.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.411 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.3 -54.62 28.56 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.351 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.22 -42.4 93.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.765 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.585 ' O ' ' HG2' ' A' ' 112' ' ' MET . 97.8 mmm -64.5 -36.52 84.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.675 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 85.8 m -64.68 -43.96 91.88 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.858 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.58 -36.59 84.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.264 0.554 . . . . 0.0 110.376 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -64.74 -44.41 90.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.411 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.585 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.5 mmt -62.24 -42.73 99.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.009 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -57.15 -40.32 76.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.544 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.41 -29.83 69.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.209 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.5 mt -85.0 -7.52 59.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.022 0.439 . . . . 0.0 111.228 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.36 21.66 56.13 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.144 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 37.5 m-85 -85.6 132.19 34.22 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 65.2 p -95.7 162.19 13.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.998 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.2 t -97.21 117.16 30.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.7 0.762 . . . . 0.0 109.7 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.94 169.71 10.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.24 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -70.8 94.48 1.04 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.045 0.45 . . . . 0.0 110.748 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.83 -11.24 5.42 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.41 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.25 -146.91 16.02 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.312 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 7.5 m-90 -103.1 133.56 48.0 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -121.04 131.54 54.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.183 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -137.03 115.55 11.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.91 172.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 22.4 t -112.72 115.98 29.4 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.942 0.401 . . . . 0.0 110.182 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.516 0 N-CA-C 111.533 -0.627 . . . . 0.9 111.533 -178.876 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.0 tttp . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 121.13 0.49 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.541 HD21 ' HB1' ' A' ' 42' ' ' ALA . 38.7 tp -79.52 115.01 18.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.688 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -82.86 103.61 12.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.834 0.35 . . . . 0.0 110.377 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.535 HD11 ' HB3' ' A' ' 40' ' ' TYR . 11.6 tt -105.7 126.25 61.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.545 0.688 . . . . 0.0 111.159 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.5 mt -125.51 160.89 31.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.476 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -85.74 141.33 29.79 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 8' ' ' LEU . 55.1 mt -77.53 103.55 7.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.044 0.449 . . . . 0.0 110.626 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -79.39 -45.76 18.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.503 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -137.85 166.65 23.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.945 -176.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -127.89 111.47 13.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.808 0.337 . . . . 0.0 111.089 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.0 m -99.55 -179.97 4.37 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -62.59 -48.92 77.32 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.821 0.344 . . . . 0.0 110.872 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -57.77 -39.31 77.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.558 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -67.02 -46.2 75.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.328 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.9 ttp85 -60.7 -46.6 89.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.649 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 80.0 mt -61.57 -46.18 97.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.881 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.96 -38.72 86.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.21 0.529 . . . . 0.0 110.395 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.519 HD23 HD12 ' A' ' 22' ' ' ILE . 76.7 mt -68.58 -25.03 64.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.264 177.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -79.94 -19.96 46.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.248 0.547 . . . . 0.0 109.894 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -74.74 -29.1 61.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 171.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.519 HD12 HD23 ' A' ' 19' ' ' LEU . 73.0 mt -79.78 -48.73 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.302 174.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -115.79 100.55 53.66 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 175.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 C--N 1.345 0.387 0 C-N-CA 123.065 2.51 . . . . 0.0 112.951 -176.514 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.7 mt . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 121.355 0.598 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -80.57 118.09 21.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.712 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.43 118.5 39.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.785 -173.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.434 ' OD1' ' HB2' ' A' ' 37' ' ' HIS . 6.3 p-10 -135.24 -164.5 1.54 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.856 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -68.57 -29.75 68.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.805 0.336 . . . . 0.0 110.972 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -89.86 -63.31 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.434 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 56.3 m80 -78.37 98.74 6.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.234 0.54 . . . . 0.0 110.651 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.578 ' HD3' HD12 ' A' ' 56' ' ' LEU . 27.7 mtp-105 -115.68 116.9 28.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.449 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.2 mt -98.48 127.14 51.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.781 0.324 . . . . 0.0 110.586 -176.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.535 ' HB3' HD11 ' A' ' 5' ' ' ILE . 55.3 m-85 -99.08 140.23 33.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.409 176.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.541 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -114.16 113.4 24.63 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.543 174.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.05 104.93 17.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.809 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 7.7 ptp180 -112.6 136.41 52.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.361 0.6 . . . . 0.0 111.756 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.43 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 44.5 t80 -99.88 95.71 7.08 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.8 t30 69.59 -76.41 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.388 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -151.31 71.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.527 0.679 . . . . 0.0 110.028 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 15.9 ptp180 -167.41 122.24 1.03 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.029 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.541 HD22 ' HB1' ' A' ' 41' ' ' ALA . 59.0 mt -78.11 90.83 4.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.588 ' HA ' ' HD3' ' A' ' 69' ' ' ARG . 62.7 mt -79.05 -39.95 32.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.307 -175.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -132.9 141.81 48.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.698 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.452 ' HB3' HG21 ' A' ' 22' ' ' ILE . . . -135.09 132.78 38.56 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.84 177.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.49 HG21 HD23 ' A' ' 63' ' ' LEU . 7.5 p -138.9 135.35 42.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.027 0.442 . . . . 0.0 111.224 -176.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.515 ' HG3' ' HB2' ' A' ' 65' ' ' SER . 33.1 mtt-85 -101.5 106.14 17.22 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 176.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.93 119.45 50.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.273 0.559 . . . . 0.0 110.017 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.0 m -92.93 97.42 10.72 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.049 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.578 HD12 ' HD3' ' A' ' 38' ' ' ARG . 81.9 mt -87.29 85.67 7.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.046 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -86.67 85.19 7.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.465 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.14 -119.84 5.05 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.189 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.0 p -96.84 8.62 43.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.021 0.439 . . . . 0.0 111.124 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -126.52 137.16 53.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.265 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -119.56 121.95 5.13 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.357 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.06 119.59 35.74 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.496 HD13 ' SD ' ' A' ' 97' ' ' MET . 5.9 mp -93.88 122.75 36.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -95.35 -79.85 0.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.106 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.515 ' HB2' ' HG3' ' A' ' 53' ' ' ARG . 13.5 m -86.9 122.51 30.87 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.959 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.443 HD13 ' HB ' ' A' ' 52' ' ' VAL . 52.3 tp -140.6 116.43 10.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.421 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 50.9 ttt180 -143.84 138.11 28.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.985 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 50' ' ' ALA . 7.3 t -114.57 142.86 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.588 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 10.3 mtp180 -63.38 147.43 51.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.124 0.488 . . . . 0.0 111.114 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -58.95 -17.99 29.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -167.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.42 -16.56 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.489 0.661 . . . . 0.0 110.6 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.489 HG22 HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -106.02 15.86 25.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.586 -173.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -86.06 144.73 27.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.988 0.423 . . . . 0.0 111.572 -173.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.2 mtp-105 56.19 26.99 10.98 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.911 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -112.32 2.36 16.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.3 0.571 . . . . 0.0 110.903 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.96 -5.98 64.12 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.114 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.489 HG21 HG22 ' A' ' 72' ' ' THR . 86.7 t -59.46 -41.81 85.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.008 0.433 . . . . 0.0 110.926 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 81' ' ' LEU . . . -64.56 -25.74 70.4 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.367 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.546 ' HA ' HD21 ' A' ' 115' ' ' LEU . 62.7 tt0 -68.6 -47.45 66.67 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -61.95 -40.29 95.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.946 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 85' ' ' VAL . 51.2 tp -45.23 -63.97 0.82 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.806 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.4 ' O ' HD13 ' A' ' 86' ' ' LEU . 3.9 mm? -65.95 -37.19 85.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.575 -176.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 79' ' ' GLN . 41.5 mt-10 -60.27 -40.74 91.45 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -79.67 -25.51 41.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.792 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 81' ' ' LEU . 73.3 t -62.75 -46.17 97.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.149 0.499 . . . . 0.0 110.012 173.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 82' ' ' LEU . 10.3 mp -70.55 -22.05 62.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.95 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -75.78 -45.65 35.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.339 173.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -57.61 -48.85 78.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.098 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -120.27 89.0 42.82 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.196 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -83.13 -15.39 7.93 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.877 2.385 . . . . 0.0 114.02 -173.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.48 57.87 5.05 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.1 -174.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.4 t -129.68 128.46 65.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.758 0.313 . . . . 0.0 110.383 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.7 m -75.56 -48.02 24.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.123 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 127' ' ' CYS . 47.1 t -131.42 124.35 30.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.835 -177.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -96.98 113.86 25.43 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 174.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -108.53 129.0 55.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.924 0.392 . . . . 0.0 110.079 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.831 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 95.9 mmm -110.9 108.42 18.2 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.76 147.5 35.3 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.948 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -63.25 -34.69 78.21 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.89 9.21 2.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.582 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.69 17.03 80.26 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.892 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 104' ' ' ASP . 57.3 t -70.25 118.35 14.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -77.33 5.96 7.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.049 -173.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.532 ' H ' HG12 ' A' ' 102' ' ' VAL . 31.3 m-20 -111.97 24.13 13.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.163 0.506 . . . . 0.0 109.834 173.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -57.47 -28.69 63.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.225 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.3 -46.1 74.04 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.4 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.2 t -66.63 -37.04 78.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.113 0.482 . . . . 0.0 110.047 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.616 ' O ' ' HG2' ' A' ' 112' ' ' MET . 68.6 mtp -66.59 -32.67 74.16 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.749 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.0 m -62.49 -44.43 96.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.644 0.259 . . . . 0.0 110.582 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.74 95.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.495 0.664 . . . . 0.0 110.135 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.408 ' CE2' HD11 ' A' ' 115' ' ' LEU . 38.7 t80 -61.69 -39.47 91.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.035 176.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.616 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.4 mmt -63.36 -36.96 85.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.768 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -67.82 -27.8 67.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.721 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.73 -40.34 66.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.917 0.389 . . . . 0.0 110.435 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 79' ' ' GLN . 97.1 mt -68.82 -48.65 63.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.161 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 124.39 27.18 1.36 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.776 -176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.567 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 26.2 m-85 -98.79 154.43 18.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.0 m -108.76 157.88 18.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.872 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.428 HG22 ' CD1' ' A' ' 124' ' ' TRP . 3.3 p -97.39 117.23 31.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.952 0.406 . . . . 0.0 110.871 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.454 ' HA ' ' OE1' ' A' ' 120' ' ' GLN . 14.4 mm-40 -102.62 -179.53 4.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.913 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -91.05 50.72 1.82 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.327 0.584 . . . . 0.0 109.977 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 165.16 43.71 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.356 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 113.44 -176.82 17.63 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 121.171 -0.538 . . . . 0.0 111.79 -176.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.831 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 9.4 m-90 -96.42 148.8 22.41 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -138.65 137.82 37.23 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.016 0.436 . . . . 0.0 111.413 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.465 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 57.5 tttm -136.97 95.52 3.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.59 169.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 94' ' ' CYS . 42.5 t -76.83 110.44 11.44 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.532 0 C-N-CA 120.956 -0.64 . . . . 0.9 112.092 -178.888 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 81.1 mttt . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 121.023 0.439 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.515 HD11 ' HB1' ' A' ' 42' ' ' ALA . 49.7 tp -76.1 115.68 16.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.622 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.7 m -87.82 92.05 8.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.051 0.453 . . . . 0.0 110.601 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' A' ' 40' ' ' TYR . 6.4 tp -81.91 105.96 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.795 0.807 . . . . 0.0 109.981 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.9 mt -99.11 148.75 5.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.367 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -95.67 139.62 31.66 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 11' ' ' PHE . 4.4 mm? -75.48 62.58 1.39 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.818 0.818 . . . . 0.0 110.586 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -94.72 -29.11 14.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.608 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -127.53 107.12 9.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.77 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 8' ' ' LEU . 69.8 m-85 -87.83 112.38 22.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.987 0.423 . . . . 0.0 111.736 -175.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.518 ' HB3' ' OD1' ' A' ' 15' ' ' ASP . 28.4 t -92.26 157.98 16.37 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 172.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.04 -47.08 84.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -63.92 -41.49 97.65 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.384 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.518 ' OD1' ' HB3' ' A' ' 12' ' ' SER . 1.6 m-20 -55.65 -44.77 77.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.453 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.676 ' HG2' HD13 ' A' ' 31' ' ' LEU . 24.4 mtp180 -60.44 -39.28 86.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.301 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 57.9 mt -77.76 -37.78 24.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.491 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -68.41 -33.05 73.55 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.473 HD23 HD12 ' A' ' 22' ' ' ILE . 73.7 mt -63.87 -37.28 86.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.241 172.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -65.67 -22.82 66.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.34 0.591 . . . . 0.0 110.398 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -80.0 -28.56 39.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.238 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.519 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 69.5 mt -76.78 -36.01 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.231 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -109.72 81.1 1.83 Allowed Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 21.1 Cg_exo . . . . . 0 C--N 1.344 0.334 0 C-N-CA 123.129 2.553 . . . . 0.0 113.534 -169.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.676 HD13 ' HG2' ' A' ' 16' ' ' ARG . 51.2 mt . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 121.154 0.502 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -83.16 98.43 9.34 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.516 HG23 ' HA ' ' A' ' 38' ' ' ARG . 8.2 p -93.13 135.76 26.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.198 -175.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -131.7 -179.56 5.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.82 -23.71 66.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.688 0.28 . . . . 0.0 111.339 -175.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.626 ' O ' ' HA ' ' A' ' 55' ' ' THR . 32.0 m-80 -85.84 -62.34 1.55 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.907 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -89.66 94.62 9.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.553 -175.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.516 ' HA ' HG23 ' A' ' 33' ' ' VAL . 53.6 mtt180 -110.27 139.08 45.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.286 0.565 . . . . 0.0 111.006 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.8 mt -106.96 134.77 47.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.787 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.6 ' HB3' HD11 ' A' ' 5' ' ' ILE . 86.0 m-85 -118.84 140.34 50.12 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.583 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -129.2 124.09 33.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.103 0.478 . . . . 0.0 110.566 -173.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.731 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.0 104.14 16.58 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.966 -176.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -87.27 122.76 31.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.701 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -140.31 124.99 18.09 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.2 t30 62.07 36.56 15.26 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.49 0.662 . . . . 0.0 110.005 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 37.3 tt0 67.01 18.41 10.56 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.213 177.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -133.7 146.24 50.63 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.583 HD22 ' HB1' ' A' ' 41' ' ' ALA . 78.7 mt -79.88 101.45 8.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.197 0.522 . . . . 0.0 110.414 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.8 tp -81.74 -21.74 37.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.615 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.731 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -141.05 140.25 34.22 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.605 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -128.52 122.39 31.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.899 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.425 HG13 ' HB2' ' A' ' 40' ' ' TYR . 7.9 p -132.59 135.97 56.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.955 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -111.26 129.83 55.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.855 0.359 . . . . 0.0 110.146 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.7 p -127.35 139.59 51.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.064 0.459 . . . . 0.0 110.189 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 29.1 m -108.28 101.71 10.89 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.083 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.89 91.07 5.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.507 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -103.54 99.16 8.97 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.118 -175.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.48 -105.55 0.92 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.358 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.8 p -107.36 2.42 24.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.854 0.359 . . . . 0.0 111.131 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -102.66 122.24 44.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.334 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.94 85.76 0.91 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -92.92 128.61 38.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.691 0.281 . . . . 0.0 110.447 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 tp -93.52 121.65 35.14 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -113.47 95.82 5.56 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.185 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.0 p 69.93 127.87 0.03 OUTLIER 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.655 1.182 . . . . 0.0 112.344 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.501 HD23 ' HE1' ' A' ' 108' ' ' MET . 47.0 tp -123.8 122.63 38.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.004 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 70.5 mtp85 -129.82 96.31 4.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.137 0.494 . . . . 0.0 111.076 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' A' ' 50' ' ' ALA . 2.3 t -86.17 142.84 12.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 175.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 48' ' ' LEU . 5.0 ttt180 -61.43 139.79 58.15 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.6 -17.56 23.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.151 -172.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.01 -21.05 27.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.973 0.416 . . . . 0.0 111.138 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.4 m -62.72 -43.1 99.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.481 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 48.79 47.81 20.79 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.09 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.9 mtm180 55.24 66.9 1.11 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.64 175.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -144.52 75.31 1.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.884 0.373 . . . . 0.0 111.654 -175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.08 -43.34 2.84 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 114.998 0.759 . . . . 0.0 114.998 167.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.6 t -49.72 -48.28 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.19 -44.24 94.98 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.808 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.459 ' HA ' HD13 ' A' ' 115' ' ' LEU . 73.5 mt-30 -55.07 -56.94 14.21 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.44 0.638 . . . . 0.0 110.104 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -60.59 -45.62 93.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.13 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.508 ' O ' HG23 ' A' ' 85' ' ' VAL . 27.0 tp -54.09 -57.51 10.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.569 -174.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 82' ' ' LEU . 4.1 mm? -62.56 -45.75 91.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.695 -176.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -60.39 -37.99 82.54 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.975 0.416 . . . . 0.0 110.797 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.447 ' HG2' HG21 ' A' ' 5' ' ' ILE . 10.4 tp10 -69.21 -39.05 78.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.533 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 81' ' ' LEU . 91.4 t -62.16 -42.4 95.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.803 0.335 . . . . 0.0 110.55 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.74 -17.78 63.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.158 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -85.62 -37.59 19.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.171 0.51 . . . . 0.0 109.699 174.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -65.94 -44.04 86.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.077 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -120.28 77.84 26.08 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.585 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -89.0 -0.71 6.31 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.569 2.179 . . . . 0.0 112.909 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.46 -50.3 38.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.13 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.4 ' H ' HG22 ' A' ' 92' ' ' VAL . 3.5 m -62.04 119.69 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.21 0.529 . . . . 0.0 111.025 176.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 m -92.04 -18.52 23.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.275 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.2 t -109.35 98.63 8.0 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -95.31 132.13 40.65 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.188 0.518 . . . . 0.0 110.933 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.459 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 75.0 t-105 -127.6 127.15 43.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.762 -177.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.989 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 74.7 mmm -106.99 110.98 23.26 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -92.0 154.31 18.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.295 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.67 -1.29 41.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.876 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.53 127.81 33.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.93 2.61 86.17 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.163 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.764 HG11 ' HG3' ' A' ' 108' ' ' MET . 60.6 t -117.31 112.51 39.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.822 0.344 . . . . 0.0 110.723 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -80.56 -34.84 35.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.557 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 108' ' ' MET . 7.6 m-20 -87.71 61.53 6.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.858 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -63.35 -40.31 96.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.301 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.94 -45.15 97.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.111 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.9 -43.91 98.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.789 0.328 . . . . 0.0 110.591 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.764 ' HG3' HG11 ' A' ' 102' ' ' VAL . 97.8 mmm -65.61 -29.41 70.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 71.8 m -61.86 -47.61 84.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.13 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.58 -37.9 83.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.356 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.453 ' HB3' ' HA ' ' A' ' 108' ' ' MET . 66.4 t80 -58.5 -52.95 63.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.268 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.534 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 65.1 mtt -76.85 -27.3 55.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.907 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -69.36 -33.79 73.61 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.704 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.11 73.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.613 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.723 HD23 ' HE2' ' A' ' 117' ' ' PHE . 32.5 tp -80.59 -51.96 8.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.018 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 141.91 69.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.285 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.723 ' HE2' HD23 ' A' ' 115' ' ' LEU . 91.1 m-85 -143.75 148.54 35.79 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 124' ' ' TRP . 18.9 m -115.69 149.93 37.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.343 -0.389 . . . . 0.0 109.967 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.2 p -97.0 115.07 26.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.144 0.497 . . . . 0.0 110.322 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.411 ' HG3' ' HG3' ' A' ' 121' ' ' GLN . 55.5 tp60 -134.6 115.7 14.15 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.468 -176.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.411 ' HG3' ' HG3' ' A' ' 120' ' ' GLN . 92.5 mt-30 62.56 35.19 14.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.323 172.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.29 4.37 56.34 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.77 -0.728 . . . . 0.0 113.877 172.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -155.08 175.94 32.91 Favored Glycine 0 C--O 1.225 -0.406 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.036 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.989 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 28.8 m-90 -95.14 127.03 40.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 117.005 0.402 . . . . 0.0 110.042 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -110.82 140.3 45.38 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.89 0.376 . . . . 0.0 110.623 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -137.03 93.4 2.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 172.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 51.0 t -86.93 132.01 33.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.704 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 C-N-CA 121.132 -0.556 . . . . 0.9 111.94 178.613 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.2 mttm . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 121.017 0.436 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.55 HD11 ' HB1' ' A' ' 42' ' ' ALA . 49.4 tp -93.37 113.7 25.94 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.464 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.6 m -83.01 100.09 10.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.249 0.547 . . . . 0.0 110.581 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.517 HD11 HD12 ' A' ' 81' ' ' LEU . 85.5 mt -95.03 129.83 44.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.393 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.5 mt -124.75 149.84 29.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.066 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 7' ' ' ARG . 15.2 ptt-85 -92.57 138.56 31.4 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 41' ' ' ALA . 4.3 mm? -74.92 50.89 0.48 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.035 0.445 . . . . 0.0 111.612 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -87.79 -24.39 23.77 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -123.53 107.31 11.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.695 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -83.67 115.24 22.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.202 0.525 . . . . 0.0 111.539 -173.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.8 t -98.37 153.32 18.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.893 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.475 ' O ' HG12 ' A' ' 17' ' ' ILE . 43.1 t0 -66.92 -49.86 64.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.439 -172.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -64.95 -37.79 88.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.723 0.297 . . . . 0.0 111.049 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.65 -39.37 88.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.297 0.57 . . . . 0.0 110.168 176.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -68.26 -29.32 68.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.6 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 13' ' ' ASP . 43.2 mm -63.84 -44.28 98.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.428 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.519 ' O ' HG13 ' A' ' 22' ' ' ILE . 7.7 m-20 -64.86 -38.4 90.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.807 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.9 mt -60.2 -41.84 93.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.962 0.411 . . . . 0.0 110.284 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -73.6 -13.54 61.03 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.368 0.604 . . . . 0.0 110.483 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -92.01 -23.37 19.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.404 0.621 . . . . 0.0 109.68 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 18' ' ' ASP . 96.1 mt -77.66 -35.36 21.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.399 174.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -112.23 80.81 3.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 169.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.344 0.309 0 C-N-CA 122.971 2.447 . . . . 0.0 113.65 -168.842 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.458 0.647 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -161.2 135.21 6.89 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.498 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.0 m -123.64 141.28 44.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.36 0.6 . . . . 0.0 111.949 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -116.7 172.52 7.18 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.14 -28.09 67.85 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.373 0.606 . . . . 0.0 109.477 171.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -98.86 -0.61 42.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.141 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -144.55 91.32 2.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.464 ' HB2' HG13 ' A' ' 54' ' ' VAL . 57.3 mtt180 -109.07 153.8 23.15 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.769 -174.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 8' ' ' LEU . 66.1 mt -122.78 118.48 55.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -104.58 127.28 52.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.112 0.482 . . . . 0.0 110.52 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.557 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.23 129.67 55.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.094 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.597 ' HB2' HD13 ' A' ' 81' ' ' LEU . . . -91.92 103.93 16.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.131 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -101.44 118.68 37.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.92 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -122.99 109.84 14.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.531 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 69.02 -69.93 0.15 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.168 0.917 . . . . 0.0 112.366 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.658 ' HG2' ' HG3' ' A' ' 47' ' ' ARG . 35.7 tt0 -94.2 -66.74 0.9 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.861 0.363 . . . . 0.0 111.381 -174.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.658 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 11.8 mtm180 -147.61 -150.79 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -174.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.557 HD22 ' HB1' ' A' ' 41' ' ' ALA . 37.8 mt -78.15 122.94 26.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.119 0.485 . . . . 0.0 110.414 -176.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.437 ' O ' ' HD3' ' A' ' 69' ' ' ARG . 32.3 tp -99.55 -25.32 14.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.076 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.538 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -152.5 163.65 39.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.636 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.29 143.43 29.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.675 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.502 ' HB ' HD13 ' A' ' 66' ' ' LEU . 11.7 p -147.02 140.52 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.361 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 -101.77 140.01 36.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.464 HG13 ' HB2' ' A' ' 38' ' ' ARG . 6.2 p -130.51 122.28 52.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.594 0.711 . . . . 0.0 111.653 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 39.2 m -91.33 140.5 29.71 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.859 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.2 mt -127.1 141.47 51.76 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.886 0.374 . . . . 0.0 110.862 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.7 m -144.23 84.49 1.76 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.475 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.15 -110.18 3.29 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.146 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 p -98.02 3.05 49.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.959 0.409 . . . . 0.0 111.281 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.426 ' HG2' ' HB3' ' A' ' 94' ' ' CYS . 42.7 mt-10 -112.24 151.43 29.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.397 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.08 158.25 27.37 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.567 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -134.39 123.33 23.91 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.76 0.314 . . . . 0.0 110.486 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.86 118.24 31.19 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -129.68 133.42 47.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.468 -174.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 m 64.98 100.83 0.04 OUTLIER 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.444 0.64 . . . . 0.0 111.641 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.502 HD13 ' HB ' ' A' ' 52' ' ' VAL . 56.7 tp -132.31 121.34 23.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.149 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 67' ' ' ARG . 31.1 ttt180 -144.0 131.41 20.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.994 0.426 . . . . 0.0 110.811 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 50' ' ' ALA . 9.0 t -109.97 164.26 6.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.437 ' HD3' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -54.66 135.29 46.95 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 173.703 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -62.52 -26.52 68.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.101 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 p -77.82 -14.62 14.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.002 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 m -91.43 64.21 5.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.671 0.748 . . . . 0.0 111.385 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 73' ' ' ARG . 52.2 mtt-85 -106.88 91.66 3.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.018 174.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -131.67 -9.44 3.58 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -171.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 69.16 88.37 0.11 Allowed 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.94 0.4 . . . . 0.0 109.976 -174.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 147.52 -43.05 0.86 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.459 -1.353 . . . . 0.0 114.006 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.44 -54.48 18.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 117.209 0.504 . . . . 0.0 111.757 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.07 -38.53 96.74 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.321 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.546 ' HG3' ' HG ' ' A' ' 115' ' ' LEU . 48.8 tt0 -62.33 -52.42 63.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.791 0.329 . . . . 0.0 110.665 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -62.38 -33.75 75.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.699 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.597 HD13 ' HB2' ' A' ' 42' ' ' ALA . 48.0 tp -54.14 -57.62 10.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.574 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.07 -41.45 95.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.572 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -54.36 -46.55 73.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.94 0.4 . . . . 0.0 111.228 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -66.06 -36.8 84.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.392 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 81' ' ' LEU . 81.2 t -66.2 -46.37 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.88 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.434 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 10.9 mp -65.79 -22.85 66.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.359 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.4 mtm-85 -89.25 -15.74 32.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.735 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.441 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 46.4 t-20 -81.87 -42.59 19.38 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -118.14 76.96 12.32 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.405 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 6.0 Cg_exo -79.0 -13.9 13.87 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.992 2.461 . . . . 0.0 112.282 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.67 -20.91 72.53 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.043 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -76.05 106.56 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.7 m -90.82 -11.78 38.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.085 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.426 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 40.2 t -131.28 95.54 3.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.88 0.371 . . . . 0.0 110.501 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 1.0 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 95.5 m95 -91.38 107.24 19.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.424 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.622 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 76.9 t-105 -97.47 130.98 44.51 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.479 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 58.9 mtp -114.48 131.82 56.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.719 0.295 . . . . 0.0 110.481 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.84 165.42 11.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.586 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -108.71 73.61 0.88 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.835 0.826 . . . . 0.0 109.115 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.77 113.59 27.28 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.521 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.51 1.02 81.37 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.91 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.97 118.23 46.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.946 0.403 . . . . 0.0 110.336 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -93.22 -20.59 20.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.341 0.591 . . . . 0.0 109.48 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -86.74 41.19 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.641 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -52.95 -43.85 66.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.053 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.7 -46.52 92.11 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.501 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.8 t -64.56 -45.26 96.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.09 0.472 . . . . 0.0 110.308 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.487 ' O ' ' HG2' ' A' ' 112' ' ' MET . 37.6 ttm -67.05 -29.2 68.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.032 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 96.9 m -61.61 -45.39 94.3 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 175.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.04 -39.35 92.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.146 0.498 . . . . 0.0 110.437 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -60.52 -49.08 78.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.042 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.529 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 22.2 mmt -66.85 -35.29 79.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.132 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -71.4 -25.54 62.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.024 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.42 -38.9 54.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.92 0.39 . . . . 0.0 110.227 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.566 HD22 ' CE2' ' A' ' 117' ' ' PHE . 7.3 tt -70.72 -49.55 45.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.078 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 134.64 47.83 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.983 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.58 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 83.1 m-85 -110.43 149.2 30.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.589 0.233 . . . . 0.0 110.422 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.0 m -94.67 143.09 26.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.912 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.8 p -97.43 122.5 40.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.0 0.429 . . . . 0.0 111.093 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -120.13 -171.48 2.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.356 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -84.42 94.07 8.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.134 0.492 . . . . 0.0 110.255 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 136.52 -48.55 0.91 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.022 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -167.74 -153.16 7.91 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.279 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 15.5 m-90 -108.49 141.77 39.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.597 0.237 . . . . 0.0 110.481 -176.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -120.18 132.52 55.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.018 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 1.0 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 57.8 tptt -119.08 85.86 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 172.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 39.2 t -98.86 137.0 38.07 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.904 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 C-N-CA 120.836 -0.697 . . . . 0.9 112.07 -179.943 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.9 tttm . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 120.957 0.408 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.4 tp -75.96 106.28 7.46 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.6 m -96.64 111.46 23.59 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.655 -177.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 42' ' ' ALA . 15.7 tt -122.01 129.35 75.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 121.416 0.627 . . . . 0.0 110.871 -175.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -134.4 168.17 24.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.755 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -75.03 124.37 26.86 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.0 tp -89.92 78.44 6.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.343 0.592 . . . . 0.0 110.143 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.578 ' HA ' HG21 ' A' ' 33' ' ' VAL . 29.3 tt0 -86.64 -40.68 14.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.513 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -102.99 122.21 44.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.965 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -105.7 110.41 22.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.709 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.558 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 0.7 OUTLIER -80.29 168.95 18.41 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.655 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.482 ' O ' HG13 ' A' ' 17' ' ' ILE . 17.1 t70 -61.08 -45.99 92.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.751 0.31 . . . . 0.0 110.388 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.534 ' HA ' HD12 ' A' ' 17' ' ' ILE . 97.6 mt-30 -66.73 -34.87 78.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.13 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.26 -35.61 79.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.784 0.326 . . . . 0.0 110.234 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 12' ' ' SER . 42.5 mtt180 -65.93 -47.08 75.9 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 14' ' ' GLN . 69.1 mt -54.37 -48.43 68.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.99 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.555 ' O ' HG13 ' A' ' 22' ' ' ILE . 99.7 m-20 -54.69 -57.84 9.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.104 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.03 -41.18 99.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.38 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -73.43 -10.54 59.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -99.54 -25.06 14.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.075 0.465 . . . . 0.0 110.111 175.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 18' ' ' ASP . 76.4 mt -65.03 -44.35 95.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -87.85 117.48 68.52 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.467 172.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo . . . . . 0 C--N 1.345 0.366 0 C-N-CA 122.985 2.456 . . . . 0.0 112.92 -176.119 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 CA--C 1.529 0.148 0 CA-C-O 120.832 0.349 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -74.32 107.68 6.63 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 9' ' ' GLU . 16.9 m -104.35 136.42 37.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.453 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -140.23 -161.73 1.24 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.617 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -81.63 -19.83 40.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 110.222 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -96.18 -68.19 0.81 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -72.53 97.32 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.626 HH11 HD12 ' A' ' 56' ' ' LEU . 71.5 mtt180 -113.54 127.62 56.14 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.011 0.434 . . . . 0.0 111.163 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.703 HG12 ' HG2' ' A' ' 53' ' ' ARG . 64.5 mt -101.88 119.34 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.804 176.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.449 ' HB3' HD11 ' A' ' 5' ' ' ILE . 80.6 m-85 -98.78 133.6 42.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.96 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.497 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.09 113.38 26.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.283 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.773 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -98.42 110.83 23.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.387 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.555 ' HB3' HD23 ' A' ' 48' ' ' LEU . 23.8 ptt180 -107.94 134.12 51.31 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.225 0.536 . . . . 0.0 110.257 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -97.15 94.2 6.99 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.793 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 72.25 -46.98 0.66 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.142 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -128.21 -67.83 0.79 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.362 . . . . 0.0 111.848 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -104.55 162.21 13.45 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.966 -170.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.555 HD23 ' HB3' ' A' ' 43' ' ' ARG . 92.3 mt -59.87 127.42 31.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.34 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.707 HD23 HG11 ' A' ' 77' ' ' VAL . 31.3 tp -115.95 -29.49 6.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.489 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.773 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -136.61 139.74 42.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.822 0.344 . . . . 0.0 111.41 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.63 116.66 22.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.843 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 40' ' ' TYR . 7.4 p -124.51 131.34 72.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.396 0.617 . . . . 0.0 111.315 -177.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.703 ' HG2' HG12 ' A' ' 39' ' ' ILE . 41.3 mtp-105 -107.75 119.05 38.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.645 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.48 128.62 68.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.405 0.621 . . . . 0.0 110.821 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.0 m -94.11 100.88 12.9 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.94 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.626 HD12 HH11 ' A' ' 38' ' ' ARG . 93.3 mt -87.04 86.54 7.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.639 177.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -95.92 105.87 17.95 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.383 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.15 -113.54 4.75 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.553 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 p -113.16 8.67 18.31 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.894 0.378 . . . . 0.0 110.939 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -107.75 137.96 44.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.312 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.47 114.22 3.0 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.923 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -111.37 128.93 56.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.562 0.22 . . . . 0.0 110.47 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.502 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 6.9 mp -93.49 108.49 20.17 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.378 0.609 . . . . 0.0 109.611 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.54 -28.43 33.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.809 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.6 m -152.4 127.77 9.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.663 0.268 . . . . 0.0 110.965 -176.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.4 tp -131.28 109.68 10.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.736 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -143.27 109.38 5.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.17 0.51 . . . . 0.0 110.853 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.596 HG13 ' HB2' ' A' ' 50' ' ' ALA . 12.4 t -97.7 157.8 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -58.22 146.45 33.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 0.0 110.707 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -52.02 -35.5 47.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.484 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -75.98 7.9 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.469 0.652 . . . . 0.0 111.487 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.49 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 1.8 m -103.91 8.93 36.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.618 0.723 . . . . 0.0 110.238 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.9 ttp85 -65.74 107.19 1.7 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.614 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 61.58 91.38 0.06 Allowed 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.606 0.567 . . . . 0.0 110.093 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -164.42 -42.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.044 -170.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.6 -24.34 6.85 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.435 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.707 HG11 HD23 ' A' ' 49' ' ' LEU . 84.5 t -55.38 -42.54 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -177.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.25 -31.82 70.49 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.006 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.545 ' HA ' HD21 ' A' ' 115' ' ' LEU . 53.0 tt0 -65.16 -43.85 90.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -69.0 -36.87 78.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.42 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.499 ' O ' HG23 ' A' ' 85' ' ' VAL . 63.2 tp -49.29 -58.72 4.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.268 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.17 -33.21 75.47 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.95 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -58.26 -54.04 51.53 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.646 0.26 . . . . 0.0 110.817 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HG2' HG22 ' A' ' 5' ' ' ILE . 6.4 tp10 -64.38 -36.78 85.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.162 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 81' ' ' LEU . 93.3 t -61.37 -49.15 85.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.912 0.387 . . . . 0.0 110.763 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.473 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 10.4 mp -78.18 -4.59 48.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.088 0.47 . . . . 0.0 110.938 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -87.76 -38.54 15.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.943 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -71.1 -37.96 72.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.097 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.433 ' O ' ' HZ2' ' A' ' 95' ' ' TRP . 20.1 m120 -120.12 74.48 21.15 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.883 176.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -88.09 -3.42 7.03 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.741 2.294 . . . . 0.0 113.733 -173.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -94.25 19.33 53.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.851 -175.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.402 ' HB ' ' CE2' ' A' ' 95' ' ' TRP . 55.7 t -107.17 125.14 63.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.0 m -91.76 -42.92 9.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.902 0.382 . . . . 0.0 110.779 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 40.6 t -104.43 96.46 6.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.051 0.453 . . . . 0.0 110.558 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.473 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 86.5 m95 -90.87 131.0 36.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.94 175.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.642 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 67.9 t-105 -120.66 133.44 55.36 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.502 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 75.2 mtp -119.15 124.84 47.82 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -84.46 173.39 10.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.832 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -57.57 -35.28 70.17 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.077 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.459 ' HB3' HG23 ' A' ' 102' ' ' VAL . . . 63.99 11.74 6.34 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.919 175.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.59 12.21 84.72 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.803 -176.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.459 HG23 ' HB3' ' A' ' 100' ' ' ALA . 45.2 t -80.85 101.49 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.962 0.41 . . . . 0.0 110.281 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -89.08 -1.37 58.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.463 0.649 . . . . 0.0 109.724 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -85.75 44.45 1.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.084 172.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -56.33 -41.69 76.47 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.2 -173.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -51.95 -54.21 26.72 Favored Glycine 0 C--O 1.236 0.275 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.706 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.2 t -66.73 -43.38 90.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.931 0.396 . . . . 0.0 111.009 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.56 ' O ' ' HG2' ' A' ' 112' ' ' MET . 34.8 ttm -69.75 -35.66 75.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.868 -176.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 33.7 m -66.58 -36.93 83.82 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.402 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.94 -37.46 86.08 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.285 0.564 . . . . 0.0 109.922 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.41 ' HB3' ' O ' ' A' ' 108' ' ' MET . 59.9 t80 -61.15 -46.63 89.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.524 174.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.5 mmt -58.77 -43.85 90.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.734 178.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -62.33 -33.93 75.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.985 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.54 -36.2 68.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.247 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.545 HD21 ' HA ' ' A' ' 79' ' ' GLN . 11.1 mp -90.66 7.98 36.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.34 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.24 68.09 1.68 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.82 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.515 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 57.9 m-85 -117.85 151.6 37.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.135 0.493 . . . . 0.0 111.026 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.697 ' HB ' ' HB2' ' A' ' 125' ' ' GLU . 24.3 m -91.4 136.0 33.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.37 176.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 41.7 p -101.29 108.65 20.35 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.423 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -95.96 160.57 14.39 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 172.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -78.86 88.01 4.7 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.253 0.549 . . . . 0.0 109.767 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.98 3.84 6.81 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.884 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.444 ' HA3' ' CZ2' ' A' ' 96' ' ' TRP . . . 173.15 173.59 39.63 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.358 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -116.0 150.65 36.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.697 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 53.1 mt-10 -126.51 156.38 40.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.774 0.321 . . . . 0.0 111.03 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.425 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 56.2 tttp -137.35 121.2 17.55 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 167.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.7 t -86.31 105.27 16.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.148 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 CA-C-N 115.884 -0.598 . . . . 0.9 112.43 -179.76 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.508 HD11 ' HB1' ' A' ' 42' ' ' ALA . 59.7 tp -83.82 111.69 19.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 43' ' ' ARG . 7.2 m -82.78 89.56 6.8 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.215 0.531 . . . . 0.0 109.794 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 15.9 tt -102.65 118.78 50.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.415 0.626 . . . . 0.0 109.982 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.8 mt -114.87 150.96 16.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.416 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.522 ' HB3' ' CE2' ' A' ' 40' ' ' TYR . 17.1 ptt180 -91.61 119.07 31.19 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.567 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.79 72.91 1.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.127 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -96.15 -9.06 31.54 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 171.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -143.08 143.68 31.95 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.1 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -124.63 145.96 49.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.142 0.496 . . . . 0.0 111.571 -173.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -119.31 177.52 4.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 172.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -75.06 -34.53 61.83 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.487 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -64.7 -53.79 41.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.583 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -62.69 -31.86 72.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.738 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -63.24 -40.25 96.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.833 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.1 mt -77.94 -26.0 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.948 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.5 ' HB3' HD12 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -72.67 -35.53 67.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.968 0.413 . . . . 0.0 110.362 174.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.04 -30.65 71.71 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 170.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -72.08 -21.92 61.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.536 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -72.59 -33.55 66.81 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.413 HG23 HH11 ' A' ' 67' ' ' ARG . 48.4 mm -75.4 -51.73 20.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.188 175.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -119.27 110.29 37.87 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.112 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo . . . . . 0 CA--C 1.527 0.156 0 C-N-CA 122.684 2.256 . . . . 0.0 111.762 178.539 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 CA--C 1.52 -0.186 0 CA-C-O 121.154 0.502 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.35 95.43 1.03 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.931 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -102.55 165.17 3.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.284 0.564 . . . . 0.0 111.94 -174.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.75 -164.51 0.91 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.049 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.54 -24.41 61.12 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.546 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 33.9 m-80 -87.15 -62.78 1.43 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.607 ' HB2' HG23 ' A' ' 55' ' ' THR . 77.9 t60 -87.0 97.98 11.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 0.0 110.12 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -111.73 148.68 32.95 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.516 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.593 HG12 ' HG2' ' A' ' 53' ' ' ARG . 68.9 mt -115.46 118.06 57.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 7' ' ' ARG . 79.1 m-85 -103.01 122.43 44.6 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.419 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -112.91 128.71 56.54 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.906 0.384 . . . . 0.0 110.884 -177.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.22 103.96 16.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.21 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.425 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 14.7 ttt85 -85.74 104.64 15.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.569 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -123.95 115.39 21.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.913 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 61.97 60.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.645 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 67.92 10.38 7.76 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 170.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -149.5 155.89 41.09 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.345 -0.242 . . . . 0.0 110.345 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 18' ' ' ASP . 69.1 mt -75.82 110.99 10.71 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 173.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.6 tp -94.61 -26.96 16.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.332 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -137.49 145.03 42.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.217 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.39 121.66 21.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.255 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.496 HG13 ' HB2' ' A' ' 40' ' ' TYR . 7.6 p -126.2 121.09 58.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.35 0.595 . . . . 0.0 110.551 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.779 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 9.8 mtp180 -103.08 138.96 39.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.108 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -137.76 135.9 45.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.954 0.407 . . . . 0.0 110.31 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.607 HG23 ' HB2' ' A' ' 37' ' ' HIS . 6.7 m -117.91 100.64 7.71 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.127 0.489 . . . . 0.0 110.124 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.63 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 49.0 mt -78.52 160.84 27.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.371 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.6 m -154.43 83.4 1.12 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.154 0.502 . . . . 0.0 109.652 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.9 -120.54 8.78 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.289 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 p -82.26 -6.84 59.51 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.015 0.436 . . . . 0.0 111.504 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.545 ' HG2' ' HB3' ' A' ' 94' ' ' CYS . 44.8 mt-10 -112.41 159.98 18.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.33 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 56' ' ' LEU . . . -153.74 116.07 0.71 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.563 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -98.86 140.87 32.38 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.38 130.74 39.06 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.779 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 3.4 t70 -120.49 99.26 6.46 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.95 -171.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.8 t 70.72 111.41 0.06 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.954 0.883 . . . . 0.0 111.905 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.1 tp -117.25 126.01 52.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.481 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.413 HH11 HG23 ' A' ' 22' ' ' ILE . 68.0 ttt-85 -143.84 110.98 5.77 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.959 178.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.564 HG13 ' HB2' ' A' ' 50' ' ' ALA . 17.1 t -98.32 146.31 8.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 166.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 69' ' ' ARG . 16.0 ttt180 -57.42 136.53 56.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -54.89 -27.87 46.22 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.325 0.65 . . . . 0.0 112.554 -168.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.8 t -69.38 -14.31 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.351 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.11 18.47 9.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.334 0.587 . . . . 0.0 110.669 -177.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -62.32 119.45 9.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.496 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.4 mtt-85 63.89 67.88 0.6 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.326 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -165.56 59.16 0.11 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.83 -59.45 1.33 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 115.724 1.05 . . . . 0.0 115.724 167.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.1 t -42.77 -50.51 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -167.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.78 -49.0 73.68 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.987 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.602 ' HA ' HD21 ' A' ' 115' ' ' LEU . 46.3 tt0 -68.28 -39.1 82.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.991 0.424 . . . . 0.0 110.402 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -61.01 -45.82 93.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.158 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 42' ' ' ALA . 1.2 mp -51.85 -57.56 8.99 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.817 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.521 HD11 ' HE1' ' A' ' 97' ' ' MET . 4.0 mm? -56.19 -48.27 76.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.434 -176.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -69.04 -33.9 74.35 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.437 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -65.02 -42.67 94.18 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.012 0.434 . . . . 0.0 110.206 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 81' ' ' LEU . 88.2 t -62.56 -48.66 87.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.713 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.2 -20.53 65.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.15 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -80.34 -52.89 7.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.175 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.402 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 66.0 t30 -73.51 -19.12 61.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.621 -172.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -113.57 83.5 7.12 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 86.4 Cg_endo -86.0 -0.67 8.56 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.641 2.227 . . . . 0.0 113.153 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -82.96 -14.89 74.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.371 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.545 HG21 HD22 ' A' ' 56' ' ' LEU . 38.5 t -92.06 120.94 42.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.811 0.339 . . . . 0.0 110.309 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 128' ' ' GLY . 7.4 t -96.89 -26.14 15.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.431 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.545 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 22.9 t -118.44 104.88 11.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.536 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.429 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 91.9 m95 -96.47 112.35 24.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.424 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.411 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 76.8 t-105 -100.85 134.17 44.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.714 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.702 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 92.1 mmm -106.95 106.59 17.19 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.17 141.31 29.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.004 0.43 . . . . 0.0 110.788 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 102' ' ' VAL . 19.1 p-10 -90.23 -46.46 8.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.535 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 66.24 -66.06 0.18 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.476 0.71 . . . . 0.0 111.786 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -145.0 37.5 1.33 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.165 -0.54 . . . . 0.0 111.863 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 99' ' ' ASP . 75.0 t -82.84 105.95 13.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.988 0.423 . . . . 0.0 110.342 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -85.52 -34.22 21.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.914 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.57 56.87 2.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.151 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -61.04 -42.66 98.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.112 -175.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.28 -52.77 47.12 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.549 -177.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.79 -45.15 87.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.0 111.129 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.56 ' O ' ' HG2' ' A' ' 112' ' ' MET . 69.3 mtp -75.5 -23.31 56.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.957 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 80.9 m -71.41 -39.28 71.22 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.136 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.4 -39.84 92.21 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.247 0.546 . . . . 0.0 109.664 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -60.56 -52.88 63.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.765 174.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 108' ' ' MET . 25.5 mmt -58.03 -45.87 86.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.416 -177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -65.02 -30.54 71.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.945 0.402 . . . . 0.0 110.815 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.64 -23.22 61.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.872 0.368 . . . . 0.0 110.814 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.602 HD21 ' HA ' ' A' ' 79' ' ' GLN . 11.2 mp -98.0 4.73 49.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.016 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.99 23.27 52.9 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.462 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.555 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 88.8 m-85 -91.73 141.55 28.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.026 0.413 . . . . 0.0 110.413 176.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.7 m -96.27 132.63 41.54 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.383 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.438 ' HB ' ' CD1' ' A' ' 124' ' ' TRP . 3.0 t -97.29 126.88 42.79 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -121.01 -72.75 0.67 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.459 0.647 . . . . 0.0 110.745 -174.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -116.87 -142.91 0.37 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.752 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.94 62.73 0.72 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.533 170.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.04 164.88 14.57 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.702 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 14.4 m-90 -112.98 157.15 21.86 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -141.09 139.37 34.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.792 0.329 . . . . 0.0 110.543 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 95' ' ' TRP . 86.3 tttt -137.01 122.82 19.99 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 31.2 t -74.2 142.01 45.43 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.895 0.379 . . . . 0.0 110.719 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 93' ' ' SER . . . . . . . . 0 N--CA 1.448 -0.5 0 CA-C-N 116.105 -0.498 . . . . 0.9 111.992 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.526 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 54.4 tp -75.71 108.33 8.48 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.429 ' HB ' ' HG3' ' A' ' 43' ' ' ARG . 14.0 m -82.85 92.86 7.36 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.205 0.526 . . . . 0.0 110.579 -173.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.641 HD11 ' HB3' ' A' ' 40' ' ' TYR . 7.9 tp -89.92 113.49 26.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.694 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.5 mt -121.1 157.48 24.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.096 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 47.7 ttt-85 -90.25 125.23 35.42 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.08 128.12 35.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.218 0.533 . . . . 0.0 111.717 -177.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -102.5 -51.49 3.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.718 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -124.39 164.18 20.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.241 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -136.46 114.02 10.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.637 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.7 p -93.16 175.18 6.87 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 170.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.88 -38.16 81.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.782 0.325 . . . . 0.0 110.667 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -64.68 -44.97 88.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.517 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -61.79 -49.77 75.03 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.179 0.514 . . . . 0.0 110.14 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -58.88 -47.1 86.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.069 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.8 mt -67.37 -36.38 76.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.54 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -68.79 -41.33 78.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.04 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.76 -43.47 93.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.727 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -77.33 -1.4 29.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.427 0.632 . . . . 0.0 110.284 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -93.34 -33.5 13.87 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.5 mt -68.94 -44.65 81.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.435 174.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -100.48 97.03 5.88 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 170.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 N--CA 1.476 0.454 0 C-N-CA 123.176 2.584 . . . . 0.0 114.189 -169.349 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.8 mt . . . . . 0 N--CA 1.461 0.09 0 CA-C-O 121.093 0.473 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -73.34 141.1 47.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.062 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.1 149.56 24.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.95 0.405 . . . . 0.0 110.76 -177.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -147.95 -162.38 1.54 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -84.57 -24.2 29.33 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.955 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -86.01 -49.99 7.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.396 0.617 . . . . 0.0 109.416 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -94.01 101.48 13.52 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -109.1 137.75 46.52 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.02 0.438 . . . . 0.0 111.41 -173.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.542 HG12 ' HG2' ' A' ' 53' ' ' ARG . 57.8 mt -108.18 112.37 39.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 170.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.641 ' HB3' HD11 ' A' ' 5' ' ' ILE . 11.7 m-85 -94.27 137.02 33.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.982 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.579 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -118.66 116.31 26.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.47 -176.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.662 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.31 91.51 7.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.68 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.552 ' HB3' HD23 ' A' ' 48' ' ' LEU . 13.5 ptm180 -92.21 133.02 36.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.573 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -108.94 99.43 8.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.716 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 67.22 -69.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.309 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -101.17 -59.82 1.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -170.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -132.81 -177.51 4.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.942 0.401 . . . . 0.0 111.944 -171.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.579 HD22 ' HB1' ' A' ' 41' ' ' ALA . 21.8 mt -78.32 113.32 16.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.219 -171.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.447 HD12 ' HD2' ' A' ' 69' ' ' ARG . 46.5 tp -89.72 -30.43 18.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.943 0.401 . . . . 0.0 110.736 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.662 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -142.49 146.48 34.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.777 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -133.62 133.81 42.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.483 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.465 ' HB ' HD13 ' A' ' 66' ' ' LEU . 10.2 p -148.34 140.58 18.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.962 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.663 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 23.8 mtp85 -100.07 150.91 21.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.235 175.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 11.9 p -151.22 138.93 13.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.011 0.434 . . . . 0.0 110.779 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.1 m -111.99 115.82 29.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.769 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.3 mt -99.45 86.87 3.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.3 0.571 . . . . 0.0 110.744 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -95.08 77.98 3.53 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.207 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.81 -85.98 0.28 Allowed Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.879 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.6 p -114.9 -2.22 12.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.962 0.411 . . . . 0.0 111.135 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -104.31 125.69 50.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.487 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.37 96.24 0.72 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -98.48 113.57 25.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.796 0.331 . . . . 0.0 111.153 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.556 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 5.9 mp -93.87 116.55 29.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.224 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.663 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 22.2 m-20 -109.38 131.59 54.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.692 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.8 m 61.11 98.89 0.03 OUTLIER 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.573 0.701 . . . . 0.0 112.06 175.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.465 HD13 ' HB ' ' A' ' 52' ' ' VAL . 22.2 tp -123.89 118.28 26.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.099 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -143.98 139.26 28.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.196 0.522 . . . . 0.0 111.223 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.438 HG12 ' HB2' ' A' ' 50' ' ' ALA . 18.1 m -101.71 169.26 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.868 173.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.447 ' HD2' HD12 ' A' ' 49' ' ' LEU . 95.2 mtt180 -65.75 157.18 30.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 172.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 6.6 tp10 -56.5 -39.08 72.66 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -172.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.79 36.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.148 0.499 . . . . 0.0 110.65 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 m -127.21 4.91 6.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.3 0.571 . . . . 0.0 110.944 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 8.4 mtm180 -81.1 130.14 34.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.74 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.9 mtp-105 62.55 36.56 13.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.261 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -125.43 17.91 8.22 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.761 -0.376 . . . . 0.0 112.012 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.08 -37.98 2.18 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.08 -0.581 . . . . 0.0 114.438 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.5 t -48.33 -44.83 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.78 97.57 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.878 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.457 ' HG3' HD23 ' A' ' 115' ' ' LEU . 53.2 tt0 -65.35 -39.21 92.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.033 0.444 . . . . 0.0 110.027 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.526 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 30.0 t80 -59.05 -49.35 78.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.238 175.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.582 HD11 HD13 ' A' ' 5' ' ' ILE . 51.6 tp -50.82 -54.12 26.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.064 -176.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.424 ' O ' HD13 ' A' ' 86' ' ' LEU . 3.9 mm? -63.73 -50.42 69.19 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.396 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -66.21 -25.86 67.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.584 -176.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -65.97 -46.8 76.76 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 81' ' ' LEU . 57.9 t -62.67 -44.41 99.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.952 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.467 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 11.2 mp -65.99 -27.9 68.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.244 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.8 ttp85 -87.6 -19.31 27.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.583 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.475 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 9.7 t30 -81.62 -46.24 14.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.663 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -102.82 97.83 10.11 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.981 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 83.0 Cg_endo -89.41 148.48 5.28 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.809 2.339 . . . . 0.0 113.498 -173.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.83 7.26 78.43 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.689 -0.687 . . . . 0.0 113.481 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.72 116.73 20.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.1 m -77.49 -32.41 54.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.18 -172.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.0 t -127.49 103.88 7.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.768 0.318 . . . . 0.0 111.458 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.467 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 98.0 m95 -94.41 98.32 10.8 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 171.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.507 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 63.6 t-105 -101.96 120.48 40.47 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.081 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.556 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 73.6 mtp -111.75 126.74 55.38 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.927 0.394 . . . . 0.0 110.571 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.63 99.17 5.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.133 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' A' ' 102' ' ' VAL . 7.7 m-20 -76.37 -31.86 58.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.602 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 67.93 -71.54 0.11 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.004 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -101.53 40.68 2.34 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.978 -174.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.524 HG13 ' HG2' ' A' ' 105' ' ' ARG . 13.2 p -81.7 125.43 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -90.38 -30.7 17.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.189 0.519 . . . . 0.0 109.724 177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.15 45.63 0.75 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.387 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.524 ' HG2' HG13 ' A' ' 102' ' ' VAL . 22.0 mtm180 -55.21 -47.08 75.82 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -172.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.76 -48.28 85.06 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.406 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.16 -41.77 92.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 110.653 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.501 ' O ' ' HG2' ' A' ' 112' ' ' MET . 10.3 tpt -64.75 -39.03 92.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.378 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 85.5 m -65.02 -38.84 92.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.702 0.287 . . . . 0.0 110.698 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.6 -41.48 99.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.204 0.525 . . . . 0.0 110.137 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -63.15 -42.4 99.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.337 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.535 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 24.7 mmt -61.71 -39.33 91.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.024 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -70.74 -21.15 62.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.252 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.98 -26.72 39.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.115 0.483 . . . . 0.0 110.375 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.457 HD23 ' HG3' ' A' ' 79' ' ' GLN . 92.1 mt -84.51 -37.76 20.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.572 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.08 25.98 3.39 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.311 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.535 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 39.7 m-85 -95.9 142.49 28.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.798 0.332 . . . . 0.0 110.99 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.6 m -104.74 148.45 26.59 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.9 m -97.19 112.23 24.12 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -135.46 133.89 39.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.484 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 58.13 30.02 18.75 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.82 -4.03 78.33 Favored Glycine 0 CA--C 1.517 0.172 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.237 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -129.17 -179.46 15.97 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.259 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.436 ' CD1' ' HG3' ' A' ' 112' ' ' MET . 26.6 m-90 -112.22 137.49 50.24 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -132.52 137.24 47.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.024 0.44 . . . . 0.0 110.982 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -119.4 102.54 8.75 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 169.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.5 t -78.11 141.61 38.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.754 -174.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 CA-C-N 115.829 -0.623 . . . . 0.9 111.723 178.498 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 tttm . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.5 tp -75.73 115.81 15.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.013 0.435 . . . . 0.0 110.311 -175.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.3 m -88.37 89.56 8.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.312 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.505 HD11 ' HB3' ' A' ' 40' ' ' TYR . 9.4 tt -96.23 132.57 40.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.003 0.43 . . . . 0.0 110.357 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.82 141.08 44.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.226 0.536 . . . . 0.0 110.625 -177.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 7' ' ' ARG . 10.9 ptt180 -79.33 126.9 31.4 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.745 176.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.9 mt -84.62 95.46 8.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.789 0.328 . . . . 0.0 110.824 -176.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -110.49 -8.27 14.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.0 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -135.1 141.37 46.01 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -130.03 115.68 17.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.143 0.497 . . . . 0.0 112.276 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.3 m -100.08 164.18 12.1 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 168.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -59.9 -37.98 80.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.623 0.249 . . . . 0.0 110.855 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -55.14 -49.99 70.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.121 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -67.1 -37.91 84.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.639 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -68.13 -40.61 82.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.059 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.8 mt -61.68 -36.6 74.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.795 0.331 . . . . 0.0 110.383 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.4 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.8 OUTLIER -64.37 -44.18 92.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.153 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.83 -40.0 96.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.93 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -72.52 -15.84 61.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.078 0.466 . . . . 0.0 110.568 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -84.76 -27.84 26.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.684 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 18' ' ' ASP . 62.2 mt -82.66 -37.28 14.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.9 175.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.635 ' HD1' ' HD2' ' A' ' 67' ' ' ARG . 2.8 m0 -111.26 87.15 7.12 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.782 175.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--N 1.343 0.265 0 C-N-CA 122.499 2.133 . . . . 0.0 112.398 -176.565 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 31' ' ' LEU . 7.1 mt . . . . . 0 CA--C 1.519 -0.236 0 CA-C-O 121.528 0.68 . . . . 0.0 109.727 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -133.8 -179.58 5.63 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.078 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.7 m -130.98 162.29 39.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.263 0.554 . . . . 0.0 111.084 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -125.64 163.52 22.6 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -60.68 -28.21 68.44 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.897 0.379 . . . . 0.0 110.533 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -93.29 -46.06 7.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.253 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -93.52 94.13 8.48 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.015 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.3 mtp85 -110.95 149.49 30.58 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.642 0.258 . . . . 0.0 110.971 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.4 mt -120.09 134.46 63.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.284 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.505 ' HB3' HD11 ' A' ' 5' ' ' ILE . 81.8 m-85 -113.84 139.52 49.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.572 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -119.57 121.34 39.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.939 0.4 . . . . 0.0 110.793 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.18 100.51 13.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.798 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -93.33 119.75 32.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.591 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -99.01 92.23 5.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.014 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.8 t30 69.36 -68.17 0.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.051 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -105.84 -53.29 2.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.783 0.325 . . . . 0.0 111.758 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.437 ' HG2' ' H ' ' A' ' 48' ' ' LEU . 35.7 ttt180 -127.47 174.18 9.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.727 -168.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.572 HD22 ' HB1' ' A' ' 41' ' ' ALA . 63.5 mt -73.17 123.74 24.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.876 0.37 . . . . 0.0 110.355 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.687 HD12 ' HD3' ' A' ' 69' ' ' ARG . 39.9 tp -95.04 -34.11 12.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.16 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.554 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -143.22 140.52 30.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.665 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.82 130.49 51.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.182 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 65' ' ' SER . 11.9 p -142.46 142.27 27.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.706 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.1 mtm180 -112.4 159.03 19.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.891 0.376 . . . . 0.0 110.735 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.59 128.99 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.356 0.598 . . . . 0.0 110.857 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.5 m -104.83 97.98 7.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.011 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.531 HD23 ' HA3' ' A' ' 61' ' ' GLY . 97.4 mt -80.34 126.14 30.78 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.779 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.5 m -105.79 77.99 1.3 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.87 -85.93 1.37 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.271 -174.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.2 p -111.32 -63.33 1.42 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.197 0.523 . . . . 0.0 110.452 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.567 ' HA ' HG13 ' A' ' 92' ' ' VAL . 30.1 mt-10 -76.04 147.51 38.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.811 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.531 ' HA3' HD23 ' A' ' 56' ' ' LEU . . . -142.21 165.46 26.65 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.504 -173.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -116.38 134.03 55.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.794 0.33 . . . . 0.0 110.887 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 76.7 mt -93.83 132.93 37.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.452 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -142.77 163.48 32.7 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 36.0 m 54.59 86.61 0.05 OUTLIER 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.64 0.588 . . . . 0.0 111.732 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.9 tp -122.51 107.02 11.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.832 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.635 ' HD2' ' HD1' ' A' ' 23' ' ' TRP . 34.8 mtt180 -130.18 105.82 8.19 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.215 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.554 HG13 ' HB2' ' A' ' 50' ' ' ALA . 8.9 t -95.91 146.95 6.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 171.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.687 ' HD3' HD12 ' A' ' 49' ' ' LEU . 31.1 mtp85 -52.51 126.32 19.12 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -58.03 -23.1 52.91 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -169.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.4 t -66.29 -21.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.052 0.453 . . . . 0.0 110.765 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.734 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 1.3 m -86.47 32.22 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.406 0.622 . . . . 0.0 110.907 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 73' ' ' ARG . 25.7 ttt180 -81.44 127.95 33.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.84 -176.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 61.35 35.79 17.8 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.898 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.734 ' HD2' ' HA ' ' A' ' 72' ' ' THR . 95.3 mtt180 -112.91 2.69 15.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.807 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.52 -12.18 52.8 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 121.003 -0.618 . . . . 0.0 114.105 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.447 HG11 HD23 ' A' ' 49' ' ' LEU . 92.8 t -61.24 -43.88 97.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.275 0.538 . . . . 0.0 111.773 -177.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.57 -33.93 79.21 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.441 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -63.01 -47.44 83.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.953 0.406 . . . . 0.0 110.278 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -61.76 -43.31 99.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.594 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 42' ' ' ALA . 44.2 tp -53.44 -55.86 21.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.443 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.487 ' HB2' HD11 ' A' ' 115' ' ' LEU . 4.3 mm? -65.68 -40.39 92.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.053 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 7.3 mm-40 -53.46 -50.74 64.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.79 0.329 . . . . 0.0 111.145 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -60.49 -45.36 94.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.8 -177.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.3 t -63.56 -49.46 82.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.174 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.59 -20.3 66.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.997 -176.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 42.8 mtm180 -92.91 -30.19 15.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.657 0.265 . . . . 0.0 111.257 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.46 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 17.3 m-80 -82.09 -20.14 38.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.606 0.241 . . . . 0.0 111.415 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -113.69 86.83 11.16 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.87 0.367 . . . . 0.0 110.443 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 5.0 Cg_exo -81.05 -13.45 11.41 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.227 2.618 . . . . 0.0 112.528 -176.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.05 -8.38 87.89 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.497 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.567 HG13 ' HA ' ' A' ' 60' ' ' GLU . 21.7 t -94.47 101.98 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 p -77.92 -36.16 49.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 51.6 t -116.36 116.04 26.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.389 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -97.86 102.13 13.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.899 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.519 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 35.8 t-105 -97.08 133.29 41.94 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.552 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 47.1 mtp -114.36 130.03 56.67 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.992 0.425 . . . . 0.0 109.982 176.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.5 160.75 14.65 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.646 -176.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -87.22 -2.48 58.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.985 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.47 114.23 5.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.292 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.57 -14.25 59.28 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.72 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.548 HG13 ' HG3' ' A' ' 108' ' ' MET . 55.1 t -89.76 97.63 7.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.352 0.596 . . . . 0.0 110.125 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -76.78 -50.46 13.47 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.77 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -91.09 92.92 8.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.658 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -73.56 -23.76 60.01 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.899 -176.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.25 -56.16 8.15 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.567 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.3 t -66.15 -41.1 88.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.654 0.264 . . . . 0.0 110.68 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.548 ' HG3' HG13 ' A' ' 102' ' ' VAL . 94.8 mmm -63.72 -37.72 88.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.326 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 m -62.58 -45.88 90.88 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.425 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.58 -40.58 95.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.969 0.414 . . . . 0.0 110.617 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -58.72 -49.18 78.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.825 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.56 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 64.9 mtt -69.76 -40.22 76.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.511 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -61.4 -44.01 97.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.77 0.319 . . . . 0.0 110.686 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.27 72.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.188 0.518 . . . . 0.0 110.437 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.487 HD11 ' HB2' ' A' ' 82' ' ' LEU . 2.7 tt -68.19 -33.41 74.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.92 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 132.75 1.59 4.13 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.065 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.56 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 98.3 m-85 -83.19 174.1 11.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.039 0.447 . . . . 0.0 110.863 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.1 m -149.73 151.35 33.5 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.7 t -97.3 110.21 22.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.698 0.761 . . . . 0.0 109.794 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -141.25 129.11 21.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.286 -174.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 63.42 32.68 14.31 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.208 0.528 . . . . 0.0 111.361 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 111.14 -74.41 0.21 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.562 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -91.09 -156.52 32.79 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.295 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 26.6 m-90 -104.37 119.85 39.89 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -119.36 117.83 29.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.903 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -126.34 136.56 52.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.921 0.391 . . . . 0.0 111.181 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 52.6 t -80.55 135.16 36.04 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.775 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 C-N-CA 120.877 -0.677 . . . . 0.9 112.137 179.464 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.7 mttp . . . . . 0 CA--C 1.519 -0.219 0 CA-C-O 120.887 0.375 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.447 HD21 ' HB1' ' A' ' 42' ' ' ALA . 43.8 tp -111.4 112.18 23.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.111 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.1 m -82.76 94.04 7.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.084 0.469 . . . . 0.0 110.532 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.539 HD12 ' HB2' ' A' ' 42' ' ' ALA . 12.7 tt -108.7 128.84 64.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.045 0.45 . . . . 0.0 110.788 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.4 mt -124.19 155.31 31.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.455 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.459 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 12.8 ptt180 -80.22 119.56 23.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.801 174.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 41' ' ' ALA . 83.7 mt -76.78 88.11 3.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.209 0.528 . . . . 0.0 110.679 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -102.18 8.59 40.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.823 0.82 . . . . 0.0 109.258 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -157.54 142.97 17.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.496 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -126.43 121.22 31.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.86 0.362 . . . . 0.0 111.067 -177.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.2 170.46 8.24 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.412 ' O ' HG13 ' A' ' 17' ' ' ILE . 4.0 m-20 -60.33 -46.47 89.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.726 0.298 . . . . 0.0 110.732 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -59.11 -41.2 87.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -62.35 -45.42 93.28 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.564 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -59.27 -45.11 92.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.886 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 13' ' ' ASP . 60.6 mt -67.01 -32.1 56.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.009 0.433 . . . . 0.0 111.173 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.402 ' O ' HG13 ' A' ' 22' ' ' ILE . 9.7 t70 -77.09 -38.69 51.85 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.078 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.542 HD23 HD12 ' A' ' 22' ' ' ILE . 97.3 mt -61.65 -34.16 75.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.294 174.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -64.35 -36.11 83.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.297 176.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -70.8 -21.99 62.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.082 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 48' ' ' LEU . 63.5 mt -79.09 -48.44 21.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.767 0.318 . . . . 0.0 110.619 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.433 ' CD1' ' HD2' ' A' ' 67' ' ' ARG . 4.4 m0 -106.83 97.86 19.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.027 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 12.9 Cg_exo . . . . . 0 C--N 1.341 0.163 0 C-N-CA 122.674 2.249 . . . . 0.0 111.832 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 N--CA 1.461 0.115 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -62.68 115.94 4.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.081 -172.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.55 HG13 ' HA ' ' A' ' 38' ' ' ARG . 73.3 t -112.31 118.32 57.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.16 170.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 14.2 p-10 -100.0 -52.2 3.48 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 16.9 t70 166.9 -40.4 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -71.69 -56.14 6.37 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.67 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -91.14 101.92 14.66 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.55 ' HA ' HG13 ' A' ' 33' ' ' VAL . 12.0 ptp180 -123.56 142.34 51.12 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.099 0.476 . . . . 0.0 111.112 -175.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.542 HG12 ' HG2' ' A' ' 53' ' ' ARG . 52.3 mt -107.19 134.42 48.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.204 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.508 ' HB3' HD11 ' A' ' 5' ' ' ILE . 76.6 m-85 -111.05 121.6 45.77 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.724 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.86 119.98 41.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.832 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.715 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -96.44 105.8 17.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.827 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.947 ' HB3' HD23 ' A' ' 48' ' ' LEU . 4.9 ptm180 -107.54 134.31 50.74 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.464 178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -97.2 82.39 3.16 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.2 t30 50.35 23.94 1.38 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.522 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.667 ' HG2' ' HG3' ' A' ' 47' ' ' ARG . 38.3 tt0 -166.86 -89.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.999 -0.438 . . . . 0.0 110.732 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.667 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 85.7 mtt180 -108.24 163.86 12.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.668 0.271 . . . . 0.0 110.759 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.947 HD23 ' HB3' ' A' ' 43' ' ' ARG . 19.6 mt -77.25 104.0 7.5 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 67.1 mt -86.21 -30.61 22.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.773 0.321 . . . . 0.0 110.867 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.715 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -129.31 137.03 50.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.626 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -131.78 125.15 31.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.832 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.8 p -134.25 134.25 55.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.613 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.542 ' HG2' HG12 ' A' ' 39' ' ' ILE . 63.6 mtm180 -108.88 141.9 40.26 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.311 176.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.471 HG13 ' HG3' ' A' ' 38' ' ' ARG . 6.0 p -133.83 132.7 56.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.295 0.569 . . . . 0.0 110.993 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.7 m -106.57 111.56 24.17 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.63 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.4 mt -83.48 85.58 7.22 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.238 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.6 t -82.98 83.7 7.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.372 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.29 -116.38 7.52 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.187 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.1 p -91.91 2.07 56.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.916 0.389 . . . . 0.0 111.288 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.596 ' HG2' ' HB3' ' A' ' 94' ' ' CYS . 35.0 mt-10 -110.88 136.36 50.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.64 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -115.01 104.17 1.32 Allowed Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.0 124.02 36.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.723 0.297 . . . . 0.0 110.746 -178.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.537 HD12 ' HG2' ' A' ' 97' ' ' MET . 94.6 mt -93.52 114.94 27.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.153 0.502 . . . . 0.0 109.698 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.541 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 10.0 t70 -117.18 127.36 54.03 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.309 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.628 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 25.0 m 66.71 92.26 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.423 0.63 . . . . 0.0 111.146 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.0 tp -114.76 102.26 9.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.292 174.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.433 ' HD2' ' CD1' ' A' ' 23' ' ' TRP . 87.7 mtt180 -136.39 115.05 11.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.421 -175.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' A' ' 50' ' ' ALA . 11.8 t -98.53 150.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -55.78 137.36 50.04 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -62.04 -17.94 58.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.289 0.566 . . . . 0.0 110.908 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.4 t -71.52 -24.73 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.761 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.9 m -86.04 18.87 2.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.06 0.457 . . . . 0.0 111.923 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -66.24 118.23 9.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -163.58 -97.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.359 -0.537 . . . . 0.0 112.19 -175.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 169.6 95.77 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 133.96 -59.03 0.68 Allowed Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.879 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.7 t -49.9 -54.32 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 81' ' ' LEU . . . -61.22 -43.99 98.69 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.026 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -66.27 -46.15 78.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.784 0.325 . . . . 0.0 110.134 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -60.14 -39.18 85.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.46 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 85' ' ' VAL . 48.2 tp -50.53 -55.51 15.79 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.536 0.523 . . . . 0.0 110.819 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.76 -43.69 88.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.29 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.57 -39.42 93.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.343 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -66.64 -44.56 81.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.024 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 81' ' ' LEU . 97.0 t -58.78 -44.18 89.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.79 0.329 . . . . 0.0 110.915 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.03 -18.91 57.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.679 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.8 -42.3 11.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.973 0.416 . . . . 0.0 110.151 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -72.75 -31.66 65.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.117 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -122.99 76.56 50.16 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.618 174.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -94.66 16.11 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.133 2.555 . . . . 0.0 112.613 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.85 2.21 87.1 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.731 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.5 128.61 52.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.731 0.301 . . . . 0.0 110.278 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.7 m -91.61 -34.72 14.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.335 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.596 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 48.9 t -117.72 102.92 9.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.894 0.378 . . . . 0.0 110.65 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 94.8 m95 -92.2 142.52 27.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.8 0.333 . . . . 0.0 110.594 178.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -134.9 142.45 46.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.743 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.537 ' HG2' HD12 ' A' ' 63' ' ' LEU . 80.2 mtp -130.03 125.84 36.25 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -102.75 172.35 6.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.596 -174.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.11 -8.64 59.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.231 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.71 121.22 13.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.231 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' ' 65' ' ' SER . . . 82.23 14.2 77.24 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.187 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.16 93.25 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.915 0.388 . . . . 0.0 110.387 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.75 -17.62 37.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.515 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -112.47 72.92 0.79 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.727 0.775 . . . . 0.0 110.02 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.522 ' HG3' ' HH2' ' A' ' 124' ' ' TRP . 41.5 ttp180 -76.22 -32.09 58.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.321 -170.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.77 -53.41 45.49 Favored Glycine 0 C--O 1.238 0.352 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.115 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.82 -42.16 81.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.972 0.415 . . . . 0.0 110.3 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.557 ' O ' ' HG2' ' A' ' 112' ' ' MET . 47.3 ttm -69.47 -25.12 63.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.424 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 94.3 m -62.9 -48.57 78.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.709 0.29 . . . . 0.0 110.243 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.86 -34.43 77.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.443 0.639 . . . . 0.0 110.249 176.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.458 ' CE2' HD11 ' A' ' 115' ' ' LEU . 55.8 t80 -63.25 -42.4 99.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.819 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.557 ' HG2' ' O ' ' A' ' 108' ' ' MET . 25.1 mmt -62.81 -39.97 95.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.37 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -69.33 -27.15 65.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.624 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.46 -40.46 57.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.438 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.458 HD11 ' CE2' ' A' ' 111' ' ' PHE . 92.9 mt -66.26 -60.78 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.108 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.34 48.45 0.13 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.825 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.434 ' CD2' ' HB2' ' A' ' 126' ' ' LYS . 41.3 m-85 -109.96 141.46 42.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.774 0.321 . . . . 0.0 110.416 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.9 p -92.49 144.08 25.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.257 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.4 p -97.48 148.28 23.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.146 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -124.55 -161.93 1.04 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.934 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -79.32 29.64 0.23 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.907 0.384 . . . . 0.0 111.77 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.08 67.38 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.087 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.62 169.01 11.78 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.428 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.522 ' HH2' ' HG3' ' A' ' 105' ' ' ARG . 11.7 m-90 -113.93 133.44 55.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.698 0.285 . . . . 0.0 110.472 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -123.1 145.3 48.69 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.081 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 64.6 tttp -137.28 96.85 3.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.924 0.392 . . . . 0.0 110.251 174.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 17.4 t -87.9 133.35 33.94 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 C-N-CA 120.833 -0.698 . . . . 0.9 112.005 -179.733 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 tttp . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.465 HD11 ' HB1' ' A' ' 42' ' ' ALA . 49.1 tp -76.04 107.1 8.02 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.534 ' HB ' ' HG2' ' A' ' 43' ' ' ARG . 9.0 m -86.65 98.87 11.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.444 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 4.6 mp -89.75 127.8 42.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 mm -101.54 146.94 9.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 13.9 ptt180 -99.21 106.16 18.28 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 39' ' ' ILE . 63.9 mt -73.09 86.06 1.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.451 0.643 . . . . 0.0 110.882 -176.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -95.69 -22.33 17.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.784 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -136.75 143.5 43.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.127 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -120.93 144.63 48.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.256 0.551 . . . . 0.0 111.782 -173.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.3 p -109.56 163.71 13.2 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 166.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.471 ' O ' HG13 ' A' ' 17' ' ' ILE . 29.5 t70 -68.19 -31.11 70.41 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.327 0.584 . . . . 0.0 109.491 177.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -65.97 -50.77 63.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.114 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.407 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 47.7 m-20 -66.42 -28.6 68.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.057 0.456 . . . . 0.0 110.477 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -65.1 -32.62 74.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.282 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 13' ' ' ASP . 75.8 mt -65.92 -42.97 92.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.566 175.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.19 -38.2 82.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.029 0.442 . . . . 0.0 110.358 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.427 ' O ' ' HE3' ' A' ' 23' ' ' TRP . 96.4 mt -61.3 -40.0 92.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.279 175.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -77.25 -6.2 52.19 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.578 0.704 . . . . 0.0 110.458 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -89.77 -18.62 25.97 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.552 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 91.5 mt -90.41 -38.77 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.774 172.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.427 ' HE3' ' O ' ' A' ' 19' ' ' LEU . 18.2 m-90 -99.21 89.02 0.85 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.369 171.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 13.0 Cg_exo . . . . . 0 C--N 1.344 0.303 0 C-N-CA 122.61 2.207 . . . . 0.0 113.064 -169.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 121.428 0.632 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -67.8 135.18 52.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.377 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.15 165.78 30.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.943 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -156.29 -171.5 3.74 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.37 -14.94 62.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 118.275 0.488 . . . . 0.0 111.307 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 34.2 m-80 -97.29 -56.8 2.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.085 0.469 . . . . 0.0 110.358 176.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -89.36 93.93 9.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.167 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -112.63 156.1 23.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.721 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.48 HG23 ' HG2' ' A' ' 53' ' ' ARG . 63.5 mt -113.3 122.05 66.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.897 177.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -94.13 117.91 30.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.122 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.49 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.14 113.3 26.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.947 178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.765 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -95.44 112.42 24.14 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.903 -175.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.603 ' HB3' HD23 ' A' ' 48' ' ' LEU . 4.7 ptm180 -102.74 125.95 49.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.408 0.623 . . . . 0.0 109.941 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.54 ' HB3' HD12 ' A' ' 49' ' ' LEU . 57.1 t80 -109.51 95.58 5.71 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.9 t30 60.06 81.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.992 -173.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 72.83 -59.25 0.57 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.165 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 59.9 mtt85 -72.44 132.28 43.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -167.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' A' ' 43' ' ' ARG . 96.2 mt -76.16 100.19 4.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 171.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.54 HD12 ' HB3' ' A' ' 44' ' ' PHE . 88.2 mt -107.0 -8.72 16.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.77 -173.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.765 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -144.07 139.02 28.68 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.86 131.47 31.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.2 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 65' ' ' SER . 10.0 p -141.45 130.2 23.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.317 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HG2' HG23 ' A' ' 39' ' ' ILE . 63.6 mtm180 -99.68 141.68 32.16 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.0 p -130.94 127.88 61.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.573 0.702 . . . . 0.0 111.121 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.4 m -100.04 93.62 5.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.476 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.514 ' O ' ' HB3' ' A' ' 36' ' ' ASN . 94.2 mt -81.24 141.29 34.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.057 0.456 . . . . 0.0 110.625 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 t -144.44 74.3 1.41 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.21 -111.41 3.9 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.854 -178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.0 p -95.85 12.81 28.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.051 0.453 . . . . 0.0 111.204 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -118.95 139.06 52.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.74 114.59 0.96 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.861 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -103.24 119.33 38.68 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.607 0.242 . . . . 0.0 110.768 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.517 HD22 ' HE3' ' A' ' 97' ' ' MET . 6.0 mp -93.42 126.27 38.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.108 0.48 . . . . 0.0 110.688 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -125.17 138.9 54.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.299 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 50.3 m 61.01 87.27 0.09 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.312 0.577 . . . . 0.0 111.283 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.7 tp -108.58 106.35 16.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.907 173.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.422 HH12 ' CD ' ' A' ' 103' ' ' GLU . 72.9 mtp85 -131.45 119.79 22.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -173.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.452 HG12 ' HB ' ' A' ' 72' ' ' THR . 1.9 t -109.07 141.61 23.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.6 ttt-85 -82.92 166.65 18.71 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.983 -174.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -48.7 -39.58 25.13 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.704 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.6 t -62.25 -28.28 44.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.207 -173.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.452 ' HB ' HG12 ' A' ' 68' ' ' VAL . 0.6 OUTLIER -97.18 19.03 13.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -168.869 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -80.29 84.86 5.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -134.73 -86.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.071 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER 168.54 99.1 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.612 0.765 . . . . 0.0 109.061 -168.931 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.85 -74.12 0.45 Allowed Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.627 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.4 t -38.15 -54.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -170.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 81' ' ' LEU . . . -56.43 -59.34 10.9 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.96 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.418 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 99.4 mt-30 -64.16 -34.34 77.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.804 0.335 . . . . 0.0 110.723 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -63.34 -38.3 90.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.529 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.477 ' O ' HG23 ' A' ' 85' ' ' VAL . 61.7 tp -55.58 -49.95 71.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.994 176.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.46 -43.89 96.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.902 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 79' ' ' GLN . 40.1 mt-10 -59.33 -42.63 91.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.266 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.433 ' HG2' HD13 ' A' ' 5' ' ' ILE . 9.1 tp10 -60.27 -44.12 95.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.49 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 81' ' ' LEU . 99.3 t -60.61 -44.94 97.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.16 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -73.9 -16.47 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.658 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 87' ' ' ARG . 63.6 mtt180 -92.89 -30.56 15.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.034 0.445 . . . . 0.0 110.632 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -73.92 -50.51 19.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.737 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.445 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 12.4 m120 -82.54 146.9 54.58 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.111 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 22.7 Cg_exo -66.38 -165.79 0.1 OUTLIER 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.161 2.574 . . . . 0.0 113.003 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.43 84.73 0.1 Allowed Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.522 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.0 t -82.56 122.83 37.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 7.1 m -68.74 -57.82 5.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.544 -174.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.7 t -103.76 106.95 17.61 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.657 -172.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -97.83 110.62 23.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.935 0.398 . . . . 0.0 110.141 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.444 ' CE3' ' HG2' ' A' ' 125' ' ' GLU . 18.9 t-105 -104.12 131.74 51.09 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.517 ' HE3' HD22 ' A' ' 63' ' ' LEU . 54.7 mtp -128.69 137.27 51.53 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 175.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.66 169.33 11.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.781 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.0 5.96 48.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.393 . . . . 0.0 110.773 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.82 124.64 21.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.429 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.51 0.12 58.09 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.541 HG21 ' SD ' ' A' ' 108' ' ' MET . 62.1 t -114.83 124.46 71.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.558 -0.321 . . . . 0.0 110.201 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.422 ' CD ' HH12 ' A' ' 67' ' ' ARG . 17.6 mp0 -71.88 -26.49 62.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.442 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -118.82 103.25 9.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.021 0.438 . . . . 0.0 110.95 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -73.1 -28.25 62.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.404 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.94 -51.68 51.34 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.123 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.6 t -59.79 -40.86 83.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.921 0.391 . . . . 0.0 110.306 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.541 ' SD ' HG21 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -61.55 -43.27 99.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.643 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 57.3 m -61.15 -48.83 79.8 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.781 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.14 96.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.069 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -62.4 -47.65 83.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.075 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.536 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 23.9 mmt -63.13 -46.22 88.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.407 -177.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -68.55 -30.2 68.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.743 -177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.46 -27.13 58.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.884 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.585 HD13 ' HE2' ' A' ' 117' ' ' PHE . 4.7 tt -82.22 -51.52 7.86 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 141.84 45.72 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.415 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.585 ' HE2' HD13 ' A' ' 115' ' ' LEU . 94.7 m-85 -123.38 134.52 53.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.828 0.347 . . . . 0.0 110.547 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.5 m -93.13 144.82 24.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.835 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.8 t -97.23 116.44 29.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.544 0.687 . . . . 0.0 110.206 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -141.1 140.17 34.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.312 -174.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 54.74 30.99 14.54 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.892 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.7 -57.15 0.52 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.486 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -90.55 -147.93 19.5 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.195 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 31.0 m-90 -121.52 124.24 43.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.696 0.284 . . . . 0.0 110.307 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.444 ' HG2' ' CE3' ' A' ' 96' ' ' TRP . 42.3 mt-10 -119.33 121.17 38.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.743 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -126.37 96.79 4.81 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.536 172.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 93' ' ' SER . 34.2 t -104.21 123.88 48.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.005 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 C-N-CA 121.095 -0.574 . . . . 0.9 112.074 -179.795 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 tttp . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.766 0.317 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.559 HD11 ' HB1' ' A' ' 42' ' ' ALA . 47.6 tp -89.41 116.32 27.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.347 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 m -89.32 93.22 9.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.567 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.69 HD11 ' HB3' ' A' ' 40' ' ' TYR . 6.5 tp -88.05 124.39 41.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.175 0.512 . . . . 0.0 110.052 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 mt -123.55 155.02 29.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.219 -176.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -89.53 127.68 35.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.131 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.438 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 42.0 tp -80.91 99.63 8.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.601 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.507 ' HA ' HG11 ' A' ' 33' ' ' VAL . 36.0 mt-10 -102.04 -17.36 16.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.655 -175.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -151.56 156.31 40.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.703 0.287 . . . . 0.0 111.29 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.444 ' CE2' HG23 ' A' ' 33' ' ' VAL . 87.7 m-85 -119.1 109.64 16.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.117 -177.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.0 p -90.74 158.86 16.64 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 168.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 17' ' ' ILE . 5.4 m-20 -58.58 -38.34 77.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.934 0.397 . . . . 0.0 110.184 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -61.54 -55.78 27.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.676 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.507 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 70.1 m-20 -61.88 -37.67 85.42 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.538 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -64.19 -36.4 83.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.67 -176.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 13' ' ' ASP . 80.2 mt -66.5 -45.12 89.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.743 177.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.545 ' O ' HG13 ' A' ' 22' ' ' ILE . 24.0 t0 -65.57 -35.06 79.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.333 . . . . 0.0 110.593 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 95.0 mt -63.65 -41.43 98.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.978 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -69.42 -21.45 63.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.514 0.673 . . . . 0.0 109.695 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -85.78 -12.34 51.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.134 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 18' ' ' ASP . 71.0 mt -85.1 -32.69 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 171.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -116.04 72.09 4.42 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.783 175.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HD3' ' C ' ' A' ' 22' ' ' ILE . 18.0 Cg_exo . . . . . 0 C--N 1.347 0.465 0 C-N-CA 122.338 2.025 . . . . 0.0 111.732 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 121.192 0.52 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -137.94 147.74 44.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.178 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' ' 9' ' ' GLU . 59.7 t -93.74 126.23 46.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.039 -176.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.646 ' HB3' ' HB2' ' A' ' 37' ' ' HIS . 30.9 t70 -138.71 158.02 45.01 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.299 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -63.2 -35.87 81.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.723 0.296 . . . . 0.0 110.805 178.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 55' ' ' THR . 89.7 m-20 -86.29 -48.04 8.86 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.646 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 40.4 m170 -87.28 84.47 7.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.914 175.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -109.36 147.79 32.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.144 -173.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 8' ' ' LEU . 56.5 mt -126.56 139.07 52.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.854 0.359 . . . . 0.0 110.379 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.69 ' HB3' HD11 ' A' ' 5' ' ' ILE . 76.9 m-85 -118.03 152.43 35.54 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.525 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -136.67 126.51 25.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.999 0.428 . . . . 0.0 111.154 -174.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.04 104.02 16.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.011 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -95.14 110.22 22.2 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.34 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -119.39 135.24 54.82 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.3 t30 61.51 30.65 18.87 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.618 0.723 . . . . 0.0 109.072 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 65.84 17.11 10.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.955 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -126.43 138.96 53.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.572 0.225 . . . . 0.0 110.404 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.525 HD22 ' HB1' ' A' ' 41' ' ' ALA . 78.4 mt -63.65 106.58 0.99 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 49' ' ' LEU . 12.8 tp -105.03 -21.41 13.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.823 -172.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -140.94 135.26 31.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.482 178.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.65 132.93 53.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.608 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.482 ' HB ' HD13 ' A' ' 66' ' ' LEU . 8.0 p -142.2 131.9 23.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.596 -178.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 1.026 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 10.6 mtm180 -103.22 155.68 18.26 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.88 176.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.79 126.5 14.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.251 0.548 . . . . 0.0 110.414 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 77.6 m -102.49 107.61 18.63 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.042 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.4 mt -83.54 95.29 8.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.043 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.3 t -86.79 93.05 9.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.368 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.83 -102.99 1.38 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.789 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.2 m -120.83 12.96 11.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.926 0.87 . . . . 0.0 109.521 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -112.87 157.88 20.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.956 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 95' ' ' TRP . . . -125.15 120.76 4.04 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.864 -174.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.78 132.07 53.78 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.834 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 73.0 mt -95.43 119.14 33.41 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.206 0.527 . . . . 0.0 110.281 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 1.026 ' HB2' ' HB2' ' A' ' 53' ' ' ARG . 1.3 m-20 -79.6 -157.66 0.14 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.117 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 p -47.27 118.45 2.17 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.138 0.494 . . . . 0.0 111.932 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.482 HD13 ' HB ' ' A' ' 52' ' ' VAL . 21.3 tp -117.64 116.97 28.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.349 175.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -143.82 123.19 13.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.192 0.52 . . . . 0.0 111.735 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' A' ' 50' ' ' ALA . 22.4 t -94.38 137.8 22.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 169.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -56.87 136.55 55.74 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -56.67 -15.82 5.19 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -166.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.07 -15.59 19.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.696 0.284 . . . . 0.0 111.487 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 m -108.99 68.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.406 0.622 . . . . 0.0 110.34 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.8 ttt85 -92.85 103.31 15.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.842 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 74' ' ' ARG . 20.9 mtp180 60.78 79.73 0.24 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.805 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -142.21 16.76 2.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.052 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.22 -19.98 11.7 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.489 175.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.9 t -51.29 -46.59 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.0 -28.95 71.27 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.101 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -69.65 -55.0 11.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -56.11 -44.65 79.31 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.165 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.628 HD11 HD13 ' A' ' 5' ' ' ILE . 30.3 tp -52.89 -57.99 8.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.496 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.3 mt -66.21 -39.69 89.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.238 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -59.0 -43.01 91.42 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.252 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -64.45 -36.42 84.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.59 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 81' ' ' LEU . 93.2 t -63.34 -48.87 85.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.803 0.335 . . . . 0.0 110.686 177.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.539 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 11.1 mp -66.22 -27.84 68.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.896 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 87' ' ' ARG . 5.5 mtp180 -77.39 -33.66 55.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.398 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -69.95 -44.09 70.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.795 -176.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -76.02 112.79 22.38 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.359 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -87.42 22.54 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.143 2.562 . . . . 0.0 113.766 -171.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -172.7 75.9 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.018 -1.087 . . . . 0.0 113.093 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.4 t -141.69 129.09 20.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.9 p -99.66 -33.13 10.73 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -177.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.6 t -130.34 137.45 49.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.131 0.491 . . . . 0.0 110.814 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.539 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 90.7 m95 -116.12 122.4 45.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.345 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -114.18 121.3 43.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.292 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.834 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 77.2 mtp -107.29 130.08 54.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.793 0.33 . . . . 0.0 110.59 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -101.26 144.95 29.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.711 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.415 ' HB2' HG12 ' A' ' 102' ' ' VAL . 2.7 p-10 -69.49 -34.26 74.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.908 0.385 . . . . 0.0 110.148 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 61.65 20.68 11.52 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.47 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.35 13.01 20.34 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.243 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.538 HG13 ' HB3' ' A' ' 105' ' ' ARG . 12.2 p -85.53 119.67 34.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.115 0.483 . . . . 0.0 109.725 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -93.27 -5.1 50.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.326 0.584 . . . . 0.0 109.762 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -86.46 16.3 4.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.14 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.538 ' HB3' HG13 ' A' ' 102' ' ' VAL . 5.1 ptt180 -56.62 -32.12 64.98 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.167 -175.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.22 -48.35 70.78 Favored Glycine 0 C--O 1.235 0.193 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.726 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.1 t -61.24 -43.27 96.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-O 122.025 0.917 . . . . 0.0 109.394 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.601 ' O ' ' HG2' ' A' ' 112' ' ' MET . 17.3 ttt -61.64 -37.97 85.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.13 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 98.9 m -61.28 -36.24 79.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.105 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.28 -45.17 88.42 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.13 0.49 . . . . 0.0 109.748 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -63.5 -45.08 92.32 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.019 173.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.601 ' HG2' ' O ' ' A' ' 108' ' ' MET . 59.5 mmm -60.57 -43.89 96.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.102 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -62.83 -35.1 78.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.807 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.51 -32.95 74.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.167 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 33.5 tp -84.8 -42.84 14.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.499 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 136.28 32.87 0.25 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.149 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.582 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 78.5 m-85 -118.58 116.24 26.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.76 0.314 . . . . 0.0 110.391 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.3 p -102.01 136.14 42.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.895 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.711 ' HB ' ' CD1' ' A' ' 124' ' ' TRP . 11.6 t -97.37 134.9 40.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.139 0.495 . . . . 0.0 110.737 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.632 ' HB2' ' OE2' ' A' ' 125' ' ' GLU . 93.5 mt-30 -140.31 -72.6 0.36 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.289 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -86.14 61.54 6.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.265 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.87 -36.96 2.49 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.139 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -118.96 -172.81 15.45 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.165 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.711 ' CD1' ' HB ' ' A' ' 119' ' ' THR . 15.8 m-90 -98.54 126.42 44.1 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.632 ' OE2' ' HB2' ' A' ' 120' ' ' GLN . 35.4 mt-10 -111.69 122.17 47.09 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.015 -175.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -137.12 148.64 46.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.396 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 38.2 t -110.82 151.07 28.25 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.329 0 C-N-CA 120.895 -0.669 . . . . 0.9 112.535 179.34 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.5 tttm . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.964 0.411 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.517 HD21 ' HB1' ' A' ' 42' ' ' ALA . 23.3 tp -76.03 118.47 18.82 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.561 ' O ' ' HB3' ' A' ' 43' ' ' ARG . 18.1 m -90.25 92.22 8.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.098 0.475 . . . . 0.0 110.458 -176.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.596 HG22 ' HA ' ' A' ' 42' ' ' ALA . 9.2 pt -106.79 150.98 8.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.091 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.1 mp -131.14 153.09 38.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -82.98 140.07 32.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.868 0.366 . . . . 0.0 110.036 176.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.9 tp -84.74 82.91 8.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.279 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -75.76 -48.8 20.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.783 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -120.19 157.24 29.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.411 -176.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -117.97 103.7 10.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.995 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -88.88 156.74 18.74 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.432 ' O ' HG13 ' A' ' 17' ' ' ILE . 19.0 t70 -56.78 -52.86 63.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.396 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.17 -35.99 80.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.68 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.488 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 22.0 m-20 -63.48 -44.01 95.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.531 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -62.53 -34.89 77.81 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 120.648 0.261 . . . . 0.0 110.958 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 13' ' ' ASP . 74.2 mt -63.13 -46.54 95.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.613 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -71.69 -31.28 66.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.013 0.435 . . . . 0.0 109.997 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 84.3 mt -63.67 -34.48 77.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.587 174.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -77.22 -18.74 57.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.165 0.507 . . . . 0.0 110.579 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -68.14 -36.81 80.26 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.516 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 67.3 mt -73.76 -55.47 12.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.23 176.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -101.18 97.34 7.07 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 35.3 Cg_exo . . . . . 0 C--N 1.345 0.377 0 C-N-CA 122.554 2.169 . . . . 0.0 111.853 -178.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.511 0.196 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -56.01 128.63 36.21 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.279 0.561 . . . . 0.0 111.934 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.1 m -103.38 167.52 2.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.399 -176.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -155.94 -158.25 0.79 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -72.64 -29.35 63.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.005 0.431 . . . . 0.0 110.77 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -85.68 -53.39 5.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.663 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -92.82 112.39 24.34 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -126.7 119.87 28.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.201 0.524 . . . . 0.0 110.806 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 65.2 mt -98.56 133.92 39.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.073 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -112.7 132.88 54.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.082 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.422 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.52 123.27 48.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.878 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.662 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -91.9 114.69 27.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.453 -176.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.561 ' HB3' ' O ' ' A' ' 4' ' ' THR . 51.9 ttt180 -108.03 127.3 53.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.273 0.559 . . . . 0.0 110.864 -177.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -99.41 82.49 2.68 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 69.13 -68.35 0.19 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.728 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -101.58 -57.74 2.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -174.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 47' ' ' ARG . 10.0 ptp180 -114.51 171.66 7.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.983 0.42 . . . . 0.0 111.076 -171.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.422 HD22 ' HB1' ' A' ' 41' ' ' ALA . 87.5 mt -75.34 133.55 41.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.431 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.8 tp -111.01 -23.98 10.63 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.734 0.302 . . . . 0.0 110.496 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.736 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -151.3 159.08 44.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.158 -177.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -144.46 133.41 22.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.963 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.08 137.76 37.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.937 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 19.1 mtm180 -110.17 129.99 55.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.207 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -133.73 139.47 48.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.316 0.579 . . . . 0.0 110.809 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -111.02 114.7 28.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.092 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.43 HD22 HG21 ' A' ' 92' ' ' VAL . 70.5 mt -86.84 93.06 9.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.965 0.412 . . . . 0.0 109.99 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 t -111.58 94.41 4.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.517 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.42 -107.72 2.04 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.498 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.3 p -93.45 -15.13 25.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.739 0.304 . . . . 0.0 111.036 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -99.66 122.19 42.33 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.247 0.546 . . . . 0.0 111.988 -172.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.23 97.37 2.17 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 167.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.47 107.54 19.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.21 0.528 . . . . 0.0 110.437 -172.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.9 tt -93.73 119.28 32.51 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.041 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 12.1 t70 -126.57 126.42 43.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.348 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.0 t 71.39 108.86 0.06 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.799 0.809 . . . . 0.0 111.111 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 45.4 tp -129.33 110.43 11.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.321 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 67' ' ' ARG . 43.5 mtt180 -125.36 128.53 48.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.095 0.474 . . . . 0.0 111.611 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.736 HG13 ' HB2' ' A' ' 50' ' ' ALA . 1.7 t -121.76 153.97 25.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 172.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.5 mtt-85 -65.22 158.58 25.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.947 0.403 . . . . 0.0 111.433 -176.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 1.5 mp0 -49.88 -38.6 36.25 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.947 -170.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.8 m -78.3 19.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.483 HG21 HG12 ' A' ' 68' ' ' VAL . 70.9 p -115.76 9.68 15.2 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.763 0.316 . . . . 0.0 111.253 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.2 ttp-105 -57.55 106.12 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.167 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 55.92 40.47 30.49 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.119 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -111.29 7.39 21.05 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.992 0.425 . . . . 0.0 111.631 -174.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.98 -23.89 12.73 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.928 173.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.7 t -53.92 -42.07 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.771 0.319 . . . . 0.0 111.713 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.85 -38.43 88.57 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.89 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -59.55 -49.72 76.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.863 0.363 . . . . 0.0 111.037 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -67.06 -33.88 76.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.961 -174.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.494 HD13 ' HB2' ' A' ' 42' ' ' ALA . 56.3 tp -57.72 -49.39 76.71 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.8 0.333 . . . . 0.0 110.301 176.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.77 -42.46 97.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.702 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.01 -46.89 84.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.108 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -59.12 -43.17 91.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.622 0.248 . . . . 0.0 110.974 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 81' ' ' LEU . 94.8 t -60.58 -52.27 63.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.918 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 11.2 mp -64.85 -32.14 73.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.571 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -76.74 -40.2 49.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.929 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -71.19 -39.6 71.7 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -174.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.52 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 47.6 m-80 -75.01 131.75 78.3 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.913 0.387 . . . . 0.0 110.674 -177.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 16.9 Cg_exo -67.05 -69.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 123.383 2.722 . . . . 0.0 114.456 -170.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.13 61.55 0.48 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.637 -170.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.43 HG21 HD22 ' A' ' 56' ' ' LEU . 25.5 t -114.52 105.11 18.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 175.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.9 t -83.25 -37.81 23.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.485 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.0 t -108.93 109.01 19.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.902 0.382 . . . . 0.0 110.822 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.427 ' CZ2' ' HA ' ' A' ' 86' ' ' LEU . 95.9 m95 -97.65 115.54 28.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.698 175.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 -114.88 126.19 54.52 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.964 -175.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 87.1 mtp -107.03 122.52 46.62 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.0 173.71 8.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.772 -172.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.31 -46.05 86.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.051 -178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 62.18 17.01 8.84 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.681 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.53 36.87 58.62 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.47 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.1 t -106.53 109.99 30.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.645 0.222 . . . . 0.0 110.724 177.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -90.95 -6.95 53.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.777 0.322 . . . . 0.0 110.6 173.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.73 52.65 1.03 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.262 0.553 . . . . 0.0 109.621 173.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 105' ' ' ARG . 48.2 mtt-85 -72.94 -21.87 60.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.884 -172.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.69 -56.64 23.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.535 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.1 t -61.51 -39.12 81.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.021 0.439 . . . . 0.0 110.837 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.6 ' SD ' ' HE3' ' A' ' 112' ' ' MET . 27.0 ttm -71.25 -37.8 71.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.119 -176.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 99.1 m -63.84 -47.35 81.12 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.634 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.18 -39.08 74.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.348 0.594 . . . . 0.0 110.602 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -62.77 -54.38 39.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.374 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.6 ' HE3' ' SD ' ' A' ' 108' ' ' MET . 66.4 mtt -76.03 -33.26 59.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -174.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -63.41 -41.03 98.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.943 0.401 . . . . 0.0 110.119 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.24 -25.28 59.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.762 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.6 tp -84.02 -0.12 50.4 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.268 0.556 . . . . 0.0 110.637 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.41 53.38 4.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.95 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -110.0 133.25 53.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.707 0.289 . . . . 0.0 110.633 174.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.8 m -84.74 143.65 29.01 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.4 p -97.32 108.27 20.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.011 0.434 . . . . 0.0 111.038 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -96.8 163.42 12.99 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -73.65 95.99 2.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.827 0.346 . . . . 0.0 110.32 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.94 -30.53 2.94 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.506 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.55 -173.93 42.58 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.375 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -102.34 136.72 41.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.629 0.252 . . . . 0.0 110.619 -177.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -125.75 131.6 52.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.857 -176.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -132.02 133.77 44.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 78.2 m -86.87 129.92 34.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.766 0.317 . . . . 0.0 110.471 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 C-N-CA 121.088 -0.577 . . . . 0.9 111.953 179.836 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 120.975 0.417 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.505 HD22 HG13 ' A' ' 77' ' ' VAL . 59.2 tp -75.86 137.05 40.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.963 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 42' ' ' ALA . 19.1 m -82.89 89.63 6.86 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.209 0.528 . . . . 0.0 110.577 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 40' ' ' TYR . 5.5 tp -98.35 105.76 17.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.003 174.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mt -94.74 149.22 4.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.359 0.6 . . . . 0.0 111.535 -170.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -91.59 101.36 14.0 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.124 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 39' ' ' ILE . 94.3 mt -73.11 92.95 1.75 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.691 -173.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -102.35 -2.69 28.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.736 0.779 . . . . 0.0 109.082 173.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -131.92 120.86 23.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.521 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -124.31 99.59 6.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.491 0.186 . . . . 0.0 111.066 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.57 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 1.4 m -79.03 158.95 27.79 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.569 ' O ' HG12 ' A' ' 17' ' ' ILE . 5.7 p-10 -58.14 -36.45 72.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.658 0.266 . . . . 0.0 110.732 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -70.0 -36.56 75.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.125 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -63.74 -38.34 90.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.272 0.558 . . . . 0.0 109.765 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.57 ' HG3' ' O ' ' A' ' 12' ' ' SER . 77.5 mtt180 -68.28 -28.46 67.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.468 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 13' ' ' ASP . 46.6 mm -66.8 -41.49 87.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.751 176.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 28.5 t0 -69.05 -32.48 71.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.04 0.447 . . . . 0.0 109.859 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.6 mt -63.23 -38.57 91.68 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.236 172.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -68.11 -22.77 64.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.559 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HE2' HG22 ' A' ' 17' ' ' ILE . 66.3 mttm -76.84 -32.87 57.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.311 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.6 mt -76.98 -39.0 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.531 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.504 ' CD1' ' HD2' ' A' ' 67' ' ' ARG . 5.0 m-90 -114.56 90.27 20.97 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.668 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 C--N 1.344 0.296 0 C-N-CA 122.786 2.324 . . . . 0.0 112.701 178.607 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.251 0.548 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -73.51 111.18 8.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.575 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.01 151.43 28.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.032 0.444 . . . . 0.0 111.519 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 73.99 -6.66 1.78 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.942 171.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -65.87 -29.7 70.19 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 174.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 171.93 -29.03 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.841 -1.527 . . . . 0.0 107.354 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -86.94 116.54 25.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.468 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.514 ' HB2' HG13 ' A' ' 54' ' ' VAL . 51.5 mtt180 -109.09 125.78 52.49 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.046 0.45 . . . . 0.0 110.4 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.483 HG22 HD12 ' A' ' 8' ' ' LEU . 54.8 mt -108.67 110.0 30.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.803 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.553 ' HB3' HD11 ' A' ' 5' ' ' ILE . 65.4 m-85 -104.27 138.49 40.65 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.524 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -128.68 120.55 26.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.973 0.416 . . . . 0.0 111.296 -175.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -94.45 105.47 17.44 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.535 177.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.513 ' HB3' HD23 ' A' ' 48' ' ' LEU . 11.9 ptt180 -99.46 134.71 41.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.383 0.611 . . . . 0.0 110.74 -177.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -118.33 119.51 34.85 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.1 t30 60.13 41.87 16.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.696 0.76 . . . . 0.0 109.04 -173.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 76.49 -27.05 0.18 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.933 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -82.21 137.03 35.01 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.524 HD22 ' HB1' ' A' ' 41' ' ' ALA . 76.4 mt -69.43 97.69 1.02 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 0.0 111.009 -175.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.4 tp -78.18 -39.0 42.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.883 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -131.23 126.48 35.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.899 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -117.35 125.86 51.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.334 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.47 127.95 60.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.62 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 5.1 mtp180 -107.04 127.36 53.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 38' ' ' ARG . 5.2 p -122.57 115.71 46.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.649 0.738 . . . . 0.0 110.827 176.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.4 m -91.93 108.63 20.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.968 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.14 154.27 19.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.106 0.479 . . . . 0.0 110.612 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 5.5 t -136.55 30.4 2.89 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.32 -108.07 3.43 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.372 -176.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 p -84.67 -1.86 56.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.366 0.603 . . . . 0.0 110.68 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 44.8 tt0 -109.93 127.57 54.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.414 177.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -127.35 112.89 1.6 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.11 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.36 118.5 33.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.888 0.375 . . . . 0.0 110.53 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 5.6 mp -93.89 125.61 38.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.97 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.62 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 4.4 p30 -122.84 135.75 54.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.104 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.1 t 66.73 94.1 0.07 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.884 0.849 . . . . 0.0 111.273 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.485 HD21 HD21 ' A' ' 82' ' ' LEU . 37.0 tp -122.99 108.01 12.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.231 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.504 ' HD2' ' CD1' ' A' ' 23' ' ' TRP . 98.2 mtt180 -130.49 117.89 20.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.269 0.557 . . . . 0.0 111.651 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 50' ' ' ALA . 5.1 t -107.03 141.91 21.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -62.65 151.23 38.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.872 0.367 . . . . 0.0 110.993 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -54.58 -26.28 31.44 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.358 -0.837 . . . . 0.0 113.022 -171.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.19 3.51 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.287 0.565 . . . . 0.0 111.177 -176.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.76 13.16 16.11 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.13 -0.356 . . . . 0.0 111.142 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -66.42 118.36 9.95 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.741 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 50.47 73.88 0.25 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.634 -172.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -138.24 11.77 2.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.265 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.95 -32.65 1.96 Allowed Glycine 0 CA--C 1.521 0.43 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.539 177.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.505 HG13 HD22 ' A' ' 3' ' ' LEU . 85.4 t -49.74 -42.17 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.281 0.632 . . . . 0.0 112.576 -176.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -52.66 -44.57 60.19 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.395 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -64.99 -43.58 92.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.0 110.785 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -63.5 -49.1 74.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.54 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.44 ' CD1' HD13 ' A' ' 5' ' ' ILE . 30.6 tp -49.47 -60.79 2.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.798 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.485 HD21 HD21 ' A' ' 66' ' ' LEU . 4.1 mm? -64.78 -43.11 94.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.581 -175.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.605 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 40.3 tt0 -63.91 -39.41 94.1 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.707 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -60.69 -40.46 92.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.962 0.41 . . . . 0.0 110.487 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 81' ' ' LEU . 90.1 t -64.16 -38.32 82.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.816 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 82' ' ' LEU . 10.6 mp -70.1 -24.94 63.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.159 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.605 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 63.6 mtt180 -76.88 -36.9 56.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.126 0.489 . . . . 0.0 109.956 174.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -66.58 -47.45 72.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.553 -176.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -75.42 147.6 82.45 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.387 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.88 -165.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.987 2.458 . . . . 0.0 112.612 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.68 96.29 0.15 Allowed Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.83 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.8 t -102.26 -50.4 9.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.072 0.463 . . . . 0.0 110.047 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.6 m 70.79 -50.12 0.67 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.037 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 47.8 t -89.4 86.36 6.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.058 0.456 . . . . 0.0 110.399 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.448 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 96.1 m95 -95.76 121.09 37.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.372 178.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -117.11 134.31 54.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.555 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.716 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 92.8 mmm -107.15 111.17 23.47 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.95 150.63 22.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.18 -174.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.614 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -70.13 -63.81 1.01 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.703 179.268 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.61 16.78 6.85 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.388 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.15 12.16 12.57 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.389 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 99' ' ' ASP . 69.2 t -69.29 104.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 117.262 0.531 . . . . 0.0 110.723 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.55 -10.59 45.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.373 0.606 . . . . 0.0 109.967 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.13 47.35 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.039 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -61.42 -40.1 93.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.93 -173.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.94 -53.17 39.2 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.456 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.29 -43.94 98.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.797 0.332 . . . . 0.0 110.674 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 91.2 mmm -64.7 -39.07 93.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.462 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 98.9 m -60.86 -43.72 98.01 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.818 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.65 -44.76 93.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.083 0.468 . . . . 0.0 110.776 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -64.82 -45.11 87.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.831 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.556 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 16.9 mmt -62.13 -45.46 93.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.105 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -63.54 -34.98 78.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.595 0.236 . . . . 0.0 111.16 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.91 -29.45 69.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.005 0.431 . . . . 0.0 110.852 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.2 tp -96.71 13.3 28.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.213 0.53 . . . . 0.0 110.73 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.86 57.67 4.03 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.124 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 55.6 m-85 -126.0 153.81 43.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 110.325 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.9 p -128.22 145.47 51.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.809 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.9 t -97.16 124.57 41.25 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -141.79 106.63 4.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.851 -172.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 57.75 35.98 26.07 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.575 168.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 158.29 -85.1 0.13 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.281 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -121.35 -137.21 5.21 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.685 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.716 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 19.2 m-90 -112.29 141.47 45.97 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -128.07 142.73 51.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.717 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.464 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 54.4 tttp -132.5 89.69 2.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 38.1 t -86.79 97.75 10.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.554 -176.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 C-N-CA 121.04 -0.6 . . . . 0.9 112.284 179.528 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 92.8 mttt . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 120.95 0.405 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.415 ' HB3' ' CE2' ' A' ' 80' ' ' TYR . 59.2 tp -87.17 114.98 24.25 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 m -82.87 93.44 7.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.342 0.592 . . . . 0.0 110.787 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.575 HG22 ' HA ' ' A' ' 42' ' ' ALA . 13.3 pt -113.12 148.55 15.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.137 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.46 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -133.94 144.4 35.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.359 -177.784 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -91.94 142.18 27.83 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.52 98.09 1.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.187 0.518 . . . . 0.0 111.373 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -89.14 -42.12 11.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.077 173.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -136.72 140.31 42.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.196 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.493 ' HE2' HG22 ' A' ' 33' ' ' VAL . 34.9 m-85 -97.42 92.95 6.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.975 0.417 . . . . 0.0 111.686 -176.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 m -71.94 139.3 48.64 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 171.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 17' ' ' ILE . 27.1 m-20 -59.32 -41.59 89.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.576 0.227 . . . . 0.0 111.106 -177.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -61.59 -39.84 92.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.956 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -72.2 -30.98 65.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.752 0.311 . . . . 0.0 110.603 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -68.98 -31.23 69.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 0.0 110.619 176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 13' ' ' ASP . 79.9 mt -70.27 -36.99 69.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.073 0.463 . . . . 0.0 109.829 174.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -64.86 -41.68 95.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.016 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.4 mt -59.91 -35.54 75.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.708 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -69.35 -25.36 64.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.199 0.523 . . . . 0.0 110.097 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 67.7 mttm -72.81 -27.48 61.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.974 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.769 HD11 ' HB3' ' A' ' 48' ' ' LEU . 60.4 mt -71.23 -43.48 74.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.309 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -113.99 87.6 13.09 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.62 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo . . . . . 0 N--CA 1.461 -0.416 0 C-N-CA 122.116 1.878 . . . . 0.0 110.768 173.172 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 121.471 0.653 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -131.43 148.53 52.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.853 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.493 HG22 ' HE2' ' A' ' 11' ' ' PHE . 15.6 m -132.72 -179.2 3.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.434 176.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -146.51 -169.24 3.22 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -82.4 -25.75 33.44 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.279 0.561 . . . . 0.0 109.696 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 9.2 p30 -96.96 -27.58 14.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.722 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -108.42 95.78 5.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.2 mtt85 -117.0 166.73 11.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.183 0.516 . . . . 0.0 111.594 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -129.73 135.58 61.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.724 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -99.78 129.16 45.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.793 0.33 . . . . 0.0 110.603 177.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.435 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -112.91 116.21 29.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.111 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.575 ' HA ' HG22 ' A' ' 5' ' ' ILE . . . -91.9 113.22 25.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.188 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -113.38 126.13 55.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.394 0.616 . . . . 0.0 111.369 -172.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -97.16 85.58 3.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 64.66 -77.86 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.067 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -107.73 -39.28 5.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.209 -174.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.628 ' HA ' ' CZ ' ' A' ' 47' ' ' ARG . 2.1 mmp_? -99.05 129.87 45.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.533 -170.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.769 ' HB3' HD11 ' A' ' 22' ' ' ILE . 54.3 mt -67.56 115.41 7.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 169.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 15.8 tp -97.54 -27.16 14.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.769 -170.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.558 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -152.35 158.0 42.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.699 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.57 144.16 26.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.108 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 65' ' ' SER . 11.0 p -148.45 143.64 18.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.733 0.302 . . . . 0.0 111.088 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -96.54 146.91 24.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.731 0.3 . . . . 0.0 110.997 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.03 121.58 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.45 0.643 . . . . 0.0 110.783 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 21.2 m -110.12 109.25 19.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.453 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.594 HD22 HG21 ' A' ' 92' ' ' VAL . 65.0 mt -89.69 113.17 24.62 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.271 0.558 . . . . 0.0 110.936 -178.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -114.62 86.17 2.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.475 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.88 -107.77 2.22 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.681 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.7 p -104.77 1.03 28.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.214 0.53 . . . . 0.0 110.575 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -98.97 138.15 36.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.918 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -119.98 107.94 1.39 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.611 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -92.62 104.59 16.86 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.9 tt -104.56 127.64 52.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.734 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -147.43 176.76 9.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.301 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 16.2 m 50.82 80.36 0.08 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.858 0.724 . . . . 0.0 111.965 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.517 ' HB3' ' HE3' ' A' ' 108' ' ' MET . 55.4 tp -120.58 120.45 35.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.084 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.8 ttt-85 -140.32 124.04 17.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.814 0.34 . . . . 0.0 110.51 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.558 HG13 ' HB2' ' A' ' 50' ' ' ALA . 10.5 t -111.1 146.66 15.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 172.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 49' ' ' LEU . 66.7 mtp85 -60.94 139.6 57.97 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.117 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 1.8 mp0 -52.32 -30.97 30.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.839 -171.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.6 t -72.15 -17.15 18.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.995 0.426 . . . . 0.0 111.308 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.57 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . 2.3 m -95.35 5.06 52.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.766 0.793 . . . . 0.0 110.806 -176.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.413 ' O ' ' HB3' ' A' ' 74' ' ' ARG . 57.7 ttt180 -71.89 134.66 46.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.139 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 29.1 tpt180 69.25 43.39 1.08 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.754 0.787 . . . . 0.0 110.191 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.57 ' HD3' ' HA ' ' A' ' 72' ' ' THR . 16.3 mtp180 -134.95 1.9 3.05 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.14 -13.6 9.49 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.998 176.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -57.5 -43.98 83.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 117.009 0.405 . . . . 0.0 111.48 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.28 -39.53 92.7 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.406 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.542 ' HA ' HD21 ' A' ' 115' ' ' LEU . 41.1 tt0 -62.43 -47.42 84.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.382 . . . . 0.0 110.51 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.435 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 81.9 t80 -57.72 -41.75 82.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.686 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' A' ' 42' ' ' ALA . 68.3 tp -56.71 -49.99 73.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.748 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.1 -40.68 98.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.963 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 33.5 mt-10 -65.9 -36.77 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.109 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 80' ' ' TYR . 7.3 mm-40 -61.79 -39.69 92.58 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.73 0.3 . . . . 0.0 111.117 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 81' ' ' LEU . 58.9 t -60.78 -54.51 34.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.005 0.431 . . . . 0.0 110.545 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.7 mp -74.9 -4.57 38.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.07 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 68.7 ttt180 -80.26 -48.87 12.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.226 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -87.67 -8.29 56.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.271 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 15.9 t30 -45.76 120.65 5.22 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.583 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 7.7 Cg_exo -73.02 -61.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.146 2.564 . . . . 0.0 112.888 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -154.54 35.06 0.69 Allowed Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.153 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.594 HG21 HD22 ' A' ' 56' ' ' LEU . 62.3 t -99.84 107.12 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 51.1 m -111.33 -13.83 13.87 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -174.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 81.8 m -103.82 94.6 5.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.858 0.361 . . . . 0.0 110.056 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -97.26 115.97 28.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.142 0.496 . . . . 0.0 111.434 -175.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.528 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 74.1 t-105 -104.14 114.29 28.42 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.959 175.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.709 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 80.6 mtp -107.35 122.67 47.05 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -176.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -124.61 168.74 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.423 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.85 -68.03 0.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.077 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.99 19.91 10.32 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.845 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.73 -20.05 3.29 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.661 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 95.7 t -67.79 101.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.121 0.486 . . . . 0.0 110.854 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -93.35 -16.56 24.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.263 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.05 54.19 1.87 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.469 176.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -60.17 -46.95 87.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.36 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.16 -49.7 62.23 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.66 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.45 -46.72 96.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.959 0.409 . . . . 0.0 111.269 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.517 ' HE3' ' HB3' ' A' ' 66' ' ' LEU . 78.0 mtp -78.62 -22.01 47.6 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -175.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 96.5 m -67.33 -40.44 85.91 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.28 -39.29 92.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.187 0.518 . . . . 0.0 110.021 175.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -58.52 -51.89 67.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.789 175.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.543 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 67.1 mtt -70.98 -27.15 63.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.481 -176.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -66.59 -34.16 77.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.922 0.391 . . . . 0.0 109.983 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.65 -32.9 66.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.75 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.542 HD21 ' HA ' ' A' ' 79' ' ' GLN . 11.0 mp -83.34 -4.8 58.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.004 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.19 41.41 17.64 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.167 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.543 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 59.7 m-85 -92.98 144.24 25.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.857 0.361 . . . . 0.0 110.186 174.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.24 144.67 25.08 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.26 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.7 p -97.46 140.64 31.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.33 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.486 ' HG3' ' HB3' ' A' ' 125' ' ' GLU . 19.3 mm-40 -120.35 -166.77 1.35 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.762 177.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -85.02 96.12 9.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.286 0.565 . . . . 0.0 111.122 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.84 44.93 4.69 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.542 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.35 -171.93 24.94 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.174 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.709 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 15.8 m-90 -116.86 149.56 39.87 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.183 -0.302 . . . . 0.0 110.183 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.486 ' HB3' ' HG3' ' A' ' 120' ' ' GLN . 31.2 tt0 -155.8 132.34 10.33 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -137.07 132.58 34.35 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 93' ' ' SER . 49.0 t -119.67 113.2 20.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.134 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 C-N-CA 121.009 -0.615 . . . . 0.9 112.186 -179.68 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 C--O 1.234 0.249 0 CA-C-O 120.869 0.366 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.7 tp -86.09 98.07 10.66 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.479 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 13.5 m -88.07 89.81 8.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.276 -174.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.538 HD11 ' HB3' ' A' ' 40' ' ' TYR . 13.8 tt -96.12 129.41 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.474 0.654 . . . . 0.0 110.767 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mt -129.01 154.59 40.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.323 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.8 ptt-85 -76.74 113.82 14.82 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 173.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.617 HD21 HD11 ' A' ' 19' ' ' LEU . 31.1 tp -77.96 100.84 6.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.997 -174.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.835 ' HA ' HG11 ' A' ' 33' ' ' VAL . 42.2 mt-10 -113.97 -18.95 11.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.902 -175.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.81 113.99 24.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.382 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -107.83 101.4 10.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.632 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.8 p -84.68 171.28 12.51 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.468 ' O ' HG13 ' A' ' 17' ' ' ILE . 6.6 p-10 -60.38 -31.98 70.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.564 0.221 . . . . 0.0 110.561 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -67.27 -51.02 58.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.556 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -60.87 -36.81 80.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.99 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -55.47 -47.39 76.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.159 176.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 13' ' ' ASP . 74.7 mt -65.79 -43.84 93.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.898 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.498 ' O ' HG13 ' A' ' 22' ' ' ILE . 12.9 m-20 -58.76 -52.83 64.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.69 0.281 . . . . 0.0 110.955 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.617 HD11 HD21 ' A' ' 8' ' ' LEU . 95.0 mt -64.74 -38.15 90.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.34 -178.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -74.2 -11.48 60.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.098 0.475 . . . . 0.0 110.56 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -98.27 -28.16 13.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.089 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 18' ' ' ASP . 74.4 mt -65.23 -48.53 83.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -107.49 92.3 8.25 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 168.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo . . . . . 0 N--CA 1.477 0.538 0 C-N-CA 123.648 2.899 . . . . 0.0 114.509 -167.307 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.5 mt . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.231 0.539 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -136.46 127.38 27.58 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.605 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.835 HG11 ' HA ' ' A' ' 9' ' ' GLU . 15.0 p -106.49 131.32 56.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.513 0.673 . . . . 0.0 110.42 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.585 ' HB2' ' H ' ' A' ' 37' ' ' HIS . 14.6 m-20 -130.62 179.28 6.04 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -85.68 -9.47 57.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -94.63 -34.47 12.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.685 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.585 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 36.0 m80 -120.33 101.0 7.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.768 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 38' ' ' ARG . 48.5 mtt180 -109.11 129.0 55.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.82 0.343 . . . . 0.0 110.275 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.4 HG12 ' HG2' ' A' ' 53' ' ' ARG . 63.7 mt -103.33 116.73 47.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.538 ' HB3' HD11 ' A' ' 5' ' ' ILE . 78.8 m-85 -97.55 125.67 42.4 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.505 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -109.37 113.4 26.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.56 -177.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . . . -92.68 102.32 14.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.959 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 4' ' ' THR . 19.9 ptt85 -103.37 129.53 50.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.344 0.592 . . . . 0.0 110.408 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -105.46 124.61 49.84 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.544 -177.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 70.91 -56.91 0.61 Allowed 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.957 0.786 . . . . 0.0 110.983 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -154.75 -45.96 0.09 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.325 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -104.92 162.83 12.99 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.12 -170.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.505 HD22 ' HB1' ' A' ' 41' ' ' ALA . 84.0 mt -60.78 132.75 54.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.865 -176.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 37.1 tp -111.76 -30.38 7.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.821 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.579 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -150.11 147.56 27.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.578 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -135.41 127.36 29.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.68 0.276 . . . . 0.0 110.434 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.418 ' HB ' HD13 ' A' ' 66' ' ' LEU . 7.1 p -131.37 134.01 61.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.03 0.443 . . . . 0.0 110.99 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.558 ' HD3' ' HB2' ' A' ' 65' ' ' SER . 21.4 mtp-105 -110.17 126.69 54.36 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.5 p -120.66 134.62 63.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.422 0.63 . . . . 0.0 111.629 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.9 m -100.71 107.69 19.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.856 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.9 mt -96.33 130.29 43.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.584 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 m -135.78 97.47 3.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.191 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.64 -112.56 4.53 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.378 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -106.9 11.98 29.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.586 0.708 . . . . 0.0 110.278 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -125.61 154.59 42.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.344 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.39 132.28 5.24 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.079 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.77 126.43 51.02 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 mp -93.46 117.06 29.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.014 0.435 . . . . 0.0 110.701 -175.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.532 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 20.2 m-20 -109.35 118.53 36.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.283 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.558 ' HB2' ' HD3' ' A' ' 53' ' ' ARG . 34.5 m 73.05 107.16 0.07 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.86 0.838 . . . . 0.0 111.797 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.418 HD13 ' HB ' ' A' ' 52' ' ' VAL . 29.9 tp -131.97 130.79 41.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.504 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.2 ttt-85 -144.02 130.48 19.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.819 0.342 . . . . 0.0 110.841 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.579 HG13 ' HB2' ' A' ' 50' ' ' ALA . 13.6 t -107.11 156.42 7.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -53.87 127.0 24.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -57.37 -31.65 65.98 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -168.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -82.87 16.7 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.365 0.602 . . . . 0.0 110.979 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -111.73 16.14 20.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.575 0.702 . . . . 0.0 110.414 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -75.45 137.01 40.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.077 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.408 ' HD3' HH11 ' A' ' 74' ' ' ARG . 5.8 ttm180 71.66 27.76 2.88 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.698 177.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -124.98 22.67 7.96 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.443 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.79 -27.21 1.64 Allowed Glycine 0 CA--C 1.521 0.454 0 N-CA-C 114.681 0.632 . . . . 0.0 114.681 172.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.2 t -50.88 -46.46 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -175.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.88 -45.51 94.93 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.604 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.503 ' HG2' ' HG ' ' A' ' 115' ' ' LEU . 51.2 mt-30 -65.57 -41.68 92.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.871 0.367 . . . . 0.0 110.733 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -68.21 -41.92 80.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.585 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.3 tp -48.23 -51.57 24.89 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.331 0.394 . . . . 0.0 111.026 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.438 ' O ' HD13 ' A' ' 86' ' ' LEU . 4.4 mm? -60.07 -52.44 65.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.433 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -72.09 -16.52 62.02 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.726 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.428 ' HG2' HG21 ' A' ' 5' ' ' ILE . 12.5 tp10 -69.77 -42.9 73.2 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 172.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.55 -41.3 88.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.352 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 82' ' ' LEU . 10.9 mp -67.43 -20.38 65.5 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.1 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 54.0 ttp85 -83.65 -41.05 18.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 109.876 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -64.35 -38.94 92.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.729 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -119.11 78.77 17.73 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.662 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.29 2.21 8.55 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.595 2.197 . . . . 0.0 112.319 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.54 10.76 72.47 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.97 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.8 t -107.68 127.26 63.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 m -85.53 -53.36 5.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.805 0.336 . . . . 0.0 111.576 -175.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.5 t -103.83 116.38 32.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.904 0.383 . . . . 0.0 111.09 -174.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -106.9 112.33 25.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.064 176.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -105.51 136.46 45.03 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.121 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.662 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 97.4 mmm -107.27 119.74 40.22 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.65 144.98 25.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.009 0.433 . . . . 0.0 111.766 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.414 ' CG ' HH21 ' A' ' 105' ' ' ARG . 10.6 t70 -80.26 -69.61 0.58 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.908 177.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 64.73 23.17 12.71 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.945 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.4 40.29 0.96 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.905 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.752 HG11 ' HG3' ' A' ' 108' ' ' MET . 77.0 t -88.31 112.48 23.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.84 0.353 . . . . 0.0 110.368 176.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -82.57 -32.27 28.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.677 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -87.49 55.23 3.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.222 0.534 . . . . 0.0 109.859 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.414 HH21 ' CG ' ' A' ' 99' ' ' ASP . 34.7 ttm180 -66.23 -31.11 71.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.043 -176.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.74 -56.39 25.53 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.062 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.5 t -61.48 -42.42 93.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 111.001 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.752 ' HG3' HG11 ' A' ' 102' ' ' VAL . 93.0 mmm -64.46 -38.23 90.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.538 -177.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 61.5 m -67.52 -41.26 84.67 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.411 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.14 88.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.302 0.573 . . . . 0.0 110.245 176.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -61.98 -48.71 79.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.716 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.546 ' HG2' ' O ' ' A' ' 108' ' ' MET . 26.4 mmt -62.44 -43.2 99.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.122 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -62.09 -39.33 92.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.204 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.51 -22.11 61.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.112 0.482 . . . . 0.0 110.888 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.503 ' HG ' ' HG2' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -91.05 -2.69 57.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.299 0.571 . . . . 0.0 110.31 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.85 32.61 20.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.03 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.539 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 75.7 m-85 -98.63 139.85 33.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.041 0.448 . . . . 0.0 110.419 176.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.1 m -90.41 144.21 26.02 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.853 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 30.2 p -97.31 115.97 28.64 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.801 0.334 . . . . 0.0 110.438 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -137.02 161.46 36.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.072 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -45.45 106.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.836 0.71 . . . . 0.0 112.188 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 120.93 -21.18 8.42 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.382 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 159.07 -131.69 2.83 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.741 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.662 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 12.8 m-90 -125.98 140.0 52.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.637 0.256 . . . . 0.0 110.504 -177.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -128.46 134.35 48.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.93 -175.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.528 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 84.8 tttt -137.19 92.17 2.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.07 0.462 . . . . 0.0 110.54 173.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 39.9 t -80.22 131.32 35.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.496 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 C-N-CA 120.867 -0.682 . . . . 0.9 111.993 179.132 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.568 HD22 HG13 ' A' ' 77' ' ' VAL . 52.5 tp -95.72 127.73 41.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.476 -177.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.9 m -89.69 95.32 10.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.898 0.38 . . . . 0.0 110.624 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.593 HG22 ' HA ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -103.49 129.1 55.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.118 0.485 . . . . 0.0 110.052 177.858 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.417 ' H ' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -130.18 151.9 36.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.888 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -75.29 130.18 38.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.466 HD21 HD11 ' A' ' 19' ' ' LEU . 38.6 tp -76.01 59.36 1.29 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.605 0.717 . . . . 0.0 110.165 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -91.39 -13.91 31.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.511 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -112.92 107.21 15.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.834 177.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -88.43 82.94 6.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.296 0.569 . . . . 0.0 110.892 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.8 m -85.66 150.56 24.53 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.303 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.62 -35.72 70.84 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -52.14 -55.77 18.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.526 175.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.449 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 18.8 m-20 -68.51 -41.3 80.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.299 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -61.11 -39.14 88.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -176.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.7 mt -70.13 -41.64 79.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.939 0.4 . . . . 0.0 110.375 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.48 -34.54 78.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.104 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.466 HD11 HD21 ' A' ' 8' ' ' LEU . 73.0 mt -62.39 -39.26 92.63 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.83 174.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -75.13 -10.43 59.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.026 0.441 . . . . 0.0 111.001 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -86.46 -22.94 26.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.24 170.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.36 -45.82 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.228 0.537 . . . . 0.0 109.611 173.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.403 ' HE1' ' HG3' ' A' ' 67' ' ' ARG . 5.8 m-90 -107.6 108.09 61.16 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.39 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo . . . . . 0 C--N 1.352 0.733 0 C-N-CA 124.46 3.44 . . . . 0.0 114.193 -172.715 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.1 mt . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.807 0.337 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -135.68 106.0 6.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.405 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.4 t -98.18 135.89 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.132 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -146.23 -173.86 4.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.81 -20.98 66.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.12 0.486 . . . . 0.0 111.084 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -93.11 -55.7 3.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.483 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -84.32 98.13 9.84 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -108.91 121.35 44.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.964 0.411 . . . . 0.0 110.41 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.833 HG12 ' HG2' ' A' ' 53' ' ' ARG . 56.4 mt -98.88 115.39 39.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.215 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -94.05 122.34 36.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.364 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.577 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.11 123.36 48.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.09 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.805 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -91.89 100.4 13.08 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -95.06 115.61 27.64 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.792 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.527 ' HB3' HD13 ' A' ' 49' ' ' LEU . 73.2 t80 -97.28 88.66 4.5 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.62 -65.09 0.36 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.859 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.461 ' HG3' ' N ' ' A' ' 47' ' ' ARG . 4.9 pt-20 -109.16 -51.24 2.9 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.461 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 28.0 ptt-85 -127.0 173.8 9.36 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.685 -171.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.577 HD22 ' HB1' ' A' ' 41' ' ' ALA . 41.9 mt -87.06 111.25 20.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.348 -175.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' A' ' 44' ' ' PHE . 9.9 mp -88.13 -31.41 19.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.687 0.28 . . . . 0.0 110.68 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.805 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -127.07 131.99 50.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.992 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.12 115.94 21.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.155 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 65' ' ' SER . 11.2 p -126.8 136.55 60.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.098 0.475 . . . . 0.0 111.151 -178.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.833 ' HG2' HG12 ' A' ' 39' ' ' ILE . 99.0 mtt180 -111.77 115.72 29.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.64 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.6 p -107.18 107.46 22.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.849 0.833 . . . . 0.0 110.032 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.9 m -87.5 106.82 18.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.185 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.8 mt -80.63 104.51 11.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.39 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -103.13 106.34 16.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.238 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.86 -96.79 0.61 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -174.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.1 p -128.27 2.68 5.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.909 0.385 . . . . 0.0 110.776 175.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.573 ' HA ' HG13 ' A' ' 92' ' ' VAL . 23.8 mm-40 -104.84 141.59 36.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.721 -175.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.12 112.35 4.38 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.352 -177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.589 ' HA ' ' HB3' ' A' ' 96' ' ' TRP . . . -105.28 111.72 24.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.696 0.284 . . . . 0.0 110.438 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 53' ' ' ARG . 5.2 mp -93.45 110.76 22.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.19 0.519 . . . . 0.0 109.803 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.625 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 1.8 p30 -96.06 -36.14 11.12 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.801 -173.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 21.0 m -120.58 125.29 47.42 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.791 0.329 . . . . 0.0 111.158 -177.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.4 tp -145.61 102.72 3.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.052 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.403 ' HG3' ' HE1' ' A' ' 23' ' ' TRP . 26.2 mmm180 -131.43 113.0 13.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.775 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.526 HG13 ' HB2' ' A' ' 50' ' ' ALA . 2.9 t -110.22 136.04 47.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -87.56 -176.28 5.51 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -174.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -55.33 -27.07 44.67 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.399 -1.273 . . . . 0.0 114.387 -165.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.6 t -65.43 -30.57 50.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.168 0.509 . . . . 0.0 111.691 -175.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.587 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 6.5 m -98.77 32.66 2.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.463 0.649 . . . . 0.0 111.16 -173.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 73' ' ' ARG . 40.0 ttm180 -65.27 97.57 0.28 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.886 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 53.02 80.04 0.11 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.091 170.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 75' ' ' ARG . 9.3 mmt180 -136.61 -54.27 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.239 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.78 -21.67 0.46 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.775 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.587 ' HB ' ' CG2' ' A' ' 72' ' ' THR . 72.6 t -55.85 -44.23 76.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 122.332 0.253 . . . . 0.0 111.499 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -54.11 -49.44 59.37 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.905 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -60.65 -52.32 65.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.454 0.169 . . . . 0.0 110.592 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -58.96 -42.45 89.9 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.128 -176.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 85' ' ' VAL . 63.6 tp -52.56 -53.31 48.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 110.679 178.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.425 ' O ' HD13 ' A' ' 86' ' ' LEU . 46.8 mt -70.31 -45.47 66.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.423 -177.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -62.67 -32.22 73.24 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.071 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -67.69 -41.42 83.64 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 176.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 81' ' ' LEU . 85.1 t -63.09 -46.27 96.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 121.205 0.526 . . . . 0.0 110.645 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.479 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 10.9 mp -70.47 -19.85 62.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.108 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -86.91 -30.22 21.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.191 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -63.62 -52.87 58.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.51 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -118.5 101.17 51.13 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.784 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.91 -6.13 12.28 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.224 2.616 . . . . 0.0 112.035 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.36 48.77 4.1 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.691 -177.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.573 HG13 ' HA ' ' A' ' 60' ' ' GLU . 97.4 t -135.94 134.51 50.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 61.8 p -96.57 -32.83 12.06 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.933 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 77.8 m -130.37 113.98 15.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.891 0.376 . . . . 0.0 111.322 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.479 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 95.6 m95 -90.94 113.49 25.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 173.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.589 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . 2.9 t-105 -96.94 128.09 43.57 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.959 -172.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' MET . . . . . 1.047 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 13.4 mmt -108.45 115.38 29.99 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.625 ' HB3' ' HA ' ' A' ' 64' ' ' ASP . . . -99.48 173.84 6.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.566 -169.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -129.29 93.04 3.48 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.42 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -92.36 26.85 2.43 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.975 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.5 46.48 0.85 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.423 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 56.8 t -78.01 98.92 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.93 0.395 . . . . 0.0 110.895 -178.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -70.83 -33.66 70.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.114 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -79.41 47.39 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.089 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.97 -57.4 13.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.879 -172.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.29 99.34 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.527 -175.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.9 t -58.39 -47.52 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.0 110.78 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 89.5 mmm -71.01 -32.62 69.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.131 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 80.1 m -59.25 -44.18 92.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.982 0.42 . . . . 0.0 110.041 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.32 -41.32 96.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.893 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -66.32 -52.4 47.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.278 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -56.75 -50.05 73.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.609 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -65.52 -31.8 73.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.619 0.247 . . . . 0.0 111.116 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.65 -31.04 63.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.931 0.396 . . . . 0.0 111.21 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.703 HD23 ' HE1' ' A' ' 117' ' ' PHE . 21.0 tp -88.36 -9.84 51.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.122 0.487 . . . . 0.0 110.542 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.95 36.54 4.96 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.13 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.703 ' HE1' HD23 ' A' ' 115' ' ' LEU . 62.5 m-85 -99.68 102.2 13.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.957 0.378 . . . . 0.0 110.239 174.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.18 143.7 56.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.828 177.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 121' ' ' GLN . 13.9 m -99.28 136.25 39.5 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.034 -174.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -79.18 11.85 2.62 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.787 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.455 ' H ' HG22 ' A' ' 119' ' ' THR . 71.3 mm-40 63.66 29.19 15.09 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.67 0.748 . . . . 0.0 109.549 -172.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -168.85 -64.89 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -109.73 -168.68 20.08 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 169.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.047 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 12.9 m-90 -113.96 144.55 42.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.876 0.838 . . . . 0.0 110.339 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -149.14 114.81 5.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 61.7 tttp -96.71 111.67 23.74 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 93' ' ' SER . 56.0 m -88.78 95.31 10.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.736 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.945 -0.645 . . . . 0.9 112.568 179.53 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.415 ' HB3' ' HE2' ' A' ' 2' ' ' LYS . 51.4 mtpt . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.471 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 43.1 tp -81.88 99.61 9.14 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.582 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 16.7 m -83.11 96.71 8.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.931 0.396 . . . . 0.0 110.174 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 tt -104.47 123.93 58.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.437 0.637 . . . . 0.0 110.937 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.448 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -131.2 177.95 6.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.314 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -94.8 147.01 23.79 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.7 mt -75.96 98.86 4.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.205 0.526 . . . . 0.0 110.765 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -106.87 -23.94 12.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.154 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -124.97 124.96 43.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.791 -172.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.96 91.92 3.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.783 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -83.33 173.74 11.31 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.558 ' O ' HG13 ' A' ' 17' ' ' ILE . 30.2 t70 -62.6 -52.63 62.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.468 -178.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.529 ' HA ' HD12 ' A' ' 17' ' ' ILE . 52.4 tt0 -72.18 -25.73 61.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.906 0.384 . . . . 0.0 110.316 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -62.48 -42.34 99.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -65.05 -39.09 92.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.217 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.6 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 76.4 mt -59.82 -41.97 87.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.356 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.95 -40.11 83.31 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.251 0.548 . . . . 0.0 110.38 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.69 -31.91 73.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.333 173.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -78.94 -10.1 59.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.221 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 64.3 mttm -82.33 -31.62 29.79 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.1 mt -72.16 -46.25 59.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.783 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -117.97 97.38 50.71 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.798 175.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 N--CA 1.476 0.479 0 C-N-CA 123.174 2.583 . . . . 0.0 113.154 -175.241 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.3 mt . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 120.992 0.425 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -73.49 98.64 2.82 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.4 m -92.97 151.39 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.382 0.611 . . . . 0.0 110.67 -175.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.403 ' HB3' ' H ' ' A' ' 37' ' ' HIS . 22.2 t70 -151.59 171.97 16.78 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.593 -173.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.96 -29.08 68.83 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -90.13 -33.28 16.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.772 176.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.403 ' H ' ' HB3' ' A' ' 34' ' ' ASP . 47.3 m-70 -104.56 99.4 9.08 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.168 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -114.64 139.47 49.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.305 0.574 . . . . 0.0 111.668 -173.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.3 mt -119.48 116.57 51.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.201 171.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -99.61 129.73 45.78 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.536 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -118.19 120.71 38.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.519 -176.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.831 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.09 107.09 18.96 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.071 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 4' ' ' THR . 26.3 ptt180 -96.53 132.62 41.94 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.403 0.62 . . . . 0.0 110.507 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.494 ' HB3' HD13 ' A' ' 49' ' ' LEU . 77.5 t80 -101.1 104.23 15.34 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 176.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 31.3 t30 72.1 -62.19 0.47 Allowed 'General case' 0 C--N 1.331 -0.217 0 O-C-N 124.005 0.816 . . . . 0.0 110.801 -176.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -136.45 -57.72 0.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -94.61 167.29 11.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.975 0.417 . . . . 0.0 111.727 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.536 HD22 ' HB1' ' A' ' 41' ' ' ALA . 35.9 mt -91.21 106.6 18.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.934 -171.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' A' ' 44' ' ' PHE . 10.9 mp -92.93 -15.18 26.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.122 -178.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.831 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -137.21 125.97 23.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.754 0.311 . . . . 0.0 111.017 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -123.67 130.22 52.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.636 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.6 p -135.15 134.05 53.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.057 0.456 . . . . 0.0 111.002 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.632 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 39.5 mtp180 -99.45 134.73 41.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.188 177.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.2 p -139.91 126.76 23.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.611 0.719 . . . . 0.0 111.596 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -108.93 115.22 29.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.756 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -85.69 106.73 17.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.247 0.546 . . . . 0.0 110.807 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -93.63 45.96 1.17 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.28 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.54 -105.87 3.05 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.761 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.5 p -83.04 -17.45 43.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.112 0.482 . . . . 0.0 110.991 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -106.01 118.47 36.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.694 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.73 114.07 4.89 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.37 105.1 17.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.902 0.382 . . . . 0.0 111.275 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.414 HD11 ' HE3' ' A' ' 95' ' ' TRP . 5.0 mp -95.16 111.97 23.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.908 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.632 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 10.3 t0 -118.23 138.31 52.42 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.465 ' HB2' ' HD3' ' A' ' 53' ' ' ARG . 20.2 m 68.39 91.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.628 0.727 . . . . 0.0 111.501 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.7 tp -108.14 110.65 22.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.409 171.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -127.3 104.62 8.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.06 0.457 . . . . 0.0 111.302 -176.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 50' ' ' ALA . 8.3 t -100.91 144.69 12.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 172.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -61.83 155.6 22.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.257 0.551 . . . . 0.0 112.363 -174.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -48.72 -41.04 30.69 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.322 -1.308 . . . . 0.0 113.481 -165.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.83 -13.92 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.975 0.417 . . . . 0.0 112.095 -171.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 m -88.02 60.6 5.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.438 0.637 . . . . 0.0 111.607 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.8 ptt-85 -115.99 130.47 56.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.675 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 74' ' ' ARG . 21.4 mtp180 52.81 53.57 11.91 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.479 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.6 ttt180 -135.98 14.13 3.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.901 0.381 . . . . 0.0 111.257 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.09 -35.64 2.56 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.108 -0.568 . . . . 0.0 113.972 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.453 HG13 HD22 ' A' ' 3' ' ' LEU . 49.6 t -50.26 -41.79 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 122.974 0.51 . . . . 0.0 112.355 -175.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.35 -45.28 93.03 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.145 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -65.69 -49.87 66.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.927 0.394 . . . . 0.0 110.245 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.471 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 48.0 t80 -54.4 -42.5 70.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.366 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.418 ' O ' HG23 ' A' ' 85' ' ' VAL . 59.3 tp -52.76 -67.65 0.23 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.847 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 82' ' ' LEU . 3.5 mm? -64.1 -41.27 97.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.693 -174.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 23.8 mt-10 -61.79 -37.53 84.69 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.804 -177.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -70.77 -31.97 68.93 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.535 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 81' ' ' LEU . 67.1 t -61.58 -45.41 98.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 174.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.551 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 11.2 mp -67.32 -18.72 65.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.19 178.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 79.3 mtp180 -81.27 -41.17 22.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.057 0.456 . . . . 0.0 110.833 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -80.42 -29.95 37.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.902 -174.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.522 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 5.9 m-20 -86.0 117.38 68.6 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.894 0.378 . . . . 0.0 110.181 176.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.522 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 1.4 Cg_endo -83.45 -73.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.426 2.751 . . . . 0.0 113.877 -172.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.43 53.45 4.67 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.64 -171.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.6 t -124.2 115.2 44.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 p -105.57 -24.36 12.6 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.766 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 46.1 t -116.67 106.07 13.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.841 0.353 . . . . 0.0 110.116 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.551 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 97.7 m95 -93.34 111.98 23.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.108 0.48 . . . . 0.0 110.248 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -111.45 123.85 51.07 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 68.6 mtp -119.03 117.11 27.88 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.22 146.75 24.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.038 0.447 . . . . 0.0 111.82 -171.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.498 ' HB3' ' CZ3' ' A' ' 124' ' ' TRP . 5.8 p-10 -98.8 14.95 26.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.651 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.93 -55.87 29.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.855 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -97.97 44.67 1.78 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.312 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.415 HG11 ' SD ' ' A' ' 108' ' ' MET . 57.3 t -135.48 101.85 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.796 0.331 . . . . 0.0 110.763 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -67.67 -41.83 83.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.065 0.46 . . . . 0.0 110.766 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -84.93 59.51 5.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.362 0.601 . . . . 0.0 110.489 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -63.16 -39.8 95.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.291 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.69 -54.28 38.36 Favored Glycine 0 C--O 1.236 0.243 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.64 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.1 t -59.07 -43.44 89.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.114 0.483 . . . . 0.0 110.562 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.66 ' SD ' ' HE3' ' A' ' 112' ' ' MET . 37.1 ttm -68.06 -27.01 66.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.154 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 91.9 m -62.25 -52.62 63.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.785 0.326 . . . . 0.0 110.161 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.61 84.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.537 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' A' ' 108' ' ' MET . 51.8 t80 -60.26 -57.83 11.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.347 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.66 ' HE3' ' SD ' ' A' ' 108' ' ' MET . 61.8 mtt -67.34 -33.06 74.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.445 -175.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -63.71 -37.62 88.05 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.09 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.71 -30.37 71.04 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.368 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.0 mp -84.13 2.2 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.085 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.16 23.34 32.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.789 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.54 ' HB3' ' HB3' ' A' ' 124' ' ' TRP . 91.4 m-85 -92.84 134.0 35.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.234 0.517 . . . . 0.0 110.426 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.4 m -90.67 145.1 25.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.484 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.42 HG22 ' CD1' ' A' ' 124' ' ' TRP . 70.9 p -97.43 118.23 33.44 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -124.12 -93.79 0.5 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.311 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -154.83 123.47 6.11 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.36 11.66 66.35 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.373 -174.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.9 -152.34 18.05 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.906 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 117' ' ' PHE . 22.7 m-90 -102.13 150.65 23.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.183 -0.508 . . . . 0.0 110.015 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -134.01 134.79 42.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.371 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -137.07 93.09 2.79 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 171.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.2 p -102.78 142.27 34.19 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.586 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.501 0 C-N-CA 120.944 -0.646 . . . . 0.9 112.187 179.445 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.8 mttt . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.511 HD21 ' HB1' ' A' ' 42' ' ' ALA . 51.9 tp -76.63 122.32 24.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.951 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.2 p -90.58 121.86 32.88 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.244 0.545 . . . . 0.0 110.835 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.513 HG22 ' HA ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -117.1 125.94 74.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.376 -178.35 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.1 mm -103.34 151.33 6.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.2 ptt85 -95.36 106.37 18.42 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.2 mt -75.91 83.72 2.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.145 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.812 ' HA ' HG11 ' A' ' 33' ' ' VAL . 30.6 mt-10 -81.81 -26.13 34.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.993 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -147.49 122.94 10.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.71 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -93.34 133.76 36.26 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.935 -173.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 m -77.47 174.3 11.01 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 168.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.478 ' O ' HG13 ' A' ' 17' ' ' ILE . 8.6 p-10 -65.08 -45.52 84.93 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.492 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -63.69 -40.11 95.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.0 110.317 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.416 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 24.1 m-20 -57.07 -50.87 71.44 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.092 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -66.08 -30.47 70.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.83 -177.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 13' ' ' ASP . 84.3 mt -72.62 -39.47 61.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.996 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -69.72 -34.96 74.6 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 79.6 mt -64.57 -32.27 73.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.385 173.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -71.31 -23.31 61.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.979 0.419 . . . . 0.0 110.45 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 83.5 mttt -70.67 -38.25 73.75 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 173.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.89 -43.95 52.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.514 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -121.52 89.2 47.09 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.998 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo . . . . . 0 C--N 1.344 0.309 0 C-N-CA 122.622 2.215 . . . . 0.0 112.212 -177.322 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 C--O 1.228 -0.066 0 CA-C-O 120.99 0.424 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -72.43 128.23 34.98 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.812 HG11 ' HA ' ' A' ' 9' ' ' GLU . 39.8 t -113.22 122.86 68.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.454 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -148.33 -171.0 3.74 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -69.95 -31.41 69.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.267 0.556 . . . . 0.0 109.836 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -84.28 -8.14 59.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.52 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -152.48 97.72 2.3 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.355 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 38' ' ' ARG . 50.0 mtt180 -111.98 135.73 52.23 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.209 -178.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.532 HG23 ' HG2' ' A' ' 53' ' ' ARG . 59.0 mt -101.56 118.79 48.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.286 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -100.72 125.31 47.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.306 0.574 . . . . 0.0 110.457 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.567 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.14 119.36 39.25 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.1 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.11 114.76 27.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.029 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.458 ' HB3' HD23 ' A' ' 48' ' ' LEU . 34.2 ptt180 -109.72 132.4 54.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.575 0.702 . . . . 0.0 111.219 -175.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.44 ' O ' ' HB3' ' A' ' 45' ' ' ASN . 75.6 t80 -98.1 102.84 14.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.078 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 10.4 t30 74.31 -43.12 0.52 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.719 0.637 . . . . 0.0 111.435 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -159.83 -56.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.023 0.44 . . . . 0.0 111.332 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 47' ' ' ARG . 51.3 mtt180 -85.73 153.22 22.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.007 -171.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.567 HD22 ' HB1' ' A' ' 41' ' ' ALA . 52.0 mt -71.06 122.75 20.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.855 -175.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.4 tp -105.29 -15.08 15.15 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.035 0.445 . . . . 0.0 110.206 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -154.48 150.07 27.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.458 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -135.24 125.52 26.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.869 0.366 . . . . 0.0 110.666 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.35 138.29 48.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.445 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.532 ' HG2' HG23 ' A' ' 39' ' ' ILE . 21.2 mtm180 -118.18 133.37 55.96 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.1 p -120.78 126.15 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.631 0.729 . . . . 0.0 111.176 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.7 m -90.69 94.58 9.75 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.535 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.11 92.15 5.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.456 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.6 m -93.29 84.42 4.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.823 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.45 -101.39 0.83 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.699 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.4 p -112.85 6.98 18.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.154 0.502 . . . . 0.0 110.488 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -101.14 111.75 24.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.41 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.98 94.06 1.7 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.711 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.92 123.39 45.05 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.806 -0.232 . . . . 0.0 110.517 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.42 HD13 ' SD ' ' A' ' 97' ' ' MET . 6.8 mp -93.45 118.84 31.82 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -101.15 -12.8 18.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.673 -170.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.4 m -155.31 133.4 11.54 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.076 -0.249 . . . . 0.0 111.28 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.9 tp -148.44 115.93 6.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.865 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -138.71 132.6 31.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.425 173.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 50' ' ' ALA . 3.5 t -103.85 152.01 6.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 172.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -71.93 154.68 41.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.612 0.244 . . . . 0.0 110.787 -175.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -43.03 -47.25 5.81 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -170.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.3 m -81.05 26.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -171.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.83 29.52 6.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.044 0.449 . . . . 0.0 111.417 -177.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -67.11 108.96 2.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.825 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 56.23 42.27 28.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.141 0.496 . . . . 0.0 110.666 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.4 ttt180 -108.59 19.36 19.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.103 -172.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.51 -40.51 2.42 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.862 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.4 t -46.81 -46.72 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 123.21 0.604 . . . . 0.0 112.581 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.68 -41.73 90.26 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.11 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.518 ' HG3' ' HG ' ' A' ' 115' ' ' LEU . 52.7 tt0 -69.36 -38.53 78.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.996 0.426 . . . . 0.0 110.356 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.479 ' HE2' ' H ' ' A' ' 3' ' ' LEU . 74.8 t80 -68.56 -38.39 80.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.184 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.444 HD13 ' HB2' ' A' ' 42' ' ' ALA . 50.2 tp -53.61 -56.78 14.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.211 177.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.454 ' O ' HD13 ' A' ' 86' ' ' LEU . 4.4 mm? -60.15 -45.72 92.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -67.84 -37.51 81.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.369 -176.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -58.78 -46.99 86.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.797 0.332 . . . . 0.0 110.539 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 73.3 t -63.82 -46.36 94.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 82' ' ' LEU . 11.0 mp -69.09 -29.06 67.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.312 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.0 ttt-85 -75.27 -30.75 60.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.107 0.48 . . . . 0.0 109.721 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -75.94 -33.62 59.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.052 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -115.8 70.78 3.65 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.344 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.33 -6.7 13.84 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.289 1.992 . . . . 0.0 112.051 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.07 -14.97 81.73 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.947 -0.645 . . . . 0.0 112.153 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.8 t -87.78 113.36 24.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.962 0.411 . . . . 0.0 110.203 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 2.5 p -89.5 -22.91 22.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.426 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.4 m -108.05 99.3 8.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.824 0.345 . . . . 0.0 111.363 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -109.05 126.13 52.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.272 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.426 ' HE3' ' HG2' ' A' ' 125' ' ' GLU . 51.9 t-105 -115.58 127.82 55.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.198 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.861 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 87.5 mmm -108.0 120.76 43.23 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.96 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.79 142.7 47.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.45 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.847 ' HB2' ' HB ' ' A' ' 102' ' ' VAL . 4.6 p-10 -86.61 -35.55 19.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.107 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.54 22.87 12.58 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.955 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 125.39 37.21 0.53 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.646 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.847 ' HB ' ' HB2' ' A' ' 99' ' ' ASP . 76.8 t -102.22 125.68 56.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -84.18 -35.81 23.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.632 -177.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -83.18 67.67 9.29 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.486 0.66 . . . . 0.0 110.886 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -72.55 -17.73 61.7 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.614 176.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.08 -57.86 12.47 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.048 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.16 -43.56 97.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.623 0.249 . . . . 0.0 111.15 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.618 ' SD ' HG11 ' A' ' 102' ' ' VAL . 50.6 mtp -71.11 -31.04 67.27 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.008 -175.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.716 HG23 HG21 ' A' ' 119' ' ' THR . 36.6 m -68.92 -43.95 74.11 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.243 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.12 -38.78 87.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.198 0.523 . . . . 0.0 110.287 176.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -61.4 -51.53 68.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.33 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.491 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 66.1 mtt -75.93 -34.5 59.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.922 -174.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -74.1 -22.61 59.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.888 0.375 . . . . 0.0 110.572 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.05 -19.22 25.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.041 0.448 . . . . 0.0 110.63 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.518 ' HG ' ' HG3' ' A' ' 79' ' ' GLN . 6.1 tt -80.32 -55.17 5.08 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 146.93 46.74 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.401 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 97.2 m-85 -121.33 143.01 49.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.802 0.335 . . . . 0.0 110.274 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.9 m -81.09 121.72 26.44 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.716 HG21 HG23 ' A' ' 109' ' ' THR . 67.2 p -97.38 130.43 44.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.141 0.496 . . . . 0.0 111.054 -173.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -129.36 176.09 8.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.53 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -81.71 87.95 6.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.081 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 129.92 -50.77 0.88 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.292 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -135.32 178.92 18.22 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.506 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.861 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 8.2 m-90 -127.3 140.98 51.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.426 ' HG2' ' HE3' ' A' ' 96' ' ' TRP . 42.3 mt-10 -129.03 150.79 50.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.933 0.397 . . . . 0.0 111.452 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.55 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 78.8 tttt -136.15 121.8 19.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.766 171.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 93' ' ' SER . 53.9 t -129.93 108.98 10.53 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.23 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 121.037 -0.601 . . . . 0.9 112.13 178.315 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.773 0.321 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -116.5 130.14 56.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.338 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.592 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 47.3 tp -76.0 115.94 16.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.805 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.0 m -82.67 101.23 10.7 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.016 0.436 . . . . 0.0 110.662 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.642 HD11 ' HB3' ' A' ' 40' ' ' TYR . 8.4 tp -90.18 113.38 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 121.749 0.785 . . . . 0.0 110.102 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.7 mt -106.57 153.34 7.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.516 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 -100.86 126.55 47.47 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.5 mt -80.9 91.51 6.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.339 0.59 . . . . 0.0 110.875 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -93.13 -23.95 18.43 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.662 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -140.06 139.53 35.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.599 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -115.38 116.0 27.53 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.519 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.4 p -84.89 171.12 12.45 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 17' ' ' ILE . 30.7 m-20 -74.24 -21.35 59.82 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -69.78 -49.26 54.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.418 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 62.8 m-20 -61.31 -38.8 88.15 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.477 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 46.6 ttm-85 -53.8 -47.05 71.2 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.059 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 13' ' ' ASP . 77.8 mt -66.59 -48.31 80.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.459 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.528 ' HB3' HD12 ' A' ' 48' ' ' LEU . 1.2 m-20 -65.43 -32.26 73.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.342 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 78.1 mt -64.89 -42.48 94.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.526 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 25.8 mt-30 -69.04 -20.65 64.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.366 0.603 . . . . 0.0 110.346 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -76.99 -26.53 53.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.557 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 18' ' ' ASP . 70.6 mt -82.57 -37.43 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.46 175.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -117.86 85.89 23.67 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.369 177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.38 -9.66 21.78 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.642 2.228 . . . . 0.0 113.102 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -101.15 -5.21 25.95 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.46 0.648 . . . . 0.0 110.04 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -99.73 116.34 31.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.441 -175.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.5 t -72.47 130.13 86.3 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.12 104.63 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.26 2.64 . . . . 0.0 113.369 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.1 m -81.49 -161.74 0.45 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.834 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.5 m -70.4 -26.18 63.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.97 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.8 mt 58.13 78.7 0.23 Allowed 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -172.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -134.03 111.34 10.3 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.309 -169.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -103.61 159.12 4.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.16 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -130.73 -166.4 1.68 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -79.14 -11.59 59.98 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.767 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -96.24 -59.83 1.75 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.117 174.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -74.31 97.47 3.02 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 38' ' ' ARG . 22.7 mtp180 -115.81 115.43 26.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.235 0.54 . . . . 0.0 110.488 -173.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.2 mt -98.59 118.85 45.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.661 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.642 ' HB3' HD11 ' A' ' 5' ' ' ILE . 96.7 m-85 -106.28 142.74 35.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.343 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.443 ' HB1' HD21 ' A' ' 48' ' ' LEU . . . -123.55 117.69 25.66 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.38 -175.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.497 ' HB1' HD21 ' A' ' 3' ' ' LEU . . . -91.71 99.78 12.61 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.03 0.443 . . . . 0.0 109.869 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.681 ' HG2' HD23 ' A' ' 48' ' ' LEU . 4.1 mtm180 -104.21 111.02 23.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.413 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -97.46 107.82 20.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.931 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.0 t30 60.53 65.32 1.07 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.012 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 72.58 -29.85 0.2 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.655 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -101.56 145.56 28.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.981 0.42 . . . . 0.0 111.821 -170.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.681 HD23 ' HG2' ' A' ' 43' ' ' ARG . 54.7 mt -65.22 117.84 8.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.962 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.9 tp -106.95 -27.14 10.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.912 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -152.76 149.22 28.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.547 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -138.35 135.51 35.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.358 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.482 ' HB ' HD13 ' A' ' 66' ' ' LEU . 8.8 p -140.62 140.98 33.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.919 0.39 . . . . 0.0 110.781 -177.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -114.51 123.5 49.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.506 ' HB ' HD23 ' A' ' 63' ' ' LEU . 6.7 p -125.2 124.37 67.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.317 0.579 . . . . 0.0 110.414 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.9 m -97.89 99.47 10.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.059 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.53 HD23 ' HA2' ' A' ' 61' ' ' GLY . 96.9 mt -85.86 70.44 10.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.938 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 m -67.31 99.06 0.67 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.005 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.18 -116.43 5.24 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.373 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.7 m -114.13 14.71 18.29 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.872 0.844 . . . . 0.0 109.386 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -101.31 134.57 44.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.853 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.53 ' HA2' HD23 ' A' ' 56' ' ' LEU . . . -106.09 106.01 2.51 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.657 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.57 108.45 20.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.929 0.395 . . . . 0.0 110.748 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.534 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 56.6 mt -93.94 119.93 33.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -99.25 -75.32 0.57 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.927 -174.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 p -121.92 141.92 50.8 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.256 0.551 . . . . 0.0 112.191 -173.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.482 HD13 ' HB ' ' A' ' 52' ' ' VAL . 33.9 tp -140.85 119.99 12.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.858 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.94 ' HA ' ' H62' ' A' ' 999' ' ' COA . 13.0 mtp180 -128.41 114.75 17.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.793 0.33 . . . . 0.0 111.191 176.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.483 ' HB ' ' H10' ' A' ' 999' ' ' COA . 11.2 t -95.33 151.73 3.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 167.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -54.06 140.28 32.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 34.4 mp0 -52.19 -38.25 57.25 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.251 0.62 . . . . 0.0 112.426 -172.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.38 -22.97 27.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.186 0.517 . . . . 0.0 111.201 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.459 ' HB ' HG12 ' A' ' 68' ' ' VAL . 6.9 m -90.86 64.02 5.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.285 0.564 . . . . 0.0 109.953 -177.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.561 ' HA ' H122 ' A' ' 999' ' ' COA . 12.6 ttp180 -94.75 12.65 27.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.198 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 74' ' ' ARG . 36.6 ttp180 173.85 90.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.715 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -156.46 17.57 0.33 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.116 0.484 . . . . 0.0 110.243 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.28 -34.46 1.76 Allowed Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.077 -0.583 . . . . 0.0 113.379 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.562 HG13 HD22 ' A' ' 3' ' ' LEU . 59.5 t -39.74 -52.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.079 0.951 . . . . 0.0 113.309 -176.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.92 -55.12 31.87 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.266 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.453 ' HB3' HD13 ' A' ' 115' ' ' LEU . 97.3 mt-30 -67.83 -39.65 83.86 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.793 -0.239 . . . . 0.0 110.614 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.592 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 47.2 t80 -53.72 -47.78 70.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.159 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.574 HD11 HD13 ' A' ' 5' ' ' ILE . 43.0 tp -62.19 -50.96 69.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.249 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.442 HD21 HD22 ' A' ' 66' ' ' LEU . 4.4 mm? -59.65 -46.58 88.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.154 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 48.0 mt-10 -61.37 -44.73 96.67 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.046 -0.261 . . . . 0.0 110.359 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -56.55 -43.75 80.24 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.906 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 81' ' ' LEU . 96.9 t -61.06 -46.77 96.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.352 . . . . 0.0 110.609 178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -72.29 -18.44 61.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.915 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.511 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 23.1 mtm180 -88.73 -22.1 23.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.537 0.208 . . . . 0.0 111.329 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -103.08 -7.35 21.41 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.638 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -118.37 85.61 25.94 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.0 110.187 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.49 162.99 12.75 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.18 2.587 . . . . 0.0 111.44 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.83 -45.87 3.25 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.782 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.86 99.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 16.5 m -92.55 -25.48 18.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 -175.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.6 t -102.35 98.75 8.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.84 0.352 . . . . 0.0 110.728 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -97.2 113.19 24.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.948 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -112.7 123.03 49.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.014 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.752 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 63.3 mtp -111.4 123.43 50.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.375 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.16 153.72 27.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.739 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -84.58 -26.55 27.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.242 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 59.09 14.38 3.44 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.18 20.88 78.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.392 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.8 t -67.92 134.31 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.583 0.23 . . . . 0.0 110.49 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -93.28 -17.2 23.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.044 0.449 . . . . 0.0 111.072 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -83.88 19.53 1.7 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 171.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.458 ' HA ' ' HB2' ' A' ' 108' ' ' MET . 6.9 ttp180 -64.77 -26.96 68.58 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.106 -176.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.0 -48.18 87.35 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.207 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.406 HG13 ' N6A' ' A' ' 999' ' ' COA . 80.2 t -65.8 -42.47 92.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.994 0.425 . . . . 0.0 110.362 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.642 ' O ' ' HG2' ' A' ' 112' ' ' MET . 96.1 mmm -59.2 -48.41 81.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.242 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.1 m -63.43 -35.54 80.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.365 0.126 . . . . 0.0 111.14 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.86 99.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.391 0.615 . . . . 0.0 109.937 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -62.12 -44.35 96.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.453 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.642 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.1 mmt -62.44 -48.08 81.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.616 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -64.93 -38.7 91.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.244 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.83 -21.9 56.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.424 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.525 HD23 ' HE2' ' A' ' 117' ' ' PHE . 40.9 tp -87.56 -45.69 10.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.527 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 138.04 44.52 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.231 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.585 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 87.3 m-85 -120.7 153.74 36.52 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.0 m -120.05 146.79 45.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.126 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.1 m -97.12 121.79 39.41 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -136.08 103.8 5.47 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 58.0 36.19 25.9 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.28 165.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.83 49.16 0.55 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.366 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.39 179.36 19.96 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.87 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.752 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 6.9 m-90 -102.95 137.83 40.63 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -125.56 137.37 53.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.758 0.314 . . . . 0.0 110.445 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.411 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 61.0 tttp -137.21 91.7 2.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.133 0.492 . . . . 0.0 109.999 172.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 93' ' ' SER . 52.4 t -91.21 112.36 24.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.228 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 CA-C-N 115.77 -0.65 . . . . 0.9 111.865 179.96 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 999' ' ' COA . . . . . 0.94 ' H62' ' HA ' ' A' ' 67' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.884 0.373 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -82.72 90.89 6.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.184 0.516 . . . . 0.0 109.956 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.1 tp -76.13 114.63 15.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.877 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.9 m -82.8 89.79 6.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.953 0.406 . . . . 0.0 110.655 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.614 HD11 ' HB3' ' A' ' 40' ' ' TYR . 5.2 tp -95.75 111.04 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.994 175.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.3 pt -130.51 171.01 18.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.836 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -92.79 137.2 32.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.447 ' O ' HG21 ' A' ' 33' ' ' VAL . 53.9 tp -78.99 70.55 5.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.245 0.545 . . . . 0.0 109.689 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -69.49 -43.8 72.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.443 -174.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -111.44 132.07 54.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.967 -175.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' A' ' 31' ' ' LEU . 72.3 m-85 -99.46 114.88 28.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.245 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.8 p -102.46 163.92 11.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.58 ' O ' HG13 ' A' ' 17' ' ' ILE . 34.1 t70 -66.12 -29.84 70.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -66.99 -50.19 63.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.008 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.439 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 32.9 m-20 -61.74 -35.04 76.92 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.622 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.407 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 35.6 ttm180 -61.47 -38.01 85.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.526 176.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 13' ' ' ASP . 72.9 mt -60.48 -42.49 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.193 0.52 . . . . 0.0 110.331 176.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.436 ' HB3' HD12 ' A' ' 48' ' ' LEU . 80.5 m-20 -68.73 -33.54 74.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.666 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 96.4 mt -65.0 -34.44 78.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.372 175.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 98.2 mt-30 -69.71 -24.71 63.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.733 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -66.52 -44.36 82.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.231 0.539 . . . . 0.0 109.867 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.2 mt -75.45 -45.59 39.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.33 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 6.0 m-90 -123.89 74.48 56.4 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.668 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.79 -21.86 9.4 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 121.922 1.748 . . . . 0.0 111.341 175.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -89.84 -3.48 58.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.378 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.548 ' HB3' ' HB3' ' A' ' 23' ' ' TRP . 31.9 t80 -92.11 142.75 27.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.134 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.8 m -66.59 125.04 89.88 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.258 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.51 97.62 0.26 Allowed 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.626 2.218 . . . . 0.0 112.277 -177.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.3 p -88.26 178.4 6.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.572 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 26.0 m -68.84 -27.0 65.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.838 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.571 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 51.4 mt 74.12 105.63 0.07 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.927 0.767 . . . . 0.0 111.505 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -129.96 139.97 51.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.353 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 13.7 m -125.72 154.19 34.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.386 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.516 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 22.9 t70 74.4 -30.11 0.2 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.53 175.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 36' ' ' ASN . 4.4 t70 -81.71 68.94 8.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 35' ' ' ASP . 19.7 m120 83.22 -40.02 0.09 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.207 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.519 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 90.2 m-70 -101.59 110.4 22.39 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.641 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.516 ' HG2' ' HA ' ' A' ' 34' ' ' ASP . 69.8 mtt180 -109.2 117.19 33.47 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.097 0.475 . . . . 0.0 110.651 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.557 HG12 ' HG2' ' A' ' 53' ' ' ARG . 53.8 mt -98.67 110.71 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.115 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.614 ' HB3' HD11 ' A' ' 5' ' ' ILE . 73.3 m-85 -97.61 141.16 30.99 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.476 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -124.62 113.74 18.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.969 0.414 . . . . 0.0 111.089 -170.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.485 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.13 101.5 14.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.528 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.516 ' HB3' HD23 ' A' ' 48' ' ' LEU . 28.5 ptt180 -102.51 118.84 37.74 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.546 0.689 . . . . 0.0 110.858 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -97.44 133.41 42.07 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.5 t30 64.61 23.35 12.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.003 0.906 . . . . 0.0 108.607 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 66.47 20.74 10.88 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.419 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -126.88 142.73 51.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' A' ' 43' ' ' ARG . 55.5 mt -54.49 130.39 39.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.182 0.515 . . . . 0.0 112.14 -172.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 34.4 tp -125.6 -40.65 2.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.205 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.529 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -133.12 143.99 49.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.325 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -135.07 132.28 37.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.387 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.59 132.46 62.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.081 0.467 . . . . 0.0 110.927 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.557 ' HG2' HG12 ' A' ' 39' ' ' ILE . 27.8 mtm180 -111.11 121.65 45.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.985 176.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.66 119.55 59.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.411 0.624 . . . . 0.0 109.71 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 89.9 m -95.56 95.53 8.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.571 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.584 ' HA ' ' HA3' ' A' ' 61' ' ' GLY . 89.2 mt -80.38 124.27 28.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.119 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.7 t -98.59 50.15 0.98 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.71 -104.83 2.45 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.549 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.5 p -94.49 -29.53 14.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.381 0.61 . . . . 0.0 110.648 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.81 ' HB3' ' HB3' ' A' ' 94' ' ' CYS . 36.0 mt-10 -119.19 151.33 38.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.008 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 56' ' ' LEU . . . -151.7 -179.84 27.7 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 119.461 -1.352 . . . . 0.0 113.894 -173.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.63 135.33 48.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.222 -0.489 . . . . 0.0 110.205 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.8 tt -93.77 112.84 24.77 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -97.24 -56.89 2.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -168.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.411 ' HA ' ' S1P' ' A' ' 999' ' ' COA . 32.1 m -107.81 106.22 16.41 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.024 0.44 . . . . 0.0 111.553 -173.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.3 tp -124.58 109.07 12.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.785 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.45 ' HG3' ' O9P' ' A' ' 999' ' ' COA . 65.1 ttt180 -138.94 136.84 35.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.233 0.54 . . . . 0.0 111.246 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.529 HG13 ' HB2' ' A' ' 50' ' ' ALA . 14.5 t -110.8 152.0 12.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -57.79 150.56 19.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.746 0.308 . . . . 0.0 110.18 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -51.7 -38.43 55.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.51 -20.85 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 111.931 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.442 ' HB ' ' CG1' ' A' ' 68' ' ' VAL . 2.0 m -113.09 24.92 11.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.157 0.503 . . . . 0.0 111.255 -175.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.465 ' HG2' ' H10' ' A' ' 999' ' ' COA . 16.5 mtp180 -78.25 38.84 0.3 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 8.3 ttm180 174.37 19.95 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.276 0.23 . . . . 0.0 111.057 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -141.04 75.28 1.49 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -167.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.74 -61.45 4.27 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 115.703 1.041 . . . . 0.0 115.703 161.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -43.42 -51.97 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -168.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.09 -41.18 77.14 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.957 -0.639 . . . . 0.0 113.595 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -68.64 -53.07 24.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.919 0.39 . . . . 0.0 110.623 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -58.21 -40.87 82.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.421 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.563 HD11 HD13 ' A' ' 5' ' ' ILE . 26.9 tp -56.3 -55.07 37.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.384 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.47 ' HB2' HD11 ' A' ' 115' ' ' LEU . 55.6 mt -62.34 -41.74 98.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.376 -176.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -62.94 -37.87 88.75 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.782 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.84 -39.1 80.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.43 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 81' ' ' LEU . 72.5 t -58.49 -45.94 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.815 0.34 . . . . 0.0 111.039 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 82' ' ' LEU . 11.1 mp -68.22 -23.75 64.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.122 0.487 . . . . 0.0 110.744 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.6 mtp85 -76.73 -33.06 58.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.852 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.41 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 89.6 m-20 -71.01 -49.69 42.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -118.27 86.21 26.76 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.763 0.316 . . . . 0.0 111.377 -178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 1.8 Cg_endo -83.75 170.61 11.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.966 2.444 . . . . 0.0 111.481 175.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.06 -14.85 62.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.216 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.559 HG13 ' HA ' ' A' ' 60' ' ' GLU . 53.3 t -78.24 118.53 25.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 128' ' ' GLY . 2.4 p -84.46 -40.23 17.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.572 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.81 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 45.1 t -101.93 100.14 10.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.904 0.383 . . . . 0.0 110.866 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -97.3 97.66 9.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -96.8 128.27 43.58 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.844 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 96.0 mmm -107.16 109.5 21.34 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.12 149.66 42.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.667 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -75.6 -43.51 47.77 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 61.07 8.74 2.07 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.773 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.87 17.78 66.93 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.882 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 104' ' ' ASP . 82.8 t -67.69 111.9 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 121.217 0.532 . . . . 0.0 110.064 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -79.79 1.26 27.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.744 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.421 ' H ' HG12 ' A' ' 102' ' ' VAL . 13.4 m-20 -101.1 21.31 14.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.442 174.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -58.9 -27.25 65.05 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.902 -175.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.36 -53.03 45.11 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.568 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 43.7 t -62.97 -37.36 79.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.169 0.509 . . . . 0.0 110.047 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.598 ' O ' ' HG2' ' A' ' 112' ' ' MET . 96.9 mmm -65.13 -36.18 83.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.232 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 93.3 m -63.9 -45.04 91.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.712 0.291 . . . . 0.0 110.693 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.28 94.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.182 0.515 . . . . 0.0 110.209 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -61.92 -48.22 81.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.227 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.598 ' HG2' ' O ' ' A' ' 108' ' ' MET . 26.3 mmt -57.59 -48.87 78.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 0.0 111.114 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -72.14 -21.87 61.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.541 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.56 -34.96 35.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.991 0.424 . . . . 0.0 110.545 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.47 HD11 ' HB2' ' A' ' 82' ' ' LEU . 7.4 tt -75.42 -56.37 4.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.002 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 149.19 33.35 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.993 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 89.0 m-85 -107.9 167.62 9.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 31.9 m -117.23 137.64 52.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.442 HG23 ' CD1' ' A' ' 124' ' ' TRP . 15.8 m -97.65 132.65 43.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.939 0.399 . . . . 0.0 110.59 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.556 ' NE2' ' HB3' ' A' ' 125' ' ' GLU . 48.4 mt-30 -126.65 -171.62 2.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.6 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -85.48 109.02 18.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.88 0.372 . . . . 0.0 110.474 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.8 7.09 32.01 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.429 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.86 -175.38 27.21 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.51 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.844 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 9.7 m-90 -107.55 160.76 15.43 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.556 ' HB3' ' NE2' ' A' ' 120' ' ' GLN . 55.7 tt0 -157.76 150.85 23.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.058 0.456 . . . . 0.0 110.791 176.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -133.49 117.3 17.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.537 174.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 33.7 t -85.0 108.91 17.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.95 0.405 . . . . 0.0 110.016 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 93' ' ' SER . . . . . . . . 0 N--CA 1.449 -0.457 0 CA-C-N 115.888 -0.596 . . . . 0.9 112.285 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 999' ' ' COA . . . . . 0.499 ' P1A' ' O9A' ' A' ' 999' ' ' COA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtm . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -90.79 92.06 8.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.112 0.482 . . . . 0.0 109.965 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.546 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 36.5 tp -75.88 137.51 40.47 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 m -111.16 109.35 19.37 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.801 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.555 HD13 HD11 ' A' ' 81' ' ' LEU . 11.2 tp -89.81 113.17 25.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.541 0.686 . . . . 0.0 109.822 176.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.99 149.9 16.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.185 0.517 . . . . 0.0 110.489 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -74.77 112.57 11.12 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.441 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.1 tp -67.77 101.93 1.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -98.77 -49.79 4.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.987 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -127.01 149.05 50.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.997 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -107.81 136.52 47.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.66 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.66 ' HB2' ' OD1' ' A' ' 15' ' ' ASP . 8.3 m -115.9 162.39 17.41 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 170.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -63.02 -42.82 99.9 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -171.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -64.92 -52.24 57.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.608 0.242 . . . . 0.0 111.178 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.66 ' OD1' ' HB2' ' A' ' 12' ' ' SER . 0.5 OUTLIER -72.04 -19.05 61.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.543 -179.017 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -64.25 -44.64 91.16 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.5 mt -68.38 -33.79 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.259 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -63.41 -39.41 94.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.961 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.0 mt -64.56 -36.92 85.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.807 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -73.28 -13.3 61.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.009 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -89.14 -24.34 22.23 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.3 mt -77.75 -49.36 22.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.728 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -104.92 91.64 4.52 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.09 -36.37 70.61 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.875 2.383 . . . . 0.0 113.432 -170.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -105.49 26.92 8.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.869 0.366 . . . . 0.0 111.243 -175.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -79.19 126.89 31.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.995 0.426 . . . . 0.0 110.364 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.0 t -89.64 120.0 69.52 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.922 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.74 114.67 2.06 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.757 2.305 . . . . 0.0 111.426 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.2 p -164.68 -78.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.397 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.7 m -74.04 -75.21 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.222 -174.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.5 mt 51.64 49.45 20.84 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.113 0.482 . . . . 0.0 110.062 -173.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -88.25 117.56 27.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.962 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.4 m -122.73 137.18 57.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.171 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.883 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 11.7 t70 72.15 8.33 5.87 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.748 170.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 37' ' ' HIS . 7.8 m-20 -120.27 77.54 1.27 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 75.85 -34.99 0.25 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.148 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.451 ' H ' ' C ' ' A' ' 35' ' ' ASP . 86.1 m-70 -112.76 112.45 23.95 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 173.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.883 ' HG2' ' HA ' ' A' ' 34' ' ' ASP . 79.4 mtt180 -113.84 126.18 54.9 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.016 0.436 . . . . 0.0 110.551 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.575 HG12 ' HG2' ' A' ' 53' ' ' ARG . 71.8 mt -100.35 119.81 48.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.935 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -102.49 133.0 48.18 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.525 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.57 125.06 51.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.802 -175.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.06 98.78 11.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.197 0.522 . . . . 0.0 110.159 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.417 ' HD3' HH11 ' A' ' 43' ' ' ARG . 15.6 ttm180 -87.61 126.88 35.2 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.495 -177.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -124.53 95.47 4.54 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.2 m120 60.94 74.26 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.981 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 71.42 -43.55 0.57 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.772 -1.103 . . . . 0.0 113.181 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -88.76 153.76 20.82 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.758 0.313 . . . . 0.0 111.111 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.525 HD22 ' HB1' ' A' ' 41' ' ' ALA . 79.5 mt -90.24 108.09 19.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.016 0.436 . . . . 0.0 110.145 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.4 tp -83.38 -31.41 26.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.639 -175.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.538 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -144.45 157.13 44.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.755 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.29 135.59 22.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.115 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 65' ' ' SER . 7.1 p -135.14 138.69 48.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.001 0.429 . . . . 0.0 111.141 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.575 ' HG2' HG12 ' A' ' 39' ' ' ILE . 88.4 mtt180 -103.16 131.24 50.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.892 176.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.43 ' HB ' HD23 ' A' ' 63' ' ' LEU . 7.1 p -125.24 122.33 62.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.356 0.598 . . . . 0.0 110.937 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 34.8 m -93.35 110.02 21.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.971 175.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.476 HD23 ' HA2' ' A' ' 61' ' ' GLY . 92.3 mt -94.98 98.63 10.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.635 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 t -95.71 97.87 10.03 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.76 -107.27 2.06 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.404 -174.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.4 p -115.43 12.6 16.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.92 0.391 . . . . 0.0 111.187 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.05 138.08 42.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.019 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.476 ' HA2' HD23 ' A' ' 56' ' ' LEU . . . -116.03 113.54 2.87 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.385 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.54 ' HB3' ' HB ' ' A' ' 55' ' ' THR . . . -96.35 110.96 23.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.963 0.411 . . . . 0.0 110.753 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.719 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 53.7 mt -93.85 109.78 21.46 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.743 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.85 -75.06 0.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.788 0.328 . . . . 0.0 111.818 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 13.6 m -82.18 85.76 6.75 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.892 0.377 . . . . 0.0 111.384 -175.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.521 HD21 HD21 ' A' ' 82' ' ' LEU . 47.0 tp -102.67 100.73 10.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.613 173.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -135.12 126.55 28.56 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.568 -175.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 50' ' ' ALA . 12.1 t -111.75 155.48 13.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 174.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -60.21 137.57 58.09 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -48.2 -41.53 27.47 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.793 0.683 . . . . 0.0 112.609 -173.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.5 m -73.09 2.44 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 m -98.69 7.76 45.72 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.099 0.476 . . . . 0.0 111.014 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.892 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 30.4 mtm180 -70.34 106.7 3.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.836 0.351 . . . . 0.0 110.369 177.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 60.7 ttt180 -157.67 -81.07 0.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.471 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 27.4 ttt180 164.86 95.71 0.0 OUTLIER 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -169.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.02 -79.53 0.2 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.506 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.514 HG13 HD22 ' A' ' 3' ' ' LEU . 69.3 t -47.47 -46.56 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 123.194 0.597 . . . . 0.0 112.589 -174.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.401 ' HA3' H122 ' A' ' 999' ' ' COA . . . -56.97 -62.67 6.1 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.06 -0.591 . . . . 0.0 113.548 -177.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -68.21 -32.61 72.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.79 0.295 . . . . 0.0 111.143 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.546 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 30.3 t80 -59.44 -49.25 78.51 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.555 HD11 HD13 ' A' ' 5' ' ' ILE . 55.9 tp -52.32 -56.04 17.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.104 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.521 HD21 HD21 ' A' ' 66' ' ' LEU . 4.2 mm? -58.23 -44.46 88.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.029 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.718 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 5.4 mt-10 -63.27 -49.34 74.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.584 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.5 ' OE1' HG22 ' A' ' 5' ' ' ILE . 35.2 tt0 -63.73 -34.95 79.03 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.064 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 81' ' ' LEU . 75.5 t -61.46 -43.9 97.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.868 0.366 . . . . 0.0 110.342 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 82' ' ' LEU . 11.0 mp -72.01 -24.16 61.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.344 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.718 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 19.2 mmt180 -76.93 -39.02 52.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.055 0.455 . . . . 0.0 109.98 176.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -67.73 -34.76 77.49 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.793 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -119.59 79.79 22.48 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.036 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -86.74 -9.48 6.57 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.544 2.163 . . . . 0.0 112.908 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.87 -35.04 55.1 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.4 t -73.47 104.85 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 p -106.01 12.22 30.71 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.059 0.457 . . . . 0.0 110.656 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 47.8 t -130.51 99.97 5.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.342 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -107.79 120.3 41.87 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.442 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.521 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 13.7 t-105 -115.98 120.42 39.08 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.191 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.719 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 76.1 mtp -107.15 126.5 52.46 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.099 0.476 . . . . 0.0 110.099 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.2 146.53 24.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.971 -176.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.68 16.67 10.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.282 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.38 106.88 4.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.701 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.52 0.81 56.65 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.162 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.49 HG22 ' S1P' ' A' ' 999' ' ' COA . 80.7 t -86.82 107.27 16.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.792 0.329 . . . . 0.0 110.381 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.69 -46.04 33.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.072 0.463 . . . . 0.0 110.032 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -94.71 81.64 3.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.257 0.551 . . . . 0.0 110.459 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.5 mtt85 -71.03 -28.85 64.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.411 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.3 -54.62 28.56 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.351 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.707 HG13 ' N7A' ' A' ' 999' ' ' COA . 55.3 t -61.22 -42.4 93.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.765 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.585 ' O ' ' HG2' ' A' ' 112' ' ' MET . 97.8 mmm -64.5 -36.52 84.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.675 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 85.8 m -64.68 -43.96 91.88 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.858 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.58 -36.59 84.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.264 0.554 . . . . 0.0 110.376 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -64.74 -44.41 90.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.411 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.585 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.5 mmt -62.24 -42.73 99.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.009 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -57.15 -40.32 76.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.544 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.41 -29.83 69.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.209 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.5 mt -85.0 -7.52 59.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.022 0.439 . . . . 0.0 111.228 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.36 21.66 56.13 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.144 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 37.5 m-85 -85.6 132.19 34.22 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 65.2 p -95.7 162.19 13.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.998 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.2 t -97.21 117.16 30.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.7 0.762 . . . . 0.0 109.7 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.94 169.71 10.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.24 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -70.8 94.48 1.04 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.045 0.45 . . . . 0.0 110.748 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.83 -11.24 5.42 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.41 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.25 -146.91 16.02 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.312 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 7.5 m-90 -103.1 133.56 48.0 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -121.04 131.54 54.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.183 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -137.03 115.55 11.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.91 172.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 22.4 t -112.72 115.98 29.4 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.942 0.401 . . . . 0.0 110.182 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.516 0 N-CA-C 111.533 -0.627 . . . . 0.9 111.533 -178.876 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 999' ' ' COA . . . . . 0.892 ' O4A' ' HA ' ' A' ' 73' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.743 0.306 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -93.19 113.79 26.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.13 0.49 . . . . 0.0 110.388 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.541 HD21 ' HB1' ' A' ' 42' ' ' ALA . 38.7 tp -79.52 115.01 18.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.688 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -82.86 103.61 12.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.834 0.35 . . . . 0.0 110.377 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.535 HD11 ' HB3' ' A' ' 40' ' ' TYR . 11.6 tt -105.7 126.25 61.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.545 0.688 . . . . 0.0 111.159 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.5 mt -125.51 160.89 31.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.476 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -85.74 141.33 29.79 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 8' ' ' LEU . 55.1 mt -77.53 103.55 7.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.044 0.449 . . . . 0.0 110.626 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -79.39 -45.76 18.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.503 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -137.85 166.65 23.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.945 -176.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -127.89 111.47 13.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.808 0.337 . . . . 0.0 111.089 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.0 m -99.55 -179.97 4.37 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -62.59 -48.92 77.32 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.821 0.344 . . . . 0.0 110.872 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -57.77 -39.31 77.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.558 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -67.02 -46.2 75.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.328 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.9 ttp85 -60.7 -46.6 89.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.649 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 80.0 mt -61.57 -46.18 97.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.881 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.96 -38.72 86.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.21 0.529 . . . . 0.0 110.395 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.519 HD23 HD12 ' A' ' 22' ' ' ILE . 76.7 mt -68.58 -25.03 64.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.264 177.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -79.94 -19.96 46.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.248 0.547 . . . . 0.0 109.894 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -74.74 -29.1 61.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 171.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.519 HD12 HD23 ' A' ' 19' ' ' LEU . 73.0 mt -79.78 -48.73 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.302 174.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -115.79 100.55 53.66 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 175.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -58.11 -29.08 86.04 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.065 2.51 . . . . 0.0 112.951 -176.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -136.22 85.99 2.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -91.87 154.5 18.83 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.064 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.0 m -100.06 120.8 55.89 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.442 171.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.71 -28.09 80.33 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.574 2.183 . . . . 0.0 112.053 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.3 m -61.56 -41.01 96.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.489 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 p -86.94 4.07 43.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.924 0.392 . . . . 0.0 111.03 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.7 mt -94.02 -1.07 55.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.355 0.598 . . . . 0.0 109.443 172.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -80.57 118.09 21.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.712 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.43 118.5 39.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.785 -173.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.434 ' OD1' ' HB2' ' A' ' 37' ' ' HIS . 6.3 p-10 -135.24 -164.5 1.54 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.856 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -68.57 -29.75 68.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.805 0.336 . . . . 0.0 110.972 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -89.86 -63.31 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.434 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 56.3 m80 -78.37 98.74 6.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.234 0.54 . . . . 0.0 110.651 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.578 ' HD3' HD12 ' A' ' 56' ' ' LEU . 27.7 mtp-105 -115.68 116.9 28.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.449 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.2 mt -98.48 127.14 51.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.781 0.324 . . . . 0.0 110.586 -176.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.535 ' HB3' HD11 ' A' ' 5' ' ' ILE . 55.3 m-85 -99.08 140.23 33.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.409 176.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.541 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -114.16 113.4 24.63 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.543 174.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.05 104.93 17.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.809 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 7.7 ptp180 -112.6 136.41 52.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.361 0.6 . . . . 0.0 111.756 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.43 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 44.5 t80 -99.88 95.71 7.08 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.8 t30 69.59 -76.41 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.388 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -151.31 71.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.527 0.679 . . . . 0.0 110.028 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 15.9 ptp180 -167.41 122.24 1.03 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.029 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.541 HD22 ' HB1' ' A' ' 41' ' ' ALA . 59.0 mt -78.11 90.83 4.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.588 ' HA ' ' HD3' ' A' ' 69' ' ' ARG . 62.7 mt -79.05 -39.95 32.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.307 -175.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -132.9 141.81 48.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.698 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.452 ' HB3' HG21 ' A' ' 22' ' ' ILE . . . -135.09 132.78 38.56 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.84 177.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.49 HG21 HD23 ' A' ' 63' ' ' LEU . 7.5 p -138.9 135.35 42.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.027 0.442 . . . . 0.0 111.224 -176.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.515 ' HG3' ' HB2' ' A' ' 65' ' ' SER . 33.1 mtt-85 -101.5 106.14 17.22 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 176.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.93 119.45 50.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.273 0.559 . . . . 0.0 110.017 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.0 m -92.93 97.42 10.72 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.049 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.578 HD12 ' HD3' ' A' ' 38' ' ' ARG . 81.9 mt -87.29 85.67 7.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.046 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -86.67 85.19 7.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.465 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.14 -119.84 5.05 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.189 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.0 p -96.84 8.62 43.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.021 0.439 . . . . 0.0 111.124 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -126.52 137.16 53.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.265 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -119.56 121.95 5.13 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.357 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.06 119.59 35.74 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.496 HD13 ' SD ' ' A' ' 97' ' ' MET . 5.9 mp -93.88 122.75 36.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -95.35 -79.85 0.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.106 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.515 ' HB2' ' HG3' ' A' ' 53' ' ' ARG . 13.5 m -86.9 122.51 30.87 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.959 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.443 HD13 ' HB ' ' A' ' 52' ' ' VAL . 52.3 tp -140.6 116.43 10.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.421 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.646 ' HA ' ' O5P' ' A' ' 999' ' ' COA . 50.9 ttt180 -143.84 138.11 28.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.985 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.552 HG23 ' OAP' ' A' ' 999' ' ' COA . 7.3 t -114.57 142.86 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.588 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 10.3 mtp180 -63.38 147.43 51.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.124 0.488 . . . . 0.0 111.114 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -58.95 -17.99 29.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -167.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.42 -16.56 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.489 0.661 . . . . 0.0 110.6 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.489 HG22 HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -106.02 15.86 25.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.586 -173.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.645 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 19.5 ptt-85 -86.06 144.73 27.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.988 0.423 . . . . 0.0 111.572 -173.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.452 ' HA ' H52A ' A' ' 999' ' ' COA . 31.2 mtp-105 56.19 26.99 10.98 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.911 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -112.32 2.36 16.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.3 0.571 . . . . 0.0 110.903 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.96 -5.98 64.12 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.114 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.489 HG21 HG22 ' A' ' 72' ' ' THR . 86.7 t -59.46 -41.81 85.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.008 0.433 . . . . 0.0 110.926 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 81' ' ' LEU . . . -64.56 -25.74 70.4 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.367 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.546 ' HA ' HD21 ' A' ' 115' ' ' LEU . 62.7 tt0 -68.6 -47.45 66.67 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -61.95 -40.29 95.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.946 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 85' ' ' VAL . 51.2 tp -45.23 -63.97 0.82 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.806 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.4 ' O ' HD13 ' A' ' 86' ' ' LEU . 3.9 mm? -65.95 -37.19 85.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.575 -176.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 79' ' ' GLN . 41.5 mt-10 -60.27 -40.74 91.45 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -79.67 -25.51 41.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.792 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 81' ' ' LEU . 73.3 t -62.75 -46.17 97.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.149 0.499 . . . . 0.0 110.012 173.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 82' ' ' LEU . 10.3 mp -70.55 -22.05 62.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.95 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -75.78 -45.65 35.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.339 173.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -57.61 -48.85 78.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.098 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -120.27 89.0 42.82 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.196 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -83.13 -15.39 7.93 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.877 2.385 . . . . 0.0 114.02 -173.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.48 57.87 5.05 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.1 -174.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.4 t -129.68 128.46 65.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.758 0.313 . . . . 0.0 110.383 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.7 m -75.56 -48.02 24.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.123 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 127' ' ' CYS . 47.1 t -131.42 124.35 30.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.835 -177.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -96.98 113.86 25.43 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 174.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -108.53 129.0 55.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.924 0.392 . . . . 0.0 110.079 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.831 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 95.9 mmm -110.9 108.42 18.2 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.76 147.5 35.3 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.948 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -63.25 -34.69 78.21 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.89 9.21 2.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.582 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.69 17.03 80.26 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.892 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 104' ' ' ASP . 57.3 t -70.25 118.35 14.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -77.33 5.96 7.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.049 -173.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.532 ' H ' HG12 ' A' ' 102' ' ' VAL . 31.3 m-20 -111.97 24.13 13.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.163 0.506 . . . . 0.0 109.834 173.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -57.47 -28.69 63.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.225 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.3 -46.1 74.04 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.4 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.2 t -66.63 -37.04 78.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.113 0.482 . . . . 0.0 110.047 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.642 ' HG2' ' CDP' ' A' ' 999' ' ' COA . 68.6 mtp -66.59 -32.67 74.16 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.749 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.0 m -62.49 -44.43 96.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.644 0.259 . . . . 0.0 110.582 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.49 ' HB1' ' N7A' ' A' ' 999' ' ' COA . . . -63.27 -39.74 95.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.495 0.664 . . . . 0.0 110.135 175.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.522 ' CE2' H143 ' A' ' 999' ' ' COA . 38.7 t80 -61.69 -39.47 91.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.035 176.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.616 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.4 mmt -63.36 -36.96 85.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.768 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -67.82 -27.8 67.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.721 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.73 -40.34 66.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.917 0.389 . . . . 0.0 110.435 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 79' ' ' GLN . 97.1 mt -68.82 -48.65 63.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.161 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 124.39 27.18 1.36 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.776 -176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.567 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 26.2 m-85 -98.79 154.43 18.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.0 m -108.76 157.88 18.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.872 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.428 HG22 ' CD1' ' A' ' 124' ' ' TRP . 3.3 p -97.39 117.23 31.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.952 0.406 . . . . 0.0 110.871 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.454 ' HA ' ' OE1' ' A' ' 120' ' ' GLN . 14.4 mm-40 -102.62 -179.53 4.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.913 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -91.05 50.72 1.82 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.327 0.584 . . . . 0.0 109.977 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 165.16 43.71 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.356 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 113.44 -176.82 17.63 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 121.171 -0.538 . . . . 0.0 111.79 -176.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.831 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 9.4 m-90 -96.42 148.8 22.41 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -138.65 137.82 37.23 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.016 0.436 . . . . 0.0 111.413 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.465 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 57.5 tttm -136.97 95.52 3.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.59 169.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 94' ' ' CYS . 42.5 t -76.83 110.44 11.44 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.532 0 C-N-CA 120.956 -0.64 . . . . 0.9 112.092 -178.888 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 999' ' ' COA . . . . . 0.676 ' O5P' ' C9P' ' A' ' 999' ' ' COA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 120.959 0.409 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -108.83 127.51 54.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.023 0.439 . . . . 0.0 110.67 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.515 HD11 ' HB1' ' A' ' 42' ' ' ALA . 49.7 tp -76.1 115.68 16.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.622 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.7 m -87.82 92.05 8.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.051 0.453 . . . . 0.0 110.601 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' A' ' 40' ' ' TYR . 6.4 tp -81.91 105.96 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.795 0.807 . . . . 0.0 109.981 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.9 mt -99.11 148.75 5.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.367 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -95.67 139.62 31.66 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 11' ' ' PHE . 4.4 mm? -75.48 62.58 1.39 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.818 0.818 . . . . 0.0 110.586 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -94.72 -29.11 14.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.608 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -127.53 107.12 9.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.77 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 8' ' ' LEU . 69.8 m-85 -87.83 112.38 22.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.987 0.423 . . . . 0.0 111.736 -175.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.518 ' HB3' ' OD1' ' A' ' 15' ' ' ASP . 28.4 t -92.26 157.98 16.37 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 172.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.04 -47.08 84.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -63.92 -41.49 97.65 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.384 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.518 ' OD1' ' HB3' ' A' ' 12' ' ' SER . 1.6 m-20 -55.65 -44.77 77.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.453 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.676 ' HG2' HD13 ' A' ' 31' ' ' LEU . 24.4 mtp180 -60.44 -39.28 86.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.301 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 57.9 mt -77.76 -37.78 24.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.491 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -68.41 -33.05 73.55 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.473 HD23 HD12 ' A' ' 22' ' ' ILE . 73.7 mt -63.87 -37.28 86.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.241 172.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.454 ' HB2' ' HG3' ' A' ' 28' ' ' PRO . 52.3 tt0 -65.67 -22.82 66.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.34 0.591 . . . . 0.0 110.398 176.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -80.0 -28.56 39.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.238 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.519 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 69.5 mt -76.78 -36.01 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.231 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 5.7 m-90 -109.72 81.1 1.83 Allowed Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 21.1 Cg_exo -65.8 -24.83 53.8 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.129 2.553 . . . . 0.0 113.534 -169.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -104.54 3.62 32.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.254 0.55 . . . . 0.0 110.605 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.48 ' HB3' ' HB3' ' A' ' 23' ' ' TRP . 52.4 t80 -118.49 114.07 22.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.844 -175.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.2 m -64.04 116.12 24.79 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 170.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.652 ' HB2' HD11 ' A' ' 31' ' ' LEU . 30.0 Cg_endo -63.3 84.26 0.12 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.931 2.421 . . . . 0.0 113.678 -170.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.1 m -112.15 -1.57 15.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.535 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 p -80.4 4.74 17.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.267 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.676 HD13 ' HG2' ' A' ' 16' ' ' ARG . 51.2 mt -77.4 7.48 5.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.242 -176.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -83.16 98.43 9.34 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.516 HG23 ' HA ' ' A' ' 38' ' ' ARG . 8.2 p -93.13 135.76 26.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.198 -175.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -131.7 -179.56 5.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.82 -23.71 66.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.688 0.28 . . . . 0.0 111.339 -175.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.626 ' O ' ' HA ' ' A' ' 55' ' ' THR . 32.0 m-80 -85.84 -62.34 1.55 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.907 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -89.66 94.62 9.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.553 -175.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.516 ' HA ' HG23 ' A' ' 33' ' ' VAL . 53.6 mtt180 -110.27 139.08 45.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.286 0.565 . . . . 0.0 111.006 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.8 mt -106.96 134.77 47.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.787 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.6 ' HB3' HD11 ' A' ' 5' ' ' ILE . 86.0 m-85 -118.84 140.34 50.12 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.583 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -129.2 124.09 33.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.103 0.478 . . . . 0.0 110.566 -173.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.731 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.0 104.14 16.58 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.966 -176.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -87.27 122.76 31.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.701 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -140.31 124.99 18.09 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.2 t30 62.07 36.56 15.26 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.49 0.662 . . . . 0.0 110.005 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 37.3 tt0 67.01 18.41 10.56 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.213 177.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -133.7 146.24 50.63 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.583 HD22 ' HB1' ' A' ' 41' ' ' ALA . 78.7 mt -79.88 101.45 8.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.197 0.522 . . . . 0.0 110.414 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.8 tp -81.74 -21.74 37.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.615 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.731 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -141.05 140.25 34.22 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.605 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -128.52 122.39 31.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.899 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.425 HG13 ' HB2' ' A' ' 40' ' ' TYR . 7.9 p -132.59 135.97 56.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.955 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -111.26 129.83 55.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.855 0.359 . . . . 0.0 110.146 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.7 p -127.35 139.59 51.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.064 0.459 . . . . 0.0 110.189 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 29.1 m -108.28 101.71 10.89 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.083 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.89 91.07 5.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.507 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -103.54 99.16 8.97 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.118 -175.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.48 -105.55 0.92 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.358 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.8 p -107.36 2.42 24.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.854 0.359 . . . . 0.0 111.131 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -102.66 122.24 44.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.334 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.94 85.76 0.91 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -92.92 128.61 38.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.691 0.281 . . . . 0.0 110.447 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 tp -93.52 121.65 35.14 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -113.47 95.82 5.56 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.185 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.0 p 69.93 127.87 0.03 OUTLIER 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.655 1.182 . . . . 0.0 112.344 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.501 HD23 ' HE1' ' A' ' 108' ' ' MET . 47.0 tp -123.8 122.63 38.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.004 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 70.5 mtp85 -129.82 96.31 4.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.137 0.494 . . . . 0.0 111.076 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' A' ' 50' ' ' ALA . 2.3 t -86.17 142.84 12.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 175.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 48' ' ' LEU . 5.0 ttt180 -61.43 139.79 58.15 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.6 -17.56 23.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.151 -172.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.01 -21.05 27.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.973 0.416 . . . . 0.0 111.138 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.4 m -62.72 -43.1 99.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.481 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 48.79 47.81 20.79 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.09 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.704 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 32.9 mtm180 55.24 66.9 1.11 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.64 175.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -144.52 75.31 1.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.884 0.373 . . . . 0.0 111.654 -175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.08 -43.34 2.84 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 114.998 0.759 . . . . 0.0 114.998 167.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.6 t -49.72 -48.28 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.19 -44.24 94.98 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.808 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.459 ' HA ' HD13 ' A' ' 115' ' ' LEU . 73.5 mt-30 -55.07 -56.94 14.21 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.44 0.638 . . . . 0.0 110.104 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -60.59 -45.62 93.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.13 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.508 ' O ' HG23 ' A' ' 85' ' ' VAL . 27.0 tp -54.09 -57.51 10.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.569 -174.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 82' ' ' LEU . 4.1 mm? -62.56 -45.75 91.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.695 -176.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -60.39 -37.99 82.54 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.975 0.416 . . . . 0.0 110.797 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.447 ' HG2' HG21 ' A' ' 5' ' ' ILE . 10.4 tp10 -69.21 -39.05 78.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.533 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 81' ' ' LEU . 91.4 t -62.16 -42.4 95.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.803 0.335 . . . . 0.0 110.55 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.74 -17.78 63.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.158 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -85.62 -37.59 19.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.171 0.51 . . . . 0.0 109.699 174.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -65.94 -44.04 86.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.077 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -120.28 77.84 26.08 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.585 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -89.0 -0.71 6.31 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.569 2.179 . . . . 0.0 112.909 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.46 -50.3 38.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.13 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.4 ' H ' HG22 ' A' ' 92' ' ' VAL . 3.5 m -62.04 119.69 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.21 0.529 . . . . 0.0 111.025 176.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 m -92.04 -18.52 23.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.275 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.2 t -109.35 98.63 8.0 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -95.31 132.13 40.65 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.188 0.518 . . . . 0.0 110.933 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.459 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 75.0 t-105 -127.6 127.15 43.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.762 -177.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.989 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 74.7 mmm -106.99 110.98 23.26 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -92.0 154.31 18.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.295 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.67 -1.29 41.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.876 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.53 127.81 33.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.93 2.61 86.17 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.163 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.764 HG11 ' HG3' ' A' ' 108' ' ' MET . 60.6 t -117.31 112.51 39.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.822 0.344 . . . . 0.0 110.723 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -80.56 -34.84 35.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.557 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 108' ' ' MET . 7.6 m-20 -87.71 61.53 6.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.858 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -63.35 -40.31 96.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.301 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.94 -45.15 97.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.111 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.9 -43.91 98.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.789 0.328 . . . . 0.0 110.591 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.764 ' HG3' HG11 ' A' ' 102' ' ' VAL . 97.8 mmm -65.61 -29.41 70.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 71.8 m -61.86 -47.61 84.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.13 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.58 -37.9 83.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.356 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.453 ' HB3' ' HA ' ' A' ' 108' ' ' MET . 66.4 t80 -58.5 -52.95 63.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.268 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.534 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 65.1 mtt -76.85 -27.3 55.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.907 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -69.36 -33.79 73.61 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.704 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.11 73.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.613 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.723 HD23 ' HE2' ' A' ' 117' ' ' PHE . 32.5 tp -80.59 -51.96 8.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.018 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 141.91 69.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.285 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.723 ' HE2' HD23 ' A' ' 115' ' ' LEU . 91.1 m-85 -143.75 148.54 35.79 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 124' ' ' TRP . 18.9 m -115.69 149.93 37.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.343 -0.389 . . . . 0.0 109.967 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.2 p -97.0 115.07 26.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.144 0.497 . . . . 0.0 110.322 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.411 ' HG3' ' HG3' ' A' ' 121' ' ' GLN . 55.5 tp60 -134.6 115.7 14.15 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.468 -176.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.411 ' HG3' ' HG3' ' A' ' 120' ' ' GLN . 92.5 mt-30 62.56 35.19 14.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.323 172.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.29 4.37 56.34 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.77 -0.728 . . . . 0.0 113.877 172.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -155.08 175.94 32.91 Favored Glycine 0 C--O 1.225 -0.406 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.036 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.989 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 28.8 m-90 -95.14 127.03 40.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 117.005 0.402 . . . . 0.0 110.042 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -110.82 140.3 45.38 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.89 0.376 . . . . 0.0 110.623 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -137.03 93.4 2.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 172.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 51.0 t -86.93 132.01 33.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.704 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 C-N-CA 121.132 -0.556 . . . . 0.9 111.94 178.613 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 999' ' ' COA . . . . . 0.704 ' O4A' ' HA ' ' A' ' 74' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.8 mtm . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.677 0.275 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -107.3 128.79 54.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.017 0.436 . . . . 0.0 110.573 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.55 HD11 ' HB1' ' A' ' 42' ' ' ALA . 49.4 tp -93.37 113.7 25.94 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.464 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.6 m -83.01 100.09 10.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.249 0.547 . . . . 0.0 110.581 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.517 HD11 HD12 ' A' ' 81' ' ' LEU . 85.5 mt -95.03 129.83 44.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.393 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.5 mt -124.75 149.84 29.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.066 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 7' ' ' ARG . 15.2 ptt-85 -92.57 138.56 31.4 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 41' ' ' ALA . 4.3 mm? -74.92 50.89 0.48 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.035 0.445 . . . . 0.0 111.612 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -87.79 -24.39 23.77 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -123.53 107.31 11.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.695 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -83.67 115.24 22.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.202 0.525 . . . . 0.0 111.539 -173.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.8 t -98.37 153.32 18.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.893 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.475 ' O ' HG12 ' A' ' 17' ' ' ILE . 43.1 t0 -66.92 -49.86 64.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.439 -172.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -64.95 -37.79 88.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.723 0.297 . . . . 0.0 111.049 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.65 -39.37 88.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.297 0.57 . . . . 0.0 110.168 176.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -68.26 -29.32 68.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.6 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 13' ' ' ASP . 43.2 mm -63.84 -44.28 98.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.428 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.519 ' O ' HG13 ' A' ' 22' ' ' ILE . 7.7 m-20 -64.86 -38.4 90.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.807 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.9 mt -60.2 -41.84 93.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.962 0.411 . . . . 0.0 110.284 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -73.6 -13.54 61.03 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.368 0.604 . . . . 0.0 110.483 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -92.01 -23.37 19.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.404 0.621 . . . . 0.0 109.68 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 18' ' ' ASP . 96.1 mt -77.66 -35.36 21.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.399 174.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 5.3 m-90 -112.23 80.81 3.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 169.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.97 -8.72 22.54 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.971 2.447 . . . . 0.0 113.65 -168.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -115.42 4.26 14.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.866 0.365 . . . . 0.0 110.697 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.557 ' CE2' ' HA ' ' A' ' 28' ' ' PRO . 58.6 t80 -133.66 122.46 23.48 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.108 0.48 . . . . 0.0 111.843 -174.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.7 m -81.64 115.62 58.01 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.248 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.557 ' HA ' ' CE2' ' A' ' 26' ' ' TYR . 49.5 Cg_exo -54.77 109.04 0.34 Allowed 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 123.069 2.513 . . . . 0.0 112.718 -174.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.4 t -118.77 -24.17 6.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.93 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.1 m -73.34 5.19 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.526 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.452 HD11 ' HB2' ' A' ' 28' ' ' PRO . 87.3 mt -59.1 90.3 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.458 0.647 . . . . 0.0 111.698 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -161.2 135.21 6.89 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.498 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.0 m -123.64 141.28 44.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.36 0.6 . . . . 0.0 111.949 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -116.7 172.52 7.18 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.14 -28.09 67.85 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.373 0.606 . . . . 0.0 109.477 171.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -98.86 -0.61 42.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.141 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -144.55 91.32 2.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.464 ' HB2' HG13 ' A' ' 54' ' ' VAL . 57.3 mtt180 -109.07 153.8 23.15 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.769 -174.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 8' ' ' LEU . 66.1 mt -122.78 118.48 55.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -104.58 127.28 52.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.112 0.482 . . . . 0.0 110.52 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.557 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.23 129.67 55.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.094 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.597 ' HB2' HD13 ' A' ' 81' ' ' LEU . . . -91.92 103.93 16.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.131 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -101.44 118.68 37.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.92 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -122.99 109.84 14.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.531 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 69.02 -69.93 0.15 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.168 0.917 . . . . 0.0 112.366 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.658 ' HG2' ' HG3' ' A' ' 47' ' ' ARG . 35.7 tt0 -94.2 -66.74 0.9 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.861 0.363 . . . . 0.0 111.381 -174.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.658 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 11.8 mtm180 -147.61 -150.79 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -174.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.557 HD22 ' HB1' ' A' ' 41' ' ' ALA . 37.8 mt -78.15 122.94 26.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.119 0.485 . . . . 0.0 110.414 -176.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.437 ' O ' ' HD3' ' A' ' 69' ' ' ARG . 32.3 tp -99.55 -25.32 14.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.076 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.538 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -152.5 163.65 39.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.636 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.29 143.43 29.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.675 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.502 ' HB ' HD13 ' A' ' 66' ' ' LEU . 11.7 p -147.02 140.52 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.361 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 -101.77 140.01 36.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.464 HG13 ' HB2' ' A' ' 38' ' ' ARG . 6.2 p -130.51 122.28 52.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.594 0.711 . . . . 0.0 111.653 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 39.2 m -91.33 140.5 29.71 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.859 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.2 mt -127.1 141.47 51.76 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.886 0.374 . . . . 0.0 110.862 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.7 m -144.23 84.49 1.76 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.475 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.15 -110.18 3.29 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.146 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 p -98.02 3.05 49.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.959 0.409 . . . . 0.0 111.281 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.426 ' HG2' ' HB3' ' A' ' 94' ' ' CYS . 42.7 mt-10 -112.24 151.43 29.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.397 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.08 158.25 27.37 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.567 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -134.39 123.33 23.91 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.76 0.314 . . . . 0.0 110.486 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.86 118.24 31.19 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -129.68 133.42 47.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.468 -174.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 m 64.98 100.83 0.04 OUTLIER 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.444 0.64 . . . . 0.0 111.641 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.502 HD13 ' HB ' ' A' ' 52' ' ' VAL . 56.7 tp -132.31 121.34 23.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.149 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 67' ' ' ARG . 31.1 ttt180 -144.0 131.41 20.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.994 0.426 . . . . 0.0 110.811 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.549 ' HB ' ' H10' ' A' ' 999' ' ' COA . 9.0 t -109.97 164.26 6.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.437 ' HD3' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -54.66 135.29 46.95 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 173.703 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -62.52 -26.52 68.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.101 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 p -77.82 -14.62 14.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.002 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 m -91.43 64.21 5.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.671 0.748 . . . . 0.0 111.385 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.573 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 52.2 mtt-85 -106.88 91.66 3.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.018 174.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -131.67 -9.44 3.58 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -171.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.557 ' HA ' ' O8A' ' A' ' 999' ' ' COA . 74.2 mtt180 69.16 88.37 0.11 Allowed 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.94 0.4 . . . . 0.0 109.976 -174.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 147.52 -43.05 0.86 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.459 -1.353 . . . . 0.0 114.006 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.44 -54.48 18.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 117.209 0.504 . . . . 0.0 111.757 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.07 -38.53 96.74 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.321 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.546 ' HG3' ' HG ' ' A' ' 115' ' ' LEU . 7.8 tt0 -62.33 -52.42 63.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.791 0.329 . . . . 0.0 110.665 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -62.38 -33.75 75.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.699 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.597 HD13 ' HB2' ' A' ' 42' ' ' ALA . 48.0 tp -54.14 -57.62 10.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.574 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.07 -41.45 95.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.572 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -54.36 -46.55 73.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.94 0.4 . . . . 0.0 111.228 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -66.06 -36.8 84.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.392 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 81' ' ' LEU . 81.2 t -66.2 -46.37 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.88 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.434 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 10.9 mp -65.79 -22.85 66.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.359 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.4 mtm-85 -89.25 -15.74 32.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.735 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.441 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 46.4 t-20 -81.87 -42.59 19.38 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -118.14 76.96 12.32 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.405 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 6.0 Cg_exo -79.0 -13.9 13.87 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.992 2.461 . . . . 0.0 112.282 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.67 -20.91 72.53 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.043 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -76.05 106.56 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.7 m -90.82 -11.78 38.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.085 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.426 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 40.2 t -131.28 95.54 3.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.88 0.371 . . . . 0.0 110.501 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 1.0 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 95.5 m95 -91.38 107.24 19.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.424 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.622 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 76.9 t-105 -97.47 130.98 44.51 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.479 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 58.9 mtp -114.48 131.82 56.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.719 0.295 . . . . 0.0 110.481 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.84 165.42 11.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.586 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -108.71 73.61 0.88 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.835 0.826 . . . . 0.0 109.115 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.77 113.59 27.28 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.521 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.51 1.02 81.37 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.91 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.97 118.23 46.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.946 0.403 . . . . 0.0 110.336 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -93.22 -20.59 20.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.341 0.591 . . . . 0.0 109.48 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -86.74 41.19 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.641 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -52.95 -43.85 66.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.053 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.7 -46.52 92.11 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.501 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.8 t -64.56 -45.26 96.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.09 0.472 . . . . 0.0 110.308 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.487 ' O ' ' HG2' ' A' ' 112' ' ' MET . 37.6 ttm -67.05 -29.2 68.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.032 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 96.9 m -61.61 -45.39 94.3 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 175.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.04 -39.35 92.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.146 0.498 . . . . 0.0 110.437 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.407 ' HA ' ' O4B' ' A' ' 999' ' ' COA . 12.4 t80 -60.52 -49.08 78.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.042 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.529 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 22.2 mmt -66.85 -35.29 79.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.132 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -71.4 -25.54 62.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.024 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.42 -38.9 54.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.92 0.39 . . . . 0.0 110.227 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.566 HD22 ' CE2' ' A' ' 117' ' ' PHE . 7.3 tt -70.72 -49.55 45.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.078 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 134.64 47.83 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.983 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.58 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 83.1 m-85 -110.43 149.2 30.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.589 0.233 . . . . 0.0 110.422 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.0 m -94.67 143.09 26.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.912 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.8 p -97.43 122.5 40.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.0 0.429 . . . . 0.0 111.093 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -120.13 -171.48 2.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.356 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -84.42 94.07 8.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.134 0.492 . . . . 0.0 110.255 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 136.52 -48.55 0.91 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.022 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -167.74 -153.16 7.91 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.279 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 15.5 m-90 -108.49 141.77 39.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.597 0.237 . . . . 0.0 110.481 -176.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -120.18 132.52 55.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.018 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 1.0 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 57.8 tptt -119.08 85.86 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 172.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 39.2 t -98.86 137.0 38.07 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.904 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 C-N-CA 120.836 -0.697 . . . . 0.9 112.07 -179.943 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 999' ' ' COA . . . . . 0.573 ' O4A' ' HA ' ' A' ' 73' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.469 ' HA ' HD21 ' A' ' 45' ' ' ASN . 67.7 mtm . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.822 0.344 . . . . 0.0 110.371 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -92.76 141.94 27.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.957 0.408 . . . . 0.0 110.354 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.4 tp -75.96 106.28 7.46 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.6 m -96.64 111.46 23.59 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.655 -177.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 42' ' ' ALA . 15.7 tt -122.01 129.35 75.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 121.416 0.627 . . . . 0.0 110.871 -175.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -134.4 168.17 24.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.755 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -75.03 124.37 26.86 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.0 tp -89.92 78.44 6.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.343 0.592 . . . . 0.0 110.143 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.578 ' HA ' HG21 ' A' ' 33' ' ' VAL . 29.3 tt0 -86.64 -40.68 14.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.513 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -102.99 122.21 44.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.965 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -105.7 110.41 22.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.709 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.558 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 0.7 OUTLIER -80.29 168.95 18.41 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.655 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.482 ' O ' HG13 ' A' ' 17' ' ' ILE . 17.1 t70 -61.08 -45.99 92.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.751 0.31 . . . . 0.0 110.388 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.534 ' HA ' HD12 ' A' ' 17' ' ' ILE . 97.6 mt-30 -66.73 -34.87 78.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.13 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.26 -35.61 79.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.784 0.326 . . . . 0.0 110.234 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 12' ' ' SER . 42.5 mtt180 -65.93 -47.08 75.9 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 14' ' ' GLN . 69.1 mt -54.37 -48.43 68.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.99 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.555 ' O ' HG13 ' A' ' 22' ' ' ILE . 99.7 m-20 -54.69 -57.84 9.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.104 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.03 -41.18 99.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.38 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -73.43 -10.54 59.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -99.54 -25.06 14.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.075 0.465 . . . . 0.0 110.111 175.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 18' ' ' ASP . 76.4 mt -65.03 -44.35 95.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -87.85 117.48 68.52 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.467 172.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.31 -45.61 36.21 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.985 2.456 . . . . 0.0 112.92 -176.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -147.31 92.49 2.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.111 0.482 . . . . 0.0 109.849 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -154.28 135.85 14.3 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.207 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.1 p -96.38 147.93 33.71 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.849 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.63 ' HB3' HD12 ' A' ' 31' ' ' LEU . 52.4 Cg_exo -55.58 100.2 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.874 2.382 . . . . 0.0 112.404 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.2 m -131.38 -53.29 1.02 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.813 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 p -79.27 4.7 14.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.6 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.63 HD12 ' HB3' ' A' ' 28' ' ' PRO . 86.6 mt -80.59 11.53 3.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.832 0.349 . . . . 0.0 111.406 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -74.32 107.68 6.63 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 9' ' ' GLU . 16.9 m -104.35 136.42 37.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.453 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -140.23 -161.73 1.24 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.617 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -81.63 -19.83 40.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 110.222 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -96.18 -68.19 0.81 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -72.53 97.32 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.626 HH11 HD12 ' A' ' 56' ' ' LEU . 71.5 mtt180 -113.54 127.62 56.14 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.011 0.434 . . . . 0.0 111.163 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.703 HG12 ' HG2' ' A' ' 53' ' ' ARG . 64.5 mt -101.88 119.34 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.804 176.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.449 ' HB3' HD11 ' A' ' 5' ' ' ILE . 80.6 m-85 -98.78 133.6 42.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.96 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.497 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.09 113.38 26.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.283 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.773 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -98.42 110.83 23.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.387 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.555 ' HB3' HD23 ' A' ' 48' ' ' LEU . 23.8 ptt180 -107.94 134.12 51.31 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.225 0.536 . . . . 0.0 110.257 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -97.15 94.2 6.99 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.793 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.469 HD21 ' HA ' ' A' ' 1' ' ' MET . 14.3 t-20 72.25 -46.98 0.66 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.142 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -128.21 -67.83 0.79 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.362 . . . . 0.0 111.848 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -104.55 162.21 13.45 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.966 -170.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.555 HD23 ' HB3' ' A' ' 43' ' ' ARG . 92.3 mt -59.87 127.42 31.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.34 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.707 HD23 HG11 ' A' ' 77' ' ' VAL . 31.3 tp -115.95 -29.49 6.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.489 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.773 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -136.61 139.74 42.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.822 0.344 . . . . 0.0 111.41 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.63 116.66 22.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.843 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 40' ' ' TYR . 7.4 p -124.51 131.34 72.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.396 0.617 . . . . 0.0 111.315 -177.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.703 ' HG2' HG12 ' A' ' 39' ' ' ILE . 41.3 mtp-105 -107.75 119.05 38.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.645 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.48 128.62 68.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.405 0.621 . . . . 0.0 110.821 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.0 m -94.11 100.88 12.9 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.94 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.626 HD12 HH11 ' A' ' 38' ' ' ARG . 93.3 mt -87.04 86.54 7.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.639 177.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -95.92 105.87 17.95 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.383 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.15 -113.54 4.75 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.553 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 p -113.16 8.67 18.31 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.894 0.378 . . . . 0.0 110.939 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -107.75 137.96 44.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.312 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.47 114.22 3.0 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.923 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -111.37 128.93 56.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.562 0.22 . . . . 0.0 110.47 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.502 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 6.9 mp -93.49 108.49 20.17 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.378 0.609 . . . . 0.0 109.611 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.54 -28.43 33.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.809 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.6 m -152.4 127.77 9.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.663 0.268 . . . . 0.0 110.965 -176.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.4 tp -131.28 109.68 10.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.736 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -143.27 109.38 5.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.17 0.51 . . . . 0.0 110.853 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.596 HG13 ' HB2' ' A' ' 50' ' ' ALA . 12.4 t -97.7 157.8 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -58.22 146.45 33.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 0.0 110.707 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -52.02 -35.5 47.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.484 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -75.98 7.9 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.469 0.652 . . . . 0.0 111.487 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.49 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 1.8 m -103.91 8.93 36.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.618 0.723 . . . . 0.0 110.238 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.9 ttp85 -65.74 107.19 1.7 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.614 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 61.58 91.38 0.06 Allowed 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.606 0.567 . . . . 0.0 110.093 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -164.42 -42.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.044 -170.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.6 -24.34 6.85 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.435 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.707 HG11 HD23 ' A' ' 49' ' ' LEU . 84.5 t -55.38 -42.54 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -177.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.25 -31.82 70.49 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.006 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.545 ' HA ' HD21 ' A' ' 115' ' ' LEU . 53.0 tt0 -65.16 -43.85 90.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -69.0 -36.87 78.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.42 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.499 ' O ' HG23 ' A' ' 85' ' ' VAL . 63.2 tp -49.29 -58.72 4.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.268 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.17 -33.21 75.47 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.95 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -58.26 -54.04 51.53 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.646 0.26 . . . . 0.0 110.817 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HG2' HG22 ' A' ' 5' ' ' ILE . 6.4 tp10 -64.38 -36.78 85.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.162 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 81' ' ' LEU . 93.3 t -61.37 -49.15 85.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.912 0.387 . . . . 0.0 110.763 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.473 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 10.4 mp -78.18 -4.59 48.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.088 0.47 . . . . 0.0 110.938 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -87.76 -38.54 15.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.943 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -71.1 -37.96 72.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.097 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.433 ' O ' ' HZ2' ' A' ' 95' ' ' TRP . 20.1 m120 -120.12 74.48 21.15 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.883 176.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -88.09 -3.42 7.03 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.741 2.294 . . . . 0.0 113.733 -173.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -94.25 19.33 53.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.851 -175.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.402 ' HB ' ' CE2' ' A' ' 95' ' ' TRP . 55.7 t -107.17 125.14 63.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.0 m -91.76 -42.92 9.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.902 0.382 . . . . 0.0 110.779 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 40.6 t -104.43 96.46 6.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.051 0.453 . . . . 0.0 110.558 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.473 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 86.5 m95 -90.87 131.0 36.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.94 175.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.642 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 67.9 t-105 -120.66 133.44 55.36 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.502 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 75.2 mtp -119.15 124.84 47.82 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -84.46 173.39 10.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.832 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -57.57 -35.28 70.17 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.077 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.459 ' HB3' HG23 ' A' ' 102' ' ' VAL . . . 63.99 11.74 6.34 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.919 175.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.59 12.21 84.72 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.803 -176.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.717 HG22 ' C3P' ' A' ' 999' ' ' COA . 45.2 t -80.85 101.49 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.962 0.41 . . . . 0.0 110.281 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -89.08 -1.37 58.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.463 0.649 . . . . 0.0 109.724 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -85.75 44.45 1.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.084 172.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -56.33 -41.69 76.47 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.2 -173.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -51.95 -54.21 26.72 Favored Glycine 0 C--O 1.236 0.275 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.706 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.2 t -66.73 -43.38 90.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.931 0.396 . . . . 0.0 111.009 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.56 ' O ' ' HG2' ' A' ' 112' ' ' MET . 34.8 ttm -69.75 -35.66 75.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.868 -176.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 33.7 m -66.58 -36.93 83.82 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.402 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.94 -37.46 86.08 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.285 0.564 . . . . 0.0 109.922 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.41 ' HB3' ' O ' ' A' ' 108' ' ' MET . 59.9 t80 -61.15 -46.63 89.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.524 174.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.5 mmt -58.77 -43.85 90.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.734 178.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -62.33 -33.93 75.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.985 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.54 -36.2 68.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.247 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.545 HD21 ' HA ' ' A' ' 79' ' ' GLN . 11.1 mp -90.66 7.98 36.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.34 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.24 68.09 1.68 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.82 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.515 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 57.9 m-85 -117.85 151.6 37.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.135 0.493 . . . . 0.0 111.026 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.697 ' HB ' ' HB2' ' A' ' 125' ' ' GLU . 24.3 m -91.4 136.0 33.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.37 176.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 41.7 p -101.29 108.65 20.35 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.423 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -95.96 160.57 14.39 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 172.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -78.86 88.01 4.7 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.253 0.549 . . . . 0.0 109.767 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.98 3.84 6.81 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.884 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.444 ' HA3' ' CZ2' ' A' ' 96' ' ' TRP . . . 173.15 173.59 39.63 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.358 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -116.0 150.65 36.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.697 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 53.1 mt-10 -126.51 156.38 40.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.774 0.321 . . . . 0.0 111.03 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.425 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 56.2 tttp -137.35 121.2 17.55 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 167.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.7 t -86.31 105.27 16.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.148 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 CA-C-N 115.884 -0.598 . . . . 0.9 112.43 -179.76 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 999' ' ' COA . . . . . 0.717 ' C3P' HG22 ' A' ' 102' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.3 mtp . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.867 0.365 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -108.99 118.1 35.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.373 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.508 HD11 ' HB1' ' A' ' 42' ' ' ALA . 59.7 tp -83.82 111.69 19.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 43' ' ' ARG . 7.2 m -82.78 89.56 6.8 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.215 0.531 . . . . 0.0 109.794 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 15.9 tt -102.65 118.78 50.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.415 0.626 . . . . 0.0 109.982 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.8 mt -114.87 150.96 16.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.416 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.522 ' HB3' ' CE2' ' A' ' 40' ' ' TYR . 17.1 ptt180 -91.61 119.07 31.19 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.567 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.79 72.91 1.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.127 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -96.15 -9.06 31.54 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 171.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -143.08 143.68 31.95 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.1 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -124.63 145.96 49.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.142 0.496 . . . . 0.0 111.571 -173.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -119.31 177.52 4.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 172.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -75.06 -34.53 61.83 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.487 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -64.7 -53.79 41.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.583 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -62.69 -31.86 72.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.738 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -63.24 -40.25 96.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.833 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.1 mt -77.94 -26.0 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.948 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.5 ' HB3' HD12 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -72.67 -35.53 67.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.968 0.413 . . . . 0.0 110.362 174.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.04 -30.65 71.71 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 170.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -72.08 -21.92 61.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.536 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -72.59 -33.55 66.81 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.413 HG23 HH11 ' A' ' 67' ' ' ARG . 48.4 mm -75.4 -51.73 20.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.188 175.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -119.27 110.29 37.87 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.112 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.79 -16.21 26.44 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 122.684 2.256 . . . . 0.0 111.762 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -137.25 86.05 2.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.991 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.444 ' CE2' HD11 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -133.25 135.68 45.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.822 -176.323 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.2 m -96.18 143.17 25.66 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.297 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.08 -15.04 31.46 Favored 'Trans proline' 0 N--CA 1.475 0.394 0 C-N-CA 123.472 2.782 . . . . 0.0 114.024 -174.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.0 m -62.29 -28.38 69.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.902 0.382 . . . . 0.0 111.192 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.1 p -85.65 -16.44 39.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.973 0.416 . . . . 0.0 110.614 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.444 HD11 ' CE2' ' A' ' 26' ' ' TYR . 84.3 mt -86.27 -2.99 58.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.844 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.35 95.43 1.03 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.931 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -102.55 165.17 3.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.284 0.564 . . . . 0.0 111.94 -174.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.75 -164.51 0.91 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.049 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.54 -24.41 61.12 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.546 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 33.9 m-80 -87.15 -62.78 1.43 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.607 ' HB2' HG23 ' A' ' 55' ' ' THR . 77.9 t60 -87.0 97.98 11.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 0.0 110.12 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -111.73 148.68 32.95 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.516 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.593 HG12 ' HG2' ' A' ' 53' ' ' ARG . 68.9 mt -115.46 118.06 57.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 7' ' ' ARG . 79.1 m-85 -103.01 122.43 44.6 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.419 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -112.91 128.71 56.54 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.906 0.384 . . . . 0.0 110.884 -177.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.22 103.96 16.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.21 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.425 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 14.7 ttt85 -85.74 104.64 15.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.569 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -123.95 115.39 21.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.913 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 61.97 60.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.645 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 67.92 10.38 7.76 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 170.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -149.5 155.89 41.09 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.345 -0.242 . . . . 0.0 110.345 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 18' ' ' ASP . 69.1 mt -75.82 110.99 10.71 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 173.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.6 tp -94.61 -26.96 16.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.332 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -137.49 145.03 42.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.217 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.39 121.66 21.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.255 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.496 HG13 ' HB2' ' A' ' 40' ' ' TYR . 7.6 p -126.2 121.09 58.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.35 0.595 . . . . 0.0 110.551 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.779 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 9.8 mtp180 -103.08 138.96 39.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.108 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -137.76 135.9 45.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.954 0.407 . . . . 0.0 110.31 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.607 HG23 ' HB2' ' A' ' 37' ' ' HIS . 6.7 m -117.91 100.64 7.71 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.127 0.489 . . . . 0.0 110.124 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.63 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 49.0 mt -78.52 160.84 27.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.371 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.6 m -154.43 83.4 1.12 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.154 0.502 . . . . 0.0 109.652 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.9 -120.54 8.78 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.289 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 p -82.26 -6.84 59.51 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.015 0.436 . . . . 0.0 111.504 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.545 ' HG2' ' HB3' ' A' ' 94' ' ' CYS . 44.8 mt-10 -112.41 159.98 18.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.33 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 56' ' ' LEU . . . -153.74 116.07 0.71 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.563 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -98.86 140.87 32.38 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.38 130.74 39.06 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.779 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 3.4 t70 -120.49 99.26 6.46 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.95 -171.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.8 t 70.72 111.41 0.06 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.954 0.883 . . . . 0.0 111.905 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.438 ' O ' ' C5P' ' A' ' 999' ' ' COA . 35.1 tp -117.25 126.01 52.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.481 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.413 HH11 HG23 ' A' ' 22' ' ' ILE . 68.0 ttt-85 -143.84 110.98 5.77 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.959 178.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.564 HG13 ' HB2' ' A' ' 50' ' ' ALA . 17.1 t -98.32 146.31 8.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 166.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 69' ' ' ARG . 16.0 ttt180 -57.42 136.53 56.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -54.89 -27.87 46.22 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.325 0.65 . . . . 0.0 112.554 -168.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.8 t -69.38 -14.31 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.351 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.11 18.47 9.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.334 0.587 . . . . 0.0 110.669 -177.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -62.32 119.45 9.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.496 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.543 ' HA ' ' O8A' ' A' ' 999' ' ' COA . 66.4 mtt-85 63.89 67.88 0.6 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.326 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -165.56 59.16 0.11 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.83 -59.45 1.33 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 115.724 1.05 . . . . 0.0 115.724 167.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.1 t -42.77 -50.51 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -167.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.78 -49.0 73.68 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.987 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.602 ' HA ' HD21 ' A' ' 115' ' ' LEU . 46.3 tt0 -68.28 -39.1 82.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.991 0.424 . . . . 0.0 110.402 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -61.01 -45.82 93.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.158 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 42' ' ' ALA . 1.2 mp -51.85 -57.56 8.99 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.817 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.521 HD11 ' HE1' ' A' ' 97' ' ' MET . 4.0 mm? -56.19 -48.27 76.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.434 -176.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -69.04 -33.9 74.35 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.437 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -65.02 -42.67 94.18 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.012 0.434 . . . . 0.0 110.206 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 81' ' ' LEU . 88.2 t -62.56 -48.66 87.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.713 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.2 -20.53 65.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.15 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -80.34 -52.89 7.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.175 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.402 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 66.0 t30 -73.51 -19.12 61.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.621 -172.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -113.57 83.5 7.12 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 86.4 Cg_endo -86.0 -0.67 8.56 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.641 2.227 . . . . 0.0 113.153 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -82.96 -14.89 74.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.371 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.545 HG21 HD22 ' A' ' 56' ' ' LEU . 38.5 t -92.06 120.94 42.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.811 0.339 . . . . 0.0 110.309 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 128' ' ' GLY . 7.4 t -96.89 -26.14 15.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.431 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.545 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 22.9 t -118.44 104.88 11.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.536 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.429 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 91.9 m95 -96.47 112.35 24.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.424 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.411 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 76.8 t-105 -100.85 134.17 44.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.714 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.702 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 92.1 mmm -106.95 106.59 17.19 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.17 141.31 29.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.004 0.43 . . . . 0.0 110.788 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 102' ' ' VAL . 19.1 p-10 -90.23 -46.46 8.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.535 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 66.24 -66.06 0.18 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.476 0.71 . . . . 0.0 111.786 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -145.0 37.5 1.33 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.165 -0.54 . . . . 0.0 111.863 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 99' ' ' ASP . 75.0 t -82.84 105.95 13.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.988 0.423 . . . . 0.0 110.342 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -85.52 -34.22 21.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.914 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.57 56.87 2.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.151 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -61.04 -42.66 98.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.112 -175.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.28 -52.77 47.12 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.549 -177.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.79 -45.15 87.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.0 111.129 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.56 ' O ' ' HG2' ' A' ' 112' ' ' MET . 69.3 mtp -75.5 -23.31 56.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.957 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 80.9 m -71.41 -39.28 71.22 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.136 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.4 -39.84 92.21 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.247 0.546 . . . . 0.0 109.664 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -60.56 -52.88 63.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.765 174.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 108' ' ' MET . 25.5 mmt -58.03 -45.87 86.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.416 -177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -65.02 -30.54 71.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.945 0.402 . . . . 0.0 110.815 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.64 -23.22 61.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.872 0.368 . . . . 0.0 110.814 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.602 HD21 ' HA ' ' A' ' 79' ' ' GLN . 11.2 mp -98.0 4.73 49.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.016 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.99 23.27 52.9 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.462 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.555 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 88.8 m-85 -91.73 141.55 28.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.026 0.413 . . . . 0.0 110.413 176.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.7 m -96.27 132.63 41.54 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.383 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.438 ' HB ' ' CD1' ' A' ' 124' ' ' TRP . 3.0 t -97.29 126.88 42.79 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -121.01 -72.75 0.67 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.459 0.647 . . . . 0.0 110.745 -174.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -116.87 -142.91 0.37 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.752 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.94 62.73 0.72 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.533 170.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.04 164.88 14.57 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.702 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 14.4 m-90 -112.98 157.15 21.86 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -141.09 139.37 34.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.792 0.329 . . . . 0.0 110.543 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 95' ' ' TRP . 86.3 tttt -137.01 122.82 19.99 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 31.2 t -74.2 142.01 45.43 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.895 0.379 . . . . 0.0 110.719 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 93' ' ' SER . . . . . . . . 0 N--CA 1.448 -0.5 0 CA-C-N 116.105 -0.498 . . . . 0.9 111.992 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 999' ' ' COA . . . . . 0.543 ' O8A' ' HA ' ' A' ' 74' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 121.021 0.439 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -121.84 129.75 52.85 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.513 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.526 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 54.4 tp -75.71 108.33 8.48 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.429 ' HB ' ' HG3' ' A' ' 43' ' ' ARG . 14.0 m -82.85 92.86 7.36 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.205 0.526 . . . . 0.0 110.579 -173.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.641 HD11 ' HB3' ' A' ' 40' ' ' TYR . 7.9 tp -89.92 113.49 26.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.694 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.5 mt -121.1 157.48 24.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.096 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 47.7 ttt-85 -90.25 125.23 35.42 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.08 128.12 35.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.218 0.533 . . . . 0.0 111.717 -177.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -102.5 -51.49 3.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.718 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -124.39 164.18 20.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.241 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -136.46 114.02 10.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.637 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.7 p -93.16 175.18 6.87 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 170.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.88 -38.16 81.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.782 0.325 . . . . 0.0 110.667 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -64.68 -44.97 88.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.517 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -61.79 -49.77 75.03 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.179 0.514 . . . . 0.0 110.14 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -58.88 -47.1 86.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.069 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.8 mt -67.37 -36.38 76.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.54 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -68.79 -41.33 78.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.04 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.76 -43.47 93.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.727 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -77.33 -1.4 29.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.427 0.632 . . . . 0.0 110.284 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -93.34 -33.5 13.87 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.5 mt -68.94 -44.65 81.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.435 174.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -100.48 97.03 5.88 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 170.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.48 20.51 0.25 Allowed 'Trans proline' 0 N--CA 1.476 0.454 0 C-N-CA 123.176 2.584 . . . . 0.0 114.189 -169.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -157.5 -81.09 0.06 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.5 t80 60.8 -173.59 0.13 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 123.773 0.67 . . . . 0.0 110.812 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.3 m -116.09 140.68 26.65 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-O 120.564 0.221 . . . . 0.0 110.599 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.36 137.52 56.13 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.6 2.2 . . . . 0.0 112.014 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.8 t 71.43 -1.42 2.77 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.036 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 m -83.73 4.97 26.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.93 0.395 . . . . 0.0 111.193 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.8 mt -85.11 21.81 1.57 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.093 0.473 . . . . 0.0 110.376 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -73.34 141.1 47.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.062 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.1 149.56 24.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.95 0.405 . . . . 0.0 110.76 -177.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -147.95 -162.38 1.54 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -84.57 -24.2 29.33 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.955 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -86.01 -49.99 7.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.396 0.617 . . . . 0.0 109.416 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -94.01 101.48 13.52 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -109.1 137.75 46.52 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.02 0.438 . . . . 0.0 111.41 -173.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.542 HG12 ' HG2' ' A' ' 53' ' ' ARG . 57.8 mt -108.18 112.37 39.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 170.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.641 ' HB3' HD11 ' A' ' 5' ' ' ILE . 11.7 m-85 -94.27 137.02 33.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.982 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.579 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -118.66 116.31 26.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.47 -176.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.662 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.31 91.51 7.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.68 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.552 ' HB3' HD23 ' A' ' 48' ' ' LEU . 13.5 ptm180 -92.21 133.02 36.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.573 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -108.94 99.43 8.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.716 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 67.22 -69.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.309 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -101.17 -59.82 1.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -170.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -132.81 -177.51 4.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.942 0.401 . . . . 0.0 111.944 -171.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.579 HD22 ' HB1' ' A' ' 41' ' ' ALA . 21.8 mt -78.32 113.32 16.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.219 -171.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.447 HD12 ' HD2' ' A' ' 69' ' ' ARG . 46.5 tp -89.72 -30.43 18.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.943 0.401 . . . . 0.0 110.736 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.662 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -142.49 146.48 34.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.777 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -133.62 133.81 42.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.483 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.465 ' HB ' HD13 ' A' ' 66' ' ' LEU . 10.2 p -148.34 140.58 18.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.962 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.663 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 23.8 mtp85 -100.07 150.91 21.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.235 175.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 11.9 p -151.22 138.93 13.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.011 0.434 . . . . 0.0 110.779 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.1 m -111.99 115.82 29.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.769 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.3 mt -99.45 86.87 3.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.3 0.571 . . . . 0.0 110.744 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -95.08 77.98 3.53 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.207 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.81 -85.98 0.28 Allowed Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.879 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.6 p -114.9 -2.22 12.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.962 0.411 . . . . 0.0 111.135 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -104.31 125.69 50.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.487 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.37 96.24 0.72 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -98.48 113.57 25.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.796 0.331 . . . . 0.0 111.153 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.556 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 5.9 mp -93.87 116.55 29.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.224 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.663 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 22.2 m-20 -109.38 131.59 54.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.692 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.8 m 61.11 98.89 0.03 OUTLIER 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.573 0.701 . . . . 0.0 112.06 175.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.465 HD13 ' HB ' ' A' ' 52' ' ' VAL . 22.2 tp -123.89 118.28 26.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.099 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.422 ' HA ' ' O9P' ' A' ' 999' ' ' COA . 26.7 ttt180 -143.98 139.26 28.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.196 0.522 . . . . 0.0 111.223 174.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.438 HG12 ' HB2' ' A' ' 50' ' ' ALA . 18.1 m -101.71 169.26 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.868 173.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.447 ' HD2' HD12 ' A' ' 49' ' ' LEU . 95.2 mtt180 -65.75 157.18 30.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 172.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 6.6 tp10 -56.5 -39.08 72.66 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -172.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.79 36.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.148 0.499 . . . . 0.0 110.65 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 m -127.21 4.91 6.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.3 0.571 . . . . 0.0 110.944 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 8.4 mtm180 -81.1 130.14 34.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.74 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.9 mtp-105 62.55 36.56 13.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.261 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -125.43 17.91 8.22 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.761 -0.376 . . . . 0.0 112.012 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.08 -37.98 2.18 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.08 -0.581 . . . . 0.0 114.438 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.5 t -48.33 -44.83 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.78 97.57 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.878 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.457 ' HG3' HD23 ' A' ' 115' ' ' LEU . 53.2 tt0 -65.35 -39.21 92.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.033 0.444 . . . . 0.0 110.027 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.526 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 30.0 t80 -59.05 -49.35 78.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.238 175.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.582 HD11 HD13 ' A' ' 5' ' ' ILE . 51.6 tp -50.82 -54.12 26.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.064 -176.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.424 ' O ' HD13 ' A' ' 86' ' ' LEU . 3.9 mm? -63.73 -50.42 69.19 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.396 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -66.21 -25.86 67.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.584 -176.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -65.97 -46.8 76.76 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 81' ' ' LEU . 57.9 t -62.67 -44.41 99.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.952 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.467 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 11.2 mp -65.99 -27.9 68.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.244 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.8 ttp85 -87.6 -19.31 27.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.583 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.475 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 9.7 t30 -81.62 -46.24 14.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.663 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -102.82 97.83 10.11 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.981 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 83.0 Cg_endo -89.41 148.48 5.28 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.809 2.339 . . . . 0.0 113.498 -173.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.83 7.26 78.43 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.689 -0.687 . . . . 0.0 113.481 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.72 116.73 20.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.1 m -77.49 -32.41 54.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.18 -172.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.0 t -127.49 103.88 7.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.768 0.318 . . . . 0.0 111.458 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.467 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 98.0 m95 -94.41 98.32 10.8 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 171.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.507 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 63.6 t-105 -101.96 120.48 40.47 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.081 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.556 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 73.6 mtp -111.75 126.74 55.38 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.927 0.394 . . . . 0.0 110.571 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.63 99.17 5.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.133 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' A' ' 102' ' ' VAL . 7.7 m-20 -76.37 -31.86 58.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.602 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 67.93 -71.54 0.11 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.004 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -101.53 40.68 2.34 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.978 -174.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.524 HG13 ' HG2' ' A' ' 105' ' ' ARG . 13.2 p -81.7 125.43 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -90.38 -30.7 17.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.189 0.519 . . . . 0.0 109.724 177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.15 45.63 0.75 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.387 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.524 ' HG2' HG13 ' A' ' 102' ' ' VAL . 22.0 mtm180 -55.21 -47.08 75.82 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -172.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.76 -48.28 85.06 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.406 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.16 -41.77 92.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 110.653 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.501 ' O ' ' HG2' ' A' ' 112' ' ' MET . 10.3 tpt -64.75 -39.03 92.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.378 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 85.5 m -65.02 -38.84 92.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.702 0.287 . . . . 0.0 110.698 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.58 ' HB1' ' N7A' ' A' ' 999' ' ' COA . . . -62.6 -41.48 99.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.204 0.525 . . . . 0.0 110.137 176.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -63.15 -42.4 99.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.337 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.535 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 24.7 mmt -61.71 -39.33 91.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.024 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -70.74 -21.15 62.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.252 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.98 -26.72 39.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.115 0.483 . . . . 0.0 110.375 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.457 HD23 ' HG3' ' A' ' 79' ' ' GLN . 92.1 mt -84.51 -37.76 20.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.572 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.08 25.98 3.39 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.311 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.535 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 39.7 m-85 -95.9 142.49 28.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.798 0.332 . . . . 0.0 110.99 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.6 m -104.74 148.45 26.59 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.9 m -97.19 112.23 24.12 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -135.46 133.89 39.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.484 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 58.13 30.02 18.75 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.82 -4.03 78.33 Favored Glycine 0 CA--C 1.517 0.172 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.237 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -129.17 -179.46 15.97 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.259 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.436 ' CD1' ' HG3' ' A' ' 112' ' ' MET . 26.6 m-90 -112.22 137.49 50.24 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -132.52 137.24 47.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.024 0.44 . . . . 0.0 110.982 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -119.4 102.54 8.75 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 169.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.5 t -78.11 141.61 38.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.754 -174.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 CA-C-N 115.829 -0.623 . . . . 0.9 111.723 178.498 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 999' ' ' COA . . . . . 0.58 ' N7A' ' HB1' ' A' ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.3 mtp . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 tttm -90.49 152.03 21.11 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.5 tp -75.73 115.81 15.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.013 0.435 . . . . 0.0 110.311 -175.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.3 m -88.37 89.56 8.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.312 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.505 HD11 ' HB3' ' A' ' 40' ' ' TYR . 9.4 tt -96.23 132.57 40.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.003 0.43 . . . . 0.0 110.357 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.82 141.08 44.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.226 0.536 . . . . 0.0 110.625 -177.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 7' ' ' ARG . 10.9 ptt180 -79.33 126.9 31.4 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.745 176.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.9 mt -84.62 95.46 8.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.789 0.328 . . . . 0.0 110.824 -176.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -110.49 -8.27 14.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.0 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -135.1 141.37 46.01 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -130.03 115.68 17.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.143 0.497 . . . . 0.0 112.276 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.3 m -100.08 164.18 12.1 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 168.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -59.9 -37.98 80.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.623 0.249 . . . . 0.0 110.855 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -55.14 -49.99 70.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.121 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -67.1 -37.91 84.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.639 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -68.13 -40.61 82.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.059 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.8 mt -61.68 -36.6 74.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.795 0.331 . . . . 0.0 110.383 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.8 OUTLIER -64.37 -44.18 92.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.153 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.83 -40.0 96.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.93 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -72.52 -15.84 61.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.078 0.466 . . . . 0.0 110.568 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -84.76 -27.84 26.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.684 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 18' ' ' ASP . 62.2 mt -82.66 -37.28 14.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.9 175.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.635 ' HD1' ' HD2' ' A' ' 67' ' ' ARG . 2.8 m0 -111.26 87.15 7.12 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.782 175.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.76 -9.57 25.08 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.499 2.133 . . . . 0.0 112.398 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -102.88 2.78 35.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.903 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -74.05 127.22 32.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.379 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.9 m -67.81 124.21 88.86 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.54 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.32 115.77 2.61 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.821 2.347 . . . . 0.0 111.873 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.3 p -152.37 -166.3 2.44 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.876 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.3 m -55.27 -43.23 74.49 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.393 0.433 . . . . 0.0 112.122 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 31' ' ' LEU . 7.1 mt 57.11 76.83 0.29 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.528 0.68 . . . . 0.0 109.727 -169.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -133.8 -179.58 5.63 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.078 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.7 m -130.98 162.29 39.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.263 0.554 . . . . 0.0 111.084 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -125.64 163.52 22.6 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -60.68 -28.21 68.44 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.897 0.379 . . . . 0.0 110.533 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -93.29 -46.06 7.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.253 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -93.52 94.13 8.48 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.015 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.3 mtp85 -110.95 149.49 30.58 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.642 0.258 . . . . 0.0 110.971 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.4 mt -120.09 134.46 63.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.284 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.505 ' HB3' HD11 ' A' ' 5' ' ' ILE . 81.8 m-85 -113.84 139.52 49.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.572 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -119.57 121.34 39.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.939 0.4 . . . . 0.0 110.793 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.18 100.51 13.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.798 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -93.33 119.75 32.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.591 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -99.01 92.23 5.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.014 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.8 t30 69.36 -68.17 0.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.051 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -105.84 -53.29 2.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.783 0.325 . . . . 0.0 111.758 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.437 ' HG2' ' H ' ' A' ' 48' ' ' LEU . 35.7 ttt180 -127.47 174.18 9.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.727 -168.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.572 HD22 ' HB1' ' A' ' 41' ' ' ALA . 63.5 mt -73.17 123.74 24.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.876 0.37 . . . . 0.0 110.355 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.687 HD12 ' HD3' ' A' ' 69' ' ' ARG . 39.9 tp -95.04 -34.11 12.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.16 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.554 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -143.22 140.52 30.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.665 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.82 130.49 51.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.182 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 65' ' ' SER . 11.9 p -142.46 142.27 27.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.706 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.1 mtm180 -112.4 159.03 19.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.891 0.376 . . . . 0.0 110.735 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.59 128.99 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.356 0.598 . . . . 0.0 110.857 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.5 m -104.83 97.98 7.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.011 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.531 HD23 ' HA3' ' A' ' 61' ' ' GLY . 97.4 mt -80.34 126.14 30.78 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.779 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.5 m -105.79 77.99 1.3 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.87 -85.93 1.37 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.271 -174.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.2 p -111.32 -63.33 1.42 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.197 0.523 . . . . 0.0 110.452 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.567 ' HA ' HG13 ' A' ' 92' ' ' VAL . 30.1 mt-10 -76.04 147.51 38.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.811 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.531 ' HA3' HD23 ' A' ' 56' ' ' LEU . . . -142.21 165.46 26.65 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.504 -173.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -116.38 134.03 55.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.794 0.33 . . . . 0.0 110.887 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 76.7 mt -93.83 132.93 37.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.452 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -142.77 163.48 32.7 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 36.0 m 54.59 86.61 0.05 OUTLIER 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.64 0.588 . . . . 0.0 111.732 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.603 HD23 ' HE1' ' A' ' 108' ' ' MET . 55.9 tp -122.51 107.02 11.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.832 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.635 ' HD2' ' HD1' ' A' ' 23' ' ' TRP . 34.8 mtt180 -130.18 105.82 8.19 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.215 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.582 ' HB ' ' H10' ' A' ' 999' ' ' COA . 8.9 t -95.91 146.95 6.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 171.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.687 ' HD3' HD12 ' A' ' 49' ' ' LEU . 31.1 mtp85 -52.51 126.32 19.12 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -58.03 -23.1 52.91 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -169.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.4 t -66.29 -21.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.052 0.453 . . . . 0.0 110.765 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.734 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 1.3 m -86.47 32.22 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.406 0.622 . . . . 0.0 110.907 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 73' ' ' ARG . 25.7 ttt180 -81.44 127.95 33.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.84 -176.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.637 ' HA ' ' O8A' ' A' ' 999' ' ' COA . 32.3 ttm180 61.35 35.79 17.8 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.898 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.734 ' HD2' ' HA ' ' A' ' 72' ' ' THR . 95.3 mtt180 -112.91 2.69 15.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.807 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.52 -12.18 52.8 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 121.003 -0.618 . . . . 0.0 114.105 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.447 HG11 HD23 ' A' ' 49' ' ' LEU . 92.8 t -61.24 -43.88 97.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.275 0.538 . . . . 0.0 111.773 -177.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.57 -33.93 79.21 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.441 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -63.01 -47.44 83.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.953 0.406 . . . . 0.0 110.278 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -61.76 -43.31 99.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.594 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 42' ' ' ALA . 44.2 tp -53.44 -55.86 21.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.443 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.487 ' HB2' HD11 ' A' ' 115' ' ' LEU . 4.3 mm? -65.68 -40.39 92.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.053 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 7.3 mm-40 -53.46 -50.74 64.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.79 0.329 . . . . 0.0 111.145 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -60.49 -45.36 94.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.8 -177.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.3 t -63.56 -49.46 82.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.174 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.59 -20.3 66.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.997 -176.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 42.8 mtm180 -92.91 -30.19 15.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.657 0.265 . . . . 0.0 111.257 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.46 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 17.3 m-80 -82.09 -20.14 38.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.606 0.241 . . . . 0.0 111.415 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -113.69 86.83 11.16 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.87 0.367 . . . . 0.0 110.443 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 5.0 Cg_exo -81.05 -13.45 11.41 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.227 2.618 . . . . 0.0 112.528 -176.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.05 -8.38 87.89 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.497 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.567 HG13 ' HA ' ' A' ' 60' ' ' GLU . 21.7 t -94.47 101.98 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 p -77.92 -36.16 49.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 51.6 t -116.36 116.04 26.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.389 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -97.86 102.13 13.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.899 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.519 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 35.8 t-105 -97.08 133.29 41.94 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.552 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 47.1 mtp -114.36 130.03 56.67 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.992 0.425 . . . . 0.0 109.982 176.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.5 160.75 14.65 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.646 -176.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -87.22 -2.48 58.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.985 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.47 114.23 5.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.292 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.57 -14.25 59.28 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.72 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.548 HG13 ' HG3' ' A' ' 108' ' ' MET . 55.1 t -89.76 97.63 7.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.352 0.596 . . . . 0.0 110.125 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.418 ' H ' ' H22' ' A' ' 999' ' ' COA . 30.4 mt-10 -76.78 -50.46 13.47 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.77 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -91.09 92.92 8.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.658 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -73.56 -23.76 60.01 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.899 -176.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.25 -56.16 8.15 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.567 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.46 HG13 ' C6A' ' A' ' 999' ' ' COA . 72.3 t -66.15 -41.1 88.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.654 0.264 . . . . 0.0 110.68 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.603 ' HE1' HD23 ' A' ' 66' ' ' LEU . 94.8 mmm -63.72 -37.72 88.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.326 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 m -62.58 -45.88 90.88 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.425 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.58 -40.58 95.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.969 0.414 . . . . 0.0 110.617 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.615 ' HD1' H52A ' A' ' 999' ' ' COA . 40.7 t80 -58.72 -49.18 78.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.825 176.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.56 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 64.9 mtt -69.76 -40.22 76.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.511 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -61.4 -44.01 97.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.77 0.319 . . . . 0.0 110.686 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.27 72.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.188 0.518 . . . . 0.0 110.437 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.487 HD11 ' HB2' ' A' ' 82' ' ' LEU . 2.7 tt -68.19 -33.41 74.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.92 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 132.75 1.59 4.13 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.065 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.56 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 98.3 m-85 -83.19 174.1 11.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.039 0.447 . . . . 0.0 110.863 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.1 m -149.73 151.35 33.5 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.7 t -97.3 110.21 22.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.698 0.761 . . . . 0.0 109.794 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -141.25 129.11 21.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.286 -174.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 63.42 32.68 14.31 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.208 0.528 . . . . 0.0 111.361 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 111.14 -74.41 0.21 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.562 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -91.09 -156.52 32.79 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.295 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 26.6 m-90 -104.37 119.85 39.89 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -119.36 117.83 29.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.903 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -126.34 136.56 52.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.921 0.391 . . . . 0.0 111.181 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 52.6 t -80.55 135.16 36.04 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.775 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 C-N-CA 120.877 -0.677 . . . . 0.9 112.137 179.464 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 999' ' ' COA . . . . . 0.637 ' O8A' ' HA ' ' A' ' 74' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.4 mtm . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.549 0.214 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -103.68 153.33 20.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.887 0.375 . . . . 0.0 110.18 174.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.447 HD21 ' HB1' ' A' ' 42' ' ' ALA . 43.8 tp -111.4 112.18 23.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.111 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.1 m -82.76 94.04 7.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.084 0.469 . . . . 0.0 110.532 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.539 HD12 ' HB2' ' A' ' 42' ' ' ALA . 12.7 tt -108.7 128.84 64.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.045 0.45 . . . . 0.0 110.788 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.4 mt -124.19 155.31 31.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.455 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.459 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 12.8 ptt180 -80.22 119.56 23.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.801 174.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 41' ' ' ALA . 83.7 mt -76.78 88.11 3.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.209 0.528 . . . . 0.0 110.679 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -102.18 8.59 40.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.823 0.82 . . . . 0.0 109.258 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -157.54 142.97 17.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.496 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -126.43 121.22 31.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.86 0.362 . . . . 0.0 111.067 -177.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.2 170.46 8.24 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.412 ' O ' HG13 ' A' ' 17' ' ' ILE . 4.0 m-20 -60.33 -46.47 89.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.726 0.298 . . . . 0.0 110.732 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -59.11 -41.2 87.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -62.35 -45.42 93.28 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.564 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -59.27 -45.11 92.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.886 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 13' ' ' ASP . 60.6 mt -67.01 -32.1 56.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.009 0.433 . . . . 0.0 111.173 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.402 ' O ' HG13 ' A' ' 22' ' ' ILE . 9.7 t70 -77.09 -38.69 51.85 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.078 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.542 HD23 HD12 ' A' ' 22' ' ' ILE . 97.3 mt -61.65 -34.16 75.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.294 174.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -64.35 -36.11 83.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.297 176.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -70.8 -21.99 62.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.082 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 48' ' ' LEU . 63.5 mt -79.09 -48.44 21.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.767 0.318 . . . . 0.0 110.619 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 26' ' ' TYR . 4.4 m0 -106.83 97.86 19.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.027 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 12.9 Cg_exo -70.64 -21.54 29.26 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.674 2.249 . . . . 0.0 111.832 178.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -84.7 -22.34 29.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.942 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.438 ' HB3' ' HB2' ' A' ' 23' ' ' TRP . 87.4 t80 -95.68 126.16 40.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.193 -172.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -82.15 129.14 65.16 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 172.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.8 96.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.148 2.565 . . . . 0.0 112.624 -176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.418 ' HB3' ' OH ' ' A' ' 26' ' ' TYR . 11.4 t -107.1 -157.9 0.63 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.144 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.1 m -57.11 -42.18 80.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.086 -0.507 . . . . 0.0 112.124 -176.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.3 mt 56.46 44.02 25.01 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -173.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -62.68 115.94 4.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.081 -172.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.55 HG13 ' HA ' ' A' ' 38' ' ' ARG . 73.3 t -112.31 118.32 57.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.16 170.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 14.2 p-10 -100.0 -52.2 3.48 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 16.9 t70 166.9 -40.4 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -71.69 -56.14 6.37 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.67 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -91.14 101.92 14.66 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.55 ' HA ' HG13 ' A' ' 33' ' ' VAL . 12.0 ptp180 -123.56 142.34 51.12 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.099 0.476 . . . . 0.0 111.112 -175.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.542 HG12 ' HG2' ' A' ' 53' ' ' ARG . 52.3 mt -107.19 134.42 48.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.204 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.508 ' HB3' HD11 ' A' ' 5' ' ' ILE . 76.6 m-85 -111.05 121.6 45.77 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.724 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.86 119.98 41.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.832 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.715 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -96.44 105.8 17.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.827 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.947 ' HB3' HD23 ' A' ' 48' ' ' LEU . 4.9 ptm180 -107.54 134.31 50.74 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.464 178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -97.2 82.39 3.16 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.2 t30 50.35 23.94 1.38 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.522 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.667 ' HG2' ' HG3' ' A' ' 47' ' ' ARG . 38.3 tt0 -166.86 -89.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.999 -0.438 . . . . 0.0 110.732 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.667 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 85.7 mtt180 -108.24 163.86 12.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.668 0.271 . . . . 0.0 110.759 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.947 HD23 ' HB3' ' A' ' 43' ' ' ARG . 19.6 mt -77.25 104.0 7.5 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 67.1 mt -86.21 -30.61 22.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.773 0.321 . . . . 0.0 110.867 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.715 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -129.31 137.03 50.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.626 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -131.78 125.15 31.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.832 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.8 p -134.25 134.25 55.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.613 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.542 ' HG2' HG12 ' A' ' 39' ' ' ILE . 63.6 mtm180 -108.88 141.9 40.26 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.311 176.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.471 HG13 ' HG3' ' A' ' 38' ' ' ARG . 6.0 p -133.83 132.7 56.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.295 0.569 . . . . 0.0 110.993 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.7 m -106.57 111.56 24.17 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.63 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.4 mt -83.48 85.58 7.22 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.238 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.6 t -82.98 83.7 7.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.372 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.29 -116.38 7.52 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.187 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.1 p -91.91 2.07 56.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.916 0.389 . . . . 0.0 111.288 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.596 ' HG2' ' HB3' ' A' ' 94' ' ' CYS . 35.0 mt-10 -110.88 136.36 50.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.64 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -115.01 104.17 1.32 Allowed Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.0 124.02 36.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.723 0.297 . . . . 0.0 110.746 -178.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.537 HD12 ' HG2' ' A' ' 97' ' ' MET . 94.6 mt -93.52 114.94 27.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.153 0.502 . . . . 0.0 109.698 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.541 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 10.0 t70 -117.18 127.36 54.03 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.309 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.628 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 25.0 m 66.71 92.26 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.423 0.63 . . . . 0.0 111.146 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.0 tp -114.76 102.26 9.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.292 174.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.516 ' HE ' ' H31' ' A' ' 999' ' ' COA . 87.7 mtt180 -136.39 115.05 11.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.421 -175.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' A' ' 50' ' ' ALA . 11.8 t -98.53 150.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -55.78 137.36 50.04 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -62.04 -17.94 58.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.289 0.566 . . . . 0.0 110.908 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.4 t -71.52 -24.73 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.761 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.9 m -86.04 18.87 2.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.06 0.457 . . . . 0.0 111.923 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.563 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 99.9 mtt180 -66.24 118.23 9.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -163.58 -97.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.359 -0.537 . . . . 0.0 112.19 -175.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.446 ' HA ' ' O5B' ' A' ' 999' ' ' COA . 34.0 ttm180 169.6 95.77 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -172.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 133.96 -59.03 0.68 Allowed Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.879 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.7 t -49.9 -54.32 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 81' ' ' LEU . . . -61.22 -43.99 98.69 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.026 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -66.27 -46.15 78.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.784 0.325 . . . . 0.0 110.134 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -60.14 -39.18 85.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.46 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 85' ' ' VAL . 48.2 tp -50.53 -55.51 15.79 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.536 0.523 . . . . 0.0 110.819 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.76 -43.69 88.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.29 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.57 -39.42 93.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.343 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -66.64 -44.56 81.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.024 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 81' ' ' LEU . 97.0 t -58.78 -44.18 89.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.79 0.329 . . . . 0.0 110.915 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.03 -18.91 57.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.679 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.8 -42.3 11.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.973 0.416 . . . . 0.0 110.151 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -72.75 -31.66 65.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.117 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -122.99 76.56 50.16 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.618 174.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -94.66 16.11 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.133 2.555 . . . . 0.0 112.613 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.85 2.21 87.1 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.731 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.5 128.61 52.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.731 0.301 . . . . 0.0 110.278 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.7 m -91.61 -34.72 14.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.335 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.596 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 48.9 t -117.72 102.92 9.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.894 0.378 . . . . 0.0 110.65 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 94.8 m95 -92.2 142.52 27.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.8 0.333 . . . . 0.0 110.594 178.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -134.9 142.45 46.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.743 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.537 ' HG2' HD12 ' A' ' 63' ' ' LEU . 80.2 mtp -130.03 125.84 36.25 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -102.75 172.35 6.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.596 -174.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.11 -8.64 59.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.231 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.71 121.22 13.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.231 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' ' 65' ' ' SER . . . 82.23 14.2 77.24 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.187 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.16 93.25 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.915 0.388 . . . . 0.0 110.387 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.75 -17.62 37.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.515 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -112.47 72.92 0.79 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.727 0.775 . . . . 0.0 110.02 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.522 ' HG3' ' HH2' ' A' ' 124' ' ' TRP . 41.5 ttp180 -76.22 -32.09 58.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.321 -170.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.77 -53.41 45.49 Favored Glycine 0 C--O 1.238 0.352 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.115 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.82 -42.16 81.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.972 0.415 . . . . 0.0 110.3 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.557 ' O ' ' HG2' ' A' ' 112' ' ' MET . 47.3 ttm -69.47 -25.12 63.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.424 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 94.3 m -62.9 -48.57 78.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.709 0.29 . . . . 0.0 110.243 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.86 -34.43 77.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.443 0.639 . . . . 0.0 110.249 176.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.458 ' CE2' HD11 ' A' ' 115' ' ' LEU . 55.8 t80 -63.25 -42.4 99.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.819 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.557 ' HG2' ' O ' ' A' ' 108' ' ' MET . 25.1 mmt -62.81 -39.97 95.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.37 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -69.33 -27.15 65.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.624 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.46 -40.46 57.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.438 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.458 HD11 ' CE2' ' A' ' 111' ' ' PHE . 92.9 mt -66.26 -60.78 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.108 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.34 48.45 0.13 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.825 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.434 ' CD2' ' HB2' ' A' ' 126' ' ' LYS . 41.3 m-85 -109.96 141.46 42.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.774 0.321 . . . . 0.0 110.416 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.9 p -92.49 144.08 25.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.257 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.4 p -97.48 148.28 23.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.146 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -124.55 -161.93 1.04 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.934 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -79.32 29.64 0.23 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.907 0.384 . . . . 0.0 111.77 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.08 67.38 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.087 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.62 169.01 11.78 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.428 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.522 ' HH2' ' HG3' ' A' ' 105' ' ' ARG . 11.7 m-90 -113.93 133.44 55.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.698 0.285 . . . . 0.0 110.472 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -123.1 145.3 48.69 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.081 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 64.6 tttp -137.28 96.85 3.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.924 0.392 . . . . 0.0 110.251 174.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 17.4 t -87.9 133.35 33.94 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 C-N-CA 120.833 -0.698 . . . . 0.9 112.005 -179.733 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 999' ' ' COA . . . . . 0.67 ' H72' ' S1P' ' A' ' 999' ' ' COA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 mtt . . . . . 0 N--CA 1.482 1.144 0 CA-C-O 121.043 0.449 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -93.99 136.96 33.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.465 HD11 ' HB1' ' A' ' 42' ' ' ALA . 49.1 tp -76.04 107.1 8.02 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.534 ' HB ' ' HG2' ' A' ' 43' ' ' ARG . 9.0 m -86.65 98.87 11.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.444 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 4.6 mp -89.75 127.8 42.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 mm -101.54 146.94 9.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 13.9 ptt180 -99.21 106.16 18.28 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 39' ' ' ILE . 63.9 mt -73.09 86.06 1.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.451 0.643 . . . . 0.0 110.882 -176.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -95.69 -22.33 17.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.784 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -136.75 143.5 43.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.127 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -120.93 144.63 48.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.256 0.551 . . . . 0.0 111.782 -173.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.3 p -109.56 163.71 13.2 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 166.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.471 ' O ' HG13 ' A' ' 17' ' ' ILE . 29.5 t70 -68.19 -31.11 70.41 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.327 0.584 . . . . 0.0 109.491 177.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -65.97 -50.77 63.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.114 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.407 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 47.7 m-20 -66.42 -28.6 68.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.057 0.456 . . . . 0.0 110.477 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -65.1 -32.62 74.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.282 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 13' ' ' ASP . 75.8 mt -65.92 -42.97 92.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.566 175.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.19 -38.2 82.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.029 0.442 . . . . 0.0 110.358 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.427 ' O ' ' HE3' ' A' ' 23' ' ' TRP . 96.4 mt -61.3 -40.0 92.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.279 175.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -77.25 -6.2 52.19 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.578 0.704 . . . . 0.0 110.458 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -89.77 -18.62 25.97 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.552 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 91.5 mt -90.41 -38.77 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.774 172.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.893 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 18.2 m-90 -99.21 89.02 0.85 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.369 171.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 13.0 Cg_exo -69.47 -59.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.61 2.207 . . . . 0.0 113.064 -169.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -94.01 9.45 37.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.205 0.526 . . . . 0.0 110.681 -176.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.893 ' HB3' ' HB3' ' A' ' 23' ' ' TRP . 91.3 t80 -97.32 130.47 44.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.274 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 p -94.0 110.93 50.88 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.516 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.44 137.71 43.9 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.915 2.41 . . . . 0.0 112.365 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.6 p -97.43 -95.81 0.21 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.836 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.436 ' CB ' ' HG3' ' A' ' 32' ' ' GLN . 51.0 m -98.32 -46.68 5.71 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 30' ' ' SER . 97.4 mt 67.47 42.27 2.19 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.428 0.632 . . . . 0.0 110.049 -174.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.436 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 89.7 mt-30 -67.8 135.18 52.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.377 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.15 165.78 30.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.943 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -156.29 -171.5 3.74 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.37 -14.94 62.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 118.275 0.488 . . . . 0.0 111.307 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 34.2 m-80 -97.29 -56.8 2.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.085 0.469 . . . . 0.0 110.358 176.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -89.36 93.93 9.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.167 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -112.63 156.1 23.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.721 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.48 HG23 ' HG2' ' A' ' 53' ' ' ARG . 63.5 mt -113.3 122.05 66.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.897 177.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -94.13 117.91 30.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.122 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.49 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.14 113.3 26.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.947 178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.765 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -95.44 112.42 24.14 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.903 -175.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.603 ' HB3' HD23 ' A' ' 48' ' ' LEU . 4.7 ptm180 -102.74 125.95 49.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.408 0.623 . . . . 0.0 109.941 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.54 ' HB3' HD12 ' A' ' 49' ' ' LEU . 57.1 t80 -109.51 95.58 5.71 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.9 t30 60.06 81.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.992 -173.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 72.83 -59.25 0.57 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.165 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 59.9 mtt85 -72.44 132.28 43.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -167.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' A' ' 43' ' ' ARG . 96.2 mt -76.16 100.19 4.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 171.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.54 HD12 ' HB3' ' A' ' 44' ' ' PHE . 88.2 mt -107.0 -8.72 16.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.77 -173.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.765 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -144.07 139.02 28.68 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.86 131.47 31.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.2 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 65' ' ' SER . 10.0 p -141.45 130.2 23.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.317 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HG2' HG23 ' A' ' 39' ' ' ILE . 63.6 mtm180 -99.68 141.68 32.16 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.0 p -130.94 127.88 61.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.573 0.702 . . . . 0.0 111.121 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.4 m -100.04 93.62 5.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.476 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.514 ' O ' ' HB3' ' A' ' 36' ' ' ASN . 94.2 mt -81.24 141.29 34.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.057 0.456 . . . . 0.0 110.625 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 t -144.44 74.3 1.41 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.21 -111.41 3.9 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.854 -178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.0 p -95.85 12.81 28.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.051 0.453 . . . . 0.0 111.204 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -118.95 139.06 52.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.74 114.59 0.96 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.861 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -103.24 119.33 38.68 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.607 0.242 . . . . 0.0 110.768 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.517 HD22 ' HE3' ' A' ' 97' ' ' MET . 6.0 mp -93.42 126.27 38.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.108 0.48 . . . . 0.0 110.688 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -125.17 138.9 54.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.299 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 50.3 m 61.01 87.27 0.09 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.312 0.577 . . . . 0.0 111.283 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.7 tp -108.58 106.35 16.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.907 173.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.541 ' NH1' ' H31' ' A' ' 999' ' ' COA . 72.9 mtp85 -131.45 119.79 22.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -173.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.452 HG12 ' HB ' ' A' ' 72' ' ' THR . 1.9 t -109.07 141.61 23.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.6 ttt-85 -82.92 166.65 18.71 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.983 -174.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -48.7 -39.58 25.13 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.704 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.6 t -62.25 -28.28 44.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.207 -173.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.452 ' HB ' HG12 ' A' ' 68' ' ' VAL . 0.6 OUTLIER -97.18 19.03 13.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -168.869 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.435 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 41.6 ttt-85 -80.29 84.86 5.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -134.73 -86.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.071 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.494 ' HA ' ' O7A' ' A' ' 999' ' ' COA . 0.3 OUTLIER 168.54 99.1 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.612 0.765 . . . . 0.0 109.061 -168.931 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.85 -74.12 0.45 Allowed Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.627 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.4 t -38.15 -54.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -170.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 81' ' ' LEU . . . -56.43 -59.34 10.9 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.96 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.418 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 99.4 mt-30 -64.16 -34.34 77.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.804 0.335 . . . . 0.0 110.723 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -63.34 -38.3 90.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.529 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.477 ' O ' HG23 ' A' ' 85' ' ' VAL . 61.7 tp -55.58 -49.95 71.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.994 176.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.46 -43.89 96.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.902 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 79' ' ' GLN . 40.1 mt-10 -59.33 -42.63 91.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.266 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.433 ' HG2' HD13 ' A' ' 5' ' ' ILE . 9.1 tp10 -60.27 -44.12 95.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.49 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 81' ' ' LEU . 99.3 t -60.61 -44.94 97.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.16 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -73.9 -16.47 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.658 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 87' ' ' ARG . 63.6 mtt180 -92.89 -30.56 15.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.034 0.445 . . . . 0.0 110.632 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -73.92 -50.51 19.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.737 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.445 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 12.4 m120 -82.54 146.9 54.58 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.111 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 22.7 Cg_exo -66.38 -165.79 0.1 OUTLIER 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.161 2.574 . . . . 0.0 113.003 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.43 84.73 0.1 Allowed Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.522 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.0 t -82.56 122.83 37.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 7.1 m -68.74 -57.82 5.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.544 -174.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.7 t -103.76 106.95 17.61 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.657 -172.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -97.83 110.62 23.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.935 0.398 . . . . 0.0 110.141 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.444 ' CE3' ' HG2' ' A' ' 125' ' ' GLU . 18.9 t-105 -104.12 131.74 51.09 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.517 ' HE3' HD22 ' A' ' 63' ' ' LEU . 54.7 mtp -128.69 137.27 51.53 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 175.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.66 169.33 11.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.781 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.0 5.96 48.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.393 . . . . 0.0 110.773 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.82 124.64 21.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.429 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.51 0.12 58.09 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.696 HG13 ' C5P' ' A' ' 999' ' ' COA . 62.1 t -114.83 124.46 71.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.558 -0.321 . . . . 0.0 110.201 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.422 ' CD ' HH12 ' A' ' 67' ' ' ARG . 17.6 mp0 -71.88 -26.49 62.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.442 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -118.82 103.25 9.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.021 0.438 . . . . 0.0 110.95 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -73.1 -28.25 62.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.404 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.94 -51.68 51.34 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.123 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.6 t -59.79 -40.86 83.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.921 0.391 . . . . 0.0 110.306 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.541 ' SD ' HG21 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -61.55 -43.27 99.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.643 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 57.3 m -61.15 -48.83 79.8 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.781 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.14 96.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.069 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -62.4 -47.65 83.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.075 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.536 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 23.9 mmt -63.13 -46.22 88.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.407 -177.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -68.55 -30.2 68.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.743 -177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.46 -27.13 58.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.884 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.585 HD13 ' HE2' ' A' ' 117' ' ' PHE . 4.7 tt -82.22 -51.52 7.86 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 141.84 45.72 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.415 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.585 ' HE2' HD13 ' A' ' 115' ' ' LEU . 94.7 m-85 -123.38 134.52 53.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.828 0.347 . . . . 0.0 110.547 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.5 m -93.13 144.82 24.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.835 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.8 t -97.23 116.44 29.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.544 0.687 . . . . 0.0 110.206 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -141.1 140.17 34.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.312 -174.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 54.74 30.99 14.54 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.892 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.7 -57.15 0.52 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.486 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -90.55 -147.93 19.5 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.195 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 31.0 m-90 -121.52 124.24 43.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.696 0.284 . . . . 0.0 110.307 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.444 ' HG2' ' CE3' ' A' ' 96' ' ' TRP . 42.3 mt-10 -119.33 121.17 38.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.743 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -126.37 96.79 4.81 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.536 172.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 93' ' ' SER . 34.2 t -104.21 123.88 48.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.005 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 C-N-CA 121.095 -0.574 . . . . 0.9 112.074 -179.795 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 999' ' ' COA . . . . . 0.757 ' N8P' H131 ' A' ' 999' ' ' COA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 120.894 0.378 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -90.4 121.04 32.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.55 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.559 HD11 ' HB1' ' A' ' 42' ' ' ALA . 47.6 tp -89.41 116.32 27.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.347 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 m -89.32 93.22 9.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.567 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.69 HD11 ' HB3' ' A' ' 40' ' ' TYR . 6.5 tp -88.05 124.39 41.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.175 0.512 . . . . 0.0 110.052 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 mt -123.55 155.02 29.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.219 -176.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -89.53 127.68 35.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.131 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.438 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 42.0 tp -80.91 99.63 8.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.601 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.507 ' HA ' HG11 ' A' ' 33' ' ' VAL . 36.0 mt-10 -102.04 -17.36 16.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.655 -175.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -151.56 156.31 40.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.703 0.287 . . . . 0.0 111.29 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.444 ' CE2' HG23 ' A' ' 33' ' ' VAL . 87.7 m-85 -119.1 109.64 16.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.117 -177.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.0 p -90.74 158.86 16.64 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 168.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 17' ' ' ILE . 5.4 m-20 -58.58 -38.34 77.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.934 0.397 . . . . 0.0 110.184 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -61.54 -55.78 27.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.676 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.507 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 70.1 m-20 -61.88 -37.67 85.42 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.538 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -64.19 -36.4 83.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.67 -176.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 13' ' ' ASP . 80.2 mt -66.5 -45.12 89.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.743 177.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.545 ' O ' HG13 ' A' ' 22' ' ' ILE . 24.0 t0 -65.57 -35.06 79.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.333 . . . . 0.0 110.593 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 95.0 mt -63.65 -41.43 98.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.978 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -69.42 -21.45 63.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.514 0.673 . . . . 0.0 109.695 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -85.78 -12.34 51.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.134 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 18' ' ' ASP . 71.0 mt -85.1 -32.69 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 171.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.613 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 5.6 m-90 -116.04 72.09 4.42 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.783 175.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HD3' ' C ' ' A' ' 22' ' ' ILE . 18.0 Cg_exo -67.87 -45.21 3.32 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.338 2.025 . . . . 0.0 111.732 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -103.17 71.27 1.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.948 0.88 . . . . 0.0 109.321 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.613 ' HB3' ' HB3' ' A' ' 23' ' ' TRP . 55.8 t80 -155.29 137.57 14.84 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.655 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 38.2 m -69.74 109.02 3.87 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 178.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 27' ' ' SER . 38.7 Cg_exo -56.93 124.33 15.99 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.211 2.607 . . . . 0.0 113.104 -173.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.4 m -85.82 -177.12 6.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.502 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.6 t -70.03 -33.29 71.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.718 0.294 . . . . 0.0 110.287 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.0 mt 64.92 84.95 0.15 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.96 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -137.94 147.74 44.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.178 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' ' 9' ' ' GLU . 59.7 t -93.74 126.23 46.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.039 -176.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.646 ' HB3' ' HB2' ' A' ' 37' ' ' HIS . 30.9 t70 -138.71 158.02 45.01 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.299 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -63.2 -35.87 81.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.723 0.296 . . . . 0.0 110.805 178.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 55' ' ' THR . 89.7 m-20 -86.29 -48.04 8.86 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.646 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 40.4 m170 -87.28 84.47 7.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.914 175.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -109.36 147.79 32.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.144 -173.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 8' ' ' LEU . 56.5 mt -126.56 139.07 52.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.854 0.359 . . . . 0.0 110.379 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.69 ' HB3' HD11 ' A' ' 5' ' ' ILE . 76.9 m-85 -118.03 152.43 35.54 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.525 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -136.67 126.51 25.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.999 0.428 . . . . 0.0 111.154 -174.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.04 104.02 16.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.011 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -95.14 110.22 22.2 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.34 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -119.39 135.24 54.82 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.3 t30 61.51 30.65 18.87 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.618 0.723 . . . . 0.0 109.072 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 65.84 17.11 10.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.955 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -126.43 138.96 53.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.572 0.225 . . . . 0.0 110.404 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.525 HD22 ' HB1' ' A' ' 41' ' ' ALA . 78.4 mt -63.65 106.58 0.99 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 49' ' ' LEU . 12.8 tp -105.03 -21.41 13.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.823 -172.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -140.94 135.26 31.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.482 178.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.65 132.93 53.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.608 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.482 ' HB ' HD13 ' A' ' 66' ' ' LEU . 8.0 p -142.2 131.9 23.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.596 -178.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 1.026 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 10.6 mtm180 -103.22 155.68 18.26 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.88 176.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.79 126.5 14.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.251 0.548 . . . . 0.0 110.414 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 77.6 m -102.49 107.61 18.63 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.042 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.4 mt -83.54 95.29 8.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.043 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.3 t -86.79 93.05 9.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.368 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.83 -102.99 1.38 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.789 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.2 m -120.83 12.96 11.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.926 0.87 . . . . 0.0 109.521 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -112.87 157.88 20.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.956 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 95' ' ' TRP . . . -125.15 120.76 4.04 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.864 -174.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.78 132.07 53.78 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.834 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 73.0 mt -95.43 119.14 33.41 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.206 0.527 . . . . 0.0 110.281 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 1.026 ' HB2' ' HB2' ' A' ' 53' ' ' ARG . 1.3 m-20 -79.6 -157.66 0.14 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.117 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 p -47.27 118.45 2.17 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.138 0.494 . . . . 0.0 111.932 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.482 HD13 ' HB ' ' A' ' 52' ' ' VAL . 21.3 tp -117.64 116.97 28.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.349 175.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.574 ' HG3' ' H72' ' A' ' 999' ' ' COA . 53.6 ttt180 -143.82 123.19 13.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.192 0.52 . . . . 0.0 111.735 177.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' A' ' 50' ' ' ALA . 22.4 t -94.38 137.8 22.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 169.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -56.87 136.55 55.74 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -56.67 -15.82 5.19 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -166.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.07 -15.59 19.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.696 0.284 . . . . 0.0 111.487 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 m -108.99 68.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.406 0.622 . . . . 0.0 110.34 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.8 ttt85 -92.85 103.31 15.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.842 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.574 ' HG2' ' C2A' ' A' ' 999' ' ' COA . 20.9 mtp180 60.78 79.73 0.24 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.805 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -142.21 16.76 2.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.052 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.22 -19.98 11.7 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.489 175.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.9 t -51.29 -46.59 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.0 -28.95 71.27 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.101 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.467 ' HG3' ' O1A' ' A' ' 999' ' ' COA . 69.3 mt-30 -69.65 -55.0 11.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -56.11 -44.65 79.31 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.165 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.628 HD11 HD13 ' A' ' 5' ' ' ILE . 30.3 tp -52.89 -57.99 8.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.496 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.3 mt -66.21 -39.69 89.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.238 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -59.0 -43.01 91.42 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.252 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -64.45 -36.42 84.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.59 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 81' ' ' LEU . 93.2 t -63.34 -48.87 85.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.803 0.335 . . . . 0.0 110.686 177.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.539 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 11.1 mp -66.22 -27.84 68.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.896 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 87' ' ' ARG . 5.5 mtp180 -77.39 -33.66 55.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.398 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -69.95 -44.09 70.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.795 -176.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -76.02 112.79 22.38 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.359 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -87.42 22.54 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.143 2.562 . . . . 0.0 113.766 -171.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -172.7 75.9 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.018 -1.087 . . . . 0.0 113.093 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.4 t -141.69 129.09 20.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.9 p -99.66 -33.13 10.73 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -177.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.6 t -130.34 137.45 49.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.131 0.491 . . . . 0.0 110.814 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.539 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 90.7 m95 -116.12 122.4 45.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.345 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -114.18 121.3 43.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.292 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.834 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 77.2 mtp -107.29 130.08 54.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.793 0.33 . . . . 0.0 110.59 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -101.26 144.95 29.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.711 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.415 ' HB2' HG12 ' A' ' 102' ' ' VAL . 2.7 p-10 -69.49 -34.26 74.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.908 0.385 . . . . 0.0 110.148 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 61.65 20.68 11.52 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.47 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.35 13.01 20.34 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.243 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.538 HG13 ' HB3' ' A' ' 105' ' ' ARG . 12.2 p -85.53 119.67 34.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.115 0.483 . . . . 0.0 109.725 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -93.27 -5.1 50.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.326 0.584 . . . . 0.0 109.762 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -86.46 16.3 4.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.14 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.538 ' HB3' HG13 ' A' ' 102' ' ' VAL . 5.1 ptt180 -56.62 -32.12 64.98 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.167 -175.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.22 -48.35 70.78 Favored Glycine 0 C--O 1.235 0.193 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.726 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.1 t -61.24 -43.27 96.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-O 122.025 0.917 . . . . 0.0 109.394 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.601 ' O ' ' HG2' ' A' ' 112' ' ' MET . 17.3 ttt -61.64 -37.97 85.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.13 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 98.9 m -61.28 -36.24 79.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.105 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.28 -45.17 88.42 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.13 0.49 . . . . 0.0 109.748 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.624 ' HB2' ' C4A' ' A' ' 999' ' ' COA . 7.3 t80 -63.5 -45.08 92.32 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.019 173.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.601 ' HG2' ' O ' ' A' ' 108' ' ' MET . 59.5 mmm -60.57 -43.89 96.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.102 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -62.83 -35.1 78.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.807 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.51 -32.95 74.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.167 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 33.5 tp -84.8 -42.84 14.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.499 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 136.28 32.87 0.25 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.149 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.582 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 78.5 m-85 -118.58 116.24 26.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.76 0.314 . . . . 0.0 110.391 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.3 p -102.01 136.14 42.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.895 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.711 ' HB ' ' CD1' ' A' ' 124' ' ' TRP . 11.6 t -97.37 134.9 40.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.139 0.495 . . . . 0.0 110.737 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.632 ' HB2' ' OE2' ' A' ' 125' ' ' GLU . 93.5 mt-30 -140.31 -72.6 0.36 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.289 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -86.14 61.54 6.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.265 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.87 -36.96 2.49 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.139 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -118.96 -172.81 15.45 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.165 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.711 ' CD1' ' HB ' ' A' ' 119' ' ' THR . 15.8 m-90 -98.54 126.42 44.1 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.632 ' OE2' ' HB2' ' A' ' 120' ' ' GLN . 35.4 mt-10 -111.69 122.17 47.09 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.015 -175.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -137.12 148.64 46.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.396 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 38.2 t -110.82 151.07 28.25 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.329 0 C-N-CA 120.895 -0.669 . . . . 0.9 112.535 179.34 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 999' ' ' COA . . . . . 0.624 ' C4A' ' HB2' ' A' ' 111' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.1 mtp . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -74.75 137.62 42.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.964 0.411 . . . . 0.0 110.663 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.517 HD21 ' HB1' ' A' ' 42' ' ' ALA . 23.3 tp -76.03 118.47 18.82 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.561 ' O ' ' HB3' ' A' ' 43' ' ' ARG . 18.1 m -90.25 92.22 8.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.098 0.475 . . . . 0.0 110.458 -176.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.596 HG22 ' HA ' ' A' ' 42' ' ' ALA . 9.2 pt -106.79 150.98 8.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.091 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.1 mp -131.14 153.09 38.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -82.98 140.07 32.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.868 0.366 . . . . 0.0 110.036 176.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.9 tp -84.74 82.91 8.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.279 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -75.76 -48.8 20.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.783 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -120.19 157.24 29.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.411 -176.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -117.97 103.7 10.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.995 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -88.88 156.74 18.74 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.432 ' O ' HG13 ' A' ' 17' ' ' ILE . 19.0 t70 -56.78 -52.86 63.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.396 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.17 -35.99 80.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.68 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.488 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 22.0 m-20 -63.48 -44.01 95.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.531 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -62.53 -34.89 77.81 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 120.648 0.261 . . . . 0.0 110.958 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 13' ' ' ASP . 74.2 mt -63.13 -46.54 95.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.613 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -71.69 -31.28 66.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.013 0.435 . . . . 0.0 109.997 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 84.3 mt -63.67 -34.48 77.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.587 174.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -77.22 -18.74 57.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.165 0.507 . . . . 0.0 110.579 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -68.14 -36.81 80.26 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.516 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 67.3 mt -73.76 -55.47 12.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.23 176.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -101.18 97.34 7.07 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 35.3 Cg_exo -57.69 -32.17 93.92 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.554 2.169 . . . . 0.0 111.853 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -144.56 91.51 2.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.029 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -103.42 167.27 9.92 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.013 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.0 t -80.37 128.89 71.29 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.95 128.41 27.82 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.997 2.465 . . . . 0.0 112.786 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.0 m 69.57 1.52 3.39 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.792 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.1 m -78.72 -8.82 59.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.216 0.531 . . . . 0.0 110.27 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.03 -21.49 62.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.557 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -56.01 128.63 36.21 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.279 0.561 . . . . 0.0 111.934 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.1 m -103.38 167.52 2.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.399 -176.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -155.94 -158.25 0.79 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -72.64 -29.35 63.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.005 0.431 . . . . 0.0 110.77 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -85.68 -53.39 5.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.663 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -92.82 112.39 24.34 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -126.7 119.87 28.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.201 0.524 . . . . 0.0 110.806 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 65.2 mt -98.56 133.92 39.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.073 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -112.7 132.88 54.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.082 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.422 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.52 123.27 48.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.878 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.662 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -91.9 114.69 27.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.453 -176.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.561 ' HB3' ' O ' ' A' ' 4' ' ' THR . 51.9 ttt180 -108.03 127.3 53.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.273 0.559 . . . . 0.0 110.864 -177.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -99.41 82.49 2.68 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 69.13 -68.35 0.19 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.728 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -101.58 -57.74 2.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -174.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 47' ' ' ARG . 10.0 ptp180 -114.51 171.66 7.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.983 0.42 . . . . 0.0 111.076 -171.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.422 HD22 ' HB1' ' A' ' 41' ' ' ALA . 87.5 mt -75.34 133.55 41.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.431 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.8 tp -111.01 -23.98 10.63 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.734 0.302 . . . . 0.0 110.496 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.736 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -151.3 159.08 44.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.158 -177.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -144.46 133.41 22.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.963 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.08 137.76 37.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.937 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 19.1 mtm180 -110.17 129.99 55.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.207 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -133.73 139.47 48.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.316 0.579 . . . . 0.0 110.809 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -111.02 114.7 28.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.092 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.43 HD22 HG21 ' A' ' 92' ' ' VAL . 70.5 mt -86.84 93.06 9.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.965 0.412 . . . . 0.0 109.99 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 t -111.58 94.41 4.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.517 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.42 -107.72 2.04 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.498 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.3 p -93.45 -15.13 25.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.739 0.304 . . . . 0.0 111.036 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -99.66 122.19 42.33 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.247 0.546 . . . . 0.0 111.988 -172.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.23 97.37 2.17 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 167.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.47 107.54 19.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.21 0.528 . . . . 0.0 110.437 -172.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.9 tt -93.73 119.28 32.51 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.041 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 12.1 t70 -126.57 126.42 43.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.348 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.0 t 71.39 108.86 0.06 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.799 0.809 . . . . 0.0 111.111 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 45.4 tp -129.33 110.43 11.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.321 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.465 ' HA ' ' O9P' ' A' ' 999' ' ' COA . 43.5 mtt180 -125.36 128.53 48.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.095 0.474 . . . . 0.0 111.611 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.736 HG13 ' HB2' ' A' ' 50' ' ' ALA . 1.7 t -121.76 153.97 25.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 172.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.5 mtt-85 -65.22 158.58 25.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.947 0.403 . . . . 0.0 111.433 -176.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 1.5 mp0 -49.88 -38.6 36.25 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.947 -170.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.8 m -78.3 19.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.483 HG21 HG12 ' A' ' 68' ' ' VAL . 70.9 p -115.76 9.68 15.2 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.763 0.316 . . . . 0.0 111.253 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.2 ttp-105 -57.55 106.12 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.167 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.6 ' HA ' H52A ' A' ' 999' ' ' COA . 94.4 mtt180 55.92 40.47 30.49 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.119 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -111.29 7.39 21.05 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.992 0.425 . . . . 0.0 111.631 -174.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.465 ' HA2' ' O9A' ' A' ' 999' ' ' COA . . . 87.98 -23.89 12.73 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.928 173.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.7 t -53.92 -42.07 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.771 0.319 . . . . 0.0 111.713 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.85 -38.43 88.57 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.89 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -59.55 -49.72 76.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.863 0.363 . . . . 0.0 111.037 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -67.06 -33.88 76.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.961 -174.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.494 HD13 ' HB2' ' A' ' 42' ' ' ALA . 56.3 tp -57.72 -49.39 76.71 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.8 0.333 . . . . 0.0 110.301 176.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.77 -42.46 97.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.702 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.01 -46.89 84.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.108 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -59.12 -43.17 91.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.622 0.248 . . . . 0.0 110.974 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 81' ' ' LEU . 94.8 t -60.58 -52.27 63.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.918 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 11.2 mp -64.85 -32.14 73.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.571 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -76.74 -40.2 49.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.929 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -71.19 -39.6 71.7 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -174.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.52 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 47.6 m-80 -75.01 131.75 78.3 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.913 0.387 . . . . 0.0 110.674 -177.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 16.9 Cg_exo -67.05 -69.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 123.383 2.722 . . . . 0.0 114.456 -170.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.13 61.55 0.48 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.637 -170.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.43 HG21 HD22 ' A' ' 56' ' ' LEU . 25.5 t -114.52 105.11 18.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 175.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.9 t -83.25 -37.81 23.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.485 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.0 t -108.93 109.01 19.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.902 0.382 . . . . 0.0 110.822 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.427 ' CZ2' ' HA ' ' A' ' 86' ' ' LEU . 95.9 m95 -97.65 115.54 28.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.698 175.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 -114.88 126.19 54.52 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.964 -175.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 87.1 mtp -107.03 122.52 46.62 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.0 173.71 8.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.772 -172.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.31 -46.05 86.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.051 -178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 62.18 17.01 8.84 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.681 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.53 36.87 58.62 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.47 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.1 t -106.53 109.99 30.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.645 0.222 . . . . 0.0 110.724 177.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -90.95 -6.95 53.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.777 0.322 . . . . 0.0 110.6 173.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.73 52.65 1.03 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.262 0.553 . . . . 0.0 109.621 173.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 105' ' ' ARG . 48.2 mtt-85 -72.94 -21.87 60.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.884 -172.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.69 -56.64 23.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.535 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.1 t -61.51 -39.12 81.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.021 0.439 . . . . 0.0 110.837 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.6 ' SD ' ' HE3' ' A' ' 112' ' ' MET . 27.0 ttm -71.25 -37.8 71.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.119 -176.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 99.1 m -63.84 -47.35 81.12 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.634 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.472 ' HB1' ' C4A' ' A' ' 999' ' ' COA . . . -57.18 -39.08 74.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.348 0.594 . . . . 0.0 110.602 177.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -62.77 -54.38 39.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.374 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.6 ' HE3' ' SD ' ' A' ' 108' ' ' MET . 66.4 mtt -76.03 -33.26 59.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -174.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -63.41 -41.03 98.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.943 0.401 . . . . 0.0 110.119 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.24 -25.28 59.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.762 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.6 tp -84.02 -0.12 50.4 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.268 0.556 . . . . 0.0 110.637 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.41 53.38 4.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.95 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -110.0 133.25 53.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.707 0.289 . . . . 0.0 110.633 174.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.8 m -84.74 143.65 29.01 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.4 p -97.32 108.27 20.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.011 0.434 . . . . 0.0 111.038 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -96.8 163.42 12.99 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -73.65 95.99 2.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.827 0.346 . . . . 0.0 110.32 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.94 -30.53 2.94 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.506 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.55 -173.93 42.58 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.375 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -102.34 136.72 41.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.629 0.252 . . . . 0.0 110.619 -177.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -125.75 131.6 52.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.857 -176.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -132.02 133.77 44.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 78.2 m -86.87 129.92 34.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.766 0.317 . . . . 0.0 110.471 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 C-N-CA 121.088 -0.577 . . . . 0.9 111.953 179.836 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 999' ' ' COA . . . . . 0.6 H52A ' HA ' ' A' ' 74' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.16 117.01 10.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.975 0.417 . . . . 0.0 110.286 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.505 HD22 HG13 ' A' ' 77' ' ' VAL . 59.2 tp -75.86 137.05 40.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.963 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 42' ' ' ALA . 19.1 m -82.89 89.63 6.86 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.209 0.528 . . . . 0.0 110.577 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 40' ' ' TYR . 5.5 tp -98.35 105.76 17.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.003 174.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mt -94.74 149.22 4.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.359 0.6 . . . . 0.0 111.535 -170.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -91.59 101.36 14.0 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.124 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 39' ' ' ILE . 94.3 mt -73.11 92.95 1.75 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.691 -173.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -102.35 -2.69 28.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.736 0.779 . . . . 0.0 109.082 173.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -131.92 120.86 23.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.521 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -124.31 99.59 6.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.491 0.186 . . . . 0.0 111.066 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.57 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 1.4 m -79.03 158.95 27.79 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.569 ' O ' HG12 ' A' ' 17' ' ' ILE . 5.7 p-10 -58.14 -36.45 72.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.658 0.266 . . . . 0.0 110.732 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -70.0 -36.56 75.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.125 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -63.74 -38.34 90.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.272 0.558 . . . . 0.0 109.765 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.57 ' HG3' ' O ' ' A' ' 12' ' ' SER . 77.5 mtt180 -68.28 -28.46 67.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.468 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 13' ' ' ASP . 46.6 mm -66.8 -41.49 87.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.751 176.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 28.5 t0 -69.05 -32.48 71.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.04 0.447 . . . . 0.0 109.859 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.6 mt -63.23 -38.57 91.68 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.236 172.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -68.11 -22.77 64.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.559 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HE2' HG22 ' A' ' 17' ' ' ILE . 66.3 mttm -76.84 -32.87 57.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.311 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.6 mt -76.98 -39.0 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.531 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.504 ' CD1' ' HD2' ' A' ' 67' ' ' ARG . 5.0 m-90 -114.56 90.27 20.97 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.668 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.67 -28.53 87.57 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.786 2.324 . . . . 0.0 112.701 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.38 2.11 48.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.791 0.329 . . . . 0.0 111.108 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' HB3' ' HB2' ' A' ' 23' ' ' TRP . 43.7 t80 -115.41 149.85 37.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -175.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.4 m -116.37 154.78 48.95 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.078 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.7 99.35 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.553 2.169 . . . . 0.0 112.535 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 m -87.76 -173.17 4.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.479 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 p -70.81 -30.39 66.82 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 170.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.1 mt 67.76 77.11 0.26 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.204 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -73.51 111.18 8.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.575 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.01 151.43 28.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.032 0.444 . . . . 0.0 111.519 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 73.99 -6.66 1.78 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.942 171.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -65.87 -29.7 70.19 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 174.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 171.93 -29.03 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.841 -1.527 . . . . 0.0 107.354 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -86.94 116.54 25.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.468 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.514 ' HB2' HG13 ' A' ' 54' ' ' VAL . 51.5 mtt180 -109.09 125.78 52.49 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.046 0.45 . . . . 0.0 110.4 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.483 HG22 HD12 ' A' ' 8' ' ' LEU . 54.8 mt -108.67 110.0 30.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.803 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.553 ' HB3' HD11 ' A' ' 5' ' ' ILE . 65.4 m-85 -104.27 138.49 40.65 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.524 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -128.68 120.55 26.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.973 0.416 . . . . 0.0 111.296 -175.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -94.45 105.47 17.44 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.535 177.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.513 ' HB3' HD23 ' A' ' 48' ' ' LEU . 11.9 ptt180 -99.46 134.71 41.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.383 0.611 . . . . 0.0 110.74 -177.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -118.33 119.51 34.85 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.1 t30 60.13 41.87 16.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.696 0.76 . . . . 0.0 109.04 -173.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 76.49 -27.05 0.18 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.933 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -82.21 137.03 35.01 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.524 HD22 ' HB1' ' A' ' 41' ' ' ALA . 76.4 mt -69.43 97.69 1.02 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 0.0 111.009 -175.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.4 tp -78.18 -39.0 42.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.883 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -131.23 126.48 35.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.899 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -117.35 125.86 51.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.334 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.47 127.95 60.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.62 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 5.1 mtp180 -107.04 127.36 53.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 38' ' ' ARG . 5.2 p -122.57 115.71 46.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.649 0.738 . . . . 0.0 110.827 176.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.4 m -91.93 108.63 20.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.968 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.14 154.27 19.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.106 0.479 . . . . 0.0 110.612 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 5.5 t -136.55 30.4 2.89 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.32 -108.07 3.43 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.372 -176.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 p -84.67 -1.86 56.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.366 0.603 . . . . 0.0 110.68 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 44.8 tt0 -109.93 127.57 54.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.414 177.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -127.35 112.89 1.6 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.11 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.36 118.5 33.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.888 0.375 . . . . 0.0 110.53 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 5.6 mp -93.89 125.61 38.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.97 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.62 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 4.4 p30 -122.84 135.75 54.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.104 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.1 t 66.73 94.1 0.07 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.884 0.849 . . . . 0.0 111.273 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.485 HD21 HD21 ' A' ' 82' ' ' LEU . 37.0 tp -122.99 108.01 12.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.231 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.504 ' HD2' ' CD1' ' A' ' 23' ' ' TRP . 98.2 mtt180 -130.49 117.89 20.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.269 0.557 . . . . 0.0 111.651 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 50' ' ' ALA . 5.1 t -107.03 141.91 21.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -62.65 151.23 38.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.872 0.367 . . . . 0.0 110.993 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -54.58 -26.28 31.44 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.358 -0.837 . . . . 0.0 113.022 -171.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.19 3.51 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.287 0.565 . . . . 0.0 111.177 -176.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.76 13.16 16.11 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.13 -0.356 . . . . 0.0 111.142 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -66.42 118.36 9.95 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.741 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.427 ' HA ' ' O8A' ' A' ' 999' ' ' COA . 51.5 ttt180 50.47 73.88 0.25 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.634 -172.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -138.24 11.77 2.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.265 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.95 -32.65 1.96 Allowed Glycine 0 CA--C 1.521 0.43 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.539 177.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.505 HG13 HD22 ' A' ' 3' ' ' LEU . 85.4 t -49.74 -42.17 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.281 0.632 . . . . 0.0 112.576 -176.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -52.66 -44.57 60.19 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.395 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -64.99 -43.58 92.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.0 110.785 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -63.5 -49.1 74.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.54 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.44 ' CD1' HD13 ' A' ' 5' ' ' ILE . 30.6 tp -49.47 -60.79 2.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.798 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.485 HD21 HD21 ' A' ' 66' ' ' LEU . 4.1 mm? -64.78 -43.11 94.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.581 -175.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.605 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 40.3 tt0 -63.91 -39.41 94.1 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.707 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -60.69 -40.46 92.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.962 0.41 . . . . 0.0 110.487 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 81' ' ' LEU . 90.1 t -64.16 -38.32 82.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.816 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 82' ' ' LEU . 10.6 mp -70.1 -24.94 63.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.159 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.605 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 63.6 mtt180 -76.88 -36.9 56.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.126 0.489 . . . . 0.0 109.956 174.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -66.58 -47.45 72.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.553 -176.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -75.42 147.6 82.45 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.387 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.88 -165.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.987 2.458 . . . . 0.0 112.612 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.68 96.29 0.15 Allowed Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.83 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.8 t -102.26 -50.4 9.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.072 0.463 . . . . 0.0 110.047 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.6 m 70.79 -50.12 0.67 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.037 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 47.8 t -89.4 86.36 6.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.058 0.456 . . . . 0.0 110.399 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.448 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 96.1 m95 -95.76 121.09 37.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.372 178.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -117.11 134.31 54.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.555 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.716 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 92.8 mmm -107.15 111.17 23.47 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.95 150.63 22.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.18 -174.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.614 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -70.13 -63.81 1.01 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.703 179.268 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.61 16.78 6.85 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.388 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.15 12.16 12.57 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.389 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 99' ' ' ASP . 69.2 t -69.29 104.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 117.262 0.531 . . . . 0.0 110.723 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.55 -10.59 45.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.373 0.606 . . . . 0.0 109.967 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.13 47.35 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.039 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -61.42 -40.1 93.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.93 -173.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.94 -53.17 39.2 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.456 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.29 -43.94 98.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.797 0.332 . . . . 0.0 110.674 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 91.2 mmm -64.7 -39.07 93.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.462 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 98.9 m -60.86 -43.72 98.01 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.818 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.65 -44.76 93.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.083 0.468 . . . . 0.0 110.776 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.556 ' HD1' H52A ' A' ' 999' ' ' COA . 17.0 t80 -64.82 -45.11 87.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.831 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.556 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 16.9 mmt -62.13 -45.46 93.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.105 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -63.54 -34.98 78.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.595 0.236 . . . . 0.0 111.16 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.91 -29.45 69.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.005 0.431 . . . . 0.0 110.852 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.2 tp -96.71 13.3 28.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.213 0.53 . . . . 0.0 110.73 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.86 57.67 4.03 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.124 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 55.6 m-85 -126.0 153.81 43.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 110.325 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.9 p -128.22 145.47 51.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.809 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.9 t -97.16 124.57 41.25 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -141.79 106.63 4.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.851 -172.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 57.75 35.98 26.07 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.575 168.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 158.29 -85.1 0.13 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.281 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -121.35 -137.21 5.21 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.685 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.716 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 19.2 m-90 -112.29 141.47 45.97 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -128.07 142.73 51.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.717 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.464 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 54.4 tttp -132.5 89.69 2.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 38.1 t -86.79 97.75 10.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.554 -176.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 C-N-CA 121.04 -0.6 . . . . 0.9 112.284 179.528 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 999' ' ' COA . . . . . 0.69 ' O5P' H141 ' A' ' 999' ' ' COA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 120.882 0.373 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -121.76 108.08 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.95 0.405 . . . . 0.0 110.918 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.415 ' HB3' ' CE2' ' A' ' 80' ' ' TYR . 59.2 tp -87.17 114.98 24.25 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 m -82.87 93.44 7.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.342 0.592 . . . . 0.0 110.787 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.575 HG22 ' HA ' ' A' ' 42' ' ' ALA . 13.3 pt -113.12 148.55 15.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.137 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.46 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -133.94 144.4 35.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.359 -177.784 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -91.94 142.18 27.83 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.52 98.09 1.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.187 0.518 . . . . 0.0 111.373 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -89.14 -42.12 11.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.077 173.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -136.72 140.31 42.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.196 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.493 ' HE2' HG22 ' A' ' 33' ' ' VAL . 34.9 m-85 -97.42 92.95 6.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.975 0.417 . . . . 0.0 111.686 -176.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 m -71.94 139.3 48.64 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 171.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 17' ' ' ILE . 27.1 m-20 -59.32 -41.59 89.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.576 0.227 . . . . 0.0 111.106 -177.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -61.59 -39.84 92.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.956 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -72.2 -30.98 65.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.752 0.311 . . . . 0.0 110.603 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -68.98 -31.23 69.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 0.0 110.619 176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 13' ' ' ASP . 79.9 mt -70.27 -36.99 69.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.073 0.463 . . . . 0.0 109.829 174.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -64.86 -41.68 95.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.016 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.4 mt -59.91 -35.54 75.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.708 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -69.35 -25.36 64.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.199 0.523 . . . . 0.0 110.097 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 67.7 mttm -72.81 -27.48 61.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.974 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.769 HD11 ' HB3' ' A' ' 48' ' ' LEU . 60.4 mt -71.23 -43.48 74.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.309 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.614 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 4.0 m-90 -113.99 87.6 13.09 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.62 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.27 -9.48 12.64 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.116 1.878 . . . . 0.0 110.768 173.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -101.65 8.38 41.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.95 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.614 ' HB3' ' HB3' ' A' ' 23' ' ' TRP . 91.9 t80 -129.61 132.72 46.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.827 -175.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.5 t -70.82 121.95 85.38 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.43 107.27 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.924 2.416 . . . . 0.0 112.735 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 m -83.52 178.55 7.95 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.013 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.9 m -60.83 -28.51 68.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.446 175.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.8 mt 65.12 98.13 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.634 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -131.43 148.53 52.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.853 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.493 HG22 ' HE2' ' A' ' 11' ' ' PHE . 15.6 m -132.72 -179.2 3.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.434 176.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -146.51 -169.24 3.22 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -82.4 -25.75 33.44 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.279 0.561 . . . . 0.0 109.696 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 9.2 p30 -96.96 -27.58 14.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.722 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -108.42 95.78 5.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.2 mtt85 -117.0 166.73 11.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.183 0.516 . . . . 0.0 111.594 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -129.73 135.58 61.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.724 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -99.78 129.16 45.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.793 0.33 . . . . 0.0 110.603 177.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.435 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -112.91 116.21 29.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.111 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.575 ' HA ' HG22 ' A' ' 5' ' ' ILE . . . -91.9 113.22 25.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.188 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -113.38 126.13 55.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.394 0.616 . . . . 0.0 111.369 -172.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -97.16 85.58 3.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 64.66 -77.86 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.067 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -107.73 -39.28 5.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.209 -174.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.628 ' HA ' ' CZ ' ' A' ' 47' ' ' ARG . 2.1 mmp_? -99.05 129.87 45.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.533 -170.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.769 ' HB3' HD11 ' A' ' 22' ' ' ILE . 54.3 mt -67.56 115.41 7.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 169.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 15.8 tp -97.54 -27.16 14.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.769 -170.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.558 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -152.35 158.0 42.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.699 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.57 144.16 26.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.108 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 65' ' ' SER . 11.0 p -148.45 143.64 18.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.733 0.302 . . . . 0.0 111.088 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -96.54 146.91 24.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.731 0.3 . . . . 0.0 110.997 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.03 121.58 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.45 0.643 . . . . 0.0 110.783 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 21.2 m -110.12 109.25 19.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.453 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.594 HD22 HG21 ' A' ' 92' ' ' VAL . 65.0 mt -89.69 113.17 24.62 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.271 0.558 . . . . 0.0 110.936 -178.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -114.62 86.17 2.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.475 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.88 -107.77 2.22 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.681 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.7 p -104.77 1.03 28.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.214 0.53 . . . . 0.0 110.575 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -98.97 138.15 36.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.918 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -119.98 107.94 1.39 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.611 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -92.62 104.59 16.86 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.9 tt -104.56 127.64 52.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.734 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -147.43 176.76 9.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.301 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 16.2 m 50.82 80.36 0.08 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.858 0.724 . . . . 0.0 111.965 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.504 ' HB3' ' HE3' ' A' ' 108' ' ' MET . 55.4 tp -120.58 120.45 35.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.084 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.649 ' HG3' ' O5P' ' A' ' 999' ' ' COA . 39.8 ttt-85 -140.32 124.04 17.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.814 0.34 . . . . 0.0 110.51 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.558 HG13 ' HB2' ' A' ' 50' ' ' ALA . 10.5 t -111.1 146.66 15.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 172.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 49' ' ' LEU . 66.7 mtp85 -60.94 139.6 57.97 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.117 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 1.8 mp0 -52.32 -30.97 30.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.839 -171.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.6 t -72.15 -17.15 18.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.995 0.426 . . . . 0.0 111.308 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.57 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . 2.3 m -95.35 5.06 52.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.766 0.793 . . . . 0.0 110.806 -176.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.674 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 57.7 ttt180 -71.89 134.66 46.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.139 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.646 ' HD3' ' O2B' ' A' ' 999' ' ' COA . 29.1 tpt180 69.25 43.39 1.08 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.754 0.787 . . . . 0.0 110.191 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.57 ' HD3' ' HA ' ' A' ' 72' ' ' THR . 16.3 mtp180 -134.95 1.9 3.05 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.14 -13.6 9.49 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.998 176.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -57.5 -43.98 83.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 117.009 0.405 . . . . 0.0 111.48 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.28 -39.53 92.7 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.406 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.542 ' HA ' HD21 ' A' ' 115' ' ' LEU . 41.1 tt0 -62.43 -47.42 84.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.382 . . . . 0.0 110.51 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.435 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 81.9 t80 -57.72 -41.75 82.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.686 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' A' ' 42' ' ' ALA . 68.3 tp -56.71 -49.99 73.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.748 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.1 -40.68 98.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.963 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 33.5 mt-10 -65.9 -36.77 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.109 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 80' ' ' TYR . 7.3 mm-40 -61.79 -39.69 92.58 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.73 0.3 . . . . 0.0 111.117 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 81' ' ' LEU . 58.9 t -60.78 -54.51 34.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.005 0.431 . . . . 0.0 110.545 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.7 mp -74.9 -4.57 38.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.07 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 68.7 ttt180 -80.26 -48.87 12.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.226 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -87.67 -8.29 56.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.271 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 15.9 t30 -45.76 120.65 5.22 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.583 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 7.7 Cg_exo -73.02 -61.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.146 2.564 . . . . 0.0 112.888 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -154.54 35.06 0.69 Allowed Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.153 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.594 HG21 HD22 ' A' ' 56' ' ' LEU . 62.3 t -99.84 107.12 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 51.1 m -111.33 -13.83 13.87 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -174.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 81.8 m -103.82 94.6 5.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.858 0.361 . . . . 0.0 110.056 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -97.26 115.97 28.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.142 0.496 . . . . 0.0 111.434 -175.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.528 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 74.1 t-105 -104.14 114.29 28.42 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.959 175.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.709 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 80.6 mtp -107.35 122.67 47.05 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -176.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -124.61 168.74 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.423 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.85 -68.03 0.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.077 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.99 19.91 10.32 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.845 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.73 -20.05 3.29 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.661 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 95.7 t -67.79 101.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.121 0.486 . . . . 0.0 110.854 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -93.35 -16.56 24.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.263 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.05 54.19 1.87 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.469 176.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -60.17 -46.95 87.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.36 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.16 -49.7 62.23 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.66 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.45 -46.72 96.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.959 0.409 . . . . 0.0 111.269 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.504 ' HE3' ' HB3' ' A' ' 66' ' ' LEU . 78.0 mtp -78.62 -22.01 47.6 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -175.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 96.5 m -67.33 -40.44 85.91 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.465 ' HB1' ' N7A' ' A' ' 999' ' ' COA . . . -65.28 -39.29 92.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.187 0.518 . . . . 0.0 110.021 175.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.452 ' HD1' ' C5B' ' A' ' 999' ' ' COA . 53.7 t80 -58.52 -51.89 67.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.789 175.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.543 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 67.1 mtt -70.98 -27.15 63.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.481 -176.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -66.59 -34.16 77.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.922 0.391 . . . . 0.0 109.983 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.65 -32.9 66.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.75 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.542 HD21 ' HA ' ' A' ' 79' ' ' GLN . 11.0 mp -83.34 -4.8 58.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.004 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.19 41.41 17.64 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.167 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.543 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 59.7 m-85 -92.98 144.24 25.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.857 0.361 . . . . 0.0 110.186 174.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.24 144.67 25.08 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.26 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.7 p -97.46 140.64 31.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.33 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.486 ' HG3' ' HB3' ' A' ' 125' ' ' GLU . 19.3 mm-40 -120.35 -166.77 1.35 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.762 177.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -85.02 96.12 9.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.286 0.565 . . . . 0.0 111.122 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.84 44.93 4.69 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.542 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.35 -171.93 24.94 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.174 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.709 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 15.8 m-90 -116.86 149.56 39.87 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.183 -0.302 . . . . 0.0 110.183 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.486 ' HB3' ' HG3' ' A' ' 120' ' ' GLN . 31.2 tt0 -155.8 132.34 10.33 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -137.07 132.58 34.35 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 93' ' ' SER . 49.0 t -119.67 113.2 20.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.134 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 C-N-CA 121.009 -0.615 . . . . 0.9 112.186 -179.68 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 999' ' ' COA . . . . . 0.674 ' O4A' ' HA ' ' A' ' 73' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 121.198 0.523 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -121.75 155.04 36.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.709 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.7 tp -86.09 98.07 10.66 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.479 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 13.5 m -88.07 89.81 8.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.276 -174.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.538 HD11 ' HB3' ' A' ' 40' ' ' TYR . 13.8 tt -96.12 129.41 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.474 0.654 . . . . 0.0 110.767 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mt -129.01 154.59 40.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.323 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.8 ptt-85 -76.74 113.82 14.82 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 173.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.617 HD21 HD11 ' A' ' 19' ' ' LEU . 31.1 tp -77.96 100.84 6.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.997 -174.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.835 ' HA ' HG11 ' A' ' 33' ' ' VAL . 42.2 mt-10 -113.97 -18.95 11.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.902 -175.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.81 113.99 24.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.382 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -107.83 101.4 10.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.632 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.8 p -84.68 171.28 12.51 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.468 ' O ' HG13 ' A' ' 17' ' ' ILE . 6.6 p-10 -60.38 -31.98 70.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.564 0.221 . . . . 0.0 110.561 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -67.27 -51.02 58.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.556 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -60.87 -36.81 80.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.99 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -55.47 -47.39 76.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.159 176.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 13' ' ' ASP . 74.7 mt -65.79 -43.84 93.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.898 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.498 ' O ' HG13 ' A' ' 22' ' ' ILE . 12.9 m-20 -58.76 -52.83 64.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.69 0.281 . . . . 0.0 110.955 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.617 HD11 HD21 ' A' ' 8' ' ' LEU . 95.0 mt -64.74 -38.15 90.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.34 -178.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -74.2 -11.48 60.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.098 0.475 . . . . 0.0 110.56 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -98.27 -28.16 13.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.089 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 18' ' ' ASP . 74.4 mt -65.23 -48.53 83.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.649 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 4.8 m-90 -107.49 92.3 8.25 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 168.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.63 -3.53 4.52 Favored 'Trans proline' 0 N--CA 1.477 0.538 0 C-N-CA 123.648 2.899 . . . . 0.0 114.509 -167.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -134.72 21.26 3.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.986 0.422 . . . . 0.0 110.766 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.649 ' HB2' ' HB2' ' A' ' 23' ' ' TRP . 52.4 t80 -81.9 123.82 29.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.634 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.9 m -64.13 125.42 88.07 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.7 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.6 -31.41 94.36 Favored 'Trans proline' 0 CA--C 1.528 0.203 0 C-N-CA 122.897 2.398 . . . . 0.0 112.48 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 p -71.12 -12.86 61.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.112 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 57.3 m -88.12 4.31 45.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.772 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.5 mt -82.86 86.5 6.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.231 0.539 . . . . 0.0 109.895 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -136.46 127.38 27.58 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.605 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.835 HG11 ' HA ' ' A' ' 9' ' ' GLU . 15.0 p -106.49 131.32 56.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.513 0.673 . . . . 0.0 110.42 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.585 ' HB2' ' H ' ' A' ' 37' ' ' HIS . 14.6 m-20 -130.62 179.28 6.04 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -85.68 -9.47 57.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -94.63 -34.47 12.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.685 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.585 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 36.0 m80 -120.33 101.0 7.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.768 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 38' ' ' ARG . 48.5 mtt180 -109.11 129.0 55.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.82 0.343 . . . . 0.0 110.275 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.4 HG12 ' HG2' ' A' ' 53' ' ' ARG . 63.7 mt -103.33 116.73 47.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.538 ' HB3' HD11 ' A' ' 5' ' ' ILE . 78.8 m-85 -97.55 125.67 42.4 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.505 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -109.37 113.4 26.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.56 -177.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . . . -92.68 102.32 14.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.959 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 4' ' ' THR . 19.9 ptt85 -103.37 129.53 50.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.344 0.592 . . . . 0.0 110.408 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -105.46 124.61 49.84 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.544 -177.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 70.91 -56.91 0.61 Allowed 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.957 0.786 . . . . 0.0 110.983 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -154.75 -45.96 0.09 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.325 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -104.92 162.83 12.99 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.12 -170.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.505 HD22 ' HB1' ' A' ' 41' ' ' ALA . 84.0 mt -60.78 132.75 54.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.865 -176.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 37.1 tp -111.76 -30.38 7.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.821 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.579 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -150.11 147.56 27.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.578 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -135.41 127.36 29.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.68 0.276 . . . . 0.0 110.434 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.418 ' HB ' HD13 ' A' ' 66' ' ' LEU . 7.1 p -131.37 134.01 61.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.03 0.443 . . . . 0.0 110.99 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.558 ' HD3' ' HB2' ' A' ' 65' ' ' SER . 21.4 mtp-105 -110.17 126.69 54.36 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.5 p -120.66 134.62 63.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.422 0.63 . . . . 0.0 111.629 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.9 m -100.71 107.69 19.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.856 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.9 mt -96.33 130.29 43.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.584 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 m -135.78 97.47 3.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.191 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.64 -112.56 4.53 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.378 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -106.9 11.98 29.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.586 0.708 . . . . 0.0 110.278 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -125.61 154.59 42.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.344 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.39 132.28 5.24 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.079 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.77 126.43 51.02 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 mp -93.46 117.06 29.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.014 0.435 . . . . 0.0 110.701 -175.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.532 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 20.2 m-20 -109.35 118.53 36.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.283 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.558 ' HB2' ' HD3' ' A' ' 53' ' ' ARG . 34.5 m 73.05 107.16 0.07 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.86 0.838 . . . . 0.0 111.797 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.418 HD13 ' HB ' ' A' ' 52' ' ' VAL . 29.9 tp -131.97 130.79 41.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.504 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.2 ttt-85 -144.02 130.48 19.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.819 0.342 . . . . 0.0 110.841 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.579 HG13 ' HB2' ' A' ' 50' ' ' ALA . 13.6 t -107.11 156.42 7.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -53.87 127.0 24.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -57.37 -31.65 65.98 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -168.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -82.87 16.7 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.365 0.602 . . . . 0.0 110.979 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -111.73 16.14 20.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.575 0.702 . . . . 0.0 110.414 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.76 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 99.9 mtt180 -75.45 137.01 40.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.077 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.408 ' HD3' HH11 ' A' ' 74' ' ' ARG . 5.8 ttm180 71.66 27.76 2.88 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.698 177.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -124.98 22.67 7.96 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.443 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.79 -27.21 1.64 Allowed Glycine 0 CA--C 1.521 0.454 0 N-CA-C 114.681 0.632 . . . . 0.0 114.681 172.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.2 t -50.88 -46.46 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -175.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.88 -45.51 94.93 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.604 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.503 ' HG2' ' HG ' ' A' ' 115' ' ' LEU . 51.2 mt-30 -65.57 -41.68 92.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.871 0.367 . . . . 0.0 110.733 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -68.21 -41.92 80.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.585 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.3 tp -48.23 -51.57 24.89 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.331 0.394 . . . . 0.0 111.026 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.438 ' O ' HD13 ' A' ' 86' ' ' LEU . 4.4 mm? -60.07 -52.44 65.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.433 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -72.09 -16.52 62.02 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.726 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.428 ' HG2' HG21 ' A' ' 5' ' ' ILE . 12.5 tp10 -69.77 -42.9 73.2 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 172.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.55 -41.3 88.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.352 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 82' ' ' LEU . 10.9 mp -67.43 -20.38 65.5 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.1 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 54.0 ttp85 -83.65 -41.05 18.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 109.876 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -64.35 -38.94 92.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.729 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -119.11 78.77 17.73 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.662 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.29 2.21 8.55 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.595 2.197 . . . . 0.0 112.319 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.54 10.76 72.47 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.97 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.8 t -107.68 127.26 63.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 m -85.53 -53.36 5.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.805 0.336 . . . . 0.0 111.576 -175.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.5 t -103.83 116.38 32.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.904 0.383 . . . . 0.0 111.09 -174.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -106.9 112.33 25.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.064 176.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -105.51 136.46 45.03 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.121 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.662 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 97.4 mmm -107.27 119.74 40.22 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.65 144.98 25.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.009 0.433 . . . . 0.0 111.766 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.414 ' CG ' HH21 ' A' ' 105' ' ' ARG . 10.6 t70 -80.26 -69.61 0.58 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.908 177.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 64.73 23.17 12.71 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.945 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.4 40.29 0.96 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.905 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.752 HG11 ' HG3' ' A' ' 108' ' ' MET . 77.0 t -88.31 112.48 23.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.84 0.353 . . . . 0.0 110.368 176.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -82.57 -32.27 28.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.677 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -87.49 55.23 3.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.222 0.534 . . . . 0.0 109.859 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.414 HH21 ' CG ' ' A' ' 99' ' ' ASP . 34.7 ttm180 -66.23 -31.11 71.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.043 -176.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.74 -56.39 25.53 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.062 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.5 t -61.48 -42.42 93.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 111.001 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.752 ' HG3' HG11 ' A' ' 102' ' ' VAL . 93.0 mmm -64.46 -38.23 90.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.538 -177.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 61.5 m -67.52 -41.26 84.67 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.411 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.14 88.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.302 0.573 . . . . 0.0 110.245 176.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.41 ' CD2' H132 ' A' ' 999' ' ' COA . 61.2 t80 -61.98 -48.71 79.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.716 175.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.546 ' HG2' ' O ' ' A' ' 108' ' ' MET . 26.4 mmt -62.44 -43.2 99.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.122 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -62.09 -39.33 92.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.204 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.51 -22.11 61.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.112 0.482 . . . . 0.0 110.888 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.503 ' HG ' ' HG2' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -91.05 -2.69 57.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.299 0.571 . . . . 0.0 110.31 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.85 32.61 20.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.03 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.539 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 75.7 m-85 -98.63 139.85 33.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.041 0.448 . . . . 0.0 110.419 176.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.1 m -90.41 144.21 26.02 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.853 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 30.2 p -97.31 115.97 28.64 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.801 0.334 . . . . 0.0 110.438 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -137.02 161.46 36.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.072 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -45.45 106.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.836 0.71 . . . . 0.0 112.188 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 120.93 -21.18 8.42 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.382 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 159.07 -131.69 2.83 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.741 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.662 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 12.8 m-90 -125.98 140.0 52.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.637 0.256 . . . . 0.0 110.504 -177.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -128.46 134.35 48.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.93 -175.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.528 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 84.8 tttt -137.19 92.17 2.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.07 0.462 . . . . 0.0 110.54 173.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 39.9 t -80.22 131.32 35.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.496 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 C-N-CA 120.867 -0.682 . . . . 0.9 111.993 179.132 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 999' ' ' COA . . . . . 0.76 ' O4A' ' HA ' ' A' ' 73' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.2 mmm . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 120.792 0.329 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.47 135.05 33.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.962 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.568 HD22 HG13 ' A' ' 77' ' ' VAL . 52.5 tp -95.72 127.73 41.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.476 -177.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.9 m -89.69 95.32 10.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.898 0.38 . . . . 0.0 110.624 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.593 HG22 ' HA ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -103.49 129.1 55.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.118 0.485 . . . . 0.0 110.052 177.858 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.417 ' H ' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -130.18 151.9 36.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.888 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -75.29 130.18 38.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.466 HD21 HD11 ' A' ' 19' ' ' LEU . 38.6 tp -76.01 59.36 1.29 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.605 0.717 . . . . 0.0 110.165 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -91.39 -13.91 31.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.511 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -112.92 107.21 15.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.834 177.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -88.43 82.94 6.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.296 0.569 . . . . 0.0 110.892 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.8 m -85.66 150.56 24.53 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.303 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.62 -35.72 70.84 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -52.14 -55.77 18.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.526 175.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.449 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 18.8 m-20 -68.51 -41.3 80.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.299 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -61.11 -39.14 88.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -176.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.7 mt -70.13 -41.64 79.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.939 0.4 . . . . 0.0 110.375 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.48 -34.54 78.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.104 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.466 HD11 HD21 ' A' ' 8' ' ' LEU . 73.0 mt -62.39 -39.26 92.63 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.83 174.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -75.13 -10.43 59.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.026 0.441 . . . . 0.0 111.001 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -86.46 -22.94 26.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.24 170.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.36 -45.82 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.228 0.537 . . . . 0.0 109.611 173.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.403 ' HE1' ' HG3' ' A' ' 67' ' ' ARG . 5.8 m-90 -107.6 108.09 61.16 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.39 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -36.13 -56.11 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 124.46 3.44 . . . . 0.0 114.193 -172.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -145.99 87.48 1.76 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.469 0.652 . . . . 0.0 109.797 174.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.666 ' HE2' ' HG ' ' A' ' 31' ' ' LEU . 74.7 t80 -100.04 137.6 38.26 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.195 -176.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 p -74.32 122.21 87.0 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.917 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.35 -4.33 15.03 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.812 2.341 . . . . 0.0 113.106 -176.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 m -65.03 -30.83 71.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.441 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.434 ' HB2' ' OH ' ' A' ' 26' ' ' TYR . 14.5 m -93.88 4.82 53.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.97 0.414 . . . . 0.0 111.547 -176.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.666 ' HG ' ' HE2' ' A' ' 26' ' ' TYR . 43.1 mt -81.89 86.51 6.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.0 110.378 176.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -135.68 106.0 6.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.405 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.4 t -98.18 135.89 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.132 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -146.23 -173.86 4.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.81 -20.98 66.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.12 0.486 . . . . 0.0 111.084 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -93.11 -55.7 3.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.483 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -84.32 98.13 9.84 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -108.91 121.35 44.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.964 0.411 . . . . 0.0 110.41 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.833 HG12 ' HG2' ' A' ' 53' ' ' ARG . 56.4 mt -98.88 115.39 39.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.215 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -94.05 122.34 36.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.364 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.577 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.11 123.36 48.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.09 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.805 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -91.89 100.4 13.08 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -95.06 115.61 27.64 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.792 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.527 ' HB3' HD13 ' A' ' 49' ' ' LEU . 73.2 t80 -97.28 88.66 4.5 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.62 -65.09 0.36 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.859 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.461 ' HG3' ' N ' ' A' ' 47' ' ' ARG . 4.9 pt-20 -109.16 -51.24 2.9 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.461 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 28.0 ptt-85 -127.0 173.8 9.36 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.685 -171.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.577 HD22 ' HB1' ' A' ' 41' ' ' ALA . 41.9 mt -87.06 111.25 20.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.348 -175.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' A' ' 44' ' ' PHE . 9.9 mp -88.13 -31.41 19.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.687 0.28 . . . . 0.0 110.68 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.805 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -127.07 131.99 50.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.992 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.12 115.94 21.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.155 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 65' ' ' SER . 11.2 p -126.8 136.55 60.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.098 0.475 . . . . 0.0 111.151 -178.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.833 ' HG2' HG12 ' A' ' 39' ' ' ILE . 99.0 mtt180 -111.77 115.72 29.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.64 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.6 p -107.18 107.46 22.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.849 0.833 . . . . 0.0 110.032 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.9 m -87.5 106.82 18.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.185 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.8 mt -80.63 104.51 11.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.39 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -103.13 106.34 16.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.238 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.86 -96.79 0.61 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -174.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.1 p -128.27 2.68 5.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.909 0.385 . . . . 0.0 110.776 175.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.573 ' HA ' HG13 ' A' ' 92' ' ' VAL . 23.8 mm-40 -104.84 141.59 36.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.721 -175.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.12 112.35 4.38 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.352 -177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.589 ' HA ' ' HB3' ' A' ' 96' ' ' TRP . . . -105.28 111.72 24.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.696 0.284 . . . . 0.0 110.438 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 53' ' ' ARG . 5.2 mp -93.45 110.76 22.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.19 0.519 . . . . 0.0 109.803 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.625 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 1.8 p30 -96.06 -36.14 11.12 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.801 -173.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 21.0 m -120.58 125.29 47.42 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.791 0.329 . . . . 0.0 111.158 -177.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.422 ' HB3' ' H22' ' A' ' 999' ' ' COA . 56.4 tp -145.61 102.72 3.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.052 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.513 ' HD2' ' H71' ' A' ' 999' ' ' COA . 26.2 mmm180 -131.43 113.0 13.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.775 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.526 HG13 ' HB2' ' A' ' 50' ' ' ALA . 2.9 t -110.22 136.04 47.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -87.56 -176.28 5.51 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -174.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -55.33 -27.07 44.67 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.399 -1.273 . . . . 0.0 114.387 -165.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.6 t -65.43 -30.57 50.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.168 0.509 . . . . 0.0 111.691 -175.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.587 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 6.5 m -98.77 32.66 2.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.463 0.649 . . . . 0.0 111.16 -173.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 73' ' ' ARG . 40.0 ttm180 -65.27 97.57 0.28 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.886 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.456 ' HG2' ' C2A' ' A' ' 999' ' ' COA . 67.6 mtp180 53.02 80.04 0.11 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.091 170.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 75' ' ' ARG . 9.3 mmt180 -136.61 -54.27 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.239 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.78 -21.67 0.46 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.775 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.587 ' HB ' ' CG2' ' A' ' 72' ' ' THR . 72.6 t -55.85 -44.23 76.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 122.332 0.253 . . . . 0.0 111.499 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -54.11 -49.44 59.37 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.905 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -60.65 -52.32 65.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.454 0.169 . . . . 0.0 110.592 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -58.96 -42.45 89.9 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.128 -176.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 85' ' ' VAL . 63.6 tp -52.56 -53.31 48.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 110.679 178.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.425 ' O ' HD13 ' A' ' 86' ' ' LEU . 46.8 mt -70.31 -45.47 66.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.423 -177.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -62.67 -32.22 73.24 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.071 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -67.69 -41.42 83.64 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 176.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 81' ' ' LEU . 85.1 t -63.09 -46.27 96.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 121.205 0.526 . . . . 0.0 110.645 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.479 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 10.9 mp -70.47 -19.85 62.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.108 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -86.91 -30.22 21.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.191 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -63.62 -52.87 58.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.51 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -118.5 101.17 51.13 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.784 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.91 -6.13 12.28 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.224 2.616 . . . . 0.0 112.035 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.36 48.77 4.1 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.691 -177.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.573 HG13 ' HA ' ' A' ' 60' ' ' GLU . 97.4 t -135.94 134.51 50.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 61.8 p -96.57 -32.83 12.06 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.933 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 77.8 m -130.37 113.98 15.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.891 0.376 . . . . 0.0 111.322 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.479 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 95.6 m95 -90.94 113.49 25.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 173.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.589 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . 2.9 t-105 -96.94 128.09 43.57 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.959 -172.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' MET . . . . . 1.047 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 13.4 mmt -108.45 115.38 29.99 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.625 ' HB3' ' HA ' ' A' ' 64' ' ' ASP . . . -99.48 173.84 6.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.566 -169.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -129.29 93.04 3.48 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.42 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -92.36 26.85 2.43 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.975 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.5 46.48 0.85 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.423 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 56.8 t -78.01 98.92 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.93 0.395 . . . . 0.0 110.895 -178.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -70.83 -33.66 70.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.114 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -79.41 47.39 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.089 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.97 -57.4 13.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.879 -172.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.29 99.34 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.527 -175.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.9 t -58.39 -47.52 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.0 110.78 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.515 ' SD ' ' H61' ' A' ' 999' ' ' COA . 89.5 mmm -71.01 -32.62 69.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.131 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 80.1 m -59.25 -44.18 92.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.982 0.42 . . . . 0.0 110.041 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.32 -41.32 96.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.893 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -66.32 -52.4 47.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.278 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -56.75 -50.05 73.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.609 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -65.52 -31.8 73.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.619 0.247 . . . . 0.0 111.116 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.65 -31.04 63.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.931 0.396 . . . . 0.0 111.21 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.703 HD23 ' HE1' ' A' ' 117' ' ' PHE . 21.0 tp -88.36 -9.84 51.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.122 0.487 . . . . 0.0 110.542 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.95 36.54 4.96 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.13 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.703 ' HE1' HD23 ' A' ' 115' ' ' LEU . 62.5 m-85 -99.68 102.2 13.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.957 0.378 . . . . 0.0 110.239 174.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.18 143.7 56.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.828 177.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 121' ' ' GLN . 13.9 m -99.28 136.25 39.5 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.034 -174.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -79.18 11.85 2.62 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.787 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.455 ' H ' HG22 ' A' ' 119' ' ' THR . 71.3 mm-40 63.66 29.19 15.09 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.67 0.748 . . . . 0.0 109.549 -172.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -168.85 -64.89 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -109.73 -168.68 20.08 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 169.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.047 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 12.9 m-90 -113.96 144.55 42.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.876 0.838 . . . . 0.0 110.339 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -149.14 114.81 5.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 61.7 tttp -96.71 111.67 23.74 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 93' ' ' SER . 56.0 m -88.78 95.31 10.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.736 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.945 -0.645 . . . . 0.9 112.568 179.53 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 999' ' ' COA . . . . . 0.515 ' H61' ' SD ' ' A' ' 108' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.753 0.311 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.415 ' HB3' ' HE2' ' A' ' 2' ' ' LYS . 51.4 mtpt -109.93 164.67 12.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.85 176.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.471 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 43.1 tp -81.88 99.61 9.14 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.582 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 16.7 m -83.11 96.71 8.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.931 0.396 . . . . 0.0 110.174 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 tt -104.47 123.93 58.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.437 0.637 . . . . 0.0 110.937 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.448 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -131.2 177.95 6.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.314 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -94.8 147.01 23.79 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.7 mt -75.96 98.86 4.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.205 0.526 . . . . 0.0 110.765 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -106.87 -23.94 12.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.154 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -124.97 124.96 43.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.791 -172.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.96 91.92 3.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.783 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -83.33 173.74 11.31 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.558 ' O ' HG13 ' A' ' 17' ' ' ILE . 30.2 t70 -62.6 -52.63 62.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.468 -178.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.529 ' HA ' HD12 ' A' ' 17' ' ' ILE . 52.4 tt0 -72.18 -25.73 61.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.906 0.384 . . . . 0.0 110.316 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -62.48 -42.34 99.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -65.05 -39.09 92.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.217 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.6 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 76.4 mt -59.82 -41.97 87.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.356 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.95 -40.11 83.31 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.251 0.548 . . . . 0.0 110.38 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.69 -31.91 73.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.333 173.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -78.94 -10.1 59.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.221 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 64.3 mttm -82.33 -31.62 29.79 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.1 mt -72.16 -46.25 59.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.783 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 6.5 m-90 -117.97 97.38 50.71 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.798 175.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -58.49 -25.05 72.36 Favored 'Trans proline' 0 N--CA 1.476 0.479 0 C-N-CA 123.174 2.583 . . . . 0.0 113.154 -175.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -143.07 86.16 1.9 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.628 ' HE2' ' HG ' ' A' ' 31' ' ' LEU . 91.9 t80 -125.52 123.2 38.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.446 -176.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.1 m -88.64 138.61 29.75 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.257 171.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.461 ' HB3' HD12 ' A' ' 31' ' ' LEU . 12.5 Cg_endo -55.8 97.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.951 2.434 . . . . 0.0 112.756 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.7 m -108.58 -60.49 1.73 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.19 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.422 ' O ' HD11 ' A' ' 39' ' ' ILE . 29.4 p -97.24 -0.43 46.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.765 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.628 ' HG ' ' HE2' ' A' ' 26' ' ' TYR . 64.3 mt -62.4 -21.11 65.11 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.992 0.425 . . . . 0.0 110.866 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -73.49 98.64 2.82 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.4 m -92.97 151.39 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.382 0.611 . . . . 0.0 110.67 -175.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.403 ' HB3' ' H ' ' A' ' 37' ' ' HIS . 22.2 t70 -151.59 171.97 16.78 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.593 -173.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.96 -29.08 68.83 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -90.13 -33.28 16.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.772 176.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.403 ' H ' ' HB3' ' A' ' 34' ' ' ASP . 47.3 m-70 -104.56 99.4 9.08 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.168 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -114.64 139.47 49.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.305 0.574 . . . . 0.0 111.668 -173.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.422 HD11 ' O ' ' A' ' 30' ' ' SER . 55.3 mt -119.48 116.57 51.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.201 171.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -99.61 129.73 45.78 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.536 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -118.19 120.71 38.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.519 -176.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.831 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.09 107.09 18.96 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.071 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 4' ' ' THR . 26.3 ptt180 -96.53 132.62 41.94 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.403 0.62 . . . . 0.0 110.507 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.494 ' HB3' HD13 ' A' ' 49' ' ' LEU . 77.5 t80 -101.1 104.23 15.34 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 176.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 31.3 t30 72.1 -62.19 0.47 Allowed 'General case' 0 C--N 1.331 -0.217 0 O-C-N 124.005 0.816 . . . . 0.0 110.801 -176.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -136.45 -57.72 0.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -94.61 167.29 11.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.975 0.417 . . . . 0.0 111.727 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.536 HD22 ' HB1' ' A' ' 41' ' ' ALA . 35.9 mt -91.21 106.6 18.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.934 -171.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' A' ' 44' ' ' PHE . 10.9 mp -92.93 -15.18 26.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.122 -178.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.831 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -137.21 125.97 23.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.754 0.311 . . . . 0.0 111.017 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -123.67 130.22 52.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.636 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.6 p -135.15 134.05 53.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.057 0.456 . . . . 0.0 111.002 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.632 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 39.5 mtp180 -99.45 134.73 41.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.188 177.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.2 p -139.91 126.76 23.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.611 0.719 . . . . 0.0 111.596 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -108.93 115.22 29.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.756 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -85.69 106.73 17.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.247 0.546 . . . . 0.0 110.807 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -93.63 45.96 1.17 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.28 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.54 -105.87 3.05 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.761 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.5 p -83.04 -17.45 43.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.112 0.482 . . . . 0.0 110.991 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -106.01 118.47 36.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.694 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.73 114.07 4.89 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.37 105.1 17.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.902 0.382 . . . . 0.0 111.275 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.414 HD11 ' HE3' ' A' ' 95' ' ' TRP . 5.0 mp -95.16 111.97 23.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.908 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.632 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 10.3 t0 -118.23 138.31 52.42 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.465 ' HB2' ' HD3' ' A' ' 53' ' ' ARG . 20.2 m 68.39 91.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.628 0.727 . . . . 0.0 111.501 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.7 tp -108.14 110.65 22.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.409 171.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.575 ' HA ' ' O5P' ' A' ' 999' ' ' COA . 83.1 mtt-85 -127.3 104.62 8.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.06 0.457 . . . . 0.0 111.302 -176.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 50' ' ' ALA . 8.3 t -100.91 144.69 12.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 172.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -61.83 155.6 22.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.257 0.551 . . . . 0.0 112.363 -174.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -48.72 -41.04 30.69 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.322 -1.308 . . . . 0.0 113.481 -165.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.83 -13.92 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.975 0.417 . . . . 0.0 112.095 -171.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 m -88.02 60.6 5.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.438 0.637 . . . . 0.0 111.607 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.528 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 29.8 ptt-85 -115.99 130.47 56.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.675 176.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 74' ' ' ARG . 21.4 mtp180 52.81 53.57 11.91 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.479 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.6 ttt180 -135.98 14.13 3.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.901 0.381 . . . . 0.0 111.257 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.09 -35.64 2.56 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.108 -0.568 . . . . 0.0 113.972 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.453 HG13 HD22 ' A' ' 3' ' ' LEU . 49.6 t -50.26 -41.79 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 122.974 0.51 . . . . 0.0 112.355 -175.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.35 -45.28 93.03 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.145 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -65.69 -49.87 66.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.927 0.394 . . . . 0.0 110.245 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.471 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 48.0 t80 -54.4 -42.5 70.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.366 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.418 ' O ' HG23 ' A' ' 85' ' ' VAL . 59.3 tp -52.76 -67.65 0.23 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.847 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 82' ' ' LEU . 3.5 mm? -64.1 -41.27 97.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.693 -174.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 23.8 mt-10 -61.79 -37.53 84.69 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.804 -177.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -70.77 -31.97 68.93 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.535 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 81' ' ' LEU . 67.1 t -61.58 -45.41 98.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 174.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.551 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 11.2 mp -67.32 -18.72 65.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.19 178.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 79.3 mtp180 -81.27 -41.17 22.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.057 0.456 . . . . 0.0 110.833 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -80.42 -29.95 37.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.902 -174.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.522 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 5.9 m-20 -86.0 117.38 68.6 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.894 0.378 . . . . 0.0 110.181 176.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.522 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 1.4 Cg_endo -83.45 -73.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.426 2.751 . . . . 0.0 113.877 -172.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.43 53.45 4.67 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.64 -171.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.6 t -124.2 115.2 44.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 p -105.57 -24.36 12.6 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.766 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 46.1 t -116.67 106.07 13.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.841 0.353 . . . . 0.0 110.116 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.551 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 97.7 m95 -93.34 111.98 23.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.108 0.48 . . . . 0.0 110.248 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -111.45 123.85 51.07 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 68.6 mtp -119.03 117.11 27.88 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.22 146.75 24.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.038 0.447 . . . . 0.0 111.82 -171.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.498 ' HB3' ' CZ3' ' A' ' 124' ' ' TRP . 5.8 p-10 -98.8 14.95 26.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.651 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.93 -55.87 29.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.855 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -97.97 44.67 1.78 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.312 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.415 HG11 ' SD ' ' A' ' 108' ' ' MET . 57.3 t -135.48 101.85 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.796 0.331 . . . . 0.0 110.763 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.717 ' HB2' ' S1P' ' A' ' 999' ' ' COA . 2.3 mp0 -67.67 -41.83 83.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.065 0.46 . . . . 0.0 110.766 178.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -84.93 59.51 5.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.362 0.601 . . . . 0.0 110.489 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -63.16 -39.8 95.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.291 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.69 -54.28 38.36 Favored Glycine 0 C--O 1.236 0.243 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.64 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.1 t -59.07 -43.44 89.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.114 0.483 . . . . 0.0 110.562 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.684 ' SD ' ' HE3' ' A' ' 112' ' ' MET . 37.1 ttm -68.06 -27.01 66.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.154 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 91.9 m -62.25 -52.62 63.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.785 0.326 . . . . 0.0 110.161 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.61 84.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.537 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' A' ' 108' ' ' MET . 51.8 t80 -60.26 -57.83 11.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.347 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.684 ' HE3' ' SD ' ' A' ' 108' ' ' MET . 61.8 mtt -67.34 -33.06 74.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.445 -175.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -63.71 -37.62 88.05 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.09 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.71 -30.37 71.04 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.368 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.0 mp -84.13 2.2 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.085 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.16 23.34 32.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.789 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.54 ' HB3' ' HB3' ' A' ' 124' ' ' TRP . 91.4 m-85 -92.84 134.0 35.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.234 0.517 . . . . 0.0 110.426 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.4 m -90.67 145.1 25.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.484 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.42 HG22 ' CD1' ' A' ' 124' ' ' TRP . 70.9 p -97.43 118.23 33.44 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -124.12 -93.79 0.5 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.311 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -154.83 123.47 6.11 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.36 11.66 66.35 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.373 -174.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.9 -152.34 18.05 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.906 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 117' ' ' PHE . 22.7 m-90 -102.13 150.65 23.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.183 -0.508 . . . . 0.0 110.015 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -134.01 134.79 42.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.371 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -137.07 93.09 2.79 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 171.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.2 p -102.78 142.27 34.19 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.586 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.501 0 C-N-CA 120.944 -0.646 . . . . 0.9 112.187 179.445 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 999' ' ' COA . . . . . 0.717 ' S1P' ' HB2' ' A' ' 103' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtm . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.44 0.162 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -109.97 135.13 51.31 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 172.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.511 HD21 ' HB1' ' A' ' 42' ' ' ALA . 51.9 tp -76.63 122.32 24.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.951 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.2 p -90.58 121.86 32.88 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.244 0.545 . . . . 0.0 110.835 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.513 HG22 ' HA ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -117.1 125.94 74.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.376 -178.35 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.1 mm -103.34 151.33 6.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.2 ptt85 -95.36 106.37 18.42 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.2 mt -75.91 83.72 2.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.145 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.812 ' HA ' HG11 ' A' ' 33' ' ' VAL . 30.6 mt-10 -81.81 -26.13 34.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.993 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -147.49 122.94 10.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.71 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -93.34 133.76 36.26 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.935 -173.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 m -77.47 174.3 11.01 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 168.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.478 ' O ' HG13 ' A' ' 17' ' ' ILE . 8.6 p-10 -65.08 -45.52 84.93 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.492 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -63.69 -40.11 95.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.0 110.317 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.416 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 24.1 m-20 -57.07 -50.87 71.44 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.092 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -66.08 -30.47 70.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.83 -177.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 13' ' ' ASP . 84.3 mt -72.62 -39.47 61.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.996 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -69.72 -34.96 74.6 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 79.6 mt -64.57 -32.27 73.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.385 173.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -71.31 -23.31 61.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.979 0.419 . . . . 0.0 110.45 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 83.5 mttt -70.67 -38.25 73.75 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 173.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.89 -43.95 52.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.514 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.709 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 5.3 m-90 -121.52 89.2 47.09 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.998 177.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -62.26 -40.03 43.64 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.622 2.215 . . . . 0.0 112.212 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -133.92 83.71 2.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.922 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.709 ' HB2' ' HB3' ' A' ' 23' ' ' TRP . 15.6 t80 -127.89 151.9 48.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.732 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.475 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 66.3 m -63.26 117.75 36.71 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 121.078 0.466 . . . . 0.0 111.673 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 27' ' ' SER . 32.8 Cg_exo -62.04 -36.32 71.41 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.498 2.798 . . . . 0.0 112.866 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.7 m -69.08 -22.91 63.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.907 0.384 . . . . 0.0 111.092 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.3 t -77.76 -8.15 57.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.18 0.514 . . . . 0.0 110.442 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.3 mt -83.78 16.37 2.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.485 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -72.43 128.23 34.98 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.812 HG11 ' HA ' ' A' ' 9' ' ' GLU . 39.8 t -113.22 122.86 68.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.454 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -148.33 -171.0 3.74 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -69.95 -31.41 69.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.267 0.556 . . . . 0.0 109.836 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -84.28 -8.14 59.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.52 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -152.48 97.72 2.3 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.355 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 38' ' ' ARG . 50.0 mtt180 -111.98 135.73 52.23 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.209 -178.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.532 HG23 ' HG2' ' A' ' 53' ' ' ARG . 59.0 mt -101.56 118.79 48.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.286 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -100.72 125.31 47.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.306 0.574 . . . . 0.0 110.457 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.567 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.14 119.36 39.25 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.1 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.11 114.76 27.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.029 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.458 ' HB3' HD23 ' A' ' 48' ' ' LEU . 34.2 ptt180 -109.72 132.4 54.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.575 0.702 . . . . 0.0 111.219 -175.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.44 ' O ' ' HB3' ' A' ' 45' ' ' ASN . 75.6 t80 -98.1 102.84 14.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.078 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 10.4 t30 74.31 -43.12 0.52 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.719 0.637 . . . . 0.0 111.435 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -159.83 -56.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.023 0.44 . . . . 0.0 111.332 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 47' ' ' ARG . 51.3 mtt180 -85.73 153.22 22.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.007 -171.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.567 HD22 ' HB1' ' A' ' 41' ' ' ALA . 52.0 mt -71.06 122.75 20.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.855 -175.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.4 tp -105.29 -15.08 15.15 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.035 0.445 . . . . 0.0 110.206 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -154.48 150.07 27.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.458 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -135.24 125.52 26.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.869 0.366 . . . . 0.0 110.666 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.35 138.29 48.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.445 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.532 ' HG2' HG23 ' A' ' 39' ' ' ILE . 21.2 mtm180 -118.18 133.37 55.96 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.1 p -120.78 126.15 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.631 0.729 . . . . 0.0 111.176 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.7 m -90.69 94.58 9.75 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.535 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.11 92.15 5.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.456 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.6 m -93.29 84.42 4.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.823 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.45 -101.39 0.83 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.699 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.4 p -112.85 6.98 18.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.154 0.502 . . . . 0.0 110.488 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -101.14 111.75 24.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.41 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.98 94.06 1.7 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.711 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.92 123.39 45.05 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.806 -0.232 . . . . 0.0 110.517 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.42 HD13 ' SD ' ' A' ' 97' ' ' MET . 6.8 mp -93.45 118.84 31.82 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -101.15 -12.8 18.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.673 -170.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.4 m -155.31 133.4 11.54 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.076 -0.249 . . . . 0.0 111.28 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.9 tp -148.44 115.93 6.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.865 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.425 ' HG2' ' C5P' ' A' ' 999' ' ' COA . 24.6 mtp180 -138.71 132.6 31.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.425 173.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 50' ' ' ALA . 3.5 t -103.85 152.01 6.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 172.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -71.93 154.68 41.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.612 0.244 . . . . 0.0 110.787 -175.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -43.03 -47.25 5.81 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -170.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.3 m -81.05 26.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -171.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.83 29.52 6.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.044 0.449 . . . . 0.0 111.417 -177.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -67.11 108.96 2.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.825 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.473 ' HA ' ' O2A' ' A' ' 999' ' ' COA . 20.2 mtp180 56.23 42.27 28.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.141 0.496 . . . . 0.0 110.666 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.4 ttt180 -108.59 19.36 19.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.103 -172.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.51 -40.51 2.42 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.862 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.4 t -46.81 -46.72 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 123.21 0.604 . . . . 0.0 112.581 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.68 -41.73 90.26 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.11 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.518 ' HG3' ' HG ' ' A' ' 115' ' ' LEU . 52.7 tt0 -69.36 -38.53 78.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.996 0.426 . . . . 0.0 110.356 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.479 ' HE2' ' H ' ' A' ' 3' ' ' LEU . 74.8 t80 -68.56 -38.39 80.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.184 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.444 HD13 ' HB2' ' A' ' 42' ' ' ALA . 50.2 tp -53.61 -56.78 14.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.211 177.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.454 ' O ' HD13 ' A' ' 86' ' ' LEU . 4.4 mm? -60.15 -45.72 92.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -67.84 -37.51 81.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.369 -176.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -58.78 -46.99 86.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.797 0.332 . . . . 0.0 110.539 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 73.3 t -63.82 -46.36 94.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 82' ' ' LEU . 11.0 mp -69.09 -29.06 67.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.312 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.0 ttt-85 -75.27 -30.75 60.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.107 0.48 . . . . 0.0 109.721 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -75.94 -33.62 59.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.052 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -115.8 70.78 3.65 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.344 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.33 -6.7 13.84 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.289 1.992 . . . . 0.0 112.051 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.07 -14.97 81.73 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.947 -0.645 . . . . 0.0 112.153 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.8 t -87.78 113.36 24.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.962 0.411 . . . . 0.0 110.203 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 2.5 p -89.5 -22.91 22.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.426 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.4 m -108.05 99.3 8.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.824 0.345 . . . . 0.0 111.363 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -109.05 126.13 52.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.272 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.426 ' HE3' ' HG2' ' A' ' 125' ' ' GLU . 51.9 t-105 -115.58 127.82 55.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.198 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.861 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 87.5 mmm -108.0 120.76 43.23 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.96 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.79 142.7 47.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.45 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.847 ' HB2' ' HB ' ' A' ' 102' ' ' VAL . 4.6 p-10 -86.61 -35.55 19.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.107 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.54 22.87 12.58 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.955 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 125.39 37.21 0.53 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.646 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.847 ' HB ' ' HB2' ' A' ' 99' ' ' ASP . 76.8 t -102.22 125.68 56.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -84.18 -35.81 23.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.632 -177.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -83.18 67.67 9.29 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.486 0.66 . . . . 0.0 110.886 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -72.55 -17.73 61.7 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.614 176.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.08 -57.86 12.47 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.048 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.16 -43.56 97.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.623 0.249 . . . . 0.0 111.15 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.618 ' SD ' HG11 ' A' ' 102' ' ' VAL . 50.6 mtp -71.11 -31.04 67.27 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.008 -175.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.716 HG23 HG21 ' A' ' 119' ' ' THR . 36.6 m -68.92 -43.95 74.11 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.243 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.12 -38.78 87.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.198 0.523 . . . . 0.0 110.287 176.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.652 ' HA ' ' O4B' ' A' ' 999' ' ' COA . 31.4 t80 -61.4 -51.53 68.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.33 176.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.491 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 66.1 mtt -75.93 -34.5 59.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.922 -174.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -74.1 -22.61 59.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.888 0.375 . . . . 0.0 110.572 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.05 -19.22 25.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.041 0.448 . . . . 0.0 110.63 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.518 ' HG ' ' HG3' ' A' ' 79' ' ' GLN . 6.1 tt -80.32 -55.17 5.08 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 146.93 46.74 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.401 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 97.2 m-85 -121.33 143.01 49.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.802 0.335 . . . . 0.0 110.274 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.9 m -81.09 121.72 26.44 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.716 HG21 HG23 ' A' ' 109' ' ' THR . 67.2 p -97.38 130.43 44.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.141 0.496 . . . . 0.0 111.054 -173.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -129.36 176.09 8.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.53 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -81.71 87.95 6.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.081 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 129.92 -50.77 0.88 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.292 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -135.32 178.92 18.22 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.506 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.861 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 8.2 m-90 -127.3 140.98 51.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.426 ' HG2' ' HE3' ' A' ' 96' ' ' TRP . 42.3 mt-10 -129.03 150.79 50.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.933 0.397 . . . . 0.0 111.452 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.55 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 78.8 tttt -136.15 121.8 19.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.766 171.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 93' ' ' SER . 53.9 t -129.93 108.98 10.53 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.23 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 121.037 -0.601 . . . . 0.9 112.13 178.315 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 999' ' ' COA . . . . . 0.652 ' O4B' ' HA ' ' A' ' 111' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 92.7 mttt . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.823 0.344 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.592 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 47.3 tp -76.0 115.94 16.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.805 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.0 m -82.67 101.23 10.7 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.016 0.436 . . . . 0.0 110.662 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.642 HD11 ' HB3' ' A' ' 40' ' ' TYR . 8.4 tp -90.18 113.38 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 121.749 0.785 . . . . 0.0 110.102 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.7 mt -106.57 153.34 7.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.516 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 -100.86 126.55 47.47 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.5 mt -80.9 91.51 6.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.339 0.59 . . . . 0.0 110.875 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -93.13 -23.95 18.43 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.662 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -140.06 139.53 35.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.599 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -115.38 116.0 27.53 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.519 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.4 p -84.89 171.12 12.45 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 17' ' ' ILE . 30.7 m-20 -74.24 -21.35 59.82 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -69.78 -49.26 54.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.418 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 62.8 m-20 -61.31 -38.8 88.15 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.672 ' HG2' HE21 ' A' ' 20' ' ' GLN . 46.6 ttm-85 -53.8 -47.05 71.2 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.059 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 13' ' ' ASP . 77.8 mt -66.59 -48.31 80.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.459 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.528 ' HB3' HD12 ' A' ' 48' ' ' LEU . 1.2 m-20 -65.43 -32.26 73.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.342 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 78.1 mt -64.89 -42.48 94.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.526 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.672 HE21 ' HG2' ' A' ' 16' ' ' ARG . 73.6 mt-30 -69.04 -20.65 64.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.366 0.603 . . . . 0.0 110.346 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -76.99 -26.53 53.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.557 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 18' ' ' ASP . 70.6 mt -82.57 -37.43 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.46 175.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -117.86 85.89 23.67 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.369 177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 C--N 1.346 0.42 0 C-N-CA 122.642 2.228 . . . . 0.0 113.102 -175.527 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 CA--C 1.52 -0.177 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -134.03 111.34 10.3 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.309 -169.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -103.61 159.12 4.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.16 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -130.73 -166.4 1.68 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -79.14 -11.59 59.98 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.767 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -96.24 -59.83 1.75 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.117 174.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -74.31 97.47 3.02 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 38' ' ' ARG . 22.7 mtp180 -115.81 115.43 26.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.235 0.54 . . . . 0.0 110.488 -173.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.2 mt -98.59 118.85 45.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.661 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.642 ' HB3' HD11 ' A' ' 5' ' ' ILE . 96.7 m-85 -106.28 142.74 35.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.343 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.443 ' HB1' HD21 ' A' ' 48' ' ' LEU . . . -123.55 117.69 25.66 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.38 -175.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.497 ' HB1' HD21 ' A' ' 3' ' ' LEU . . . -91.71 99.78 12.61 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.03 0.443 . . . . 0.0 109.869 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.681 ' HG2' HD23 ' A' ' 48' ' ' LEU . 4.1 mtm180 -104.21 111.02 23.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.413 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -97.46 107.82 20.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.931 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.0 t30 60.53 65.32 1.07 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.012 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 72.58 -29.85 0.2 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.655 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -101.56 145.56 28.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.981 0.42 . . . . 0.0 111.821 -170.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.681 HD23 ' HG2' ' A' ' 43' ' ' ARG . 54.7 mt -65.22 117.84 8.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.962 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.9 tp -106.95 -27.14 10.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.912 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -152.76 149.22 28.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.547 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -138.35 135.51 35.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.358 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.482 ' HB ' HD13 ' A' ' 66' ' ' LEU . 8.8 p -140.62 140.98 33.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.919 0.39 . . . . 0.0 110.781 -177.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -114.51 123.5 49.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.506 ' HB ' HD23 ' A' ' 63' ' ' LEU . 6.7 p -125.2 124.37 67.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.317 0.579 . . . . 0.0 110.414 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.9 m -97.89 99.47 10.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.059 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.53 HD23 ' HA2' ' A' ' 61' ' ' GLY . 96.9 mt -85.86 70.44 10.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.938 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 m -67.31 99.06 0.67 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.005 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.18 -116.43 5.24 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.373 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.7 m -114.13 14.71 18.29 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.872 0.844 . . . . 0.0 109.386 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -101.31 134.57 44.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.853 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.53 ' HA2' HD23 ' A' ' 56' ' ' LEU . . . -106.09 106.01 2.51 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.657 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.57 108.45 20.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.929 0.395 . . . . 0.0 110.748 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.534 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 56.6 mt -93.94 119.93 33.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -99.25 -75.32 0.57 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.927 -174.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 p -121.92 141.92 50.8 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.256 0.551 . . . . 0.0 112.191 -173.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.482 HD13 ' HB ' ' A' ' 52' ' ' VAL . 33.9 tp -140.85 119.99 12.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.858 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 67' ' ' ARG . 13.0 mtp180 -128.41 114.75 17.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.793 0.33 . . . . 0.0 111.191 176.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.459 HG12 ' HB ' ' A' ' 72' ' ' THR . 11.2 t -95.33 151.73 3.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 167.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -54.06 140.28 32.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 34.4 mp0 -52.19 -38.25 57.25 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.251 0.62 . . . . 0.0 112.426 -172.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.38 -22.97 27.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.186 0.517 . . . . 0.0 111.201 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.459 ' HB ' HG12 ' A' ' 68' ' ' VAL . 6.9 m -90.86 64.02 5.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.285 0.564 . . . . 0.0 109.953 -177.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 12.6 ttp180 -94.75 12.65 27.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.198 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 74' ' ' ARG . 36.6 ttp180 173.85 90.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.715 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -156.46 17.57 0.33 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.116 0.484 . . . . 0.0 110.243 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.28 -34.46 1.76 Allowed Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.077 -0.583 . . . . 0.0 113.379 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.562 HG13 HD22 ' A' ' 3' ' ' LEU . 59.5 t -39.74 -52.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.079 0.951 . . . . 0.0 113.309 -176.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.92 -55.12 31.87 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.266 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.453 ' HB3' HD13 ' A' ' 115' ' ' LEU . 24.9 mt-30 -67.83 -39.65 83.86 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.793 -0.239 . . . . 0.0 110.614 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.592 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 47.2 t80 -53.72 -47.78 70.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.159 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.574 HD11 HD13 ' A' ' 5' ' ' ILE . 43.0 tp -62.19 -50.96 69.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.249 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.442 HD21 HD22 ' A' ' 66' ' ' LEU . 4.4 mm? -59.65 -46.58 88.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.154 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 48.0 mt-10 -61.37 -44.73 96.67 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.046 -0.261 . . . . 0.0 110.359 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -56.55 -43.75 80.24 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.906 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 81' ' ' LEU . 96.9 t -61.06 -46.77 96.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.352 . . . . 0.0 110.609 178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -72.29 -18.44 61.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.915 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.511 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 23.1 mtm180 -88.73 -22.1 23.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.537 0.208 . . . . 0.0 111.329 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -103.08 -7.35 21.41 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.638 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -118.37 85.61 25.94 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.0 110.187 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.49 162.99 12.75 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.18 2.587 . . . . 0.0 111.44 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.83 -45.87 3.25 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.782 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.86 99.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 16.5 m -92.55 -25.48 18.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 -175.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.6 t -102.35 98.75 8.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.84 0.352 . . . . 0.0 110.728 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -97.2 113.19 24.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.948 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -112.7 123.03 49.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.014 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.752 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 63.3 mtp -111.4 123.43 50.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.375 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.16 153.72 27.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.739 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -84.58 -26.55 27.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.242 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 59.09 14.38 3.44 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.18 20.88 78.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.392 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.8 t -67.92 134.31 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.583 0.23 . . . . 0.0 110.49 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -93.28 -17.2 23.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.044 0.449 . . . . 0.0 111.072 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -83.88 19.53 1.7 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 171.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.458 ' HA ' ' HB2' ' A' ' 108' ' ' MET . 6.9 ttp180 -64.77 -26.96 68.58 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.106 -176.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.0 -48.18 87.35 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.207 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 80.2 t -65.8 -42.47 92.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.994 0.425 . . . . 0.0 110.362 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.642 ' O ' ' HG2' ' A' ' 112' ' ' MET . 96.1 mmm -59.2 -48.41 81.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.242 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.1 m -63.43 -35.54 80.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.365 0.126 . . . . 0.0 111.14 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.86 99.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.391 0.615 . . . . 0.0 109.937 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -62.12 -44.35 96.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.453 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.642 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.1 mmt -62.44 -48.08 81.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.616 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -64.93 -38.7 91.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.244 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.83 -21.9 56.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.424 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.525 HD23 ' HE2' ' A' ' 117' ' ' PHE . 40.9 tp -87.56 -45.69 10.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.527 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 138.04 44.52 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.231 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.585 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 87.3 m-85 -120.7 153.74 36.52 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.0 m -120.05 146.79 45.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.126 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.1 m -97.12 121.79 39.41 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -136.08 103.8 5.47 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 58.0 36.19 25.9 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.28 165.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.83 49.16 0.55 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.366 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.39 179.36 19.96 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.87 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.752 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 6.9 m-90 -102.95 137.83 40.63 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -125.56 137.37 53.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.758 0.314 . . . . 0.0 110.445 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.411 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 61.0 tttp -137.21 91.7 2.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.133 0.492 . . . . 0.0 109.999 172.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 93' ' ' SER . 52.4 t -91.21 112.36 24.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.228 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 CA-C-N 115.77 -0.65 . . . . 0.9 111.865 179.96 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 121.184 0.516 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.1 tp -76.13 114.63 15.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.877 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.9 m -82.8 89.79 6.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.953 0.406 . . . . 0.0 110.655 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.614 HD11 ' HB3' ' A' ' 40' ' ' TYR . 5.2 tp -95.75 111.04 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.994 175.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.3 pt -130.51 171.01 18.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.836 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -92.79 137.2 32.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.447 ' O ' HG21 ' A' ' 33' ' ' VAL . 53.9 tp -78.99 70.55 5.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.245 0.545 . . . . 0.0 109.689 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -69.49 -43.8 72.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.443 -174.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -111.44 132.07 54.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.967 -175.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' A' ' 31' ' ' LEU . 72.3 m-85 -99.46 114.88 28.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.245 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.8 p -102.46 163.92 11.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.58 ' O ' HG13 ' A' ' 17' ' ' ILE . 34.1 t70 -66.12 -29.84 70.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -66.99 -50.19 63.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.008 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.439 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 32.9 m-20 -61.74 -35.04 76.92 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.622 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.407 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 35.6 ttm180 -61.47 -38.01 85.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.526 176.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 13' ' ' ASP . 72.9 mt -60.48 -42.49 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.193 0.52 . . . . 0.0 110.331 176.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.436 ' HB3' HD12 ' A' ' 48' ' ' LEU . 80.5 m-20 -68.73 -33.54 74.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.666 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 96.4 mt -65.0 -34.44 78.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.372 175.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 25.4 mt-30 -69.71 -24.71 63.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.733 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -66.52 -44.36 82.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.231 0.539 . . . . 0.0 109.867 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.2 mt -75.45 -45.59 39.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.33 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -123.89 74.48 56.4 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.668 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 C--N 1.344 0.3 0 C-N-CA 121.922 1.748 . . . . 0.0 111.341 175.072 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.571 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 51.4 mt . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 121.198 0.523 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -129.96 139.97 51.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.353 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 13.7 m -125.72 154.19 34.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.386 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.516 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 22.9 t70 74.4 -30.11 0.2 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.53 175.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 36' ' ' ASN . 4.4 t70 -81.71 68.94 8.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 35' ' ' ASP . 19.7 m120 83.22 -40.02 0.09 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.207 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.519 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 90.2 m-70 -101.59 110.4 22.39 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.641 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.516 ' HG2' ' HA ' ' A' ' 34' ' ' ASP . 69.8 mtt180 -109.2 117.19 33.47 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.097 0.475 . . . . 0.0 110.651 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.557 HG12 ' HG2' ' A' ' 53' ' ' ARG . 53.8 mt -98.67 110.71 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.115 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.614 ' HB3' HD11 ' A' ' 5' ' ' ILE . 73.3 m-85 -97.61 141.16 30.99 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.476 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -124.62 113.74 18.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.969 0.414 . . . . 0.0 111.089 -170.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.485 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.13 101.5 14.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.528 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.516 ' HB3' HD23 ' A' ' 48' ' ' LEU . 28.5 ptt180 -102.51 118.84 37.74 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.546 0.689 . . . . 0.0 110.858 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -97.44 133.41 42.07 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.5 t30 64.61 23.35 12.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.003 0.906 . . . . 0.0 108.607 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 66.47 20.74 10.88 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.419 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -126.88 142.73 51.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' A' ' 43' ' ' ARG . 55.5 mt -54.49 130.39 39.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.182 0.515 . . . . 0.0 112.14 -172.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 34.4 tp -125.6 -40.65 2.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.205 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.529 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -133.12 143.99 49.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.325 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -135.07 132.28 37.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.387 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.59 132.46 62.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.081 0.467 . . . . 0.0 110.927 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.557 ' HG2' HG12 ' A' ' 39' ' ' ILE . 27.8 mtm180 -111.11 121.65 45.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.985 176.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.66 119.55 59.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.411 0.624 . . . . 0.0 109.71 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 89.9 m -95.56 95.53 8.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.571 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.584 ' HA ' ' HA3' ' A' ' 61' ' ' GLY . 89.2 mt -80.38 124.27 28.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.119 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.7 t -98.59 50.15 0.98 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.71 -104.83 2.45 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.549 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.5 p -94.49 -29.53 14.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.381 0.61 . . . . 0.0 110.648 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.81 ' HB3' ' HB3' ' A' ' 94' ' ' CYS . 36.0 mt-10 -119.19 151.33 38.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.008 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 56' ' ' LEU . . . -151.7 -179.84 27.7 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 119.461 -1.352 . . . . 0.0 113.894 -173.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.63 135.33 48.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.222 -0.489 . . . . 0.0 110.205 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.8 tt -93.77 112.84 24.77 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -97.24 -56.89 2.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -168.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.1 m -107.81 106.22 16.41 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.024 0.44 . . . . 0.0 111.553 -173.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.3 tp -124.58 109.07 12.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.785 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -138.94 136.84 35.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.233 0.54 . . . . 0.0 111.246 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.529 HG13 ' HB2' ' A' ' 50' ' ' ALA . 14.5 t -110.8 152.0 12.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -57.79 150.56 19.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.746 0.308 . . . . 0.0 110.18 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -51.7 -38.43 55.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.51 -20.85 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 111.931 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.442 ' HB ' ' CG1' ' A' ' 68' ' ' VAL . 2.0 m -113.09 24.92 11.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.157 0.503 . . . . 0.0 111.255 -175.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 16.5 mtp180 -78.25 38.84 0.3 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 8.3 ttm180 174.37 19.95 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.276 0.23 . . . . 0.0 111.057 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -141.04 75.28 1.49 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -167.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.74 -61.45 4.27 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 115.703 1.041 . . . . 0.0 115.703 161.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -43.42 -51.97 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -168.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.09 -41.18 77.14 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.957 -0.639 . . . . 0.0 113.595 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -68.64 -53.07 24.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.919 0.39 . . . . 0.0 110.623 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -58.21 -40.87 82.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.421 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.563 HD11 HD13 ' A' ' 5' ' ' ILE . 26.9 tp -56.3 -55.07 37.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.384 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.47 ' HB2' HD11 ' A' ' 115' ' ' LEU . 55.6 mt -62.34 -41.74 98.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.376 -176.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -62.94 -37.87 88.75 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.782 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.84 -39.1 80.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.43 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 81' ' ' LEU . 72.5 t -58.49 -45.94 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.815 0.34 . . . . 0.0 111.039 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 82' ' ' LEU . 11.1 mp -68.22 -23.75 64.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.122 0.487 . . . . 0.0 110.744 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.6 mtp85 -76.73 -33.06 58.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.852 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.41 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 13.2 m120 -71.01 -49.69 42.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -118.27 86.21 26.76 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.763 0.316 . . . . 0.0 111.377 -178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 1.8 Cg_endo -83.75 170.61 11.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.966 2.444 . . . . 0.0 111.481 175.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.06 -14.85 62.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.216 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.559 HG13 ' HA ' ' A' ' 60' ' ' GLU . 53.3 t -78.24 118.53 25.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 128' ' ' GLY . 2.4 p -84.46 -40.23 17.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.572 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.81 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 45.1 t -101.93 100.14 10.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.904 0.383 . . . . 0.0 110.866 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -97.3 97.66 9.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -96.8 128.27 43.58 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.844 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 96.0 mmm -107.16 109.5 21.34 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.12 149.66 42.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.667 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -75.6 -43.51 47.77 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 61.07 8.74 2.07 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.773 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.87 17.78 66.93 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.882 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 104' ' ' ASP . 82.8 t -67.69 111.9 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 121.217 0.532 . . . . 0.0 110.064 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -79.79 1.26 27.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.744 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.421 ' H ' HG12 ' A' ' 102' ' ' VAL . 13.4 m-20 -101.1 21.31 14.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.442 174.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -58.9 -27.25 65.05 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.902 -175.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.36 -53.03 45.11 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.568 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 43.7 t -62.97 -37.36 79.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.169 0.509 . . . . 0.0 110.047 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.598 ' O ' ' HG2' ' A' ' 112' ' ' MET . 96.9 mmm -65.13 -36.18 83.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.232 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 93.3 m -63.9 -45.04 91.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.712 0.291 . . . . 0.0 110.693 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.28 94.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.182 0.515 . . . . 0.0 110.209 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -61.92 -48.22 81.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.227 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.598 ' HG2' ' O ' ' A' ' 108' ' ' MET . 26.3 mmt -57.59 -48.87 78.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 0.0 111.114 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -72.14 -21.87 61.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.541 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.56 -34.96 35.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.991 0.424 . . . . 0.0 110.545 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.47 HD11 ' HB2' ' A' ' 82' ' ' LEU . 7.4 tt -75.42 -56.37 4.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.002 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 149.19 33.35 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.993 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 89.0 m-85 -107.9 167.62 9.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 31.9 m -117.23 137.64 52.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.442 HG23 ' CD1' ' A' ' 124' ' ' TRP . 15.8 m -97.65 132.65 43.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.939 0.399 . . . . 0.0 110.59 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.556 ' NE2' ' HB3' ' A' ' 125' ' ' GLU . 48.4 mt-30 -126.65 -171.62 2.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.6 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -85.48 109.02 18.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.88 0.372 . . . . 0.0 110.474 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.8 7.09 32.01 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.429 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.86 -175.38 27.21 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.51 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.844 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 9.7 m-90 -107.55 160.76 15.43 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.556 ' HB3' ' NE2' ' A' ' 120' ' ' GLN . 55.7 tt0 -157.76 150.85 23.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.058 0.456 . . . . 0.0 110.791 176.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -133.49 117.3 17.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.537 174.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 33.7 t -85.0 108.91 17.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.95 0.405 . . . . 0.0 110.016 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 93' ' ' SER . . . . . . . . 0 N--CA 1.449 -0.457 0 CA-C-N 115.888 -0.596 . . . . 0.9 112.285 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.8 tttm . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 121.112 0.482 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.546 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 36.5 tp -75.88 137.51 40.47 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 m -111.16 109.35 19.37 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.801 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.555 HD13 HD11 ' A' ' 81' ' ' LEU . 11.2 tp -89.81 113.17 25.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.541 0.686 . . . . 0.0 109.822 176.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.99 149.9 16.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.185 0.517 . . . . 0.0 110.489 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -74.77 112.57 11.12 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.441 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.1 tp -67.77 101.93 1.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -98.77 -49.79 4.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.987 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -127.01 149.05 50.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.997 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -107.81 136.52 47.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.66 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.66 ' HB2' ' OD1' ' A' ' 15' ' ' ASP . 8.3 m -115.9 162.39 17.41 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 170.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -63.02 -42.82 99.9 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -171.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -64.92 -52.24 57.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.608 0.242 . . . . 0.0 111.178 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.66 ' OD1' ' HB2' ' A' ' 12' ' ' SER . 0.5 OUTLIER -72.04 -19.05 61.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.543 -179.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -64.25 -44.64 91.16 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.5 mt -68.38 -33.79 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.259 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -63.41 -39.41 94.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.961 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.0 mt -64.56 -36.92 85.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.807 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -73.28 -13.3 61.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.009 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -89.14 -24.34 22.23 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.3 mt -77.75 -49.36 22.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.728 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -104.92 91.64 4.52 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo . . . . . 0 C--N 1.344 0.297 0 C-N-CA 122.875 2.383 . . . . 0.0 113.432 -170.067 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.5 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 121.113 0.482 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -88.25 117.56 27.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.962 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.4 m -122.73 137.18 57.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.171 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.883 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 11.7 t70 72.15 8.33 5.87 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.748 170.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 37' ' ' HIS . 7.8 m-20 -120.27 77.54 1.27 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.5 m120 75.85 -34.99 0.25 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.148 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.451 ' H ' ' C ' ' A' ' 35' ' ' ASP . 86.1 m-70 -112.76 112.45 23.95 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 173.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.883 ' HG2' ' HA ' ' A' ' 34' ' ' ASP . 79.4 mtt180 -113.84 126.18 54.9 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.016 0.436 . . . . 0.0 110.551 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.575 HG12 ' HG2' ' A' ' 53' ' ' ARG . 71.8 mt -100.35 119.81 48.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.935 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -102.49 133.0 48.18 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.525 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.57 125.06 51.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.802 -175.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.06 98.78 11.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.197 0.522 . . . . 0.0 110.159 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.417 ' HD3' HH11 ' A' ' 43' ' ' ARG . 15.6 ttm180 -87.61 126.88 35.2 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.495 -177.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -124.53 95.47 4.54 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.2 m120 60.94 74.26 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.981 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 71.42 -43.55 0.57 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.772 -1.103 . . . . 0.0 113.181 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -88.76 153.76 20.82 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.758 0.313 . . . . 0.0 111.111 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.525 HD22 ' HB1' ' A' ' 41' ' ' ALA . 79.5 mt -90.24 108.09 19.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.016 0.436 . . . . 0.0 110.145 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.4 tp -83.38 -31.41 26.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.639 -175.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.538 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -144.45 157.13 44.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.755 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.29 135.59 22.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.115 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 65' ' ' SER . 7.1 p -135.14 138.69 48.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.001 0.429 . . . . 0.0 111.141 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.575 ' HG2' HG12 ' A' ' 39' ' ' ILE . 88.4 mtt180 -103.16 131.24 50.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.892 176.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.43 ' HB ' HD23 ' A' ' 63' ' ' LEU . 7.1 p -125.24 122.33 62.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.356 0.598 . . . . 0.0 110.937 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 34.8 m -93.35 110.02 21.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.971 175.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.476 HD23 ' HA2' ' A' ' 61' ' ' GLY . 92.3 mt -94.98 98.63 10.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.635 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 t -95.71 97.87 10.03 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.76 -107.27 2.06 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.404 -174.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.4 p -115.43 12.6 16.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.92 0.391 . . . . 0.0 111.187 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.05 138.08 42.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.019 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.476 ' HA2' HD23 ' A' ' 56' ' ' LEU . . . -116.03 113.54 2.87 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.385 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.54 ' HB3' ' HB ' ' A' ' 55' ' ' THR . . . -96.35 110.96 23.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.963 0.411 . . . . 0.0 110.753 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.719 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 53.7 mt -93.85 109.78 21.46 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.743 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.85 -75.06 0.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.788 0.328 . . . . 0.0 111.818 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 13.6 m -82.18 85.76 6.75 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.892 0.377 . . . . 0.0 111.384 -175.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.521 HD21 HD21 ' A' ' 82' ' ' LEU . 47.0 tp -102.67 100.73 10.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.613 173.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -135.12 126.55 28.56 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.568 -175.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 50' ' ' ALA . 12.1 t -111.75 155.48 13.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 174.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -60.21 137.57 58.09 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -48.2 -41.53 27.47 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.793 0.683 . . . . 0.0 112.609 -173.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.5 m -73.09 2.44 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 m -98.69 7.76 45.72 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.099 0.476 . . . . 0.0 111.014 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 73' ' ' ARG . 30.4 mtm180 -70.34 106.7 3.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.836 0.351 . . . . 0.0 110.369 177.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 60.7 ttt180 -157.67 -81.07 0.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.471 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 27.4 ttt180 164.86 95.71 0.0 OUTLIER 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -169.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.02 -79.53 0.2 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.506 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.514 HG13 HD22 ' A' ' 3' ' ' LEU . 69.3 t -47.47 -46.56 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 123.194 0.597 . . . . 0.0 112.589 -174.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.97 -62.67 6.1 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.06 -0.591 . . . . 0.0 113.548 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -68.21 -32.61 72.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.79 0.295 . . . . 0.0 111.143 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.546 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 30.3 t80 -59.44 -49.25 78.51 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.555 HD11 HD13 ' A' ' 5' ' ' ILE . 55.9 tp -52.32 -56.04 17.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.104 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.521 HD21 HD21 ' A' ' 66' ' ' LEU . 4.2 mm? -58.23 -44.46 88.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.029 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.718 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 5.4 mt-10 -63.27 -49.34 74.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.584 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.5 ' OE1' HG22 ' A' ' 5' ' ' ILE . 35.2 tt0 -63.73 -34.95 79.03 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.064 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 81' ' ' LEU . 75.5 t -61.46 -43.9 97.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.868 0.366 . . . . 0.0 110.342 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 82' ' ' LEU . 11.0 mp -72.01 -24.16 61.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.344 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.718 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 19.2 mmt180 -76.93 -39.02 52.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.055 0.455 . . . . 0.0 109.98 176.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -67.73 -34.76 77.49 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.793 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -119.59 79.79 22.48 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.036 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -86.74 -9.48 6.57 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.544 2.163 . . . . 0.0 112.908 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.87 -35.04 55.1 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.4 t -73.47 104.85 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 p -106.01 12.22 30.71 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.059 0.457 . . . . 0.0 110.656 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 47.8 t -130.51 99.97 5.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.342 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -107.79 120.3 41.87 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.442 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.521 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 13.7 t-105 -115.98 120.42 39.08 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.191 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.719 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 76.1 mtp -107.15 126.5 52.46 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.099 0.476 . . . . 0.0 110.099 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.2 146.53 24.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.971 -176.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.68 16.67 10.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.282 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.38 106.88 4.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.701 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.52 0.81 56.65 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.162 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 80.7 t -86.82 107.27 16.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.792 0.329 . . . . 0.0 110.381 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.69 -46.04 33.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.072 0.463 . . . . 0.0 110.032 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -94.71 81.64 3.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.257 0.551 . . . . 0.0 110.459 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.5 mtt85 -71.03 -28.85 64.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.411 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.3 -54.62 28.56 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.351 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.22 -42.4 93.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.765 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.585 ' O ' ' HG2' ' A' ' 112' ' ' MET . 97.8 mmm -64.5 -36.52 84.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.675 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 85.8 m -64.68 -43.96 91.88 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.858 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.58 -36.59 84.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.264 0.554 . . . . 0.0 110.376 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -64.74 -44.41 90.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.411 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.585 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.5 mmt -62.24 -42.73 99.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.009 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -57.15 -40.32 76.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.544 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.41 -29.83 69.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.209 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.5 mt -85.0 -7.52 59.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.022 0.439 . . . . 0.0 111.228 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.36 21.66 56.13 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.144 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 37.5 m-85 -85.6 132.19 34.22 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 65.2 p -95.7 162.19 13.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.998 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.2 t -97.21 117.16 30.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.7 0.762 . . . . 0.0 109.7 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.94 169.71 10.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.24 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -70.8 94.48 1.04 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.045 0.45 . . . . 0.0 110.748 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.83 -11.24 5.42 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.41 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.25 -146.91 16.02 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.312 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 7.5 m-90 -103.1 133.56 48.0 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -121.04 131.54 54.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.183 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -137.03 115.55 11.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.91 172.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 22.4 t -112.72 115.98 29.4 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.942 0.401 . . . . 0.0 110.182 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.516 0 N-CA-C 111.533 -0.627 . . . . 0.9 111.533 -178.876 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.0 tttp . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 121.13 0.49 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.541 HD21 ' HB1' ' A' ' 42' ' ' ALA . 38.7 tp -79.52 115.01 18.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.688 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -82.86 103.61 12.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.834 0.35 . . . . 0.0 110.377 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.535 HD11 ' HB3' ' A' ' 40' ' ' TYR . 11.6 tt -105.7 126.25 61.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.545 0.688 . . . . 0.0 111.159 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.5 mt -125.51 160.89 31.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.476 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -85.74 141.33 29.79 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 8' ' ' LEU . 55.1 mt -77.53 103.55 7.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.044 0.449 . . . . 0.0 110.626 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -79.39 -45.76 18.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.503 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -137.85 166.65 23.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.945 -176.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -127.89 111.47 13.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.808 0.337 . . . . 0.0 111.089 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.0 m -99.55 -179.97 4.37 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -62.59 -48.92 77.32 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.821 0.344 . . . . 0.0 110.872 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -57.77 -39.31 77.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.558 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -67.02 -46.2 75.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.328 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.9 ttp85 -60.7 -46.6 89.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.649 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 80.0 mt -61.57 -46.18 97.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.881 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.96 -38.72 86.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.21 0.529 . . . . 0.0 110.395 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.519 HD23 HD12 ' A' ' 22' ' ' ILE . 76.7 mt -68.58 -25.03 64.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.264 177.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -79.94 -19.96 46.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.248 0.547 . . . . 0.0 109.894 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -74.74 -29.1 61.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 171.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.519 HD12 HD23 ' A' ' 19' ' ' LEU . 73.0 mt -79.78 -48.73 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.302 174.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -115.79 100.55 53.66 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 175.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 C--N 1.345 0.387 0 C-N-CA 123.065 2.51 . . . . 0.0 112.951 -176.514 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.7 mt . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 121.355 0.598 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -80.57 118.09 21.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.712 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.43 118.5 39.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.785 -173.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.434 ' OD1' ' HB2' ' A' ' 37' ' ' HIS . 6.3 p-10 -135.24 -164.5 1.54 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.856 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -68.57 -29.75 68.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.805 0.336 . . . . 0.0 110.972 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -89.86 -63.31 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.434 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 56.3 m80 -78.37 98.74 6.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.234 0.54 . . . . 0.0 110.651 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.578 ' HD3' HD12 ' A' ' 56' ' ' LEU . 27.7 mtp-105 -115.68 116.9 28.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.449 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.2 mt -98.48 127.14 51.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.781 0.324 . . . . 0.0 110.586 -176.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.535 ' HB3' HD11 ' A' ' 5' ' ' ILE . 55.3 m-85 -99.08 140.23 33.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.409 176.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.541 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -114.16 113.4 24.63 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.543 174.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.05 104.93 17.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.809 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 7.7 ptp180 -112.6 136.41 52.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.361 0.6 . . . . 0.0 111.756 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.43 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 44.5 t80 -99.88 95.71 7.08 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.8 t30 69.59 -76.41 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.388 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -151.31 71.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.527 0.679 . . . . 0.0 110.028 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 15.9 ptp180 -167.41 122.24 1.03 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.029 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.541 HD22 ' HB1' ' A' ' 41' ' ' ALA . 59.0 mt -78.11 90.83 4.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.588 ' HA ' ' HD3' ' A' ' 69' ' ' ARG . 62.7 mt -79.05 -39.95 32.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.307 -175.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -132.9 141.81 48.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.698 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.452 ' HB3' HG21 ' A' ' 22' ' ' ILE . . . -135.09 132.78 38.56 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.84 177.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.49 HG21 HD23 ' A' ' 63' ' ' LEU . 7.5 p -138.9 135.35 42.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.027 0.442 . . . . 0.0 111.224 -176.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.515 ' HG3' ' HB2' ' A' ' 65' ' ' SER . 33.1 mtt-85 -101.5 106.14 17.22 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 176.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.93 119.45 50.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.273 0.559 . . . . 0.0 110.017 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.0 m -92.93 97.42 10.72 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.049 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.578 HD12 ' HD3' ' A' ' 38' ' ' ARG . 81.9 mt -87.29 85.67 7.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.046 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -86.67 85.19 7.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.465 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.14 -119.84 5.05 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.189 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.0 p -96.84 8.62 43.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.021 0.439 . . . . 0.0 111.124 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -126.52 137.16 53.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.265 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -119.56 121.95 5.13 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.357 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.06 119.59 35.74 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.496 HD13 ' SD ' ' A' ' 97' ' ' MET . 5.9 mp -93.88 122.75 36.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -95.35 -79.85 0.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.106 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.515 ' HB2' ' HG3' ' A' ' 53' ' ' ARG . 13.5 m -86.9 122.51 30.87 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.959 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.443 HD13 ' HB ' ' A' ' 52' ' ' VAL . 52.3 tp -140.6 116.43 10.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.421 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 50.9 ttt180 -143.84 138.11 28.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.985 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 50' ' ' ALA . 7.3 t -114.57 142.86 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.588 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 10.3 mtp180 -63.38 147.43 51.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.124 0.488 . . . . 0.0 111.114 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -58.95 -17.99 29.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -167.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.42 -16.56 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.489 0.661 . . . . 0.0 110.6 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.489 HG22 HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -106.02 15.86 25.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.586 -173.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.5 ptt-85 -86.06 144.73 27.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.988 0.423 . . . . 0.0 111.572 -173.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.2 mtp-105 56.19 26.99 10.98 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.911 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -112.32 2.36 16.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.3 0.571 . . . . 0.0 110.903 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.96 -5.98 64.12 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.114 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.489 HG21 HG22 ' A' ' 72' ' ' THR . 86.7 t -59.46 -41.81 85.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.008 0.433 . . . . 0.0 110.926 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 81' ' ' LEU . . . -64.56 -25.74 70.4 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.367 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.546 ' HA ' HD21 ' A' ' 115' ' ' LEU . 62.7 tt0 -68.6 -47.45 66.67 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -61.95 -40.29 95.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.946 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 85' ' ' VAL . 51.2 tp -45.23 -63.97 0.82 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.806 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.4 ' O ' HD13 ' A' ' 86' ' ' LEU . 3.9 mm? -65.95 -37.19 85.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.575 -176.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 79' ' ' GLN . 41.5 mt-10 -60.27 -40.74 91.45 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -79.67 -25.51 41.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.792 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 81' ' ' LEU . 73.3 t -62.75 -46.17 97.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.149 0.499 . . . . 0.0 110.012 173.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 82' ' ' LEU . 10.3 mp -70.55 -22.05 62.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.95 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -75.78 -45.65 35.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.339 173.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -57.61 -48.85 78.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.098 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -120.27 89.0 42.82 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.196 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -83.13 -15.39 7.93 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.877 2.385 . . . . 0.0 114.02 -173.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.48 57.87 5.05 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.1 -174.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.4 t -129.68 128.46 65.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.758 0.313 . . . . 0.0 110.383 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.7 m -75.56 -48.02 24.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.123 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 127' ' ' CYS . 47.1 t -131.42 124.35 30.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.835 -177.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -96.98 113.86 25.43 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 174.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -108.53 129.0 55.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.924 0.392 . . . . 0.0 110.079 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.831 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 95.9 mmm -110.9 108.42 18.2 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.76 147.5 35.3 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.948 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -63.25 -34.69 78.21 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.89 9.21 2.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.582 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.69 17.03 80.26 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.892 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 104' ' ' ASP . 57.3 t -70.25 118.35 14.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -77.33 5.96 7.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.049 -173.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.532 ' H ' HG12 ' A' ' 102' ' ' VAL . 31.3 m-20 -111.97 24.13 13.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.163 0.506 . . . . 0.0 109.834 173.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -57.47 -28.69 63.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.225 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.3 -46.1 74.04 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.4 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.2 t -66.63 -37.04 78.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.113 0.482 . . . . 0.0 110.047 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.616 ' O ' ' HG2' ' A' ' 112' ' ' MET . 68.6 mtp -66.59 -32.67 74.16 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.749 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.0 m -62.49 -44.43 96.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.644 0.259 . . . . 0.0 110.582 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.74 95.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.495 0.664 . . . . 0.0 110.135 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.408 ' CE2' HD11 ' A' ' 115' ' ' LEU . 38.7 t80 -61.69 -39.47 91.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.035 176.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.616 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.4 mmt -63.36 -36.96 85.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.768 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -67.82 -27.8 67.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.721 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.73 -40.34 66.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.917 0.389 . . . . 0.0 110.435 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 79' ' ' GLN . 97.1 mt -68.82 -48.65 63.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.161 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 124.39 27.18 1.36 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.776 -176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.567 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 26.2 m-85 -98.79 154.43 18.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.0 m -108.76 157.88 18.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.872 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.428 HG22 ' CD1' ' A' ' 124' ' ' TRP . 3.3 p -97.39 117.23 31.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.952 0.406 . . . . 0.0 110.871 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.454 ' HA ' ' OE1' ' A' ' 120' ' ' GLN . 14.4 mm-40 -102.62 -179.53 4.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.913 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -91.05 50.72 1.82 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.327 0.584 . . . . 0.0 109.977 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 165.16 43.71 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.356 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 113.44 -176.82 17.63 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 121.171 -0.538 . . . . 0.0 111.79 -176.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.831 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 9.4 m-90 -96.42 148.8 22.41 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -138.65 137.82 37.23 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.016 0.436 . . . . 0.0 111.413 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.465 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 57.5 tttm -136.97 95.52 3.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.59 169.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 94' ' ' CYS . 42.5 t -76.83 110.44 11.44 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.532 0 C-N-CA 120.956 -0.64 . . . . 0.9 112.092 -178.888 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 81.1 mttt . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 121.023 0.439 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.515 HD11 ' HB1' ' A' ' 42' ' ' ALA . 49.7 tp -76.1 115.68 16.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.622 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.7 m -87.82 92.05 8.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.051 0.453 . . . . 0.0 110.601 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' A' ' 40' ' ' TYR . 6.4 tp -81.91 105.96 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.795 0.807 . . . . 0.0 109.981 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.9 mt -99.11 148.75 5.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.367 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -95.67 139.62 31.66 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 11' ' ' PHE . 4.4 mm? -75.48 62.58 1.39 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.818 0.818 . . . . 0.0 110.586 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -94.72 -29.11 14.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.608 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -127.53 107.12 9.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.77 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 8' ' ' LEU . 69.8 m-85 -87.83 112.38 22.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.987 0.423 . . . . 0.0 111.736 -175.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.518 ' HB3' ' OD1' ' A' ' 15' ' ' ASP . 28.4 t -92.26 157.98 16.37 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 172.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.04 -47.08 84.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -63.92 -41.49 97.65 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.384 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.518 ' OD1' ' HB3' ' A' ' 12' ' ' SER . 1.6 m-20 -55.65 -44.77 77.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.453 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.676 ' HG2' HD13 ' A' ' 31' ' ' LEU . 24.4 mtp180 -60.44 -39.28 86.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.301 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 57.9 mt -77.76 -37.78 24.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.491 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -68.41 -33.05 73.55 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.473 HD23 HD12 ' A' ' 22' ' ' ILE . 73.7 mt -63.87 -37.28 86.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.241 172.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -65.67 -22.82 66.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.34 0.591 . . . . 0.0 110.398 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -80.0 -28.56 39.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.238 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.519 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 69.5 mt -76.78 -36.01 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.231 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -109.72 81.1 1.83 Allowed Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 21.1 Cg_exo . . . . . 0 C--N 1.344 0.334 0 C-N-CA 123.129 2.553 . . . . 0.0 113.534 -169.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.676 HD13 ' HG2' ' A' ' 16' ' ' ARG . 51.2 mt . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 121.154 0.502 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -83.16 98.43 9.34 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.516 HG23 ' HA ' ' A' ' 38' ' ' ARG . 8.2 p -93.13 135.76 26.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.198 -175.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -131.7 -179.56 5.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.82 -23.71 66.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.688 0.28 . . . . 0.0 111.339 -175.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.626 ' O ' ' HA ' ' A' ' 55' ' ' THR . 32.0 m-80 -85.84 -62.34 1.55 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.907 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -89.66 94.62 9.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.553 -175.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.516 ' HA ' HG23 ' A' ' 33' ' ' VAL . 53.6 mtt180 -110.27 139.08 45.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.286 0.565 . . . . 0.0 111.006 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.8 mt -106.96 134.77 47.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.787 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.6 ' HB3' HD11 ' A' ' 5' ' ' ILE . 86.0 m-85 -118.84 140.34 50.12 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.583 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -129.2 124.09 33.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.103 0.478 . . . . 0.0 110.566 -173.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.731 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.0 104.14 16.58 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.966 -176.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -87.27 122.76 31.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.701 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -140.31 124.99 18.09 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.2 t30 62.07 36.56 15.26 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.49 0.662 . . . . 0.0 110.005 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 37.3 tt0 67.01 18.41 10.56 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.213 177.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -133.7 146.24 50.63 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.583 HD22 ' HB1' ' A' ' 41' ' ' ALA . 78.7 mt -79.88 101.45 8.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.197 0.522 . . . . 0.0 110.414 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.8 tp -81.74 -21.74 37.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.615 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.731 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -141.05 140.25 34.22 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.605 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -128.52 122.39 31.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.899 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.425 HG13 ' HB2' ' A' ' 40' ' ' TYR . 7.9 p -132.59 135.97 56.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.955 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -111.26 129.83 55.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.855 0.359 . . . . 0.0 110.146 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.7 p -127.35 139.59 51.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.064 0.459 . . . . 0.0 110.189 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 29.1 m -108.28 101.71 10.89 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.083 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.89 91.07 5.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.507 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -103.54 99.16 8.97 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.118 -175.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.48 -105.55 0.92 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.358 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.8 p -107.36 2.42 24.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.854 0.359 . . . . 0.0 111.131 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -102.66 122.24 44.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.334 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.94 85.76 0.91 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -92.92 128.61 38.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.691 0.281 . . . . 0.0 110.447 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 tp -93.52 121.65 35.14 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -113.47 95.82 5.56 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.185 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.0 p 69.93 127.87 0.03 OUTLIER 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.655 1.182 . . . . 0.0 112.344 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.501 HD23 ' HE1' ' A' ' 108' ' ' MET . 47.0 tp -123.8 122.63 38.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.004 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 70.5 mtp85 -129.82 96.31 4.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.137 0.494 . . . . 0.0 111.076 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' A' ' 50' ' ' ALA . 2.3 t -86.17 142.84 12.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 175.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 48' ' ' LEU . 5.0 ttt180 -61.43 139.79 58.15 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.6 -17.56 23.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.151 -172.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.01 -21.05 27.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.973 0.416 . . . . 0.0 111.138 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.4 m -62.72 -43.1 99.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.481 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 48.79 47.81 20.79 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.09 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.9 mtm180 55.24 66.9 1.11 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.64 175.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -144.52 75.31 1.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.884 0.373 . . . . 0.0 111.654 -175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.08 -43.34 2.84 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 114.998 0.759 . . . . 0.0 114.998 167.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.6 t -49.72 -48.28 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.19 -44.24 94.98 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.808 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.459 ' HA ' HD13 ' A' ' 115' ' ' LEU . 73.5 mt-30 -55.07 -56.94 14.21 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.44 0.638 . . . . 0.0 110.104 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -60.59 -45.62 93.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.13 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.508 ' O ' HG23 ' A' ' 85' ' ' VAL . 27.0 tp -54.09 -57.51 10.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.569 -174.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 82' ' ' LEU . 4.1 mm? -62.56 -45.75 91.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.695 -176.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -60.39 -37.99 82.54 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.975 0.416 . . . . 0.0 110.797 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.447 ' HG2' HG21 ' A' ' 5' ' ' ILE . 10.4 tp10 -69.21 -39.05 78.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.533 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 81' ' ' LEU . 91.4 t -62.16 -42.4 95.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.803 0.335 . . . . 0.0 110.55 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.74 -17.78 63.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.158 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -85.62 -37.59 19.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.171 0.51 . . . . 0.0 109.699 174.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.453 ' C ' HD22 ' A' ' 88' ' ' ASN . 0.2 OUTLIER -65.94 -44.04 86.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.077 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -120.28 77.84 26.08 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.585 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -89.0 -0.71 6.31 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.569 2.179 . . . . 0.0 112.909 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.46 -50.3 38.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.13 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.4 ' H ' HG22 ' A' ' 92' ' ' VAL . 3.5 m -62.04 119.69 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.21 0.529 . . . . 0.0 111.025 176.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 m -92.04 -18.52 23.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.275 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.2 t -109.35 98.63 8.0 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -95.31 132.13 40.65 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.188 0.518 . . . . 0.0 110.933 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.459 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 75.0 t-105 -127.6 127.15 43.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.762 -177.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.989 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 74.7 mmm -106.99 110.98 23.26 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -92.0 154.31 18.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.295 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.67 -1.29 41.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.876 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.53 127.81 33.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.93 2.61 86.17 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.163 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.764 HG11 ' HG3' ' A' ' 108' ' ' MET . 60.6 t -117.31 112.51 39.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.822 0.344 . . . . 0.0 110.723 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -80.56 -34.84 35.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.557 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 108' ' ' MET . 7.6 m-20 -87.71 61.53 6.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.858 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -63.35 -40.31 96.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.301 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.94 -45.15 97.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.111 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.9 -43.91 98.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.789 0.328 . . . . 0.0 110.591 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.764 ' HG3' HG11 ' A' ' 102' ' ' VAL . 97.8 mmm -65.61 -29.41 70.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 71.8 m -61.86 -47.61 84.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.13 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.58 -37.9 83.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.356 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.453 ' HB3' ' HA ' ' A' ' 108' ' ' MET . 66.4 t80 -58.5 -52.95 63.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.268 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.534 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 65.1 mtt -76.85 -27.3 55.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.907 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -69.36 -33.79 73.61 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.704 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.11 73.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.613 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.723 HD23 ' HE2' ' A' ' 117' ' ' PHE . 32.5 tp -80.59 -51.96 8.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.018 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 141.91 69.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.285 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.723 ' HE2' HD23 ' A' ' 115' ' ' LEU . 91.1 m-85 -143.75 148.54 35.79 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 124' ' ' TRP . 18.9 m -115.69 149.93 37.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.343 -0.389 . . . . 0.0 109.967 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.2 p -97.0 115.07 26.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.144 0.497 . . . . 0.0 110.322 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.411 ' HG3' ' HG3' ' A' ' 121' ' ' GLN . 55.5 tp60 -134.6 115.7 14.15 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.468 -176.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.411 ' HG3' ' HG3' ' A' ' 120' ' ' GLN . 92.5 mt-30 62.56 35.19 14.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.323 172.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.29 4.37 56.34 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.77 -0.728 . . . . 0.0 113.877 172.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -155.08 175.94 32.91 Favored Glycine 0 C--O 1.225 -0.406 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.036 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.989 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 28.8 m-90 -95.14 127.03 40.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 117.005 0.402 . . . . 0.0 110.042 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -110.82 140.3 45.38 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.89 0.376 . . . . 0.0 110.623 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -137.03 93.4 2.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 172.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 51.0 t -86.93 132.01 33.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.704 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 C-N-CA 121.132 -0.556 . . . . 0.9 111.94 178.613 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.2 mttm . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 121.017 0.436 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.55 HD11 ' HB1' ' A' ' 42' ' ' ALA . 49.4 tp -93.37 113.7 25.94 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.464 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.6 m -83.01 100.09 10.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.249 0.547 . . . . 0.0 110.581 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.517 HD11 HD12 ' A' ' 81' ' ' LEU . 85.5 mt -95.03 129.83 44.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.393 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.5 mt -124.75 149.84 29.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.066 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 7' ' ' ARG . 15.2 ptt-85 -92.57 138.56 31.4 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 41' ' ' ALA . 4.3 mm? -74.92 50.89 0.48 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.035 0.445 . . . . 0.0 111.612 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -87.79 -24.39 23.77 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -123.53 107.31 11.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.695 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -83.67 115.24 22.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.202 0.525 . . . . 0.0 111.539 -173.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.8 t -98.37 153.32 18.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.893 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.475 ' O ' HG12 ' A' ' 17' ' ' ILE . 43.1 t0 -66.92 -49.86 64.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.439 -172.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -64.95 -37.79 88.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.723 0.297 . . . . 0.0 111.049 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.65 -39.37 88.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.297 0.57 . . . . 0.0 110.168 176.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -68.26 -29.32 68.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.6 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 13' ' ' ASP . 43.2 mm -63.84 -44.28 98.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.428 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.519 ' O ' HG13 ' A' ' 22' ' ' ILE . 7.7 m-20 -64.86 -38.4 90.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.807 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.9 mt -60.2 -41.84 93.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.962 0.411 . . . . 0.0 110.284 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -73.6 -13.54 61.03 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.368 0.604 . . . . 0.0 110.483 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -92.01 -23.37 19.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.404 0.621 . . . . 0.0 109.68 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 18' ' ' ASP . 96.1 mt -77.66 -35.36 21.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.399 174.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -112.23 80.81 3.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 169.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.344 0.309 0 C-N-CA 122.971 2.447 . . . . 0.0 113.65 -168.842 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.458 0.647 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -161.2 135.21 6.89 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.498 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.0 m -123.64 141.28 44.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.36 0.6 . . . . 0.0 111.949 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -116.7 172.52 7.18 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.14 -28.09 67.85 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.373 0.606 . . . . 0.0 109.477 171.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -98.86 -0.61 42.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.141 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -144.55 91.32 2.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.464 ' HB2' HG13 ' A' ' 54' ' ' VAL . 57.3 mtt180 -109.07 153.8 23.15 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.769 -174.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 8' ' ' LEU . 66.1 mt -122.78 118.48 55.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -104.58 127.28 52.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.112 0.482 . . . . 0.0 110.52 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.557 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.23 129.67 55.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.094 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.597 ' HB2' HD13 ' A' ' 81' ' ' LEU . . . -91.92 103.93 16.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.131 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -101.44 118.68 37.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.92 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -122.99 109.84 14.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.531 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 69.02 -69.93 0.15 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.168 0.917 . . . . 0.0 112.366 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.658 ' HG2' ' HG3' ' A' ' 47' ' ' ARG . 35.7 tt0 -94.2 -66.74 0.9 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.861 0.363 . . . . 0.0 111.381 -174.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.658 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 11.8 mtm180 -147.61 -150.79 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -174.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.557 HD22 ' HB1' ' A' ' 41' ' ' ALA . 37.8 mt -78.15 122.94 26.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.119 0.485 . . . . 0.0 110.414 -176.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.437 ' O ' ' HD3' ' A' ' 69' ' ' ARG . 32.3 tp -99.55 -25.32 14.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.076 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.538 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -152.5 163.65 39.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.636 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.29 143.43 29.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.675 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.502 ' HB ' HD13 ' A' ' 66' ' ' LEU . 11.7 p -147.02 140.52 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.361 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 -101.77 140.01 36.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.464 HG13 ' HB2' ' A' ' 38' ' ' ARG . 6.2 p -130.51 122.28 52.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.594 0.711 . . . . 0.0 111.653 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 39.2 m -91.33 140.5 29.71 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.859 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.2 mt -127.1 141.47 51.76 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.886 0.374 . . . . 0.0 110.862 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.7 m -144.23 84.49 1.76 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.475 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.15 -110.18 3.29 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.146 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 p -98.02 3.05 49.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.959 0.409 . . . . 0.0 111.281 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.426 ' HG2' ' HB3' ' A' ' 94' ' ' CYS . 42.7 mt-10 -112.24 151.43 29.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.397 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.08 158.25 27.37 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.567 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -134.39 123.33 23.91 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.76 0.314 . . . . 0.0 110.486 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.86 118.24 31.19 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -129.68 133.42 47.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.468 -174.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 m 64.98 100.83 0.04 OUTLIER 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.444 0.64 . . . . 0.0 111.641 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.502 HD13 ' HB ' ' A' ' 52' ' ' VAL . 56.7 tp -132.31 121.34 23.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.149 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 67' ' ' ARG . 31.1 ttt180 -144.0 131.41 20.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.994 0.426 . . . . 0.0 110.811 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 50' ' ' ALA . 9.0 t -109.97 164.26 6.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.437 ' HD3' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -54.66 135.29 46.95 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 173.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -62.52 -26.52 68.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.101 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 p -77.82 -14.62 14.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.002 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 m -91.43 64.21 5.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.671 0.748 . . . . 0.0 111.385 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 73' ' ' ARG . 52.2 mtt-85 -106.88 91.66 3.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.018 174.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -131.67 -9.44 3.58 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -171.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 69.16 88.37 0.11 Allowed 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.94 0.4 . . . . 0.0 109.976 -174.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 147.52 -43.05 0.86 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.459 -1.353 . . . . 0.0 114.006 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.44 -54.48 18.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 117.209 0.504 . . . . 0.0 111.757 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.07 -38.53 96.74 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.321 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.546 ' HG3' ' HG ' ' A' ' 115' ' ' LEU . 7.8 tt0 -62.33 -52.42 63.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.791 0.329 . . . . 0.0 110.665 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -62.38 -33.75 75.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.699 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.597 HD13 ' HB2' ' A' ' 42' ' ' ALA . 48.0 tp -54.14 -57.62 10.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.574 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.07 -41.45 95.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.572 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -54.36 -46.55 73.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.94 0.4 . . . . 0.0 111.228 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -66.06 -36.8 84.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.392 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 81' ' ' LEU . 81.2 t -66.2 -46.37 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.88 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.434 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 10.9 mp -65.79 -22.85 66.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.359 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.4 mtm-85 -89.25 -15.74 32.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.735 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.441 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 46.4 t-20 -81.87 -42.59 19.38 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -118.14 76.96 12.32 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.405 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 6.0 Cg_exo -79.0 -13.9 13.87 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.992 2.461 . . . . 0.0 112.282 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.67 -20.91 72.53 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.043 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -76.05 106.56 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.7 m -90.82 -11.78 38.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.085 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.426 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 40.2 t -131.28 95.54 3.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.88 0.371 . . . . 0.0 110.501 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 1.0 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 95.5 m95 -91.38 107.24 19.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.424 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.622 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 76.9 t-105 -97.47 130.98 44.51 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.479 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 58.9 mtp -114.48 131.82 56.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.719 0.295 . . . . 0.0 110.481 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.84 165.42 11.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.586 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -108.71 73.61 0.88 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.835 0.826 . . . . 0.0 109.115 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.77 113.59 27.28 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.521 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.51 1.02 81.37 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.91 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.97 118.23 46.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.946 0.403 . . . . 0.0 110.336 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -93.22 -20.59 20.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.341 0.591 . . . . 0.0 109.48 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -86.74 41.19 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.641 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -52.95 -43.85 66.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.053 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.7 -46.52 92.11 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.501 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.8 t -64.56 -45.26 96.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.09 0.472 . . . . 0.0 110.308 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.487 ' O ' ' HG2' ' A' ' 112' ' ' MET . 37.6 ttm -67.05 -29.2 68.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.032 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 96.9 m -61.61 -45.39 94.3 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 175.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.04 -39.35 92.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.146 0.498 . . . . 0.0 110.437 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -60.52 -49.08 78.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.042 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.529 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 22.2 mmt -66.85 -35.29 79.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.132 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -71.4 -25.54 62.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.024 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.42 -38.9 54.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.92 0.39 . . . . 0.0 110.227 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.566 HD22 ' CE2' ' A' ' 117' ' ' PHE . 7.3 tt -70.72 -49.55 45.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.078 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 134.64 47.83 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.983 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.58 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 83.1 m-85 -110.43 149.2 30.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.589 0.233 . . . . 0.0 110.422 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.0 m -94.67 143.09 26.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.912 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.8 p -97.43 122.5 40.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.0 0.429 . . . . 0.0 111.093 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -120.13 -171.48 2.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.356 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -84.42 94.07 8.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.134 0.492 . . . . 0.0 110.255 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 136.52 -48.55 0.91 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.022 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -167.74 -153.16 7.91 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.279 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 15.5 m-90 -108.49 141.77 39.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.597 0.237 . . . . 0.0 110.481 -176.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -120.18 132.52 55.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.018 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 1.0 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 57.8 tptt -119.08 85.86 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 172.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 39.2 t -98.86 137.0 38.07 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.904 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 C-N-CA 120.836 -0.697 . . . . 0.9 112.07 -179.943 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.9 tttm . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 120.957 0.408 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.4 tp -75.96 106.28 7.46 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.6 m -96.64 111.46 23.59 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.655 -177.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 42' ' ' ALA . 15.7 tt -122.01 129.35 75.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 121.416 0.627 . . . . 0.0 110.871 -175.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -134.4 168.17 24.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.755 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -75.03 124.37 26.86 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.0 tp -89.92 78.44 6.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.343 0.592 . . . . 0.0 110.143 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.578 ' HA ' HG21 ' A' ' 33' ' ' VAL . 29.3 tt0 -86.64 -40.68 14.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.513 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -102.99 122.21 44.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.965 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -105.7 110.41 22.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.709 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.558 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 0.7 OUTLIER -80.29 168.95 18.41 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.482 ' O ' HG13 ' A' ' 17' ' ' ILE . 17.1 t70 -61.08 -45.99 92.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.751 0.31 . . . . 0.0 110.388 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.534 ' HA ' HD12 ' A' ' 17' ' ' ILE . 97.6 mt-30 -66.73 -34.87 78.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.13 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.26 -35.61 79.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.784 0.326 . . . . 0.0 110.234 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 12' ' ' SER . 42.5 mtt180 -65.93 -47.08 75.9 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 14' ' ' GLN . 69.1 mt -54.37 -48.43 68.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.99 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.555 ' O ' HG13 ' A' ' 22' ' ' ILE . 99.7 m-20 -54.69 -57.84 9.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.104 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.03 -41.18 99.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.38 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -73.43 -10.54 59.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -99.54 -25.06 14.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.075 0.465 . . . . 0.0 110.111 175.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 18' ' ' ASP . 76.4 mt -65.03 -44.35 95.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -87.85 117.48 68.52 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.467 172.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo . . . . . 0 C--N 1.345 0.366 0 C-N-CA 122.985 2.456 . . . . 0.0 112.92 -176.119 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 CA--C 1.529 0.148 0 CA-C-O 120.832 0.349 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -74.32 107.68 6.63 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 9' ' ' GLU . 16.9 m -104.35 136.42 37.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.453 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -140.23 -161.73 1.24 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.617 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -81.63 -19.83 40.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 110.222 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.18 -68.19 0.81 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -72.53 97.32 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.626 HH11 HD12 ' A' ' 56' ' ' LEU . 71.5 mtt180 -113.54 127.62 56.14 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.011 0.434 . . . . 0.0 111.163 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.703 HG12 ' HG2' ' A' ' 53' ' ' ARG . 64.5 mt -101.88 119.34 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.804 176.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.449 ' HB3' HD11 ' A' ' 5' ' ' ILE . 80.6 m-85 -98.78 133.6 42.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.96 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.497 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.09 113.38 26.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.283 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.773 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -98.42 110.83 23.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.387 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.555 ' HB3' HD23 ' A' ' 48' ' ' LEU . 23.8 ptt180 -107.94 134.12 51.31 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.225 0.536 . . . . 0.0 110.257 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -97.15 94.2 6.99 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.793 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.747 HD22 ' HG3' ' A' ' 46' ' ' GLU . 9.3 t30 72.25 -46.98 0.66 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.142 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.747 ' HG3' HD22 ' A' ' 45' ' ' ASN . 46.0 mt-10 -128.21 -67.83 0.79 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.362 . . . . 0.0 111.848 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -104.55 162.21 13.45 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.966 -170.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.555 HD23 ' HB3' ' A' ' 43' ' ' ARG . 92.3 mt -59.87 127.42 31.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.34 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.707 HD23 HG11 ' A' ' 77' ' ' VAL . 31.3 tp -115.95 -29.49 6.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.489 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.773 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -136.61 139.74 42.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.822 0.344 . . . . 0.0 111.41 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.63 116.66 22.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.843 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 40' ' ' TYR . 7.4 p -124.51 131.34 72.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.396 0.617 . . . . 0.0 111.315 -177.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.703 ' HG2' HG12 ' A' ' 39' ' ' ILE . 41.3 mtp-105 -107.75 119.05 38.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.645 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.48 128.62 68.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.405 0.621 . . . . 0.0 110.821 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.0 m -94.11 100.88 12.9 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.94 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.626 HD12 HH11 ' A' ' 38' ' ' ARG . 93.3 mt -87.04 86.54 7.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.639 177.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -95.92 105.87 17.95 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.383 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.15 -113.54 4.75 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.553 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 p -113.16 8.67 18.31 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.894 0.378 . . . . 0.0 110.939 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -107.75 137.96 44.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.312 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.47 114.22 3.0 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.923 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -111.37 128.93 56.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.562 0.22 . . . . 0.0 110.47 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.502 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 6.9 mp -93.49 108.49 20.17 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.378 0.609 . . . . 0.0 109.611 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.54 -28.43 33.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.809 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.6 m -152.4 127.77 9.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.663 0.268 . . . . 0.0 110.965 -176.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.4 tp -131.28 109.68 10.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.736 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -143.27 109.38 5.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.17 0.51 . . . . 0.0 110.853 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.596 HG13 ' HB2' ' A' ' 50' ' ' ALA . 12.4 t -97.7 157.8 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -58.22 146.45 33.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 0.0 110.707 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -52.02 -35.5 47.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.484 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -75.98 7.9 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.469 0.652 . . . . 0.0 111.487 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.49 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 1.8 m -103.91 8.93 36.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.618 0.723 . . . . 0.0 110.238 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.9 ttp85 -65.74 107.19 1.7 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.614 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 61.58 91.38 0.06 Allowed 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.606 0.567 . . . . 0.0 110.093 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -164.42 -42.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.044 -170.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.6 -24.34 6.85 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.435 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.707 HG11 HD23 ' A' ' 49' ' ' LEU . 84.5 t -55.38 -42.54 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -177.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.25 -31.82 70.49 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.006 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.545 ' HA ' HD21 ' A' ' 115' ' ' LEU . 53.0 tt0 -65.16 -43.85 90.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -69.0 -36.87 78.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.42 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.499 ' O ' HG23 ' A' ' 85' ' ' VAL . 63.2 tp -49.29 -58.72 4.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.268 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.17 -33.21 75.47 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.95 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -58.26 -54.04 51.53 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.646 0.26 . . . . 0.0 110.817 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HG2' HG22 ' A' ' 5' ' ' ILE . 6.4 tp10 -64.38 -36.78 85.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.162 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 81' ' ' LEU . 93.3 t -61.37 -49.15 85.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.912 0.387 . . . . 0.0 110.763 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.473 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 10.4 mp -78.18 -4.59 48.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.088 0.47 . . . . 0.0 110.938 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -87.76 -38.54 15.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.943 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -71.1 -37.96 72.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.097 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.433 ' O ' ' HZ2' ' A' ' 95' ' ' TRP . 20.1 m120 -120.12 74.48 21.15 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.883 176.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -88.09 -3.42 7.03 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.741 2.294 . . . . 0.0 113.733 -173.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -94.25 19.33 53.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.851 -175.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.402 ' HB ' ' CE2' ' A' ' 95' ' ' TRP . 55.7 t -107.17 125.14 63.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.0 m -91.76 -42.92 9.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.902 0.382 . . . . 0.0 110.779 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 40.6 t -104.43 96.46 6.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.051 0.453 . . . . 0.0 110.558 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.473 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 86.5 m95 -90.87 131.0 36.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.94 175.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.642 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 67.9 t-105 -120.66 133.44 55.36 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.502 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 75.2 mtp -119.15 124.84 47.82 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -84.46 173.39 10.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.832 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -57.57 -35.28 70.17 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.077 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.459 ' HB3' HG23 ' A' ' 102' ' ' VAL . . . 63.99 11.74 6.34 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.919 175.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.59 12.21 84.72 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.803 -176.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.459 HG23 ' HB3' ' A' ' 100' ' ' ALA . 45.2 t -80.85 101.49 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.962 0.41 . . . . 0.0 110.281 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -89.08 -1.37 58.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.463 0.649 . . . . 0.0 109.724 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -85.75 44.45 1.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.084 172.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -56.33 -41.69 76.47 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.2 -173.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -51.95 -54.21 26.72 Favored Glycine 0 C--O 1.236 0.275 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.706 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.2 t -66.73 -43.38 90.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.931 0.396 . . . . 0.0 111.009 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.56 ' O ' ' HG2' ' A' ' 112' ' ' MET . 34.8 ttm -69.75 -35.66 75.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.868 -176.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 33.7 m -66.58 -36.93 83.82 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.402 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.94 -37.46 86.08 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.285 0.564 . . . . 0.0 109.922 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.41 ' HB3' ' O ' ' A' ' 108' ' ' MET . 59.9 t80 -61.15 -46.63 89.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.524 174.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.5 mmt -58.77 -43.85 90.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.734 178.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -62.33 -33.93 75.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.985 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.54 -36.2 68.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.247 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.545 HD21 ' HA ' ' A' ' 79' ' ' GLN . 11.1 mp -90.66 7.98 36.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.34 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.24 68.09 1.68 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.82 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.515 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 57.9 m-85 -117.85 151.6 37.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.135 0.493 . . . . 0.0 111.026 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.697 ' HB ' ' HB2' ' A' ' 125' ' ' GLU . 24.3 m -91.4 136.0 33.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.37 176.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 41.7 p -101.29 108.65 20.35 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.423 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -95.96 160.57 14.39 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 172.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -78.86 88.01 4.7 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.253 0.549 . . . . 0.0 109.767 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.98 3.84 6.81 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.884 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.444 ' HA3' ' CZ2' ' A' ' 96' ' ' TRP . . . 173.15 173.59 39.63 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.358 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -116.0 150.65 36.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.697 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 53.1 mt-10 -126.51 156.38 40.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.774 0.321 . . . . 0.0 111.03 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.425 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 56.2 tttp -137.35 121.2 17.55 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 167.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.7 t -86.31 105.27 16.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.148 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 CA-C-N 115.884 -0.598 . . . . 0.9 112.43 -179.76 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.508 HD11 ' HB1' ' A' ' 42' ' ' ALA . 59.7 tp -83.82 111.69 19.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 43' ' ' ARG . 7.2 m -82.78 89.56 6.8 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.215 0.531 . . . . 0.0 109.794 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 15.9 tt -102.65 118.78 50.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.415 0.626 . . . . 0.0 109.982 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.8 mt -114.87 150.96 16.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.416 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.522 ' HB3' ' CE2' ' A' ' 40' ' ' TYR . 17.1 ptt180 -91.61 119.07 31.19 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.567 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.79 72.91 1.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.127 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -96.15 -9.06 31.54 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 171.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -143.08 143.68 31.95 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.1 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -124.63 145.96 49.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.142 0.496 . . . . 0.0 111.571 -173.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -119.31 177.52 4.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 172.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -75.06 -34.53 61.83 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.487 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -64.7 -53.79 41.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.583 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -62.69 -31.86 72.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.738 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -63.24 -40.25 96.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.833 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.1 mt -77.94 -26.0 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.948 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.5 ' HB3' HD12 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -72.67 -35.53 67.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.968 0.413 . . . . 0.0 110.362 174.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.04 -30.65 71.71 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 170.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -72.08 -21.92 61.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.536 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -72.59 -33.55 66.81 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.413 HG23 HH11 ' A' ' 67' ' ' ARG . 48.4 mm -75.4 -51.73 20.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.188 175.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -119.27 110.29 37.87 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.112 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo . . . . . 0 CA--C 1.527 0.156 0 C-N-CA 122.684 2.256 . . . . 0.0 111.762 178.539 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 CA--C 1.52 -0.186 0 CA-C-O 121.154 0.502 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.35 95.43 1.03 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.931 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -102.55 165.17 3.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.284 0.564 . . . . 0.0 111.94 -174.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.75 -164.51 0.91 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.049 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.54 -24.41 61.12 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.546 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 33.9 m-80 -87.15 -62.78 1.43 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.607 ' HB2' HG23 ' A' ' 55' ' ' THR . 77.9 t60 -87.0 97.98 11.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 0.0 110.12 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -111.73 148.68 32.95 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.516 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.593 HG12 ' HG2' ' A' ' 53' ' ' ARG . 68.9 mt -115.46 118.06 57.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 7' ' ' ARG . 79.1 m-85 -103.01 122.43 44.6 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.419 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -112.91 128.71 56.54 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.906 0.384 . . . . 0.0 110.884 -177.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.22 103.96 16.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.21 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.425 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 14.7 ttt85 -85.74 104.64 15.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.569 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -123.95 115.39 21.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.913 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 61.97 60.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.645 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 67.92 10.38 7.76 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 170.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -149.5 155.89 41.09 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.345 -0.242 . . . . 0.0 110.345 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 18' ' ' ASP . 69.1 mt -75.82 110.99 10.71 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 173.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.6 tp -94.61 -26.96 16.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.332 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -137.49 145.03 42.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.217 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.39 121.66 21.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.255 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.496 HG13 ' HB2' ' A' ' 40' ' ' TYR . 7.6 p -126.2 121.09 58.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.35 0.595 . . . . 0.0 110.551 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.779 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 9.8 mtp180 -103.08 138.96 39.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.108 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -137.76 135.9 45.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.954 0.407 . . . . 0.0 110.31 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.607 HG23 ' HB2' ' A' ' 37' ' ' HIS . 6.7 m -117.91 100.64 7.71 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.127 0.489 . . . . 0.0 110.124 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.63 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 49.0 mt -78.52 160.84 27.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.371 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.6 m -154.43 83.4 1.12 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.154 0.502 . . . . 0.0 109.652 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.9 -120.54 8.78 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.289 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 p -82.26 -6.84 59.51 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.015 0.436 . . . . 0.0 111.504 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.545 ' HG2' ' HB3' ' A' ' 94' ' ' CYS . 44.8 mt-10 -112.41 159.98 18.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.33 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 56' ' ' LEU . . . -153.74 116.07 0.71 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.563 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -98.86 140.87 32.38 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.38 130.74 39.06 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.779 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 3.4 t70 -120.49 99.26 6.46 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.95 -171.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.8 t 70.72 111.41 0.06 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.954 0.883 . . . . 0.0 111.905 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.1 tp -117.25 126.01 52.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.481 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.413 HH11 HG23 ' A' ' 22' ' ' ILE . 68.0 ttt-85 -143.84 110.98 5.77 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.959 178.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.564 HG13 ' HB2' ' A' ' 50' ' ' ALA . 17.1 t -98.32 146.31 8.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 166.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 69' ' ' ARG . 16.0 ttt180 -57.42 136.53 56.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -54.89 -27.87 46.22 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.325 0.65 . . . . 0.0 112.554 -168.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.8 t -69.38 -14.31 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.351 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.11 18.47 9.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.334 0.587 . . . . 0.0 110.669 -177.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -62.32 119.45 9.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.496 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.4 mtt-85 63.89 67.88 0.6 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.326 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -165.56 59.16 0.11 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.83 -59.45 1.33 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 115.724 1.05 . . . . 0.0 115.724 167.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.1 t -42.77 -50.51 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -167.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.78 -49.0 73.68 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.987 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.602 ' HA ' HD21 ' A' ' 115' ' ' LEU . 46.3 tt0 -68.28 -39.1 82.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.991 0.424 . . . . 0.0 110.402 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -61.01 -45.82 93.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.158 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 42' ' ' ALA . 1.2 mp -51.85 -57.56 8.99 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.817 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.521 HD11 ' HE1' ' A' ' 97' ' ' MET . 4.0 mm? -56.19 -48.27 76.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.434 -176.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -69.04 -33.9 74.35 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.437 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -65.02 -42.67 94.18 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.012 0.434 . . . . 0.0 110.206 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 81' ' ' LEU . 88.2 t -62.56 -48.66 87.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.713 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.2 -20.53 65.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.15 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -80.34 -52.89 7.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.175 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.402 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 66.0 t30 -73.51 -19.12 61.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.621 -172.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -113.57 83.5 7.12 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 86.4 Cg_endo -86.0 -0.67 8.56 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.641 2.227 . . . . 0.0 113.153 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -82.96 -14.89 74.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.371 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.545 HG21 HD22 ' A' ' 56' ' ' LEU . 38.5 t -92.06 120.94 42.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.811 0.339 . . . . 0.0 110.309 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 128' ' ' GLY . 7.4 t -96.89 -26.14 15.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.431 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.545 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 22.9 t -118.44 104.88 11.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.536 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.429 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 91.9 m95 -96.47 112.35 24.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.424 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.411 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 76.8 t-105 -100.85 134.17 44.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.714 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.702 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 92.1 mmm -106.95 106.59 17.19 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.17 141.31 29.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.004 0.43 . . . . 0.0 110.788 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 102' ' ' VAL . 19.1 p-10 -90.23 -46.46 8.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.535 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 66.24 -66.06 0.18 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.476 0.71 . . . . 0.0 111.786 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -145.0 37.5 1.33 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.165 -0.54 . . . . 0.0 111.863 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 99' ' ' ASP . 75.0 t -82.84 105.95 13.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.988 0.423 . . . . 0.0 110.342 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -85.52 -34.22 21.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.914 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.57 56.87 2.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.151 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -61.04 -42.66 98.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.112 -175.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.28 -52.77 47.12 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.549 -177.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.79 -45.15 87.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.0 111.129 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.56 ' O ' ' HG2' ' A' ' 112' ' ' MET . 69.3 mtp -75.5 -23.31 56.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.957 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 80.9 m -71.41 -39.28 71.22 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.136 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.4 -39.84 92.21 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.247 0.546 . . . . 0.0 109.664 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -60.56 -52.88 63.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.765 174.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 108' ' ' MET . 25.5 mmt -58.03 -45.87 86.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.416 -177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -65.02 -30.54 71.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.945 0.402 . . . . 0.0 110.815 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.64 -23.22 61.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.872 0.368 . . . . 0.0 110.814 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.602 HD21 ' HA ' ' A' ' 79' ' ' GLN . 11.2 mp -98.0 4.73 49.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.016 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.99 23.27 52.9 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.462 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.555 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 88.8 m-85 -91.73 141.55 28.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.026 0.413 . . . . 0.0 110.413 176.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.7 m -96.27 132.63 41.54 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.383 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.438 ' HB ' ' CD1' ' A' ' 124' ' ' TRP . 3.0 t -97.29 126.88 42.79 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -121.01 -72.75 0.67 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.459 0.647 . . . . 0.0 110.745 -174.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -116.87 -142.91 0.37 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.752 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.94 62.73 0.72 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.533 170.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.04 164.88 14.57 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.702 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 14.4 m-90 -112.98 157.15 21.86 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -141.09 139.37 34.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.792 0.329 . . . . 0.0 110.543 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 95' ' ' TRP . 86.3 tttt -137.01 122.82 19.99 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 31.2 t -74.2 142.01 45.43 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.895 0.379 . . . . 0.0 110.719 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 93' ' ' SER . . . . . . . . 0 N--CA 1.448 -0.5 0 CA-C-N 116.105 -0.498 . . . . 0.9 111.992 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.526 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 54.4 tp -75.71 108.33 8.48 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.429 ' HB ' ' HG3' ' A' ' 43' ' ' ARG . 14.0 m -82.85 92.86 7.36 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.205 0.526 . . . . 0.0 110.579 -173.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.641 HD11 ' HB3' ' A' ' 40' ' ' TYR . 7.9 tp -89.92 113.49 26.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.694 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.5 mt -121.1 157.48 24.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.096 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 47.7 ttt-85 -90.25 125.23 35.42 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.08 128.12 35.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.218 0.533 . . . . 0.0 111.717 -177.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -102.5 -51.49 3.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.718 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -124.39 164.18 20.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.241 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -136.46 114.02 10.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.637 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.7 p -93.16 175.18 6.87 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 170.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.88 -38.16 81.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.782 0.325 . . . . 0.0 110.667 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -64.68 -44.97 88.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.517 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -61.79 -49.77 75.03 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.179 0.514 . . . . 0.0 110.14 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -58.88 -47.1 86.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.069 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.8 mt -67.37 -36.38 76.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.54 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -68.79 -41.33 78.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.04 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.76 -43.47 93.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.727 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -77.33 -1.4 29.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.427 0.632 . . . . 0.0 110.284 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -93.34 -33.5 13.87 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.5 mt -68.94 -44.65 81.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.435 174.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -100.48 97.03 5.88 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 170.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 N--CA 1.476 0.454 0 C-N-CA 123.176 2.584 . . . . 0.0 114.189 -169.349 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.8 mt . . . . . 0 N--CA 1.461 0.09 0 CA-C-O 121.093 0.473 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -73.34 141.1 47.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.062 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.1 149.56 24.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.95 0.405 . . . . 0.0 110.76 -177.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -147.95 -162.38 1.54 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -84.57 -24.2 29.33 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.955 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -86.01 -49.99 7.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.396 0.617 . . . . 0.0 109.416 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -94.01 101.48 13.52 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -109.1 137.75 46.52 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.02 0.438 . . . . 0.0 111.41 -173.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.542 HG12 ' HG2' ' A' ' 53' ' ' ARG . 57.8 mt -108.18 112.37 39.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 170.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.641 ' HB3' HD11 ' A' ' 5' ' ' ILE . 11.7 m-85 -94.27 137.02 33.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.982 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.579 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -118.66 116.31 26.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.47 -176.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.662 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.31 91.51 7.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.68 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.552 ' HB3' HD23 ' A' ' 48' ' ' LEU . 13.5 ptm180 -92.21 133.02 36.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.573 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -108.94 99.43 8.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.716 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 67.22 -69.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.309 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -101.17 -59.82 1.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -170.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -132.81 -177.51 4.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.942 0.401 . . . . 0.0 111.944 -171.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.579 HD22 ' HB1' ' A' ' 41' ' ' ALA . 21.8 mt -78.32 113.32 16.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.219 -171.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.447 HD12 ' HD2' ' A' ' 69' ' ' ARG . 46.5 tp -89.72 -30.43 18.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.943 0.401 . . . . 0.0 110.736 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.662 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -142.49 146.48 34.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.777 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -133.62 133.81 42.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.483 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.465 ' HB ' HD13 ' A' ' 66' ' ' LEU . 10.2 p -148.34 140.58 18.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.962 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.663 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 23.8 mtp85 -100.07 150.91 21.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.235 175.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 11.9 p -151.22 138.93 13.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.011 0.434 . . . . 0.0 110.779 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.1 m -111.99 115.82 29.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.769 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.3 mt -99.45 86.87 3.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.3 0.571 . . . . 0.0 110.744 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -95.08 77.98 3.53 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.207 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.81 -85.98 0.28 Allowed Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.879 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.6 p -114.9 -2.22 12.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.962 0.411 . . . . 0.0 111.135 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -104.31 125.69 50.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.487 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.37 96.24 0.72 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -98.48 113.57 25.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.796 0.331 . . . . 0.0 111.153 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.556 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 5.9 mp -93.87 116.55 29.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.224 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.663 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 22.2 m-20 -109.38 131.59 54.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.692 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.8 m 61.11 98.89 0.03 OUTLIER 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.573 0.701 . . . . 0.0 112.06 175.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.465 HD13 ' HB ' ' A' ' 52' ' ' VAL . 22.2 tp -123.89 118.28 26.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.099 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -143.98 139.26 28.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.196 0.522 . . . . 0.0 111.223 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.438 HG12 ' HB2' ' A' ' 50' ' ' ALA . 18.1 m -101.71 169.26 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.868 173.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.447 ' HD2' HD12 ' A' ' 49' ' ' LEU . 95.2 mtt180 -65.75 157.18 30.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 172.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 6.6 tp10 -56.5 -39.08 72.66 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -172.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.79 36.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.148 0.499 . . . . 0.0 110.65 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 m -127.21 4.91 6.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.3 0.571 . . . . 0.0 110.944 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 8.4 mtm180 -81.1 130.14 34.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.74 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.9 mtp-105 62.55 36.56 13.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.261 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -125.43 17.91 8.22 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.761 -0.376 . . . . 0.0 112.012 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.08 -37.98 2.18 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.08 -0.581 . . . . 0.0 114.438 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.5 t -48.33 -44.83 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.78 97.57 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.878 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.457 ' HG3' HD23 ' A' ' 115' ' ' LEU . 53.2 tt0 -65.35 -39.21 92.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.033 0.444 . . . . 0.0 110.027 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.526 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 30.0 t80 -59.05 -49.35 78.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.238 175.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.582 HD11 HD13 ' A' ' 5' ' ' ILE . 51.6 tp -50.82 -54.12 26.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.064 -176.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.424 ' O ' HD13 ' A' ' 86' ' ' LEU . 3.9 mm? -63.73 -50.42 69.19 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.396 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -66.21 -25.86 67.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.584 -176.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -65.97 -46.8 76.76 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 81' ' ' LEU . 57.9 t -62.67 -44.41 99.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.952 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.467 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 11.2 mp -65.99 -27.9 68.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.244 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.8 ttp85 -87.6 -19.31 27.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.583 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.475 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 9.7 t30 -81.62 -46.24 14.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.663 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -102.82 97.83 10.11 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.981 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 83.0 Cg_endo -89.41 148.48 5.28 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.809 2.339 . . . . 0.0 113.498 -173.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.83 7.26 78.43 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.689 -0.687 . . . . 0.0 113.481 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.72 116.73 20.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.1 m -77.49 -32.41 54.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.18 -172.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.0 t -127.49 103.88 7.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.768 0.318 . . . . 0.0 111.458 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.467 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 98.0 m95 -94.41 98.32 10.8 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 171.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.507 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 63.6 t-105 -101.96 120.48 40.47 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.081 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.556 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 73.6 mtp -111.75 126.74 55.38 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.927 0.394 . . . . 0.0 110.571 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.63 99.17 5.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.133 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' A' ' 102' ' ' VAL . 7.7 m-20 -76.37 -31.86 58.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.602 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 67.93 -71.54 0.11 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.004 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -101.53 40.68 2.34 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.978 -174.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.524 HG13 ' HG2' ' A' ' 105' ' ' ARG . 13.2 p -81.7 125.43 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -90.38 -30.7 17.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.189 0.519 . . . . 0.0 109.724 177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.15 45.63 0.75 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.387 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.524 ' HG2' HG13 ' A' ' 102' ' ' VAL . 22.0 mtm180 -55.21 -47.08 75.82 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -172.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.76 -48.28 85.06 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.406 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.16 -41.77 92.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 110.653 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.501 ' O ' ' HG2' ' A' ' 112' ' ' MET . 10.3 tpt -64.75 -39.03 92.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.378 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 85.5 m -65.02 -38.84 92.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.702 0.287 . . . . 0.0 110.698 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.6 -41.48 99.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.204 0.525 . . . . 0.0 110.137 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -63.15 -42.4 99.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.337 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.535 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 24.7 mmt -61.71 -39.33 91.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.024 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -70.74 -21.15 62.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.252 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.98 -26.72 39.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.115 0.483 . . . . 0.0 110.375 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.457 HD23 ' HG3' ' A' ' 79' ' ' GLN . 92.1 mt -84.51 -37.76 20.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.572 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.08 25.98 3.39 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.311 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.535 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 39.7 m-85 -95.9 142.49 28.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.798 0.332 . . . . 0.0 110.99 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.6 m -104.74 148.45 26.59 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.9 m -97.19 112.23 24.12 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -135.46 133.89 39.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.484 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 58.13 30.02 18.75 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.82 -4.03 78.33 Favored Glycine 0 CA--C 1.517 0.172 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.237 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -129.17 -179.46 15.97 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.259 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.436 ' CD1' ' HG3' ' A' ' 112' ' ' MET . 26.6 m-90 -112.22 137.49 50.24 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -132.52 137.24 47.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.024 0.44 . . . . 0.0 110.982 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -119.4 102.54 8.75 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 169.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.5 t -78.11 141.61 38.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.754 -174.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 CA-C-N 115.829 -0.623 . . . . 0.9 111.723 178.498 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 tttm . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.5 tp -75.73 115.81 15.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.013 0.435 . . . . 0.0 110.311 -175.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.3 m -88.37 89.56 8.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.312 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.505 HD11 ' HB3' ' A' ' 40' ' ' TYR . 9.4 tt -96.23 132.57 40.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.003 0.43 . . . . 0.0 110.357 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.82 141.08 44.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.226 0.536 . . . . 0.0 110.625 -177.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 7' ' ' ARG . 10.9 ptt180 -79.33 126.9 31.4 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.745 176.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.9 mt -84.62 95.46 8.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.789 0.328 . . . . 0.0 110.824 -176.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -110.49 -8.27 14.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.0 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -135.1 141.37 46.01 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -130.03 115.68 17.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.143 0.497 . . . . 0.0 112.276 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.3 m -100.08 164.18 12.1 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 168.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -59.9 -37.98 80.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.623 0.249 . . . . 0.0 110.855 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -55.14 -49.99 70.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.121 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -67.1 -37.91 84.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.639 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -68.13 -40.61 82.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.059 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.8 mt -61.68 -36.6 74.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.795 0.331 . . . . 0.0 110.383 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.4 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.8 OUTLIER -64.37 -44.18 92.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.153 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.83 -40.0 96.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.93 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -72.52 -15.84 61.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.078 0.466 . . . . 0.0 110.568 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -84.76 -27.84 26.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.684 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 18' ' ' ASP . 62.2 mt -82.66 -37.28 14.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.9 175.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.635 ' HD1' ' HD2' ' A' ' 67' ' ' ARG . 2.8 m0 -111.26 87.15 7.12 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.782 175.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--N 1.343 0.265 0 C-N-CA 122.499 2.133 . . . . 0.0 112.398 -176.565 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 31' ' ' LEU . 7.1 mt . . . . . 0 CA--C 1.519 -0.236 0 CA-C-O 121.528 0.68 . . . . 0.0 109.727 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -133.8 -179.58 5.63 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.078 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.7 m -130.98 162.29 39.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.263 0.554 . . . . 0.0 111.084 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -125.64 163.52 22.6 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -60.68 -28.21 68.44 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.897 0.379 . . . . 0.0 110.533 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -93.29 -46.06 7.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.253 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -93.52 94.13 8.48 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.015 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.3 mtp85 -110.95 149.49 30.58 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.642 0.258 . . . . 0.0 110.971 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.4 mt -120.09 134.46 63.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.284 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.505 ' HB3' HD11 ' A' ' 5' ' ' ILE . 81.8 m-85 -113.84 139.52 49.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.572 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -119.57 121.34 39.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.939 0.4 . . . . 0.0 110.793 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.18 100.51 13.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.798 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -93.33 119.75 32.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.591 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -99.01 92.23 5.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.014 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.8 t30 69.36 -68.17 0.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.051 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -105.84 -53.29 2.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.783 0.325 . . . . 0.0 111.758 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.437 ' HG2' ' H ' ' A' ' 48' ' ' LEU . 35.7 ttt180 -127.47 174.18 9.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.727 -168.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.572 HD22 ' HB1' ' A' ' 41' ' ' ALA . 63.5 mt -73.17 123.74 24.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.876 0.37 . . . . 0.0 110.355 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.687 HD12 ' HD3' ' A' ' 69' ' ' ARG . 39.9 tp -95.04 -34.11 12.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.16 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.554 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -143.22 140.52 30.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.665 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.82 130.49 51.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.182 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 65' ' ' SER . 11.9 p -142.46 142.27 27.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.706 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.1 mtm180 -112.4 159.03 19.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.891 0.376 . . . . 0.0 110.735 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.59 128.99 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.356 0.598 . . . . 0.0 110.857 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.5 m -104.83 97.98 7.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.011 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.531 HD23 ' HA3' ' A' ' 61' ' ' GLY . 97.4 mt -80.34 126.14 30.78 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.779 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.5 m -105.79 77.99 1.3 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.87 -85.93 1.37 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.271 -174.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.2 p -111.32 -63.33 1.42 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.197 0.523 . . . . 0.0 110.452 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.567 ' HA ' HG13 ' A' ' 92' ' ' VAL . 30.1 mt-10 -76.04 147.51 38.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.811 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.531 ' HA3' HD23 ' A' ' 56' ' ' LEU . . . -142.21 165.46 26.65 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.504 -173.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -116.38 134.03 55.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.794 0.33 . . . . 0.0 110.887 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 76.7 mt -93.83 132.93 37.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.452 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -142.77 163.48 32.7 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 36.0 m 54.59 86.61 0.05 OUTLIER 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.64 0.588 . . . . 0.0 111.732 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.9 tp -122.51 107.02 11.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.832 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.635 ' HD2' ' HD1' ' A' ' 23' ' ' TRP . 34.8 mtt180 -130.18 105.82 8.19 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.215 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.554 HG13 ' HB2' ' A' ' 50' ' ' ALA . 8.9 t -95.91 146.95 6.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 171.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.687 ' HD3' HD12 ' A' ' 49' ' ' LEU . 31.1 mtp85 -52.51 126.32 19.12 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -58.03 -23.1 52.91 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -169.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.4 t -66.29 -21.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.052 0.453 . . . . 0.0 110.765 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.734 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 1.3 m -86.47 32.22 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.406 0.622 . . . . 0.0 110.907 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 73' ' ' ARG . 25.7 ttt180 -81.44 127.95 33.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.84 -176.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 61.35 35.79 17.8 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.898 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.734 ' HD2' ' HA ' ' A' ' 72' ' ' THR . 95.3 mtt180 -112.91 2.69 15.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.807 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.52 -12.18 52.8 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 121.003 -0.618 . . . . 0.0 114.105 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.447 HG11 HD23 ' A' ' 49' ' ' LEU . 92.8 t -61.24 -43.88 97.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.275 0.538 . . . . 0.0 111.773 -177.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.57 -33.93 79.21 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.441 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -63.01 -47.44 83.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.953 0.406 . . . . 0.0 110.278 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -61.76 -43.31 99.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.594 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 42' ' ' ALA . 44.2 tp -53.44 -55.86 21.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.443 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.487 ' HB2' HD11 ' A' ' 115' ' ' LEU . 4.3 mm? -65.68 -40.39 92.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.053 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 7.3 mm-40 -53.46 -50.74 64.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.79 0.329 . . . . 0.0 111.145 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -60.49 -45.36 94.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.8 -177.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.3 t -63.56 -49.46 82.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.174 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.59 -20.3 66.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.997 -176.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 42.8 mtm180 -92.91 -30.19 15.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.657 0.265 . . . . 0.0 111.257 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.46 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 17.3 m-80 -82.09 -20.14 38.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.606 0.241 . . . . 0.0 111.415 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -113.69 86.83 11.16 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.87 0.367 . . . . 0.0 110.443 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 5.0 Cg_exo -81.05 -13.45 11.41 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.227 2.618 . . . . 0.0 112.528 -176.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.05 -8.38 87.89 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.497 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.567 HG13 ' HA ' ' A' ' 60' ' ' GLU . 21.7 t -94.47 101.98 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 p -77.92 -36.16 49.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 51.6 t -116.36 116.04 26.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.389 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -97.86 102.13 13.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.899 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.519 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 35.8 t-105 -97.08 133.29 41.94 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.552 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 47.1 mtp -114.36 130.03 56.67 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.992 0.425 . . . . 0.0 109.982 176.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.5 160.75 14.65 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.646 -176.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -87.22 -2.48 58.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.985 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.47 114.23 5.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.292 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.57 -14.25 59.28 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.72 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.548 HG13 ' HG3' ' A' ' 108' ' ' MET . 55.1 t -89.76 97.63 7.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.352 0.596 . . . . 0.0 110.125 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -76.78 -50.46 13.47 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.77 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -91.09 92.92 8.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.658 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -73.56 -23.76 60.01 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.899 -176.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.25 -56.16 8.15 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.567 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.3 t -66.15 -41.1 88.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.654 0.264 . . . . 0.0 110.68 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.548 ' HG3' HG13 ' A' ' 102' ' ' VAL . 94.8 mmm -63.72 -37.72 88.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.326 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 m -62.58 -45.88 90.88 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.425 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.58 -40.58 95.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.969 0.414 . . . . 0.0 110.617 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -58.72 -49.18 78.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.825 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.56 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 64.9 mtt -69.76 -40.22 76.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.511 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -61.4 -44.01 97.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.77 0.319 . . . . 0.0 110.686 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.27 72.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.188 0.518 . . . . 0.0 110.437 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.487 HD11 ' HB2' ' A' ' 82' ' ' LEU . 2.7 tt -68.19 -33.41 74.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.92 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 132.75 1.59 4.13 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.065 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.56 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 98.3 m-85 -83.19 174.1 11.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.039 0.447 . . . . 0.0 110.863 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.1 m -149.73 151.35 33.5 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.7 t -97.3 110.21 22.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.698 0.761 . . . . 0.0 109.794 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -141.25 129.11 21.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.286 -174.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.436 HE21 ' HB2' ' A' ' 121' ' ' GLN . 0.9 OUTLIER 63.42 32.68 14.31 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.208 0.528 . . . . 0.0 111.361 176.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 111.14 -74.41 0.21 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.562 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -91.09 -156.52 32.79 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.295 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 26.6 m-90 -104.37 119.85 39.89 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -119.36 117.83 29.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.903 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -126.34 136.56 52.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.921 0.391 . . . . 0.0 111.181 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 52.6 t -80.55 135.16 36.04 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.775 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 C-N-CA 120.877 -0.677 . . . . 0.9 112.137 179.464 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.7 mttp . . . . . 0 CA--C 1.519 -0.219 0 CA-C-O 120.887 0.375 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.447 HD21 ' HB1' ' A' ' 42' ' ' ALA . 43.8 tp -111.4 112.18 23.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.111 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.1 m -82.76 94.04 7.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.084 0.469 . . . . 0.0 110.532 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.539 HD12 ' HB2' ' A' ' 42' ' ' ALA . 12.7 tt -108.7 128.84 64.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.045 0.45 . . . . 0.0 110.788 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.4 mt -124.19 155.31 31.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.455 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.459 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 12.8 ptt180 -80.22 119.56 23.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.801 174.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 41' ' ' ALA . 83.7 mt -76.78 88.11 3.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.209 0.528 . . . . 0.0 110.679 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -102.18 8.59 40.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.823 0.82 . . . . 0.0 109.258 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -157.54 142.97 17.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.496 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -126.43 121.22 31.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.86 0.362 . . . . 0.0 111.067 -177.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.2 170.46 8.24 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.412 ' O ' HG13 ' A' ' 17' ' ' ILE . 4.0 m-20 -60.33 -46.47 89.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.726 0.298 . . . . 0.0 110.732 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -59.11 -41.2 87.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -62.35 -45.42 93.28 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.564 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -59.27 -45.11 92.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.886 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 13' ' ' ASP . 60.6 mt -67.01 -32.1 56.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.009 0.433 . . . . 0.0 111.173 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.402 ' O ' HG13 ' A' ' 22' ' ' ILE . 9.7 t70 -77.09 -38.69 51.85 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.078 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.542 HD23 HD12 ' A' ' 22' ' ' ILE . 97.3 mt -61.65 -34.16 75.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.294 174.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -64.35 -36.11 83.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.297 176.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -70.8 -21.99 62.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.082 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 48' ' ' LEU . 63.5 mt -79.09 -48.44 21.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.767 0.318 . . . . 0.0 110.619 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.433 ' CD1' ' HD2' ' A' ' 67' ' ' ARG . 4.4 m0 -106.83 97.86 19.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.027 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 12.9 Cg_exo . . . . . 0 C--N 1.341 0.163 0 C-N-CA 122.674 2.249 . . . . 0.0 111.832 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 N--CA 1.461 0.115 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -62.68 115.94 4.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.081 -172.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.55 HG13 ' HA ' ' A' ' 38' ' ' ARG . 73.3 t -112.31 118.32 57.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.16 170.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 14.2 p-10 -100.0 -52.2 3.48 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 16.9 t70 166.9 -40.4 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -71.69 -56.14 6.37 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.67 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -91.14 101.92 14.66 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.55 ' HA ' HG13 ' A' ' 33' ' ' VAL . 12.0 ptp180 -123.56 142.34 51.12 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.099 0.476 . . . . 0.0 111.112 -175.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.542 HG12 ' HG2' ' A' ' 53' ' ' ARG . 52.3 mt -107.19 134.42 48.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.204 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.508 ' HB3' HD11 ' A' ' 5' ' ' ILE . 76.6 m-85 -111.05 121.6 45.77 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.724 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.86 119.98 41.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.832 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.715 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -96.44 105.8 17.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.827 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.947 ' HB3' HD23 ' A' ' 48' ' ' LEU . 4.9 ptm180 -107.54 134.31 50.74 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.464 178.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -97.2 82.39 3.16 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.2 t30 50.35 23.94 1.38 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.522 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.667 ' HG2' ' HG3' ' A' ' 47' ' ' ARG . 38.3 tt0 -166.86 -89.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.999 -0.438 . . . . 0.0 110.732 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.667 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 85.7 mtt180 -108.24 163.86 12.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.668 0.271 . . . . 0.0 110.759 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.947 HD23 ' HB3' ' A' ' 43' ' ' ARG . 19.6 mt -77.25 104.0 7.5 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 67.1 mt -86.21 -30.61 22.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.773 0.321 . . . . 0.0 110.867 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.715 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -129.31 137.03 50.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.626 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -131.78 125.15 31.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.832 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.8 p -134.25 134.25 55.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.613 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.542 ' HG2' HG12 ' A' ' 39' ' ' ILE . 63.6 mtm180 -108.88 141.9 40.26 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.311 176.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.471 HG13 ' HG3' ' A' ' 38' ' ' ARG . 6.0 p -133.83 132.7 56.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.295 0.569 . . . . 0.0 110.993 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.7 m -106.57 111.56 24.17 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.63 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.4 mt -83.48 85.58 7.22 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.238 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.6 t -82.98 83.7 7.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.372 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.29 -116.38 7.52 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.187 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.1 p -91.91 2.07 56.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.916 0.389 . . . . 0.0 111.288 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.596 ' HG2' ' HB3' ' A' ' 94' ' ' CYS . 35.0 mt-10 -110.88 136.36 50.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.64 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -115.01 104.17 1.32 Allowed Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.0 124.02 36.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.723 0.297 . . . . 0.0 110.746 -178.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.537 HD12 ' HG2' ' A' ' 97' ' ' MET . 94.6 mt -93.52 114.94 27.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.153 0.502 . . . . 0.0 109.698 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.541 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 10.0 t70 -117.18 127.36 54.03 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.309 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.628 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 25.0 m 66.71 92.26 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.423 0.63 . . . . 0.0 111.146 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.0 tp -114.76 102.26 9.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.292 174.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.433 ' HD2' ' CD1' ' A' ' 23' ' ' TRP . 87.7 mtt180 -136.39 115.05 11.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.421 -175.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' A' ' 50' ' ' ALA . 11.8 t -98.53 150.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -55.78 137.36 50.04 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -62.04 -17.94 58.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.289 0.566 . . . . 0.0 110.908 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.4 t -71.52 -24.73 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.761 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.9 m -86.04 18.87 2.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.06 0.457 . . . . 0.0 111.923 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -66.24 118.23 9.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -163.58 -97.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.359 -0.537 . . . . 0.0 112.19 -175.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 169.6 95.77 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 133.96 -59.03 0.68 Allowed Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.879 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.7 t -49.9 -54.32 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 81' ' ' LEU . . . -61.22 -43.99 98.69 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.026 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -66.27 -46.15 78.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.784 0.325 . . . . 0.0 110.134 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -60.14 -39.18 85.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.46 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 85' ' ' VAL . 48.2 tp -50.53 -55.51 15.79 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.536 0.523 . . . . 0.0 110.819 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.76 -43.69 88.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.29 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.57 -39.42 93.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.343 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -66.64 -44.56 81.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.024 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 81' ' ' LEU . 97.0 t -58.78 -44.18 89.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.79 0.329 . . . . 0.0 110.915 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.03 -18.91 57.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.679 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.8 -42.3 11.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.973 0.416 . . . . 0.0 110.151 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -72.75 -31.66 65.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.117 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -122.99 76.56 50.16 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.618 174.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -94.66 16.11 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.133 2.555 . . . . 0.0 112.613 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.85 2.21 87.1 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.731 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.5 128.61 52.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.731 0.301 . . . . 0.0 110.278 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.7 m -91.61 -34.72 14.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.335 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.596 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 48.9 t -117.72 102.92 9.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.894 0.378 . . . . 0.0 110.65 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 94.8 m95 -92.2 142.52 27.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.8 0.333 . . . . 0.0 110.594 178.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -134.9 142.45 46.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.743 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.537 ' HG2' HD12 ' A' ' 63' ' ' LEU . 80.2 mtp -130.03 125.84 36.25 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -102.75 172.35 6.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.596 -174.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.11 -8.64 59.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.231 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.71 121.22 13.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.231 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' ' 65' ' ' SER . . . 82.23 14.2 77.24 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.187 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.16 93.25 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.915 0.388 . . . . 0.0 110.387 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.75 -17.62 37.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.515 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -112.47 72.92 0.79 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.727 0.775 . . . . 0.0 110.02 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.522 ' HG3' ' HH2' ' A' ' 124' ' ' TRP . 41.5 ttp180 -76.22 -32.09 58.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.321 -170.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.77 -53.41 45.49 Favored Glycine 0 C--O 1.238 0.352 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.115 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.82 -42.16 81.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.972 0.415 . . . . 0.0 110.3 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.557 ' O ' ' HG2' ' A' ' 112' ' ' MET . 47.3 ttm -69.47 -25.12 63.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.424 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 94.3 m -62.9 -48.57 78.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.709 0.29 . . . . 0.0 110.243 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.86 -34.43 77.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.443 0.639 . . . . 0.0 110.249 176.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.458 ' CE2' HD11 ' A' ' 115' ' ' LEU . 55.8 t80 -63.25 -42.4 99.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.819 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.557 ' HG2' ' O ' ' A' ' 108' ' ' MET . 25.1 mmt -62.81 -39.97 95.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.37 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -69.33 -27.15 65.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.624 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.46 -40.46 57.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.438 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.458 HD11 ' CE2' ' A' ' 111' ' ' PHE . 92.9 mt -66.26 -60.78 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.108 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.34 48.45 0.13 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.825 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.434 ' CD2' ' HB2' ' A' ' 126' ' ' LYS . 41.3 m-85 -109.96 141.46 42.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.774 0.321 . . . . 0.0 110.416 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.9 p -92.49 144.08 25.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.257 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.4 p -97.48 148.28 23.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.146 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -124.55 -161.93 1.04 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.934 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -79.32 29.64 0.23 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.907 0.384 . . . . 0.0 111.77 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.08 67.38 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.087 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.62 169.01 11.78 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.428 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.522 ' HH2' ' HG3' ' A' ' 105' ' ' ARG . 11.7 m-90 -113.93 133.44 55.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.698 0.285 . . . . 0.0 110.472 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -123.1 145.3 48.69 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.081 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 64.6 tttp -137.28 96.85 3.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.924 0.392 . . . . 0.0 110.251 174.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 17.4 t -87.9 133.35 33.94 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 C-N-CA 120.833 -0.698 . . . . 0.9 112.005 -179.733 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 tttp . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.465 HD11 ' HB1' ' A' ' 42' ' ' ALA . 49.1 tp -76.04 107.1 8.02 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.534 ' HB ' ' HG2' ' A' ' 43' ' ' ARG . 9.0 m -86.65 98.87 11.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.444 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 4.6 mp -89.75 127.8 42.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 mm -101.54 146.94 9.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 13.9 ptt180 -99.21 106.16 18.28 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 39' ' ' ILE . 63.9 mt -73.09 86.06 1.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.451 0.643 . . . . 0.0 110.882 -176.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -95.69 -22.33 17.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.784 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -136.75 143.5 43.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.127 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -120.93 144.63 48.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.256 0.551 . . . . 0.0 111.782 -173.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.3 p -109.56 163.71 13.2 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 166.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.471 ' O ' HG13 ' A' ' 17' ' ' ILE . 29.5 t70 -68.19 -31.11 70.41 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.327 0.584 . . . . 0.0 109.491 177.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -65.97 -50.77 63.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.114 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.407 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 47.7 m-20 -66.42 -28.6 68.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.057 0.456 . . . . 0.0 110.477 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -65.1 -32.62 74.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.282 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 13' ' ' ASP . 75.8 mt -65.92 -42.97 92.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.566 175.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.19 -38.2 82.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.029 0.442 . . . . 0.0 110.358 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.427 ' O ' ' HE3' ' A' ' 23' ' ' TRP . 96.4 mt -61.3 -40.0 92.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.279 175.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -77.25 -6.2 52.19 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.578 0.704 . . . . 0.0 110.458 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -89.77 -18.62 25.97 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.552 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 91.5 mt -90.41 -38.77 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.774 172.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.427 ' HE3' ' O ' ' A' ' 19' ' ' LEU . 18.2 m-90 -99.21 89.02 0.85 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.369 171.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 13.0 Cg_exo . . . . . 0 C--N 1.344 0.303 0 C-N-CA 122.61 2.207 . . . . 0.0 113.064 -169.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 121.428 0.632 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -67.8 135.18 52.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.377 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.15 165.78 30.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.943 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -156.29 -171.5 3.74 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.37 -14.94 62.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 118.275 0.488 . . . . 0.0 111.307 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 34.2 m-80 -97.29 -56.8 2.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.085 0.469 . . . . 0.0 110.358 176.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -89.36 93.93 9.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.167 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -112.63 156.1 23.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.721 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.48 HG23 ' HG2' ' A' ' 53' ' ' ARG . 63.5 mt -113.3 122.05 66.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.897 177.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -94.13 117.91 30.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.122 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.49 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.14 113.3 26.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.947 178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.765 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -95.44 112.42 24.14 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.903 -175.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.603 ' HB3' HD23 ' A' ' 48' ' ' LEU . 4.7 ptm180 -102.74 125.95 49.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.408 0.623 . . . . 0.0 109.941 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.54 ' HB3' HD12 ' A' ' 49' ' ' LEU . 57.1 t80 -109.51 95.58 5.71 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.9 t30 60.06 81.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.992 -173.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 72.83 -59.25 0.57 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.165 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 59.9 mtt85 -72.44 132.28 43.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -167.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' A' ' 43' ' ' ARG . 96.2 mt -76.16 100.19 4.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 171.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.54 HD12 ' HB3' ' A' ' 44' ' ' PHE . 88.2 mt -107.0 -8.72 16.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.77 -173.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.765 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -144.07 139.02 28.68 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.86 131.47 31.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.2 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 65' ' ' SER . 10.0 p -141.45 130.2 23.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.317 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HG2' HG23 ' A' ' 39' ' ' ILE . 63.6 mtm180 -99.68 141.68 32.16 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.0 p -130.94 127.88 61.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.573 0.702 . . . . 0.0 111.121 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.4 m -100.04 93.62 5.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.476 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.514 ' O ' ' HB3' ' A' ' 36' ' ' ASN . 94.2 mt -81.24 141.29 34.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.057 0.456 . . . . 0.0 110.625 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 t -144.44 74.3 1.41 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.21 -111.41 3.9 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.854 -178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.0 p -95.85 12.81 28.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.051 0.453 . . . . 0.0 111.204 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -118.95 139.06 52.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.74 114.59 0.96 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.861 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -103.24 119.33 38.68 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.607 0.242 . . . . 0.0 110.768 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.517 HD22 ' HE3' ' A' ' 97' ' ' MET . 6.0 mp -93.42 126.27 38.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.108 0.48 . . . . 0.0 110.688 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -125.17 138.9 54.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.299 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 50.3 m 61.01 87.27 0.09 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.312 0.577 . . . . 0.0 111.283 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.7 tp -108.58 106.35 16.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.907 173.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.422 HH12 ' CD ' ' A' ' 103' ' ' GLU . 72.9 mtp85 -131.45 119.79 22.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -173.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.452 HG12 ' HB ' ' A' ' 72' ' ' THR . 1.9 t -109.07 141.61 23.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.6 ttt-85 -82.92 166.65 18.71 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.983 -174.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -48.7 -39.58 25.13 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.704 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.6 t -62.25 -28.28 44.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.207 -173.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.452 ' HB ' HG12 ' A' ' 68' ' ' VAL . 0.6 OUTLIER -97.18 19.03 13.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -168.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -80.29 84.86 5.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -134.73 -86.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.071 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER 168.54 99.1 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.612 0.765 . . . . 0.0 109.061 -168.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.85 -74.12 0.45 Allowed Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.627 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.4 t -38.15 -54.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -170.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 81' ' ' LEU . . . -56.43 -59.34 10.9 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.96 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.418 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 99.4 mt-30 -64.16 -34.34 77.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.804 0.335 . . . . 0.0 110.723 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -63.34 -38.3 90.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.529 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.477 ' O ' HG23 ' A' ' 85' ' ' VAL . 61.7 tp -55.58 -49.95 71.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.994 176.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.46 -43.89 96.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.902 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 79' ' ' GLN . 40.1 mt-10 -59.33 -42.63 91.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.266 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.433 ' HG2' HD13 ' A' ' 5' ' ' ILE . 9.1 tp10 -60.27 -44.12 95.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.49 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 81' ' ' LEU . 99.3 t -60.61 -44.94 97.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.16 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -73.9 -16.47 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.658 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 87' ' ' ARG . 63.6 mtt180 -92.89 -30.56 15.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.034 0.445 . . . . 0.0 110.632 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -73.92 -50.51 19.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.737 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.445 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 12.4 m120 -82.54 146.9 54.58 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.111 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 22.7 Cg_exo -66.38 -165.79 0.1 OUTLIER 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.161 2.574 . . . . 0.0 113.003 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.43 84.73 0.1 Allowed Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.522 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.0 t -82.56 122.83 37.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 7.1 m -68.74 -57.82 5.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.544 -174.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.7 t -103.76 106.95 17.61 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.657 -172.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -97.83 110.62 23.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.935 0.398 . . . . 0.0 110.141 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.444 ' CE3' ' HG2' ' A' ' 125' ' ' GLU . 18.9 t-105 -104.12 131.74 51.09 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.517 ' HE3' HD22 ' A' ' 63' ' ' LEU . 54.7 mtp -128.69 137.27 51.53 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 175.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.66 169.33 11.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.781 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.0 5.96 48.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.393 . . . . 0.0 110.773 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.82 124.64 21.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.429 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.51 0.12 58.09 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.541 HG21 ' SD ' ' A' ' 108' ' ' MET . 62.1 t -114.83 124.46 71.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.558 -0.321 . . . . 0.0 110.201 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.422 ' CD ' HH12 ' A' ' 67' ' ' ARG . 17.6 mp0 -71.88 -26.49 62.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.442 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -118.82 103.25 9.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.021 0.438 . . . . 0.0 110.95 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -73.1 -28.25 62.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.404 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.94 -51.68 51.34 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.123 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.6 t -59.79 -40.86 83.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.921 0.391 . . . . 0.0 110.306 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.541 ' SD ' HG21 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -61.55 -43.27 99.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.643 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 57.3 m -61.15 -48.83 79.8 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.781 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.14 96.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.069 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -62.4 -47.65 83.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.075 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.536 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 23.9 mmt -63.13 -46.22 88.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.407 -177.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -68.55 -30.2 68.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.743 -177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.46 -27.13 58.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.884 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.585 HD13 ' HE2' ' A' ' 117' ' ' PHE . 4.7 tt -82.22 -51.52 7.86 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 141.84 45.72 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.415 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.585 ' HE2' HD13 ' A' ' 115' ' ' LEU . 94.7 m-85 -123.38 134.52 53.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.828 0.347 . . . . 0.0 110.547 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.5 m -93.13 144.82 24.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.835 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.8 t -97.23 116.44 29.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.544 0.687 . . . . 0.0 110.206 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -141.1 140.17 34.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.312 -174.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 54.74 30.99 14.54 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.892 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.7 -57.15 0.52 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.486 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -90.55 -147.93 19.5 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.195 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 31.0 m-90 -121.52 124.24 43.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.696 0.284 . . . . 0.0 110.307 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.444 ' HG2' ' CE3' ' A' ' 96' ' ' TRP . 42.3 mt-10 -119.33 121.17 38.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.743 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -126.37 96.79 4.81 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.536 172.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 93' ' ' SER . 34.2 t -104.21 123.88 48.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.005 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 C-N-CA 121.095 -0.574 . . . . 0.9 112.074 -179.795 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 tttp . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.766 0.317 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.559 HD11 ' HB1' ' A' ' 42' ' ' ALA . 47.6 tp -89.41 116.32 27.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.347 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 m -89.32 93.22 9.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.567 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.69 HD11 ' HB3' ' A' ' 40' ' ' TYR . 6.5 tp -88.05 124.39 41.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.175 0.512 . . . . 0.0 110.052 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 mt -123.55 155.02 29.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.219 -176.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -89.53 127.68 35.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.131 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.438 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 42.0 tp -80.91 99.63 8.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.601 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.507 ' HA ' HG11 ' A' ' 33' ' ' VAL . 36.0 mt-10 -102.04 -17.36 16.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.655 -175.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -151.56 156.31 40.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.703 0.287 . . . . 0.0 111.29 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.444 ' CE2' HG23 ' A' ' 33' ' ' VAL . 87.7 m-85 -119.1 109.64 16.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.117 -177.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.0 p -90.74 158.86 16.64 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 168.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 17' ' ' ILE . 5.4 m-20 -58.58 -38.34 77.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.934 0.397 . . . . 0.0 110.184 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -61.54 -55.78 27.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.676 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.507 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 70.1 m-20 -61.88 -37.67 85.42 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.538 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -64.19 -36.4 83.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.67 -176.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 13' ' ' ASP . 80.2 mt -66.5 -45.12 89.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.743 177.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.545 ' O ' HG13 ' A' ' 22' ' ' ILE . 24.0 t0 -65.57 -35.06 79.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.333 . . . . 0.0 110.593 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 95.0 mt -63.65 -41.43 98.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.978 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -69.42 -21.45 63.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.514 0.673 . . . . 0.0 109.695 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -85.78 -12.34 51.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.134 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 18' ' ' ASP . 71.0 mt -85.1 -32.69 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 171.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -116.04 72.09 4.42 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.783 175.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HD3' ' C ' ' A' ' 22' ' ' ILE . 18.0 Cg_exo . . . . . 0 C--N 1.347 0.465 0 C-N-CA 122.338 2.025 . . . . 0.0 111.732 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 121.192 0.52 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -137.94 147.74 44.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.178 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' ' 9' ' ' GLU . 59.7 t -93.74 126.23 46.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.039 -176.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.646 ' HB3' ' HB2' ' A' ' 37' ' ' HIS . 30.9 t70 -138.71 158.02 45.01 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.299 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -63.2 -35.87 81.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.723 0.296 . . . . 0.0 110.805 178.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 55' ' ' THR . 15.8 m120 -86.29 -48.04 8.86 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.646 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 40.4 m170 -87.28 84.47 7.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.914 175.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -109.36 147.79 32.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.144 -173.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 8' ' ' LEU . 56.5 mt -126.56 139.07 52.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.854 0.359 . . . . 0.0 110.379 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.69 ' HB3' HD11 ' A' ' 5' ' ' ILE . 76.9 m-85 -118.03 152.43 35.54 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.525 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -136.67 126.51 25.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.999 0.428 . . . . 0.0 111.154 -174.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.04 104.02 16.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.011 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -95.14 110.22 22.2 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.34 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -119.39 135.24 54.82 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.3 t30 61.51 30.65 18.87 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.618 0.723 . . . . 0.0 109.072 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 65.84 17.11 10.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.955 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -126.43 138.96 53.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.572 0.225 . . . . 0.0 110.404 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.525 HD22 ' HB1' ' A' ' 41' ' ' ALA . 78.4 mt -63.65 106.58 0.99 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 49' ' ' LEU . 12.8 tp -105.03 -21.41 13.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.823 -172.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -140.94 135.26 31.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.482 178.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.65 132.93 53.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.608 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.482 ' HB ' HD13 ' A' ' 66' ' ' LEU . 8.0 p -142.2 131.9 23.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.596 -178.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 1.026 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 10.6 mtm180 -103.22 155.68 18.26 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.88 176.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.79 126.5 14.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.251 0.548 . . . . 0.0 110.414 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 77.6 m -102.49 107.61 18.63 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.042 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.4 mt -83.54 95.29 8.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.043 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.3 t -86.79 93.05 9.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.368 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.83 -102.99 1.38 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.789 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.2 m -120.83 12.96 11.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.926 0.87 . . . . 0.0 109.521 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -112.87 157.88 20.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.956 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 95' ' ' TRP . . . -125.15 120.76 4.04 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.864 -174.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.78 132.07 53.78 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.834 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 73.0 mt -95.43 119.14 33.41 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.206 0.527 . . . . 0.0 110.281 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 1.026 ' HB2' ' HB2' ' A' ' 53' ' ' ARG . 1.3 m-20 -79.6 -157.66 0.14 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.117 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 p -47.27 118.45 2.17 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.138 0.494 . . . . 0.0 111.932 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.482 HD13 ' HB ' ' A' ' 52' ' ' VAL . 21.3 tp -117.64 116.97 28.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.349 175.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -143.82 123.19 13.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.192 0.52 . . . . 0.0 111.735 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' A' ' 50' ' ' ALA . 22.4 t -94.38 137.8 22.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 169.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -56.87 136.55 55.74 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -56.67 -15.82 5.19 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -166.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.07 -15.59 19.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.696 0.284 . . . . 0.0 111.487 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 m -108.99 68.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.406 0.622 . . . . 0.0 110.34 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.8 ttt85 -92.85 103.31 15.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.842 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 74' ' ' ARG . 20.9 mtp180 60.78 79.73 0.24 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.805 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -142.21 16.76 2.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.052 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.22 -19.98 11.7 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.489 175.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.9 t -51.29 -46.59 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.0 -28.95 71.27 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.101 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -69.65 -55.0 11.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -56.11 -44.65 79.31 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.165 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.628 HD11 HD13 ' A' ' 5' ' ' ILE . 30.3 tp -52.89 -57.99 8.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.496 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.3 mt -66.21 -39.69 89.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.238 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -59.0 -43.01 91.42 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.252 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -64.45 -36.42 84.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.59 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 81' ' ' LEU . 93.2 t -63.34 -48.87 85.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.803 0.335 . . . . 0.0 110.686 177.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.539 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 11.1 mp -66.22 -27.84 68.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.896 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 87' ' ' ARG . 5.5 mtp180 -77.39 -33.66 55.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.398 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -69.95 -44.09 70.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.795 -176.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.651 HD22 ' HH2' ' A' ' 95' ' ' TRP . 90.9 m-20 -76.02 112.79 22.38 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.359 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -87.42 22.54 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.143 2.562 . . . . 0.0 113.766 -171.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -172.7 75.9 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.018 -1.087 . . . . 0.0 113.093 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.4 t -141.69 129.09 20.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.9 p -99.66 -33.13 10.73 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -177.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.6 t -130.34 137.45 49.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.131 0.491 . . . . 0.0 110.814 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.651 ' HH2' HD22 ' A' ' 89' ' ' ASN . 90.7 m95 -116.12 122.4 45.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.345 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -114.18 121.3 43.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.292 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.834 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 77.2 mtp -107.29 130.08 54.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.793 0.33 . . . . 0.0 110.59 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -101.26 144.95 29.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.711 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.415 ' HB2' HG12 ' A' ' 102' ' ' VAL . 2.7 p-10 -69.49 -34.26 74.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.908 0.385 . . . . 0.0 110.148 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 61.65 20.68 11.52 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.47 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.35 13.01 20.34 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.243 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.538 HG13 ' HB3' ' A' ' 105' ' ' ARG . 12.2 p -85.53 119.67 34.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.115 0.483 . . . . 0.0 109.725 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -93.27 -5.1 50.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.326 0.584 . . . . 0.0 109.762 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -86.46 16.3 4.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.14 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.538 ' HB3' HG13 ' A' ' 102' ' ' VAL . 5.1 ptt180 -56.62 -32.12 64.98 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.167 -175.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.22 -48.35 70.78 Favored Glycine 0 C--O 1.235 0.193 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.726 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.1 t -61.24 -43.27 96.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-O 122.025 0.917 . . . . 0.0 109.394 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.601 ' O ' ' HG2' ' A' ' 112' ' ' MET . 17.3 ttt -61.64 -37.97 85.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.13 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 98.9 m -61.28 -36.24 79.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.105 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.28 -45.17 88.42 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.13 0.49 . . . . 0.0 109.748 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -63.5 -45.08 92.32 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.019 173.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.601 ' HG2' ' O ' ' A' ' 108' ' ' MET . 59.5 mmm -60.57 -43.89 96.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.102 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -62.83 -35.1 78.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.807 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.51 -32.95 74.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.167 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 33.5 tp -84.8 -42.84 14.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.499 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 136.28 32.87 0.25 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.149 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.582 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 78.5 m-85 -118.58 116.24 26.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.76 0.314 . . . . 0.0 110.391 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.3 p -102.01 136.14 42.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.895 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.711 ' HB ' ' CD1' ' A' ' 124' ' ' TRP . 11.6 t -97.37 134.9 40.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.139 0.495 . . . . 0.0 110.737 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.632 ' HB2' ' OE2' ' A' ' 125' ' ' GLU . 19.0 mt-30 -140.31 -72.6 0.36 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.289 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -86.14 61.54 6.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.265 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.87 -36.96 2.49 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.139 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -118.96 -172.81 15.45 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.165 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.711 ' CD1' ' HB ' ' A' ' 119' ' ' THR . 15.8 m-90 -98.54 126.42 44.1 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.632 ' OE2' ' HB2' ' A' ' 120' ' ' GLN . 35.4 mt-10 -111.69 122.17 47.09 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.015 -175.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -137.12 148.64 46.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.396 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 38.2 t -110.82 151.07 28.25 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.329 0 C-N-CA 120.895 -0.669 . . . . 0.9 112.535 179.34 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.5 tttm . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.964 0.411 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.517 HD21 ' HB1' ' A' ' 42' ' ' ALA . 23.3 tp -76.03 118.47 18.82 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.561 ' O ' ' HB3' ' A' ' 43' ' ' ARG . 18.1 m -90.25 92.22 8.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.098 0.475 . . . . 0.0 110.458 -176.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.596 HG22 ' HA ' ' A' ' 42' ' ' ALA . 9.2 pt -106.79 150.98 8.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.091 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.1 mp -131.14 153.09 38.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -82.98 140.07 32.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.868 0.366 . . . . 0.0 110.036 176.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.9 tp -84.74 82.91 8.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.279 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -75.76 -48.8 20.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.783 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -120.19 157.24 29.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.411 -176.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -117.97 103.7 10.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.995 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -88.88 156.74 18.74 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.432 ' O ' HG13 ' A' ' 17' ' ' ILE . 19.0 t70 -56.78 -52.86 63.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.396 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.17 -35.99 80.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.68 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.488 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 22.0 m-20 -63.48 -44.01 95.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.531 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -62.53 -34.89 77.81 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 120.648 0.261 . . . . 0.0 110.958 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 13' ' ' ASP . 74.2 mt -63.13 -46.54 95.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.613 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -71.69 -31.28 66.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.013 0.435 . . . . 0.0 109.997 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 84.3 mt -63.67 -34.48 77.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.587 174.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -77.22 -18.74 57.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.165 0.507 . . . . 0.0 110.579 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -68.14 -36.81 80.26 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.516 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 67.3 mt -73.76 -55.47 12.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.23 176.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -101.18 97.34 7.07 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 35.3 Cg_exo . . . . . 0 C--N 1.345 0.377 0 C-N-CA 122.554 2.169 . . . . 0.0 111.853 -178.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.511 0.196 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -56.01 128.63 36.21 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.279 0.561 . . . . 0.0 111.934 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.1 m -103.38 167.52 2.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.399 -176.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -155.94 -158.25 0.79 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -72.64 -29.35 63.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.005 0.431 . . . . 0.0 110.77 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -85.68 -53.39 5.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.663 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -92.82 112.39 24.34 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -126.7 119.87 28.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.201 0.524 . . . . 0.0 110.806 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 65.2 mt -98.56 133.92 39.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.073 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -112.7 132.88 54.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.082 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.422 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.52 123.27 48.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.878 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.662 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -91.9 114.69 27.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.453 -176.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.561 ' HB3' ' O ' ' A' ' 4' ' ' THR . 51.9 ttt180 -108.03 127.3 53.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.273 0.559 . . . . 0.0 110.864 -177.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -99.41 82.49 2.68 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 69.13 -68.35 0.19 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.728 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -101.58 -57.74 2.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -174.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 47' ' ' ARG . 10.0 ptp180 -114.51 171.66 7.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.983 0.42 . . . . 0.0 111.076 -171.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.422 HD22 ' HB1' ' A' ' 41' ' ' ALA . 87.5 mt -75.34 133.55 41.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.431 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.8 tp -111.01 -23.98 10.63 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.734 0.302 . . . . 0.0 110.496 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.736 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -151.3 159.08 44.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.158 -177.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -144.46 133.41 22.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.963 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.08 137.76 37.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.937 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 19.1 mtm180 -110.17 129.99 55.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.207 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -133.73 139.47 48.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.316 0.579 . . . . 0.0 110.809 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -111.02 114.7 28.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.092 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.43 HD22 HG21 ' A' ' 92' ' ' VAL . 70.5 mt -86.84 93.06 9.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.965 0.412 . . . . 0.0 109.99 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 t -111.58 94.41 4.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.517 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.42 -107.72 2.04 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.498 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.3 p -93.45 -15.13 25.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.739 0.304 . . . . 0.0 111.036 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -99.66 122.19 42.33 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.247 0.546 . . . . 0.0 111.988 -172.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.23 97.37 2.17 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 167.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.47 107.54 19.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.21 0.528 . . . . 0.0 110.437 -172.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.9 tt -93.73 119.28 32.51 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.041 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 12.1 t70 -126.57 126.42 43.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.348 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.0 t 71.39 108.86 0.06 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.799 0.809 . . . . 0.0 111.111 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 45.4 tp -129.33 110.43 11.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.321 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 67' ' ' ARG . 43.5 mtt180 -125.36 128.53 48.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.095 0.474 . . . . 0.0 111.611 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.736 HG13 ' HB2' ' A' ' 50' ' ' ALA . 1.7 t -121.76 153.97 25.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 172.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.5 mtt-85 -65.22 158.58 25.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.947 0.403 . . . . 0.0 111.433 -176.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 1.5 mp0 -49.88 -38.6 36.25 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.947 -170.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.8 m -78.3 19.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.483 HG21 HG12 ' A' ' 68' ' ' VAL . 70.9 p -115.76 9.68 15.2 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.763 0.316 . . . . 0.0 111.253 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.2 ttp-105 -57.55 106.12 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.167 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 55.92 40.47 30.49 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.119 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -111.29 7.39 21.05 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.992 0.425 . . . . 0.0 111.631 -174.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.98 -23.89 12.73 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.928 173.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.7 t -53.92 -42.07 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.771 0.319 . . . . 0.0 111.713 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.85 -38.43 88.57 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.89 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -59.55 -49.72 76.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.863 0.363 . . . . 0.0 111.037 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -67.06 -33.88 76.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.961 -174.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.494 HD13 ' HB2' ' A' ' 42' ' ' ALA . 56.3 tp -57.72 -49.39 76.71 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.8 0.333 . . . . 0.0 110.301 176.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.77 -42.46 97.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.702 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.01 -46.89 84.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.108 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -59.12 -43.17 91.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.622 0.248 . . . . 0.0 110.974 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 81' ' ' LEU . 94.8 t -60.58 -52.27 63.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.918 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 11.2 mp -64.85 -32.14 73.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.571 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -76.74 -40.2 49.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.929 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -71.19 -39.6 71.7 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -174.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.52 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 47.6 m-80 -75.01 131.75 78.3 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.913 0.387 . . . . 0.0 110.674 -177.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 16.9 Cg_exo -67.05 -69.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 123.383 2.722 . . . . 0.0 114.456 -170.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.13 61.55 0.48 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.637 -170.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.43 HG21 HD22 ' A' ' 56' ' ' LEU . 25.5 t -114.52 105.11 18.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 175.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.9 t -83.25 -37.81 23.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.485 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.0 t -108.93 109.01 19.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.902 0.382 . . . . 0.0 110.822 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.427 ' CZ2' ' HA ' ' A' ' 86' ' ' LEU . 95.9 m95 -97.65 115.54 28.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.698 175.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 -114.88 126.19 54.52 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.964 -175.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 87.1 mtp -107.03 122.52 46.62 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.0 173.71 8.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.772 -172.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.31 -46.05 86.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.051 -178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 62.18 17.01 8.84 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.681 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.53 36.87 58.62 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.47 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.1 t -106.53 109.99 30.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.645 0.222 . . . . 0.0 110.724 177.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -90.95 -6.95 53.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.777 0.322 . . . . 0.0 110.6 173.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.73 52.65 1.03 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.262 0.553 . . . . 0.0 109.621 173.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 105' ' ' ARG . 48.2 mtt-85 -72.94 -21.87 60.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.884 -172.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.69 -56.64 23.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.535 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.1 t -61.51 -39.12 81.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.021 0.439 . . . . 0.0 110.837 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.6 ' SD ' ' HE3' ' A' ' 112' ' ' MET . 27.0 ttm -71.25 -37.8 71.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.119 -176.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 99.1 m -63.84 -47.35 81.12 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.634 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.18 -39.08 74.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.348 0.594 . . . . 0.0 110.602 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -62.77 -54.38 39.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.374 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.6 ' HE3' ' SD ' ' A' ' 108' ' ' MET . 66.4 mtt -76.03 -33.26 59.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -174.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -63.41 -41.03 98.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.943 0.401 . . . . 0.0 110.119 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.24 -25.28 59.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.762 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.6 tp -84.02 -0.12 50.4 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.268 0.556 . . . . 0.0 110.637 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.41 53.38 4.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.95 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -110.0 133.25 53.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.707 0.289 . . . . 0.0 110.633 174.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.8 m -84.74 143.65 29.01 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.4 p -97.32 108.27 20.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.011 0.434 . . . . 0.0 111.038 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -96.8 163.42 12.99 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -73.65 95.99 2.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.827 0.346 . . . . 0.0 110.32 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.94 -30.53 2.94 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.506 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.55 -173.93 42.58 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.375 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -102.34 136.72 41.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.629 0.252 . . . . 0.0 110.619 -177.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -125.75 131.6 52.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.857 -176.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -132.02 133.77 44.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 78.2 m -86.87 129.92 34.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.766 0.317 . . . . 0.0 110.471 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 C-N-CA 121.088 -0.577 . . . . 0.9 111.953 179.836 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 120.975 0.417 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.505 HD22 HG13 ' A' ' 77' ' ' VAL . 59.2 tp -75.86 137.05 40.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.963 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 42' ' ' ALA . 19.1 m -82.89 89.63 6.86 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.209 0.528 . . . . 0.0 110.577 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 40' ' ' TYR . 5.5 tp -98.35 105.76 17.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.003 174.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mt -94.74 149.22 4.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.359 0.6 . . . . 0.0 111.535 -170.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -91.59 101.36 14.0 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.124 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 39' ' ' ILE . 94.3 mt -73.11 92.95 1.75 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.691 -173.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -102.35 -2.69 28.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.736 0.779 . . . . 0.0 109.082 173.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -131.92 120.86 23.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.521 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -124.31 99.59 6.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.491 0.186 . . . . 0.0 111.066 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.57 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 1.4 m -79.03 158.95 27.79 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.569 ' O ' HG12 ' A' ' 17' ' ' ILE . 5.7 p-10 -58.14 -36.45 72.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.658 0.266 . . . . 0.0 110.732 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -70.0 -36.56 75.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.125 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -63.74 -38.34 90.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.272 0.558 . . . . 0.0 109.765 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.57 ' HG3' ' O ' ' A' ' 12' ' ' SER . 77.5 mtt180 -68.28 -28.46 67.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.468 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 13' ' ' ASP . 46.6 mm -66.8 -41.49 87.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.751 176.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 28.5 t0 -69.05 -32.48 71.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.04 0.447 . . . . 0.0 109.859 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.6 mt -63.23 -38.57 91.68 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.236 172.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -68.11 -22.77 64.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.559 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HE2' HG22 ' A' ' 17' ' ' ILE . 66.3 mttm -76.84 -32.87 57.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.311 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.6 mt -76.98 -39.0 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.531 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.504 ' CD1' ' HD2' ' A' ' 67' ' ' ARG . 5.0 m-90 -114.56 90.27 20.97 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.668 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 C--N 1.344 0.296 0 C-N-CA 122.786 2.324 . . . . 0.0 112.701 178.607 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.251 0.548 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -73.51 111.18 8.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.575 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.01 151.43 28.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.032 0.444 . . . . 0.0 111.519 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 73.99 -6.66 1.78 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.942 171.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -65.87 -29.7 70.19 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 174.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 171.93 -29.03 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.841 -1.527 . . . . 0.0 107.354 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -86.94 116.54 25.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.468 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.514 ' HB2' HG13 ' A' ' 54' ' ' VAL . 51.5 mtt180 -109.09 125.78 52.49 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.046 0.45 . . . . 0.0 110.4 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.483 HG22 HD12 ' A' ' 8' ' ' LEU . 54.8 mt -108.67 110.0 30.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.803 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.553 ' HB3' HD11 ' A' ' 5' ' ' ILE . 65.4 m-85 -104.27 138.49 40.65 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.524 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -128.68 120.55 26.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.973 0.416 . . . . 0.0 111.296 -175.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -94.45 105.47 17.44 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.535 177.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.513 ' HB3' HD23 ' A' ' 48' ' ' LEU . 11.9 ptt180 -99.46 134.71 41.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.383 0.611 . . . . 0.0 110.74 -177.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -118.33 119.51 34.85 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.1 t30 60.13 41.87 16.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.696 0.76 . . . . 0.0 109.04 -173.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 76.49 -27.05 0.18 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.933 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -82.21 137.03 35.01 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.524 HD22 ' HB1' ' A' ' 41' ' ' ALA . 76.4 mt -69.43 97.69 1.02 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 0.0 111.009 -175.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.4 tp -78.18 -39.0 42.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.883 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -131.23 126.48 35.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.899 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -117.35 125.86 51.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.334 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.47 127.95 60.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.62 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 5.1 mtp180 -107.04 127.36 53.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 38' ' ' ARG . 5.2 p -122.57 115.71 46.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.649 0.738 . . . . 0.0 110.827 176.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.4 m -91.93 108.63 20.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.968 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.14 154.27 19.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.106 0.479 . . . . 0.0 110.612 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 5.5 t -136.55 30.4 2.89 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.32 -108.07 3.43 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.372 -176.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 p -84.67 -1.86 56.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.366 0.603 . . . . 0.0 110.68 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 44.8 tt0 -109.93 127.57 54.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.414 177.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -127.35 112.89 1.6 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.11 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.36 118.5 33.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.888 0.375 . . . . 0.0 110.53 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 5.6 mp -93.89 125.61 38.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.97 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.62 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 4.4 p30 -122.84 135.75 54.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.104 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.1 t 66.73 94.1 0.07 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.884 0.849 . . . . 0.0 111.273 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.485 HD21 HD21 ' A' ' 82' ' ' LEU . 37.0 tp -122.99 108.01 12.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.231 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.504 ' HD2' ' CD1' ' A' ' 23' ' ' TRP . 98.2 mtt180 -130.49 117.89 20.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.269 0.557 . . . . 0.0 111.651 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 50' ' ' ALA . 5.1 t -107.03 141.91 21.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -62.65 151.23 38.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.872 0.367 . . . . 0.0 110.993 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -54.58 -26.28 31.44 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.358 -0.837 . . . . 0.0 113.022 -171.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.19 3.51 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.287 0.565 . . . . 0.0 111.177 -176.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.76 13.16 16.11 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.13 -0.356 . . . . 0.0 111.142 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -66.42 118.36 9.95 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.741 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 50.47 73.88 0.25 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.634 -172.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -138.24 11.77 2.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.265 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.95 -32.65 1.96 Allowed Glycine 0 CA--C 1.521 0.43 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.539 177.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.505 HG13 HD22 ' A' ' 3' ' ' LEU . 85.4 t -49.74 -42.17 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.281 0.632 . . . . 0.0 112.576 -176.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -52.66 -44.57 60.19 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.395 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -64.99 -43.58 92.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.0 110.785 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -63.5 -49.1 74.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.54 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.44 ' CD1' HD13 ' A' ' 5' ' ' ILE . 30.6 tp -49.47 -60.79 2.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.798 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.485 HD21 HD21 ' A' ' 66' ' ' LEU . 4.1 mm? -64.78 -43.11 94.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.581 -175.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.605 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 40.3 tt0 -63.91 -39.41 94.1 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.707 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -60.69 -40.46 92.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.962 0.41 . . . . 0.0 110.487 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 81' ' ' LEU . 90.1 t -64.16 -38.32 82.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.816 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 82' ' ' LEU . 10.6 mp -70.1 -24.94 63.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.159 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.605 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 63.6 mtt180 -76.88 -36.9 56.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.126 0.489 . . . . 0.0 109.956 174.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -66.58 -47.45 72.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.553 -176.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -75.42 147.6 82.45 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.387 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.88 -165.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.987 2.458 . . . . 0.0 112.612 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.68 96.29 0.15 Allowed Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.83 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.8 t -102.26 -50.4 9.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.072 0.463 . . . . 0.0 110.047 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.6 m 70.79 -50.12 0.67 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.037 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 47.8 t -89.4 86.36 6.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.058 0.456 . . . . 0.0 110.399 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.448 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 96.1 m95 -95.76 121.09 37.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.372 178.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -117.11 134.31 54.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.555 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.716 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 92.8 mmm -107.15 111.17 23.47 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.95 150.63 22.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.18 -174.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.614 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -70.13 -63.81 1.01 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.703 179.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.61 16.78 6.85 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.388 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.15 12.16 12.57 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.389 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 99' ' ' ASP . 69.2 t -69.29 104.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 117.262 0.531 . . . . 0.0 110.723 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.55 -10.59 45.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.373 0.606 . . . . 0.0 109.967 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.13 47.35 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.039 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -61.42 -40.1 93.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.93 -173.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.94 -53.17 39.2 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.456 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.29 -43.94 98.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.797 0.332 . . . . 0.0 110.674 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 91.2 mmm -64.7 -39.07 93.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.462 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 98.9 m -60.86 -43.72 98.01 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.818 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.65 -44.76 93.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.083 0.468 . . . . 0.0 110.776 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -64.82 -45.11 87.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.831 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.556 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 16.9 mmt -62.13 -45.46 93.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.105 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -63.54 -34.98 78.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.595 0.236 . . . . 0.0 111.16 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.91 -29.45 69.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.005 0.431 . . . . 0.0 110.852 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.2 tp -96.71 13.3 28.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.213 0.53 . . . . 0.0 110.73 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.86 57.67 4.03 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.124 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 55.6 m-85 -126.0 153.81 43.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 110.325 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.9 p -128.22 145.47 51.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.809 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.9 t -97.16 124.57 41.25 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -141.79 106.63 4.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.851 -172.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 57.75 35.98 26.07 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.575 168.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 158.29 -85.1 0.13 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.281 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -121.35 -137.21 5.21 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.685 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.716 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 19.2 m-90 -112.29 141.47 45.97 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -128.07 142.73 51.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.717 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.464 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 54.4 tttp -132.5 89.69 2.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 38.1 t -86.79 97.75 10.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.554 -176.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 C-N-CA 121.04 -0.6 . . . . 0.9 112.284 179.528 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 92.8 mttt . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 120.95 0.405 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.415 ' HB3' ' CE2' ' A' ' 80' ' ' TYR . 59.2 tp -87.17 114.98 24.25 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 m -82.87 93.44 7.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.342 0.592 . . . . 0.0 110.787 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.575 HG22 ' HA ' ' A' ' 42' ' ' ALA . 13.3 pt -113.12 148.55 15.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.137 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.46 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -133.94 144.4 35.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.359 -177.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -91.94 142.18 27.83 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.52 98.09 1.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.187 0.518 . . . . 0.0 111.373 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -89.14 -42.12 11.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.077 173.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -136.72 140.31 42.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.196 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.493 ' HE2' HG22 ' A' ' 33' ' ' VAL . 34.9 m-85 -97.42 92.95 6.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.975 0.417 . . . . 0.0 111.686 -176.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 m -71.94 139.3 48.64 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 171.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 17' ' ' ILE . 27.1 m-20 -59.32 -41.59 89.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.576 0.227 . . . . 0.0 111.106 -177.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -61.59 -39.84 92.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.956 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -72.2 -30.98 65.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.752 0.311 . . . . 0.0 110.603 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -68.98 -31.23 69.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 0.0 110.619 176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 13' ' ' ASP . 79.9 mt -70.27 -36.99 69.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.073 0.463 . . . . 0.0 109.829 174.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -64.86 -41.68 95.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.016 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.4 mt -59.91 -35.54 75.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.708 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -69.35 -25.36 64.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.199 0.523 . . . . 0.0 110.097 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 67.7 mttm -72.81 -27.48 61.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.974 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.769 HD11 ' HB3' ' A' ' 48' ' ' LEU . 60.4 mt -71.23 -43.48 74.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.309 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -113.99 87.6 13.09 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.62 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo . . . . . 0 N--CA 1.461 -0.416 0 C-N-CA 122.116 1.878 . . . . 0.0 110.768 173.172 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 121.471 0.653 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -131.43 148.53 52.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.853 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.493 HG22 ' HE2' ' A' ' 11' ' ' PHE . 15.6 m -132.72 -179.2 3.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.434 176.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -146.51 -169.24 3.22 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -82.4 -25.75 33.44 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.279 0.561 . . . . 0.0 109.696 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 9.2 p30 -96.96 -27.58 14.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.722 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -108.42 95.78 5.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.2 mtt85 -117.0 166.73 11.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.183 0.516 . . . . 0.0 111.594 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -129.73 135.58 61.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.724 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -99.78 129.16 45.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.793 0.33 . . . . 0.0 110.603 177.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.435 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -112.91 116.21 29.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.111 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.575 ' HA ' HG22 ' A' ' 5' ' ' ILE . . . -91.9 113.22 25.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.188 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -113.38 126.13 55.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.394 0.616 . . . . 0.0 111.369 -172.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -97.16 85.58 3.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 64.66 -77.86 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.067 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -107.73 -39.28 5.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.209 -174.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.628 ' HA ' ' CZ ' ' A' ' 47' ' ' ARG . 2.1 mmp_? -99.05 129.87 45.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.533 -170.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.769 ' HB3' HD11 ' A' ' 22' ' ' ILE . 54.3 mt -67.56 115.41 7.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 169.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 15.8 tp -97.54 -27.16 14.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.769 -170.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.558 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -152.35 158.0 42.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.699 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.57 144.16 26.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.108 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 65' ' ' SER . 11.0 p -148.45 143.64 18.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.733 0.302 . . . . 0.0 111.088 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -96.54 146.91 24.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.731 0.3 . . . . 0.0 110.997 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.03 121.58 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.45 0.643 . . . . 0.0 110.783 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 21.2 m -110.12 109.25 19.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.453 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.594 HD22 HG21 ' A' ' 92' ' ' VAL . 65.0 mt -89.69 113.17 24.62 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.271 0.558 . . . . 0.0 110.936 -178.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -114.62 86.17 2.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.475 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.88 -107.77 2.22 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.681 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.7 p -104.77 1.03 28.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.214 0.53 . . . . 0.0 110.575 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -98.97 138.15 36.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.918 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -119.98 107.94 1.39 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.611 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -92.62 104.59 16.86 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.9 tt -104.56 127.64 52.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.734 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -147.43 176.76 9.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.301 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 16.2 m 50.82 80.36 0.08 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.858 0.724 . . . . 0.0 111.965 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.517 ' HB3' ' HE3' ' A' ' 108' ' ' MET . 55.4 tp -120.58 120.45 35.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.084 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.8 ttt-85 -140.32 124.04 17.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.814 0.34 . . . . 0.0 110.51 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.558 HG13 ' HB2' ' A' ' 50' ' ' ALA . 10.5 t -111.1 146.66 15.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 172.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 49' ' ' LEU . 66.7 mtp85 -60.94 139.6 57.97 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.117 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 1.8 mp0 -52.32 -30.97 30.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.839 -171.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.6 t -72.15 -17.15 18.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.995 0.426 . . . . 0.0 111.308 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.57 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . 2.3 m -95.35 5.06 52.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.766 0.793 . . . . 0.0 110.806 -176.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.413 ' O ' ' HB3' ' A' ' 74' ' ' ARG . 57.7 ttt180 -71.89 134.66 46.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.139 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 29.1 tpt180 69.25 43.39 1.08 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.754 0.787 . . . . 0.0 110.191 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.57 ' HD3' ' HA ' ' A' ' 72' ' ' THR . 16.3 mtp180 -134.95 1.9 3.05 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.14 -13.6 9.49 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.998 176.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -57.5 -43.98 83.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 117.009 0.405 . . . . 0.0 111.48 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.28 -39.53 92.7 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.406 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.542 ' HA ' HD21 ' A' ' 115' ' ' LEU . 41.1 tt0 -62.43 -47.42 84.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.382 . . . . 0.0 110.51 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.435 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 81.9 t80 -57.72 -41.75 82.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.686 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' A' ' 42' ' ' ALA . 68.3 tp -56.71 -49.99 73.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.748 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.1 -40.68 98.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.963 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 33.5 mt-10 -65.9 -36.77 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.109 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 80' ' ' TYR . 7.3 mm-40 -61.79 -39.69 92.58 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.73 0.3 . . . . 0.0 111.117 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 81' ' ' LEU . 58.9 t -60.78 -54.51 34.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.005 0.431 . . . . 0.0 110.545 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.7 mp -74.9 -4.57 38.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.07 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 68.7 ttt180 -80.26 -48.87 12.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.226 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -87.67 -8.29 56.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.271 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 15.9 t30 -45.76 120.65 5.22 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.583 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 7.7 Cg_exo -73.02 -61.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.146 2.564 . . . . 0.0 112.888 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -154.54 35.06 0.69 Allowed Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.153 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.594 HG21 HD22 ' A' ' 56' ' ' LEU . 62.3 t -99.84 107.12 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 51.1 m -111.33 -13.83 13.87 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -174.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 81.8 m -103.82 94.6 5.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.858 0.361 . . . . 0.0 110.056 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -97.26 115.97 28.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.142 0.496 . . . . 0.0 111.434 -175.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.528 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 74.1 t-105 -104.14 114.29 28.42 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.959 175.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.709 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 80.6 mtp -107.35 122.67 47.05 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -176.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -124.61 168.74 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.423 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.85 -68.03 0.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.077 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.99 19.91 10.32 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.845 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.73 -20.05 3.29 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.661 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 95.7 t -67.79 101.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.121 0.486 . . . . 0.0 110.854 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -93.35 -16.56 24.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.263 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.05 54.19 1.87 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.469 176.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -60.17 -46.95 87.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.36 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.16 -49.7 62.23 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.66 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.45 -46.72 96.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.959 0.409 . . . . 0.0 111.269 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.517 ' HE3' ' HB3' ' A' ' 66' ' ' LEU . 78.0 mtp -78.62 -22.01 47.6 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -175.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 96.5 m -67.33 -40.44 85.91 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.28 -39.29 92.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.187 0.518 . . . . 0.0 110.021 175.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -58.52 -51.89 67.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.789 175.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.543 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 67.1 mtt -70.98 -27.15 63.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.481 -176.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -66.59 -34.16 77.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.922 0.391 . . . . 0.0 109.983 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.65 -32.9 66.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.75 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.542 HD21 ' HA ' ' A' ' 79' ' ' GLN . 11.0 mp -83.34 -4.8 58.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.004 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.19 41.41 17.64 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.167 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.543 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 59.7 m-85 -92.98 144.24 25.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.857 0.361 . . . . 0.0 110.186 174.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.24 144.67 25.08 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.26 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.7 p -97.46 140.64 31.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.33 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.486 ' HG3' ' HB3' ' A' ' 125' ' ' GLU . 19.3 mm-40 -120.35 -166.77 1.35 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.762 177.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -85.02 96.12 9.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.286 0.565 . . . . 0.0 111.122 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.84 44.93 4.69 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.542 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.35 -171.93 24.94 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.174 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.709 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 15.8 m-90 -116.86 149.56 39.87 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.183 -0.302 . . . . 0.0 110.183 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.486 ' HB3' ' HG3' ' A' ' 120' ' ' GLN . 31.2 tt0 -155.8 132.34 10.33 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -137.07 132.58 34.35 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 93' ' ' SER . 49.0 t -119.67 113.2 20.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.134 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 C-N-CA 121.009 -0.615 . . . . 0.9 112.186 -179.68 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 C--O 1.234 0.249 0 CA-C-O 120.869 0.366 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.7 tp -86.09 98.07 10.66 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.479 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 13.5 m -88.07 89.81 8.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.276 -174.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.538 HD11 ' HB3' ' A' ' 40' ' ' TYR . 13.8 tt -96.12 129.41 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.474 0.654 . . . . 0.0 110.767 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mt -129.01 154.59 40.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.323 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.8 ptt-85 -76.74 113.82 14.82 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 173.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.617 HD21 HD11 ' A' ' 19' ' ' LEU . 31.1 tp -77.96 100.84 6.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.997 -174.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.835 ' HA ' HG11 ' A' ' 33' ' ' VAL . 42.2 mt-10 -113.97 -18.95 11.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.902 -175.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.81 113.99 24.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.382 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -107.83 101.4 10.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.632 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.8 p -84.68 171.28 12.51 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.468 ' O ' HG13 ' A' ' 17' ' ' ILE . 6.6 p-10 -60.38 -31.98 70.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.564 0.221 . . . . 0.0 110.561 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -67.27 -51.02 58.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.556 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -60.87 -36.81 80.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.99 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -55.47 -47.39 76.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.159 176.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 13' ' ' ASP . 74.7 mt -65.79 -43.84 93.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.898 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.498 ' O ' HG13 ' A' ' 22' ' ' ILE . 12.9 m-20 -58.76 -52.83 64.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.69 0.281 . . . . 0.0 110.955 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.617 HD11 HD21 ' A' ' 8' ' ' LEU . 95.0 mt -64.74 -38.15 90.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.34 -178.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -74.2 -11.48 60.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.098 0.475 . . . . 0.0 110.56 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -98.27 -28.16 13.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.089 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 18' ' ' ASP . 74.4 mt -65.23 -48.53 83.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -107.49 92.3 8.25 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 168.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo . . . . . 0 N--CA 1.477 0.538 0 C-N-CA 123.648 2.899 . . . . 0.0 114.509 -167.307 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.5 mt . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.231 0.539 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -136.46 127.38 27.58 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.605 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.835 HG11 ' HA ' ' A' ' 9' ' ' GLU . 15.0 p -106.49 131.32 56.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.513 0.673 . . . . 0.0 110.42 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.585 ' HB2' ' H ' ' A' ' 37' ' ' HIS . 14.6 m-20 -130.62 179.28 6.04 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -85.68 -9.47 57.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -94.63 -34.47 12.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.685 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.585 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 36.0 m80 -120.33 101.0 7.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.768 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 38' ' ' ARG . 48.5 mtt180 -109.11 129.0 55.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.82 0.343 . . . . 0.0 110.275 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.4 HG12 ' HG2' ' A' ' 53' ' ' ARG . 63.7 mt -103.33 116.73 47.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.538 ' HB3' HD11 ' A' ' 5' ' ' ILE . 78.8 m-85 -97.55 125.67 42.4 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.505 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -109.37 113.4 26.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.56 -177.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . . . -92.68 102.32 14.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.959 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 4' ' ' THR . 19.9 ptt85 -103.37 129.53 50.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.344 0.592 . . . . 0.0 110.408 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -105.46 124.61 49.84 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.544 -177.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 70.91 -56.91 0.61 Allowed 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.957 0.786 . . . . 0.0 110.983 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -154.75 -45.96 0.09 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.325 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -104.92 162.83 12.99 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.12 -170.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.505 HD22 ' HB1' ' A' ' 41' ' ' ALA . 84.0 mt -60.78 132.75 54.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.865 -176.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 37.1 tp -111.76 -30.38 7.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.821 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.579 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -150.11 147.56 27.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.578 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -135.41 127.36 29.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.68 0.276 . . . . 0.0 110.434 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.418 ' HB ' HD13 ' A' ' 66' ' ' LEU . 7.1 p -131.37 134.01 61.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.03 0.443 . . . . 0.0 110.99 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.558 ' HD3' ' HB2' ' A' ' 65' ' ' SER . 21.4 mtp-105 -110.17 126.69 54.36 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.5 p -120.66 134.62 63.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.422 0.63 . . . . 0.0 111.629 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.9 m -100.71 107.69 19.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.856 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.9 mt -96.33 130.29 43.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.584 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 m -135.78 97.47 3.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.191 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.64 -112.56 4.53 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.378 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -106.9 11.98 29.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.586 0.708 . . . . 0.0 110.278 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -125.61 154.59 42.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.344 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.39 132.28 5.24 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.079 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.77 126.43 51.02 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 mp -93.46 117.06 29.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.014 0.435 . . . . 0.0 110.701 -175.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.532 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 20.2 m-20 -109.35 118.53 36.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.283 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.558 ' HB2' ' HD3' ' A' ' 53' ' ' ARG . 34.5 m 73.05 107.16 0.07 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.86 0.838 . . . . 0.0 111.797 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.418 HD13 ' HB ' ' A' ' 52' ' ' VAL . 29.9 tp -131.97 130.79 41.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.504 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.2 ttt-85 -144.02 130.48 19.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.819 0.342 . . . . 0.0 110.841 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.579 HG13 ' HB2' ' A' ' 50' ' ' ALA . 13.6 t -107.11 156.42 7.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -53.87 127.0 24.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -57.37 -31.65 65.98 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -168.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -82.87 16.7 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.365 0.602 . . . . 0.0 110.979 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -111.73 16.14 20.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.575 0.702 . . . . 0.0 110.414 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -75.45 137.01 40.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.077 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.408 ' HD3' HH11 ' A' ' 74' ' ' ARG . 5.8 ttm180 71.66 27.76 2.88 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.698 177.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -124.98 22.67 7.96 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.443 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.79 -27.21 1.64 Allowed Glycine 0 CA--C 1.521 0.454 0 N-CA-C 114.681 0.632 . . . . 0.0 114.681 172.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.2 t -50.88 -46.46 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -175.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.88 -45.51 94.93 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.604 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.503 ' HG2' ' HG ' ' A' ' 115' ' ' LEU . 51.2 mt-30 -65.57 -41.68 92.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.871 0.367 . . . . 0.0 110.733 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -68.21 -41.92 80.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.585 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.3 tp -48.23 -51.57 24.89 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.331 0.394 . . . . 0.0 111.026 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.438 ' O ' HD13 ' A' ' 86' ' ' LEU . 4.4 mm? -60.07 -52.44 65.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.433 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -72.09 -16.52 62.02 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.726 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.428 ' HG2' HG21 ' A' ' 5' ' ' ILE . 12.5 tp10 -69.77 -42.9 73.2 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 172.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.55 -41.3 88.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.352 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 82' ' ' LEU . 10.9 mp -67.43 -20.38 65.5 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.1 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 54.0 ttp85 -83.65 -41.05 18.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 109.876 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -64.35 -38.94 92.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.729 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -119.11 78.77 17.73 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.662 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.29 2.21 8.55 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.595 2.197 . . . . 0.0 112.319 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.54 10.76 72.47 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.97 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.8 t -107.68 127.26 63.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 m -85.53 -53.36 5.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.805 0.336 . . . . 0.0 111.576 -175.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.5 t -103.83 116.38 32.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.904 0.383 . . . . 0.0 111.09 -174.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -106.9 112.33 25.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.064 176.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -105.51 136.46 45.03 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.121 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.662 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 97.4 mmm -107.27 119.74 40.22 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.65 144.98 25.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.009 0.433 . . . . 0.0 111.766 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.414 ' CG ' HH21 ' A' ' 105' ' ' ARG . 10.6 t70 -80.26 -69.61 0.58 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.908 177.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 64.73 23.17 12.71 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.945 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.4 40.29 0.96 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.905 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.752 HG11 ' HG3' ' A' ' 108' ' ' MET . 77.0 t -88.31 112.48 23.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.84 0.353 . . . . 0.0 110.368 176.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -82.57 -32.27 28.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.677 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -87.49 55.23 3.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.222 0.534 . . . . 0.0 109.859 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.414 HH21 ' CG ' ' A' ' 99' ' ' ASP . 34.7 ttm180 -66.23 -31.11 71.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.043 -176.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.74 -56.39 25.53 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.062 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.5 t -61.48 -42.42 93.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 111.001 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.752 ' HG3' HG11 ' A' ' 102' ' ' VAL . 93.0 mmm -64.46 -38.23 90.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.538 -177.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 61.5 m -67.52 -41.26 84.67 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.411 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.14 88.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.302 0.573 . . . . 0.0 110.245 176.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -61.98 -48.71 79.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.716 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.546 ' HG2' ' O ' ' A' ' 108' ' ' MET . 26.4 mmt -62.44 -43.2 99.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.122 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -62.09 -39.33 92.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.204 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.51 -22.11 61.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.112 0.482 . . . . 0.0 110.888 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.503 ' HG ' ' HG2' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -91.05 -2.69 57.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.299 0.571 . . . . 0.0 110.31 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.85 32.61 20.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.03 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.539 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 75.7 m-85 -98.63 139.85 33.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.041 0.448 . . . . 0.0 110.419 176.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.1 m -90.41 144.21 26.02 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.853 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 30.2 p -97.31 115.97 28.64 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.801 0.334 . . . . 0.0 110.438 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -137.02 161.46 36.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.072 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -45.45 106.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.836 0.71 . . . . 0.0 112.188 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 120.93 -21.18 8.42 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.382 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 159.07 -131.69 2.83 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.741 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.662 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 12.8 m-90 -125.98 140.0 52.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.637 0.256 . . . . 0.0 110.504 -177.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -128.46 134.35 48.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.93 -175.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.528 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 84.8 tttt -137.19 92.17 2.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.07 0.462 . . . . 0.0 110.54 173.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 39.9 t -80.22 131.32 35.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.496 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 C-N-CA 120.867 -0.682 . . . . 0.9 111.993 179.132 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.568 HD22 HG13 ' A' ' 77' ' ' VAL . 52.5 tp -95.72 127.73 41.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.476 -177.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.9 m -89.69 95.32 10.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.898 0.38 . . . . 0.0 110.624 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.593 HG22 ' HA ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -103.49 129.1 55.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.118 0.485 . . . . 0.0 110.052 177.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.417 ' H ' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -130.18 151.9 36.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.888 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -75.29 130.18 38.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.466 HD21 HD11 ' A' ' 19' ' ' LEU . 38.6 tp -76.01 59.36 1.29 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.605 0.717 . . . . 0.0 110.165 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -91.39 -13.91 31.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.511 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -112.92 107.21 15.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.834 177.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -88.43 82.94 6.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.296 0.569 . . . . 0.0 110.892 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.8 m -85.66 150.56 24.53 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.303 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.62 -35.72 70.84 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -52.14 -55.77 18.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.526 175.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.449 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 18.8 m-20 -68.51 -41.3 80.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.299 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -61.11 -39.14 88.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -176.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.7 mt -70.13 -41.64 79.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.939 0.4 . . . . 0.0 110.375 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.48 -34.54 78.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.104 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.466 HD11 HD21 ' A' ' 8' ' ' LEU . 73.0 mt -62.39 -39.26 92.63 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.83 174.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -75.13 -10.43 59.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.026 0.441 . . . . 0.0 111.001 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -86.46 -22.94 26.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.24 170.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.36 -45.82 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.228 0.537 . . . . 0.0 109.611 173.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.403 ' HE1' ' HG3' ' A' ' 67' ' ' ARG . 5.8 m-90 -107.6 108.09 61.16 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.39 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo . . . . . 0 C--N 1.352 0.733 0 C-N-CA 124.46 3.44 . . . . 0.0 114.193 -172.715 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.1 mt . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.807 0.337 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -135.68 106.0 6.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.405 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.4 t -98.18 135.89 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.132 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -146.23 -173.86 4.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.81 -20.98 66.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.12 0.486 . . . . 0.0 111.084 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -93.11 -55.7 3.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.483 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -84.32 98.13 9.84 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -108.91 121.35 44.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.964 0.411 . . . . 0.0 110.41 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.833 HG12 ' HG2' ' A' ' 53' ' ' ARG . 56.4 mt -98.88 115.39 39.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.215 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -94.05 122.34 36.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.364 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.577 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.11 123.36 48.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.09 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.805 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -91.89 100.4 13.08 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -95.06 115.61 27.64 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.792 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.527 ' HB3' HD13 ' A' ' 49' ' ' LEU . 73.2 t80 -97.28 88.66 4.5 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.62 -65.09 0.36 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.859 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.461 ' HG3' ' N ' ' A' ' 47' ' ' ARG . 4.9 pt-20 -109.16 -51.24 2.9 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.461 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 28.0 ptt-85 -127.0 173.8 9.36 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.685 -171.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.577 HD22 ' HB1' ' A' ' 41' ' ' ALA . 41.9 mt -87.06 111.25 20.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.348 -175.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' A' ' 44' ' ' PHE . 9.9 mp -88.13 -31.41 19.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.687 0.28 . . . . 0.0 110.68 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.805 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -127.07 131.99 50.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.992 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.12 115.94 21.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.155 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 65' ' ' SER . 11.2 p -126.8 136.55 60.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.098 0.475 . . . . 0.0 111.151 -178.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.833 ' HG2' HG12 ' A' ' 39' ' ' ILE . 99.0 mtt180 -111.77 115.72 29.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.64 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.6 p -107.18 107.46 22.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.849 0.833 . . . . 0.0 110.032 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.9 m -87.5 106.82 18.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.185 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.8 mt -80.63 104.51 11.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.39 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -103.13 106.34 16.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.238 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.86 -96.79 0.61 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -174.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.1 p -128.27 2.68 5.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.909 0.385 . . . . 0.0 110.776 175.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.573 ' HA ' HG13 ' A' ' 92' ' ' VAL . 23.8 mm-40 -104.84 141.59 36.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.721 -175.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.12 112.35 4.38 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.352 -177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.589 ' HA ' ' HB3' ' A' ' 96' ' ' TRP . . . -105.28 111.72 24.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.696 0.284 . . . . 0.0 110.438 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 53' ' ' ARG . 5.2 mp -93.45 110.76 22.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.19 0.519 . . . . 0.0 109.803 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.625 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 1.8 p30 -96.06 -36.14 11.12 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.801 -173.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 21.0 m -120.58 125.29 47.42 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.791 0.329 . . . . 0.0 111.158 -177.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.4 tp -145.61 102.72 3.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.052 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.403 ' HG3' ' HE1' ' A' ' 23' ' ' TRP . 26.2 mmm180 -131.43 113.0 13.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.775 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.526 HG13 ' HB2' ' A' ' 50' ' ' ALA . 2.9 t -110.22 136.04 47.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -87.56 -176.28 5.51 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -174.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -55.33 -27.07 44.67 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.399 -1.273 . . . . 0.0 114.387 -165.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.6 t -65.43 -30.57 50.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.168 0.509 . . . . 0.0 111.691 -175.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.587 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 6.5 m -98.77 32.66 2.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.463 0.649 . . . . 0.0 111.16 -173.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 73' ' ' ARG . 40.0 ttm180 -65.27 97.57 0.28 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.886 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 53.02 80.04 0.11 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.091 170.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 75' ' ' ARG . 9.3 mmt180 -136.61 -54.27 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.239 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.78 -21.67 0.46 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.775 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.587 ' HB ' ' CG2' ' A' ' 72' ' ' THR . 72.6 t -55.85 -44.23 76.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 122.332 0.253 . . . . 0.0 111.499 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -54.11 -49.44 59.37 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.905 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -60.65 -52.32 65.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.454 0.169 . . . . 0.0 110.592 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -58.96 -42.45 89.9 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.128 -176.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 85' ' ' VAL . 63.6 tp -52.56 -53.31 48.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 110.679 178.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.425 ' O ' HD13 ' A' ' 86' ' ' LEU . 46.8 mt -70.31 -45.47 66.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.423 -177.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -62.67 -32.22 73.24 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.071 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -67.69 -41.42 83.64 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 176.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 81' ' ' LEU . 85.1 t -63.09 -46.27 96.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 121.205 0.526 . . . . 0.0 110.645 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.479 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 10.9 mp -70.47 -19.85 62.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.108 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -86.91 -30.22 21.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.191 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -63.62 -52.87 58.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.51 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -118.5 101.17 51.13 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.784 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.91 -6.13 12.28 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.224 2.616 . . . . 0.0 112.035 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.36 48.77 4.1 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.691 -177.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.573 HG13 ' HA ' ' A' ' 60' ' ' GLU . 97.4 t -135.94 134.51 50.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 61.8 p -96.57 -32.83 12.06 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.933 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 77.8 m -130.37 113.98 15.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.891 0.376 . . . . 0.0 111.322 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.479 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 95.6 m95 -90.94 113.49 25.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 173.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.589 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . 2.9 t-105 -96.94 128.09 43.57 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.959 -172.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 1.047 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 13.4 mmt -108.45 115.38 29.99 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.625 ' HB3' ' HA ' ' A' ' 64' ' ' ASP . . . -99.48 173.84 6.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.566 -169.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -129.29 93.04 3.48 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.42 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -92.36 26.85 2.43 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.975 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.5 46.48 0.85 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.423 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 56.8 t -78.01 98.92 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.93 0.395 . . . . 0.0 110.895 -178.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -70.83 -33.66 70.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.114 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -79.41 47.39 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.089 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.97 -57.4 13.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.879 -172.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.29 99.34 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.527 -175.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.9 t -58.39 -47.52 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.0 110.78 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 89.5 mmm -71.01 -32.62 69.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.131 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 80.1 m -59.25 -44.18 92.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.982 0.42 . . . . 0.0 110.041 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.32 -41.32 96.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.893 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -66.32 -52.4 47.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.278 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -56.75 -50.05 73.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.609 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -65.52 -31.8 73.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.619 0.247 . . . . 0.0 111.116 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.65 -31.04 63.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.931 0.396 . . . . 0.0 111.21 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.703 HD23 ' HE1' ' A' ' 117' ' ' PHE . 21.0 tp -88.36 -9.84 51.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.122 0.487 . . . . 0.0 110.542 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.95 36.54 4.96 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.13 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.703 ' HE1' HD23 ' A' ' 115' ' ' LEU . 62.5 m-85 -99.68 102.2 13.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.957 0.378 . . . . 0.0 110.239 174.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.18 143.7 56.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.828 177.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 121' ' ' GLN . 13.9 m -99.28 136.25 39.5 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.034 -174.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -79.18 11.85 2.62 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.787 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.455 ' H ' HG22 ' A' ' 119' ' ' THR . 71.3 mm-40 63.66 29.19 15.09 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.67 0.748 . . . . 0.0 109.549 -172.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -168.85 -64.89 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -109.73 -168.68 20.08 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 169.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.047 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 12.9 m-90 -113.96 144.55 42.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.876 0.838 . . . . 0.0 110.339 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -149.14 114.81 5.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 61.7 tttp -96.71 111.67 23.74 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 93' ' ' SER . 56.0 m -88.78 95.31 10.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.736 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.945 -0.645 . . . . 0.9 112.568 179.53 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.415 ' HB3' ' HE2' ' A' ' 2' ' ' LYS . 51.4 mtpt . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.471 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 43.1 tp -81.88 99.61 9.14 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.582 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 16.7 m -83.11 96.71 8.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.931 0.396 . . . . 0.0 110.174 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 tt -104.47 123.93 58.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.437 0.637 . . . . 0.0 110.937 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.448 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -131.2 177.95 6.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.314 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -94.8 147.01 23.79 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.7 mt -75.96 98.86 4.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.205 0.526 . . . . 0.0 110.765 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -106.87 -23.94 12.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.154 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -124.97 124.96 43.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.791 -172.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.96 91.92 3.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.783 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -83.33 173.74 11.31 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.558 ' O ' HG13 ' A' ' 17' ' ' ILE . 30.2 t70 -62.6 -52.63 62.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.468 -178.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.529 ' HA ' HD12 ' A' ' 17' ' ' ILE . 52.4 tt0 -72.18 -25.73 61.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.906 0.384 . . . . 0.0 110.316 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -62.48 -42.34 99.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -65.05 -39.09 92.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.217 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.6 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 76.4 mt -59.82 -41.97 87.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.356 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.95 -40.11 83.31 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.251 0.548 . . . . 0.0 110.38 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.69 -31.91 73.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.333 173.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -78.94 -10.1 59.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.221 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 64.3 mttm -82.33 -31.62 29.79 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.1 mt -72.16 -46.25 59.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.783 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -117.97 97.38 50.71 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.798 175.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 N--CA 1.476 0.479 0 C-N-CA 123.174 2.583 . . . . 0.0 113.154 -175.241 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.3 mt . . . . . 0 N--CA 1.463 0.194 0 CA-C-O 120.992 0.425 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -73.49 98.64 2.82 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.4 m -92.97 151.39 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.382 0.611 . . . . 0.0 110.67 -175.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.403 ' HB3' ' H ' ' A' ' 37' ' ' HIS . 22.2 t70 -151.59 171.97 16.78 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.593 -173.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.96 -29.08 68.83 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -90.13 -33.28 16.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.772 176.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.403 ' H ' ' HB3' ' A' ' 34' ' ' ASP . 32.0 m170 -104.56 99.4 9.08 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.168 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -114.64 139.47 49.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.305 0.574 . . . . 0.0 111.668 -173.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.3 mt -119.48 116.57 51.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.201 171.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -99.61 129.73 45.78 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.536 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -118.19 120.71 38.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.519 -176.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.831 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.09 107.09 18.96 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.071 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 4' ' ' THR . 26.3 ptt180 -96.53 132.62 41.94 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.403 0.62 . . . . 0.0 110.507 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.494 ' HB3' HD13 ' A' ' 49' ' ' LEU . 77.5 t80 -101.1 104.23 15.34 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 176.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 31.3 t30 72.1 -62.19 0.47 Allowed 'General case' 0 C--N 1.331 -0.217 0 O-C-N 124.005 0.816 . . . . 0.0 110.801 -176.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -136.45 -57.72 0.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -94.61 167.29 11.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.975 0.417 . . . . 0.0 111.727 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.536 HD22 ' HB1' ' A' ' 41' ' ' ALA . 35.9 mt -91.21 106.6 18.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.934 -171.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' A' ' 44' ' ' PHE . 10.9 mp -92.93 -15.18 26.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.122 -178.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.831 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -137.21 125.97 23.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.754 0.311 . . . . 0.0 111.017 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -123.67 130.22 52.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.636 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.6 p -135.15 134.05 53.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.057 0.456 . . . . 0.0 111.002 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.632 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 39.5 mtp180 -99.45 134.73 41.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.188 177.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.2 p -139.91 126.76 23.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.611 0.719 . . . . 0.0 111.596 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -108.93 115.22 29.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.756 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -85.69 106.73 17.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.247 0.546 . . . . 0.0 110.807 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -93.63 45.96 1.17 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.28 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.54 -105.87 3.05 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.761 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.5 p -83.04 -17.45 43.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.112 0.482 . . . . 0.0 110.991 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -106.01 118.47 36.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.694 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.73 114.07 4.89 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.37 105.1 17.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.902 0.382 . . . . 0.0 111.275 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.414 HD11 ' HE3' ' A' ' 95' ' ' TRP . 5.0 mp -95.16 111.97 23.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.908 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.632 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 10.3 t0 -118.23 138.31 52.42 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.465 ' HB2' ' HD3' ' A' ' 53' ' ' ARG . 20.2 m 68.39 91.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.628 0.727 . . . . 0.0 111.501 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.7 tp -108.14 110.65 22.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.409 171.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -127.3 104.62 8.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.06 0.457 . . . . 0.0 111.302 -176.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 50' ' ' ALA . 8.3 t -100.91 144.69 12.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 172.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -61.83 155.6 22.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.257 0.551 . . . . 0.0 112.363 -174.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -48.72 -41.04 30.69 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.322 -1.308 . . . . 0.0 113.481 -165.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.83 -13.92 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.975 0.417 . . . . 0.0 112.095 -171.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 m -88.02 60.6 5.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.438 0.637 . . . . 0.0 111.607 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.8 ptt-85 -115.99 130.47 56.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.675 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 74' ' ' ARG . 21.4 mtp180 52.81 53.57 11.91 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.479 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.6 ttt180 -135.98 14.13 3.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.901 0.381 . . . . 0.0 111.257 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.09 -35.64 2.56 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.108 -0.568 . . . . 0.0 113.972 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.453 HG13 HD22 ' A' ' 3' ' ' LEU . 49.6 t -50.26 -41.79 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 122.974 0.51 . . . . 0.0 112.355 -175.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.35 -45.28 93.03 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.145 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -65.69 -49.87 66.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.927 0.394 . . . . 0.0 110.245 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.471 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 48.0 t80 -54.4 -42.5 70.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.366 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.418 ' O ' HG23 ' A' ' 85' ' ' VAL . 59.3 tp -52.76 -67.65 0.23 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.847 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 82' ' ' LEU . 3.5 mm? -64.1 -41.27 97.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.693 -174.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 23.8 mt-10 -61.79 -37.53 84.69 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.804 -177.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -70.77 -31.97 68.93 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.535 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 81' ' ' LEU . 67.1 t -61.58 -45.41 98.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 174.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.551 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 11.2 mp -67.32 -18.72 65.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.19 178.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 79.3 mtp180 -81.27 -41.17 22.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.057 0.456 . . . . 0.0 110.833 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -80.42 -29.95 37.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.902 -174.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.522 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 0.9 OUTLIER -86.0 117.38 68.6 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.894 0.378 . . . . 0.0 110.181 176.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.522 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 1.4 Cg_endo -83.45 -73.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.426 2.751 . . . . 0.0 113.877 -172.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.43 53.45 4.67 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.64 -171.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.6 t -124.2 115.2 44.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 p -105.57 -24.36 12.6 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.766 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 46.1 t -116.67 106.07 13.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.841 0.353 . . . . 0.0 110.116 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.551 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 97.7 m95 -93.34 111.98 23.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.108 0.48 . . . . 0.0 110.248 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -111.45 123.85 51.07 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 68.6 mtp -119.03 117.11 27.88 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.22 146.75 24.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.038 0.447 . . . . 0.0 111.82 -171.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.498 ' HB3' ' CZ3' ' A' ' 124' ' ' TRP . 5.8 p-10 -98.8 14.95 26.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.651 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.93 -55.87 29.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.855 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -97.97 44.67 1.78 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.312 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.415 HG11 ' SD ' ' A' ' 108' ' ' MET . 57.3 t -135.48 101.85 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.796 0.331 . . . . 0.0 110.763 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -67.67 -41.83 83.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.065 0.46 . . . . 0.0 110.766 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -84.93 59.51 5.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.362 0.601 . . . . 0.0 110.489 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -63.16 -39.8 95.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.291 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.69 -54.28 38.36 Favored Glycine 0 C--O 1.236 0.243 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.64 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.1 t -59.07 -43.44 89.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.114 0.483 . . . . 0.0 110.562 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.66 ' SD ' ' HE3' ' A' ' 112' ' ' MET . 37.1 ttm -68.06 -27.01 66.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.154 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 91.9 m -62.25 -52.62 63.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.785 0.326 . . . . 0.0 110.161 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.61 84.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.537 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' A' ' 108' ' ' MET . 51.8 t80 -60.26 -57.83 11.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.347 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.66 ' HE3' ' SD ' ' A' ' 108' ' ' MET . 61.8 mtt -67.34 -33.06 74.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.445 -175.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -63.71 -37.62 88.05 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.09 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.71 -30.37 71.04 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.368 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.0 mp -84.13 2.2 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.085 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.16 23.34 32.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.789 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.54 ' HB3' ' HB3' ' A' ' 124' ' ' TRP . 91.4 m-85 -92.84 134.0 35.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.234 0.517 . . . . 0.0 110.426 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.4 m -90.67 145.1 25.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.484 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.42 HG22 ' CD1' ' A' ' 124' ' ' TRP . 70.9 p -97.43 118.23 33.44 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -124.12 -93.79 0.5 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.311 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -154.83 123.47 6.11 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.36 11.66 66.35 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.373 -174.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.9 -152.34 18.05 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.906 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 117' ' ' PHE . 22.7 m-90 -102.13 150.65 23.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.183 -0.508 . . . . 0.0 110.015 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -134.01 134.79 42.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.371 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -137.07 93.09 2.79 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 171.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.2 p -102.78 142.27 34.19 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.586 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.501 0 C-N-CA 120.944 -0.646 . . . . 0.9 112.187 179.445 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.8 mttt . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.511 HD21 ' HB1' ' A' ' 42' ' ' ALA . 51.9 tp -76.63 122.32 24.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.951 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.2 p -90.58 121.86 32.88 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.244 0.545 . . . . 0.0 110.835 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.513 HG22 ' HA ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -117.1 125.94 74.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.376 -178.35 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.1 mm -103.34 151.33 6.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.2 ptt85 -95.36 106.37 18.42 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.2 mt -75.91 83.72 2.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.145 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.812 ' HA ' HG11 ' A' ' 33' ' ' VAL . 30.6 mt-10 -81.81 -26.13 34.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.993 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -147.49 122.94 10.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.71 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -93.34 133.76 36.26 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.935 -173.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 m -77.47 174.3 11.01 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 168.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.478 ' O ' HG13 ' A' ' 17' ' ' ILE . 8.6 p-10 -65.08 -45.52 84.93 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.492 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -63.69 -40.11 95.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.0 110.317 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.416 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 24.1 m-20 -57.07 -50.87 71.44 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.092 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -66.08 -30.47 70.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.83 -177.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 13' ' ' ASP . 84.3 mt -72.62 -39.47 61.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.996 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -69.72 -34.96 74.6 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 79.6 mt -64.57 -32.27 73.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.385 173.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -71.31 -23.31 61.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.979 0.419 . . . . 0.0 110.45 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 83.5 mttt -70.67 -38.25 73.75 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 173.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.89 -43.95 52.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.514 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -121.52 89.2 47.09 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.998 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo . . . . . 0 C--N 1.344 0.309 0 C-N-CA 122.622 2.215 . . . . 0.0 112.212 -177.322 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 C--O 1.228 -0.066 0 CA-C-O 120.99 0.424 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -72.43 128.23 34.98 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.812 HG11 ' HA ' ' A' ' 9' ' ' GLU . 39.8 t -113.22 122.86 68.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.454 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -148.33 -171.0 3.74 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -69.95 -31.41 69.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.267 0.556 . . . . 0.0 109.836 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -84.28 -8.14 59.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.52 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -152.48 97.72 2.3 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.355 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 38' ' ' ARG . 50.0 mtt180 -111.98 135.73 52.23 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.209 -178.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.532 HG23 ' HG2' ' A' ' 53' ' ' ARG . 59.0 mt -101.56 118.79 48.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.286 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -100.72 125.31 47.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.306 0.574 . . . . 0.0 110.457 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.567 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.14 119.36 39.25 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.1 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.11 114.76 27.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.029 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.458 ' HB3' HD23 ' A' ' 48' ' ' LEU . 34.2 ptt180 -109.72 132.4 54.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.575 0.702 . . . . 0.0 111.219 -175.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.44 ' O ' ' HB3' ' A' ' 45' ' ' ASN . 75.6 t80 -98.1 102.84 14.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.078 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 10.4 t30 74.31 -43.12 0.52 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.719 0.637 . . . . 0.0 111.435 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -159.83 -56.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.023 0.44 . . . . 0.0 111.332 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 47' ' ' ARG . 51.3 mtt180 -85.73 153.22 22.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.007 -171.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.567 HD22 ' HB1' ' A' ' 41' ' ' ALA . 52.0 mt -71.06 122.75 20.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.855 -175.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.4 tp -105.29 -15.08 15.15 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.035 0.445 . . . . 0.0 110.206 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -154.48 150.07 27.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.458 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -135.24 125.52 26.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.869 0.366 . . . . 0.0 110.666 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.35 138.29 48.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.445 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.532 ' HG2' HG23 ' A' ' 39' ' ' ILE . 21.2 mtm180 -118.18 133.37 55.96 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.1 p -120.78 126.15 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.631 0.729 . . . . 0.0 111.176 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.7 m -90.69 94.58 9.75 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.535 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.11 92.15 5.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.456 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.6 m -93.29 84.42 4.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.823 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.45 -101.39 0.83 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.699 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.4 p -112.85 6.98 18.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.154 0.502 . . . . 0.0 110.488 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -101.14 111.75 24.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.41 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.98 94.06 1.7 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.711 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.92 123.39 45.05 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.806 -0.232 . . . . 0.0 110.517 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.42 HD13 ' SD ' ' A' ' 97' ' ' MET . 6.8 mp -93.45 118.84 31.82 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -101.15 -12.8 18.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.673 -170.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.4 m -155.31 133.4 11.54 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.076 -0.249 . . . . 0.0 111.28 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.9 tp -148.44 115.93 6.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.865 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -138.71 132.6 31.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.425 173.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 50' ' ' ALA . 3.5 t -103.85 152.01 6.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 172.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -71.93 154.68 41.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.612 0.244 . . . . 0.0 110.787 -175.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -43.03 -47.25 5.81 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -170.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.3 m -81.05 26.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -171.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.83 29.52 6.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.044 0.449 . . . . 0.0 111.417 -177.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -67.11 108.96 2.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.825 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 56.23 42.27 28.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.141 0.496 . . . . 0.0 110.666 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.4 ttt180 -108.59 19.36 19.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.103 -172.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.51 -40.51 2.42 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.862 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.4 t -46.81 -46.72 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 123.21 0.604 . . . . 0.0 112.581 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.68 -41.73 90.26 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.11 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.518 ' HG3' ' HG ' ' A' ' 115' ' ' LEU . 52.7 tt0 -69.36 -38.53 78.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.996 0.426 . . . . 0.0 110.356 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.479 ' HE2' ' H ' ' A' ' 3' ' ' LEU . 74.8 t80 -68.56 -38.39 80.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.184 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.444 HD13 ' HB2' ' A' ' 42' ' ' ALA . 50.2 tp -53.61 -56.78 14.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.211 177.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.454 ' O ' HD13 ' A' ' 86' ' ' LEU . 4.4 mm? -60.15 -45.72 92.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -67.84 -37.51 81.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.369 -176.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -58.78 -46.99 86.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.797 0.332 . . . . 0.0 110.539 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 73.3 t -63.82 -46.36 94.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 82' ' ' LEU . 11.0 mp -69.09 -29.06 67.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.312 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.0 ttt-85 -75.27 -30.75 60.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.107 0.48 . . . . 0.0 109.721 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -75.94 -33.62 59.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.052 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -115.8 70.78 3.65 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.344 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.33 -6.7 13.84 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.289 1.992 . . . . 0.0 112.051 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.07 -14.97 81.73 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.947 -0.645 . . . . 0.0 112.153 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.8 t -87.78 113.36 24.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.962 0.411 . . . . 0.0 110.203 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 2.5 p -89.5 -22.91 22.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.426 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.4 m -108.05 99.3 8.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.824 0.345 . . . . 0.0 111.363 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -109.05 126.13 52.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.272 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.426 ' HE3' ' HG2' ' A' ' 125' ' ' GLU . 51.9 t-105 -115.58 127.82 55.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.198 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.861 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 87.5 mmm -108.0 120.76 43.23 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.96 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.79 142.7 47.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.45 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.847 ' HB2' ' HB ' ' A' ' 102' ' ' VAL . 4.6 p-10 -86.61 -35.55 19.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.107 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.54 22.87 12.58 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.955 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 125.39 37.21 0.53 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.646 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.847 ' HB ' ' HB2' ' A' ' 99' ' ' ASP . 76.8 t -102.22 125.68 56.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -84.18 -35.81 23.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.632 -177.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -83.18 67.67 9.29 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.486 0.66 . . . . 0.0 110.886 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -72.55 -17.73 61.7 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.614 176.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.08 -57.86 12.47 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.048 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.16 -43.56 97.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.623 0.249 . . . . 0.0 111.15 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.618 ' SD ' HG11 ' A' ' 102' ' ' VAL . 50.6 mtp -71.11 -31.04 67.27 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.008 -175.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.716 HG23 HG21 ' A' ' 119' ' ' THR . 36.6 m -68.92 -43.95 74.11 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.243 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.12 -38.78 87.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.198 0.523 . . . . 0.0 110.287 176.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -61.4 -51.53 68.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.33 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.491 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 66.1 mtt -75.93 -34.5 59.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.922 -174.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -74.1 -22.61 59.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.888 0.375 . . . . 0.0 110.572 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.05 -19.22 25.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.041 0.448 . . . . 0.0 110.63 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.518 ' HG ' ' HG3' ' A' ' 79' ' ' GLN . 6.1 tt -80.32 -55.17 5.08 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 146.93 46.74 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.401 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 97.2 m-85 -121.33 143.01 49.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.802 0.335 . . . . 0.0 110.274 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.9 m -81.09 121.72 26.44 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.716 HG21 HG23 ' A' ' 109' ' ' THR . 67.2 p -97.38 130.43 44.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.141 0.496 . . . . 0.0 111.054 -173.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -129.36 176.09 8.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.53 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -81.71 87.95 6.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.081 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 129.92 -50.77 0.88 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.292 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -135.32 178.92 18.22 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.506 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.861 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 8.2 m-90 -127.3 140.98 51.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.426 ' HG2' ' HE3' ' A' ' 96' ' ' TRP . 42.3 mt-10 -129.03 150.79 50.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.933 0.397 . . . . 0.0 111.452 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.55 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 78.8 tttt -136.15 121.8 19.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.766 171.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 93' ' ' SER . 53.9 t -129.93 108.98 10.53 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.23 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 121.037 -0.601 . . . . 0.9 112.13 178.315 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.773 0.321 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -116.5 130.14 56.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.338 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.592 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 47.3 tp -76.0 115.94 16.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.805 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.0 m -82.67 101.23 10.7 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.016 0.436 . . . . 0.0 110.662 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.642 HD11 ' HB3' ' A' ' 40' ' ' TYR . 8.4 tp -90.18 113.38 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-O 121.749 0.785 . . . . 0.0 110.102 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.7 mt -106.57 153.34 7.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.516 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 -100.86 126.55 47.47 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.5 mt -80.9 91.51 6.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.339 0.59 . . . . 0.0 110.875 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -93.13 -23.95 18.43 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.662 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -140.06 139.53 35.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.599 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -115.38 116.0 27.53 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.519 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.4 p -84.89 171.12 12.45 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 17' ' ' ILE . 30.7 m-20 -74.24 -21.35 59.82 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -69.78 -49.26 54.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.418 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 62.8 m-20 -61.31 -38.8 88.15 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.672 ' HG2' HE21 ' A' ' 20' ' ' GLN . 46.6 ttm-85 -53.8 -47.05 71.2 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.059 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 13' ' ' ASP . 77.8 mt -66.59 -48.31 80.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.459 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.528 ' HB3' HD12 ' A' ' 48' ' ' LEU . 1.2 m-20 -65.43 -32.26 73.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.342 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 78.1 mt -64.89 -42.48 94.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.526 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.672 HE21 ' HG2' ' A' ' 16' ' ' ARG . 73.6 mt-30 -69.04 -20.65 64.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.366 0.603 . . . . 0.0 110.346 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -76.99 -26.53 53.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.557 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 18' ' ' ASP . 70.6 mt -82.57 -37.43 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.46 175.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -117.86 85.89 23.67 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.369 177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.38 -9.66 21.78 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.642 2.228 . . . . 0.0 113.102 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -101.15 -5.21 25.95 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.46 0.648 . . . . 0.0 110.04 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -99.73 116.34 31.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.441 -175.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.5 t -72.47 130.13 86.3 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.12 104.63 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.26 2.64 . . . . 0.0 113.369 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.1 m -81.49 -161.74 0.45 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.834 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.5 m -70.4 -26.18 63.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.97 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.8 mt 58.13 78.7 0.23 Allowed 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -172.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -134.03 111.34 10.3 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.309 -169.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -103.61 159.12 4.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.16 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -130.73 -166.4 1.68 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -79.14 -11.59 59.98 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.767 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -96.24 -59.83 1.75 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.117 174.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -74.31 97.47 3.02 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 38' ' ' ARG . 22.7 mtp180 -115.81 115.43 26.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.235 0.54 . . . . 0.0 110.488 -173.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 67.2 mt -98.59 118.85 45.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.661 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.642 ' HB3' HD11 ' A' ' 5' ' ' ILE . 96.7 m-85 -106.28 142.74 35.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.343 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.443 ' HB1' HD21 ' A' ' 48' ' ' LEU . . . -123.55 117.69 25.66 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.38 -175.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.497 ' HB1' HD21 ' A' ' 3' ' ' LEU . . . -91.71 99.78 12.61 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.03 0.443 . . . . 0.0 109.869 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.681 ' HG2' HD23 ' A' ' 48' ' ' LEU . 4.1 mtm180 -104.21 111.02 23.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.413 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -97.46 107.82 20.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.931 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.0 t30 60.53 65.32 1.07 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.012 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 72.58 -29.85 0.2 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.655 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -101.56 145.56 28.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.981 0.42 . . . . 0.0 111.821 -170.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.681 HD23 ' HG2' ' A' ' 43' ' ' ARG . 54.7 mt -65.22 117.84 8.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.962 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.9 tp -106.95 -27.14 10.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.912 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -152.76 149.22 28.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.547 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -138.35 135.51 35.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.358 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.482 ' HB ' HD13 ' A' ' 66' ' ' LEU . 8.8 p -140.62 140.98 33.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.919 0.39 . . . . 0.0 110.781 -177.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -114.51 123.5 49.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.506 ' HB ' HD23 ' A' ' 63' ' ' LEU . 6.7 p -125.2 124.37 67.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.317 0.579 . . . . 0.0 110.414 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.9 m -97.89 99.47 10.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.059 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.53 HD23 ' HA2' ' A' ' 61' ' ' GLY . 96.9 mt -85.86 70.44 10.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.938 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 m -67.31 99.06 0.67 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.005 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.18 -116.43 5.24 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.373 -175.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.7 m -114.13 14.71 18.29 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.872 0.844 . . . . 0.0 109.386 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -101.31 134.57 44.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.853 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.53 ' HA2' HD23 ' A' ' 56' ' ' LEU . . . -106.09 106.01 2.51 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.657 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.57 108.45 20.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.929 0.395 . . . . 0.0 110.748 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.534 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 56.6 mt -93.94 119.93 33.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -99.25 -75.32 0.57 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.927 -174.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 p -121.92 141.92 50.8 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.256 0.551 . . . . 0.0 112.191 -173.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.482 HD13 ' HB ' ' A' ' 52' ' ' VAL . 33.9 tp -140.85 119.99 12.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.858 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.94 ' HA ' ' H62' ' A' ' 999' ' ' COA . 13.0 mtp180 -128.41 114.75 17.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.793 0.33 . . . . 0.0 111.191 176.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.483 ' HB ' ' H10' ' A' ' 999' ' ' COA . 11.2 t -95.33 151.73 3.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 167.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -54.06 140.28 32.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 34.4 mp0 -52.19 -38.25 57.25 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.251 0.62 . . . . 0.0 112.426 -172.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.38 -22.97 27.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.186 0.517 . . . . 0.0 111.201 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.459 ' HB ' HG12 ' A' ' 68' ' ' VAL . 6.9 m -90.86 64.02 5.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.285 0.564 . . . . 0.0 109.953 -177.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.561 ' HA ' H122 ' A' ' 999' ' ' COA . 12.6 ttp180 -94.75 12.65 27.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.198 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 74' ' ' ARG . 36.6 ttp180 173.85 90.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.715 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -156.46 17.57 0.33 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.116 0.484 . . . . 0.0 110.243 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.28 -34.46 1.76 Allowed Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.077 -0.583 . . . . 0.0 113.379 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.562 HG13 HD22 ' A' ' 3' ' ' LEU . 59.5 t -39.74 -52.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.079 0.951 . . . . 0.0 113.309 -176.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.92 -55.12 31.87 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.266 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.453 ' HB3' HD13 ' A' ' 115' ' ' LEU . 24.9 mt-30 -67.83 -39.65 83.86 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.793 -0.239 . . . . 0.0 110.614 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.592 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 47.2 t80 -53.72 -47.78 70.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.159 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.574 HD11 HD13 ' A' ' 5' ' ' ILE . 43.0 tp -62.19 -50.96 69.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.249 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.442 HD21 HD22 ' A' ' 66' ' ' LEU . 4.4 mm? -59.65 -46.58 88.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.154 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 48.0 mt-10 -61.37 -44.73 96.67 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.046 -0.261 . . . . 0.0 110.359 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -56.55 -43.75 80.24 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.906 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 81' ' ' LEU . 96.9 t -61.06 -46.77 96.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.352 . . . . 0.0 110.609 178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -72.29 -18.44 61.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.915 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.511 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 23.1 mtm180 -88.73 -22.1 23.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.537 0.208 . . . . 0.0 111.329 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -103.08 -7.35 21.41 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.638 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -118.37 85.61 25.94 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.0 110.187 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -84.49 162.99 12.75 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.18 2.587 . . . . 0.0 111.44 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.83 -45.87 3.25 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.782 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.86 99.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 16.5 m -92.55 -25.48 18.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.154 -175.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.6 t -102.35 98.75 8.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.84 0.352 . . . . 0.0 110.728 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -97.2 113.19 24.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.948 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -112.7 123.03 49.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.014 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.752 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 63.3 mtp -111.4 123.43 50.2 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.375 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.16 153.72 27.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.739 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -84.58 -26.55 27.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.242 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 59.09 14.38 3.44 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.18 20.88 78.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.392 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.8 t -67.92 134.31 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.583 0.23 . . . . 0.0 110.49 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -93.28 -17.2 23.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.044 0.449 . . . . 0.0 111.072 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -83.88 19.53 1.7 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 171.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.458 ' HA ' ' HB2' ' A' ' 108' ' ' MET . 6.9 ttp180 -64.77 -26.96 68.58 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.106 -176.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.0 -48.18 87.35 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.207 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.406 HG13 ' N6A' ' A' ' 999' ' ' COA . 80.2 t -65.8 -42.47 92.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.994 0.425 . . . . 0.0 110.362 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.642 ' O ' ' HG2' ' A' ' 112' ' ' MET . 96.1 mmm -59.2 -48.41 81.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.242 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 70.1 m -63.43 -35.54 80.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.365 0.126 . . . . 0.0 111.14 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.86 99.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.391 0.615 . . . . 0.0 109.937 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -62.12 -44.35 96.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.453 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.642 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.1 mmt -62.44 -48.08 81.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.616 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -64.93 -38.7 91.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.244 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.83 -21.9 56.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.424 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.525 HD23 ' HE2' ' A' ' 117' ' ' PHE . 40.9 tp -87.56 -45.69 10.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.527 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 138.04 44.52 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.231 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.585 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 87.3 m-85 -120.7 153.74 36.52 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.0 m -120.05 146.79 45.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.126 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.1 m -97.12 121.79 39.41 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -136.08 103.8 5.47 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 58.0 36.19 25.9 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.28 165.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 113.83 49.16 0.55 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.366 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.39 179.36 19.96 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.87 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.752 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 6.9 m-90 -102.95 137.83 40.63 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -125.56 137.37 53.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.758 0.314 . . . . 0.0 110.445 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.411 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 61.0 tttp -137.21 91.7 2.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.133 0.492 . . . . 0.0 109.999 172.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 93' ' ' SER . 52.4 t -91.21 112.36 24.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.228 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 CA-C-N 115.77 -0.65 . . . . 0.9 111.865 179.96 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 999' ' ' COA . . . . . 0.94 ' H62' ' HA ' ' A' ' 67' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.884 0.373 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -82.72 90.89 6.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.184 0.516 . . . . 0.0 109.956 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.1 tp -76.13 114.63 15.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.877 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.9 m -82.8 89.79 6.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.953 0.406 . . . . 0.0 110.655 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.614 HD11 ' HB3' ' A' ' 40' ' ' TYR . 5.2 tp -95.75 111.04 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.994 175.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.3 pt -130.51 171.01 18.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.836 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -92.79 137.2 32.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.447 ' O ' HG21 ' A' ' 33' ' ' VAL . 53.9 tp -78.99 70.55 5.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.245 0.545 . . . . 0.0 109.689 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -69.49 -43.8 72.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.443 -174.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -111.44 132.07 54.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.967 -175.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' A' ' 31' ' ' LEU . 72.3 m-85 -99.46 114.88 28.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.245 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.8 p -102.46 163.92 11.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.58 ' O ' HG13 ' A' ' 17' ' ' ILE . 34.1 t70 -66.12 -29.84 70.22 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -66.99 -50.19 63.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.008 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.439 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 32.9 m-20 -61.74 -35.04 76.92 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.622 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.407 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 35.6 ttm180 -61.47 -38.01 85.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.526 176.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 13' ' ' ASP . 72.9 mt -60.48 -42.49 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.193 0.52 . . . . 0.0 110.331 176.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.436 ' HB3' HD12 ' A' ' 48' ' ' LEU . 80.5 m-20 -68.73 -33.54 74.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.666 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 96.4 mt -65.0 -34.44 78.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.372 175.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 16' ' ' ARG . 25.4 mt-30 -69.71 -24.71 63.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.733 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -66.52 -44.36 82.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.231 0.539 . . . . 0.0 109.867 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.2 mt -75.45 -45.59 39.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.33 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 6.0 m-90 -123.89 74.48 56.4 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.668 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.79 -21.86 9.4 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 121.922 1.748 . . . . 0.0 111.341 175.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -89.84 -3.48 58.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.378 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.548 ' HB3' ' HB3' ' A' ' 23' ' ' TRP . 31.9 t80 -92.11 142.75 27.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.134 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.8 m -66.59 125.04 89.88 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.258 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.51 97.62 0.26 Allowed 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.626 2.218 . . . . 0.0 112.277 -177.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.3 p -88.26 178.4 6.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.572 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 26.0 m -68.84 -27.0 65.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.838 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.571 ' HB3' ' CE1' ' A' ' 11' ' ' PHE . 51.4 mt 74.12 105.63 0.07 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.927 0.767 . . . . 0.0 111.505 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -129.96 139.97 51.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.353 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 13.7 m -125.72 154.19 34.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.386 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.516 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 22.9 t70 74.4 -30.11 0.2 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.53 175.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 36' ' ' ASN . 4.4 t70 -81.71 68.94 8.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 35' ' ' ASP . 19.7 m120 83.22 -40.02 0.09 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.207 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.519 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 90.2 m-70 -101.59 110.4 22.39 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.641 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.516 ' HG2' ' HA ' ' A' ' 34' ' ' ASP . 69.8 mtt180 -109.2 117.19 33.47 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.097 0.475 . . . . 0.0 110.651 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.557 HG12 ' HG2' ' A' ' 53' ' ' ARG . 53.8 mt -98.67 110.71 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.115 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.614 ' HB3' HD11 ' A' ' 5' ' ' ILE . 73.3 m-85 -97.61 141.16 30.99 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.476 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -124.62 113.74 18.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.969 0.414 . . . . 0.0 111.089 -170.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.485 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.13 101.5 14.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.528 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.516 ' HB3' HD23 ' A' ' 48' ' ' LEU . 28.5 ptt180 -102.51 118.84 37.74 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.546 0.689 . . . . 0.0 110.858 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -97.44 133.41 42.07 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.5 t30 64.61 23.35 12.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.003 0.906 . . . . 0.0 108.607 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 66.47 20.74 10.88 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.419 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -126.88 142.73 51.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' A' ' 43' ' ' ARG . 55.5 mt -54.49 130.39 39.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.182 0.515 . . . . 0.0 112.14 -172.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 34.4 tp -125.6 -40.65 2.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.205 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.529 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -133.12 143.99 49.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.325 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -135.07 132.28 37.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.387 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.59 132.46 62.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.081 0.467 . . . . 0.0 110.927 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.557 ' HG2' HG12 ' A' ' 39' ' ' ILE . 27.8 mtm180 -111.11 121.65 45.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.985 176.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.66 119.55 59.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.411 0.624 . . . . 0.0 109.71 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 89.9 m -95.56 95.53 8.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.571 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.584 ' HA ' ' HA3' ' A' ' 61' ' ' GLY . 89.2 mt -80.38 124.27 28.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.119 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.7 t -98.59 50.15 0.98 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.71 -104.83 2.45 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.549 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.5 p -94.49 -29.53 14.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.381 0.61 . . . . 0.0 110.648 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.81 ' HB3' ' HB3' ' A' ' 94' ' ' CYS . 36.0 mt-10 -119.19 151.33 38.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.008 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 56' ' ' LEU . . . -151.7 -179.84 27.7 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 119.461 -1.352 . . . . 0.0 113.894 -173.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.63 135.33 48.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.222 -0.489 . . . . 0.0 110.205 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.8 tt -93.77 112.84 24.77 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -97.24 -56.89 2.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -168.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.411 ' HA ' ' S1P' ' A' ' 999' ' ' COA . 32.1 m -107.81 106.22 16.41 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.024 0.44 . . . . 0.0 111.553 -173.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.3 tp -124.58 109.07 12.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.785 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.45 ' HG3' ' O9P' ' A' ' 999' ' ' COA . 65.1 ttt180 -138.94 136.84 35.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.233 0.54 . . . . 0.0 111.246 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.529 HG13 ' HB2' ' A' ' 50' ' ' ALA . 14.5 t -110.8 152.0 12.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -57.79 150.56 19.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.746 0.308 . . . . 0.0 110.18 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -51.7 -38.43 55.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.51 -20.85 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 111.931 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.442 ' HB ' ' CG1' ' A' ' 68' ' ' VAL . 2.0 m -113.09 24.92 11.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.157 0.503 . . . . 0.0 111.255 -175.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.465 ' HG2' ' H10' ' A' ' 999' ' ' COA . 16.5 mtp180 -78.25 38.84 0.3 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 8.3 ttm180 174.37 19.95 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.276 0.23 . . . . 0.0 111.057 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -141.04 75.28 1.49 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -167.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.74 -61.45 4.27 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 115.703 1.041 . . . . 0.0 115.703 161.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -43.42 -51.97 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -168.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.09 -41.18 77.14 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.957 -0.639 . . . . 0.0 113.595 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -68.64 -53.07 24.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.919 0.39 . . . . 0.0 110.623 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -58.21 -40.87 82.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.421 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.563 HD11 HD13 ' A' ' 5' ' ' ILE . 26.9 tp -56.3 -55.07 37.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.384 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.47 ' HB2' HD11 ' A' ' 115' ' ' LEU . 55.6 mt -62.34 -41.74 98.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.376 -176.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -62.94 -37.87 88.75 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.782 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.84 -39.1 80.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.43 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 81' ' ' LEU . 72.5 t -58.49 -45.94 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.815 0.34 . . . . 0.0 111.039 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 82' ' ' LEU . 11.1 mp -68.22 -23.75 64.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.122 0.487 . . . . 0.0 110.744 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.6 mtp85 -76.73 -33.06 58.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.852 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.41 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 13.2 m120 -71.01 -49.69 42.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -118.27 86.21 26.76 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.763 0.316 . . . . 0.0 111.377 -178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 1.8 Cg_endo -83.75 170.61 11.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.966 2.444 . . . . 0.0 111.481 175.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.06 -14.85 62.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.216 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.559 HG13 ' HA ' ' A' ' 60' ' ' GLU . 53.3 t -78.24 118.53 25.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 128' ' ' GLY . 2.4 p -84.46 -40.23 17.97 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.572 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.81 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 45.1 t -101.93 100.14 10.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.904 0.383 . . . . 0.0 110.866 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -97.3 97.66 9.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -96.8 128.27 43.58 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.844 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 96.0 mmm -107.16 109.5 21.34 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.12 149.66 42.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.667 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -75.6 -43.51 47.77 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 61.07 8.74 2.07 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.773 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.87 17.78 66.93 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.882 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 104' ' ' ASP . 82.8 t -67.69 111.9 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 121.217 0.532 . . . . 0.0 110.064 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -79.79 1.26 27.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.744 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.421 ' H ' HG12 ' A' ' 102' ' ' VAL . 13.4 m-20 -101.1 21.31 14.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.442 174.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -58.9 -27.25 65.05 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.902 -175.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.36 -53.03 45.11 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.568 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 43.7 t -62.97 -37.36 79.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.169 0.509 . . . . 0.0 110.047 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.598 ' O ' ' HG2' ' A' ' 112' ' ' MET . 96.9 mmm -65.13 -36.18 83.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.232 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 93.3 m -63.9 -45.04 91.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.712 0.291 . . . . 0.0 110.693 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.28 94.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.182 0.515 . . . . 0.0 110.209 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -61.92 -48.22 81.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.227 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.598 ' HG2' ' O ' ' A' ' 108' ' ' MET . 26.3 mmt -57.59 -48.87 78.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 0.0 111.114 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -72.14 -21.87 61.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.541 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.56 -34.96 35.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.991 0.424 . . . . 0.0 110.545 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.47 HD11 ' HB2' ' A' ' 82' ' ' LEU . 7.4 tt -75.42 -56.37 4.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.002 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 149.19 33.35 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.993 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 89.0 m-85 -107.9 167.62 9.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 31.9 m -117.23 137.64 52.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.442 HG23 ' CD1' ' A' ' 124' ' ' TRP . 15.8 m -97.65 132.65 43.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.939 0.399 . . . . 0.0 110.59 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.556 ' NE2' ' HB3' ' A' ' 125' ' ' GLU . 48.4 mt-30 -126.65 -171.62 2.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.6 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -85.48 109.02 18.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.88 0.372 . . . . 0.0 110.474 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.8 7.09 32.01 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.429 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.86 -175.38 27.21 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.51 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.844 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 9.7 m-90 -107.55 160.76 15.43 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.556 ' HB3' ' NE2' ' A' ' 120' ' ' GLN . 55.7 tt0 -157.76 150.85 23.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.058 0.456 . . . . 0.0 110.791 176.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -133.49 117.3 17.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.537 174.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 33.7 t -85.0 108.91 17.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.95 0.405 . . . . 0.0 110.016 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 93' ' ' SER . . . . . . . . 0 N--CA 1.449 -0.457 0 CA-C-N 115.888 -0.596 . . . . 0.9 112.285 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 999' ' ' COA . . . . . 0.499 ' P1A' ' O9A' ' A' ' 999' ' ' COA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtm . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -90.79 92.06 8.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.112 0.482 . . . . 0.0 109.965 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.546 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 36.5 tp -75.88 137.51 40.47 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 m -111.16 109.35 19.37 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.801 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.555 HD13 HD11 ' A' ' 81' ' ' LEU . 11.2 tp -89.81 113.17 25.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.541 0.686 . . . . 0.0 109.822 176.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.99 149.9 16.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.185 0.517 . . . . 0.0 110.489 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -74.77 112.57 11.12 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.441 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.1 tp -67.77 101.93 1.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -98.77 -49.79 4.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.987 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -127.01 149.05 50.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.997 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -107.81 136.52 47.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.66 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.66 ' HB2' ' OD1' ' A' ' 15' ' ' ASP . 8.3 m -115.9 162.39 17.41 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 170.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -63.02 -42.82 99.9 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -171.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -64.92 -52.24 57.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.608 0.242 . . . . 0.0 111.178 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.66 ' OD1' ' HB2' ' A' ' 12' ' ' SER . 0.5 OUTLIER -72.04 -19.05 61.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.543 -179.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -64.25 -44.64 91.16 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.5 mt -68.38 -33.79 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.259 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -63.41 -39.41 94.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.961 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.0 mt -64.56 -36.92 85.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.807 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -73.28 -13.3 61.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.009 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -89.14 -24.34 22.23 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.3 mt -77.75 -49.36 22.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.728 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -104.92 91.64 4.52 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.09 -36.37 70.61 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.875 2.383 . . . . 0.0 113.432 -170.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -105.49 26.92 8.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.869 0.366 . . . . 0.0 111.243 -175.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -79.19 126.89 31.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.995 0.426 . . . . 0.0 110.364 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.0 t -89.64 120.0 69.52 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.922 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.74 114.67 2.06 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.757 2.305 . . . . 0.0 111.426 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.2 p -164.68 -78.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.397 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.7 m -74.04 -75.21 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.222 -174.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.5 mt 51.64 49.45 20.84 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.113 0.482 . . . . 0.0 110.062 -173.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -88.25 117.56 27.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.962 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.4 m -122.73 137.18 57.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.171 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.883 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 11.7 t70 72.15 8.33 5.87 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.748 170.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 37' ' ' HIS . 7.8 m-20 -120.27 77.54 1.27 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.5 m120 75.85 -34.99 0.25 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.148 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.451 ' H ' ' C ' ' A' ' 35' ' ' ASP . 86.1 m-70 -112.76 112.45 23.95 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 173.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.883 ' HG2' ' HA ' ' A' ' 34' ' ' ASP . 79.4 mtt180 -113.84 126.18 54.9 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.016 0.436 . . . . 0.0 110.551 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.575 HG12 ' HG2' ' A' ' 53' ' ' ARG . 71.8 mt -100.35 119.81 48.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.935 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -102.49 133.0 48.18 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.525 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.57 125.06 51.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.802 -175.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.06 98.78 11.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.197 0.522 . . . . 0.0 110.159 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.417 ' HD3' HH11 ' A' ' 43' ' ' ARG . 15.6 ttm180 -87.61 126.88 35.2 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.495 -177.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -124.53 95.47 4.54 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.2 m120 60.94 74.26 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.981 -176.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 71.42 -43.55 0.57 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.772 -1.103 . . . . 0.0 113.181 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -88.76 153.76 20.82 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.758 0.313 . . . . 0.0 111.111 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.525 HD22 ' HB1' ' A' ' 41' ' ' ALA . 79.5 mt -90.24 108.09 19.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.016 0.436 . . . . 0.0 110.145 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.4 tp -83.38 -31.41 26.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.639 -175.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.538 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -144.45 157.13 44.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.755 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.29 135.59 22.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.115 177.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 65' ' ' SER . 7.1 p -135.14 138.69 48.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.001 0.429 . . . . 0.0 111.141 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.575 ' HG2' HG12 ' A' ' 39' ' ' ILE . 88.4 mtt180 -103.16 131.24 50.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.892 176.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.43 ' HB ' HD23 ' A' ' 63' ' ' LEU . 7.1 p -125.24 122.33 62.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.356 0.598 . . . . 0.0 110.937 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 34.8 m -93.35 110.02 21.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.971 175.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.476 HD23 ' HA2' ' A' ' 61' ' ' GLY . 92.3 mt -94.98 98.63 10.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.635 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 t -95.71 97.87 10.03 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.76 -107.27 2.06 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.404 -174.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.4 p -115.43 12.6 16.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.92 0.391 . . . . 0.0 111.187 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.05 138.08 42.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.019 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.476 ' HA2' HD23 ' A' ' 56' ' ' LEU . . . -116.03 113.54 2.87 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.385 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.54 ' HB3' ' HB ' ' A' ' 55' ' ' THR . . . -96.35 110.96 23.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.963 0.411 . . . . 0.0 110.753 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.719 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 53.7 mt -93.85 109.78 21.46 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.743 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.85 -75.06 0.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.788 0.328 . . . . 0.0 111.818 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 13.6 m -82.18 85.76 6.75 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.892 0.377 . . . . 0.0 111.384 -175.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.521 HD21 HD21 ' A' ' 82' ' ' LEU . 47.0 tp -102.67 100.73 10.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.613 173.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -135.12 126.55 28.56 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.568 -175.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 50' ' ' ALA . 12.1 t -111.75 155.48 13.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 174.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -60.21 137.57 58.09 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -48.2 -41.53 27.47 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.793 0.683 . . . . 0.0 112.609 -173.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.5 m -73.09 2.44 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 m -98.69 7.76 45.72 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.099 0.476 . . . . 0.0 111.014 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.892 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 30.4 mtm180 -70.34 106.7 3.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.836 0.351 . . . . 0.0 110.369 177.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 60.7 ttt180 -157.67 -81.07 0.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.471 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 27.4 ttt180 164.86 95.71 0.0 OUTLIER 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -169.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.02 -79.53 0.2 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.506 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.514 HG13 HD22 ' A' ' 3' ' ' LEU . 69.3 t -47.47 -46.56 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 123.194 0.597 . . . . 0.0 112.589 -174.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.401 ' HA3' H122 ' A' ' 999' ' ' COA . . . -56.97 -62.67 6.1 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.06 -0.591 . . . . 0.0 113.548 -177.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -68.21 -32.61 72.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.79 0.295 . . . . 0.0 111.143 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.546 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 30.3 t80 -59.44 -49.25 78.51 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.555 HD11 HD13 ' A' ' 5' ' ' ILE . 55.9 tp -52.32 -56.04 17.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.104 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.521 HD21 HD21 ' A' ' 66' ' ' LEU . 4.2 mm? -58.23 -44.46 88.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.029 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.718 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 5.4 mt-10 -63.27 -49.34 74.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.584 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.5 ' OE1' HG22 ' A' ' 5' ' ' ILE . 35.2 tt0 -63.73 -34.95 79.03 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.064 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 81' ' ' LEU . 75.5 t -61.46 -43.9 97.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.868 0.366 . . . . 0.0 110.342 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 82' ' ' LEU . 11.0 mp -72.01 -24.16 61.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.344 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.718 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 19.2 mmt180 -76.93 -39.02 52.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.055 0.455 . . . . 0.0 109.98 176.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -67.73 -34.76 77.49 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.793 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -119.59 79.79 22.48 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.036 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -86.74 -9.48 6.57 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.544 2.163 . . . . 0.0 112.908 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.87 -35.04 55.1 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.4 t -73.47 104.85 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 p -106.01 12.22 30.71 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.059 0.457 . . . . 0.0 110.656 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 47.8 t -130.51 99.97 5.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.342 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -107.79 120.3 41.87 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.442 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.521 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 13.7 t-105 -115.98 120.42 39.08 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.191 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.719 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 76.1 mtp -107.15 126.5 52.46 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.099 0.476 . . . . 0.0 110.099 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.2 146.53 24.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.971 -176.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.68 16.67 10.17 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.282 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.38 106.88 4.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.701 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.52 0.81 56.65 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.162 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.49 HG22 ' S1P' ' A' ' 999' ' ' COA . 80.7 t -86.82 107.27 16.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.792 0.329 . . . . 0.0 110.381 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.69 -46.04 33.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.072 0.463 . . . . 0.0 110.032 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -94.71 81.64 3.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.257 0.551 . . . . 0.0 110.459 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.5 mtt85 -71.03 -28.85 64.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.411 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.3 -54.62 28.56 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.351 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.707 HG13 ' N7A' ' A' ' 999' ' ' COA . 55.3 t -61.22 -42.4 93.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.765 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.585 ' O ' ' HG2' ' A' ' 112' ' ' MET . 97.8 mmm -64.5 -36.52 84.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.675 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 85.8 m -64.68 -43.96 91.88 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.858 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.58 -36.59 84.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.264 0.554 . . . . 0.0 110.376 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -64.74 -44.41 90.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.411 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.585 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.5 mmt -62.24 -42.73 99.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.009 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -57.15 -40.32 76.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.544 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.41 -29.83 69.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.209 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.5 mt -85.0 -7.52 59.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.022 0.439 . . . . 0.0 111.228 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.36 21.66 56.13 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.144 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 37.5 m-85 -85.6 132.19 34.22 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 65.2 p -95.7 162.19 13.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.998 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.2 t -97.21 117.16 30.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.7 0.762 . . . . 0.0 109.7 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.94 169.71 10.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.24 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -70.8 94.48 1.04 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.045 0.45 . . . . 0.0 110.748 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.83 -11.24 5.42 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.41 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.25 -146.91 16.02 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.312 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 7.5 m-90 -103.1 133.56 48.0 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -121.04 131.54 54.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.183 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -137.03 115.55 11.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.91 172.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 22.4 t -112.72 115.98 29.4 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.942 0.401 . . . . 0.0 110.182 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.516 0 N-CA-C 111.533 -0.627 . . . . 0.9 111.533 -178.876 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 999' ' ' COA . . . . . 0.892 ' O4A' ' HA ' ' A' ' 73' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.743 0.306 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -93.19 113.79 26.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.13 0.49 . . . . 0.0 110.388 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.541 HD21 ' HB1' ' A' ' 42' ' ' ALA . 38.7 tp -79.52 115.01 18.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.688 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -82.86 103.61 12.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.834 0.35 . . . . 0.0 110.377 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.535 HD11 ' HB3' ' A' ' 40' ' ' TYR . 11.6 tt -105.7 126.25 61.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.545 0.688 . . . . 0.0 111.159 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.5 mt -125.51 160.89 31.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.476 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -85.74 141.33 29.79 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 8' ' ' LEU . 55.1 mt -77.53 103.55 7.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.044 0.449 . . . . 0.0 110.626 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -79.39 -45.76 18.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.503 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -137.85 166.65 23.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.945 -176.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -127.89 111.47 13.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.808 0.337 . . . . 0.0 111.089 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.0 m -99.55 -179.97 4.37 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -62.59 -48.92 77.32 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.821 0.344 . . . . 0.0 110.872 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -57.77 -39.31 77.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.558 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -67.02 -46.2 75.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.328 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.9 ttp85 -60.7 -46.6 89.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.649 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 80.0 mt -61.57 -46.18 97.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.881 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.96 -38.72 86.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.21 0.529 . . . . 0.0 110.395 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.519 HD23 HD12 ' A' ' 22' ' ' ILE . 76.7 mt -68.58 -25.03 64.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.264 177.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -79.94 -19.96 46.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.248 0.547 . . . . 0.0 109.894 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -74.74 -29.1 61.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 171.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.519 HD12 HD23 ' A' ' 19' ' ' LEU . 73.0 mt -79.78 -48.73 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.302 174.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -115.79 100.55 53.66 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 175.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -58.11 -29.08 86.04 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.065 2.51 . . . . 0.0 112.951 -176.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -136.22 85.99 2.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -91.87 154.5 18.83 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.064 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.0 m -100.06 120.8 55.89 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.442 171.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.71 -28.09 80.33 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.574 2.183 . . . . 0.0 112.053 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.3 m -61.56 -41.01 96.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.489 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 p -86.94 4.07 43.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.924 0.392 . . . . 0.0 111.03 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.7 mt -94.02 -1.07 55.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.355 0.598 . . . . 0.0 109.443 172.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -80.57 118.09 21.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.712 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.43 118.5 39.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.785 -173.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.434 ' OD1' ' HB2' ' A' ' 37' ' ' HIS . 6.3 p-10 -135.24 -164.5 1.54 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.856 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -68.57 -29.75 68.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.805 0.336 . . . . 0.0 110.972 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -89.86 -63.31 1.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.162 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.434 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 56.3 m80 -78.37 98.74 6.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.234 0.54 . . . . 0.0 110.651 -178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.578 ' HD3' HD12 ' A' ' 56' ' ' LEU . 27.7 mtp-105 -115.68 116.9 28.89 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.449 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.2 mt -98.48 127.14 51.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.781 0.324 . . . . 0.0 110.586 -176.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.535 ' HB3' HD11 ' A' ' 5' ' ' ILE . 55.3 m-85 -99.08 140.23 33.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.409 176.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.541 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -114.16 113.4 24.63 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.543 174.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.05 104.93 17.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.809 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 7.7 ptp180 -112.6 136.41 52.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.361 0.6 . . . . 0.0 111.756 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.43 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 44.5 t80 -99.88 95.71 7.08 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.8 t30 69.59 -76.41 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.388 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -151.31 71.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.527 0.679 . . . . 0.0 110.028 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 43' ' ' ARG . 15.9 ptp180 -167.41 122.24 1.03 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.029 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.541 HD22 ' HB1' ' A' ' 41' ' ' ALA . 59.0 mt -78.11 90.83 4.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.588 ' HA ' ' HD3' ' A' ' 69' ' ' ARG . 62.7 mt -79.05 -39.95 32.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.307 -175.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -132.9 141.81 48.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.698 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.452 ' HB3' HG21 ' A' ' 22' ' ' ILE . . . -135.09 132.78 38.56 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.84 177.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.49 HG21 HD23 ' A' ' 63' ' ' LEU . 7.5 p -138.9 135.35 42.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.027 0.442 . . . . 0.0 111.224 -176.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.515 ' HG3' ' HB2' ' A' ' 65' ' ' SER . 33.1 mtt-85 -101.5 106.14 17.22 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 176.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.93 119.45 50.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.273 0.559 . . . . 0.0 110.017 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.0 m -92.93 97.42 10.72 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.049 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.578 HD12 ' HD3' ' A' ' 38' ' ' ARG . 81.9 mt -87.29 85.67 7.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.046 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -86.67 85.19 7.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.465 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.14 -119.84 5.05 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.189 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.0 p -96.84 8.62 43.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.021 0.439 . . . . 0.0 111.124 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -126.52 137.16 53.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.265 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -119.56 121.95 5.13 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.357 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.06 119.59 35.74 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.496 HD13 ' SD ' ' A' ' 97' ' ' MET . 5.9 mp -93.88 122.75 36.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -95.35 -79.85 0.43 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.106 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.515 ' HB2' ' HG3' ' A' ' 53' ' ' ARG . 13.5 m -86.9 122.51 30.87 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.959 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.443 HD13 ' HB ' ' A' ' 52' ' ' VAL . 52.3 tp -140.6 116.43 10.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.421 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.646 ' HA ' ' O5P' ' A' ' 999' ' ' COA . 50.9 ttt180 -143.84 138.11 28.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.985 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.552 HG23 ' OAP' ' A' ' 999' ' ' COA . 7.3 t -114.57 142.86 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.588 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 10.3 mtp180 -63.38 147.43 51.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.124 0.488 . . . . 0.0 111.114 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -58.95 -17.99 29.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -167.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.42 -16.56 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.489 0.661 . . . . 0.0 110.6 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.489 HG22 HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -106.02 15.86 25.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.586 -173.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.645 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 19.5 ptt-85 -86.06 144.73 27.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.988 0.423 . . . . 0.0 111.572 -173.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.452 ' HA ' H52A ' A' ' 999' ' ' COA . 31.2 mtp-105 56.19 26.99 10.98 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.911 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -112.32 2.36 16.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.3 0.571 . . . . 0.0 110.903 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.96 -5.98 64.12 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.114 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.489 HG21 HG22 ' A' ' 72' ' ' THR . 86.7 t -59.46 -41.81 85.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.008 0.433 . . . . 0.0 110.926 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 81' ' ' LEU . . . -64.56 -25.74 70.4 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.367 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.546 ' HA ' HD21 ' A' ' 115' ' ' LEU . 62.7 tt0 -68.6 -47.45 66.67 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -61.95 -40.29 95.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.946 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 85' ' ' VAL . 51.2 tp -45.23 -63.97 0.82 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.806 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.4 ' O ' HD13 ' A' ' 86' ' ' LEU . 3.9 mm? -65.95 -37.19 85.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.575 -176.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 79' ' ' GLN . 41.5 mt-10 -60.27 -40.74 91.45 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -79.67 -25.51 41.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.792 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 81' ' ' LEU . 73.3 t -62.75 -46.17 97.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.149 0.499 . . . . 0.0 110.012 173.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 82' ' ' LEU . 10.3 mp -70.55 -22.05 62.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.95 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -75.78 -45.65 35.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.339 173.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -57.61 -48.85 78.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.098 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -120.27 89.0 42.82 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.196 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -83.13 -15.39 7.93 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.877 2.385 . . . . 0.0 114.02 -173.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.48 57.87 5.05 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.1 -174.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.4 t -129.68 128.46 65.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.758 0.313 . . . . 0.0 110.383 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.7 m -75.56 -48.02 24.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.123 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 127' ' ' CYS . 47.1 t -131.42 124.35 30.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.835 -177.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -96.98 113.86 25.43 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 174.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -108.53 129.0 55.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.924 0.392 . . . . 0.0 110.079 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.831 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 95.9 mmm -110.9 108.42 18.2 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.76 147.5 35.3 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.948 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -63.25 -34.69 78.21 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.89 9.21 2.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.582 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.69 17.03 80.26 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.892 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 104' ' ' ASP . 57.3 t -70.25 118.35 14.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -77.33 5.96 7.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.049 -173.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.532 ' H ' HG12 ' A' ' 102' ' ' VAL . 31.3 m-20 -111.97 24.13 13.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.163 0.506 . . . . 0.0 109.834 173.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -57.47 -28.69 63.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.225 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.3 -46.1 74.04 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.4 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.2 t -66.63 -37.04 78.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.113 0.482 . . . . 0.0 110.047 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.642 ' HG2' ' CDP' ' A' ' 999' ' ' COA . 68.6 mtp -66.59 -32.67 74.16 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.749 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 53.0 m -62.49 -44.43 96.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.644 0.259 . . . . 0.0 110.582 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.49 ' HB1' ' N7A' ' A' ' 999' ' ' COA . . . -63.27 -39.74 95.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.495 0.664 . . . . 0.0 110.135 175.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.522 ' CE2' H143 ' A' ' 999' ' ' COA . 38.7 t80 -61.69 -39.47 91.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.035 176.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.616 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.4 mmt -63.36 -36.96 85.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.768 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -67.82 -27.8 67.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.721 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.73 -40.34 66.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.917 0.389 . . . . 0.0 110.435 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 79' ' ' GLN . 97.1 mt -68.82 -48.65 63.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.161 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 124.39 27.18 1.36 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.776 -176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.567 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 26.2 m-85 -98.79 154.43 18.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.0 m -108.76 157.88 18.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.872 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.428 HG22 ' CD1' ' A' ' 124' ' ' TRP . 3.3 p -97.39 117.23 31.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.952 0.406 . . . . 0.0 110.871 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.454 ' HA ' ' OE1' ' A' ' 120' ' ' GLN . 14.4 mm-40 -102.62 -179.53 4.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.913 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -91.05 50.72 1.82 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.327 0.584 . . . . 0.0 109.977 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 165.16 43.71 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.356 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 113.44 -176.82 17.63 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 121.171 -0.538 . . . . 0.0 111.79 -176.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.831 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 9.4 m-90 -96.42 148.8 22.41 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -138.65 137.82 37.23 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.016 0.436 . . . . 0.0 111.413 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.465 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 57.5 tttm -136.97 95.52 3.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.59 169.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 94' ' ' CYS . 42.5 t -76.83 110.44 11.44 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.532 0 C-N-CA 120.956 -0.64 . . . . 0.9 112.092 -178.888 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 999' ' ' COA . . . . . 0.676 ' O5P' ' C9P' ' A' ' 999' ' ' COA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 120.959 0.409 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -108.83 127.51 54.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.023 0.439 . . . . 0.0 110.67 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.515 HD11 ' HB1' ' A' ' 42' ' ' ALA . 49.7 tp -76.1 115.68 16.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.622 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.7 m -87.82 92.05 8.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.051 0.453 . . . . 0.0 110.601 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' A' ' 40' ' ' TYR . 6.4 tp -81.91 105.96 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.795 0.807 . . . . 0.0 109.981 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.9 mt -99.11 148.75 5.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.367 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -95.67 139.62 31.66 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 11' ' ' PHE . 4.4 mm? -75.48 62.58 1.39 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.818 0.818 . . . . 0.0 110.586 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -94.72 -29.11 14.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.608 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -127.53 107.12 9.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.77 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 8' ' ' LEU . 69.8 m-85 -87.83 112.38 22.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.987 0.423 . . . . 0.0 111.736 -175.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.518 ' HB3' ' OD1' ' A' ' 15' ' ' ASP . 28.4 t -92.26 157.98 16.37 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 172.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.04 -47.08 84.55 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -63.92 -41.49 97.65 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.384 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.518 ' OD1' ' HB3' ' A' ' 12' ' ' SER . 1.6 m-20 -55.65 -44.77 77.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.453 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.676 ' HG2' HD13 ' A' ' 31' ' ' LEU . 24.4 mtp180 -60.44 -39.28 86.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.301 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 57.9 mt -77.76 -37.78 24.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.491 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -68.41 -33.05 73.55 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.473 HD23 HD12 ' A' ' 22' ' ' ILE . 73.7 mt -63.87 -37.28 86.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.241 172.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.454 ' HB2' ' HG3' ' A' ' 28' ' ' PRO . 52.3 tt0 -65.67 -22.82 66.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.34 0.591 . . . . 0.0 110.398 176.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -80.0 -28.56 39.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.238 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.519 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 69.5 mt -76.78 -36.01 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.231 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 5.7 m-90 -109.72 81.1 1.83 Allowed Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 21.1 Cg_exo -65.8 -24.83 53.8 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.129 2.553 . . . . 0.0 113.534 -169.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -104.54 3.62 32.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.254 0.55 . . . . 0.0 110.605 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.48 ' HB3' ' HB3' ' A' ' 23' ' ' TRP . 52.4 t80 -118.49 114.07 22.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.844 -175.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.2 m -64.04 116.12 24.79 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 170.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.652 ' HB2' HD11 ' A' ' 31' ' ' LEU . 30.0 Cg_endo -63.3 84.26 0.12 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.931 2.421 . . . . 0.0 113.678 -170.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.1 m -112.15 -1.57 15.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.535 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 p -80.4 4.74 17.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.267 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.676 HD13 ' HG2' ' A' ' 16' ' ' ARG . 51.2 mt -77.4 7.48 5.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.242 -176.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -83.16 98.43 9.34 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.516 HG23 ' HA ' ' A' ' 38' ' ' ARG . 8.2 p -93.13 135.76 26.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.198 -175.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -131.7 -179.56 5.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -65.82 -23.71 66.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.688 0.28 . . . . 0.0 111.339 -175.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.626 ' O ' ' HA ' ' A' ' 55' ' ' THR . 32.0 m-80 -85.84 -62.34 1.55 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.907 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -89.66 94.62 9.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.553 -175.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.516 ' HA ' HG23 ' A' ' 33' ' ' VAL . 53.6 mtt180 -110.27 139.08 45.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.286 0.565 . . . . 0.0 111.006 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.8 mt -106.96 134.77 47.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.787 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.6 ' HB3' HD11 ' A' ' 5' ' ' ILE . 86.0 m-85 -118.84 140.34 50.12 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.583 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -129.2 124.09 33.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.103 0.478 . . . . 0.0 110.566 -173.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.731 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.0 104.14 16.58 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.966 -176.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -87.27 122.76 31.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.701 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -140.31 124.99 18.09 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.2 t30 62.07 36.56 15.26 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.49 0.662 . . . . 0.0 110.005 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 37.3 tt0 67.01 18.41 10.56 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.213 177.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.3 ttp-105 -133.7 146.24 50.63 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.583 HD22 ' HB1' ' A' ' 41' ' ' ALA . 78.7 mt -79.88 101.45 8.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.197 0.522 . . . . 0.0 110.414 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.8 tp -81.74 -21.74 37.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.615 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.731 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -141.05 140.25 34.22 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.605 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -128.52 122.39 31.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.899 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.425 HG13 ' HB2' ' A' ' 40' ' ' TYR . 7.9 p -132.59 135.97 56.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.955 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -111.26 129.83 55.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.855 0.359 . . . . 0.0 110.146 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.7 p -127.35 139.59 51.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.064 0.459 . . . . 0.0 110.189 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 29.1 m -108.28 101.71 10.89 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.083 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.89 91.07 5.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.507 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -103.54 99.16 8.97 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.118 -175.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 61.48 -105.55 0.92 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.358 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.8 p -107.36 2.42 24.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.854 0.359 . . . . 0.0 111.131 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -102.66 122.24 44.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.334 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.94 85.76 0.91 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -92.92 128.61 38.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.691 0.281 . . . . 0.0 110.447 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 tp -93.52 121.65 35.14 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -113.47 95.82 5.56 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.185 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.0 p 69.93 127.87 0.03 OUTLIER 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.655 1.182 . . . . 0.0 112.344 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.501 HD23 ' HE1' ' A' ' 108' ' ' MET . 47.0 tp -123.8 122.63 38.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.004 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 70.5 mtp85 -129.82 96.31 4.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.137 0.494 . . . . 0.0 111.076 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' A' ' 50' ' ' ALA . 2.3 t -86.17 142.84 12.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 175.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 48' ' ' LEU . 5.0 ttt180 -61.43 139.79 58.15 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.6 -17.56 23.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.151 -172.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.01 -21.05 27.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.973 0.416 . . . . 0.0 111.138 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.4 m -62.72 -43.1 99.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.481 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 48.79 47.81 20.79 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.09 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.704 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 32.9 mtm180 55.24 66.9 1.11 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.64 175.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -144.52 75.31 1.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.884 0.373 . . . . 0.0 111.654 -175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.08 -43.34 2.84 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 114.998 0.759 . . . . 0.0 114.998 167.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.6 t -49.72 -48.28 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -174.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.19 -44.24 94.98 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.808 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.459 ' HA ' HD13 ' A' ' 115' ' ' LEU . 73.5 mt-30 -55.07 -56.94 14.21 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.44 0.638 . . . . 0.0 110.104 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -60.59 -45.62 93.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.13 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.508 ' O ' HG23 ' A' ' 85' ' ' VAL . 27.0 tp -54.09 -57.51 10.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.569 -174.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 82' ' ' LEU . 4.1 mm? -62.56 -45.75 91.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.695 -176.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -60.39 -37.99 82.54 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.975 0.416 . . . . 0.0 110.797 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.447 ' HG2' HG21 ' A' ' 5' ' ' ILE . 10.4 tp10 -69.21 -39.05 78.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.533 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 81' ' ' LEU . 91.4 t -62.16 -42.4 95.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.803 0.335 . . . . 0.0 110.55 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.74 -17.78 63.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.158 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -85.62 -37.59 19.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.171 0.51 . . . . 0.0 109.699 174.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.453 ' C ' HD22 ' A' ' 88' ' ' ASN . 0.2 OUTLIER -65.94 -44.04 86.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.077 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -120.28 77.84 26.08 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.585 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -89.0 -0.71 6.31 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.569 2.179 . . . . 0.0 112.909 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.46 -50.3 38.74 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.13 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.4 ' H ' HG22 ' A' ' 92' ' ' VAL . 3.5 m -62.04 119.69 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.21 0.529 . . . . 0.0 111.025 176.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 m -92.04 -18.52 23.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.275 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.2 t -109.35 98.63 8.0 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -95.31 132.13 40.65 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.188 0.518 . . . . 0.0 110.933 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.459 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 75.0 t-105 -127.6 127.15 43.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.762 -177.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.989 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 74.7 mmm -106.99 110.98 23.26 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -92.0 154.31 18.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.295 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.67 -1.29 41.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.876 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.53 127.81 33.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.93 2.61 86.17 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.163 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.764 HG11 ' HG3' ' A' ' 108' ' ' MET . 60.6 t -117.31 112.51 39.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.822 0.344 . . . . 0.0 110.723 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -80.56 -34.84 35.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.557 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 108' ' ' MET . 7.6 m-20 -87.71 61.53 6.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.858 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -63.35 -40.31 96.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.301 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.94 -45.15 97.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.111 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.9 -43.91 98.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.789 0.328 . . . . 0.0 110.591 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.764 ' HG3' HG11 ' A' ' 102' ' ' VAL . 97.8 mmm -65.61 -29.41 70.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 71.8 m -61.86 -47.61 84.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.824 0.345 . . . . 0.0 110.13 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.58 -37.9 83.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.356 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.453 ' HB3' ' HA ' ' A' ' 108' ' ' MET . 66.4 t80 -58.5 -52.95 63.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.268 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.534 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 65.1 mtt -76.85 -27.3 55.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.907 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -69.36 -33.79 73.61 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.704 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.11 73.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.613 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.723 HD23 ' HE2' ' A' ' 117' ' ' PHE . 32.5 tp -80.59 -51.96 8.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.018 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 141.91 69.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.285 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.723 ' HE2' HD23 ' A' ' 115' ' ' LEU . 91.1 m-85 -143.75 148.54 35.79 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 124' ' ' TRP . 18.9 m -115.69 149.93 37.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.343 -0.389 . . . . 0.0 109.967 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.2 p -97.0 115.07 26.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.144 0.497 . . . . 0.0 110.322 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.411 ' HG3' ' HG3' ' A' ' 121' ' ' GLN . 55.5 tp60 -134.6 115.7 14.15 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.468 -176.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.411 ' HG3' ' HG3' ' A' ' 120' ' ' GLN . 92.5 mt-30 62.56 35.19 14.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.323 172.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.29 4.37 56.34 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.77 -0.728 . . . . 0.0 113.877 172.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -155.08 175.94 32.91 Favored Glycine 0 C--O 1.225 -0.406 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.036 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.989 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 28.8 m-90 -95.14 127.03 40.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 117.005 0.402 . . . . 0.0 110.042 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -110.82 140.3 45.38 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.89 0.376 . . . . 0.0 110.623 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -137.03 93.4 2.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 172.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 51.0 t -86.93 132.01 33.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.704 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 C-N-CA 121.132 -0.556 . . . . 0.9 111.94 178.613 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 999' ' ' COA . . . . . 0.704 ' O4A' ' HA ' ' A' ' 74' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.8 mtm . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.677 0.275 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -107.3 128.79 54.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.017 0.436 . . . . 0.0 110.573 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.55 HD11 ' HB1' ' A' ' 42' ' ' ALA . 49.4 tp -93.37 113.7 25.94 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.464 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.6 m -83.01 100.09 10.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.249 0.547 . . . . 0.0 110.581 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.517 HD11 HD12 ' A' ' 81' ' ' LEU . 85.5 mt -95.03 129.83 44.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.393 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.5 mt -124.75 149.84 29.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.066 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 7' ' ' ARG . 15.2 ptt-85 -92.57 138.56 31.4 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 41' ' ' ALA . 4.3 mm? -74.92 50.89 0.48 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.035 0.445 . . . . 0.0 111.612 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -87.79 -24.39 23.77 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -123.53 107.31 11.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.695 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -83.67 115.24 22.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.202 0.525 . . . . 0.0 111.539 -173.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.8 t -98.37 153.32 18.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.893 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.475 ' O ' HG12 ' A' ' 17' ' ' ILE . 43.1 t0 -66.92 -49.86 64.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.439 -172.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -64.95 -37.79 88.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.723 0.297 . . . . 0.0 111.049 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.65 -39.37 88.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.297 0.57 . . . . 0.0 110.168 176.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -68.26 -29.32 68.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.6 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 13' ' ' ASP . 43.2 mm -63.84 -44.28 98.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.428 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.519 ' O ' HG13 ' A' ' 22' ' ' ILE . 7.7 m-20 -64.86 -38.4 90.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.807 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.9 mt -60.2 -41.84 93.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.962 0.411 . . . . 0.0 110.284 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -73.6 -13.54 61.03 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.368 0.604 . . . . 0.0 110.483 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -92.01 -23.37 19.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.404 0.621 . . . . 0.0 109.68 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 18' ' ' ASP . 96.1 mt -77.66 -35.36 21.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.399 174.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 5.3 m-90 -112.23 80.81 3.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 169.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.97 -8.72 22.54 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.971 2.447 . . . . 0.0 113.65 -168.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -115.42 4.26 14.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.866 0.365 . . . . 0.0 110.697 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.557 ' CE2' ' HA ' ' A' ' 28' ' ' PRO . 58.6 t80 -133.66 122.46 23.48 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.108 0.48 . . . . 0.0 111.843 -174.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.7 m -81.64 115.62 58.01 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.248 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.557 ' HA ' ' CE2' ' A' ' 26' ' ' TYR . 49.5 Cg_exo -54.77 109.04 0.34 Allowed 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 123.069 2.513 . . . . 0.0 112.718 -174.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.4 t -118.77 -24.17 6.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.93 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.1 m -73.34 5.19 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.526 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.452 HD11 ' HB2' ' A' ' 28' ' ' PRO . 87.3 mt -59.1 90.3 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.458 0.647 . . . . 0.0 111.698 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -161.2 135.21 6.89 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.498 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.0 m -123.64 141.28 44.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.36 0.6 . . . . 0.0 111.949 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -116.7 172.52 7.18 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.14 -28.09 67.85 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.373 0.606 . . . . 0.0 109.477 171.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -98.86 -0.61 42.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.141 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -144.55 91.32 2.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.464 ' HB2' HG13 ' A' ' 54' ' ' VAL . 57.3 mtt180 -109.07 153.8 23.15 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.769 -174.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 8' ' ' LEU . 66.1 mt -122.78 118.48 55.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -104.58 127.28 52.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.112 0.482 . . . . 0.0 110.52 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.557 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.23 129.67 55.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.094 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.597 ' HB2' HD13 ' A' ' 81' ' ' LEU . . . -91.92 103.93 16.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.131 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -101.44 118.68 37.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.92 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -122.99 109.84 14.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.531 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 69.02 -69.93 0.15 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 124.168 0.917 . . . . 0.0 112.366 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.658 ' HG2' ' HG3' ' A' ' 47' ' ' ARG . 35.7 tt0 -94.2 -66.74 0.9 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.861 0.363 . . . . 0.0 111.381 -174.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.658 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 11.8 mtm180 -147.61 -150.79 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -174.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.557 HD22 ' HB1' ' A' ' 41' ' ' ALA . 37.8 mt -78.15 122.94 26.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.119 0.485 . . . . 0.0 110.414 -176.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.437 ' O ' ' HD3' ' A' ' 69' ' ' ARG . 32.3 tp -99.55 -25.32 14.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.076 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.538 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -152.5 163.65 39.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.636 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.29 143.43 29.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.675 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.502 ' HB ' HD13 ' A' ' 66' ' ' LEU . 11.7 p -147.02 140.52 19.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.361 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 -101.77 140.01 36.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.464 HG13 ' HB2' ' A' ' 38' ' ' ARG . 6.2 p -130.51 122.28 52.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.594 0.711 . . . . 0.0 111.653 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 39.2 m -91.33 140.5 29.71 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.859 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.2 mt -127.1 141.47 51.76 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.886 0.374 . . . . 0.0 110.862 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.7 m -144.23 84.49 1.76 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.475 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.15 -110.18 3.29 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.146 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 p -98.02 3.05 49.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.959 0.409 . . . . 0.0 111.281 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.426 ' HG2' ' HB3' ' A' ' 94' ' ' CYS . 42.7 mt-10 -112.24 151.43 29.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.397 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.08 158.25 27.37 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.567 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -134.39 123.33 23.91 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.76 0.314 . . . . 0.0 110.486 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.86 118.24 31.19 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -129.68 133.42 47.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.468 -174.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 m 64.98 100.83 0.04 OUTLIER 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.444 0.64 . . . . 0.0 111.641 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.502 HD13 ' HB ' ' A' ' 52' ' ' VAL . 56.7 tp -132.31 121.34 23.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.149 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 67' ' ' ARG . 31.1 ttt180 -144.0 131.41 20.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.994 0.426 . . . . 0.0 110.811 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.549 ' HB ' ' H10' ' A' ' 999' ' ' COA . 9.0 t -109.97 164.26 6.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.437 ' HD3' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -54.66 135.29 46.95 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 173.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -62.52 -26.52 68.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.101 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 p -77.82 -14.62 14.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.002 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.9 m -91.43 64.21 5.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.671 0.748 . . . . 0.0 111.385 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.573 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 52.2 mtt-85 -106.88 91.66 3.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.018 174.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -131.67 -9.44 3.58 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -171.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.557 ' HA ' ' O8A' ' A' ' 999' ' ' COA . 74.2 mtt180 69.16 88.37 0.11 Allowed 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.94 0.4 . . . . 0.0 109.976 -174.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 147.52 -43.05 0.86 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.459 -1.353 . . . . 0.0 114.006 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.5 t -53.44 -54.48 18.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 117.209 0.504 . . . . 0.0 111.757 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.07 -38.53 96.74 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.321 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.546 ' HG3' ' HG ' ' A' ' 115' ' ' LEU . 7.8 tt0 -62.33 -52.42 63.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.791 0.329 . . . . 0.0 110.665 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -62.38 -33.75 75.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.699 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.597 HD13 ' HB2' ' A' ' 42' ' ' ALA . 48.0 tp -54.14 -57.62 10.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.574 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.07 -41.45 95.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.572 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -54.36 -46.55 73.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.94 0.4 . . . . 0.0 111.228 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -66.06 -36.8 84.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.392 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 81' ' ' LEU . 81.2 t -66.2 -46.37 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.88 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.434 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 10.9 mp -65.79 -22.85 66.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.359 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.4 mtm-85 -89.25 -15.74 32.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.735 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.441 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 46.4 t-20 -81.87 -42.59 19.38 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 175.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -118.14 76.96 12.32 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.405 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 6.0 Cg_exo -79.0 -13.9 13.87 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.992 2.461 . . . . 0.0 112.282 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.67 -20.91 72.53 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.043 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -76.05 106.56 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.7 m -90.82 -11.78 38.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.085 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.426 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 40.2 t -131.28 95.54 3.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.88 0.371 . . . . 0.0 110.501 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 1.0 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 95.5 m95 -91.38 107.24 19.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.424 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.622 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 76.9 t-105 -97.47 130.98 44.51 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.479 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 58.9 mtp -114.48 131.82 56.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.719 0.295 . . . . 0.0 110.481 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.84 165.42 11.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.586 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -108.71 73.61 0.88 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.835 0.826 . . . . 0.0 109.115 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.77 113.59 27.28 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.521 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.51 1.02 81.37 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.91 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.97 118.23 46.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.946 0.403 . . . . 0.0 110.336 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -93.22 -20.59 20.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.341 0.591 . . . . 0.0 109.48 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -86.74 41.19 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.641 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -52.95 -43.85 66.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.053 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.7 -46.52 92.11 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.501 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.8 t -64.56 -45.26 96.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.09 0.472 . . . . 0.0 110.308 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.487 ' O ' ' HG2' ' A' ' 112' ' ' MET . 37.6 ttm -67.05 -29.2 68.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.032 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 96.9 m -61.61 -45.39 94.3 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 175.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.04 -39.35 92.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.146 0.498 . . . . 0.0 110.437 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.407 ' HA ' ' O4B' ' A' ' 999' ' ' COA . 12.4 t80 -60.52 -49.08 78.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.042 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.529 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 22.2 mmt -66.85 -35.29 79.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.132 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -71.4 -25.54 62.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.024 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.42 -38.9 54.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.92 0.39 . . . . 0.0 110.227 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.566 HD22 ' CE2' ' A' ' 117' ' ' PHE . 7.3 tt -70.72 -49.55 45.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.078 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 134.64 47.83 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.983 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.58 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 83.1 m-85 -110.43 149.2 30.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.589 0.233 . . . . 0.0 110.422 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.0 m -94.67 143.09 26.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.912 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.8 p -97.43 122.5 40.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.0 0.429 . . . . 0.0 111.093 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -120.13 -171.48 2.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.356 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -84.42 94.07 8.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.134 0.492 . . . . 0.0 110.255 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 136.52 -48.55 0.91 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.022 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -167.74 -153.16 7.91 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.279 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 15.5 m-90 -108.49 141.77 39.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.597 0.237 . . . . 0.0 110.481 -176.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -120.18 132.52 55.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.018 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 1.0 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 57.8 tptt -119.08 85.86 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 172.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 39.2 t -98.86 137.0 38.07 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.904 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 C-N-CA 120.836 -0.697 . . . . 0.9 112.07 -179.943 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 999' ' ' COA . . . . . 0.573 ' O4A' ' HA ' ' A' ' 73' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtm . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.822 0.344 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -92.76 141.94 27.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.957 0.408 . . . . 0.0 110.354 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.4 tp -75.96 106.28 7.46 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 172.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.6 m -96.64 111.46 23.59 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.655 -177.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 42' ' ' ALA . 15.7 tt -122.01 129.35 75.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-O 121.416 0.627 . . . . 0.0 110.871 -175.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -134.4 168.17 24.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.755 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -75.03 124.37 26.86 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.0 tp -89.92 78.44 6.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.343 0.592 . . . . 0.0 110.143 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.578 ' HA ' HG21 ' A' ' 33' ' ' VAL . 29.3 tt0 -86.64 -40.68 14.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.513 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -102.99 122.21 44.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.965 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -105.7 110.41 22.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.709 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.558 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 0.7 OUTLIER -80.29 168.95 18.41 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.482 ' O ' HG13 ' A' ' 17' ' ' ILE . 17.1 t70 -61.08 -45.99 92.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.751 0.31 . . . . 0.0 110.388 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.534 ' HA ' HD12 ' A' ' 17' ' ' ILE . 97.6 mt-30 -66.73 -34.87 78.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.13 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.26 -35.61 79.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.784 0.326 . . . . 0.0 110.234 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 12' ' ' SER . 42.5 mtt180 -65.93 -47.08 75.9 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 14' ' ' GLN . 69.1 mt -54.37 -48.43 68.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.99 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.555 ' O ' HG13 ' A' ' 22' ' ' ILE . 99.7 m-20 -54.69 -57.84 9.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.104 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.03 -41.18 99.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.38 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -73.43 -10.54 59.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -99.54 -25.06 14.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.075 0.465 . . . . 0.0 110.111 175.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 18' ' ' ASP . 76.4 mt -65.03 -44.35 95.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -87.85 117.48 68.52 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.467 172.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.31 -45.61 36.21 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.985 2.456 . . . . 0.0 112.92 -176.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -147.31 92.49 2.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.111 0.482 . . . . 0.0 109.849 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -154.28 135.85 14.3 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.207 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.1 p -96.38 147.93 33.71 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.849 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.63 ' HB3' HD12 ' A' ' 31' ' ' LEU . 52.4 Cg_exo -55.58 100.2 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.874 2.382 . . . . 0.0 112.404 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.2 m -131.38 -53.29 1.02 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.813 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 p -79.27 4.7 14.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.6 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.63 HD12 ' HB3' ' A' ' 28' ' ' PRO . 86.6 mt -80.59 11.53 3.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.832 0.349 . . . . 0.0 111.406 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -74.32 107.68 6.63 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 9' ' ' GLU . 16.9 m -104.35 136.42 37.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.453 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -140.23 -161.73 1.24 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.617 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -81.63 -19.83 40.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 110.222 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.18 -68.19 0.81 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -72.53 97.32 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.626 HH11 HD12 ' A' ' 56' ' ' LEU . 71.5 mtt180 -113.54 127.62 56.14 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.011 0.434 . . . . 0.0 111.163 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.703 HG12 ' HG2' ' A' ' 53' ' ' ARG . 64.5 mt -101.88 119.34 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.804 176.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.449 ' HB3' HD11 ' A' ' 5' ' ' ILE . 80.6 m-85 -98.78 133.6 42.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.96 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.497 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.09 113.38 26.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.283 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.773 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -98.42 110.83 23.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.387 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.555 ' HB3' HD23 ' A' ' 48' ' ' LEU . 23.8 ptt180 -107.94 134.12 51.31 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.225 0.536 . . . . 0.0 110.257 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -97.15 94.2 6.99 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.793 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.747 HD22 ' HG3' ' A' ' 46' ' ' GLU . 9.3 t30 72.25 -46.98 0.66 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.142 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.747 ' HG3' HD22 ' A' ' 45' ' ' ASN . 46.0 mt-10 -128.21 -67.83 0.79 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.362 . . . . 0.0 111.848 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -104.55 162.21 13.45 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.966 -170.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.555 HD23 ' HB3' ' A' ' 43' ' ' ARG . 92.3 mt -59.87 127.42 31.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.34 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.707 HD23 HG11 ' A' ' 77' ' ' VAL . 31.3 tp -115.95 -29.49 6.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.489 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.773 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -136.61 139.74 42.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.822 0.344 . . . . 0.0 111.41 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.63 116.66 22.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.843 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 40' ' ' TYR . 7.4 p -124.51 131.34 72.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.396 0.617 . . . . 0.0 111.315 -177.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.703 ' HG2' HG12 ' A' ' 39' ' ' ILE . 41.3 mtp-105 -107.75 119.05 38.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.645 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.48 128.62 68.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.405 0.621 . . . . 0.0 110.821 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.0 m -94.11 100.88 12.9 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.94 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.626 HD12 HH11 ' A' ' 38' ' ' ARG . 93.3 mt -87.04 86.54 7.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.639 177.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -95.92 105.87 17.95 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.383 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.15 -113.54 4.75 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.553 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 p -113.16 8.67 18.31 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.894 0.378 . . . . 0.0 110.939 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -107.75 137.96 44.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.312 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.47 114.22 3.0 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.923 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -111.37 128.93 56.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.562 0.22 . . . . 0.0 110.47 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.502 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 6.9 mp -93.49 108.49 20.17 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.378 0.609 . . . . 0.0 109.611 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.54 -28.43 33.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.809 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.6 m -152.4 127.77 9.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.663 0.268 . . . . 0.0 110.965 -176.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.4 tp -131.28 109.68 10.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.736 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -143.27 109.38 5.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.17 0.51 . . . . 0.0 110.853 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.596 HG13 ' HB2' ' A' ' 50' ' ' ALA . 12.4 t -97.7 157.8 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -58.22 146.45 33.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 0.0 110.707 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -52.02 -35.5 47.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.484 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -75.98 7.9 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.469 0.652 . . . . 0.0 111.487 -175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.49 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 1.8 m -103.91 8.93 36.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.618 0.723 . . . . 0.0 110.238 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.9 ttp85 -65.74 107.19 1.7 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.614 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 61.58 91.38 0.06 Allowed 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.606 0.567 . . . . 0.0 110.093 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -164.42 -42.81 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.044 -170.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.6 -24.34 6.85 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.435 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.707 HG11 HD23 ' A' ' 49' ' ' LEU . 84.5 t -55.38 -42.54 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -177.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.25 -31.82 70.49 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.006 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.545 ' HA ' HD21 ' A' ' 115' ' ' LEU . 53.0 tt0 -65.16 -43.85 90.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -69.0 -36.87 78.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.42 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.499 ' O ' HG23 ' A' ' 85' ' ' VAL . 63.2 tp -49.29 -58.72 4.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.268 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.17 -33.21 75.47 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.95 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -58.26 -54.04 51.53 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.646 0.26 . . . . 0.0 110.817 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HG2' HG22 ' A' ' 5' ' ' ILE . 6.4 tp10 -64.38 -36.78 85.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.162 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 81' ' ' LEU . 93.3 t -61.37 -49.15 85.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.912 0.387 . . . . 0.0 110.763 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.473 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 10.4 mp -78.18 -4.59 48.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.088 0.47 . . . . 0.0 110.938 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -87.76 -38.54 15.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.943 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -71.1 -37.96 72.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.097 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.433 ' O ' ' HZ2' ' A' ' 95' ' ' TRP . 20.1 m120 -120.12 74.48 21.15 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.883 176.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -88.09 -3.42 7.03 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.741 2.294 . . . . 0.0 113.733 -173.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -94.25 19.33 53.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.851 -175.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.402 ' HB ' ' CE2' ' A' ' 95' ' ' TRP . 55.7 t -107.17 125.14 63.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.0 m -91.76 -42.92 9.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.902 0.382 . . . . 0.0 110.779 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 40.6 t -104.43 96.46 6.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.051 0.453 . . . . 0.0 110.558 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.473 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 86.5 m95 -90.87 131.0 36.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.94 175.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.642 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 67.9 t-105 -120.66 133.44 55.36 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.502 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 75.2 mtp -119.15 124.84 47.82 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -84.46 173.39 10.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.832 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -57.57 -35.28 70.17 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.077 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.459 ' HB3' HG23 ' A' ' 102' ' ' VAL . . . 63.99 11.74 6.34 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.919 175.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.59 12.21 84.72 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.803 -176.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.717 HG22 ' C3P' ' A' ' 999' ' ' COA . 45.2 t -80.85 101.49 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.962 0.41 . . . . 0.0 110.281 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -89.08 -1.37 58.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.463 0.649 . . . . 0.0 109.724 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -85.75 44.45 1.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.084 172.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -56.33 -41.69 76.47 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.2 -173.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -51.95 -54.21 26.72 Favored Glycine 0 C--O 1.236 0.275 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.706 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.2 t -66.73 -43.38 90.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.931 0.396 . . . . 0.0 111.009 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.56 ' O ' ' HG2' ' A' ' 112' ' ' MET . 34.8 ttm -69.75 -35.66 75.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.868 -176.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 33.7 m -66.58 -36.93 83.82 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.402 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.94 -37.46 86.08 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.285 0.564 . . . . 0.0 109.922 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.41 ' HB3' ' O ' ' A' ' 108' ' ' MET . 59.9 t80 -61.15 -46.63 89.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.524 174.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 108' ' ' MET . 24.5 mmt -58.77 -43.85 90.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.734 178.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -62.33 -33.93 75.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.985 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.54 -36.2 68.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.247 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.545 HD21 ' HA ' ' A' ' 79' ' ' GLN . 11.1 mp -90.66 7.98 36.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.34 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.24 68.09 1.68 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.82 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.515 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 57.9 m-85 -117.85 151.6 37.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.135 0.493 . . . . 0.0 111.026 177.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.697 ' HB ' ' HB2' ' A' ' 125' ' ' GLU . 24.3 m -91.4 136.0 33.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.37 176.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 41.7 p -101.29 108.65 20.35 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.423 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -95.96 160.57 14.39 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 172.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -78.86 88.01 4.7 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.253 0.549 . . . . 0.0 109.767 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 125.98 3.84 6.81 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.884 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.444 ' HA3' ' CZ2' ' A' ' 96' ' ' TRP . . . 173.15 173.59 39.63 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.358 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -116.0 150.65 36.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.697 ' HB2' ' HB ' ' A' ' 118' ' ' THR . 53.1 mt-10 -126.51 156.38 40.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.774 0.321 . . . . 0.0 111.03 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.425 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 56.2 tttp -137.35 121.2 17.55 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 167.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.7 t -86.31 105.27 16.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.148 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 CA-C-N 115.884 -0.598 . . . . 0.9 112.43 -179.76 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 999' ' ' COA . . . . . 0.717 ' C3P' HG22 ' A' ' 102' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.3 mtp . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.867 0.365 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -108.99 118.1 35.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.373 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.508 HD11 ' HB1' ' A' ' 42' ' ' ALA . 59.7 tp -83.82 111.69 19.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 43' ' ' ARG . 7.2 m -82.78 89.56 6.8 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.215 0.531 . . . . 0.0 109.794 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 15.9 tt -102.65 118.78 50.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.415 0.626 . . . . 0.0 109.982 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.8 mt -114.87 150.96 16.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.416 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.522 ' HB3' ' CE2' ' A' ' 40' ' ' TYR . 17.1 ptt180 -91.61 119.07 31.19 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.567 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.79 72.91 1.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.127 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -96.15 -9.06 31.54 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 171.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -143.08 143.68 31.95 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.1 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -124.63 145.96 49.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.142 0.496 . . . . 0.0 111.571 -173.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -119.31 177.52 4.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 172.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -75.06 -34.53 61.83 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.487 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -64.7 -53.79 41.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.583 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -62.69 -31.86 72.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.738 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -63.24 -40.25 96.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.833 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.1 mt -77.94 -26.0 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.948 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.5 ' HB3' HD12 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -72.67 -35.53 67.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.968 0.413 . . . . 0.0 110.362 174.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.04 -30.65 71.71 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 170.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -72.08 -21.92 61.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.536 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -72.59 -33.55 66.81 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.413 HG23 HH11 ' A' ' 67' ' ' ARG . 48.4 mm -75.4 -51.73 20.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.188 175.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -119.27 110.29 37.87 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.112 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.79 -16.21 26.44 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 122.684 2.256 . . . . 0.0 111.762 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -137.25 86.05 2.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.991 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.444 ' CE2' HD11 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -133.25 135.68 45.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.822 -176.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.2 m -96.18 143.17 25.66 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.297 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.08 -15.04 31.46 Favored 'Trans proline' 0 N--CA 1.475 0.394 0 C-N-CA 123.472 2.782 . . . . 0.0 114.024 -174.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.0 m -62.29 -28.38 69.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.902 0.382 . . . . 0.0 111.192 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.1 p -85.65 -16.44 39.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.973 0.416 . . . . 0.0 110.614 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.444 HD11 ' CE2' ' A' ' 26' ' ' TYR . 84.3 mt -86.27 -2.99 58.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.844 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.35 95.43 1.03 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.931 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -102.55 165.17 3.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.284 0.564 . . . . 0.0 111.94 -174.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.75 -164.51 0.91 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.049 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.54 -24.41 61.12 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.546 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 33.9 m-80 -87.15 -62.78 1.43 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.607 ' HB2' HG23 ' A' ' 55' ' ' THR . 77.9 t60 -87.0 97.98 11.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 0.0 110.12 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -111.73 148.68 32.95 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.516 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.593 HG12 ' HG2' ' A' ' 53' ' ' ARG . 68.9 mt -115.46 118.06 57.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 7' ' ' ARG . 79.1 m-85 -103.01 122.43 44.6 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.419 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -112.91 128.71 56.54 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.906 0.384 . . . . 0.0 110.884 -177.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.22 103.96 16.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.21 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.425 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 14.7 ttt85 -85.74 104.64 15.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.569 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -123.95 115.39 21.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.913 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 61.97 60.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.645 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 67.92 10.38 7.76 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 170.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -149.5 155.89 41.09 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.345 -0.242 . . . . 0.0 110.345 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 18' ' ' ASP . 69.1 mt -75.82 110.99 10.71 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 173.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.6 tp -94.61 -26.96 16.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.332 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.712 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -137.49 145.03 42.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.217 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.39 121.66 21.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.255 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.496 HG13 ' HB2' ' A' ' 40' ' ' TYR . 7.6 p -126.2 121.09 58.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.35 0.595 . . . . 0.0 110.551 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.779 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 9.8 mtp180 -103.08 138.96 39.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.108 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -137.76 135.9 45.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.954 0.407 . . . . 0.0 110.31 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.607 HG23 ' HB2' ' A' ' 37' ' ' HIS . 6.7 m -117.91 100.64 7.71 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.127 0.489 . . . . 0.0 110.124 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.63 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 49.0 mt -78.52 160.84 27.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.371 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.6 m -154.43 83.4 1.12 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.154 0.502 . . . . 0.0 109.652 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.9 -120.54 8.78 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.289 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 p -82.26 -6.84 59.51 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.015 0.436 . . . . 0.0 111.504 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.545 ' HG2' ' HB3' ' A' ' 94' ' ' CYS . 44.8 mt-10 -112.41 159.98 18.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.33 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 56' ' ' LEU . . . -153.74 116.07 0.71 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.563 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -98.86 140.87 32.38 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.38 130.74 39.06 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.779 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 3.4 t70 -120.49 99.26 6.46 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.95 -171.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.8 t 70.72 111.41 0.06 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.954 0.883 . . . . 0.0 111.905 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.438 ' O ' ' C5P' ' A' ' 999' ' ' COA . 35.1 tp -117.25 126.01 52.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.481 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.413 HH11 HG23 ' A' ' 22' ' ' ILE . 68.0 ttt-85 -143.84 110.98 5.77 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.959 178.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.564 HG13 ' HB2' ' A' ' 50' ' ' ALA . 17.1 t -98.32 146.31 8.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 166.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 69' ' ' ARG . 16.0 ttt180 -57.42 136.53 56.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -54.89 -27.87 46.22 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.325 0.65 . . . . 0.0 112.554 -168.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.8 t -69.38 -14.31 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.351 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.11 18.47 9.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.334 0.587 . . . . 0.0 110.669 -177.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -62.32 119.45 9.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.496 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.543 ' HA ' ' O8A' ' A' ' 999' ' ' COA . 66.4 mtt-85 63.89 67.88 0.6 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.326 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -165.56 59.16 0.11 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.83 -59.45 1.33 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 115.724 1.05 . . . . 0.0 115.724 167.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.1 t -42.77 -50.51 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -167.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.78 -49.0 73.68 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.987 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.602 ' HA ' HD21 ' A' ' 115' ' ' LEU . 46.3 tt0 -68.28 -39.1 82.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.991 0.424 . . . . 0.0 110.402 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -61.01 -45.82 93.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.158 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 42' ' ' ALA . 1.2 mp -51.85 -57.56 8.99 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.817 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.521 HD11 ' HE1' ' A' ' 97' ' ' MET . 4.0 mm? -56.19 -48.27 76.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.434 -176.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -69.04 -33.9 74.35 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.437 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -65.02 -42.67 94.18 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.012 0.434 . . . . 0.0 110.206 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 81' ' ' LEU . 88.2 t -62.56 -48.66 87.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.713 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.2 -20.53 65.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.15 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -80.34 -52.89 7.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.175 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.402 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 66.0 t30 -73.51 -19.12 61.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.621 -172.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -113.57 83.5 7.12 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 86.4 Cg_endo -86.0 -0.67 8.56 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.641 2.227 . . . . 0.0 113.153 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -82.96 -14.89 74.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.371 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.545 HG21 HD22 ' A' ' 56' ' ' LEU . 38.5 t -92.06 120.94 42.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.811 0.339 . . . . 0.0 110.309 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 128' ' ' GLY . 7.4 t -96.89 -26.14 15.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.431 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.545 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 22.9 t -118.44 104.88 11.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.536 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.429 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 91.9 m95 -96.47 112.35 24.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.424 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.411 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 76.8 t-105 -100.85 134.17 44.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.714 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.702 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 92.1 mmm -106.95 106.59 17.19 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.17 141.31 29.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.004 0.43 . . . . 0.0 110.788 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 102' ' ' VAL . 19.1 p-10 -90.23 -46.46 8.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.535 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 66.24 -66.06 0.18 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.476 0.71 . . . . 0.0 111.786 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -145.0 37.5 1.33 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.165 -0.54 . . . . 0.0 111.863 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 99' ' ' ASP . 75.0 t -82.84 105.95 13.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.988 0.423 . . . . 0.0 110.342 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -85.52 -34.22 21.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.914 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.57 56.87 2.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.151 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -61.04 -42.66 98.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.112 -175.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.28 -52.77 47.12 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.549 -177.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.79 -45.15 87.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.0 111.129 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.56 ' O ' ' HG2' ' A' ' 112' ' ' MET . 69.3 mtp -75.5 -23.31 56.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.957 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 80.9 m -71.41 -39.28 71.22 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.136 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.4 -39.84 92.21 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.247 0.546 . . . . 0.0 109.664 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -60.56 -52.88 63.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.765 174.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 108' ' ' MET . 25.5 mmt -58.03 -45.87 86.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.416 -177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -65.02 -30.54 71.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.945 0.402 . . . . 0.0 110.815 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.64 -23.22 61.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.872 0.368 . . . . 0.0 110.814 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.602 HD21 ' HA ' ' A' ' 79' ' ' GLN . 11.2 mp -98.0 4.73 49.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.016 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.99 23.27 52.9 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.462 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.555 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 88.8 m-85 -91.73 141.55 28.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 117.026 0.413 . . . . 0.0 110.413 176.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.7 m -96.27 132.63 41.54 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.383 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.438 ' HB ' ' CD1' ' A' ' 124' ' ' TRP . 3.0 t -97.29 126.88 42.79 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -121.01 -72.75 0.67 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.459 0.647 . . . . 0.0 110.745 -174.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -116.87 -142.91 0.37 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.752 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.94 62.73 0.72 Allowed Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.533 170.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.04 164.88 14.57 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.702 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 14.4 m-90 -112.98 157.15 21.86 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -141.09 139.37 34.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.792 0.329 . . . . 0.0 110.543 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 95' ' ' TRP . 86.3 tttt -137.01 122.82 19.99 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 31.2 t -74.2 142.01 45.43 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.895 0.379 . . . . 0.0 110.719 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 93' ' ' SER . . . . . . . . 0 N--CA 1.448 -0.5 0 CA-C-N 116.105 -0.498 . . . . 0.9 111.992 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 999' ' ' COA . . . . . 0.543 ' O8A' ' HA ' ' A' ' 74' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 121.021 0.439 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -121.84 129.75 52.85 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.513 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.526 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 54.4 tp -75.71 108.33 8.48 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.429 ' HB ' ' HG3' ' A' ' 43' ' ' ARG . 14.0 m -82.85 92.86 7.36 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.205 0.526 . . . . 0.0 110.579 -173.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.641 HD11 ' HB3' ' A' ' 40' ' ' TYR . 7.9 tp -89.92 113.49 26.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.694 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.5 mt -121.1 157.48 24.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.096 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 47.7 ttt-85 -90.25 125.23 35.42 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.08 128.12 35.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.218 0.533 . . . . 0.0 111.717 -177.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -102.5 -51.49 3.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.718 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -124.39 164.18 20.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.241 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -136.46 114.02 10.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.637 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.7 p -93.16 175.18 6.87 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 170.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.88 -38.16 81.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.782 0.325 . . . . 0.0 110.667 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -64.68 -44.97 88.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.517 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -61.79 -49.77 75.03 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.179 0.514 . . . . 0.0 110.14 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -58.88 -47.1 86.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.069 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.8 mt -67.37 -36.38 76.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.54 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -68.79 -41.33 78.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.04 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.76 -43.47 93.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.727 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -77.33 -1.4 29.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.427 0.632 . . . . 0.0 110.284 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -93.34 -33.5 13.87 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.5 mt -68.94 -44.65 81.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.435 174.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -100.48 97.03 5.88 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 170.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.48 20.51 0.25 Allowed 'Trans proline' 0 N--CA 1.476 0.454 0 C-N-CA 123.176 2.584 . . . . 0.0 114.189 -169.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -157.5 -81.09 0.06 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.5 t80 60.8 -173.59 0.13 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 123.773 0.67 . . . . 0.0 110.812 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.3 m -116.09 140.68 26.65 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-O 120.564 0.221 . . . . 0.0 110.599 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.36 137.52 56.13 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.6 2.2 . . . . 0.0 112.014 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.8 t 71.43 -1.42 2.77 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.036 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 m -83.73 4.97 26.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.93 0.395 . . . . 0.0 111.193 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.8 mt -85.11 21.81 1.57 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.093 0.473 . . . . 0.0 110.376 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -73.34 141.1 47.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.062 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.1 149.56 24.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.95 0.405 . . . . 0.0 110.76 -177.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -147.95 -162.38 1.54 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -84.57 -24.2 29.33 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.955 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -86.01 -49.99 7.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.396 0.617 . . . . 0.0 109.416 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -94.01 101.48 13.52 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -109.1 137.75 46.52 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.02 0.438 . . . . 0.0 111.41 -173.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.542 HG12 ' HG2' ' A' ' 53' ' ' ARG . 57.8 mt -108.18 112.37 39.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 170.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.641 ' HB3' HD11 ' A' ' 5' ' ' ILE . 11.7 m-85 -94.27 137.02 33.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.982 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.579 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -118.66 116.31 26.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.47 -176.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.662 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.31 91.51 7.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.68 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.552 ' HB3' HD23 ' A' ' 48' ' ' LEU . 13.5 ptm180 -92.21 133.02 36.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.573 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -108.94 99.43 8.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.716 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 67.22 -69.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.309 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -101.17 -59.82 1.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -170.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -132.81 -177.51 4.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.942 0.401 . . . . 0.0 111.944 -171.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.579 HD22 ' HB1' ' A' ' 41' ' ' ALA . 21.8 mt -78.32 113.32 16.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.219 -171.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.447 HD12 ' HD2' ' A' ' 69' ' ' ARG . 46.5 tp -89.72 -30.43 18.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.943 0.401 . . . . 0.0 110.736 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.662 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -142.49 146.48 34.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.777 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -133.62 133.81 42.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.483 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.465 ' HB ' HD13 ' A' ' 66' ' ' LEU . 10.2 p -148.34 140.58 18.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.962 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.663 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 23.8 mtp85 -100.07 150.91 21.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.235 175.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 11.9 p -151.22 138.93 13.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.011 0.434 . . . . 0.0 110.779 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.1 m -111.99 115.82 29.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.769 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.3 mt -99.45 86.87 3.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.3 0.571 . . . . 0.0 110.744 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -95.08 77.98 3.53 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.207 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.81 -85.98 0.28 Allowed Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.879 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.6 p -114.9 -2.22 12.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.962 0.411 . . . . 0.0 111.135 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -104.31 125.69 50.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.487 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.37 96.24 0.72 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -98.48 113.57 25.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.796 0.331 . . . . 0.0 111.153 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.556 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 5.9 mp -93.87 116.55 29.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.224 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.663 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 22.2 m-20 -109.38 131.59 54.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.692 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.8 m 61.11 98.89 0.03 OUTLIER 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.573 0.701 . . . . 0.0 112.06 175.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.465 HD13 ' HB ' ' A' ' 52' ' ' VAL . 22.2 tp -123.89 118.28 26.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.099 177.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.422 ' HA ' ' O9P' ' A' ' 999' ' ' COA . 26.7 ttt180 -143.98 139.26 28.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.196 0.522 . . . . 0.0 111.223 174.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.438 HG12 ' HB2' ' A' ' 50' ' ' ALA . 18.1 m -101.71 169.26 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.868 173.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.447 ' HD2' HD12 ' A' ' 49' ' ' LEU . 95.2 mtt180 -65.75 157.18 30.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 172.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 6.6 tp10 -56.5 -39.08 72.66 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -172.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.79 36.5 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.148 0.499 . . . . 0.0 110.65 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 m -127.21 4.91 6.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.3 0.571 . . . . 0.0 110.944 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 8.4 mtm180 -81.1 130.14 34.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.74 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.9 mtp-105 62.55 36.56 13.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.261 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -125.43 17.91 8.22 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.761 -0.376 . . . . 0.0 112.012 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.08 -37.98 2.18 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.08 -0.581 . . . . 0.0 114.438 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.5 t -48.33 -44.83 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.78 97.57 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.878 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.457 ' HG3' HD23 ' A' ' 115' ' ' LEU . 53.2 tt0 -65.35 -39.21 92.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.033 0.444 . . . . 0.0 110.027 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.526 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 30.0 t80 -59.05 -49.35 78.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.238 175.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.582 HD11 HD13 ' A' ' 5' ' ' ILE . 51.6 tp -50.82 -54.12 26.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.064 -176.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.424 ' O ' HD13 ' A' ' 86' ' ' LEU . 3.9 mm? -63.73 -50.42 69.19 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.396 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -66.21 -25.86 67.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.584 -176.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -65.97 -46.8 76.76 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 81' ' ' LEU . 57.9 t -62.67 -44.41 99.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.952 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.467 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 11.2 mp -65.99 -27.9 68.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.244 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.8 ttp85 -87.6 -19.31 27.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.583 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.475 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 9.7 t30 -81.62 -46.24 14.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.663 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -102.82 97.83 10.11 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.981 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 83.0 Cg_endo -89.41 148.48 5.28 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.809 2.339 . . . . 0.0 113.498 -173.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.83 7.26 78.43 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.689 -0.687 . . . . 0.0 113.481 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.72 116.73 20.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.1 m -77.49 -32.41 54.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.18 -172.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.0 t -127.49 103.88 7.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.768 0.318 . . . . 0.0 111.458 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.467 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 98.0 m95 -94.41 98.32 10.8 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 171.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.507 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 63.6 t-105 -101.96 120.48 40.47 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.081 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.556 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 73.6 mtp -111.75 126.74 55.38 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.927 0.394 . . . . 0.0 110.571 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.63 99.17 5.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.133 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' A' ' 102' ' ' VAL . 7.7 m-20 -76.37 -31.86 58.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.602 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 67.93 -71.54 0.11 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.004 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -101.53 40.68 2.34 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.978 -174.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.524 HG13 ' HG2' ' A' ' 105' ' ' ARG . 13.2 p -81.7 125.43 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -90.38 -30.7 17.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.189 0.519 . . . . 0.0 109.724 177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.15 45.63 0.75 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.387 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.524 ' HG2' HG13 ' A' ' 102' ' ' VAL . 22.0 mtm180 -55.21 -47.08 75.82 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -172.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.76 -48.28 85.06 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.406 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.16 -41.77 92.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 110.653 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.501 ' O ' ' HG2' ' A' ' 112' ' ' MET . 10.3 tpt -64.75 -39.03 92.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.378 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 85.5 m -65.02 -38.84 92.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.702 0.287 . . . . 0.0 110.698 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.58 ' HB1' ' N7A' ' A' ' 999' ' ' COA . . . -62.6 -41.48 99.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.204 0.525 . . . . 0.0 110.137 176.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -63.15 -42.4 99.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.337 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.535 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 24.7 mmt -61.71 -39.33 91.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.024 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -70.74 -21.15 62.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.252 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.98 -26.72 39.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.115 0.483 . . . . 0.0 110.375 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.457 HD23 ' HG3' ' A' ' 79' ' ' GLN . 92.1 mt -84.51 -37.76 20.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.572 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.08 25.98 3.39 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.311 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.535 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 39.7 m-85 -95.9 142.49 28.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.798 0.332 . . . . 0.0 110.99 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.6 m -104.74 148.45 26.59 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.9 m -97.19 112.23 24.12 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -135.46 133.89 39.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.484 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 58.13 30.02 18.75 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.82 -4.03 78.33 Favored Glycine 0 CA--C 1.517 0.172 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.237 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -129.17 -179.46 15.97 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.259 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.436 ' CD1' ' HG3' ' A' ' 112' ' ' MET . 26.6 m-90 -112.22 137.49 50.24 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -132.52 137.24 47.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.024 0.44 . . . . 0.0 110.982 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -119.4 102.54 8.75 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 169.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 49.5 t -78.11 141.61 38.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.754 -174.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 CA-C-N 115.829 -0.623 . . . . 0.9 111.723 178.498 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 999' ' ' COA . . . . . 0.58 ' N7A' ' HB1' ' A' ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.3 mtp . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 tttm -90.49 152.03 21.11 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.5 tp -75.73 115.81 15.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.013 0.435 . . . . 0.0 110.311 -175.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.3 m -88.37 89.56 8.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.312 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.505 HD11 ' HB3' ' A' ' 40' ' ' TYR . 9.4 tt -96.23 132.57 40.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.003 0.43 . . . . 0.0 110.357 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.82 141.08 44.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.226 0.536 . . . . 0.0 110.625 -177.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 7' ' ' ARG . 10.9 ptt180 -79.33 126.9 31.4 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.745 176.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.9 mt -84.62 95.46 8.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.789 0.328 . . . . 0.0 110.824 -176.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -110.49 -8.27 14.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.0 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -135.1 141.37 46.01 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -130.03 115.68 17.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.143 0.497 . . . . 0.0 112.276 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.3 m -100.08 164.18 12.1 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 168.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -59.9 -37.98 80.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.623 0.249 . . . . 0.0 110.855 -177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -55.14 -49.99 70.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.121 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -67.1 -37.91 84.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.639 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -68.13 -40.61 82.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.059 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.8 mt -61.68 -36.6 74.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.795 0.331 . . . . 0.0 110.383 176.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.8 OUTLIER -64.37 -44.18 92.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.153 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.83 -40.0 96.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.93 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -72.52 -15.84 61.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.078 0.466 . . . . 0.0 110.568 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -84.76 -27.84 26.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.684 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 18' ' ' ASP . 62.2 mt -82.66 -37.28 14.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.9 175.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.635 ' HD1' ' HD2' ' A' ' 67' ' ' ARG . 2.8 m0 -111.26 87.15 7.12 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.782 175.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.76 -9.57 25.08 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.499 2.133 . . . . 0.0 112.398 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -102.88 2.78 35.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.903 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -74.05 127.22 32.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.379 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.9 m -67.81 124.21 88.86 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.54 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.32 115.77 2.61 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.821 2.347 . . . . 0.0 111.873 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.3 p -152.37 -166.3 2.44 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.876 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.3 m -55.27 -43.23 74.49 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.393 0.433 . . . . 0.0 112.122 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 31' ' ' LEU . 7.1 mt 57.11 76.83 0.29 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.528 0.68 . . . . 0.0 109.727 -169.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -133.8 -179.58 5.63 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.078 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.7 m -130.98 162.29 39.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.263 0.554 . . . . 0.0 111.084 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -125.64 163.52 22.6 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -60.68 -28.21 68.44 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.897 0.379 . . . . 0.0 110.533 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -93.29 -46.06 7.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.253 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -93.52 94.13 8.48 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.015 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.3 mtp85 -110.95 149.49 30.58 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.642 0.258 . . . . 0.0 110.971 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.4 mt -120.09 134.46 63.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.284 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.505 ' HB3' HD11 ' A' ' 5' ' ' ILE . 81.8 m-85 -113.84 139.52 49.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.572 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -119.57 121.34 39.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.939 0.4 . . . . 0.0 110.793 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.18 100.51 13.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.798 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -93.33 119.75 32.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.591 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -99.01 92.23 5.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.014 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.8 t30 69.36 -68.17 0.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.051 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -105.84 -53.29 2.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.783 0.325 . . . . 0.0 111.758 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.437 ' HG2' ' H ' ' A' ' 48' ' ' LEU . 35.7 ttt180 -127.47 174.18 9.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.727 -168.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.572 HD22 ' HB1' ' A' ' 41' ' ' ALA . 63.5 mt -73.17 123.74 24.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.876 0.37 . . . . 0.0 110.355 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.687 HD12 ' HD3' ' A' ' 69' ' ' ARG . 39.9 tp -95.04 -34.11 12.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.16 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.554 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -143.22 140.52 30.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.665 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.82 130.49 51.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.182 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 65' ' ' SER . 11.9 p -142.46 142.27 27.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.706 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.1 mtm180 -112.4 159.03 19.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.891 0.376 . . . . 0.0 110.735 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.59 128.99 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.356 0.598 . . . . 0.0 110.857 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.5 m -104.83 97.98 7.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.011 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.531 HD23 ' HA3' ' A' ' 61' ' ' GLY . 97.4 mt -80.34 126.14 30.78 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.779 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.5 m -105.79 77.99 1.3 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.87 -85.93 1.37 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.271 -174.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.2 p -111.32 -63.33 1.42 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.197 0.523 . . . . 0.0 110.452 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.567 ' HA ' HG13 ' A' ' 92' ' ' VAL . 30.1 mt-10 -76.04 147.51 38.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.811 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.531 ' HA3' HD23 ' A' ' 56' ' ' LEU . . . -142.21 165.46 26.65 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.504 -173.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -116.38 134.03 55.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.794 0.33 . . . . 0.0 110.887 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 76.7 mt -93.83 132.93 37.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.452 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -142.77 163.48 32.7 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 36.0 m 54.59 86.61 0.05 OUTLIER 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.64 0.588 . . . . 0.0 111.732 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.603 HD23 ' HE1' ' A' ' 108' ' ' MET . 55.9 tp -122.51 107.02 11.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.832 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.635 ' HD2' ' HD1' ' A' ' 23' ' ' TRP . 34.8 mtt180 -130.18 105.82 8.19 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.215 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.582 ' HB ' ' H10' ' A' ' 999' ' ' COA . 8.9 t -95.91 146.95 6.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 171.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.687 ' HD3' HD12 ' A' ' 49' ' ' LEU . 31.1 mtp85 -52.51 126.32 19.12 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -58.03 -23.1 52.91 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -169.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.4 t -66.29 -21.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.052 0.453 . . . . 0.0 110.765 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.734 ' HA ' ' HD2' ' A' ' 75' ' ' ARG . 1.3 m -86.47 32.22 0.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.406 0.622 . . . . 0.0 110.907 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 73' ' ' ARG . 25.7 ttt180 -81.44 127.95 33.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.84 -176.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.637 ' HA ' ' O8A' ' A' ' 999' ' ' COA . 32.3 ttm180 61.35 35.79 17.8 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.898 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.734 ' HD2' ' HA ' ' A' ' 72' ' ' THR . 95.3 mtt180 -112.91 2.69 15.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.807 -178.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.52 -12.18 52.8 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 121.003 -0.618 . . . . 0.0 114.105 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.447 HG11 HD23 ' A' ' 49' ' ' LEU . 92.8 t -61.24 -43.88 97.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.275 0.538 . . . . 0.0 111.773 -177.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.57 -33.93 79.21 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.441 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -63.01 -47.44 83.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.953 0.406 . . . . 0.0 110.278 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -61.76 -43.31 99.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.594 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 42' ' ' ALA . 44.2 tp -53.44 -55.86 21.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.443 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.487 ' HB2' HD11 ' A' ' 115' ' ' LEU . 4.3 mm? -65.68 -40.39 92.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.053 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 7.3 mm-40 -53.46 -50.74 64.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.79 0.329 . . . . 0.0 111.145 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -60.49 -45.36 94.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.8 -177.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.3 t -63.56 -49.46 82.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.174 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.59 -20.3 66.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.997 -176.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 42.8 mtm180 -92.91 -30.19 15.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.657 0.265 . . . . 0.0 111.257 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.46 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 17.3 m-80 -82.09 -20.14 38.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.606 0.241 . . . . 0.0 111.415 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -113.69 86.83 11.16 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.87 0.367 . . . . 0.0 110.443 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 88' ' ' ASN . 5.0 Cg_exo -81.05 -13.45 11.41 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.227 2.618 . . . . 0.0 112.528 -176.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.05 -8.38 87.89 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.497 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.567 HG13 ' HA ' ' A' ' 60' ' ' GLU . 21.7 t -94.47 101.98 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 p -77.92 -36.16 49.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 51.6 t -116.36 116.04 26.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.389 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -97.86 102.13 13.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.899 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.519 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 35.8 t-105 -97.08 133.29 41.94 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.552 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 47.1 mtp -114.36 130.03 56.67 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.992 0.425 . . . . 0.0 109.982 176.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.5 160.75 14.65 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.646 -176.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -87.22 -2.48 58.65 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.985 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.47 114.23 5.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.292 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.57 -14.25 59.28 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.72 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.548 HG13 ' HG3' ' A' ' 108' ' ' MET . 55.1 t -89.76 97.63 7.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.352 0.596 . . . . 0.0 110.125 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.418 ' H ' ' H22' ' A' ' 999' ' ' COA . 30.4 mt-10 -76.78 -50.46 13.47 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.77 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -91.09 92.92 8.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.658 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -73.56 -23.76 60.01 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.899 -176.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.25 -56.16 8.15 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.567 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.46 HG13 ' C6A' ' A' ' 999' ' ' COA . 72.3 t -66.15 -41.1 88.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.654 0.264 . . . . 0.0 110.68 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.603 ' HE1' HD23 ' A' ' 66' ' ' LEU . 94.8 mmm -63.72 -37.72 88.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.326 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 m -62.58 -45.88 90.88 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.425 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.58 -40.58 95.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.969 0.414 . . . . 0.0 110.617 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.615 ' HD1' H52A ' A' ' 999' ' ' COA . 40.7 t80 -58.72 -49.18 78.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.825 176.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.56 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 64.9 mtt -69.76 -40.22 76.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.511 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -61.4 -44.01 97.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.77 0.319 . . . . 0.0 110.686 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.27 72.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.188 0.518 . . . . 0.0 110.437 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.487 HD11 ' HB2' ' A' ' 82' ' ' LEU . 2.7 tt -68.19 -33.41 74.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.92 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 132.75 1.59 4.13 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.065 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.56 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 98.3 m-85 -83.19 174.1 11.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.039 0.447 . . . . 0.0 110.863 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.1 m -149.73 151.35 33.5 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.7 t -97.3 110.21 22.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.698 0.761 . . . . 0.0 109.794 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -141.25 129.11 21.77 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.286 -174.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.436 HE21 ' HB2' ' A' ' 121' ' ' GLN . 0.9 OUTLIER 63.42 32.68 14.31 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.208 0.528 . . . . 0.0 111.361 176.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 111.14 -74.41 0.21 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.562 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -91.09 -156.52 32.79 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.295 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 26.6 m-90 -104.37 119.85 39.89 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -119.36 117.83 29.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.903 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -126.34 136.56 52.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.921 0.391 . . . . 0.0 111.181 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 52.6 t -80.55 135.16 36.04 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.775 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 C-N-CA 120.877 -0.677 . . . . 0.9 112.137 179.464 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 999' ' ' COA . . . . . 0.637 ' O8A' ' HA ' ' A' ' 74' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.4 mtm . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.549 0.214 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -103.68 153.33 20.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.887 0.375 . . . . 0.0 110.18 174.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.447 HD21 ' HB1' ' A' ' 42' ' ' ALA . 43.8 tp -111.4 112.18 23.74 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.111 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.1 m -82.76 94.04 7.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.084 0.469 . . . . 0.0 110.532 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.539 HD12 ' HB2' ' A' ' 42' ' ' ALA . 12.7 tt -108.7 128.84 64.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.045 0.45 . . . . 0.0 110.788 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.4 mt -124.19 155.31 31.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.455 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.459 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 12.8 ptt180 -80.22 119.56 23.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.801 174.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 41' ' ' ALA . 83.7 mt -76.78 88.11 3.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.209 0.528 . . . . 0.0 110.679 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -102.18 8.59 40.56 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.823 0.82 . . . . 0.0 109.258 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -157.54 142.97 17.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.496 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -126.43 121.22 31.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.86 0.362 . . . . 0.0 111.067 -177.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.2 170.46 8.24 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.412 ' O ' HG13 ' A' ' 17' ' ' ILE . 4.0 m-20 -60.33 -46.47 89.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.726 0.298 . . . . 0.0 110.732 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -59.11 -41.2 87.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -62.35 -45.42 93.28 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.564 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -59.27 -45.11 92.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.886 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 13' ' ' ASP . 60.6 mt -67.01 -32.1 56.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.009 0.433 . . . . 0.0 111.173 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.402 ' O ' HG13 ' A' ' 22' ' ' ILE . 9.7 t70 -77.09 -38.69 51.85 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.078 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.542 HD23 HD12 ' A' ' 22' ' ' ILE . 97.3 mt -61.65 -34.16 75.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.294 174.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -64.35 -36.11 83.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.297 176.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -70.8 -21.99 62.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.082 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 48' ' ' LEU . 63.5 mt -79.09 -48.44 21.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.767 0.318 . . . . 0.0 110.619 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 26' ' ' TYR . 4.4 m0 -106.83 97.86 19.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.027 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 12.9 Cg_exo -70.64 -21.54 29.26 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.674 2.249 . . . . 0.0 111.832 178.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -84.7 -22.34 29.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.942 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.438 ' HB3' ' HB2' ' A' ' 23' ' ' TRP . 87.4 t80 -95.68 126.16 40.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.193 -172.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -82.15 129.14 65.16 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 172.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.8 96.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.148 2.565 . . . . 0.0 112.624 -176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.418 ' HB3' ' OH ' ' A' ' 26' ' ' TYR . 11.4 t -107.1 -157.9 0.63 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.144 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.1 m -57.11 -42.18 80.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.086 -0.507 . . . . 0.0 112.124 -176.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.3 mt 56.46 44.02 25.01 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -173.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -62.68 115.94 4.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.081 -172.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.55 HG13 ' HA ' ' A' ' 38' ' ' ARG . 73.3 t -112.31 118.32 57.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.16 170.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 35' ' ' ASP . 14.2 p-10 -100.0 -52.2 3.48 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 16.9 t70 166.9 -40.4 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -71.69 -56.14 6.37 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.67 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -91.14 101.92 14.66 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.55 ' HA ' HG13 ' A' ' 33' ' ' VAL . 12.0 ptp180 -123.56 142.34 51.12 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.099 0.476 . . . . 0.0 111.112 -175.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.542 HG12 ' HG2' ' A' ' 53' ' ' ARG . 52.3 mt -107.19 134.42 48.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.204 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.508 ' HB3' HD11 ' A' ' 5' ' ' ILE . 76.6 m-85 -111.05 121.6 45.77 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.724 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.86 119.98 41.15 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.832 -176.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.715 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -96.44 105.8 17.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.827 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.947 ' HB3' HD23 ' A' ' 48' ' ' LEU . 4.9 ptm180 -107.54 134.31 50.74 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.464 178.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -97.2 82.39 3.16 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.2 t30 50.35 23.94 1.38 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.522 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.667 ' HG2' ' HG3' ' A' ' 47' ' ' ARG . 38.3 tt0 -166.86 -89.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.999 -0.438 . . . . 0.0 110.732 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.667 ' HG3' ' HG2' ' A' ' 46' ' ' GLU . 85.7 mtt180 -108.24 163.86 12.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.668 0.271 . . . . 0.0 110.759 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.947 HD23 ' HB3' ' A' ' 43' ' ' ARG . 19.6 mt -77.25 104.0 7.5 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 67.1 mt -86.21 -30.61 22.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.773 0.321 . . . . 0.0 110.867 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.715 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -129.31 137.03 50.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.626 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -131.78 125.15 31.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.832 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.8 p -134.25 134.25 55.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.613 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.542 ' HG2' HG12 ' A' ' 39' ' ' ILE . 63.6 mtm180 -108.88 141.9 40.26 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.311 176.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.471 HG13 ' HG3' ' A' ' 38' ' ' ARG . 6.0 p -133.83 132.7 56.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.295 0.569 . . . . 0.0 110.993 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.7 m -106.57 111.56 24.17 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.63 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.4 mt -83.48 85.58 7.22 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.238 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.6 t -82.98 83.7 7.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.372 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.29 -116.38 7.52 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.187 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.1 p -91.91 2.07 56.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.916 0.389 . . . . 0.0 111.288 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.596 ' HG2' ' HB3' ' A' ' 94' ' ' CYS . 35.0 mt-10 -110.88 136.36 50.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.64 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -115.01 104.17 1.32 Allowed Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.0 124.02 36.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.723 0.297 . . . . 0.0 110.746 -178.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.537 HD12 ' HG2' ' A' ' 97' ' ' MET . 94.6 mt -93.52 114.94 27.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.153 0.502 . . . . 0.0 109.698 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.541 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 10.0 t70 -117.18 127.36 54.03 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.309 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.628 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 25.0 m 66.71 92.26 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.423 0.63 . . . . 0.0 111.146 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.0 tp -114.76 102.26 9.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.292 174.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.516 ' HE ' ' H31' ' A' ' 999' ' ' COA . 87.7 mtt180 -136.39 115.05 11.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.421 -175.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' A' ' 50' ' ' ALA . 11.8 t -98.53 150.33 4.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -55.78 137.36 50.04 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -62.04 -17.94 58.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.289 0.566 . . . . 0.0 110.908 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.4 t -71.52 -24.73 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.761 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.9 m -86.04 18.87 2.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.06 0.457 . . . . 0.0 111.923 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.563 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 99.9 mtt180 -66.24 118.23 9.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -163.58 -97.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.359 -0.537 . . . . 0.0 112.19 -175.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.446 ' HA ' ' O5B' ' A' ' 999' ' ' COA . 34.0 ttm180 169.6 95.77 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -172.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 133.96 -59.03 0.68 Allowed Glycine 0 C--N 1.317 -0.505 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.879 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.7 t -49.9 -54.32 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 81' ' ' LEU . . . -61.22 -43.99 98.69 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.026 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -66.27 -46.15 78.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.784 0.325 . . . . 0.0 110.134 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -60.14 -39.18 85.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.46 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 85' ' ' VAL . 48.2 tp -50.53 -55.51 15.79 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.536 0.523 . . . . 0.0 110.819 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.76 -43.69 88.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.29 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.57 -39.42 93.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.343 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -66.64 -44.56 81.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.024 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 81' ' ' LEU . 97.0 t -58.78 -44.18 89.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.79 0.329 . . . . 0.0 110.915 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.03 -18.91 57.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.679 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.8 -42.3 11.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.973 0.416 . . . . 0.0 110.151 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -72.75 -31.66 65.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.117 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -122.99 76.56 50.16 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.618 174.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -94.66 16.11 1.07 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.133 2.555 . . . . 0.0 112.613 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.85 2.21 87.1 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.731 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.5 128.61 52.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.731 0.301 . . . . 0.0 110.278 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.7 m -91.61 -34.72 14.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.335 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.596 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 48.9 t -117.72 102.92 9.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.894 0.378 . . . . 0.0 110.65 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 94.8 m95 -92.2 142.52 27.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.8 0.333 . . . . 0.0 110.594 178.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -134.9 142.45 46.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.743 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.537 ' HG2' HD12 ' A' ' 63' ' ' LEU . 80.2 mtp -130.03 125.84 36.25 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -102.75 172.35 6.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.596 -174.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.11 -8.64 59.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.231 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.71 121.22 13.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.231 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' ' 65' ' ' SER . . . 82.23 14.2 77.24 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.187 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.16 93.25 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.915 0.388 . . . . 0.0 110.387 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.75 -17.62 37.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.515 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -112.47 72.92 0.79 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.727 0.775 . . . . 0.0 110.02 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.522 ' HG3' ' HH2' ' A' ' 124' ' ' TRP . 41.5 ttp180 -76.22 -32.09 58.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.321 -170.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.77 -53.41 45.49 Favored Glycine 0 C--O 1.238 0.352 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.115 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.8 t -57.82 -42.16 81.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.972 0.415 . . . . 0.0 110.3 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.557 ' O ' ' HG2' ' A' ' 112' ' ' MET . 47.3 ttm -69.47 -25.12 63.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.424 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 94.3 m -62.9 -48.57 78.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.709 0.29 . . . . 0.0 110.243 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.86 -34.43 77.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.443 0.639 . . . . 0.0 110.249 176.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.458 ' CE2' HD11 ' A' ' 115' ' ' LEU . 55.8 t80 -63.25 -42.4 99.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.819 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.557 ' HG2' ' O ' ' A' ' 108' ' ' MET . 25.1 mmt -62.81 -39.97 95.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.37 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -69.33 -27.15 65.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.624 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.46 -40.46 57.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.438 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.458 HD11 ' CE2' ' A' ' 111' ' ' PHE . 92.9 mt -66.26 -60.78 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.108 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 130.34 48.45 0.13 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.825 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.434 ' CD2' ' HB2' ' A' ' 126' ' ' LYS . 41.3 m-85 -109.96 141.46 42.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.774 0.321 . . . . 0.0 110.416 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.9 p -92.49 144.08 25.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.257 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.4 p -97.48 148.28 23.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.146 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -124.55 -161.93 1.04 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.934 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -79.32 29.64 0.23 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.907 0.384 . . . . 0.0 111.77 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.08 67.38 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.087 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.62 169.01 11.78 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.428 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.522 ' HH2' ' HG3' ' A' ' 105' ' ' ARG . 11.7 m-90 -113.93 133.44 55.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.698 0.285 . . . . 0.0 110.472 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -123.1 145.3 48.69 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.081 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 64.6 tttp -137.28 96.85 3.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.924 0.392 . . . . 0.0 110.251 174.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 17.4 t -87.9 133.35 33.94 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 C-N-CA 120.833 -0.698 . . . . 0.9 112.005 -179.733 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 999' ' ' COA . . . . . 0.67 ' H72' ' S1P' ' A' ' 999' ' ' COA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 mtt . . . . . 0 N--CA 1.482 1.144 0 CA-C-O 121.043 0.449 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -93.99 136.96 33.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.465 HD11 ' HB1' ' A' ' 42' ' ' ALA . 49.1 tp -76.04 107.1 8.02 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.534 ' HB ' ' HG2' ' A' ' 43' ' ' ARG . 9.0 m -86.65 98.87 11.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.444 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 4.6 mp -89.75 127.8 42.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 mm -101.54 146.94 9.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 13.9 ptt180 -99.21 106.16 18.28 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 39' ' ' ILE . 63.9 mt -73.09 86.06 1.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.451 0.643 . . . . 0.0 110.882 -176.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -95.69 -22.33 17.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.784 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -136.75 143.5 43.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.127 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -120.93 144.63 48.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.256 0.551 . . . . 0.0 111.782 -173.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.3 p -109.56 163.71 13.2 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 166.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.471 ' O ' HG13 ' A' ' 17' ' ' ILE . 29.5 t70 -68.19 -31.11 70.41 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.327 0.584 . . . . 0.0 109.491 177.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -65.97 -50.77 63.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.114 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.407 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 47.7 m-20 -66.42 -28.6 68.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.057 0.456 . . . . 0.0 110.477 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -65.1 -32.62 74.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.282 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 13' ' ' ASP . 75.8 mt -65.92 -42.97 92.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.566 175.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.19 -38.2 82.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.029 0.442 . . . . 0.0 110.358 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.427 ' O ' ' HE3' ' A' ' 23' ' ' TRP . 96.4 mt -61.3 -40.0 92.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.279 175.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -77.25 -6.2 52.19 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.578 0.704 . . . . 0.0 110.458 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -89.77 -18.62 25.97 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.552 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 91.5 mt -90.41 -38.77 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.774 172.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.893 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 18.2 m-90 -99.21 89.02 0.85 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.369 171.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 13.0 Cg_exo -69.47 -59.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.61 2.207 . . . . 0.0 113.064 -169.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -94.01 9.45 37.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.205 0.526 . . . . 0.0 110.681 -176.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.893 ' HB3' ' HB3' ' A' ' 23' ' ' TRP . 91.3 t80 -97.32 130.47 44.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.274 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 p -94.0 110.93 50.88 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.516 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.44 137.71 43.9 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.915 2.41 . . . . 0.0 112.365 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.6 p -97.43 -95.81 0.21 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.836 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.436 ' CB ' ' HG3' ' A' ' 32' ' ' GLN . 51.0 m -98.32 -46.68 5.71 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 30' ' ' SER . 97.4 mt 67.47 42.27 2.19 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.428 0.632 . . . . 0.0 110.049 -174.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.436 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 89.7 mt-30 -67.8 135.18 52.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.377 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.15 165.78 30.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.943 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -156.29 -171.5 3.74 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.37 -14.94 62.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 118.275 0.488 . . . . 0.0 111.307 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 34.2 m-80 -97.29 -56.8 2.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.085 0.469 . . . . 0.0 110.358 176.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -89.36 93.93 9.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.167 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -112.63 156.1 23.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.721 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.48 HG23 ' HG2' ' A' ' 53' ' ' ARG . 63.5 mt -113.3 122.05 66.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.897 177.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -94.13 117.91 30.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.122 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.49 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.14 113.3 26.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.947 178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.765 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -95.44 112.42 24.14 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.903 -175.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.603 ' HB3' HD23 ' A' ' 48' ' ' LEU . 4.7 ptm180 -102.74 125.95 49.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.408 0.623 . . . . 0.0 109.941 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.54 ' HB3' HD12 ' A' ' 49' ' ' LEU . 57.1 t80 -109.51 95.58 5.71 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.9 t30 60.06 81.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.992 -173.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 72.83 -59.25 0.57 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.165 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 59.9 mtt85 -72.44 132.28 43.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -167.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' A' ' 43' ' ' ARG . 96.2 mt -76.16 100.19 4.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 171.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.54 HD12 ' HB3' ' A' ' 44' ' ' PHE . 88.2 mt -107.0 -8.72 16.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.77 -173.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.765 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -144.07 139.02 28.68 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.86 131.47 31.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.2 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 65' ' ' SER . 10.0 p -141.45 130.2 23.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.317 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HG2' HG23 ' A' ' 39' ' ' ILE . 63.6 mtm180 -99.68 141.68 32.16 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.0 p -130.94 127.88 61.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.573 0.702 . . . . 0.0 111.121 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.4 m -100.04 93.62 5.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.476 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.514 ' O ' ' HB3' ' A' ' 36' ' ' ASN . 94.2 mt -81.24 141.29 34.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.057 0.456 . . . . 0.0 110.625 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 t -144.44 74.3 1.41 Allowed 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.21 -111.41 3.9 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.854 -178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.0 p -95.85 12.81 28.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.051 0.453 . . . . 0.0 111.204 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -118.95 139.06 52.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.74 114.59 0.96 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.861 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -103.24 119.33 38.68 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.607 0.242 . . . . 0.0 110.768 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.517 HD22 ' HE3' ' A' ' 97' ' ' MET . 6.0 mp -93.42 126.27 38.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.108 0.48 . . . . 0.0 110.688 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -125.17 138.9 54.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.299 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 50.3 m 61.01 87.27 0.09 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.312 0.577 . . . . 0.0 111.283 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.7 tp -108.58 106.35 16.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.907 173.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.541 ' NH1' ' H31' ' A' ' 999' ' ' COA . 72.9 mtp85 -131.45 119.79 22.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -173.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.452 HG12 ' HB ' ' A' ' 72' ' ' THR . 1.9 t -109.07 141.61 23.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.6 ttt-85 -82.92 166.65 18.71 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.983 -174.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -48.7 -39.58 25.13 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.704 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.6 t -62.25 -28.28 44.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.207 -173.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.452 ' HB ' HG12 ' A' ' 68' ' ' VAL . 0.6 OUTLIER -97.18 19.03 13.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -168.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.435 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 41.6 ttt-85 -80.29 84.86 5.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -134.73 -86.11 0.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.071 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.494 ' HA ' ' O7A' ' A' ' 999' ' ' COA . 0.3 OUTLIER 168.54 99.1 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.612 0.765 . . . . 0.0 109.061 -168.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.85 -74.12 0.45 Allowed Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.627 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.4 t -38.15 -54.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -170.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 81' ' ' LEU . . . -56.43 -59.34 10.9 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.96 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.418 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 99.4 mt-30 -64.16 -34.34 77.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.804 0.335 . . . . 0.0 110.723 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -63.34 -38.3 90.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.529 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.477 ' O ' HG23 ' A' ' 85' ' ' VAL . 61.7 tp -55.58 -49.95 71.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.994 176.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.46 -43.89 96.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.902 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 79' ' ' GLN . 40.1 mt-10 -59.33 -42.63 91.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.266 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.433 ' HG2' HD13 ' A' ' 5' ' ' ILE . 9.1 tp10 -60.27 -44.12 95.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.49 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 81' ' ' LEU . 99.3 t -60.61 -44.94 97.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.16 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -73.9 -16.47 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.658 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 87' ' ' ARG . 63.6 mtt180 -92.89 -30.56 15.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.034 0.445 . . . . 0.0 110.632 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -73.92 -50.51 19.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.737 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.445 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 12.4 m120 -82.54 146.9 54.58 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.111 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 22.7 Cg_exo -66.38 -165.79 0.1 OUTLIER 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 123.161 2.574 . . . . 0.0 113.003 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.43 84.73 0.1 Allowed Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.522 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.0 t -82.56 122.83 37.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 7.1 m -68.74 -57.82 5.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.544 -174.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.7 t -103.76 106.95 17.61 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.657 -172.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -97.83 110.62 23.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.935 0.398 . . . . 0.0 110.141 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.444 ' CE3' ' HG2' ' A' ' 125' ' ' GLU . 18.9 t-105 -104.12 131.74 51.09 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.517 ' HE3' HD22 ' A' ' 63' ' ' LEU . 54.7 mtp -128.69 137.27 51.53 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 175.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.66 169.33 11.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.781 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.0 5.96 48.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.393 . . . . 0.0 110.773 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.82 124.64 21.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.429 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.51 0.12 58.09 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.696 HG13 ' C5P' ' A' ' 999' ' ' COA . 62.1 t -114.83 124.46 71.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.558 -0.321 . . . . 0.0 110.201 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.422 ' CD ' HH12 ' A' ' 67' ' ' ARG . 17.6 mp0 -71.88 -26.49 62.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.442 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -118.82 103.25 9.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.021 0.438 . . . . 0.0 110.95 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -73.1 -28.25 62.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.404 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.94 -51.68 51.34 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.123 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.6 t -59.79 -40.86 83.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.921 0.391 . . . . 0.0 110.306 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.541 ' SD ' HG21 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -61.55 -43.27 99.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.643 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 57.3 m -61.15 -48.83 79.8 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.781 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.14 96.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.069 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -62.4 -47.65 83.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.075 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.536 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 23.9 mmt -63.13 -46.22 88.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.407 -177.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -68.55 -30.2 68.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.743 -177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.46 -27.13 58.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.884 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.585 HD13 ' HE2' ' A' ' 117' ' ' PHE . 4.7 tt -82.22 -51.52 7.86 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 141.84 45.72 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.415 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.585 ' HE2' HD13 ' A' ' 115' ' ' LEU . 94.7 m-85 -123.38 134.52 53.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.828 0.347 . . . . 0.0 110.547 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.5 m -93.13 144.82 24.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.835 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.8 t -97.23 116.44 29.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.544 0.687 . . . . 0.0 110.206 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -141.1 140.17 34.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.312 -174.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 54.74 30.99 14.54 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.892 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.7 -57.15 0.52 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.486 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -90.55 -147.93 19.5 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.195 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 31.0 m-90 -121.52 124.24 43.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.696 0.284 . . . . 0.0 110.307 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.444 ' HG2' ' CE3' ' A' ' 96' ' ' TRP . 42.3 mt-10 -119.33 121.17 38.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.743 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -126.37 96.79 4.81 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.536 172.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 93' ' ' SER . 34.2 t -104.21 123.88 48.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.005 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 C-N-CA 121.095 -0.574 . . . . 0.9 112.074 -179.795 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 999' ' ' COA . . . . . 0.757 ' N8P' H131 ' A' ' 999' ' ' COA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 120.894 0.378 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -90.4 121.04 32.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.55 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.559 HD11 ' HB1' ' A' ' 42' ' ' ALA . 47.6 tp -89.41 116.32 27.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.347 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 m -89.32 93.22 9.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.567 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.69 HD11 ' HB3' ' A' ' 40' ' ' TYR . 6.5 tp -88.05 124.39 41.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.175 0.512 . . . . 0.0 110.052 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 mt -123.55 155.02 29.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.219 -176.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -89.53 127.68 35.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.131 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.438 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 42.0 tp -80.91 99.63 8.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.601 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.507 ' HA ' HG11 ' A' ' 33' ' ' VAL . 36.0 mt-10 -102.04 -17.36 16.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.655 -175.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -151.56 156.31 40.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.703 0.287 . . . . 0.0 111.29 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.444 ' CE2' HG23 ' A' ' 33' ' ' VAL . 87.7 m-85 -119.1 109.64 16.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.117 -177.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.0 p -90.74 158.86 16.64 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 168.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 17' ' ' ILE . 5.4 m-20 -58.58 -38.34 77.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.934 0.397 . . . . 0.0 110.184 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -61.54 -55.78 27.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.676 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.507 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 70.1 m-20 -61.88 -37.67 85.42 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.538 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -64.19 -36.4 83.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.67 -176.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 13' ' ' ASP . 80.2 mt -66.5 -45.12 89.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.743 177.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.545 ' O ' HG13 ' A' ' 22' ' ' ILE . 24.0 t0 -65.57 -35.06 79.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.333 . . . . 0.0 110.593 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 95.0 mt -63.65 -41.43 98.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.978 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -69.42 -21.45 63.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.514 0.673 . . . . 0.0 109.695 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -85.78 -12.34 51.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.134 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 18' ' ' ASP . 71.0 mt -85.1 -32.69 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 171.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.613 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 5.6 m-90 -116.04 72.09 4.42 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.783 175.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HD3' ' C ' ' A' ' 22' ' ' ILE . 18.0 Cg_exo -67.87 -45.21 3.32 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.338 2.025 . . . . 0.0 111.732 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -103.17 71.27 1.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.948 0.88 . . . . 0.0 109.321 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.613 ' HB3' ' HB3' ' A' ' 23' ' ' TRP . 55.8 t80 -155.29 137.57 14.84 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.655 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 38.2 m -69.74 109.02 3.87 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 178.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 27' ' ' SER . 38.7 Cg_exo -56.93 124.33 15.99 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.211 2.607 . . . . 0.0 113.104 -173.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.4 m -85.82 -177.12 6.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.502 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.6 t -70.03 -33.29 71.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.718 0.294 . . . . 0.0 110.287 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.0 mt 64.92 84.95 0.15 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.96 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -137.94 147.74 44.61 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.178 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' ' 9' ' ' GLU . 59.7 t -93.74 126.23 46.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.039 -176.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.646 ' HB3' ' HB2' ' A' ' 37' ' ' HIS . 30.9 t70 -138.71 158.02 45.01 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.299 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -63.2 -35.87 81.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.723 0.296 . . . . 0.0 110.805 178.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 55' ' ' THR . 15.8 m120 -86.29 -48.04 8.86 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.646 ' HB2' ' HB3' ' A' ' 34' ' ' ASP . 40.4 m170 -87.28 84.47 7.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.914 175.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -109.36 147.79 32.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.144 -173.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 8' ' ' LEU . 56.5 mt -126.56 139.07 52.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.854 0.359 . . . . 0.0 110.379 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.69 ' HB3' HD11 ' A' ' 5' ' ' ILE . 76.9 m-85 -118.03 152.43 35.54 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.525 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -136.67 126.51 25.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.999 0.428 . . . . 0.0 111.154 -174.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.04 104.02 16.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.011 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -95.14 110.22 22.2 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.34 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -119.39 135.24 54.82 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.3 t30 61.51 30.65 18.87 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.618 0.723 . . . . 0.0 109.072 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 65.84 17.11 10.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.955 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -126.43 138.96 53.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.572 0.225 . . . . 0.0 110.404 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.525 HD22 ' HB1' ' A' ' 41' ' ' ALA . 78.4 mt -63.65 106.58 0.99 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 49' ' ' LEU . 12.8 tp -105.03 -21.41 13.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.823 -172.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -140.94 135.26 31.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.482 178.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.65 132.93 53.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.608 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.482 ' HB ' HD13 ' A' ' 66' ' ' LEU . 8.0 p -142.2 131.9 23.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.596 -178.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 1.026 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 10.6 mtm180 -103.22 155.68 18.26 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.88 176.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.79 126.5 14.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.251 0.548 . . . . 0.0 110.414 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 77.6 m -102.49 107.61 18.63 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.042 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.4 mt -83.54 95.29 8.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.043 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.3 t -86.79 93.05 9.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.368 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.83 -102.99 1.38 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.789 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.2 m -120.83 12.96 11.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.926 0.87 . . . . 0.0 109.521 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -112.87 157.88 20.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.956 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 95' ' ' TRP . . . -125.15 120.76 4.04 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.864 -174.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.78 132.07 53.78 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 174.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.834 ' HB2' ' HG2' ' A' ' 97' ' ' MET . 73.0 mt -95.43 119.14 33.41 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.206 0.527 . . . . 0.0 110.281 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 1.026 ' HB2' ' HB2' ' A' ' 53' ' ' ARG . 1.3 m-20 -79.6 -157.66 0.14 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.117 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 p -47.27 118.45 2.17 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.138 0.494 . . . . 0.0 111.932 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.482 HD13 ' HB ' ' A' ' 52' ' ' VAL . 21.3 tp -117.64 116.97 28.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.349 175.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.574 ' HG3' ' H72' ' A' ' 999' ' ' COA . 53.6 ttt180 -143.82 123.19 13.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.192 0.52 . . . . 0.0 111.735 177.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' A' ' 50' ' ' ALA . 22.4 t -94.38 137.8 22.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 169.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -56.87 136.55 55.74 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -56.67 -15.82 5.19 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -166.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.9 m -66.07 -15.59 19.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.696 0.284 . . . . 0.0 111.487 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 m -108.99 68.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.406 0.622 . . . . 0.0 110.34 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.8 ttt85 -92.85 103.31 15.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.842 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.574 ' HG2' ' C2A' ' A' ' 999' ' ' COA . 20.9 mtp180 60.78 79.73 0.24 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.805 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -142.21 16.76 2.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.052 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.22 -19.98 11.7 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.489 175.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.9 t -51.29 -46.59 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.0 -28.95 71.27 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.101 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.467 ' HG3' ' O1A' ' A' ' 999' ' ' COA . 20.5 mt-30 -69.65 -55.0 11.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -56.11 -44.65 79.31 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.165 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.628 HD11 HD13 ' A' ' 5' ' ' ILE . 30.3 tp -52.89 -57.99 8.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.496 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.3 mt -66.21 -39.69 89.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.238 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -59.0 -43.01 91.42 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.252 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -64.45 -36.42 84.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.59 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 81' ' ' LEU . 93.2 t -63.34 -48.87 85.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.803 0.335 . . . . 0.0 110.686 177.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.539 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 11.1 mp -66.22 -27.84 68.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.896 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 87' ' ' ARG . 5.5 mtp180 -77.39 -33.66 55.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.398 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -69.95 -44.09 70.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.795 -176.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.651 HD22 ' HH2' ' A' ' 95' ' ' TRP . 90.9 m-20 -76.02 112.79 22.38 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.359 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -87.42 22.54 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.143 2.562 . . . . 0.0 113.766 -171.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -172.7 75.9 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.018 -1.087 . . . . 0.0 113.093 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.4 t -141.69 129.09 20.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.9 p -99.66 -33.13 10.73 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -177.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.6 t -130.34 137.45 49.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.131 0.491 . . . . 0.0 110.814 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.651 ' HH2' HD22 ' A' ' 89' ' ' ASN . 90.7 m95 -116.12 122.4 45.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.345 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -114.18 121.3 43.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.292 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.834 ' HG2' ' HB2' ' A' ' 63' ' ' LEU . 77.2 mtp -107.29 130.08 54.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.793 0.33 . . . . 0.0 110.59 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -101.26 144.95 29.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.711 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.415 ' HB2' HG12 ' A' ' 102' ' ' VAL . 2.7 p-10 -69.49 -34.26 74.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.908 0.385 . . . . 0.0 110.148 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 61.65 20.68 11.52 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.47 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.35 13.01 20.34 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.243 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.538 HG13 ' HB3' ' A' ' 105' ' ' ARG . 12.2 p -85.53 119.67 34.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.115 0.483 . . . . 0.0 109.725 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -93.27 -5.1 50.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.326 0.584 . . . . 0.0 109.762 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -86.46 16.3 4.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.14 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.538 ' HB3' HG13 ' A' ' 102' ' ' VAL . 5.1 ptt180 -56.62 -32.12 64.98 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.167 -175.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.22 -48.35 70.78 Favored Glycine 0 C--O 1.235 0.193 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.726 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.1 t -61.24 -43.27 96.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-O 122.025 0.917 . . . . 0.0 109.394 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.601 ' O ' ' HG2' ' A' ' 112' ' ' MET . 17.3 ttt -61.64 -37.97 85.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.13 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 98.9 m -61.28 -36.24 79.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.105 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.28 -45.17 88.42 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.13 0.49 . . . . 0.0 109.748 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.624 ' HB2' ' C4A' ' A' ' 999' ' ' COA . 7.3 t80 -63.5 -45.08 92.32 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.019 173.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.601 ' HG2' ' O ' ' A' ' 108' ' ' MET . 59.5 mmm -60.57 -43.89 96.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.102 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -62.83 -35.1 78.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.807 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.51 -32.95 74.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.167 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 33.5 tp -84.8 -42.84 14.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.499 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 136.28 32.87 0.25 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.149 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.582 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 78.5 m-85 -118.58 116.24 26.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.76 0.314 . . . . 0.0 110.391 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.3 p -102.01 136.14 42.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.895 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.711 ' HB ' ' CD1' ' A' ' 124' ' ' TRP . 11.6 t -97.37 134.9 40.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.139 0.495 . . . . 0.0 110.737 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.632 ' HB2' ' OE2' ' A' ' 125' ' ' GLU . 19.0 mt-30 -140.31 -72.6 0.36 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.289 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -86.14 61.54 6.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.265 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.87 -36.96 2.49 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.139 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -118.96 -172.81 15.45 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.165 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.711 ' CD1' ' HB ' ' A' ' 119' ' ' THR . 15.8 m-90 -98.54 126.42 44.1 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.632 ' OE2' ' HB2' ' A' ' 120' ' ' GLN . 35.4 mt-10 -111.69 122.17 47.09 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.015 -175.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -137.12 148.64 46.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.396 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 38.2 t -110.82 151.07 28.25 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.329 0 C-N-CA 120.895 -0.669 . . . . 0.9 112.535 179.34 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 999' ' ' COA . . . . . 0.624 ' C4A' ' HB2' ' A' ' 111' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.1 mtp . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -74.75 137.62 42.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.964 0.411 . . . . 0.0 110.663 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.517 HD21 ' HB1' ' A' ' 42' ' ' ALA . 23.3 tp -76.03 118.47 18.82 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.561 ' O ' ' HB3' ' A' ' 43' ' ' ARG . 18.1 m -90.25 92.22 8.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.098 0.475 . . . . 0.0 110.458 -176.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.596 HG22 ' HA ' ' A' ' 42' ' ' ALA . 9.2 pt -106.79 150.98 8.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.091 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.1 mp -131.14 153.09 38.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -82.98 140.07 32.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.868 0.366 . . . . 0.0 110.036 176.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.9 tp -84.74 82.91 8.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.279 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -75.76 -48.8 20.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.783 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -120.19 157.24 29.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.411 -176.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -117.97 103.7 10.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.995 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -88.88 156.74 18.74 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.432 ' O ' HG13 ' A' ' 17' ' ' ILE . 19.0 t70 -56.78 -52.86 63.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.396 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.17 -35.99 80.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.68 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.488 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 22.0 m-20 -63.48 -44.01 95.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.531 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 -62.53 -34.89 77.81 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 120.648 0.261 . . . . 0.0 110.958 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 13' ' ' ASP . 74.2 mt -63.13 -46.54 95.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.613 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -71.69 -31.28 66.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.013 0.435 . . . . 0.0 109.997 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 84.3 mt -63.67 -34.48 77.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.587 174.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -77.22 -18.74 57.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.165 0.507 . . . . 0.0 110.579 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -68.14 -36.81 80.26 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.516 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 67.3 mt -73.76 -55.47 12.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.23 176.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -101.18 97.34 7.07 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 22' ' ' ILE . 35.3 Cg_exo -57.69 -32.17 93.92 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.554 2.169 . . . . 0.0 111.853 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -144.56 91.51 2.19 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.029 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -103.42 167.27 9.92 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.013 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.0 t -80.37 128.89 71.29 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.95 128.41 27.82 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.997 2.465 . . . . 0.0 112.786 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.0 m 69.57 1.52 3.39 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.792 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.1 m -78.72 -8.82 59.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.216 0.531 . . . . 0.0 110.27 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.03 -21.49 62.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.557 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -56.01 128.63 36.21 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.279 0.561 . . . . 0.0 111.934 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.1 m -103.38 167.52 2.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.399 -176.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -155.94 -158.25 0.79 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -72.64 -29.35 63.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.005 0.431 . . . . 0.0 110.77 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -85.68 -53.39 5.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.663 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -92.82 112.39 24.34 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -126.7 119.87 28.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.201 0.524 . . . . 0.0 110.806 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 65.2 mt -98.56 133.92 39.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.073 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -112.7 132.88 54.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.082 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.422 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.52 123.27 48.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.878 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.662 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -91.9 114.69 27.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.453 -176.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.561 ' HB3' ' O ' ' A' ' 4' ' ' THR . 51.9 ttt180 -108.03 127.3 53.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.273 0.559 . . . . 0.0 110.864 -177.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -99.41 82.49 2.68 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 69.13 -68.35 0.19 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.728 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -101.58 -57.74 2.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -174.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 47' ' ' ARG . 10.0 ptp180 -114.51 171.66 7.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.983 0.42 . . . . 0.0 111.076 -171.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.422 HD22 ' HB1' ' A' ' 41' ' ' ALA . 87.5 mt -75.34 133.55 41.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.431 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.8 tp -111.01 -23.98 10.63 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.734 0.302 . . . . 0.0 110.496 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.736 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -151.3 159.08 44.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.158 -177.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -144.46 133.41 22.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.963 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.08 137.76 37.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.937 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 19.1 mtm180 -110.17 129.99 55.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.207 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.8 p -133.73 139.47 48.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.316 0.579 . . . . 0.0 110.809 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -111.02 114.7 28.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.092 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.43 HD22 HG21 ' A' ' 92' ' ' VAL . 70.5 mt -86.84 93.06 9.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.965 0.412 . . . . 0.0 109.99 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 t -111.58 94.41 4.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.517 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.42 -107.72 2.04 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.498 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.3 p -93.45 -15.13 25.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.739 0.304 . . . . 0.0 111.036 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -99.66 122.19 42.33 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.247 0.546 . . . . 0.0 111.988 -172.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.23 97.37 2.17 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 167.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.47 107.54 19.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.21 0.528 . . . . 0.0 110.437 -172.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.9 tt -93.73 119.28 32.51 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.041 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 12.1 t70 -126.57 126.42 43.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.348 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.0 t 71.39 108.86 0.06 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.799 0.809 . . . . 0.0 111.111 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 45.4 tp -129.33 110.43 11.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.321 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.465 ' HA ' ' O9P' ' A' ' 999' ' ' COA . 43.5 mtt180 -125.36 128.53 48.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.095 0.474 . . . . 0.0 111.611 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.736 HG13 ' HB2' ' A' ' 50' ' ' ALA . 1.7 t -121.76 153.97 25.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 172.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 71.5 mtt-85 -65.22 158.58 25.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.947 0.403 . . . . 0.0 111.433 -176.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 1.5 mp0 -49.88 -38.6 36.25 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.947 -170.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.8 m -78.3 19.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.483 HG21 HG12 ' A' ' 68' ' ' VAL . 70.9 p -115.76 9.68 15.2 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.763 0.316 . . . . 0.0 111.253 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.2 ttp-105 -57.55 106.12 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.167 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.6 ' HA ' H52A ' A' ' 999' ' ' COA . 94.4 mtt180 55.92 40.47 30.49 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.119 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -111.29 7.39 21.05 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.992 0.425 . . . . 0.0 111.631 -174.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.465 ' HA2' ' O9A' ' A' ' 999' ' ' COA . . . 87.98 -23.89 12.73 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.928 173.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.7 t -53.92 -42.07 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.771 0.319 . . . . 0.0 111.713 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.85 -38.43 88.57 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.89 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -59.55 -49.72 76.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.863 0.363 . . . . 0.0 111.037 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -67.06 -33.88 76.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.961 -174.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.494 HD13 ' HB2' ' A' ' 42' ' ' ALA . 56.3 tp -57.72 -49.39 76.71 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.8 0.333 . . . . 0.0 110.301 176.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.77 -42.46 97.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.702 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.01 -46.89 84.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.108 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -59.12 -43.17 91.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.622 0.248 . . . . 0.0 110.974 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 81' ' ' LEU . 94.8 t -60.58 -52.27 63.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.918 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.427 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 11.2 mp -64.85 -32.14 73.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.571 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -76.74 -40.2 49.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.929 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -71.19 -39.6 71.7 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -174.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.52 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 47.6 m-80 -75.01 131.75 78.3 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.913 0.387 . . . . 0.0 110.674 -177.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 16.9 Cg_exo -67.05 -69.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 123.383 2.722 . . . . 0.0 114.456 -170.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.13 61.55 0.48 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.186 -1.007 . . . . 0.0 113.637 -170.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.43 HG21 HD22 ' A' ' 56' ' ' LEU . 25.5 t -114.52 105.11 18.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 175.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.9 t -83.25 -37.81 23.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.485 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.0 t -108.93 109.01 19.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.902 0.382 . . . . 0.0 110.822 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.427 ' CZ2' ' HA ' ' A' ' 86' ' ' LEU . 95.9 m95 -97.65 115.54 28.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.698 175.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 -114.88 126.19 54.52 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.964 -175.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 87.1 mtp -107.03 122.52 46.62 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.0 173.71 8.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.772 -172.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.31 -46.05 86.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.051 -178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 62.18 17.01 8.84 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.681 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.53 36.87 58.62 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.47 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.1 t -106.53 109.99 30.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.645 0.222 . . . . 0.0 110.724 177.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -90.95 -6.95 53.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.777 0.322 . . . . 0.0 110.6 173.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.73 52.65 1.03 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.262 0.553 . . . . 0.0 109.621 173.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 105' ' ' ARG . 48.2 mtt-85 -72.94 -21.87 60.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.884 -172.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.69 -56.64 23.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.535 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.1 t -61.51 -39.12 81.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.021 0.439 . . . . 0.0 110.837 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.6 ' SD ' ' HE3' ' A' ' 112' ' ' MET . 27.0 ttm -71.25 -37.8 71.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.119 -176.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 99.1 m -63.84 -47.35 81.12 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.634 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.472 ' HB1' ' C4A' ' A' ' 999' ' ' COA . . . -57.18 -39.08 74.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.348 0.594 . . . . 0.0 110.602 177.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -62.77 -54.38 39.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.374 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.6 ' HE3' ' SD ' ' A' ' 108' ' ' MET . 66.4 mtt -76.03 -33.26 59.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -174.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -63.41 -41.03 98.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.943 0.401 . . . . 0.0 110.119 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.24 -25.28 59.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.762 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.6 tp -84.02 -0.12 50.4 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.268 0.556 . . . . 0.0 110.637 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.41 53.38 4.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.95 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -110.0 133.25 53.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.707 0.289 . . . . 0.0 110.633 174.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.8 m -84.74 143.65 29.01 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.4 p -97.32 108.27 20.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.011 0.434 . . . . 0.0 111.038 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -96.8 163.42 12.99 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -73.65 95.99 2.41 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.827 0.346 . . . . 0.0 110.32 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 133.94 -30.53 2.94 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.506 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.55 -173.93 42.58 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.375 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -102.34 136.72 41.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.629 0.252 . . . . 0.0 110.619 -177.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -125.75 131.6 52.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.857 -176.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -132.02 133.77 44.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 78.2 m -86.87 129.92 34.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.766 0.317 . . . . 0.0 110.471 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 C-N-CA 121.088 -0.577 . . . . 0.9 111.953 179.836 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 999' ' ' COA . . . . . 0.6 H52A ' HA ' ' A' ' 74' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.16 117.01 10.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.975 0.417 . . . . 0.0 110.286 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.505 HD22 HG13 ' A' ' 77' ' ' VAL . 59.2 tp -75.86 137.05 40.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.963 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 42' ' ' ALA . 19.1 m -82.89 89.63 6.86 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.209 0.528 . . . . 0.0 110.577 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 40' ' ' TYR . 5.5 tp -98.35 105.76 17.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.003 174.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mt -94.74 149.22 4.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.359 0.6 . . . . 0.0 111.535 -170.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -91.59 101.36 14.0 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.124 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 39' ' ' ILE . 94.3 mt -73.11 92.95 1.75 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.691 -173.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -102.35 -2.69 28.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.736 0.779 . . . . 0.0 109.082 173.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -131.92 120.86 23.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.521 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -124.31 99.59 6.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.491 0.186 . . . . 0.0 111.066 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.57 ' O ' ' HG3' ' A' ' 16' ' ' ARG . 1.4 m -79.03 158.95 27.79 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.569 ' O ' HG12 ' A' ' 17' ' ' ILE . 5.7 p-10 -58.14 -36.45 72.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.658 0.266 . . . . 0.0 110.732 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -70.0 -36.56 75.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.125 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -63.74 -38.34 90.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.272 0.558 . . . . 0.0 109.765 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.57 ' HG3' ' O ' ' A' ' 12' ' ' SER . 77.5 mtt180 -68.28 -28.46 67.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.468 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 13' ' ' ASP . 46.6 mm -66.8 -41.49 87.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.751 176.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 28.5 t0 -69.05 -32.48 71.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.04 0.447 . . . . 0.0 109.859 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.6 mt -63.23 -38.57 91.68 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.236 172.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -68.11 -22.77 64.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.559 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HE2' HG22 ' A' ' 17' ' ' ILE . 66.3 mttm -76.84 -32.87 57.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.311 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.6 mt -76.98 -39.0 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.531 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.504 ' CD1' ' HD2' ' A' ' 67' ' ' ARG . 5.0 m-90 -114.56 90.27 20.97 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.668 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.67 -28.53 87.57 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.786 2.324 . . . . 0.0 112.701 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.38 2.11 48.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.791 0.329 . . . . 0.0 111.108 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' HB3' ' HB2' ' A' ' 23' ' ' TRP . 43.7 t80 -115.41 149.85 37.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -175.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.4 m -116.37 154.78 48.95 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.078 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.7 99.35 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.553 2.169 . . . . 0.0 112.535 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 m -87.76 -173.17 4.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.479 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.4 p -70.81 -30.39 66.82 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 170.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.1 mt 67.76 77.11 0.26 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.204 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -73.51 111.18 8.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.575 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.01 151.43 28.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.032 0.444 . . . . 0.0 111.519 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 73.99 -6.66 1.78 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.942 171.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -65.87 -29.7 70.19 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 174.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 171.93 -29.03 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.841 -1.527 . . . . 0.0 107.354 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -86.94 116.54 25.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.468 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.514 ' HB2' HG13 ' A' ' 54' ' ' VAL . 51.5 mtt180 -109.09 125.78 52.49 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.046 0.45 . . . . 0.0 110.4 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.483 HG22 HD12 ' A' ' 8' ' ' LEU . 54.8 mt -108.67 110.0 30.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.803 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.553 ' HB3' HD11 ' A' ' 5' ' ' ILE . 65.4 m-85 -104.27 138.49 40.65 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.524 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -128.68 120.55 26.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.973 0.416 . . . . 0.0 111.296 -175.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -94.45 105.47 17.44 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.535 177.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.513 ' HB3' HD23 ' A' ' 48' ' ' LEU . 11.9 ptt180 -99.46 134.71 41.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.383 0.611 . . . . 0.0 110.74 -177.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -118.33 119.51 34.85 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.1 t30 60.13 41.87 16.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.696 0.76 . . . . 0.0 109.04 -173.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 76.49 -27.05 0.18 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.933 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -82.21 137.03 35.01 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.524 HD22 ' HB1' ' A' ' 41' ' ' ALA . 76.4 mt -69.43 97.69 1.02 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 0.0 111.009 -175.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 42.4 tp -78.18 -39.0 42.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.883 -174.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.648 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -131.23 126.48 35.63 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.899 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -117.35 125.86 51.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.334 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.47 127.95 60.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.62 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 5.1 mtp180 -107.04 127.36 53.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 38' ' ' ARG . 5.2 p -122.57 115.71 46.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.649 0.738 . . . . 0.0 110.827 176.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.4 m -91.93 108.63 20.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.968 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.14 154.27 19.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.106 0.479 . . . . 0.0 110.612 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 60' ' ' GLU . 5.5 t -136.55 30.4 2.89 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.32 -108.07 3.43 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.372 -176.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 p -84.67 -1.86 56.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.366 0.603 . . . . 0.0 110.68 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 57' ' ' SER . 44.8 tt0 -109.93 127.57 54.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.414 177.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -127.35 112.89 1.6 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.11 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.36 118.5 33.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.888 0.375 . . . . 0.0 110.53 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 5.6 mp -93.89 125.61 38.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.97 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.62 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 4.4 p30 -122.84 135.75 54.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.104 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.1 t 66.73 94.1 0.07 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.884 0.849 . . . . 0.0 111.273 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.485 HD21 HD21 ' A' ' 82' ' ' LEU . 37.0 tp -122.99 108.01 12.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.231 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.504 ' HD2' ' CD1' ' A' ' 23' ' ' TRP . 98.2 mtt180 -130.49 117.89 20.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.269 0.557 . . . . 0.0 111.651 -176.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 50' ' ' ALA . 5.1 t -107.03 141.91 21.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -62.65 151.23 38.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.872 0.367 . . . . 0.0 110.993 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -54.58 -26.28 31.44 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.358 -0.837 . . . . 0.0 113.022 -171.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.19 3.51 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.287 0.565 . . . . 0.0 111.177 -176.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.76 13.16 16.11 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.13 -0.356 . . . . 0.0 111.142 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -66.42 118.36 9.95 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.741 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.427 ' HA ' ' O8A' ' A' ' 999' ' ' COA . 51.5 ttt180 50.47 73.88 0.25 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.634 -172.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -138.24 11.77 2.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.265 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.95 -32.65 1.96 Allowed Glycine 0 CA--C 1.521 0.43 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.539 177.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.505 HG13 HD22 ' A' ' 3' ' ' LEU . 85.4 t -49.74 -42.17 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.281 0.632 . . . . 0.0 112.576 -176.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -52.66 -44.57 60.19 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.395 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -64.99 -43.58 92.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.0 110.785 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -63.5 -49.1 74.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.54 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.44 ' CD1' HD13 ' A' ' 5' ' ' ILE . 30.6 tp -49.47 -60.79 2.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.798 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.485 HD21 HD21 ' A' ' 66' ' ' LEU . 4.1 mm? -64.78 -43.11 94.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.581 -175.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.605 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 40.3 tt0 -63.91 -39.41 94.1 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.707 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -60.69 -40.46 92.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.962 0.41 . . . . 0.0 110.487 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 81' ' ' LEU . 90.1 t -64.16 -38.32 82.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.816 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 82' ' ' LEU . 10.6 mp -70.1 -24.94 63.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.159 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.605 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 63.6 mtt180 -76.88 -36.9 56.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.126 0.489 . . . . 0.0 109.956 174.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -66.58 -47.45 72.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.553 -176.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -75.42 147.6 82.45 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.387 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.88 -165.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.987 2.458 . . . . 0.0 112.612 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.68 96.29 0.15 Allowed Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.83 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.8 t -102.26 -50.4 9.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.072 0.463 . . . . 0.0 110.047 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.6 m 70.79 -50.12 0.67 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.037 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 47.8 t -89.4 86.36 6.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.058 0.456 . . . . 0.0 110.399 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.448 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 96.1 m95 -95.76 121.09 37.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.372 178.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -117.11 134.31 54.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.555 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.716 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 92.8 mmm -107.15 111.17 23.47 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.95 150.63 22.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.18 -174.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.614 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -70.13 -63.81 1.01 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.703 179.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.61 16.78 6.85 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.388 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.15 12.16 12.57 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.389 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 99' ' ' ASP . 69.2 t -69.29 104.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 117.262 0.531 . . . . 0.0 110.723 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.55 -10.59 45.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.373 0.606 . . . . 0.0 109.967 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.13 47.35 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.039 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -61.42 -40.1 93.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.93 -173.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.94 -53.17 39.2 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.456 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.29 -43.94 98.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.797 0.332 . . . . 0.0 110.674 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 91.2 mmm -64.7 -39.07 93.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.462 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 98.9 m -60.86 -43.72 98.01 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.818 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.65 -44.76 93.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.083 0.468 . . . . 0.0 110.776 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.556 ' HD1' H52A ' A' ' 999' ' ' COA . 17.0 t80 -64.82 -45.11 87.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.831 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.556 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 16.9 mmt -62.13 -45.46 93.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.105 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -63.54 -34.98 78.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.595 0.236 . . . . 0.0 111.16 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.91 -29.45 69.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.005 0.431 . . . . 0.0 110.852 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.2 tp -96.71 13.3 28.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.213 0.53 . . . . 0.0 110.73 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.86 57.67 4.03 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.124 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 55.6 m-85 -126.0 153.81 43.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 110.325 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.9 p -128.22 145.47 51.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.809 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.9 t -97.16 124.57 41.25 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -141.79 106.63 4.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.851 -172.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 57.75 35.98 26.07 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.575 168.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 158.29 -85.1 0.13 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.281 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -121.35 -137.21 5.21 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.685 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.716 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 19.2 m-90 -112.29 141.47 45.97 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -128.07 142.73 51.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.717 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.464 ' HB2' ' CD2' ' A' ' 117' ' ' PHE . 54.4 tttp -132.5 89.69 2.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 38.1 t -86.79 97.75 10.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.554 -176.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 C-N-CA 121.04 -0.6 . . . . 0.9 112.284 179.528 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 999' ' ' COA . . . . . 0.69 ' O5P' H141 ' A' ' 999' ' ' COA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 120.882 0.373 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -121.76 108.08 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.95 0.405 . . . . 0.0 110.918 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.415 ' HB3' ' CE2' ' A' ' 80' ' ' TYR . 59.2 tp -87.17 114.98 24.25 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 m -82.87 93.44 7.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.342 0.592 . . . . 0.0 110.787 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.575 HG22 ' HA ' ' A' ' 42' ' ' ALA . 13.3 pt -113.12 148.55 15.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.137 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.46 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -133.94 144.4 35.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.359 -177.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -91.94 142.18 27.83 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.52 98.09 1.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.187 0.518 . . . . 0.0 111.373 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -89.14 -42.12 11.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.077 173.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -136.72 140.31 42.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.196 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.493 ' HE2' HG22 ' A' ' 33' ' ' VAL . 34.9 m-85 -97.42 92.95 6.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.975 0.417 . . . . 0.0 111.686 -176.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.7 m -71.94 139.3 48.64 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 171.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 17' ' ' ILE . 27.1 m-20 -59.32 -41.59 89.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.576 0.227 . . . . 0.0 111.106 -177.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -61.59 -39.84 92.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.956 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -72.2 -30.98 65.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.752 0.311 . . . . 0.0 110.603 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -68.98 -31.23 69.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 0.0 110.619 176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 13' ' ' ASP . 79.9 mt -70.27 -36.99 69.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.073 0.463 . . . . 0.0 109.829 174.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -64.86 -41.68 95.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.016 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.4 mt -59.91 -35.54 75.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.708 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -69.35 -25.36 64.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.199 0.523 . . . . 0.0 110.097 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 67.7 mttm -72.81 -27.48 61.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.974 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.769 HD11 ' HB3' ' A' ' 48' ' ' LEU . 60.4 mt -71.23 -43.48 74.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.309 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.614 ' HB3' ' HB3' ' A' ' 26' ' ' TYR . 4.0 m-90 -113.99 87.6 13.09 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.62 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.27 -9.48 12.64 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.116 1.878 . . . . 0.0 110.768 173.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -101.65 8.38 41.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.95 -177.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.614 ' HB3' ' HB3' ' A' ' 23' ' ' TRP . 91.9 t80 -129.61 132.72 46.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.827 -175.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.5 t -70.82 121.95 85.38 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.43 107.27 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.924 2.416 . . . . 0.0 112.735 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 m -83.52 178.55 7.95 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.013 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.9 m -60.83 -28.51 68.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.446 175.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.8 mt 65.12 98.13 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.634 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -131.43 148.53 52.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.853 -173.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.493 HG22 ' HE2' ' A' ' 11' ' ' PHE . 15.6 m -132.72 -179.2 3.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.434 176.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -146.51 -169.24 3.22 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 176.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -82.4 -25.75 33.44 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.279 0.561 . . . . 0.0 109.696 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 56' ' ' LEU . 9.2 p30 -96.96 -27.58 14.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.722 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -108.42 95.78 5.9 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.2 mtt85 -117.0 166.73 11.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.183 0.516 . . . . 0.0 111.594 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.7 mt -129.73 135.58 61.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.724 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -99.78 129.16 45.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.793 0.33 . . . . 0.0 110.603 177.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.435 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -112.91 116.21 29.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.111 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.575 ' HA ' HG22 ' A' ' 5' ' ' ILE . . . -91.9 113.22 25.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.188 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -113.38 126.13 55.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.394 0.616 . . . . 0.0 111.369 -172.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -97.16 85.58 3.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 64.66 -77.86 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.067 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -107.73 -39.28 5.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.209 -174.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.628 ' HA ' ' CZ ' ' A' ' 47' ' ' ARG . 2.1 mmp_? -99.05 129.87 45.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.533 -170.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.769 ' HB3' HD11 ' A' ' 22' ' ' ILE . 54.3 mt -67.56 115.41 7.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 169.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 15.8 tp -97.54 -27.16 14.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.769 -170.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.558 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -152.35 158.0 42.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.699 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.57 144.16 26.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.108 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 65' ' ' SER . 11.0 p -148.45 143.64 18.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.733 0.302 . . . . 0.0 111.088 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -96.54 146.91 24.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.731 0.3 . . . . 0.0 110.997 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.03 121.58 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.45 0.643 . . . . 0.0 110.783 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 21.2 m -110.12 109.25 19.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.453 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.594 HD22 HG21 ' A' ' 92' ' ' VAL . 65.0 mt -89.69 113.17 24.62 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.271 0.558 . . . . 0.0 110.936 -178.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -114.62 86.17 2.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.475 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.88 -107.77 2.22 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.681 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.7 p -104.77 1.03 28.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.214 0.53 . . . . 0.0 110.575 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -98.97 138.15 36.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.918 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -119.98 107.94 1.39 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.611 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 96' ' ' TRP . . . -92.62 104.59 16.86 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.9 tt -104.56 127.64 52.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.734 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -147.43 176.76 9.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.301 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 16.2 m 50.82 80.36 0.08 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.858 0.724 . . . . 0.0 111.965 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.504 ' HB3' ' HE3' ' A' ' 108' ' ' MET . 55.4 tp -120.58 120.45 35.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.084 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.649 ' HG3' ' O5P' ' A' ' 999' ' ' COA . 39.8 ttt-85 -140.32 124.04 17.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.814 0.34 . . . . 0.0 110.51 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.558 HG13 ' HB2' ' A' ' 50' ' ' ALA . 10.5 t -111.1 146.66 15.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 172.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 49' ' ' LEU . 66.7 mtp85 -60.94 139.6 57.97 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.117 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 1.8 mp0 -52.32 -30.97 30.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.839 -171.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.6 t -72.15 -17.15 18.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.995 0.426 . . . . 0.0 111.308 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.57 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . 2.3 m -95.35 5.06 52.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.766 0.793 . . . . 0.0 110.806 -176.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.674 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 57.7 ttt180 -71.89 134.66 46.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.139 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.646 ' HD3' ' O2B' ' A' ' 999' ' ' COA . 29.1 tpt180 69.25 43.39 1.08 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.754 0.787 . . . . 0.0 110.191 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.57 ' HD3' ' HA ' ' A' ' 72' ' ' THR . 16.3 mtp180 -134.95 1.9 3.05 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.14 -13.6 9.49 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.998 176.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -57.5 -43.98 83.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 117.009 0.405 . . . . 0.0 111.48 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.28 -39.53 92.7 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.406 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.542 ' HA ' HD21 ' A' ' 115' ' ' LEU . 41.1 tt0 -62.43 -47.42 84.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.901 0.382 . . . . 0.0 110.51 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.435 ' O ' ' HG2' ' A' ' 84' ' ' GLU . 81.9 t80 -57.72 -41.75 82.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.686 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' A' ' 42' ' ' ALA . 68.3 tp -56.71 -49.99 73.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.748 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.1 -40.68 98.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.963 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 33.5 mt-10 -65.9 -36.77 84.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.109 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 80' ' ' TYR . 7.3 mm-40 -61.79 -39.69 92.58 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.73 0.3 . . . . 0.0 111.117 177.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 81' ' ' LEU . 58.9 t -60.78 -54.51 34.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.005 0.431 . . . . 0.0 110.545 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.7 mp -74.9 -4.57 38.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.07 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 68.7 ttt180 -80.26 -48.87 12.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.226 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -87.67 -8.29 56.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.271 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 15.9 t30 -45.76 120.65 5.22 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.583 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 7.7 Cg_exo -73.02 -61.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.146 2.564 . . . . 0.0 112.888 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -154.54 35.06 0.69 Allowed Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.153 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.594 HG21 HD22 ' A' ' 56' ' ' LEU . 62.3 t -99.84 107.12 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 51.1 m -111.33 -13.83 13.87 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -174.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 81.8 m -103.82 94.6 5.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.858 0.361 . . . . 0.0 110.056 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -97.26 115.97 28.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.142 0.496 . . . . 0.0 111.434 -175.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.528 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 74.1 t-105 -104.14 114.29 28.42 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.959 175.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.709 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 80.6 mtp -107.35 122.67 47.05 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -176.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -124.61 168.74 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.423 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.85 -68.03 0.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.077 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.99 19.91 10.32 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.845 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.73 -20.05 3.29 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.661 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 95.7 t -67.79 101.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.121 0.486 . . . . 0.0 110.854 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -93.35 -16.56 24.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.263 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.05 54.19 1.87 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.469 176.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -60.17 -46.95 87.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.36 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.16 -49.7 62.23 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.66 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.45 -46.72 96.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.959 0.409 . . . . 0.0 111.269 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.504 ' HE3' ' HB3' ' A' ' 66' ' ' LEU . 78.0 mtp -78.62 -22.01 47.6 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -175.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 96.5 m -67.33 -40.44 85.91 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.465 ' HB1' ' N7A' ' A' ' 999' ' ' COA . . . -65.28 -39.29 92.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.187 0.518 . . . . 0.0 110.021 175.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.452 ' HD1' ' C5B' ' A' ' 999' ' ' COA . 53.7 t80 -58.52 -51.89 67.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.789 175.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.543 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 67.1 mtt -70.98 -27.15 63.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.481 -176.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -66.59 -34.16 77.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.922 0.391 . . . . 0.0 109.983 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.65 -32.9 66.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.75 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.542 HD21 ' HA ' ' A' ' 79' ' ' GLN . 11.0 mp -83.34 -4.8 58.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.004 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.19 41.41 17.64 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.167 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.543 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 59.7 m-85 -92.98 144.24 25.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.857 0.361 . . . . 0.0 110.186 174.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.24 144.67 25.08 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.26 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.7 p -97.46 140.64 31.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.33 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.486 ' HG3' ' HB3' ' A' ' 125' ' ' GLU . 19.3 mm-40 -120.35 -166.77 1.35 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.762 177.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -85.02 96.12 9.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.286 0.565 . . . . 0.0 111.122 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.84 44.93 4.69 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.542 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.35 -171.93 24.94 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.174 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.709 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 15.8 m-90 -116.86 149.56 39.87 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.183 -0.302 . . . . 0.0 110.183 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.486 ' HB3' ' HG3' ' A' ' 120' ' ' GLN . 31.2 tt0 -155.8 132.34 10.33 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -137.07 132.58 34.35 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 93' ' ' SER . 49.0 t -119.67 113.2 20.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.134 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 C-N-CA 121.009 -0.615 . . . . 0.9 112.186 -179.68 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 999' ' ' COA . . . . . 0.674 ' O4A' ' HA ' ' A' ' 73' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 121.198 0.523 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -121.75 155.04 36.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.709 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.7 tp -86.09 98.07 10.66 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.479 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 13.5 m -88.07 89.81 8.14 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.276 -174.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.538 HD11 ' HB3' ' A' ' 40' ' ' TYR . 13.8 tt -96.12 129.41 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.474 0.654 . . . . 0.0 110.767 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mt -129.01 154.59 40.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.323 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.8 ptt-85 -76.74 113.82 14.82 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 173.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.617 HD21 HD11 ' A' ' 19' ' ' LEU . 31.1 tp -77.96 100.84 6.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.997 -174.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.835 ' HA ' HG11 ' A' ' 33' ' ' VAL . 42.2 mt-10 -113.97 -18.95 11.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.902 -175.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.81 113.99 24.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.382 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -107.83 101.4 10.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.632 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.8 p -84.68 171.28 12.51 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.468 ' O ' HG13 ' A' ' 17' ' ' ILE . 6.6 p-10 -60.38 -31.98 70.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.564 0.221 . . . . 0.0 110.561 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -67.27 -51.02 58.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.556 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -60.87 -36.81 80.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.99 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -55.47 -47.39 76.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.159 176.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 13' ' ' ASP . 74.7 mt -65.79 -43.84 93.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.898 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.498 ' O ' HG13 ' A' ' 22' ' ' ILE . 12.9 m-20 -58.76 -52.83 64.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.69 0.281 . . . . 0.0 110.955 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.617 HD11 HD21 ' A' ' 8' ' ' LEU . 95.0 mt -64.74 -38.15 90.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.34 -178.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -74.2 -11.48 60.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.098 0.475 . . . . 0.0 110.56 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -98.27 -28.16 13.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.089 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 18' ' ' ASP . 74.4 mt -65.23 -48.53 83.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.649 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 4.8 m-90 -107.49 92.3 8.25 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 168.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.63 -3.53 4.52 Favored 'Trans proline' 0 N--CA 1.477 0.538 0 C-N-CA 123.648 2.899 . . . . 0.0 114.509 -167.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -134.72 21.26 3.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.986 0.422 . . . . 0.0 110.766 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.649 ' HB2' ' HB2' ' A' ' 23' ' ' TRP . 52.4 t80 -81.9 123.82 29.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.634 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.9 m -64.13 125.42 88.07 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.7 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.6 -31.41 94.36 Favored 'Trans proline' 0 CA--C 1.528 0.203 0 C-N-CA 122.897 2.398 . . . . 0.0 112.48 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 p -71.12 -12.86 61.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.112 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 57.3 m -88.12 4.31 45.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.772 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.5 mt -82.86 86.5 6.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.231 0.539 . . . . 0.0 109.895 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -136.46 127.38 27.58 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.605 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.835 HG11 ' HA ' ' A' ' 9' ' ' GLU . 15.0 p -106.49 131.32 56.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.513 0.673 . . . . 0.0 110.42 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.585 ' HB2' ' H ' ' A' ' 37' ' ' HIS . 14.6 m-20 -130.62 179.28 6.04 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -85.68 -9.47 57.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 172.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -94.63 -34.47 12.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.685 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.585 ' H ' ' HB2' ' A' ' 34' ' ' ASP . 36.0 m80 -120.33 101.0 7.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.768 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 38' ' ' ARG . 48.5 mtt180 -109.11 129.0 55.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.82 0.343 . . . . 0.0 110.275 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.4 HG12 ' HG2' ' A' ' 53' ' ' ARG . 63.7 mt -103.33 116.73 47.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 176.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.538 ' HB3' HD11 ' A' ' 5' ' ' ILE . 78.8 m-85 -97.55 125.67 42.4 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.505 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -109.37 113.4 26.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.56 -177.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . . . -92.68 102.32 14.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.959 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 4' ' ' THR . 19.9 ptt85 -103.37 129.53 50.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.344 0.592 . . . . 0.0 110.408 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -105.46 124.61 49.84 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.544 -177.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 70.91 -56.91 0.61 Allowed 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.957 0.786 . . . . 0.0 110.983 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -154.75 -45.96 0.09 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.325 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -104.92 162.83 12.99 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.12 -170.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.505 HD22 ' HB1' ' A' ' 41' ' ' ALA . 84.0 mt -60.78 132.75 54.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.865 -176.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 37.1 tp -111.76 -30.38 7.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.821 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.579 ' HB2' HG13 ' A' ' 68' ' ' VAL . . . -150.11 147.56 27.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.578 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -135.41 127.36 29.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.68 0.276 . . . . 0.0 110.434 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.418 ' HB ' HD13 ' A' ' 66' ' ' LEU . 7.1 p -131.37 134.01 61.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.03 0.443 . . . . 0.0 110.99 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.558 ' HD3' ' HB2' ' A' ' 65' ' ' SER . 21.4 mtp-105 -110.17 126.69 54.36 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.5 p -120.66 134.62 63.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.422 0.63 . . . . 0.0 111.629 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.9 m -100.71 107.69 19.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.856 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.9 mt -96.33 130.29 43.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.584 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.6 m -135.78 97.47 3.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.191 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.64 -112.56 4.53 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.378 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -106.9 11.98 29.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.586 0.708 . . . . 0.0 110.278 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -125.61 154.59 42.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.344 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.39 132.28 5.24 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.079 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.77 126.43 51.02 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.4 mp -93.46 117.06 29.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.014 0.435 . . . . 0.0 110.701 -175.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.532 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 20.2 m-20 -109.35 118.53 36.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.283 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.558 ' HB2' ' HD3' ' A' ' 53' ' ' ARG . 34.5 m 73.05 107.16 0.07 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.86 0.838 . . . . 0.0 111.797 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.418 HD13 ' HB ' ' A' ' 52' ' ' VAL . 29.9 tp -131.97 130.79 41.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.504 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.2 ttt-85 -144.02 130.48 19.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.819 0.342 . . . . 0.0 110.841 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.579 HG13 ' HB2' ' A' ' 50' ' ' ALA . 13.6 t -107.11 156.42 7.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -53.87 127.0 24.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -57.37 -31.65 65.98 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -168.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -82.87 16.7 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.365 0.602 . . . . 0.0 110.979 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -111.73 16.14 20.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.575 0.702 . . . . 0.0 110.414 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.76 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 99.9 mtt180 -75.45 137.01 40.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.077 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.408 ' HD3' HH11 ' A' ' 74' ' ' ARG . 5.8 ttm180 71.66 27.76 2.88 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.698 177.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -124.98 22.67 7.96 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.443 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.79 -27.21 1.64 Allowed Glycine 0 CA--C 1.521 0.454 0 N-CA-C 114.681 0.632 . . . . 0.0 114.681 172.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.2 t -50.88 -46.46 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -175.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.88 -45.51 94.93 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.604 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.503 ' HG2' ' HG ' ' A' ' 115' ' ' LEU . 51.2 mt-30 -65.57 -41.68 92.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.871 0.367 . . . . 0.0 110.733 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -68.21 -41.92 80.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.585 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.3 tp -48.23 -51.57 24.89 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.331 0.394 . . . . 0.0 111.026 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.438 ' O ' HD13 ' A' ' 86' ' ' LEU . 4.4 mm? -60.07 -52.44 65.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.433 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -72.09 -16.52 62.02 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.726 -175.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.428 ' HG2' HG21 ' A' ' 5' ' ' ILE . 12.5 tp10 -69.77 -42.9 73.2 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 172.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.55 -41.3 88.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.352 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 82' ' ' LEU . 10.9 mp -67.43 -20.38 65.5 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.1 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 54.0 ttp85 -83.65 -41.05 18.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 109.876 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -64.35 -38.94 92.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.729 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -119.11 78.77 17.73 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.662 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.29 2.21 8.55 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.595 2.197 . . . . 0.0 112.319 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.54 10.76 72.47 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.97 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.8 t -107.68 127.26 63.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 m -85.53 -53.36 5.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.805 0.336 . . . . 0.0 111.576 -175.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.5 t -103.83 116.38 32.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.904 0.383 . . . . 0.0 111.09 -174.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -106.9 112.33 25.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.064 176.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -105.51 136.46 45.03 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.121 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.662 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 97.4 mmm -107.27 119.74 40.22 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.65 144.98 25.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.009 0.433 . . . . 0.0 111.766 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.414 ' CG ' HH21 ' A' ' 105' ' ' ARG . 10.6 t70 -80.26 -69.61 0.58 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.908 177.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 64.73 23.17 12.71 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.945 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.4 40.29 0.96 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.905 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.752 HG11 ' HG3' ' A' ' 108' ' ' MET . 77.0 t -88.31 112.48 23.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.84 0.353 . . . . 0.0 110.368 176.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -82.57 -32.27 28.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.677 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -87.49 55.23 3.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.222 0.534 . . . . 0.0 109.859 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.414 HH21 ' CG ' ' A' ' 99' ' ' ASP . 34.7 ttm180 -66.23 -31.11 71.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.043 -176.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.74 -56.39 25.53 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.062 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.5 t -61.48 -42.42 93.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 111.001 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.752 ' HG3' HG11 ' A' ' 102' ' ' VAL . 93.0 mmm -64.46 -38.23 90.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.538 -177.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 61.5 m -67.52 -41.26 84.67 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.411 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.14 88.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.302 0.573 . . . . 0.0 110.245 176.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.41 ' CD2' H132 ' A' ' 999' ' ' COA . 61.2 t80 -61.98 -48.71 79.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.716 175.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.546 ' HG2' ' O ' ' A' ' 108' ' ' MET . 26.4 mmt -62.44 -43.2 99.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.122 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -62.09 -39.33 92.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.204 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.51 -22.11 61.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.112 0.482 . . . . 0.0 110.888 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.503 ' HG ' ' HG2' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -91.05 -2.69 57.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.299 0.571 . . . . 0.0 110.31 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.85 32.61 20.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.03 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.539 ' HB2' ' HB3' ' A' ' 112' ' ' MET . 75.7 m-85 -98.63 139.85 33.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.041 0.448 . . . . 0.0 110.419 176.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.1 m -90.41 144.21 26.02 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.853 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 30.2 p -97.31 115.97 28.64 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.801 0.334 . . . . 0.0 110.438 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -137.02 161.46 36.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.072 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -45.45 106.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.836 0.71 . . . . 0.0 112.188 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 120.93 -21.18 8.42 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.382 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 159.07 -131.69 2.83 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.741 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.662 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 12.8 m-90 -125.98 140.0 52.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.637 0.256 . . . . 0.0 110.504 -177.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -128.46 134.35 48.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.93 -175.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.528 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 84.8 tttt -137.19 92.17 2.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.07 0.462 . . . . 0.0 110.54 173.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 39.9 t -80.22 131.32 35.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.496 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 C-N-CA 120.867 -0.682 . . . . 0.9 111.993 179.132 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 999' ' ' COA . . . . . 0.76 ' O4A' ' HA ' ' A' ' 73' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.2 mmm . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 120.792 0.329 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.47 135.05 33.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.962 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.568 HD22 HG13 ' A' ' 77' ' ' VAL . 52.5 tp -95.72 127.73 41.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.476 -177.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.9 m -89.69 95.32 10.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.898 0.38 . . . . 0.0 110.624 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.593 HG22 ' HA ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -103.49 129.1 55.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.118 0.485 . . . . 0.0 110.052 177.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.417 ' H ' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -130.18 151.9 36.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.888 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -75.29 130.18 38.66 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.466 HD21 HD11 ' A' ' 19' ' ' LEU . 38.6 tp -76.01 59.36 1.29 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.605 0.717 . . . . 0.0 110.165 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -91.39 -13.91 31.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.511 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -112.92 107.21 15.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.834 177.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -88.43 82.94 6.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.296 0.569 . . . . 0.0 110.892 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.8 m -85.66 150.56 24.53 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.303 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.62 -35.72 70.84 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -52.14 -55.77 18.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.526 175.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.449 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 18.8 m-20 -68.51 -41.3 80.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.299 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -61.11 -39.14 88.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -176.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.7 mt -70.13 -41.64 79.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.939 0.4 . . . . 0.0 110.375 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.48 -34.54 78.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.104 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.466 HD11 HD21 ' A' ' 8' ' ' LEU . 73.0 mt -62.39 -39.26 92.63 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.83 174.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -75.13 -10.43 59.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.026 0.441 . . . . 0.0 111.001 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -86.46 -22.94 26.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.24 170.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.36 -45.82 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.228 0.537 . . . . 0.0 109.611 173.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.403 ' HE1' ' HG3' ' A' ' 67' ' ' ARG . 5.8 m-90 -107.6 108.09 61.16 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.39 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -36.13 -56.11 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 124.46 3.44 . . . . 0.0 114.193 -172.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -145.99 87.48 1.76 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.469 0.652 . . . . 0.0 109.797 174.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.666 ' HE2' ' HG ' ' A' ' 31' ' ' LEU . 74.7 t80 -100.04 137.6 38.26 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.195 -176.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 p -74.32 122.21 87.0 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.917 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.35 -4.33 15.03 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.812 2.341 . . . . 0.0 113.106 -176.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 m -65.03 -30.83 71.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.441 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.434 ' HB2' ' OH ' ' A' ' 26' ' ' TYR . 14.5 m -93.88 4.82 53.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.97 0.414 . . . . 0.0 111.547 -176.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.666 ' HG ' ' HE2' ' A' ' 26' ' ' TYR . 43.1 mt -81.89 86.51 6.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.0 110.378 176.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.2 tp60 -135.68 106.0 6.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.405 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.4 t -98.18 135.89 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.132 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -146.23 -173.86 4.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.81 -20.98 66.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.12 0.486 . . . . 0.0 111.084 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -93.11 -55.7 3.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.483 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -84.32 98.13 9.84 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -108.91 121.35 44.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.964 0.411 . . . . 0.0 110.41 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.833 HG12 ' HG2' ' A' ' 53' ' ' ARG . 56.4 mt -98.88 115.39 39.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.215 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -94.05 122.34 36.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.364 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.577 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.11 123.36 48.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.09 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.805 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -91.89 100.4 13.08 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -95.06 115.61 27.64 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.792 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.527 ' HB3' HD13 ' A' ' 49' ' ' LEU . 73.2 t80 -97.28 88.66 4.5 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.62 -65.09 0.36 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.859 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.461 ' HG3' ' N ' ' A' ' 47' ' ' ARG . 4.9 pt-20 -109.16 -51.24 2.9 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -174.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.461 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 28.0 ptt-85 -127.0 173.8 9.36 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.685 -171.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.577 HD22 ' HB1' ' A' ' 41' ' ' ALA . 41.9 mt -87.06 111.25 20.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.348 -175.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' A' ' 44' ' ' PHE . 9.9 mp -88.13 -31.41 19.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.687 0.28 . . . . 0.0 110.68 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.805 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -127.07 131.99 50.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.992 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.12 115.94 21.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.155 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 65' ' ' SER . 11.2 p -126.8 136.55 60.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.098 0.475 . . . . 0.0 111.151 -178.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.833 ' HG2' HG12 ' A' ' 39' ' ' ILE . 99.0 mtt180 -111.77 115.72 29.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.64 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.6 p -107.18 107.46 22.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.849 0.833 . . . . 0.0 110.032 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.9 m -87.5 106.82 18.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.185 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.8 mt -80.63 104.51 11.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.39 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -103.13 106.34 16.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.238 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.86 -96.79 0.61 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -174.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.1 p -128.27 2.68 5.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.909 0.385 . . . . 0.0 110.776 175.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.573 ' HA ' HG13 ' A' ' 92' ' ' VAL . 23.8 mm-40 -104.84 141.59 36.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.721 -175.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.12 112.35 4.38 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.352 -177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.589 ' HA ' ' HB3' ' A' ' 96' ' ' TRP . . . -105.28 111.72 24.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.696 0.284 . . . . 0.0 110.438 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 53' ' ' ARG . 5.2 mp -93.45 110.76 22.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.19 0.519 . . . . 0.0 109.803 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.625 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 1.8 p30 -96.06 -36.14 11.12 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.801 -173.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 21.0 m -120.58 125.29 47.42 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.791 0.329 . . . . 0.0 111.158 -177.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.422 ' HB3' ' H22' ' A' ' 999' ' ' COA . 56.4 tp -145.61 102.72 3.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.052 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.513 ' HD2' ' H71' ' A' ' 999' ' ' COA . 26.2 mmm180 -131.43 113.0 13.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.775 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.526 HG13 ' HB2' ' A' ' 50' ' ' ALA . 2.9 t -110.22 136.04 47.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -87.56 -176.28 5.51 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -174.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -55.33 -27.07 44.67 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 114.399 -1.273 . . . . 0.0 114.387 -165.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.6 t -65.43 -30.57 50.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.168 0.509 . . . . 0.0 111.691 -175.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.587 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 6.5 m -98.77 32.66 2.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.463 0.649 . . . . 0.0 111.16 -173.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 73' ' ' ARG . 40.0 ttm180 -65.27 97.57 0.28 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.886 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.456 ' HG2' ' C2A' ' A' ' 999' ' ' COA . 67.6 mtp180 53.02 80.04 0.11 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.091 170.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 75' ' ' ARG . 9.3 mmt180 -136.61 -54.27 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.239 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.78 -21.67 0.46 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.775 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.587 ' HB ' ' CG2' ' A' ' 72' ' ' THR . 72.6 t -55.85 -44.23 76.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 122.332 0.253 . . . . 0.0 111.499 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -54.11 -49.44 59.37 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.905 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -60.65 -52.32 65.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.454 0.169 . . . . 0.0 110.592 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -58.96 -42.45 89.9 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.128 -176.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 85' ' ' VAL . 63.6 tp -52.56 -53.31 48.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 110.679 178.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.425 ' O ' HD13 ' A' ' 86' ' ' LEU . 46.8 mt -70.31 -45.47 66.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.423 -177.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -62.67 -32.22 73.24 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.071 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -67.69 -41.42 83.64 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 176.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 81' ' ' LEU . 85.1 t -63.09 -46.27 96.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 121.205 0.526 . . . . 0.0 110.645 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.479 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 10.9 mp -70.47 -19.85 62.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.108 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -86.91 -30.22 21.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.191 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -63.62 -52.87 58.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.51 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -118.5 101.17 51.13 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.784 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.91 -6.13 12.28 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.224 2.616 . . . . 0.0 112.035 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.36 48.77 4.1 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.691 -177.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.573 HG13 ' HA ' ' A' ' 60' ' ' GLU . 97.4 t -135.94 134.51 50.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 61.8 p -96.57 -32.83 12.06 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.933 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 77.8 m -130.37 113.98 15.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.891 0.376 . . . . 0.0 111.322 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.479 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 95.6 m95 -90.94 113.49 25.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 173.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.589 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . 2.9 t-105 -96.94 128.09 43.57 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.959 -172.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 1.047 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 13.4 mmt -108.45 115.38 29.99 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.625 ' HB3' ' HA ' ' A' ' 64' ' ' ASP . . . -99.48 173.84 6.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.566 -169.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -129.29 93.04 3.48 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.42 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -92.36 26.85 2.43 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.975 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.5 46.48 0.85 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.423 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 56.8 t -78.01 98.92 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.93 0.395 . . . . 0.0 110.895 -178.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -70.83 -33.66 70.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.114 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -79.41 47.39 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.089 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.97 -57.4 13.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.879 -172.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.29 99.34 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.527 -175.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.9 t -58.39 -47.52 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.0 110.78 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.515 ' SD ' ' H61' ' A' ' 999' ' ' COA . 89.5 mmm -71.01 -32.62 69.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.131 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 80.1 m -59.25 -44.18 92.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.982 0.42 . . . . 0.0 110.041 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.32 -41.32 96.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.893 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -66.32 -52.4 47.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.278 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -56.75 -50.05 73.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.609 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -65.52 -31.8 73.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.619 0.247 . . . . 0.0 111.116 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.65 -31.04 63.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.931 0.396 . . . . 0.0 111.21 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.703 HD23 ' HE1' ' A' ' 117' ' ' PHE . 21.0 tp -88.36 -9.84 51.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.122 0.487 . . . . 0.0 110.542 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.95 36.54 4.96 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.13 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.703 ' HE1' HD23 ' A' ' 115' ' ' LEU . 62.5 m-85 -99.68 102.2 13.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.957 0.378 . . . . 0.0 110.239 174.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.18 143.7 56.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.828 177.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 121' ' ' GLN . 13.9 m -99.28 136.25 39.5 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.034 -174.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -79.18 11.85 2.62 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.787 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.455 ' H ' HG22 ' A' ' 119' ' ' THR . 71.3 mm-40 63.66 29.19 15.09 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.67 0.748 . . . . 0.0 109.549 -172.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -168.85 -64.89 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -109.73 -168.68 20.08 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 169.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.047 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 12.9 m-90 -113.96 144.55 42.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.876 0.838 . . . . 0.0 110.339 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -149.14 114.81 5.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 95' ' ' TRP . 61.7 tttp -96.71 111.67 23.74 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 93' ' ' SER . 56.0 m -88.78 95.31 10.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.736 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.945 -0.645 . . . . 0.9 112.568 179.53 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 999' ' ' COA . . . . . 0.515 ' H61' ' SD ' ' A' ' 108' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.753 0.311 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.415 ' HB3' ' HE2' ' A' ' 2' ' ' LYS . 51.4 mtpt -109.93 164.67 12.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.85 176.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.471 ' HB3' ' CE1' ' A' ' 80' ' ' TYR . 43.1 tp -81.88 99.61 9.14 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.582 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 16.7 m -83.11 96.71 8.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.931 0.396 . . . . 0.0 110.174 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 tt -104.47 123.93 58.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.437 0.637 . . . . 0.0 110.937 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.448 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -131.2 177.95 6.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.314 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -94.8 147.01 23.79 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.7 mt -75.96 98.86 4.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.205 0.526 . . . . 0.0 110.765 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -106.87 -23.94 12.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.154 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -124.97 124.96 43.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.791 -172.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.96 91.92 3.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.783 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -83.33 173.74 11.31 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.558 ' O ' HG13 ' A' ' 17' ' ' ILE . 30.2 t70 -62.6 -52.63 62.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.468 -178.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.529 ' HA ' HD12 ' A' ' 17' ' ' ILE . 52.4 tt0 -72.18 -25.73 61.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.906 0.384 . . . . 0.0 110.316 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -62.48 -42.34 99.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -65.05 -39.09 92.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.217 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.6 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 76.4 mt -59.82 -41.97 87.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.356 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.95 -40.11 83.31 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.251 0.548 . . . . 0.0 110.38 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.69 -31.91 73.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.333 173.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -78.94 -10.1 59.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.221 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 64.3 mttm -82.33 -31.62 29.79 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.1 mt -72.16 -46.25 59.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.783 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 6.5 m-90 -117.97 97.38 50.71 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.798 175.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -58.49 -25.05 72.36 Favored 'Trans proline' 0 N--CA 1.476 0.479 0 C-N-CA 123.174 2.583 . . . . 0.0 113.154 -175.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -143.07 86.16 1.9 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.628 ' HE2' ' HG ' ' A' ' 31' ' ' LEU . 91.9 t80 -125.52 123.2 38.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.446 -176.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.1 m -88.64 138.61 29.75 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.257 171.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.461 ' HB3' HD12 ' A' ' 31' ' ' LEU . 12.5 Cg_endo -55.8 97.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.951 2.434 . . . . 0.0 112.756 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.7 m -108.58 -60.49 1.73 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.19 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.422 ' O ' HD11 ' A' ' 39' ' ' ILE . 29.4 p -97.24 -0.43 46.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.765 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.628 ' HG ' ' HE2' ' A' ' 26' ' ' TYR . 64.3 mt -62.4 -21.11 65.11 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.992 0.425 . . . . 0.0 110.866 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -73.49 98.64 2.82 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.4 m -92.97 151.39 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.382 0.611 . . . . 0.0 110.67 -175.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.403 ' HB3' ' H ' ' A' ' 37' ' ' HIS . 22.2 t70 -151.59 171.97 16.78 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.593 -173.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.96 -29.08 68.83 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -90.13 -33.28 16.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.772 176.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.403 ' H ' ' HB3' ' A' ' 34' ' ' ASP . 32.0 m170 -104.56 99.4 9.08 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.168 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -114.64 139.47 49.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.305 0.574 . . . . 0.0 111.668 -173.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.422 HD11 ' O ' ' A' ' 30' ' ' SER . 55.3 mt -119.48 116.57 51.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.201 171.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -99.61 129.73 45.78 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.536 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -118.19 120.71 38.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.519 -176.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.831 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.09 107.09 18.96 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.071 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 4' ' ' THR . 26.3 ptt180 -96.53 132.62 41.94 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.403 0.62 . . . . 0.0 110.507 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.494 ' HB3' HD13 ' A' ' 49' ' ' LEU . 77.5 t80 -101.1 104.23 15.34 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 176.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 31.3 t30 72.1 -62.19 0.47 Allowed 'General case' 0 C--N 1.331 -0.217 0 O-C-N 124.005 0.816 . . . . 0.0 110.801 -176.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -136.45 -57.72 0.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -94.61 167.29 11.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.975 0.417 . . . . 0.0 111.727 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.536 HD22 ' HB1' ' A' ' 41' ' ' ALA . 35.9 mt -91.21 106.6 18.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.934 -171.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' A' ' 44' ' ' PHE . 10.9 mp -92.93 -15.18 26.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.122 -178.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.831 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -137.21 125.97 23.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.754 0.311 . . . . 0.0 111.017 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -123.67 130.22 52.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.636 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.6 p -135.15 134.05 53.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.057 0.456 . . . . 0.0 111.002 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.632 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 39.5 mtp180 -99.45 134.73 41.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.188 177.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.2 p -139.91 126.76 23.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.611 0.719 . . . . 0.0 111.596 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -108.93 115.22 29.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.756 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.9 mt -85.69 106.73 17.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.247 0.546 . . . . 0.0 110.807 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -93.63 45.96 1.17 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.28 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.54 -105.87 3.05 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.761 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.5 p -83.04 -17.45 43.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.112 0.482 . . . . 0.0 110.991 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -106.01 118.47 36.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.694 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.73 114.07 4.89 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.37 105.1 17.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.902 0.382 . . . . 0.0 111.275 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.414 HD11 ' HE3' ' A' ' 95' ' ' TRP . 5.0 mp -95.16 111.97 23.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.908 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.632 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 10.3 t0 -118.23 138.31 52.42 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.465 ' HB2' ' HD3' ' A' ' 53' ' ' ARG . 20.2 m 68.39 91.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.628 0.727 . . . . 0.0 111.501 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.7 tp -108.14 110.65 22.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.409 171.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.575 ' HA ' ' O5P' ' A' ' 999' ' ' COA . 83.1 mtt-85 -127.3 104.62 8.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.06 0.457 . . . . 0.0 111.302 -176.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 50' ' ' ALA . 8.3 t -100.91 144.69 12.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 172.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -61.83 155.6 22.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.257 0.551 . . . . 0.0 112.363 -174.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -48.72 -41.04 30.69 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.322 -1.308 . . . . 0.0 113.481 -165.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.83 -13.92 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.975 0.417 . . . . 0.0 112.095 -171.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 m -88.02 60.6 5.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.438 0.637 . . . . 0.0 111.607 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.528 ' HA ' ' O4A' ' A' ' 999' ' ' COA . 29.8 ptt-85 -115.99 130.47 56.83 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.675 176.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 74' ' ' ARG . 21.4 mtp180 52.81 53.57 11.91 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.479 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.6 ttt180 -135.98 14.13 3.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.901 0.381 . . . . 0.0 111.257 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.09 -35.64 2.56 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.108 -0.568 . . . . 0.0 113.972 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.453 HG13 HD22 ' A' ' 3' ' ' LEU . 49.6 t -50.26 -41.79 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 122.974 0.51 . . . . 0.0 112.355 -175.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.35 -45.28 93.03 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.145 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -65.69 -49.87 66.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.927 0.394 . . . . 0.0 110.245 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.471 ' CE1' ' HB3' ' A' ' 3' ' ' LEU . 48.0 t80 -54.4 -42.5 70.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.366 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.418 ' O ' HG23 ' A' ' 85' ' ' VAL . 59.3 tp -52.76 -67.65 0.23 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.847 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 82' ' ' LEU . 3.5 mm? -64.1 -41.27 97.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.693 -174.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 87' ' ' ARG . 23.8 mt-10 -61.79 -37.53 84.69 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.804 -177.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -70.77 -31.97 68.93 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.535 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 81' ' ' LEU . 67.1 t -61.58 -45.41 98.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 174.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.551 ' HG ' ' CE2' ' A' ' 95' ' ' TRP . 11.2 mp -67.32 -18.72 65.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.19 178.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 79.3 mtp180 -81.27 -41.17 22.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.057 0.456 . . . . 0.0 110.833 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -80.42 -29.95 37.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.902 -174.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.522 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 0.9 OUTLIER -86.0 117.38 68.6 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.894 0.378 . . . . 0.0 110.181 176.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.522 ' HD3' ' HA ' ' A' ' 89' ' ' ASN . 1.4 Cg_endo -83.45 -73.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.426 2.751 . . . . 0.0 113.877 -172.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.43 53.45 4.67 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.64 -171.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.6 t -124.2 115.2 44.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.7 p -105.57 -24.36 12.6 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.766 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 46.1 t -116.67 106.07 13.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.841 0.353 . . . . 0.0 110.116 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.551 ' CE2' ' HG ' ' A' ' 86' ' ' LEU . 97.7 m95 -93.34 111.98 23.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.108 0.48 . . . . 0.0 110.248 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -111.45 123.85 51.07 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 68.6 mtp -119.03 117.11 27.88 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.22 146.75 24.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.038 0.447 . . . . 0.0 111.82 -171.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.498 ' HB3' ' CZ3' ' A' ' 124' ' ' TRP . 5.8 p-10 -98.8 14.95 26.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.651 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.93 -55.87 29.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.855 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -97.97 44.67 1.78 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.312 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.415 HG11 ' SD ' ' A' ' 108' ' ' MET . 57.3 t -135.48 101.85 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.796 0.331 . . . . 0.0 110.763 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.717 ' HB2' ' S1P' ' A' ' 999' ' ' COA . 2.3 mp0 -67.67 -41.83 83.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.065 0.46 . . . . 0.0 110.766 178.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -84.93 59.51 5.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.362 0.601 . . . . 0.0 110.489 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -63.16 -39.8 95.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.291 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.69 -54.28 38.36 Favored Glycine 0 C--O 1.236 0.243 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.64 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.1 t -59.07 -43.44 89.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.114 0.483 . . . . 0.0 110.562 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.684 ' SD ' ' HE3' ' A' ' 112' ' ' MET . 37.1 ttm -68.06 -27.01 66.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.154 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 91.9 m -62.25 -52.62 63.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.785 0.326 . . . . 0.0 110.161 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.61 84.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.537 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' A' ' 108' ' ' MET . 51.8 t80 -60.26 -57.83 11.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.347 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.684 ' HE3' ' SD ' ' A' ' 108' ' ' MET . 61.8 mtt -67.34 -33.06 74.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.445 -175.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -63.71 -37.62 88.05 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.09 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.71 -30.37 71.04 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.368 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.0 mp -84.13 2.2 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.085 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.16 23.34 32.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.789 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.54 ' HB3' ' HB3' ' A' ' 124' ' ' TRP . 91.4 m-85 -92.84 134.0 35.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.234 0.517 . . . . 0.0 110.426 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.4 m -90.67 145.1 25.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.484 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.42 HG22 ' CD1' ' A' ' 124' ' ' TRP . 70.9 p -97.43 118.23 33.44 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -124.12 -93.79 0.5 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.311 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -154.83 123.47 6.11 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.36 11.66 66.35 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.373 -174.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.9 -152.34 18.05 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.906 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 117' ' ' PHE . 22.7 m-90 -102.13 150.65 23.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.183 -0.508 . . . . 0.0 110.015 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -134.01 134.79 42.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.371 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -137.07 93.09 2.79 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 171.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.2 p -102.78 142.27 34.19 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.586 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.501 0 C-N-CA 120.944 -0.646 . . . . 0.9 112.187 179.445 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 999' ' ' COA . . . . . 0.717 ' S1P' ' HB2' ' A' ' 103' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtm . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.44 0.162 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -109.97 135.13 51.31 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 172.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.511 HD21 ' HB1' ' A' ' 42' ' ' ALA . 51.9 tp -76.63 122.32 24.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.951 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.2 p -90.58 121.86 32.88 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.244 0.545 . . . . 0.0 110.835 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.513 HG22 ' HA ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -117.1 125.94 74.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.376 -178.35 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.1 mm -103.34 151.33 6.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.2 ptt85 -95.36 106.37 18.42 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.2 mt -75.91 83.72 2.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.145 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.812 ' HA ' HG11 ' A' ' 33' ' ' VAL . 30.6 mt-10 -81.81 -26.13 34.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.993 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -147.49 122.94 10.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.71 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -93.34 133.76 36.26 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.935 -173.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 m -77.47 174.3 11.01 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 168.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.478 ' O ' HG13 ' A' ' 17' ' ' ILE . 8.6 p-10 -65.08 -45.52 84.93 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.492 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -63.69 -40.11 95.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.0 110.317 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.416 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 24.1 m-20 -57.07 -50.87 71.44 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.092 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -66.08 -30.47 70.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.83 -177.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 13' ' ' ASP . 84.3 mt -72.62 -39.47 61.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.996 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -69.72 -34.96 74.6 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 15' ' ' ASP . 79.6 mt -64.57 -32.27 73.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.385 173.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -71.31 -23.31 61.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.979 0.419 . . . . 0.0 110.45 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 83.5 mttt -70.67 -38.25 73.75 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 173.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.89 -43.95 52.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.514 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.709 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 5.3 m-90 -121.52 89.2 47.09 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.998 177.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -62.26 -40.03 43.64 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.622 2.215 . . . . 0.0 112.212 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -133.92 83.71 2.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.922 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.709 ' HB2' ' HB3' ' A' ' 23' ' ' TRP . 15.6 t80 -127.89 151.9 48.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.732 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.475 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 66.3 m -63.26 117.75 36.71 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 121.078 0.466 . . . . 0.0 111.673 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 27' ' ' SER . 32.8 Cg_exo -62.04 -36.32 71.41 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.498 2.798 . . . . 0.0 112.866 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.7 m -69.08 -22.91 63.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.907 0.384 . . . . 0.0 111.092 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.3 t -77.76 -8.15 57.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.18 0.514 . . . . 0.0 110.442 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.3 mt -83.78 16.37 2.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.485 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -72.43 128.23 34.98 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.812 HG11 ' HA ' ' A' ' 9' ' ' GLU . 39.8 t -113.22 122.86 68.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.454 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -148.33 -171.0 3.74 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -69.95 -31.41 69.14 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.267 0.556 . . . . 0.0 109.836 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -84.28 -8.14 59.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.52 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -152.48 97.72 2.3 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.355 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 38' ' ' ARG . 50.0 mtt180 -111.98 135.73 52.23 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.209 -178.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.532 HG23 ' HG2' ' A' ' 53' ' ' ARG . 59.0 mt -101.56 118.79 48.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.286 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -100.72 125.31 47.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.306 0.574 . . . . 0.0 110.457 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.567 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -108.14 119.36 39.25 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.1 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . . . -92.11 114.76 27.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.029 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.458 ' HB3' HD23 ' A' ' 48' ' ' LEU . 34.2 ptt180 -109.72 132.4 54.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.575 0.702 . . . . 0.0 111.219 -175.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.44 ' O ' ' HB3' ' A' ' 45' ' ' ASN . 75.6 t80 -98.1 102.84 14.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.078 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 10.4 t30 74.31 -43.12 0.52 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.719 0.637 . . . . 0.0 111.435 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -159.83 -56.12 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.023 0.44 . . . . 0.0 111.332 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 47' ' ' ARG . 51.3 mtt180 -85.73 153.22 22.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.007 -171.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.567 HD22 ' HB1' ' A' ' 41' ' ' ALA . 52.0 mt -71.06 122.75 20.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.855 -175.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.4 tp -105.29 -15.08 15.15 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.035 0.445 . . . . 0.0 110.206 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . . . -154.48 150.07 27.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.458 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -135.24 125.52 26.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.869 0.366 . . . . 0.0 110.666 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.35 138.29 48.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.445 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.532 ' HG2' HG23 ' A' ' 39' ' ' ILE . 21.2 mtm180 -118.18 133.37 55.96 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.1 p -120.78 126.15 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.631 0.729 . . . . 0.0 111.176 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.7 m -90.69 94.58 9.75 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.535 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.11 92.15 5.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.456 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.6 m -93.29 84.42 4.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.823 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.45 -101.39 0.83 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.699 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.4 p -112.85 6.98 18.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.154 0.502 . . . . 0.0 110.488 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -101.14 111.75 24.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.41 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.98 94.06 1.7 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.711 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.92 123.39 45.05 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.806 -0.232 . . . . 0.0 110.517 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.42 HD13 ' SD ' ' A' ' 97' ' ' MET . 6.8 mp -93.45 118.84 31.82 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -101.15 -12.8 18.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.673 -170.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.4 m -155.31 133.4 11.54 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.076 -0.249 . . . . 0.0 111.28 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.9 tp -148.44 115.93 6.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.865 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.425 ' HG2' ' C5P' ' A' ' 999' ' ' COA . 24.6 mtp180 -138.71 132.6 31.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.425 173.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 50' ' ' ALA . 3.5 t -103.85 152.01 6.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 172.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -71.93 154.68 41.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.612 0.244 . . . . 0.0 110.787 -175.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -43.03 -47.25 5.81 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -170.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.3 m -81.05 26.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -171.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.83 29.52 6.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.044 0.449 . . . . 0.0 111.417 -177.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -67.11 108.96 2.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.825 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.473 ' HA ' ' O2A' ' A' ' 999' ' ' COA . 20.2 mtp180 56.23 42.27 28.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.141 0.496 . . . . 0.0 110.666 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.4 ttt180 -108.59 19.36 19.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.103 -172.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.51 -40.51 2.42 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.862 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.4 t -46.81 -46.72 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 123.21 0.604 . . . . 0.0 112.581 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -56.68 -41.73 90.26 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.11 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.518 ' HG3' ' HG ' ' A' ' 115' ' ' LEU . 52.7 tt0 -69.36 -38.53 78.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.996 0.426 . . . . 0.0 110.356 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.479 ' HE2' ' H ' ' A' ' 3' ' ' LEU . 74.8 t80 -68.56 -38.39 80.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.184 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.444 HD13 ' HB2' ' A' ' 42' ' ' ALA . 50.2 tp -53.61 -56.78 14.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.211 177.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.454 ' O ' HD13 ' A' ' 86' ' ' LEU . 4.4 mm? -60.15 -45.72 92.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -67.84 -37.51 81.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.369 -176.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -58.78 -46.99 86.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.797 0.332 . . . . 0.0 110.539 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 73.3 t -63.82 -46.36 94.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 82' ' ' LEU . 11.0 mp -69.09 -29.06 67.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.312 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.0 ttt-85 -75.27 -30.75 60.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.107 0.48 . . . . 0.0 109.721 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -75.94 -33.62 59.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.052 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -115.8 70.78 3.65 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.344 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.33 -6.7 13.84 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.289 1.992 . . . . 0.0 112.051 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.07 -14.97 81.73 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.947 -0.645 . . . . 0.0 112.153 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.8 t -87.78 113.36 24.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.962 0.411 . . . . 0.0 110.203 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 127' ' ' CYS . 2.5 p -89.5 -22.91 22.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.426 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.4 m -108.05 99.3 8.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.824 0.345 . . . . 0.0 111.363 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -109.05 126.13 52.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.272 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.426 ' HE3' ' HG2' ' A' ' 125' ' ' GLU . 51.9 t-105 -115.58 127.82 55.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.198 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.861 ' HB2' ' HB2' ' A' ' 124' ' ' TRP . 87.5 mmm -108.0 120.76 43.23 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.96 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.79 142.7 47.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.45 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.847 ' HB2' ' HB ' ' A' ' 102' ' ' VAL . 4.6 p-10 -86.61 -35.55 19.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.107 178.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.54 22.87 12.58 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.955 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 125.39 37.21 0.53 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.646 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.847 ' HB ' ' HB2' ' A' ' 99' ' ' ASP . 76.8 t -102.22 125.68 56.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -84.18 -35.81 23.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.632 -177.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -83.18 67.67 9.29 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.486 0.66 . . . . 0.0 110.886 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -72.55 -17.73 61.7 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.614 176.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.08 -57.86 12.47 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.048 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.16 -43.56 97.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.623 0.249 . . . . 0.0 111.15 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.618 ' SD ' HG11 ' A' ' 102' ' ' VAL . 50.6 mtp -71.11 -31.04 67.27 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.008 -175.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.716 HG23 HG21 ' A' ' 119' ' ' THR . 36.6 m -68.92 -43.95 74.11 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.243 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.12 -38.78 87.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.198 0.523 . . . . 0.0 110.287 176.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.652 ' HA ' ' O4B' ' A' ' 999' ' ' COA . 31.4 t80 -61.4 -51.53 68.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.33 176.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.491 ' HB3' ' HB2' ' A' ' 117' ' ' PHE . 66.1 mtt -75.93 -34.5 59.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.922 -174.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -74.1 -22.61 59.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.888 0.375 . . . . 0.0 110.572 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.05 -19.22 25.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.041 0.448 . . . . 0.0 110.63 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.518 ' HG ' ' HG3' ' A' ' 79' ' ' GLN . 6.1 tt -80.32 -55.17 5.08 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 146.93 46.74 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.401 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 126' ' ' LYS . 97.2 m-85 -121.33 143.01 49.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.802 0.335 . . . . 0.0 110.274 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.9 m -81.09 121.72 26.44 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.716 HG21 HG23 ' A' ' 109' ' ' THR . 67.2 p -97.38 130.43 44.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.141 0.496 . . . . 0.0 111.054 -173.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -129.36 176.09 8.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.53 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -81.71 87.95 6.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.081 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 129.92 -50.77 0.88 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.292 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -135.32 178.92 18.22 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.506 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.861 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 8.2 m-90 -127.3 140.98 51.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.426 ' HG2' ' HE3' ' A' ' 96' ' ' TRP . 42.3 mt-10 -129.03 150.79 50.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.933 0.397 . . . . 0.0 111.452 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.55 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 78.8 tttt -136.15 121.8 19.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.766 171.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 93' ' ' SER . 53.9 t -129.93 108.98 10.53 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.23 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 121.037 -0.601 . . . . 0.9 112.13 178.315 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 999' ' ' COA . . . . . 0.652 ' O4B' ' HA ' ' A' ' 111' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_